dl_datetime,drug,drug_link
2020-09-18T04:24:24Z,(61)Cu-ATSM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/61cu-atsm
2020-09-18T04:24:24Z,[18F]-labeled substance P antagonist receptor quantifier,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-substance-p-antagonist-receptor-quantifier
2020-09-18T04:24:24Z,[18F]-ML-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-ml-10
2020-09-18T04:24:24Z,[18F]L-FAC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac
2020-09-18T04:24:24Z,[18F]L-FMAC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fmac
2020-09-18T04:24:24Z,[F-18]HX4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18hx4
2020-09-18T04:24:24Z,[F18]VM4-037,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f18vm4-037
2020-09-18T04:24:24Z,[Leu15] gastrin-17,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797962
2020-09-18T04:24:24Z,11beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792667
2020-09-18T04:24:24Z,11C topotecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11c-topotecan
2020-09-18T04:24:24Z,123-I-MIP-1095,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/123-i-mip-1095
2020-09-18T04:24:24Z,14C BMS-275183,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/14c-bms-275183
2020-09-18T04:24:24Z,"16, 16-dimethyl prostaglandin E2",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/16-16-dimethyl-prostaglandin-e2
2020-09-18T04:24:24Z,18-F-fluoroacetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18-f-fluoroacetate
2020-09-18T04:24:24Z,18F-FHBG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fhbg
2020-09-18T04:24:24Z,18F-fluoromisonidazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoromisonidazole
2020-09-18T04:24:24Z,18F-labeled mini-PEG spacered RGD dimer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-labeled-mini-peg-spacered-rgd-dimer
2020-09-18T04:24:24Z,"2-0, 3-0 desulfated heparin",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-0-3-0-desulfated-heparin
2020-09-18T04:24:24Z,2-fluorofucose-containing SGN-2FF,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose-containing-sgn-2ff
2020-09-18T04:24:24Z,2-fluoropropionyl-labeled pegylated dimeric RGD peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluoropropionyl-labeled-pegylated-dimeric-rgd-peptide
2020-09-18T04:24:24Z,2-hydroxyflutamide depot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyflutamide-depot
2020-09-18T04:24:24Z,2-hydroxyoleic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-hydroxyoleic-acid
2020-09-18T04:24:24Z,2-methoxyestradiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol
2020-09-18T04:24:24Z,2'-F-ara-deoxyuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-f-ara-deoxyuridine
2020-09-18T04:24:24Z,2G-1 TCR retroviral vector-transduced lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2g-1-tcr-retroviral-vector-transduced-lymphocytes
2020-09-18T04:24:24Z,3-deazauridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-deazauridine
2020-09-18T04:24:24Z,"3,4-methylenedioxymethamphetamine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/34-methylenedioxymethamphetamine
2020-09-18T04:24:24Z,3'-aminomethyl nicotine-P. aeruginosa r-exoprotein A conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-aminomethyl-nicotine-p-aeruginosa-r-exoprotein-a-conjugate-vaccine
2020-09-18T04:24:24Z,3'-C-ethynylcytidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-c-ethynylcytidine
2020-09-18T04:24:24Z,3D-expanded placenta-derived cells PLX-R18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18
2020-09-18T04:24:24Z,3M Cavilon Advanced Skin Protectant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797360
2020-09-18T04:24:24Z,4-[18F]fluoroglutamic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653979
2020-09-18T04:24:24Z,4-nitroestrone 3-methyl ether,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-nitroestrone-3-methyl-ether
2020-09-18T04:24:24Z,4-peptide melanoma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-peptide-melanoma-vaccine
2020-09-18T04:24:24Z,4-thio-2-deoxycytidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-thio-2-deoxycytidine
2020-09-18T04:24:24Z,4'-iodo-4'-deoxydoxorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-iodo-4-deoxydoxorubicin
2020-09-18T04:24:24Z,4H11-28z/fIL-12/EGFRt-expressing autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4h11-28z-fil-12-egfrt-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,4SCAR-GD2-modified T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4scar-gd2-modified-t-lymphocytes
2020-09-18T04:24:24Z,5-[18F]fluorouracil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-18ffluorouracil
2020-09-18T04:24:24Z,5-aza-4’-thio-2’-deoxycytidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794175
2020-09-18T04:24:24Z,5-FITC-labeled colon-heptapeptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-colon-heptapeptide
2020-09-18T04:24:24Z,5-FITC-labeled GI-heptapeptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fitc-labeled-gi-heptapeptide
2020-09-18T04:24:24Z,5-fluoro-2-deoxycytidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluoro-2-deoxycytidine
2020-09-18T04:24:24Z,5-fluorouracil/salicylic acid topical solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution
2020-09-18T04:24:24Z,5-HT4 agonist TAK-954,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799096
2020-09-18T04:24:24Z,50% oxygen/50% nitrous oxide premix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/50pct-oxygen-50pct-nitrous-oxide-premix
2020-09-18T04:24:24Z,6 melanoma helper peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794177
2020-09-18T04:24:24Z,6-azauridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine
2020-09-18T04:24:24Z,"6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatases isoform 3 inhibitor ACT-PFK-158",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757225
2020-09-18T04:24:24Z,"6,8-bis(benzylthio)octanoic acid",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid
2020-09-18T04:24:24Z,7-cyanoquinocarcinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-cyanoquinocarcinol
2020-09-18T04:24:24Z,7-hydroxystaurosporine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-hydroxystaurosporine
2020-09-18T04:24:24Z,7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521
2020-09-18T04:24:24Z,8-hydroxyquinoline sulfate ointment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment
2020-09-18T04:24:24Z,851B gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/851b-gel
2020-09-18T04:24:24Z,852A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/852a
2020-09-18T04:24:24Z,A-101 topical solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792737
2020-09-18T04:24:24Z,A-Hydrocort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate
2020-09-18T04:24:24Z,A2A receptor antagonist EOS100850,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801361
2020-09-18T04:24:24Z,abacavir sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abacavir-sulfate
2020-09-18T04:24:24Z,abagovomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abagovomab
2020-09-18T04:24:24Z,abaloparatide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359
2020-09-18T04:24:24Z,abarelix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abarelix
2020-09-18T04:24:24Z,abatacept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept
2020-09-18T04:24:24Z,ABBV-221,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abbv-221
2020-09-18T04:24:24Z,Abegrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab
2020-09-18T04:24:24Z,Abelcet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b
2020-09-18T04:24:24Z,abemaciclib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib
2020-09-18T04:24:24Z,Aberel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
2020-09-18T04:24:24Z,abexinostat tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abexinostat
2020-09-18T04:24:24Z,abiraterone acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate
2020-09-18T04:24:24Z,Ablavar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium
2020-09-18T04:24:24Z,Abraxane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation
2020-09-18T04:24:24Z,absorbable adhesion barrier gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-adhesion-barrier-gel
2020-09-18T04:24:24Z,absorbable fibrin sealant patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch
2020-09-18T04:24:24Z,absorbable gelatin sponge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-gelatin-sponge
2020-09-18T04:24:24Z,absorbable modified polymer hemostatic powder,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder
2020-09-18T04:24:24Z,ABT-510,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-510
2020-09-18T04:24:24Z,ABT-751,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abt-751
2020-09-18T04:24:24Z,ABVD regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen
2020-09-18T04:24:24Z,ABVE regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-regimen
2020-09-18T04:24:24Z,ABVE-PC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abve-pc-regimen
2020-09-18T04:24:24Z,AC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-regimen
2020-09-18T04:24:24Z,AC-T regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-t-regimen
2020-09-18T04:24:24Z,acadesine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acadesine
2020-09-18T04:24:24Z,acai berry juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acai-berry-juice
2020-09-18T04:24:24Z,acalabrutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib
2020-09-18T04:24:24Z,acalisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p110beta-delta-pi3k-inhibitor-gs-9820
2020-09-18T04:24:24Z,acarbose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose
2020-09-18T04:24:24Z,Accolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zafirlukast
2020-09-18T04:24:24Z,Accutane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin
2020-09-18T04:24:24Z,Acelarin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031
2020-09-18T04:24:24Z,acelullar cadaveric dermal matrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix
2020-09-18T04:24:24Z,acenocoumarol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acenocoumarol
2020-09-18T04:24:24Z,Aceon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine
2020-09-18T04:24:24Z,acetaminophen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen
2020-09-18T04:24:24Z,acetic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetic-acid
2020-09-18T04:24:24Z,acetohexamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide
2020-09-18T04:24:24Z,acetylcysteine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine
2020-09-18T04:24:24Z,acetylsalicylic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid
2020-09-18T04:24:24Z,acetylsalicylic acid/simvastatin/atenolol/ramipril/thiazide capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid-simvastatin-atenolol-ramipril-thiazide-capsule
2020-09-18T04:24:24Z,Achromycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-hydrochloride
2020-09-18T04:24:24Z,Aciphex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium
2020-09-18T04:24:24Z,acitretin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin
2020-09-18T04:24:24Z,acivicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acivicin
2020-09-18T04:24:24Z,aclarubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin
2020-09-18T04:24:24Z,Acnestrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,ACNU 50,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine
2020-09-18T04:24:24Z,acodazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acodazole
2020-09-18T04:24:24Z,acoustic coupling fluid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoustic-coupling-fluid
2020-09-18T04:24:24Z,acridine carboxamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acridine-carboxamide
2020-09-18T04:24:24Z,Actemra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab
2020-09-18T04:24:24Z,ActHIB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine
2020-09-18T04:24:24Z,Actigall,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol
2020-09-18T04:24:24Z,Actimmune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b
2020-09-18T04:24:24Z,Actinex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol
2020-09-18T04:24:24Z,actinium Ac 225 lintuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-lintuzumab
2020-09-18T04:24:24Z,actinium Ac 225-FPI-1434,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797340
2020-09-18T04:24:24Z,actinium Ac-225 anti-PSMA monoclonal antibody J591,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793676
2020-09-18T04:24:24Z,Actiq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate
2020-09-18T04:24:24Z,Activase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase
2020-09-18T04:24:24Z,activated marrow infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activated-marrow-infiltrating-lymphocytes
2020-09-18T04:24:24Z,Activella,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-norethindrone-acetate-tablet
2020-09-18T04:24:24Z,ActiVin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ih636-grape-seed-proanthocyanidin-extract
2020-09-18T04:24:24Z,activin type 2B receptor Fc fusion protein STM 434,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-2b-receptor-fc-fusion-protein-stm-434
2020-09-18T04:24:24Z,activin type IIA receptor Fc fusion protein KER-050,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801849
2020-09-18T04:24:24Z,ACTolog IMA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101
2020-09-18T04:24:24Z,Actonel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium
2020-09-18T04:24:24Z,ACTOplus Met XR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformide-hydrochloride-pioglitazone-hydrochloride-extended-release-tablet
2020-09-18T04:24:24Z,Actos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pioglitazone-hydrochloride
2020-09-18T04:24:24Z,acyclic nucleoside phosphonate prodrug ABI-1968,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793142
2020-09-18T04:24:24Z,acyclovir sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/531923
2020-09-18T04:24:24Z,acyclovir sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium
2020-09-18T04:24:24Z,Aczone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone
2020-09-18T04:24:24Z,Aczone Gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone-gel-5pct
2020-09-18T04:24:24Z,Ad-hCMV-Flt3L,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-hcmv-flt3l
2020-09-18T04:24:24Z,Ad-hCMV-TK,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-hcmv-tk
2020-09-18T04:24:24Z,Ad-ISF35,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35
2020-09-18T04:24:24Z,Ad-REIC/DKK3 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-reic-dkk3-vaccine
2020-09-18T04:24:24Z,Ad-RTS-hIL-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792151
2020-09-18T04:24:24Z,Ad-sig-hMUC-1/ecdCD40L vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-sig-hmuc-1-ecdcd40l-vaccine
2020-09-18T04:24:24Z,"Ad5 [E1-, E2b-]-HER2/Neu vaccine ETBX-021",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793072
2020-09-18T04:24:24Z,Ad5-CMV-NIS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-cmv-nis
2020-09-18T04:24:24Z,Ad5-SGE-REIC/Dkk-3 MTG-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800680
2020-09-18T04:24:24Z,Ad5-survivin-transduced autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-survivin-transduced-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,Ad5-yCD/mutTK(SR39)rep-ADP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-adp
2020-09-18T04:24:24Z,Ad5-yCD/mutTKSR39rep-hIL12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-hil12
2020-09-18T04:24:24Z,Ad5.SSTR/TK.RGD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5sstr-tkrgd
2020-09-18T04:24:24Z,Ad5CMV-p53 gene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene
2020-09-18T04:24:24Z,Ad5F35-LMP1/LMP2-transduced autologous dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5f35-lmp1-lmp2-transduced-autologous-dendritic-cells
2020-09-18T04:24:24Z,Adacel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed
2020-09-18T04:24:24Z,adagloxad simolenin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin
2020-09-18T04:24:24Z,adalimumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab
2020-09-18T04:24:24Z,Adanon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride
2020-09-18T04:24:24Z,Adapin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride
2020-09-18T04:24:24Z,adavosertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-inhibitor-azd1775
2020-09-18T04:24:24Z,Adcetris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin
2020-09-18T04:24:24Z,Adderall,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine
2020-09-18T04:24:24Z,Adderall XR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine
2020-09-18T04:24:24Z,ADE regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ade-regimen
2020-09-18T04:24:24Z,adecatumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adecatumumab
2020-09-18T04:24:24Z,adefovir dipivoxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adefovir-dipivoxil
2020-09-18T04:24:24Z,adenosine A2A receptor antagonist NIR178,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793151
2020-09-18T04:24:24Z,adenosine A2A receptor antagonist PBF-509,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-pbf-509
2020-09-18T04:24:24Z,adenosine A2A receptor antagonist/phosphodiesterase 10A PBF-999,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796763
2020-09-18T04:24:24Z,adenosine A2A/A2B receptor antagonist AB928,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797798
2020-09-18T04:24:24Z,adenosine A2B receptor antagonist PBF-1129,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793680
2020-09-18T04:24:24Z,adenosine A3 receptor agonist CF102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a3-receptor-agonist-cf102
2020-09-18T04:24:24Z,adenosine-A2A receptor antagonist CPI-444,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-cpi-444
2020-09-18T04:24:24Z,adenovector encoding MDA7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovector-encoding-mda7
2020-09-18T04:24:24Z,adenovector-transduced AP1903-inducible MyD88/CD40-expressing autologous PSMA-specific prostate cancer vaccine BPX-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/748904
2020-09-18T04:24:24Z,adenoviral brachyury vaccine ETBX-051,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-brachyury-vaccine-etbx-051
2020-09-18T04:24:24Z,adenoviral cancer vaccine PF-06936308,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795350
2020-09-18T04:24:24Z,adenoviral MUC1 vaccine ETBX-061,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-muc1-vaccine-etbx-061
2020-09-18T04:24:24Z,adenoviral PSA vaccine ETBX-071,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795436
2020-09-18T04:24:24Z,adenoviral tumor-specific neoantigen priming vaccine GAd-209-FSP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799098
2020-09-18T04:24:24Z,adenoviral tumor-specific neoantigen priming vaccine GRT-C901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478
2020-09-18T04:24:24Z,adenoviral vector Ad5-CEA(6D) vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine
2020-09-18T04:24:24Z,adenoviral vector encoding VEGF-C LX-1101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798716
2020-09-18T04:24:24Z,adenoviral-transduced hIL-12-expressing autologous dendritic cells INXN-3001 plus activator ligand INXN-1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/733561
2020-09-18T04:24:24Z,adenovirus 5-human guanylyl cyclase C-PADRE vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-5-human-guanylyl-cyclase-c-padre-vaccine
2020-09-18T04:24:24Z,adenovirus B7-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-b7-1
2020-09-18T04:24:24Z,adenovirus encoding E.coli PNP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp
2020-09-18T04:24:24Z,adenovirus encoding human aquaporin-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-human-aquaporin-1
2020-09-18T04:24:24Z,adenovirus encoding rat Her-2/neu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-rat-her-2-neu
2020-09-18T04:24:24Z,adenovirus encoding recombinant human endostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-recombinant-human-endostatin
2020-09-18T04:24:24Z,"adenovirus encoding tyrosinase, MART-1/MAGE-A6-transduced autologous dendritic cell vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735883
2020-09-18T04:24:24Z,adenovirus HER2-transduced autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-her2-transduced-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,adenovirus vector,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-vector
2020-09-18T04:24:24Z,adenovirus-expressing mutant HPV E6/E7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797169
2020-09-18T04:24:24Z,adenovirus-expressing TLR5/TLR5 agonist nanoformulation M-VM3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-tlr5-tlr5-agonist-nanoformulation-m-vm3
2020-09-18T04:24:24Z,adenovirus-mediated human interleukin-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12
2020-09-18T04:24:24Z,adenovirus-mediated human interleukin-12 INXN-2001 plus veledimex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-mediated-human-interleukin-12-inxn-2001-plus-veledimex
2020-09-18T04:24:24Z,adenovirus-p53 transduced dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-p53-transduced-dendritic-cell-vaccine
2020-09-18T04:24:24Z,adenovirus-PSA prostate cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-psa-prostate-cancer-vaccine
2020-09-18T04:24:24Z,adenovirus/cytomegalovirus/Epstein-Barr virus-specific allogeneic cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/727131
2020-09-18T04:24:24Z,AdGMCAIX-transduced autologous dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adgmcaix-transduced-autologous-dendritic-cells
2020-09-18T04:24:24Z,ADH-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adh-1
2020-09-18T04:24:24Z,adipose-derived expanded mesenchymal stem cells SCM-010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798284
2020-09-18T04:24:24Z,adipose-derived regenerative cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-regenerative-cells
2020-09-18T04:24:24Z,adipose-derived stromal vascular fraction cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-stromal-vascular-fraction-cells
2020-09-18T04:24:24Z,ado trastuzumab emtansine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine
2020-09-18T04:24:24Z,adozelesin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adozelesin
2020-09-18T04:24:24Z,adrenocorticotropic hormone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrenocorticotropic-hormone
2020-09-18T04:24:24Z,AdRTVP-1-transduced prostate cancer cell-based vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adrtvp-1-transduced-prostate-cancer-cell-based-vaccine
2020-09-18T04:24:24Z,ADVEXIN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5cmv-p53-gene
2020-09-18T04:24:24Z,AE37 peptide/GM-CSF vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ae37-peptide-gm-csf-vaccine
2020-09-18T04:24:24Z,AEE788,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aee788
2020-09-18T04:24:24Z,AEG35156,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aeg35156
2020-09-18T04:24:24Z,Aeroseb-HC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,aerosol gemcitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793934
2020-09-18T04:24:24Z,aerosol sargramostim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosol-sargramostim
2020-09-18T04:24:24Z,aerosolized aldesleukin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-aldesleukin
2020-09-18T04:24:24Z,aerosolized liposomal rubitecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosolized-liposomal-rubitecan
2020-09-18T04:24:24Z,Aerrane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane
2020-09-18T04:24:24Z,Aezea®,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen
2020-09-18T04:24:24Z,afamelanotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamelanotide
2020-09-18T04:24:24Z,afatinib dimaleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate
2020-09-18T04:24:24Z,Affinitac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521
2020-09-18T04:24:24Z,Affinitak,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521
2020-09-18T04:24:24Z,afimoxifene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afimoxifene
2020-09-18T04:24:24Z,Afinitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus
2020-09-18T04:24:24Z,Afinitor Disperz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus
2020-09-18T04:24:24Z,Afinitor Disperz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-tablets-for-oral-suspension
2020-09-18T04:24:24Z,Aflodac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac
2020-09-18T04:24:24Z,AFP gene hepatocellular carcinoma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afp-gene-hepatocellular-carcinoma-vaccine
2020-09-18T04:24:24Z,AFP464,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afp464
2020-09-18T04:24:24Z,afuresertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afuresertib
2020-09-18T04:24:24Z,AG-024322,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ag-024322
2020-09-18T04:24:24Z,Agaricus blazei Murill extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agaricus-blazei-murill-extract
2020-09-18T04:24:24Z,agatolimod sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agatolimod-sodium
2020-09-18T04:24:24Z,agerafenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792523
2020-09-18T04:24:24Z,aglatimagene besadenovec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec
2020-09-18T04:24:24Z,agonistic anti-CD40 monoclonal antibody ADC-1013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-cd40-monoclonal-antibody-adc-1013
2020-09-18T04:24:24Z,agonistic anti-OX40 monoclonal antibody INCAGN01949,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785256
2020-09-18T04:24:24Z,agonistic anti-OX40 monoclonal antibody MEDI6383,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6383
2020-09-18T04:24:24Z,agonistic anti-OX40 monoclonal antibody MEDI6469,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6469
2020-09-18T04:24:24Z,Agriflu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
2020-09-18T04:24:24Z,Agrylin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride
2020-09-18T04:24:24Z,AIM2(-1)/HT001(-1)/TAF1B(-1) frameshift peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aim2-1-ht001-1-taf1b-1-frameshift-peptide-vaccine
2020-09-18T04:24:24Z,AK 3012,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ak-3012
2020-09-18T04:24:24Z,Aknoten,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
2020-09-18T04:24:24Z,AKR1C3-activated prodrug OBI-3424,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795700
2020-09-18T04:24:24Z,AKT 1/2 inhibitor BAY1125976,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-bay1125976
2020-09-18T04:24:24Z,Akt antisense oligonucleotide RX-0201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-antisense-oligonucleotide-rx-0201
2020-09-18T04:24:24Z,AKT inhibitor ARQ 092,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-arq-092
2020-09-18T04:24:24Z,Akt inhibitor GSK2141795,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-gsk2141795
2020-09-18T04:24:24Z,Akt inhibitor LY2780301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-ly2780301
2020-09-18T04:24:24Z,Akt inhibitor MK2206,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-mk2206
2020-09-18T04:24:24Z,Akt inhibitor SR13668,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-sr13668
2020-09-18T04:24:24Z,Akt/ERK inhibitor ONC201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-erk-inhibitor-onc201
2020-09-18T04:24:24Z,Akten,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride-ophthalmic-gel
2020-09-18T04:24:24Z,Akti-1/2 inhibitor treated tumor infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akti-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes
2020-09-18T04:24:24Z,Akynzeo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-and-palonosetron-hydrochloride
2020-09-18T04:24:24Z,Alantel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799796
2020-09-18T04:24:24Z,albendazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650
2020-09-18T04:24:24Z,Albenza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650
2020-09-18T04:24:24Z,albumin-binding cisplatin prodrug BTP-114,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114
2020-09-18T04:24:24Z,albuterol sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate
2020-09-18T04:24:24Z,alcohol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol
2020-09-18T04:24:24Z,Aldactone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone
2020-09-18T04:24:24Z,Aldara,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod
2020-09-18T04:24:24Z,aldesleukin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin
2020-09-18T04:24:24Z,aldoxorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldoxorubicin
2020-09-18T04:24:24Z,Alecensa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib
2020-09-18T04:24:24Z,alectinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib
2020-09-18T04:24:24Z,alefacept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept
2020-09-18T04:24:24Z,alemtuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab
2020-09-18T04:24:24Z,alendronate sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium
2020-09-18T04:24:24Z,Alesse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,Alfenta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride
2020-09-18T04:24:24Z,alfentanil hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfentanil-hydrochloride
2020-09-18T04:24:24Z,Alferon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa
2020-09-18T04:24:24Z,alflutinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate
2020-09-18T04:24:24Z,alfuzosin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfuzosin-hydrochloride
2020-09-18T04:24:24Z,algenpantucel-L,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l
2020-09-18T04:24:24Z,Alimta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium
2020-09-18T04:24:24Z,Alinia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitazoxanide
2020-09-18T04:24:24Z,Aliqopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride
2020-09-18T04:24:24Z,alisertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib
2020-09-18T04:24:24Z,alitretinoin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin
2020-09-18T04:24:24Z,ALK Inhibitor ASP3026,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026
2020-09-18T04:24:24Z,ALK inhibitor PLB 1003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792707
2020-09-18T04:24:24Z,ALK inhibitor RO5424802,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-ro5424802
2020-09-18T04:24:24Z,ALK inhibitor WX-0593,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794180
2020-09-18T04:24:24Z,ALK-FAK inhibitor CEP-37440,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-inhibitor-cep-37440
2020-09-18T04:24:24Z,ALK/c-Met inhibitor TQ-B3139,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792652
2020-09-18T04:24:24Z,ALK/FAK/Pyk2 inhibitor CT-707,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-pyk2-inhibitor-ct-707
2020-09-18T04:24:24Z,ALK/TRK inhibitor TSR-011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-trk-inhibitor-tsr-011
2020-09-18T04:24:24Z,Alka Seltzer Gold,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate-potassium-bicarbonate-anhydrous-citric-acid
2020-09-18T04:24:24Z,Alkagin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/708408
2020-09-18T04:24:24Z,Alkeran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan
2020-09-18T04:24:24Z,alkotinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799671
2020-09-18T04:24:24Z,alkylglycerol/rosemary capsules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795374
2020-09-18T04:24:24Z,Allegra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexofenadine-hydrochloride
2020-09-18T04:24:24Z,AllerNaze,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide
2020-09-18T04:24:24Z,alloantigen-specific allogeneic type 1 regulatory T cells T-allo10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alloantigen-specific-allogeneic-type-1-regulatory-t-cells-t-allo10
2020-09-18T04:24:24Z,allodepleted haploidentical T cells expressing inducible Caspase 9,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-haploidentical-t-cells-expressing-inducible-caspase-9
2020-09-18T04:24:24Z,allodepleted T cell immunotherapeutic ATIR101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101
2020-09-18T04:24:24Z,Allodepleted T-cell ImmunotheRapeutics,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101
2020-09-18T04:24:24Z,AlloDerm,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix
2020-09-18T04:24:24Z,allogeneic acute myeloid leukemia antigen-expressing dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-acute-myeloid-leukemia-antigen-expressing-dendritic-cell-vaccine
2020-09-18T04:24:24Z,allogeneic adenovirus-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-adenovirus-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,allogeneic adipose-derived mesenchymal stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801471
2020-09-18T04:24:24Z,allogeneic anti-BCMA CAR-transduced T cells ALLO-715,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800201
2020-09-18T04:24:24Z,allogeneic anti-BCMA-CAR T cells PBCAR269A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801229
2020-09-18T04:24:24Z,allogeneic anti-BCMA/CS1 bispecific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802179
2020-09-18T04:24:24Z,allogeneic anti-CD19 universal CAR-T cells CTA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802167
2020-09-18T04:24:24Z,allogeneic anti-CD19-CAR T cells PBCAR0191,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797475
2020-09-18T04:24:24Z,allogeneic anti-CD20 CAR T cells LUCAR-20S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802323
2020-09-18T04:24:24Z,allogeneic anti-CD20-CAR T cells PBCAR20A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800688
2020-09-18T04:24:24Z,allogeneic autophagosome-enriched vaccine DPV-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cell-derived-dribbles-vaccine
2020-09-18T04:24:24Z,allogeneic B7.1/HLA-A1 transfected tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-b71-hla-a1-transfected-tumor-cell-vaccine
2020-09-18T04:24:24Z,allogeneic CD123-specific universal CAR123-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792167
2020-09-18T04:24:24Z,allogeneic CD19-specific CAR-modified CD8 positive central memory-derived virus-specific T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/717909
2020-09-18T04:24:24Z,allogeneic CD19-specific universal CAR19-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19-specific-universal-car19-expressing-t-lymphocytes
2020-09-18T04:24:24Z,allogeneic CD19CAR-transfected cytokine-induced killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794267
2020-09-18T04:24:24Z,allogeneic CD3- CD19- CD57+ NKG2C+ NK cells FATE-NK100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd3--cd19--cd57-nkg2c-nk-cells-fate-nk100
2020-09-18T04:24:24Z,allogeneic CD34-positive E-rosetted T-cell depleted peripheral blood stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794297
2020-09-18T04:24:24Z,allogeneic CD34-positive E-rosetted T-cell-depleted peripheral blood stem sells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794648
2020-09-18T04:24:24Z,allogeneic CD4+ memory Th1-like T cells/microparticle-bound anti-CD3/anti-CD28,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/580835
2020-09-18T04:24:24Z,allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801194
2020-09-18T04:24:24Z,allogeneic CMV antigen-specific CD4+/CD8+ T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796811
2020-09-18T04:24:24Z,allogeneic CMV/AdV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cmv-adv-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,allogeneic CRISPR-Cas9 engineered anti-CD19 CAR T cells CTX110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799962
2020-09-18T04:24:24Z,allogeneic CS1-specific universal CAR-expressing T lymphocytes UCARTCS1A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800121
2020-09-18T04:24:24Z,allogeneic cytomegalovirus-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cytomegalovirus-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,allogeneic dendritic cell vaccine COMBIG-DC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-vaccine-combig-dc
2020-09-18T04:24:24Z,allogeneic dendritic cell-myeloma idiotype vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-myeloma-idiotype-vaccine
2020-09-18T04:24:24Z,allogeneic double negative T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792387
2020-09-18T04:24:24Z,allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-epstein-barr-virus-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,allogeneic glial progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801494
2020-09-18T04:24:24Z,allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756037
2020-09-18T04:24:24Z,allogeneic GM-CSF-secreting breast cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine
2020-09-18T04:24:24Z,allogeneic GM-CSF-secreting breast cancer vaccine SV-BR-1-GM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158
2020-09-18T04:24:24Z,allogeneic GM-CSF-secreting lethally irradiated pancreatic tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794145
2020-09-18T04:24:24Z,allogeneic GM-CSF-secreting lethally irradiated whole melanoma cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-lethally-irradiated-whole-melanoma-cell-vaccine
2020-09-18T04:24:24Z,allogeneic GM-CSF-secreting myeloma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798454
2020-09-18T04:24:24Z,allogeneic GM-CSF-secreting tumor vaccine PANC 10.05 pcDNA-1/GM-Neo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-tumor-vaccine-panc-1005-pcdna-1-gm-neo
2020-09-18T04:24:24Z,allogeneic GM-CSF-secreting tumor vaccine PANC 6.03 pcDNA-1/GM-Neo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-tumor-vaccine-panc-603-pcdna-1-gm-neo
2020-09-18T04:24:24Z,allogeneic GM-CSF-transfected myeloma cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-transfected-myeloma-cell-vaccine
2020-09-18T04:24:24Z,allogeneic HAdV antigen-specific T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796810
2020-09-18T04:24:24Z,allogeneic HLA A2/4-1BB ligand-expressing melanoma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hla-a2-4-1bb-ligand-expressing-melanoma-vaccine
2020-09-18T04:24:24Z,allogeneic HPV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794788
2020-09-18T04:24:24Z,allogeneic iC9/CD19-CAR-CD28-zeta-2A-IL15-transduced cord blood-derived natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792530
2020-09-18T04:24:24Z,allogeneic IL13-zetakine/HyTK-expressing-glucocorticoid resistant cytotoxic T lymphocytes GRm13Z40-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/668180
2020-09-18T04:24:24Z,allogeneic interleukin-17-producing CD8-positive T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792631
2020-09-18T04:24:24Z,allogeneic irradiated melanoma cell vaccine CSF470,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-irradiated-melanoma-cell-vaccine-csf470
2020-09-18T04:24:24Z,allogeneic large multivalent immunogen breast cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-breast-cancer-vaccine
2020-09-18T04:24:24Z,allogeneic large multivalent immunogen melanoma vaccine LP2307,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307
2020-09-18T04:24:24Z,allogeneic LMP1-/LMP2- specific cytotoxic T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-lmp1--lmp2--specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,allogeneic melanoma vaccine AGI-101H,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-melanoma-vaccine-agi-101h
2020-09-18T04:24:24Z,allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770460
2020-09-18T04:24:24Z,allogeneic most closely HLA-matched adenovirus-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793439
2020-09-18T04:24:24Z,allogeneic multipotent adult progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multipotent-adult-progenitor-cells
2020-09-18T04:24:24Z,allogeneic multivirus-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multivirus-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,allogeneic natural killer cell line MG4101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-mg4101
2020-09-18T04:24:24Z,allogeneic natural killer cell line NK-92,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92
2020-09-18T04:24:24Z,allogeneic nicotinamide-expanded natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nicotinamide-expanded-natural-killer-cells
2020-09-18T04:24:24Z,allogeneic NKG2DL-targeting CAR-grafted gamma delta T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800069
2020-09-18T04:24:24Z,allogeneic plasmacytoid dendritic cells expressing lung tumor antigens PDC*lung01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801755
2020-09-18T04:24:24Z,allogeneic renal cell carcinoma vaccine MGN1601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-renal-cell-carcinoma-vaccine-mgn1601
2020-09-18T04:24:24Z,allogeneic T lymphocytes expressing NY-ESO-1-C259-specific TCR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793046
2020-09-18T04:24:24Z,allogeneic TCR alpha/beta-positive T lymphocyte-depleted peripheral blood stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792505
2020-09-18T04:24:24Z,allogeneic third-party suicide gene-transduced anti-HLA-DPB1*0401 CD4+ T cells CTL 19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802327
2020-09-18T04:24:24Z,allogeneic tri-functional anti-CD19 CAR-NK cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796718
2020-09-18T04:24:24Z,allogeneic tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tumor-cell-vaccine
2020-09-18T04:24:24Z,allogeneic umbilical cord blood-derived HSPCs NLA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792373
2020-09-18T04:24:24Z,allopurinol sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium
2020-09-18T04:24:24Z,allosteric ErbB inhibitor BDTX-189,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801228
2020-09-18T04:24:24Z,almurtide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/almurtide
2020-09-18T04:24:24Z,Alocrest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine
2020-09-18T04:24:24Z,aloe vera gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aloe-vera-gel
2020-09-18T04:24:24Z,aloe vera/chamomile/thyme topical cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799796
2020-09-18T04:24:24Z,aloe/anise/ascorbic acid/clove/glycerin/peppermint/spearmint/thyme-based herbal mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751302
2020-09-18T04:24:24Z,alogliptin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alogliptin
2020-09-18T04:24:24Z,Aloprim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium
2020-09-18T04:24:24Z,Aloxi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride
2020-09-18T04:24:24Z,alpelisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib
2020-09-18T04:24:24Z,alpha fetoprotein adenoviral vector vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-adenoviral-vector-vaccine
2020-09-18T04:24:24Z,alpha fetoprotein plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-plasmid-dna-vaccine
2020-09-18T04:24:24Z,alpha Gal AGI-134,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799503
2020-09-18T04:24:24Z,alpha-1-proteinase inhibitor human,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human
2020-09-18T04:24:24Z,"alpha-1,3-galactosyltransferase-expressing allogeneic lung tumor cell vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/539100
2020-09-18T04:24:24Z,"alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756792
2020-09-18T04:24:24Z,alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-fetoprotein-peptide-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,alpha-folate receptor-targeting thymidylate synthase inhibitor ONX-0801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801
2020-09-18T04:24:24Z,alpha-Gal glycosphingolipids,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-glycosphingolipids
2020-09-18T04:24:24Z,alpha-galactosylceramide-pulsed autologous dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-galactosylceramide-pulsed-autologous-dendritic-cells
2020-09-18T04:24:24Z,alpha-lipoic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid
2020-09-18T04:24:24Z,alpha-lipoic acid/Boswellia serrata extract/methylsulfonylmethane/bromelain dietary supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802261
2020-09-18T04:24:24Z,alpha-lipoic acid/vitamin/mineral supplement PolyMVA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva
2020-09-18T04:24:24Z,alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-methyl-4-deoxy-4-18ffluoro-d-glucopyranoside
2020-09-18T04:24:24Z,alpha-tocopherol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopherol
2020-09-18T04:24:24Z,alpha-tocopheryloxyacetic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-tocopheryloxyacetic-acid
2020-09-18T04:24:24Z,alpha-type-1 polarized dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-type-1-polarized-dendritic-cells
2020-09-18T04:24:24Z,alpha/beta T-cell/CD19+ B-cell-depleted unrelated or partially matched donor-derived allogeneic peripheral blood stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797965
2020-09-18T04:24:24Z,Alphagan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate
2020-09-18T04:24:24Z,alprazolam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam
2020-09-18T04:24:24Z,alprostadil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil
2020-09-18T04:24:24Z,Altace,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramipril
2020-09-18T04:24:24Z,alteplase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alteplase
2020-09-18T04:24:24Z,Althose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride
2020-09-18T04:24:24Z,altiratinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altiratinib
2020-09-18T04:24:24Z,altretamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine
2020-09-18T04:24:24Z,aluminum hydroxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide
2020-09-18T04:24:24Z,Alunbrig,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib
2020-09-18T04:24:24Z,ALVAC-CEA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-cea-vaccine
2020-09-18T04:24:24Z,ALVAC-ESO-1 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-eso-1-vaccine
2020-09-18T04:24:24Z,ALVAC-hB7.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-hb71
2020-09-18T04:24:24Z,ALVAC-MART-1 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac-mart-1-vaccine
2020-09-18T04:24:24Z,ALVAC(2) melanoma multi-antigen therapeutic vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-melanoma-multi-antigen-therapeutic-vaccine
2020-09-18T04:24:24Z,ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-ny-eso-1-m-tricom-vaccine
2020-09-18T04:24:24Z,alvelestat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvelestat
2020-09-18T04:24:24Z,alvespimycin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride
2020-09-18T04:24:24Z,alvimopan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan
2020-09-18T04:24:24Z,alvocidib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib
2020-09-18T04:24:24Z,alvocidib prodrug TP-1287,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799663
2020-09-18T04:24:24Z,amantadine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride
2020-09-18T04:24:24Z,Amaryl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glimepiride
2020-09-18T04:24:24Z,amatuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amatuximab
2020-09-18T04:24:24Z,Ambien,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolpidem-tartrate
2020-09-18T04:24:24Z,AmBisome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b
2020-09-18T04:24:24Z,amblyomin-X,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792680
2020-09-18T04:24:24Z,Amdray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar
2020-09-18T04:24:24Z,Ameluz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride
2020-09-18T04:24:24Z,Amen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate
2020-09-18T04:24:24Z,American ginseng,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/american-ginseng
2020-09-18T04:24:24Z,Amevive,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alefacept
2020-09-18T04:24:24Z,Amfebutamone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride
2020-09-18T04:24:24Z,Amicar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid
2020-09-18T04:24:24Z,amifampridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifampridine
2020-09-18T04:24:24Z,amifostine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine
2020-09-18T04:24:24Z,amikacin inhalation solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amikacin-inhalation-solution
2020-09-18T04:24:24Z,amino acid injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-injection
2020-09-18T04:24:24Z,amino acid/electrolyte mixture-based dietary supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement
2020-09-18T04:24:24Z,aminobenzoate potassium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminobenzoate-potassium
2020-09-18T04:24:24Z,aminocamptothecin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocamptothecin
2020-09-18T04:24:24Z,aminocaproic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminocaproic-acid
2020-09-18T04:24:24Z,aminolevulinic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid
2020-09-18T04:24:24Z,aminolevulinic acid hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride
2020-09-18T04:24:24Z,aminophylline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline
2020-09-18T04:24:24Z,aminopterin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin
2020-09-18T04:24:24Z,aminothiadiazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminothiadiazole
2020-09-18T04:24:24Z,amiodarone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride
2020-09-18T04:24:24Z,Amitiza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lubiprostone
2020-09-18T04:24:24Z,amitriptyline hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amitriptyline-hydrochloride
2020-09-18T04:24:24Z,AML mRNA plus lysate loaded autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aml-mrna-plus-lysate-loaded-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,Ammoidin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen
2020-09-18T04:24:24Z,ammonia N-13,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonia-n-13
2020-09-18T04:24:24Z,ammonium trichlorotellurate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate
2020-09-18T04:24:24Z,Amnesteem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin
2020-09-18T04:24:24Z,AmnioFix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dehydrated-human-amnion-chorion-membrane
2020-09-18T04:24:24Z,amnion-derived cellular cytokine solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amnion-derived-cellular-cytokine-solution
2020-09-18T04:24:24Z,Amoban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone
2020-09-18T04:24:24Z,amonafide dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride
2020-09-18T04:24:24Z,amonafide L-malate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-l-malate
2020-09-18T04:24:24Z,amorphous calcium carbonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792531
2020-09-18T04:24:24Z,amoxicillin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin
2020-09-18T04:24:24Z,amoxicillin-clavulanate potassium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin-clavulanate-potassium
2020-09-18T04:24:24Z,Amoxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin
2020-09-18T04:24:24Z,amphotericin B deoxycholate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amphotericin-b-deoxycholate
2020-09-18T04:24:24Z,ampicillin sodium/sulbactam sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ampicillin-sodium-sulbactam-sodium
2020-09-18T04:24:24Z,Ampligen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod
2020-09-18T04:24:24Z,Amplimexon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imexon
2020-09-18T04:24:24Z,amrubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride
2020-09-18T04:24:24Z,Amsa P-D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine
2020-09-18T04:24:24Z,amsacrine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine
2020-09-18T04:24:24Z,amsilarotene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsilarotene
2020-09-18T04:24:24Z,amuvatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib
2020-09-18T04:24:24Z,anagrelide hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-hydrochloride
2020-09-18T04:24:24Z,anagrelide prolonged-release formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anagrelide-prolonged-release-formulation
2020-09-18T04:24:24Z,anakinra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra
2020-09-18T04:24:24Z,anamorelin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anamorelin-hydrochloride
2020-09-18T04:24:24Z,anastrozole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole
2020-09-18T04:24:24Z,anaxirone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anaxirone
2020-09-18T04:24:24Z,Ancef,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium
2020-09-18T04:24:24Z,ancitabine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ancitabine-hydrochloride
2020-09-18T04:24:24Z,Ancobon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine
2020-09-18T04:24:24Z,Andro LA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022
2020-09-18T04:24:24Z,AndroGel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-gel
2020-09-18T04:24:24Z,androgen antagonist APC-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-antagonist-apc-100
2020-09-18T04:24:24Z,androgen receptor antagonist BAY 1161116,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792679
2020-09-18T04:24:24Z,androgen receptor antagonist ONC1-0013B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792562
2020-09-18T04:24:24Z,androgen receptor antagonist SHR3680,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-shr3680
2020-09-18T04:24:24Z,androgen receptor antagonist TAS3681,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-tas3681
2020-09-18T04:24:24Z,androgen receptor antagonist TRC253,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253
2020-09-18T04:24:24Z,androgen receptor antisense oligonucleotide AZD5312,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312
2020-09-18T04:24:24Z,androgen receptor antisense oligonucleotide EZN-4176,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-ezn-4176
2020-09-18T04:24:24Z,androgen receptor degrader ARV-110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798419
2020-09-18T04:24:24Z,androgen receptor degrader CC-94676,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801809
2020-09-18T04:24:24Z,androgen receptor inhibitor EPI-506,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-506
2020-09-18T04:24:24Z,androgen receptor inhibitor EPI-7386,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801842
2020-09-18T04:24:24Z,androgen receptor ligand-binding domain-encoding plasmid DNA vaccine MVI-118,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/771098
2020-09-18T04:24:24Z,androgen receptor/glucocorticoid receptor antagonist CB-03-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801352
2020-09-18T04:24:24Z,Android-F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone
2020-09-18T04:24:24Z,androstane steroid HE3235,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androstane-steroid-he3235
2020-09-18T04:24:24Z,Anectine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677
2020-09-18T04:24:24Z,anetumab ravtansine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anetumab-ravtansine
2020-09-18T04:24:24Z,Aneustat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54
2020-09-18T04:24:24Z,ANF-Rho,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor
2020-09-18T04:24:24Z,Ang2/VEGF-binding peptides-antibody fusion protein CVX-241,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ang2-vegf-binding-peptides-antibody-fusion-protein-cvx-241
2020-09-18T04:24:24Z,Angelica sinensis root extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angelica-sinensis-root-extract
2020-09-18T04:24:24Z,Angiocal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40
2020-09-18T04:24:24Z,Angiocept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib
2020-09-18T04:24:24Z,angiogenesis inhibitor JI-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-inhibitor-ji-101
2020-09-18T04:24:24Z,angiogenesis/heparanase inhibitor PG545,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-heparanase-inhibitor-pg545
2020-09-18T04:24:24Z,angiostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiostatin
2020-09-18T04:24:24Z,Angiozyme,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme
2020-09-18T04:24:24Z,anguidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anguidine
2020-09-18T04:24:24Z,anhydrous enol-oxaloacetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800694
2020-09-18T04:24:24Z,anidulafungin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin
2020-09-18T04:24:24Z,aniline mustard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aniline-mustard
2020-09-18T04:24:24Z,anlotinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anlotinib-hydrochloride
2020-09-18T04:24:24Z,Aroplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp
2020-09-18T04:24:24Z,Annonaceous acetogenins,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/annonaceous-acetogenins
2020-09-18T04:24:24Z,Ansaid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen
2020-09-18T04:24:24Z,Antabuse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram
2020-09-18T04:24:24Z,anthocyanin-rich corn extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthocyanin-rich-corn-extract
2020-09-18T04:24:24Z,anthracycline analogue GPX-150,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anthracycline-analogue-gpx-150
2020-09-18T04:24:24Z,anti c-KIT antibody-drug conjugate LOP628,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-antibody-drug-conjugate-lop628
2020-09-18T04:24:24Z,anti-5T4 antibody-drug conjugate ASN004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801910
2020-09-18T04:24:24Z,anti-5T4 antibody-drug conjugate PF-06263507,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-pf-06263507
2020-09-18T04:24:24Z,anti-A33 monoclonal antibody KRN330,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a33-monoclonal-antibody-krn330
2020-09-18T04:24:24Z,anti-A5B1 integrin monoclonal antibody PF-04605412,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-a5b1-integrin-monoclonal-antibody-pf-04605412
2020-09-18T04:24:24Z,anti-ACTR/4-1BB/CD3zeta-viral vector-transduced autologous T lymphocytes ACTR087,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784523
2020-09-18T04:24:24Z,anti-AGS-16 monoclonal antibody AGS-16M18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-16-monoclonal-antibody-ags-16m18
2020-09-18T04:24:24Z,anti-AGS-5 antibody-drug conjugate ASG-5ME,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-5-antibody-drug-conjugate-asg-5me
2020-09-18T04:24:24Z,anti-AGS-8 monoclonal antibody AGS-8M4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-8-monoclonal-antibody-ags-8m4
2020-09-18T04:24:24Z,anti-ALK-1 monoclonal antibody PF-03446962,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alk-1-monoclonal-antibody-pf-03446962
2020-09-18T04:24:24Z,anti-alpha BCMA/anti-alpha CD3 T-cell engaging bispecific antibody TNB-383B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799707
2020-09-18T04:24:24Z,anti-AMHR2 monoclonal antibody GM102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amhr2-monoclonal-antibody-gm102
2020-09-18T04:24:24Z,anti-amyloid monoclonal antibody NEOD001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-amyloid-monoclonal-antibody-neod001
2020-09-18T04:24:24Z,anti-androgen siRNA SXL01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-androgen-sirna-sxl01
2020-09-18T04:24:24Z,anti-ANG2 monoclonal antibody MEDI-3617,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617
2020-09-18T04:24:24Z,anti-APRIL monoclonal antibody BION-1301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-april-monoclonal-antibody-bion-1301
2020-09-18T04:24:24Z,anti-AXL fusion protein AVB-S6-500,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795349
2020-09-18T04:24:24Z,anti-AXL monoclonal antibody-MMAE conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-monoclonal-antibody-mmae-conjugate
2020-09-18T04:24:24Z,anti-AXL/PBD antibody-drug conjugate ADCT-601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798273
2020-09-18T04:24:24Z,anti-B4 blocked ricin immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b4-blocked-ricin-immunotoxin
2020-09-18T04:24:24Z,anti-B7-H3 antibody DS-5573a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-antibody-ds-5573a
2020-09-18T04:24:24Z,anti-B7-H3/DXd antibody-drug conjugate DS-7300a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801901
2020-09-18T04:24:24Z,anti-B7-H4 monoclonal antibody FPA150,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795105
2020-09-18T04:24:24Z,anti-B7-H4 monoclonal antibody FPA150,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795341
2020-09-18T04:24:24Z,anti-BCMA antibody SEA-BCMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793894
2020-09-18T04:24:24Z,anti-BCMA SparX protein plus BCMA-directed anti-TAAG ARC T cells CART-ddBCMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800471
2020-09-18T04:24:24Z,anti-BCMA/anti-CD3 bispecific antibody REGN5459,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800119
2020-09-18T04:24:24Z,anti-BCMA/CD3 BiTE antibody AMG 420,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801291
2020-09-18T04:24:24Z,anti-BCMA/CD3 BiTE antibody AMG 701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792377
2020-09-18T04:24:24Z,anti-BCMA/CD3 BiTE antibody REGN5458,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797141
2020-09-18T04:24:24Z,anti-BCMA/PBD ADC MEDI2228,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795378
2020-09-18T04:24:24Z,anti-BTLA monoclonal antibody TAB004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800693
2020-09-18T04:24:24Z,anti-c-fms monoclonal antibody AMG 820,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-fms-monoclonal-antibody-amg-820
2020-09-18T04:24:24Z,anti-c-KIT monoclonal antibody KTN0158,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-monoclonal-antibody-ktn0158
2020-09-18T04:24:24Z,anti-c-Met antibody-drug conjugate SHR-A1403,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792156
2020-09-18T04:24:24Z,anti-c-Met antibody-drug conjugate TR1801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797392
2020-09-18T04:24:24Z,anti-c-Met monoclonal antibody ABT-700,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-abt-700
2020-09-18T04:24:24Z,anti-c-Met monoclonal antibody ARGX-111,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-argx-111
2020-09-18T04:24:24Z,anti-c-MET monoclonal antibody HLX55,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802302
2020-09-18T04:24:24Z,anti-c-MET monoclonal antibody LY2875358,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-ly2875358
2020-09-18T04:24:24Z,anti-C-met monoclonal antibody SAIT301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-sait301
2020-09-18T04:24:24Z,anti-C4.4a antibody-drug conjugate BAY1129980,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c44a-antibody-drug-conjugate-bay1129980
2020-09-18T04:24:24Z,anti-C5aR monoclonal antibody IPH5401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798695
2020-09-18T04:24:24Z,anti-CA19-9 monoclonal antibody 5B1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1
2020-09-18T04:24:24Z,anti-CA6-DM4 immunoconjugate SAR566658,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca6-dm4-immunoconjugate-sar566658
2020-09-18T04:24:24Z,anti-CD123 ADC IMGN632,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792150
2020-09-18T04:24:24Z,anti-CD123 monoclonal antibody KHK2823,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-monoclonal-antibody-khk2823
2020-09-18T04:24:24Z,anti-CD123 x anti-CD3 bispecific antibody XmAb14045,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-x-anti-cd3-bispecific-antibody-xmab14045
2020-09-18T04:24:24Z,anti-CD123-pyrrolobenzodiazepine dimer antibody drug conjugate SGN-CD123A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a
2020-09-18T04:24:24Z,anti-CD123/CD3 bispecific antibody APVO436,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796808
2020-09-18T04:24:24Z,anti-CD123/CD3 bispecific antibody JNJ-63709178,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-jnj-63709178
2020-09-18T04:24:24Z,anti-CD123/CD3 BiTE antibody SAR440234,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798327
2020-09-18T04:24:24Z,anti-CD133-CAR vector-transduced allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-car-vector-transduced-allogeneic-t-lymphocytes
2020-09-18T04:24:24Z,anti-CD133-PE38-KDEL fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd133-pe38-kdel-fusion-protein
2020-09-18T04:24:24Z,anti-CD137 agonistic monoclonal antibody ADG106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797894
2020-09-18T04:24:24Z,anti-CD137 agonistic monoclonal antibody AGEN2373,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800682
2020-09-18T04:24:24Z,anti-CD137 agonistic monoclonal antibody ATOR-1017,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801898
2020-09-18T04:24:24Z,anti-CD137 agonistic monoclonal antibody CTX-471,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798594
2020-09-18T04:24:24Z,anti-CD137 agonistic monoclonal antibody LVGN6051,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801858
2020-09-18T04:24:24Z,anti-CD157 monoclonal antibody MEN1112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd157-monoclonal-antibody-men1112
2020-09-18T04:24:24Z,anti-CD166 probody-drug conjugate CX-2009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd166-probody-drug-conjugate-cx-2009
2020-09-18T04:24:24Z,anti-CD19 antibody-T-cell receptor-expressing T cells ET019003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801620
2020-09-18T04:24:24Z,anti-CD19 CAR-T cells XLCART001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799644
2020-09-18T04:24:24Z,anti-CD19 fully human monoclonal antibody MDX-1342,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-fully-human-monoclonal-antibody-mdx-1342
2020-09-18T04:24:24Z,anti-CD19 monoclonal antibody DI-B4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4
2020-09-18T04:24:24Z,anti-CD19 monoclonal antibody MEDI-551,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-medi-551
2020-09-18T04:24:24Z,anti-CD19-CAR FMC63-28Z retroviral vector-transduced allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751864
2020-09-18T04:24:24Z,anti-CD19-CAR retroviral vector-transduced autologous T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-retroviral-vector-transduced-autologous-t-cells
2020-09-18T04:24:24Z,anti-CD19-CAR-CD28/CD20-CAR-4-1BB-expressing autologous T lymphocytes Hu1928-Hu20BB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800198
2020-09-18T04:24:24Z,anti-CD19-CAR-CD3zeta-4-1BB-expressing natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-natural-killer-cells
2020-09-18T04:24:24Z,anti-CD19-CD20-CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-CD19-CD28-zeta modified CAR CD3+ T lymphocytes JCAR015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd28-zeta-modified-car-cd3-t-lymphocytes-jcar015
2020-09-18T04:24:24Z,anti-CD19-DM4 immunoconjugate SAR3419,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-dm4-immunoconjugate-sar3419
2020-09-18T04:24:24Z,anti-CD19/CD20/CD22/CD30 CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793132
2020-09-18T04:24:24Z,anti-CD19/CD22 bispecific ligand-directed toxin DT2219ARL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd22-bispecific-ligand-directed-toxin-dt2219arl
2020-09-18T04:24:24Z,anti-CD19/CD3 BiTE antibody AMG 562,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794049
2020-09-18T04:24:24Z,anti-CD19/CD3 tetravalent antibody AFM11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-tetravalent-antibody-afm11
2020-09-18T04:24:24Z,anti-CD20 B9E9 scFv-streptavidin fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-b9e9-scfv-streptavidin-fusion-protein
2020-09-18T04:24:24Z,anti-CD20 monoclonal antibody B001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794877
2020-09-18T04:24:24Z,anti-CD20 monoclonal antibody BAT4306F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802165
2020-09-18T04:24:24Z,anti-CD20 monoclonal antibody MIL62,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799905
2020-09-18T04:24:24Z,anti-CD20 monoclonal antibody SCT400,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-sct400
2020-09-18T04:24:24Z,anti-CD20 monoclonal antibody TL011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-tl011
2020-09-18T04:24:24Z,anti-CD20 monoclonal antibody-interferon alpha fusion protein IGN002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-interferon-alpha-fusion-protein-ign002
2020-09-18T04:24:24Z,anti-CD20-CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-CD20-engineered toxin body MT-3724,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-engineered-toxin-body-mt-3724
2020-09-18T04:24:24Z,anti-CD20/anti-CD3 bispecific IgM antibody IGM2323,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799710
2020-09-18T04:24:24Z,anti-CD20/CD3 monoclonal antibody REGN1979,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-regn1979
2020-09-18T04:24:24Z,anti-CD20/CD3 monoclonal antibody XmAb13676,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-cd3-monoclonal-antibody-xmab13676
2020-09-18T04:24:24Z,anti-CD205 antibody-drug conjugate OBT076,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799986
2020-09-18T04:24:24Z,anti-CD22 ADC TRPH-222,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796465
2020-09-18T04:24:24Z,anti-CD22 CAR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-car-expressing-t-lymphocytes
2020-09-18T04:24:24Z,anti-CD22 monoclonal antibody-MMAE conjugate DCDT2980S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-monoclonal-antibody-mmae-conjugate-dcdt2980s
2020-09-18T04:24:24Z,anti-CD22 scFv TCRz:41BB-CAR lentiviral vector-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776843
2020-09-18T04:24:24Z,anti-CD22-CAR m971-BBz lentiviral vector-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767368
2020-09-18T04:24:24Z,anti-CD228/MMAE antibody-drug conjugate SGN-CD228A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800848
2020-09-18T04:24:24Z,anti-CD25 monoclonal antibody RO7296682,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802183
2020-09-18T04:24:24Z,anti-CD26 monoclonal antibody YS110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793089
2020-09-18T04:24:24Z,anti-CD27L antibody-drug conjugate AMG 172,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd27l-antibody-drug-conjugate-amg-172
2020-09-18T04:24:24Z,anti-CD3 immunotoxin A-dmDT390-bisFv(UCHT1),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1
2020-09-18T04:24:24Z,anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-x-anti-cd20-bispecific-antibody-armed-activated-t-cells
2020-09-18T04:24:24Z,anti-CD3/5T4 IgG1 bispecific antibody GEN1044,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801833
2020-09-18T04:24:24Z,anti-CD3/anti-BCMA bispecific monoclonal antibody JNJ-64007957,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-jnj-64007957
2020-09-18T04:24:24Z,anti-CD3/anti-BCMA bispecific monoclonal antibody PF-06863135,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792267
2020-09-18T04:24:24Z,anti-CD3/anti-CD20 trifunctional bispecific monoclonal antibody FBTA05,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-cd20-trifunctional-bispecific-monoclonal-antibody-fbta05
2020-09-18T04:24:24Z,anti-CD3/anti-GPRC5D bispecific monoclonal antibody JNJ-64407564,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792477
2020-09-18T04:24:24Z,anti-CD3/anti-GUCY2C bispecific antibody PF-07062119,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800221
2020-09-18T04:24:24Z,anti-CD3/CD20 bispecific antibody GEN3013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973
2020-09-18T04:24:24Z,anti-CD3/CD38 bispecific monoclonal antibody AMG 424,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793935
2020-09-18T04:24:24Z,anti-CD3/CD7-ricin toxin A immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985
2020-09-18T04:24:24Z,anti-CD3/humanized 3F8 bispecific antibody-activated T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-humanized-3f8-bispecific-antibody-activated-t-lymphocytes
2020-09-18T04:24:24Z,anti-CD3/MUC1 antibody-armed PD-1 inhibitor-induced cytokine-induced killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792734
2020-09-18T04:24:24Z,anti-CD30 monoclonal antibody MDX-1401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-monoclonal-antibody-mdx-1401
2020-09-18T04:24:24Z,anti-CD30 monoclonal antibody XmAb2513,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-monoclonal-antibody-xmab2513
2020-09-18T04:24:24Z,anti-CD30/CD16A monoclonal antibody AFM13,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-cd16a-monoclonal-antibody-afm13
2020-09-18T04:24:24Z,anti-CD30/DM1 antibody-drug conjugate F0002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801498
2020-09-18T04:24:24Z,anti-CD32B monoclonal antibody BI-1206,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795804
2020-09-18T04:24:24Z,anti-CD33 antigen/CD3 receptor bispecific monoclonal antibody AMV564,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antigen-cd3-receptor-bispecific-monoclonal-antibody-amv564
2020-09-18T04:24:24Z,anti-CD33 monoclonal antibody BI 836858,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-bi-836858
2020-09-18T04:24:24Z,anti-CD33 monoclonal antibody-DM4 conjugate AVE9633,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-dm4-conjugate-ave9633
2020-09-18T04:24:24Z,anti-CD33/CD3 bispecific antibody GEM 333,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795023
2020-09-18T04:24:24Z,anti-CD33/CD3 bispecific antibody JNJ-67571244,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798705
2020-09-18T04:24:24Z,anti-CD33/CD3 BiTE antibody AMG 330,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-330
2020-09-18T04:24:24Z,anti-CD33/CD3 BiTE antibody AMG 673,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792374
2020-09-18T04:24:24Z,anti-CD352 antibody-drug conjugate SGN-CD352A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a
2020-09-18T04:24:24Z,anti-CD37 antibody-drug conjugate IMGN529,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-antibody-drug-conjugate-imgn529
2020-09-18T04:24:24Z,anti-CD37 monoclonal antibody BI 836826,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-monoclonal-antibody-bi-836826
2020-09-18T04:24:24Z,anti-CD37-CAR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801227
2020-09-18T04:24:24Z,anti-CD38 monoclonal antibody SAR442085,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800231
2020-09-18T04:24:24Z,anti-CD38 monoclonal antibody TAK-079,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795705
2020-09-18T04:24:24Z,anti-CD38 monoclonal antibody TJ202/MOR202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-mor03087
2020-09-18T04:24:24Z,anti-CD38-targeted IgG4-attenuated IFNa TAK-573,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-targeted-igg4-attenuated-ifna-tak-573
2020-09-18T04:24:24Z,anti-CD38/BCMA CAR T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797082
2020-09-18T04:24:24Z,anti-CD38/CD28xCD3 trispecific T cell engager SAR442257,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802010
2020-09-18T04:24:24Z,anti-CD38/CD3 bispecific monoclonal antibody GBR 1342,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792483
2020-09-18T04:24:24Z,anti-CD39 monoclonal antibody TTX-030,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798967
2020-09-18T04:24:24Z,anti-CD4 CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802265
2020-09-18T04:24:24Z,anti-CD40 agonist monoclonal antibody ABBV-927,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-abbv-927
2020-09-18T04:24:24Z,anti-CD40 agonist monoclonal antibody CDX-1140,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793440
2020-09-18T04:24:24Z,anti-CD40 monoclonal antibody Chi Lob 7/4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-chi-lob-7-4
2020-09-18T04:24:24Z,anti-CD40 monoclonal antibody SEA-CD40,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-sea-cd40
2020-09-18T04:24:24Z,anti-CD40/anti-4-1BB bispecific agonist monoclonal antibody GEN1042,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800410
2020-09-18T04:24:24Z,anti-CD40L Fc-fusion protein BMS-986004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40l-fc-fusion-protein-bms-986004
2020-09-18T04:24:24Z,anti-CD44 monoclonal antibody RO5429083,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd44-monoclonal-antibody-ro5429083
2020-09-18T04:24:24Z,anti-CD45 monoclonal antibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody
2020-09-18T04:24:24Z,anti-CD45 monoclonal antibody AHN-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-ahn-12
2020-09-18T04:24:24Z,anti-CD45 monoclonal antibody BC8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8
2020-09-18T04:24:24Z,anti-CD45 monoclonal antibody BC8-streptavidin conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-monoclonal-antibody-bc8-streptavidin-conjugate
2020-09-18T04:24:24Z,anti-CD46 antibody-drug conjugate FOR46,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795803
2020-09-18T04:24:24Z,anti-CD47 ADC SGN-CD47M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801749
2020-09-18T04:24:24Z,anti-CD47 monoclonal antibody AO-176,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797803
2020-09-18T04:24:24Z,anti-CD47 monoclonal antibody CC-90002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002
2020-09-18T04:24:24Z,anti-CD47 monoclonal antibody SHR-1603,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797797
2020-09-18T04:24:24Z,anti-CD47 monoclonal antibody SRF231,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795110
2020-09-18T04:24:24Z,anti-CD47 monoclonal antibody TJC4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801670
2020-09-18T04:24:24Z,anti-CD47/CD19 bispecific monoclonal antibody TG-1801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799809
2020-09-18T04:24:24Z,anti-CD48/MMAE antibody-drug conjugate SGN-CD48A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794392
2020-09-18T04:24:24Z,anti-CD52 monoclonal antibody ALLO-647,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798418
2020-09-18T04:24:24Z,anti-CD7 CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801681
2020-09-18T04:24:24Z,anti-CD70 antibody-drug conjugate MDX-1203,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-mdx-1203
2020-09-18T04:24:24Z,anti-CD70 antibody-drug conjugate SGN-CD70A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-sgn-cd70a
2020-09-18T04:24:24Z,anti-CD70 monoclonal antibody MDX-1411,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-mdx-1411
2020-09-18T04:24:24Z,anti-CD71/vcMMAE probody-drug conjugate CX-2029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794073
2020-09-18T04:24:24Z,anti-CD73 monoclonal antibody BMS-986179,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-bms-986179
2020-09-18T04:24:24Z,anti-CD73 monoclonal antibody CPI-006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795397
2020-09-18T04:24:24Z,anti-CD73 monoclonal antibody NZV930,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797358
2020-09-18T04:24:24Z,anti-CD73 monoclonal antibody TJ4309,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797647
2020-09-18T04:24:24Z,anti-CD98 monoclonal antibody IGN523,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd98-monoclonal-antibody-ign523
2020-09-18T04:24:24Z,anti-CDH6 antibody-drug conjugate HKT288,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288
2020-09-18T04:24:24Z,anti-CEA BiTE monoclonal antibody AMG211,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211
2020-09-18T04:24:24Z,anti-CEA IgCD28TCR-transduced autologous T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-igcd28tcr-transduced-autologous-t-cells
2020-09-18T04:24:24Z,anti-CEA TCR retroviral vector-transduced autologous lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-tcr-retroviral-vector-transduced-autologous-lymphocytes
2020-09-18T04:24:24Z,anti-CEA-CAR autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-car-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-CEA/anti-DTPA-In (F6-734) bispecific antibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-dtpa-in-f6-734-bispecific-antibody
2020-09-18T04:24:24Z,anti-CEA/anti-HSG bispecific monoclonal antibody TF2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-hsg-bispecific-monoclonal-antibody-tf2
2020-09-18T04:24:24Z,anti-CEACAM1 monoclonal antibody CM-24,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam1-monoclonal-antibody-cm-24
2020-09-18T04:24:24Z,anti-CEACAM5 antibody-drug conjugate SAR408701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam5-antibody-drug-conjugate-sar408701
2020-09-18T04:24:24Z,anti-CEACAM6 AFAIKL2 antibody fragment/Jack Bean urease immunoconjugate L-DOS47,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/768359
2020-09-18T04:24:24Z,anti-CEACAM6 antibody BAY1834942,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797774
2020-09-18T04:24:24Z,anti-claudin18.2 monoclonal antibody AB011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802013
2020-09-18T04:24:24Z,anti-claudin18.2 monoclonal antibody TST001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802035
2020-09-18T04:24:24Z,anti-CLDN6 monoclonal antibody IMAB027,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-imab027
2020-09-18T04:24:24Z,anti-CLEC12A/CD3 bispecific antibody MCLA117,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792475
2020-09-18T04:24:24Z,anti-CSF-1R monoclonal antibody IMC-CS4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf-1r-monoclonal-antibody-imc-cs4
2020-09-18T04:24:24Z,anti-CSF-1R monoclonal antibody SNDX-6352,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794081
2020-09-18T04:24:24Z,anti-CSF1 monoclonal antibody PD-0360324,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324
2020-09-18T04:24:24Z,anti-CTLA-4 mAb RNA-transfected autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-mab-rna-transfected-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,anti-CTLA-4 monoclonal antibody ADG116,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799904
2020-09-18T04:24:24Z,anti-CTLA-4 monoclonal antibody ADU-1604,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798657
2020-09-18T04:24:24Z,anti-CTLA-4 monoclonal antibody AGEN1181,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797474
2020-09-18T04:24:24Z,anti-CTLA-4 monoclonal antibody AGEN1884,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1884
2020-09-18T04:24:24Z,anti-CTLA-4 monoclonal antibody MK-1308,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793094
2020-09-18T04:24:24Z,anti-CTLA-4 monoclonal antibody ONC-392,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801887
2020-09-18T04:24:24Z,anti-CTLA-4 monoclonal antibody REGN4659,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797920
2020-09-18T04:24:24Z,anti-CTLA-4 probody BMS-986288,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801762
2020-09-18T04:24:24Z,anti-CTLA-4/anti-PD-1 monoclonal antibody combination BCD-217,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801536
2020-09-18T04:24:24Z,anti-CTLA-4/LAG-3 bispecific antibody XmAb22841,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797814
2020-09-18T04:24:24Z,anti-CTLA-4/OX40 bispecific antibody ATOR-1015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796793
2020-09-18T04:24:24Z,anti-CTLA4 antibody Fc fusion protein KN044,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801856
2020-09-18T04:24:24Z,anti-CTLA4 mAb RNA/GITRL RNA-transfected autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-mab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,anti-CTLA4 monoclonal antibody BMS-986218,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218
2020-09-18T04:24:24Z,anti-CTLA4 monoclonal antibody HBM4003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801868
2020-09-18T04:24:24Z,anti-CXCR4 monoclonal antibody PF-06747143,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143
2020-09-18T04:24:24Z,anti-denatured collagen recombinant monoclonal antibody TRC093,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-recombinant-monoclonal-antibody-trc093
2020-09-18T04:24:24Z,anti-DKK-1 monoclonal antibody LY2812176,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk-1-monoclonal-antibody-ly2812176
2020-09-18T04:24:24Z,anti-DKK1 monoclonal antibody BHQ880,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk1-monoclonal-antibody-bhq880
2020-09-18T04:24:24Z,anti-DLL3/CD3 BiTE antibody AMG 757,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792376
2020-09-18T04:24:24Z,anti-DLL4 monoclonal antibody MEDI0639,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-medi0639
2020-09-18T04:24:24Z,anti-DLL4 monoclonal antibody REGN421,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-monoclonal-antibody-regn421
2020-09-18T04:24:24Z,anti-DLL4/VEGF bispecific monoclonal antibody OMP-305B83,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll4-vegf-bispecific-monoclonal-antibody-omp-305b83
2020-09-18T04:24:24Z,anti-DR5 agonist monoclonal antibody TRA-8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonist-monoclonal-antibody-tra-8
2020-09-18T04:24:24Z,anti-DR5 agonistic monoclonal antibody INBRX-109,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796494
2020-09-18T04:24:24Z,anti-EGFL7 monoclonal antibody MEGF0444A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfl7-monoclonal-antibody-megf0444a
2020-09-18T04:24:24Z,anti-EGFR CAR-transduced IL-12-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797091
2020-09-18T04:24:24Z,anti-EGFR fluorescence imaging agent ABY-029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029
2020-09-18T04:24:24Z,anti-EGFR monoclonal antibody ABT-806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-abt-806
2020-09-18T04:24:24Z,anti-EGFR monoclonal antibody CPGJ 602,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794677
2020-09-18T04:24:24Z,anti-EGFR monoclonal antibody GC1118,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-gc1118
2020-09-18T04:24:24Z,anti-EGFR monoclonal antibody HLX07,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799130
2020-09-18T04:24:24Z,anti-EGFR monoclonal antibody mixture MM-151,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-mm-151
2020-09-18T04:24:24Z,anti-EGFR monoclonal antibody mixture sym004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-sym004
2020-09-18T04:24:24Z,anti-EGFR monoclonal antibody RO5083945,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-ro5083945
2020-09-18T04:24:24Z,anti-EGFR monoclonal antibody SYN004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-syn004
2020-09-18T04:24:24Z,anti-EGFR TAP antibody-drug conjugate IMGN289,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-tap-antibody-drug-conjugate-imgn289
2020-09-18T04:24:24Z,anti-EGFR/c-Met bispecific antibody EMB-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797352
2020-09-18T04:24:24Z,anti-EGFR/c-Met bispecific antibody JNJ-61186372,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-jnj-61186372
2020-09-18T04:24:24Z,anti-EGFR/DM1 antibody-drug conjugate AVID100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792639
2020-09-18T04:24:24Z,anti-EGFR/HER2/HER3 monoclonal antibody mixture Sym013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013
2020-09-18T04:24:24Z,anti-EGFR/HER3 monoclonal antibody MEHD7945A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her3-monoclonal-antibody-mehd7945a
2020-09-18T04:24:24Z,anti-EGFR/PBD antibody-drug conjugate ABBV-321,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793472
2020-09-18T04:24:24Z,anti-EGFRvIII antibody drug conjugate AMG 595,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-antibody-drug-conjugate-amg-595
2020-09-18T04:24:24Z,anti-EGFRvIII CAR-transduced allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-car-transduced-allogeneic-t-lymphocytes
2020-09-18T04:24:24Z,anti-EGFRvIII immunotoxin MR1-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-immunotoxin-mr1-1
2020-09-18T04:24:24Z,anti-EGFRvIII/CD3 BiTE antibody AMG 596,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792074
2020-09-18T04:24:24Z,anti-EGP-2 immunotoxin MOC31-PE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egp-2-immunotoxin-moc31-pe
2020-09-18T04:24:24Z,anti-endosialin/TEM1 monoclonal antibody MORAb-004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-endosialin-tem1-monoclonal-antibody-morab-004
2020-09-18T04:24:24Z,anti-ENPP3 antibody-drug conjugate AGS-16C3F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-enpp3-antibody-drug-conjugate-ags-16c3f
2020-09-18T04:24:24Z,anti-Ep-CAM monoclonal antibody ING-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ep-cam-monoclonal-antibody-ing-1
2020-09-18T04:24:24Z,anti-EphA2 antibody-directed liposomal docetaxel prodrug MM-310,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-antibody-directed-liposomal-docetaxel-prodrug-mm-310
2020-09-18T04:24:24Z,anti-EphA2 monoclonal antibody DS-8895a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-ds-8895a
2020-09-18T04:24:24Z,anti-EphA2 monoclonal antibody-MMAF immunoconjugate MEDI-547,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-mmaf-immunoconjugate-medi-547
2020-09-18T04:24:24Z,anti-EphA3 monoclonal antibody KB004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha3-monoclonal-antibody-kb004
2020-09-18T04:24:24Z,anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778383
2020-09-18T04:24:24Z,anti-ErbB2/anti-ErbB3 bispecific monoclonal antibody MM-111,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb2-anti-erbb3-bispecific-monoclonal-antibody-mm-111
2020-09-18T04:24:24Z,anti-ErbB3 antibody ISU104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797411
2020-09-18T04:24:24Z,anti-ErbB3 monoclonal antibody AV-203,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-av-203
2020-09-18T04:24:24Z,anti-ErbB3 monoclonal antibody CDX-3379,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-ktn3379
2020-09-18T04:24:24Z,anti-ErbB3 monoclonal antibody REGN1400,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-regn1400
2020-09-18T04:24:24Z,anti-ErbB3/anti-IGF-1R bispecific monoclonal antibody MM-141,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-anti-igf-1r-bispecific-monoclonal-antibody-mm-141
2020-09-18T04:24:24Z,anti-FAP/interleukin-2 fusion protein RO6874281,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281
2020-09-18T04:24:24Z,anti-FCRH5/CD3 BiTE antibody BFCR4350A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a
2020-09-18T04:24:24Z,anti-FcRn monoclonal antibody SYNT001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrn-monoclonal-antibody-synt001
2020-09-18T04:24:24Z,anti-FGFR2 antibody BAY1179470,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-bay1179470
2020-09-18T04:24:24Z,anti-FGFR3 antibody-drug conjugate LY3076226,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226
2020-09-18T04:24:24Z,anti-FGFR3 monoclonal antibody MFGR1877S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-monoclonal-antibody-mfgr1877s
2020-09-18T04:24:24Z,anti-FGFR4 monoclonal antibody U3-1784,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr4-monoclonal-antibody-u3-1784
2020-09-18T04:24:24Z,anti-FL(FITC-E2) CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797354
2020-09-18T04:24:24Z,anti-FLT-1 ribozyme,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt-1-ribozyme
2020-09-18T04:24:24Z,anti-FLT3 monoclonal antibody 4G8-SDIEM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-4g8-sdiem
2020-09-18T04:24:24Z,anti-FLT3 monoclonal antibody IMC-EB10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-monoclonal-antibody-imc-eb10
2020-09-18T04:24:24Z,anti-FLT3/CD3 BiTE antibody AMG 427,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795695
2020-09-18T04:24:24Z,anti-folate receptor-alpha antibody drug conjugate STRO-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797174
2020-09-18T04:24:24Z,anti-fucosyl-GM1 monoclonal antibody BMS-986012,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fucosyl-gm1-monoclonal-antibody-bms-986012
2020-09-18T04:24:24Z,anti-ganglioside GM2 monoclonal antibody BIW-8962,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ganglioside-gm2-monoclonal-antibody-biw-8962
2020-09-18T04:24:24Z,anti-GARP monoclonal antibody ABBV-151,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800125
2020-09-18T04:24:24Z,anti-GCC antibody-drug conjugate MLN0264,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-mln0264
2020-09-18T04:24:24Z,anti-GCC antibody-drug conjugate TAK-164,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795729
2020-09-18T04:24:24Z,anti-GD2 monoclonal antibody hu14.18K322A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-hu1418k322a
2020-09-18T04:24:24Z,anti-GD2 monoclonal antibody MORAb-028,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-morab-028
2020-09-18T04:24:24Z,anti-GD3 antibody-drug conjugate PF-06688992,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992
2020-09-18T04:24:24Z,anti-GFRAL monoclonal antibody NGM120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799444
2020-09-18T04:24:24Z,anti-GITR agonistic monoclonal antibody ASP1951,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797644
2020-09-18T04:24:24Z,anti-GITR agonistic monoclonal antibody INCAGN01876,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-incagn01876
2020-09-18T04:24:24Z,anti-GITR agonistic monoclonal MS-986156,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-ms-986156
2020-09-18T04:24:24Z,anti-GITR monoclonal antibody GWN 323,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-gwn-323
2020-09-18T04:24:24Z,anti-GITR monoclonal antibody MK-4166,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-mk-4166
2020-09-18T04:24:24Z,anti-globo H monoclonal antibody OBI-888,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794060
2020-09-18T04:24:24Z,anti-globo H/MMAE antibody-drug conjugate OBI 999,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800120
2020-09-18T04:24:24Z,anti-glypican 3-scFvGC33-CAR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-glypican-3-scfvgc33-car-expressing-t-lymphocytes
2020-09-18T04:24:24Z,anti-GnRH vaccine PEP223,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gnrh-vaccine-pep223
2020-09-18T04:24:24Z,anti-gpA33/CD3 monoclonal antibody MGD007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpa33-cd3-monoclonal-antibody-mgd007
2020-09-18T04:24:24Z,anti-GPC3 monoclonal antibody GC33,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-monoclonal-antibody-gc33
2020-09-18T04:24:24Z,anti-GPC3-CAR autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801493
2020-09-18T04:24:24Z,anti-GPC3-CAR autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-GPC3-CAR-T lymphocytes TAK-102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801936
2020-09-18T04:24:24Z,anti-gremlin-1 monoclonal antibody UCB6114,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802055
2020-09-18T04:24:24Z,anti-GRP78 monoclonal antibody PAT-SM6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-grp78-monoclonal-antibody-pat-sm6
2020-09-18T04:24:24Z,anti-HA epitope monoclonal antibody MEDI8852,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ha-epitope-monoclonal-antibody-medi8852
2020-09-18T04:24:24Z,anti-HB-EGF monoclonal antibody KHK2866,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hb-egf-monoclonal-antibody-khk2866
2020-09-18T04:24:24Z,anti-HBEGF monoclonal antibody U3-1565,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hbegf-monoclonal-antibody-u3-1565
2020-09-18T04:24:24Z,anti-hCD70-CAR retroviral vector-transduced autologous PBLs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcd70-car-retroviral-vector-transduced-autologous-pbls
2020-09-18T04:24:24Z,anti-HCV E2 monoclonal antibody MBL-HCV1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hcv-e2-monoclonal-antibody-mbl-hcv1
2020-09-18T04:24:24Z,anti-HER-2 bispecific antibody KN026,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798820
2020-09-18T04:24:24Z,anti-Her-2-CAR retroviral vector-transduced autologous peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/629766
2020-09-18T04:24:24Z,anti-HER2 antibody-drug conjugate A166,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795827
2020-09-18T04:24:24Z,anti-HER2 antibody-drug conjugate ARX788,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-arx788
2020-09-18T04:24:24Z,anti-HER2 antibody-drug conjugate BAT8001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802162
2020-09-18T04:24:24Z,anti-HER2 antibody-drug conjugate DP303c,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802152
2020-09-18T04:24:24Z,anti-HER2 antibody-drug conjugate MEDI4276,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276
2020-09-18T04:24:24Z,anti-HER2 antibody-drug conjugate RC48,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-rc48
2020-09-18T04:24:24Z,anti-HER2 bispecific antibody-drug conjugate ZW49,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798595
2020-09-18T04:24:24Z,anti-HER2 immune stimulator-antibody conjugate NJH395,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798283
2020-09-18T04:24:24Z,anti-HER2 monoclonal antibody B002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802228
2020-09-18T04:24:24Z,anti-HER2 monoclonal antibody CT-P6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-ct-p6
2020-09-18T04:24:24Z,anti-HER2 monoclonal antibody HLX22,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801537
2020-09-18T04:24:24Z,anti-HER2 monoclonal antibody/anti-CD137 anticalin bispecific fusion protein PRS-343,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791831
2020-09-18T04:24:24Z,anti-HER2-CAR autologous CMV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-car-autologous-cmv-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,anti-HER2-DM1 ADC B003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801748
2020-09-18T04:24:24Z,anti-HER2-vc0101 ADC PF-06804103,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-vc0101-adc-pf-06804103
2020-09-18T04:24:24Z,anti-HER2/Anti-CD3 bispecific monoclonal antibody BTRC 4017A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795725
2020-09-18T04:24:24Z,Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-gbr-1302
2020-09-18T04:24:24Z,anti-HER2/Anti-HER3 bispecific monoclonal antibody MCLA-128,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794043
2020-09-18T04:24:24Z,anti-HER2/auristatin payload antibody-drug conjugate XMT-1522,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522
2020-09-18T04:24:24Z,anti-HER2/HER2 bispecific antibody ZW25,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bi-specific-monoclonal-antibody-zw25
2020-09-18T04:24:24Z,anti-HER2/HER3 dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801200
2020-09-18T04:24:24Z,anti-HER2/PBD-MA antibody-drug conjugate DHES0815A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795265
2020-09-18T04:24:24Z,anti-HER3 antibody-drug conjugate U3 1402,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-antibody-drug-conjugate-u3-1402
2020-09-18T04:24:24Z,anti-HER3 monoclonal antibody GSK2849330,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-gsk2849330
2020-09-18T04:24:24Z,anti-HER3 monoclonal antibody LJM716,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-ljm716
2020-09-18T04:24:24Z,anti-HGF monoclonal antibody TAK-701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hgf-monoclonal-antibody-tak-701
2020-09-18T04:24:24Z,anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hif-1alpha-lna-antisense-oligonucleotide-ezn-2968
2020-09-18T04:24:24Z,anti-HIV-1 lentiviral vector-expressing sh5/C46 Cal-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799502
2020-09-18T04:24:24Z,anti-HLA-A2/NY-ESO-1 TCR-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-a2-ny-eso-1-tcr-transduced-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-HLA-DR monoclonal antibody IMMU-114,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hla-dr-monoclonal-antibody-immu-114
2020-09-18T04:24:24Z,anti-human chorionic gonadotropin vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-chorionic-gonadotropin-vaccine
2020-09-18T04:24:24Z,anti-human GITR monoclonal antibody TRX518,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518
2020-09-18T04:24:24Z,anti-human integrin alpha v subunit monoclonal antibody EMD 525797,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-integrin-alpha-v-subunit-monoclonal-antibody-emd-525797
2020-09-18T04:24:24Z,anti-ICAM-1 monoclonal antibody BI-505,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icam-1-monoclonal-antibody-bi-505
2020-09-18T04:24:24Z,anti-ICOS agonist antibody GSK3359609,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-antibody-gsk3359609
2020-09-18T04:24:24Z,anti-ICOS agonist monoclonal antibody BMS-986226,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792161
2020-09-18T04:24:24Z,anti-ICOS monoclonal antibody KY1044,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798819
2020-09-18T04:24:24Z,anti-ICOS monoclonal antibody MEDI-570,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-medi-570
2020-09-18T04:24:24Z,anti-IGF-1R monoclonal antibody AVE1642,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-monoclonal-antibody-ave1642
2020-09-18T04:24:24Z,anti-IGF-1R recombinant monoclonal antibody BIIB022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf-1r-recombinant-monoclonal-antibody-biib022
2020-09-18T04:24:24Z,anti-IGF1/2 monoclonal antibody MEDI-573,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-igf1-2-monoclonal-antibody-medi-573
2020-09-18T04:24:24Z,anti-IL-1 alpha monoclonal antibody CA-18C3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-ca-18c3
2020-09-18T04:24:24Z,anti-IL-13 humanized monoclonal antibody TNX-650,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-13-humanized-monoclonal-antibody-tnx-650
2020-09-18T04:24:24Z,anti-IL-15 monoclonal antibody AMG 714,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-15-monoclonal-antibody-amg-714
2020-09-18T04:24:24Z,anti-IL-4/IL-13 combination agent QBX258,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258
2020-09-18T04:24:24Z,anti-IL-8 monoclonal antibody HuMax-IL8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-humax-il8
2020-09-18T04:24:24Z,anti-IL17A monoclonal antibody CJM112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792169
2020-09-18T04:24:24Z,anti-ILDR2 monoclonal antibody BAY 1905254,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795831
2020-09-18T04:24:24Z,anti-ILT4 monoclonal antibody MK-4830,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797844
2020-09-18T04:24:24Z,anti-inflammatory antibody ALXN1007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antibody-alxn1007
2020-09-18T04:24:24Z,anti-inflammatory/antimicrobial/analgesic aqueous mouth rinse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-inflammatory-antimicrobial-analgesic-aqueous-mouth-rinse
2020-09-18T04:24:24Z,anti-integrin monoclonal antibody-DM4 immunoconjugate IMGN388,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-integrin-monoclonal-antibody-dm4-immunoconjugate-imgn388
2020-09-18T04:24:24Z,anti-interleukin 6 monoclonal antibody ALD518,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-6-monoclonal-antibody-ald518
2020-09-18T04:24:24Z,anti-interleukin-1 alpha monoclonal antibody MABp1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1
2020-09-18T04:24:24Z,anti-IRF4 antisense oligonucleotide ION251,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802018
2020-09-18T04:24:24Z,anti-K-RAS G12D mTCR-transduced autologous peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796467
2020-09-18T04:24:24Z,anti-K-RAS G12V mTCR-transduced autologous peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12v-mtcr-transduced-autologous-peripheral-blood-lymphocytes
2020-09-18T04:24:24Z,anti-KIR monoclonal antibody IHP 2101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-ihp-2101
2020-09-18T04:24:24Z,anti-KIR3DL2 monoclonal antibody IPH4102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir3dl2-monoclonal-antibody-iph4102
2020-09-18T04:24:24Z,anti-LAG-3 monoclonal antibody BI 754111,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792749
2020-09-18T04:24:24Z,anti-LAG-3 monoclonal antibody IBI-110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800401
2020-09-18T04:24:24Z,anti-LAG-3 monoclonal antibody LAG525,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-lag525
2020-09-18T04:24:24Z,anti-LAG-3 monoclonal antibody REGN3767,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-regn3767
2020-09-18T04:24:24Z,anti-LAG-3 monoclonal antibody Sym022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795379
2020-09-18T04:24:24Z,anti-LAG-3/PD-L1 bispecific antibody FS118,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793522
2020-09-18T04:24:24Z,anti-LAG3 monoclonal antibody MK-4280,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-mk-4280
2020-09-18T04:24:24Z,anti-LAG3 monoclonal antibody TSR-033,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag3-monoclonal-antibody-tsr-033
2020-09-18T04:24:24Z,anti-LAMP1 antibody-drug conjugate SAR428926,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926
2020-09-18T04:24:24Z,anti-LeY-CAR-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ley-car-transduced-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-LGR5 monoclonal antibody BNC101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101
2020-09-18T04:24:24Z,anti-LIF monoclonal antibody MSC-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795377
2020-09-18T04:24:24Z,anti-LOXL2 monoclonal antibody GS-6634,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-loxl2-monoclonal-antibody-gs-6634
2020-09-18T04:24:24Z,anti-Ly6E antibody-drug conjugate DLYE5953A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-dlye5953a
2020-09-18T04:24:24Z,Anti-M-CSF monoclonal antibody MCS110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-m-csf-monoclonal-antibody-mcs110
2020-09-18T04:24:24Z,anti-MAGE-A4 T-cell receptor/anti-CD3 scFv fusion protein IMC-C103C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801761
2020-09-18T04:24:24Z,anti-MASP-2 monoclonal antibody OMS721,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-masp-2-monoclonal-antibody-oms721
2020-09-18T04:24:24Z,anti-mesothelin antibody-drug conjugate BMS-986148,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-antibody-drug-conjugate-bms-986148
2020-09-18T04:24:24Z,anti-mesothelin CAR vector-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-vector-transduced-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-mesothelin cytolytic fusion protein LMB-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cytolytic-fusion-protein-lmb-100
2020-09-18T04:24:24Z,anti-mesothelin iCasp9M28z CAR-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-icasp9m28z-car-transduced-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-mesothelin-CAR mRNA-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-car-mrna-transduced-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-mesothelin/MMAE antibody-drug conjugate RC88,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802312
2020-09-18T04:24:24Z,anti-Met monoclonal antibody mixture Sym015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015
2020-09-18T04:24:24Z,anti-Met/EGFR monoclonal antibody LY3164530,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-egfr-monoclonal-antibody-ly3164530
2020-09-18T04:24:24Z,anti-minor histocompatibility complex donor T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792634
2020-09-18T04:24:24Z,anti-MMP-9 monoclonal antibody GS-5745,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mmp-9-monoclonal-antibody-gs-5745
2020-09-18T04:24:24Z,anti-MUC1 CAR-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc1-car-transduced-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-MUC16/CD3 bispecific antibody REGN4018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793937
2020-09-18T04:24:24Z,anti-MUC16/MMAE antibody-drug conjugate DMUC4064A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792380
2020-09-18T04:24:24Z,anti-MUC17/CD3 BiTE antibody AMG 199,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799758
2020-09-18T04:24:24Z,anti-myeloma monoclonal antibody-DM4 immunoconjugate BT-062,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myeloma-monoclonal-antibody-dm4-immunoconjugate-bt-062
2020-09-18T04:24:24Z,anti-myostatin monoclonal antibody LY2495655,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-myostatin-monoclonal-antibody-ly2495655
2020-09-18T04:24:24Z,anti-NaPi2b antibody-drug conjugate XMT-1592,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802039
2020-09-18T04:24:24Z,anti-NaPi2b monoclonal antibody XMT-1535,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792494
2020-09-18T04:24:24Z,anti-NaPi2b/MMAE antibody-drug conjugate DNIB0600A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-mmae-antibody-drug-conjugate-dnib0600a
2020-09-18T04:24:24Z,anti-Nectin-4 monoclonal antibody-drug conjugate AGS-22M6E,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-monoclonal-antibody-drug-conjugate-ags-22m6e
2020-09-18T04:24:24Z,anti-neuropilin-1 monoclonal antibody MNRP1685A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-neuropilin-1-monoclonal-antibody-mnrp1685a
2020-09-18T04:24:24Z,anti-nf-P2X7 antibody ointment BIL-010t,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nf-p2x7-antibody-ointment-bil-010t
2020-09-18T04:24:24Z,anti-nucleolin aptamer AS1411,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nucleolin-aptamer-as1411
2020-09-18T04:24:24Z,anti-NY-ESO-1 TCR LV-transduced autologous T cells TAEST16001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792389
2020-09-18T04:24:24Z,anti-NY-ESO1 TCR-transduced autologous CD62L+-derived T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso1-tcr-transduced-autologous-cd62l-derived-t-lymphocytes
2020-09-18T04:24:24Z,anti-NY-ESO1/LAGE-1A TCR/scFv anti-CD3 IMCnyeso,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793936
2020-09-18T04:24:24Z,anti-OX40 agonist monoclonal antibody ABBV-368,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792559
2020-09-18T04:24:24Z,anti-OX40 antibody BMS 986178,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-bms-986178
2020-09-18T04:24:24Z,anti-OX40 antibody PF-04518600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-pf-04518600
2020-09-18T04:24:24Z,anti-OX40 monoclonal antibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody
2020-09-18T04:24:24Z,anti-OX40 monoclonal antibody IBI101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797150
2020-09-18T04:24:24Z,anti-OX40 monoclonal antibody MEDI0562,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-medi0562
2020-09-18T04:24:24Z,anti-PLGF monoclonal antibody TB-403,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-plgf-monoclonal-antibody-tb-403
2020-09-18T04:24:24Z,anti-p53 T-cell receptor-transduced peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-p53-t-cell-receptor-transduced-peripheral-blood-lymphocytes
2020-09-18T04:24:24Z,anti-PD-1 fusion protein AMP-224,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-fusion-protein-amp-224
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody 609A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801688
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody AK105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794779
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody AMG 404,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798431
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody BCD-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792520
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody BI 754091,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-bi-754091
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody F520,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798724
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody HX008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797959
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody JTX-4014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796722
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody LZM009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793463
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody MEDI0680,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody MGA012,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012
2020-09-18T04:24:24Z,anti-PD-1 monoclonal antibody Sym021,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-sym021
2020-09-18T04:24:24Z,anti-PD-1/anti-CTLA-4 DART protein MGD019,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797142
2020-09-18T04:24:24Z,anti-PD-1/anti-HER2 bispecific antibody IBI315,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802264
2020-09-18T04:24:24Z,anti-PD-1/anti-LAG-3 bispecific antibody RO7247669,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801886
2020-09-18T04:24:24Z,anti-PD-1/anti-LAG-3 DART protein MGD013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792154
2020-09-18T04:24:24Z,anti-PD-1/anti-PD-L1 bispecific antibody IBI318,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801472
2020-09-18T04:24:24Z,anti-PD-1/anti-PD-L1 bispecific antibody LY3434172,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801671
2020-09-18T04:24:24Z,anti-PD-1/CD47 infusion protein HX009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800318
2020-09-18T04:24:24Z,anti-PD-1/CTLA-4 bispecific antibody AK104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793930
2020-09-18T04:24:24Z,anti-PD-1/TIM-3 bispecific antibody RO7121661,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797892
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody A167,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799136
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody BCD-135,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795701
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody BGB-A333,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794412
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody CBT-502,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795708
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody CK-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793157
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody CS1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794350
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody FAZ053,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody HLX20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799415
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody IMC-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801687
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody KN035,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-kn035
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody MDX-1105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-mdx-1105
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody MSB2311,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795264
2020-09-20T05:26:50Z,anti-PD-L1 monoclonal antibody RC98,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802372
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody SHR-1316,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792709
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody TG-1501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797005
2020-09-18T04:24:24Z,anti-PD-L1 monoclonal antibody ZKAB001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798649
2020-09-18T04:24:24Z,anti-PD-L1/4-1BB bispecific antibody INBRX-105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797967
2020-09-18T04:24:24Z,anti-PD-L1/anti-4-1BB bispecific monoclonal antibody GEN1046,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801584
2020-09-18T04:24:24Z,anti-PD-L1/CTLA-4 bispecific antibody KN046,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796892
2020-09-18T04:24:24Z,anti-PD-L1/TIM-3 bispecific antibody LY3415244,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796576
2020-09-18T04:24:24Z,anti-PD1 monoclonal antibody AGEN2034,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-agen2034
2020-09-18T04:24:24Z,anti-PD1/anti-CTLA4 antibody mixture PSB205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798992
2020-09-18T04:24:24Z,anti-PD1/CTLA4 bispecific antibody XmAb20717,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793410
2020-09-18T04:24:24Z,anti-PD1/ICOS bispecific monoclonal antibody XmAb23104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796973
2020-09-18T04:24:24Z,anti-PDGFR alpha monoclonal antibody MEDI-575,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdgfr-alpha-monoclonal-antibody-medi-575
2020-09-18T04:24:24Z,anti-PGF monoclonal antibody RO5323441,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pgf-monoclonal-antibody-ro5323441
2020-09-18T04:24:24Z,anti-PKN3 siRNA Atu027,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pkn3-sirna-atu027
2020-09-18T04:24:24Z,Aromasin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane
2020-09-18T04:24:24Z,anti-PR1/HLA-A2 monoclonal antibody Hu8F4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pr1-hla-a2-monoclonal-antibody-hu8f4
2020-09-18T04:24:24Z,anti-PRAME T-cell receptor/anti-CD3 scFv fusion protein IMC-F106C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801222
2020-09-18T04:24:24Z,anti-PRL-3 monoclonal antibody PRL3-zumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793124
2020-09-18T04:24:24Z,anti-programmed cell death protein 1 antibody expressing pluripotent killer T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778444
2020-09-18T04:24:24Z,anti-prolactin receptor antibody LFA102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prolactin-receptor-antibody-lfa102
2020-09-18T04:24:24Z,anti-PSCA fully human monoclonal antibody AGS-1C4D4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psca-fully-human-monoclonal-antibody-ags-1c4d4
2020-09-18T04:24:24Z,anti-PSMA monoclonal antibody MDX1201-A488,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mdx1201-a488
2020-09-18T04:24:24Z,anti-PSMA monoclonal antibody-MMAE conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mmae-conjugate
2020-09-18T04:24:24Z,anti-PSMA/CD28 bispecific antibody REGN5678,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799093
2020-09-18T04:24:24Z,anti-PSMA/CD3 bispecific antibody CCW702,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800617
2020-09-18T04:24:24Z,anti-PSMA/CD3 bispecific antibody JNJ-63898081,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801628
2020-09-18T04:24:24Z,anti-PSMA/CD3 BiTE antibody AMG 160,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796695
2020-09-18T04:24:24Z,anti-PSMA/CD3 BiTE monoclonal antibody MT112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-monoclonal-antibody-mt112
2020-09-18T04:24:24Z,anti-PSMA/CD3 monoclonal antibody MOR209/ES414,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-monoclonal-antibody-mor209-es414
2020-09-18T04:24:24Z,anti-PSMA/PBD ADC MEDI3726,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-pbd-adc-medi3726
2020-09-18T04:24:24Z,anti-PVRIG monoclonal antibody COM701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796463
2020-09-18T04:24:24Z,anti-RANKL monoclonal antibody GB-223,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802325
2020-09-18T04:24:24Z,anti-ROR1 ADC VLS-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797160
2020-09-18T04:24:24Z,anti-RSPO3 monoclonal antibody OMP-131R10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-rspo3-monoclonal-antibody-omp-131r10
2020-09-18T04:24:24Z,anti-RSV nanobody ALX-0171,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795427
2020-09-18T04:24:24Z,anti-S15 monoclonal antibody NC318,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796496
2020-09-18T04:24:24Z,anti-sCLU monoclonal antibody AB-16B5,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sclu-monoclonal-antibody-ab-16b5
2020-09-18T04:24:24Z,anti-SEMA4D monoclonal antibody VX15/2503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sema4d-monoclonal-antibody-vx15-2503
2020-09-18T04:24:24Z,anti-SIRPa monoclonal antibody CC-95251,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796792
2020-09-18T04:24:24Z,anti-SLITRK6 monoclonal antibody-MMAE conjugate AGS15E,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-slitrk6-monoclonal-antibody-mmae-conjugate-ags15e
2020-09-18T04:24:24Z,anti-SSTR2/CD3 monoclonal antibody XmAb18087,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792257
2020-09-18T04:24:24Z,anti-TAG-72 monoclonal antibody CC49-streptavidin conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tag-72-monoclonal-antibody-cc49-streptavidin-conjugate
2020-09-18T04:24:24Z,anti-TF monoclonal antibody ALT-836,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-alt-836
2020-09-18T04:24:24Z,anti-TGF-beta monoclonal antibody NIS793,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-nis793
2020-09-18T04:24:24Z,anti-TGF-beta monoclonal antibody SAR-439459,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792270
2020-09-18T04:24:24Z,anti-TGF-beta RII monoclonal antibody IMC-TR1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1
2020-09-18T04:24:24Z,anti-thymocyte globulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin
2020-09-18T04:24:24Z,anti-thyroglobulin mTCR-transduced autologous peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thyroglobulin-mtcr-transduced-autologous-peripheral-blood-lymphocytes
2020-09-18T04:24:24Z,anti-TIGIT monoclonal antibody BMS-986207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-bms-986207
2020-09-18T04:24:24Z,anti-TIGIT monoclonal antibody OMP-313M32,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tigit-monoclonal-antibody-omp-313m32
2020-09-18T04:24:24Z,anti-TIM-3 antibody BMS-986258,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795721
2020-09-18T04:24:24Z,anti-TIM-3 monoclonal antibody BGB-A425,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796770
2020-09-18T04:24:24Z,anti-TIM-3 monoclonal antibody INCAGN02390,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798754
2020-09-18T04:24:24Z,anti-TIM-3 monoclonal antibody Sym023,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793443
2020-09-18T04:24:24Z,anti-TIM-3 monoclonal antibody TSR-022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-tsr-022
2020-09-18T04:24:24Z,anti-TIM3 monoclonal antibody LY3321367,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-ly3321367
2020-09-18T04:24:24Z,anti-TIM3 monoclonal antibody SHR-1702,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801357
2020-09-18T04:24:24Z,anti-tissue factor monoclonal antibody MORAb-066,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tissue-factor-monoclonal-antibody-morab-066
2020-09-18T04:24:24Z,anti-TLR2 monoclonal antibody OPN-305,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tlr2-monoclonal-antibody-opn-305
2020-09-18T04:24:24Z,anti-TRAILR2/CDH17 tetravalent bispecific antibody BI 905711,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801873
2020-09-18T04:24:24Z,anti-transthyretin siRNA ALN-TTR02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02
2020-09-18T04:24:24Z,anti-TRBC1-CAR-CD3zeta-4-1BB-RQR8-expressing autologous T lymphocytes AUTO4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799460
2020-09-18T04:24:24Z,anti-TROP2 antibody-drug conjugate BAT8003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801492
2020-09-18T04:24:24Z,anti-TROP2 antibody-drug conjugate SKB264,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800236
2020-09-18T04:24:24Z,anti-TROP2/DXd antibody-drug conjugate DS-1062a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793720
2020-09-18T04:24:24Z,anti-TWEAK monoclonal antibody RO5458640,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tweak-monoclonal-antibody-ro5458640
2020-09-18T04:24:24Z,anti-VEGF anticalin PRS-050-PEG40,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-anticalin-prs-050-peg40
2020-09-18T04:24:24Z,anti-VEGF monoclonal antibody hPV19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795278
2020-09-18T04:24:24Z,anti-VEGF-C monoclonal antibody VGX-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-c-monoclonal-antibody-vgx-100
2020-09-18T04:24:24Z,anti-VEGF/ANG2 nanobody BI 836880,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880
2020-09-18T04:24:24Z,anti-VEGFR2 monoclonal antibody HLX06,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795367
2020-09-18T04:24:24Z,anti-VEGFR2 monoclonal antibody MSB0254,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802274
2020-09-18T04:24:24Z,anti-VEGFR2-CAR retroviral vector-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr2-car-retroviral-vector-transduced-autologous-t-lymphocytes
2020-09-18T04:24:24Z,anti-VEGFR3 monoclonal antibody IMC-3C5,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr3-monoclonal-antibody-imc-3c5
2020-09-18T04:24:24Z,anti-VISTA monoclonal antibody JNJ 61610588,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vista-monoclonal-antibody-jnj-61610588
2020-09-18T04:24:24Z,anti-von Willebrand factor nanobody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-von-willebrand-factor-nanobody
2020-09-18T04:24:24Z,antiangiogenic drug combination TL-118,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiangiogenic-drug-combination-tl-118
2020-09-18T04:24:24Z,antibiotic SQ109,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibiotic-sq109
2020-09-18T04:24:24Z,antibody-drug conjugate ABBV-011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798433
2020-09-18T04:24:24Z,antibody-drug conjugate ABBV-085,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-085
2020-09-18T04:24:24Z,antibody-drug conjugate ABBV-155,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796806
2020-09-18T04:24:24Z,antibody-drug conjugate ABBV-176,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-176
2020-09-18T04:24:24Z,antibody-drug conjugate ADC XMT-1536,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792493
2020-09-18T04:24:24Z,antibody-drug conjugate anti-TIM-1-vcMMAE CDX-014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014
2020-09-18T04:24:24Z,antibody-drug conjugate BAY79-4620,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-bay79-4620
2020-09-18T04:24:24Z,antibody-drug conjugate DFRF4539A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-dfrf4539a
2020-09-18T04:24:24Z,antibody-drug conjugate MEDI7247,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-medi7247
2020-09-18T04:24:24Z,antibody-drug conjugate SC-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-002
2020-09-18T04:24:24Z,antibody-drug conjugate SC-003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-003
2020-09-18T04:24:24Z,antibody-drug conjugate SC-004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004
2020-09-18T04:24:24Z,antibody-drug conjugate SC-005,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794353
2020-09-18T04:24:24Z,antibody-drug conjugate SC-006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006
2020-09-18T04:24:24Z,antibody-drug conjugate SC-007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792378
2020-09-18T04:24:24Z,antibody-like CD95 receptor/Fc-fusion protein CAN-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-like-cd95-receptor-fc-fusion-protein-can-008
2020-09-18T04:24:24Z,anticachexia agent MT-102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anticachexia-agent-mt-102
2020-09-18T04:24:24Z,antifungal agent F901318,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-f901318
2020-09-18T04:24:24Z,antifungal agent VL-2397,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793892
2020-09-18T04:24:24Z,antifungal PC945,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797368
2020-09-18T04:24:24Z,antigen-presenting cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799743
2020-09-18T04:24:24Z,antigen-targeted personalized breast cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-targeted-personalized-breast-cancer-vaccine
2020-09-18T04:24:24Z,"antihemophilic factor, human recombinant",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antihemophilic-factor-human-recombinant
2020-09-18T04:24:24Z,antimetabolite FF-10502,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antimetabolite-ff-10502
2020-09-18T04:24:24Z,antineoplaston A10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10
2020-09-18T04:24:24Z,antineoplaston AS2-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1
2020-09-18T04:24:24Z,antiperspirant cream F511,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiperspirant-cream-f511
2020-09-18T04:24:24Z,antisecretory factor-enriched egg yolk powder supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799798
2020-09-18T04:24:24Z,antisense oligonucleotide QR-313,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798741
2020-09-18T04:24:24Z,antitumor B key active component-alpha,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795710
2020-09-18T04:24:24Z,antiviral agent CSJ148,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antiviral-agent-csj148
2020-09-18T04:24:24Z,Antrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium
2020-09-18T04:24:24Z,Antrodia cinnamomea supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antrodia-cinnamomea-supplement
2020-09-18T04:24:24Z,AO+ Mist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123
2020-09-18T04:24:24Z,apadamtase alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801172
2020-09-18T04:24:24Z,apalutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide
2020-09-18T04:24:24Z,apatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatinib
2020-09-18T04:24:24Z,apatorsen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen
2020-09-18T04:24:24Z,apaziquone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone
2020-09-18T04:24:24Z,APC8015F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apc8015f
2020-09-18T04:24:24Z,APE1/Ref-1 redox inhibitor APX3330,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794415
2020-09-18T04:24:24Z,APF530,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apf530
2020-09-18T04:24:24Z,apilimod dimesylate capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apilimod-dimesylate-capsule
2020-09-18T04:24:24Z,apixaban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban
2020-09-18T04:24:24Z,Aplenzin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878
2020-09-18T04:24:24Z,Aplidin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin
2020-09-18T04:24:24Z,apolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab
2020-09-18T04:24:24Z,apomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apomab
2020-09-18T04:24:24Z,apoptosis inducer BZL101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-bzl101
2020-09-18T04:24:24Z,apoptosis inducer GCS-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-gcs-100
2020-09-18T04:24:24Z,apoptosis inducer MPC-2130,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apoptosis-inducer-mpc-2130
2020-09-18T04:24:24Z,apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/739744
2020-09-18T04:24:24Z,APOTONE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androstane-steroid-he3235
2020-09-18T04:24:24Z,aprepitant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant
2020-09-18T04:24:24Z,apricoxib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apricoxib
2020-09-18T04:24:24Z,Apriso,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine
2020-09-18T04:24:24Z,aprotinin bovine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprotinin-bovine
2020-09-18T04:24:24Z,aprutumab ixadotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-antibody-drug-conjugate-bay1187982
2020-09-18T04:24:24Z,Aptosyn,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind
2020-09-18T04:24:24Z,Aquacel AG with Hydrofiber,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/632702
2020-09-18T04:24:24Z,Aquacel Dressing,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-carboxymethylcellulose-dressing
2020-09-18T04:24:24Z,Aquadiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol
2020-09-18T04:24:24Z,Aquaphor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/petrolatum-mineral-oil-lanolin-ceresin-ointment
2020-09-18T04:24:24Z,Aquasol A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839
2020-09-18T04:24:24Z,AR antagonist BMS-641988,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-bms-641988
2020-09-18T04:24:24Z,Aralast,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human
2020-09-18T04:24:24Z,Aranelle,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,Aranesp,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa
2020-09-18T04:24:24Z,Arava,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide
2020-09-18T04:24:24Z,ARC fusion protein SL-279252,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798455
2020-09-18T04:24:24Z,Archexin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-antisense-oligonucleotide-rx-0201
2020-09-18T04:24:24Z,arcitumomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab
2020-09-18T04:24:24Z,Arcoxia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib
2020-09-18T04:24:24Z,Aredia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium
2020-09-18T04:24:24Z,arfolitixorin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585
2020-09-18T04:24:24Z,arginase inhibitor INCB001158,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158
2020-09-18T04:24:24Z,arginase-1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798381
2020-09-18T04:24:24Z,arginine butyrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-butyrate
2020-09-18T04:24:24Z,arginine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793609
2020-09-18T04:24:24Z,arginine/nucleotides/omega-3 fatty acids/olive oil polyphenols/antioxidants/L-carnitine oral supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800949
2020-09-18T04:24:24Z,arginine/omega-3 fatty acids/nucleotides oral supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement
2020-09-18T04:24:24Z,ArginMax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng--gingko-biloba-damiana-based-supplement
2020-09-18T04:24:24Z,Aricept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride
2020-09-18T04:24:24Z,Arimidex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole
2020-09-18T04:24:24Z,Aristocort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone
2020-09-18T04:24:24Z,Aristocort A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide
2020-09-18T04:24:24Z,Arixtra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fondaparinux-sodium
2020-09-18T04:24:24Z,armodafinil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/armodafinil
2020-09-18T04:24:24Z,Arnebia Indigo Jade Pearl topical cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arnebia-indigo-jade-pearl-topical-cream
2020-09-18T04:24:24Z,Arranon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine
2020-09-18T04:24:24Z,arsenic trioxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide
2020-09-18T04:24:24Z,arsenic trioxide capsule formulation ORH 2014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014
2020-09-18T04:24:24Z,artemether sublingual spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artemether-sublingual-spray
2020-09-18T04:24:24Z,artesunate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artesunate
2020-09-18T04:24:24Z,artichoke whole phytocomplex concentrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artichoke-whole-phytocomplex-concentrate
2020-09-18T04:24:24Z,artificial saliva spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/artificial-saliva-spray
2020-09-18T04:24:24Z,aryl hydrocarbon receptor antagonist BAY2416964,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799706
2020-09-18T04:24:24Z,Arzerra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab
2020-09-18T04:24:24Z,arzoxifene hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arzoxifene-hydrochloride
2020-09-18T04:24:24Z,AS03-adjuvanted H1N1 pandemic influenza vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/as03-adjuvanted-h1n1-pandemic-influenza-vaccine
2020-09-18T04:24:24Z,Asacol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine
2020-09-18T04:24:24Z,asaley,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asaley
2020-09-18T04:24:24Z,asciminib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-bcr-abl-tyrosine-kinase-inhibitor-abl001
2020-09-18T04:24:24Z,Asclera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212
2020-09-18T04:24:24Z,ascorbic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid
2020-09-18T04:24:24Z,ashwagandha root powder extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ashwagandha-root-powder-extract
2020-09-18T04:24:24Z,Asian ginseng,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asian-ginseng
2020-09-18T04:24:24Z,ASK1 inhibitor GS-4997,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ask1-inhibitor-gs-4997
2020-09-18T04:24:24Z,ASONEP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab
2020-09-18T04:24:24Z,Asorbicap,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid
2020-09-18T04:24:24Z,ASP4132,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp4132
2020-09-18T04:24:24Z,ASP9853,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp9853
2020-09-18T04:24:24Z,asparaginase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase
2020-09-18T04:24:24Z,asparaginase Erwinia chrysanthemi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi
2020-09-18T04:24:24Z,Asparlas,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol
2020-09-18T04:24:24Z,Aspergum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid
2020-09-18T04:24:24Z,astatine At 211 anti-CD38 monoclonal antibody OKT10-B10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799762
2020-09-18T04:24:24Z,astaxanthin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801793
2020-09-18T04:24:24Z,Astragalus membranaceus/Angelica gigas/Trichosanthes kirilowii Maximowicz mixed herbal extract SH003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792574
2020-09-18T04:24:24Z,Astragalus-based formulation Qing Shu Yi Qi Tang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astragalus-based-formulation-qing-shu-yi-qi-tang
2020-09-18T04:24:24Z,Astugenal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-as2-1
2020-09-18T04:24:24Z,astuprotimut-R,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astuprotimut-r
2020-09-18T04:24:24Z,asulacrine isethionate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asulacrine-isethionate
2020-09-18T04:24:24Z,asunaprevir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunaprevir
2020-09-18T04:24:24Z,Atacand,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil
2020-09-18T04:24:24Z,atamestane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atamestane
2020-09-18T04:24:24Z,Atengenal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10
2020-09-18T04:24:24Z,atenolol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atenolol
2020-09-18T04:24:24Z,atezolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab
2020-09-18T04:24:24Z,Atgam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074
2020-09-18T04:24:24Z,ATGAM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin
2020-09-18T04:24:24Z,atiprimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atiprimod
2020-09-18T04:24:24Z,Ativan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorazepam
2020-09-18T04:24:24Z,ATM inhibitor M 3541,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541
2020-09-18T04:24:24Z,ATM kinase inhibitor AZD0156,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-kinase-inhibitor-azd0156
2020-09-18T04:24:24Z,ATN-161,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atn-161
2020-09-18T04:24:24Z,atomoxetine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atomoxetine-hydrochloride
2020-09-18T04:24:24Z,atorvastatin calcium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium
2020-09-18T04:24:24Z,ATR kinase inhibitor BAY1895344,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792166
2020-09-18T04:24:24Z,ATR kinase inhibitor M1774,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801231
2020-09-18T04:24:24Z,ATR kinase inhibitor M6620,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-vx-970
2020-09-18T04:24:24Z,ATR-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-101
2020-09-18T04:24:24Z,Atragen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin
2020-09-18T04:24:24Z,atrasentan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride
2020-09-18T04:24:24Z,Atromid-S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate
2020-09-18T04:24:24Z,atropine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atropine-sulfate
2020-09-18T04:24:24Z,attenuated chimpanzee adenovirus 5T4 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-chimpanzee-adenovirus-5t4-vaccine
2020-09-18T04:24:24Z,attenuated Listeria monocytogenes CRS-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/attenuated-listeria-monocytogenes-crs-100
2020-09-18T04:24:24Z,Augmentin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin-clavulanate-potassium
2020-09-18T04:24:24Z,auranofin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/auranofin
2020-09-18T04:24:24Z,Aurimmune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor
2020-09-18T04:24:24Z,Aurixim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533
2020-09-18T04:24:24Z,Aurolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate
2020-09-18T04:24:24Z,aurora A kinase inhibitor LY3295668 erbumine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792635
2020-09-18T04:24:24Z,Aurora A kinase inhibitor TAS-119,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-tas-119
2020-09-18T04:24:24Z,Aurora A kinase/tyrosine kinase inhibitor ENMD-2076,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-tyrosine-kinase-inhibitor-enmd-2076
2020-09-18T04:24:24Z,Aurora B kinase inhibitor TAK-901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-kinase-inhibitor-tak-901
2020-09-18T04:24:24Z,Aurora B/C kinase inhibitor GSK1070916A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-c-kinase-inhibitor-gsk1070916a
2020-09-18T04:24:24Z,Aurora kinase A/B inhibitor TT-00420,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798739
2020-09-18T04:24:24Z,Aurora kinase inhibitor AMG 900,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-amg-900
2020-09-18T04:24:24Z,Aurora kinase inhibitor BI 811283,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-bi-811283
2020-09-18T04:24:24Z,Aurora kinase inhibitor MLN8054,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-mln8054
2020-09-18T04:24:24Z,Aurora kinase inhibitor PF-03814735,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-pf-03814735
2020-09-18T04:24:24Z,Aurora kinase inhibitor SNS-314,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-sns-314
2020-09-18T04:24:24Z,Aurora kinase inhibitor TTP607,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-inhibitor-ttp607
2020-09-18T04:24:24Z,Aurora kinase/VEGFR2 inhibitor CYC116,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-vegfr2-inhibitor-cyc116
2020-09-18T04:24:24Z,autologous ACTR-CD16-CD28-expressing T lymphocytes ACTR707,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-actr-cd16-cd28-expressing-t-lymphocytes-actr707
2020-09-18T04:24:24Z,autologous Ad-CD154-transduced CLL B cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ad-cd154-transduced-cll-b-cells
2020-09-18T04:24:24Z,autologous AFP-specific T cell receptor T cells C-TCR055,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801757
2020-09-18T04:24:24Z,autologous AML/dendritic cell fusion vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792537
2020-09-18T04:24:24Z,autologous anti-BCMA CAR-T cells IM21,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797877
2020-09-18T04:24:24Z,autologous anti-BCMA CAR-transduced T cells KITE-585,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794792
2020-09-18T04:24:24Z,autologous anti-BCMA CD8+ CAR T cells Descartes-11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801760
2020-09-18T04:24:24Z,autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T lymphocytes JCARH125,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792482
2020-09-18T04:24:24Z,autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing memory T lymphocytes bb21217,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791258
2020-09-18T04:24:24Z,autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing T cells CT053,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799961
2020-09-18T04:24:24Z,autologous anti-BCMA-CAR-expressing CD4+/CD8+ T lymphocytes FCARH143,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794992
2020-09-18T04:24:24Z,autologous anti-BCMA-CAR-expressing stem memory T cells P-BCMA-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-stem-memory-t-cells-p-bcma-101
2020-09-18T04:24:24Z,autologous anti-BCMA-CAR-mRNA-transfected CD8+ T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795728
2020-09-18T04:24:24Z,autologous anti-BCMA-CAR-TCRz/4-1BB-expressing T lymphocytes CART-BCMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795542
2020-09-18T04:24:24Z,autologous anti-CD123 CAR TCR/4-1BB-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd123-car-tcr-4-1bb-expressing-t-lymphocytes
2020-09-18T04:24:24Z,autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T lymphocytes BinD19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792748
2020-09-18T04:24:24Z,autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T lymphocytes huCART19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795543
2020-09-18T04:24:24Z,autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793525
2020-09-18T04:24:24Z,autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells PZ01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793588
2020-09-18T04:24:24Z,autologous anti-CD19 CAR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes
2020-09-18T04:24:24Z,autologous anti-CD19 CAR-expressing T lymphocytes CLIC-1901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797095
2020-09-18T04:24:24Z,autologous anti-CD19 CAR-T cells IM19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794869
2020-09-18T04:24:24Z,autologous anti-CD19 CAR-T cells TBI-1501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792746
2020-09-18T04:24:24Z,autologous anti-CD19 chimeric antigen receptor T cells AUTO1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801949
2020-09-18T04:24:24Z,autologous anti-CD19 chimeric antigen receptor T cells C-CAR011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-c-car011
2020-09-18T04:24:24Z,autologous anti-CD19 chimeric antigen receptor T cells SJCAR19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-sjcar19
2020-09-18T04:24:24Z,autologous anti-CD19 T-cell receptor T cells ET190L1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794393
2020-09-18T04:24:24Z,autologous anti-CD19 TAC-T cells TAC01-CD19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801474
2020-09-18T04:24:24Z,autologous anti-CD19/anti-CD20-CAR-CD28-4-1BB-CD3zeta-EGFRt+-expressing Tn/mem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798415
2020-09-18T04:24:24Z,autologous anti-CD19/CD20 bispecific nanobody-based CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801489
2020-09-18T04:24:24Z,autologous anti-CD19/CD22 CAR-T cells AUTO3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798924
2020-09-18T04:24:24Z,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ central memory T lymphocytes JCAR014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780444
2020-09-18T04:24:24Z,autologous anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19car-4-1bb-cd3zeta-egfrt-expressing-t-lymphocytes
2020-09-18T04:24:24Z,autologous anti-CD19CAR-CD28tm/4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T lymphocytes SCRI-huCAR19v1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797052
2020-09-18T04:24:24Z,autologous anti-CD19CAR-CD3zeta-4-1BB-IL-15-PD1-expressing tri-functional T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795364
2020-09-18T04:24:24Z,autologous anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794873
2020-09-18T04:24:24Z,autologous anti-CD20 CAR transduced CD4/CD8 enriched T cells MB-CART20.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801497
2020-09-18T04:24:24Z,autologous anti-CD22 CAR-4-1BB-TCRz-transduced T lymphocytes CART22-65s,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795556
2020-09-18T04:24:24Z,autologous anti-CD38 A2 CAR2-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795452
2020-09-18T04:24:24Z,autologous anti-CD7 CAR/28zeta CRISPR-edited T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798380
2020-09-18T04:24:24Z,autologous anti-Claudin18.2-transduced T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792788
2020-09-18T04:24:24Z,autologous anti-CS1 hinge-optimized CAR-4-1BB-EGFRt-expressing memory-enriched T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797881
2020-09-18T04:24:24Z,autologous anti-EGFR CAR-transduced CXCR 5-modified T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802166
2020-09-18T04:24:24Z,autologous anti-EGFRvIII 4SCAR-IgT cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793086
2020-09-18T04:24:24Z,autologous anti-FLT3 CAR T cells AMG 553,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801528
2020-09-18T04:24:24Z,autologous anti-GD2CAR-CD28-CD3zeta-IL-15-expressing natural killer T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797483
2020-09-18T04:24:24Z,autologous anti-gp100:154-162 T-cell receptor gene-engineered peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560190
2020-09-18T04:24:24Z,autologous anti-gp100CAR-CD3zeta-4-1BB-IL-15-PD1-expressing tri-functional T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798757
2020-09-18T04:24:24Z,autologous anti-HER2-CAR-4-1BB-CD3zeta-CD19t+-expressing Tcm-enriched T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794190
2020-09-18T04:24:24Z,autologous anti-HLA-A*02/AFP TCRm-expressing T cells ET140202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798638
2020-09-18T04:24:24Z,autologous anti-HLA-A*0201/AFP CAR-T cells ET1402L1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794793
2020-09-18T04:24:24Z,autologous anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T cells AIC100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801844
2020-09-18T04:24:24Z,autologous anti-MART-1 F5 T-cell receptor gene-engineered peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/560192
2020-09-18T04:24:24Z,autologous anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795279
2020-09-18T04:24:24Z,autologous anti-MG7-CAR T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mg7-car-t-lymphocytes
2020-09-18T04:24:24Z,autologous anti-MUC1*-CAR-4-1BB-CD3zeta-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801391
2020-09-18T04:24:24Z,autologous anti-Muc1/CD33/CD38/CD56/CD123 gene-engineered CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793184
2020-09-18T04:24:24Z,autologous anti-NY-ESO-1 mTCR retroviral vector-transduced PBLs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796924
2020-09-18T04:24:24Z,autologous anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T lymphocytes GSK3377794,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-lage-1-tcr-transduced-c259-t-lymphocytes
2020-09-18T04:24:24Z,autologous anti-PD-1 antibody-activated tumor-infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801527
2020-09-18T04:24:24Z,autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797158
2020-09-18T04:24:24Z,autologous anti-PSMA gene-modified T-cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psma-gene-modified-t-cells
2020-09-18T04:24:24Z,autologous anti-SLAMF7 CAR-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798436
2020-09-18T04:24:24Z,autologous AXL-targeted CAR-T cells CCT301-38,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794160
2020-09-18T04:24:24Z,autologous B-cell/monocyte-presenting HER2/neu antigen vaccine BVAC-B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795331
2020-09-18T04:24:24Z,autologous BCMA-4-1BBz-targeted CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792637
2020-09-18T04:24:24Z,autologous BCMA-targeted CAR T cells LCAR-B4822M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798658
2020-09-18T04:24:24Z,autologous BCMA-targeted CAR-T cells CC-98633,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802040
2020-09-18T04:24:24Z,autologous BCMA/TACI-targeted CAR T cells AUTO2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793032
2020-09-18T04:24:24Z,autologous beta-A(T87Q)-globin gene-transduced CD34-positive cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells
2020-09-18T04:24:24Z,B-Raf/VEGFR-2 inhibitor RAF265,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b-raf-vegfr-2-inhibitor-raf265
2020-09-18T04:24:24Z,autologous bi-epitope BCMA-targeted CAR T cells JNJ-68284528,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792630
2020-09-18T04:24:24Z,autologous bispecific CD19/CD22-targeted CAR-T cells GC022F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800937
2020-09-18T04:24:24Z,autologous bone marrow-derived CD34/CXCR4-positive stem cells AMR-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bone-marrow-derived-cd34-cxcr4-positive-stem-cells-amr-001
2020-09-18T04:24:24Z,autologous c-Met/PD-L1-specific CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798662
2020-09-18T04:24:24Z,autologous CAR-mbIL15-safety switch T cells PRGN-3006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798420
2020-09-18T04:24:24Z,autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794781
2020-09-18T04:24:24Z,autologous CD123-4SCAR-expressing T cells 4SCAR123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792687
2020-09-18T04:24:24Z,autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes
2020-09-18T04:24:24Z,autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T lymphocytes MB-102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799773
2020-09-18T04:24:24Z,autologous CD133-positive BTSC mRNA-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642488
2020-09-18T04:24:24Z,autologous CD138-specific CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798661
2020-09-18T04:24:24Z,autologous CD171-specific CAR-CD28 zeta-4-1-BB-EGFRt-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/767199
2020-09-18T04:24:24Z,autologous CD19 CAR-expressing CD4+/CD8+ T cells MB-CART19.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801342
2020-09-18T04:24:24Z,autologous CD19-28z chimeric antigen receptor-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-28z-chimeric-antigen-receptor-expressing-t-lymphocytes
2020-09-18T04:24:24Z,autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793561
2020-09-18T04:24:24Z,autologous CD19-targeted CAR T cells JWCAR029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794777
2020-09-18T04:24:24Z,autologous CD19-targeted CAR-T cells GC007F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800931
2020-09-18T04:24:24Z,autologous CD19/CD22 chimeric antigen receptor T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-cd22-chimeric-antigen-receptor-t-cells
2020-09-18T04:24:24Z,autologous CD19/PD-1 bispecific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801669
2020-09-18T04:24:24Z,autologous CD19CAR-CD28-CD137/CD27/CD3zeta-iCasp9-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792521
2020-09-18T04:24:24Z,autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-cells
2020-09-18T04:24:24Z,autologous CD20-4SCAR-expressing T cells 4SCAR20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792686
2020-09-18T04:24:24Z,autologous CD22-4SCAR-expressing T cells 4SCAR22,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792685
2020-09-18T04:24:24Z,autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794782
2020-09-18T04:24:24Z,autologous CD34-positive BCL11A-disrupted hematopoietic progenitor cells BIVV003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796965
2020-09-18T04:24:24Z,autologous CD34-positive hematopoietic progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd34-positive-hematopoietic-progenitor-cells
2020-09-18T04:24:24Z,autologous CD34-positive peripheral blood stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800131
2020-09-18T04:24:24Z,autologous CD34+-enriched HSPCs transduced with VSV-G encoding IFN-a2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801353
2020-09-18T04:24:24Z,autologous CD38-4SCAR-expressing T cells 4SCAR38,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792684
2020-09-18T04:24:24Z,autologous CD4- and CD8-positive truncated CD19-expressing antigen presenting T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791464
2020-09-18T04:24:24Z,autologous CD4+/CD8+ 4-1BB-CD3zeta-EGFR806-CAR-EGFRt/4-1BB-CD3zeta- CD19-CAR-HER2tG-expressing CARs T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796591
2020-09-18T04:24:24Z,autologous CD4+/CD8+ EGFR806 specific 4-1BB-CD3zeta-EGFRt-expressing CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796466
2020-09-18T04:24:24Z,autologous CD4+/CD8+ EGFR806-specific 4-1BB-CD3zeta-EGFRt-expressing CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796590
2020-09-18T04:24:24Z,autologous CD5-specific CAR-28 zeta CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792575
2020-09-18T04:24:24Z,autologous CD8-positive PBL sensitized to Drosophila cell-presented melanoma peptides,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/693322
2020-09-18T04:24:24Z,autologous CD8+ melanoma-specific T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd8-melanoma-specific-t-cells
2020-09-18T04:24:24Z,autologous CEA-specific cytotoxic T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cea-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,autologous cervical cancer-specific engineered immune effector cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794651
2020-09-18T04:24:24Z,autologous CISH-inactivated TILs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793668
2020-09-18T04:24:24Z,autologous CLL1-CD33 compound CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796670
2020-09-18T04:24:24Z,autologous clonal neoantigen T cells ATL001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800942
2020-09-18T04:24:24Z,autologous CMV-pp65-flLAMP mRNA-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795394
2020-09-18T04:24:24Z,autologous CMV-pp65-shLAMP-1 mRNA loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797472
2020-09-18T04:24:24Z,autologous colon cancer cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colon-cancer-cell-vaccine
2020-09-18T04:24:24Z,autologous colorectal tumor antigen-pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-colorectal-tumor-antigen-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted CD8+/CD34t+ T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796813
2020-09-18T04:24:24Z,autologous CT7/MAGE-A3/WT1 mRNA-electroporated Langerhans-type dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755477
2020-09-18T04:24:24Z,autologous cultured acute myeloid leukemia-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cultured-acute-myeloid-leukemia-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,autologous cytokine-induced killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cytokine-induced-killer-cells
2020-09-18T04:24:24Z,autologous cytoplasmic activated PD-1 CAR-Tcells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797088
2020-09-18T04:24:24Z,autologous cytotoxic T lymphocytes exposed to dendritic cells loaded with 6B11 anti-idiotype minibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797090
2020-09-18T04:24:24Z,autologous cytotoxic T lymphocytes induced with MUC1 gene-transfected dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777274
2020-09-18T04:24:24Z,autologous cytotoxic T lymphocytes induced with MUC1 peptide-transfected dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777275
2020-09-18T04:24:24Z,autologous deep IL-15 primed T cells TRQ15-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797353
2020-09-18T04:24:24Z,autologous dendritic cell vaccine ACT2001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-vaccine-act2001
2020-09-18T04:24:24Z,autologous dendritic cell-adenovirus CCL21 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-ccl21-vaccine
2020-09-18T04:24:24Z,autologous dendritic cell-adenovirus p53 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-adenovirus-p53-vaccine
2020-09-18T04:24:24Z,autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine
2020-09-18T04:24:24Z,autologous dendritic cell-autologous tumor mRNA-human CD40L vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-autologous-tumor-mrna-human-cd40l-vaccine
2020-09-18T04:24:24Z,autologous dendritic cell-based immunotherapeutic AV0113,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-based-immunotherapeutic-av0113
2020-09-18T04:24:24Z,autologous dendritic cell-tumor fusion vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-tumor-fusion-vaccine
2020-09-18T04:24:24Z,autologous dendritic cells pulsed with MART-1 (26-35) peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cells-pulsed-with-mart-1-26-35-peptide
2020-09-18T04:24:24Z,autologous dinitrophenyl-modified ovarian cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine
2020-09-18T04:24:24Z,autologous E6 T cell receptor genetically-modified T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793136
2020-09-18T04:24:24Z,autologous EBV-CTL CD19CAR zeta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ebv-ctl-cd19car-zeta
2020-09-18T04:24:24Z,autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ebv-transformed-b-lymphoblastoid-tumor-fusion-cell-vaccine
2020-09-18T04:24:24Z,autologous EGFR-specific CAR-T cells expressing anti-PD-1/CTLA-4 antibodies,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793115
2020-09-18T04:24:24Z,autologous EGFRt/BCMA-41BBz-targeted CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792554
2020-09-18T04:24:24Z,autologous Epstein-Barr virus-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-epstein-barr-virus-transformed-b-lymphoblastoid-cell-vaccine
2020-09-18T04:24:24Z,autologous expanded mesenchymal stem cells OTI-010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-expanded-mesenchymal-stem-cells-oti-010
2020-09-18T04:24:24Z,autologous FRa-4SCAR-expressing T cells 4SCAR-FRa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793118
2020-09-18T04:24:24Z,autologous gamma-globinG16D/sh RNA734 gene-transduced CD34-positive cells CSL200,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799772
2020-09-18T04:24:24Z,autologous gamma-retroviral MSGV1 139 scFv EGFRvIII CAR gene-modified T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791887
2020-09-18T04:24:24Z,autologous genetically modified MAGE-A4 C1032 T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-t-cells
2020-09-18T04:24:24Z,autologous genetically-modified MAGE-A4 C1032 CD8alpha T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799099
2020-09-18T04:24:24Z,autologous glioma cell lysate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-glioma-cell-lysate
2020-09-18T04:24:24Z,autologous GM-CSF-secreting breast cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-breast-cancer-vaccine
2020-09-18T04:24:24Z,autologous GM-CSF-secreting lethally irradiated colorectal cancer cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/754007
2020-09-18T04:24:24Z,autologous GM-CSF-secreting lethally irradiated lung cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-lung-cancer-vaccine
2020-09-18T04:24:24Z,autologous GPC3/NY-ESO-1/AFP-specific CD8-positive T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793088
2020-09-18T04:24:24Z,autologous HBV-specific TCR-redirected T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hbv-specific-tcr-redirected-t-lymphocytes
2020-09-18T04:24:24Z,autologous heat-shock protein 70 peptide vaccine AG-858,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-heat-shock-protein-70-peptide-vaccine-ag-858
2020-09-18T04:24:24Z,autologous HER2 chimeric receptor/TGFbeta dominant negative receptor-expressing EBV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/643475
2020-09-18T04:24:24Z,autologous HER2-CAR-modified adenovirus-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797396
2020-09-18T04:24:24Z,autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795343
2020-09-18T04:24:24Z,autologous HNSCC DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hnscc-dna-transfected-semi-allogeneic-fibroblasts-mrc-5-vaccine
2020-09-18T04:24:24Z,autologous HPV-16/18 E6/E7-specific TGF-beta-resistant T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hpv-16-18-e6-e7-specific-tgf-beta-resistant-t-lymphocytes
2020-09-18T04:24:24Z,autologous HPV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794787
2020-09-18T04:24:24Z,autologous HPV16 E7-specific HLA-A*02:01-restricted TCR gene engineered lymphocytes KITE-439,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797966
2020-09-18T04:24:24Z,autologous human anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788957
2020-09-18T04:24:24Z,autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795822
2020-09-18T04:24:24Z,autologous iC9-GD2-CAR-expressing VZV-specific T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-gd2-car-expressing-vzv-specific-t-lymphocytes
2020-09-18T04:24:24Z,autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797486
2020-09-18T04:24:24Z,autologous iCASP9-CD19-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791844
2020-09-18T04:24:24Z,autologous ICASP9-CD19-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-cd19-expressing-t-lymphocytes
2020-09-18T04:24:24Z,autologous IL-21-modulated CD8+ MART1-specific T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-il-21-modulated-cd8-mart1-specific-t-cells
2020-09-18T04:24:24Z,autologous immunoglobulin idiotype-KLH conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-immunoglobulin-idiotype-klh-conjugate-vaccine
2020-09-18T04:24:24Z,autologous interferon-producing killer dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-interferon-producing-killer-dendritic-cells
2020-09-18T04:24:24Z,autologous LMP1-/LMP2- specific cytotoxic T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lmp1--lmp2--specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T lymphocytes YT-E001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798763
2020-09-18T04:24:24Z,autologous lymphoid effector cells specific against tumor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoid-effector-cells-specific-against-tumor-cells
2020-09-18T04:24:24Z,autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoma-cell-lysate-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642645
2020-09-18T04:24:24Z,autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/642644
2020-09-18T04:24:24Z,autologous lymphoma immunoglobulin-derived scFV-chemokine DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-lymphoma-immunoglobulin-derived-scfv-chemokine-dna-vaccine
2020-09-18T04:24:24Z,autologous MAGE-A10-specific HLA-A2-restricted TCR c796 gene-engineered T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786272
2020-09-18T04:24:24Z,"autologous MAGE-A3-specific, HLA-A*01-restricted T cell receptor gene engineered lymphocytes",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/762213
2020-09-18T04:24:24Z,autologous MAGE-A3/A6-specific TCR gene-engineered lymphocytes KITE-718,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718
2020-09-18T04:24:24Z,autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T cells FH-MCVA2TCR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795693
2020-09-18T04:24:24Z,autologous mDC3 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798639
2020-09-18T04:24:24Z,autologous mDC3/8-KRAS vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798704
2020-09-18T04:24:24Z,autologous melanoma lysate-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-melanoma-lysate-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous melanoma lysate/KLH-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-melanoma-lysate-klh-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous melanoma lysate/NY-ESO-1-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/753553
2020-09-18T04:24:24Z,autologous mesenchymal stem cells apceth_101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesenchymal-stem-cells-apceth-101
2020-09-18T04:24:24Z,autologous mesothelin-specific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792529
2020-09-18T04:24:24Z,autologous mesothelin-specific CAR-T cells expressing anti-PD-1/CTLA-4 antibodies,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793113
2020-09-18T04:24:24Z,autologous mesothelin-specific human mRNA CAR-transfected PBMCs MCY-M11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794988
2020-09-18T04:24:24Z,autologous monocyte-derived lysate-pulsed dendritic cells PV-001-DC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801794
2020-09-18T04:24:24Z,autologous mRNA-modified anti-cMET CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792542
2020-09-18T04:24:24Z,autologous MUC1-mannan fusion protein pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-muc1-mannan-fusion-protein-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous natural killer cell-like CTLs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795451
2020-09-18T04:24:24Z,autologous nectin-4/FAP-targeted CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801659
2020-09-18T04:24:24Z,BRAF inhibitor LUT014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797806
2020-09-18T04:24:24Z,autologous neuroblastoma lysate/KLH-pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-neuroblastoma-lysate-klh-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous NKG2D CAR-CD3zeta-DAP10-expressing T lymphocytes CYAD-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-expressing-t-lymphocytes-cm-cs1
2020-09-18T04:24:24Z,autologous NSCLC DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nsclc-dna-transfected-semi-allogeneic-fibroblasts-mrc-5-vaccine
2020-09-18T04:24:24Z,autologous NSCLC peptide-specific dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nsclc-peptide-specific-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous NY-ESO-1 TCR-targeted T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792517
2020-09-18T04:24:24Z,autologous NY-ESO-1-melanoma-specific CD8+ T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-melanoma-specific-cd8-t-cells
2020-09-18T04:24:24Z,autologous NY-ESO-1-redirected CRISPR-edited T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794140
2020-09-18T04:24:24Z,autologous NY-ESO-1-specific CD8-positive T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795738
2020-09-18T04:24:24Z,autologous OFA-iLRP RNA-transfected dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ofa-ilrp-rna-transfected-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous ovarian cancer immunogene-modified T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793116
2020-09-18T04:24:24Z,autologous ovarian cancer-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794654
2020-09-18T04:24:24Z,autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-tumor-cell-lysate-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous oxidized ovarian tumor cell lysate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-oxidized-ovarian-tumor-cell-lysate-vaccine
2020-09-18T04:24:24Z,autologous pancreatic adenocarcinoma lysate- and mRNA-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802181
2020-09-18T04:24:24Z,autologous PBLs retrovirally-transduced with TCRs targeting neoantigens,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792330
2020-09-18T04:24:24Z,autologous PD-1 antibody-expressing mesothelin-specific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792459
2020-09-18T04:24:24Z,autologous PD-1-targeted chimeric switch receptor-modified T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-targeted-chimeric-switch-receptor-modified-t-lymphocytes
2020-09-18T04:24:24Z,autologous PD-L1/CD80/CD86-targeted CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792541
2020-09-18T04:24:24Z,autologous PD1-inhibiting anti-CD19 4-1BB CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793152
2020-09-18T04:24:24Z,autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible IL-12 and anti-NY-ESO-1 TCR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755595
2020-09-18T04:24:24Z,autologous peripheral blood lymphocytes from ibrutinib-treated chronic lymphocytic leukemia patients IOV-2001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800421
2020-09-18T04:24:24Z,autologous pluripotent ALDHbr stem cells ALD-451,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pluripotent-aldhbr-stem-cells-ald-451
2020-09-18T04:24:24Z,autologous PRAME-targeting TCR-modified T cells MDG1011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795276
2020-09-18T04:24:24Z,autologous prostate cancer antigen-expressing dendritic cell vaccine BPX-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/640422
2020-09-18T04:24:24Z,autologous prostate stem cell antigen-specific CAR T cells BPX-601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601
2020-09-18T04:24:24Z,autologous PSMA-4SCAR-expressing T cells 4SCAR-PSMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793119
2020-09-18T04:24:24Z,autologous PSMA-specific TGFβ-resistant CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792627
2020-09-18T04:24:24Z,autologous rapamycin-resistant Th1/Tc1 cells RAPA-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802318
2020-09-18T04:24:24Z,autologous renal cell carcinoma tumor lysate-dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-renal-cell-carcinoma-tumor-lysate-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous ROR2-targeted CAR-T cells CCT301-59,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794161
2020-09-18T04:24:24Z,autologous sarcoma cell lysate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-sarcoma-cell-lysate
2020-09-18T04:24:24Z,autologous sarcoma lysate-pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-sarcoma-lysate-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous T lymphocytes expressing NY-ESO-1-C259-specific enhanced T cell receptors,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776841
2020-09-18T04:24:24Z,autologous TAAs-loaded autologous dendritic cells AV-GBM-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794138
2020-09-18T04:24:24Z,autologous TBX-4000-treated peripheral blood mononuclear cells TBX-3400,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794318
2020-09-18T04:24:24Z,autologous TCR-engineered T cells IMA201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792163
2020-09-18T04:24:24Z,autologous TCR-engineered T cells IMA202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794052
2020-09-18T04:24:24Z,autologous TCR-engineered T cells IMA203,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798429
2020-09-18T04:24:24Z,autologous tetravalent dendritic cell vaccine MIDRIX4-LUNG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800431
2020-09-18T04:24:24Z,autologous Tn-MUC1-specific CAR T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799771
2020-09-18T04:24:24Z,autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-proteoliposome-chronic-lymphocytic-leukemia-vaccine
2020-09-18T04:24:24Z,autologous tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine
2020-09-18T04:24:24Z,autologous tumor infiltrating lymphocytes LN-144,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144
2020-09-18T04:24:24Z,autologous tumor infiltrating lymphocytes LN-145,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145
2020-09-18T04:24:24Z,autologous tumor-associated antigen-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798753
2020-09-18T04:24:24Z,autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-associated-peptide-antigen-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,autologous tumor-infiltrating lymphocytes MDA-TIL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794072
2020-09-18T04:24:24Z,autologous tumor-specific antigen-loaded dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793117
2020-09-18T04:24:24Z,autologous WT1-TCRc4 gene-transduced CD8-positive Tcm/Tn lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-wt1-tcrc4-gene-transduced-cd8-positive-tcm-tn-lymphocytes
2020-09-18T04:24:24Z,avadomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798417
2020-09-18T04:24:24Z,Avage,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene
2020-09-18T04:24:24Z,avanafil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avanafil
2020-09-18T04:24:24Z,Avandia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate
2020-09-18T04:24:24Z,avapritinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285
2020-09-18T04:24:24Z,Avastin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab
2020-09-18T04:24:24Z,avatrombopag maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793425
2020-09-18T04:24:24Z,Aveeno cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-oatmeal-cream
2020-09-18T04:24:24Z,Avelox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride
2020-09-18T04:24:24Z,avelumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab
2020-09-18T04:24:24Z,Avemar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract
2020-09-18T04:24:24Z,Aviane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,Avinza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,Avita,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
2020-09-18T04:24:24Z,avitinib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avitinib-maleate
2020-09-18T04:24:24Z,Avlosulfon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone
2020-09-18T04:24:24Z,Avmacol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-broccoli-seed-extract-supplement
2020-09-18T04:24:24Z,AVN944,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avn944
2020-09-18T04:24:24Z,Avodart,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride
2020-09-18T04:24:24Z,Avycaz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium
2020-09-18T04:24:24Z,axicabtagene ciloleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel
2020-09-18T04:24:24Z,axitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axitinib
2020-09-18T04:24:24Z,AXL inhibitor BGB324,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-bgb324
2020-09-18T04:24:24Z,AXL inhibitor DS-1205c,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793863
2020-09-18T04:24:24Z,AXL inhibitor SLC-391,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801796
2020-09-18T04:24:24Z,AXL kinase inhibitor TP-0903,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-kinase-inhibitor-tp-0903
2020-09-18T04:24:24Z,AXL/ FLT3/VEGFR2 inhibitor KC1036,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802085
2020-09-18T04:24:24Z,AXL/cMET receptor tyrosine kinase inhibitor BPI-9016M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-cmet-receptor-tyrosine-kinase-inhibitor-bpi-9016m
2020-09-18T04:24:24Z,Axl/Mer inhibitor INCB081776,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793938
2020-09-18T04:24:24Z,Axl/Mer inhibitor ONO-7475,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-ono-7475
2020-09-18T04:24:24Z,Axumin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine
2020-09-18T04:24:24Z,Aygestin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate
2020-09-18T04:24:24Z,Ayvakit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdgfr-alpha-kit-mutant-specific-inhibitor-blu-285
2020-09-18T04:24:24Z,azacitidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine
2020-09-18T04:24:24Z,Azactam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aztreonam
2020-09-18T04:24:24Z,azapicyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azapicyl
2020-09-18T04:24:24Z,azaserine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine
2020-09-18T04:24:24Z,AzaSite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin
2020-09-18T04:24:24Z,azathioprine sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azathioprine-sodium
2020-09-18T04:24:24Z,Azedra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131
2020-09-18T04:24:24Z,Azedra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131
2020-09-18T04:24:24Z,aziridinylbenzoquinone RH1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aziridinylbenzoquinone-rh1
2020-09-18T04:24:24Z,azithromycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin
2020-09-18T04:24:24Z,Azixa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verubulin-hydrochloride
2020-09-18T04:24:24Z,AZP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azp
2020-09-18T04:24:24Z,aztreonam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aztreonam
2020-09-18T04:24:24Z,Azulfidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine
2020-09-18T04:24:24Z,azurin-derived cell-penetrating peptide p28,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azurin-derived-cell-penetrating-peptide-p28
2020-09-18T04:24:24Z,B16alphaGal melanoma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b16alphagal-melanoma-vaccine
2020-09-18T04:24:24Z,B43-PAP immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b43-pap-immunotoxin
2020-09-18T04:24:24Z,B7-DC cross-linking antibody rHIgM12B7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b7-dc-cross-linking-antibody-rhigm12b7
2020-09-18T04:24:24Z,babaodan capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795030
2020-09-18T04:24:24Z,bacitracin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacitracin
2020-09-18T04:24:24Z,baclofen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen
2020-09-18T04:24:24Z,baclofen/amitriptyline/ketamine gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen-amitriptyline-ketamine-gel
2020-09-18T04:24:24Z,bacteriophage phi X 174,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bacteriophage-phi-x-174
2020-09-18T04:24:24Z,Bactrim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole
2020-09-18T04:24:24Z,bafetinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bafetinib
2020-09-18T04:24:24Z,Bag Balm,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment
2020-09-18T04:24:24Z,balanced crystalloid solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balanced-crystalloid-solution
2020-09-18T04:24:24Z,balixafortide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-pol6326
2020-09-18T04:24:24Z,baloxavir marboxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205
2020-09-18T04:24:24Z,baltaleucel-T,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t
2020-09-18T04:24:24Z,Balversa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib
2020-09-18T04:24:24Z,Balziva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,banoxantrone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/banoxantrone
2020-09-18T04:24:24Z,Baraclude,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entecavir
2020-09-18T04:24:24Z,barasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barasertib
2020-09-18T04:24:24Z,bardoxolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bardoxolone
2020-09-18T04:24:24Z,baricitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib
2020-09-18T04:24:24Z,barium sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barium-sulfate
2020-09-18T04:24:24Z,Barseb HC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,Basen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose
2020-09-18T04:24:24Z,basiliximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/basiliximab
2020-09-18T04:24:24Z,batabulin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/batabulin-sodium
2020-09-18T04:24:24Z,Bavencio,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab
2020-09-18T04:24:24Z,bavituximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bavituximab
2020-09-18T04:24:24Z,BAY 56-3722,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bay-56-3722
2020-09-18T04:24:24Z,BayGam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,bazedoxifene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bazedoxifene
2020-09-18T04:24:24Z,BC-819 plasmid/polyethylenimine complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bc-819-plasmid-polyethylenimine-complex
2020-09-18T04:24:24Z,BCG solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution
2020-09-18T04:24:24Z,BCG Tokyo-172 strain vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792633
2020-09-18T04:24:24Z,BCG vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-vaccine
2020-09-18T04:24:24Z,Bcl-2 inhibitor APG 2575,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795558
2020-09-18T04:24:24Z,Bcl-2 inhibitor BCL201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201
2020-09-18T04:24:24Z,Bcl-2 inhibitor LP-108,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801885
2020-09-18T04:24:24Z,Bcl-2 inhibitor S65487,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797175
2020-09-18T04:24:24Z,Bcl-2/Bcl-XL inhibitor APG-1252,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792573
2020-09-18T04:24:24Z,BCMA CART cells secreting mutant PD-1Fc fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802262
2020-09-18T04:24:24Z,BCMA x CD3 T-cell-engaging antibody CC-93269,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795389
2020-09-18T04:24:24Z,BCMA-CD19 compound CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795784
2020-09-18T04:24:24Z,BCMA-specific CAR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-specific-car-expressing-t-lymphocytes
2020-09-18T04:24:24Z,bcr-abl (b2a2)-derived peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-b2a2-derived-peptide-vaccine
2020-09-18T04:24:24Z,bcr-abl (b3a2)-derived peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-b3a2-derived-peptide-vaccine
2020-09-18T04:24:24Z,Bcr-Abl kinase inhibitor K0706,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706
2020-09-18T04:24:24Z,Bcr-Abl kinase inhibitor PF-114,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-pf-114
2020-09-18T04:24:24Z,bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-p210-b3a2-breakpoint-derived-multipeptide-vaccine
2020-09-18T04:24:24Z,bcr-abl peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-peptide-vaccine
2020-09-18T04:24:24Z,BCR-ABL/KIT/AKT/ERK inhibitor HQP1351,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799639
2020-09-18T04:24:24Z,BEACOPP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beacopp-regimen
2020-09-18T04:24:24Z,Bead Block Compressible Microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pva-microporous-hydrospheres
2020-09-18T04:24:24Z,becatecarin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/becatecarin
2020-09-18T04:24:24Z,Caprelsa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib
2020-09-18T04:24:24Z,beclomethasone dipropionate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate
2020-09-18T04:24:24Z,Beclovent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate
2020-09-18T04:24:24Z,Beconase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate
2020-09-18T04:24:24Z,Beesix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride
2020-09-18T04:24:24Z,BeetElite NeoShot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-beet-crystals
2020-09-18T04:24:24Z,beetroot juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beetroot-juice
2020-09-18T04:24:24Z,Begedina,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab
2020-09-18T04:24:24Z,begelomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab
2020-09-18T04:24:24Z,belagenpumatucel-L,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belagenpumatucel-l
2020-09-18T04:24:24Z,belantamab mafodotin-blmf,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916
2020-09-18T04:24:24Z,Beleodaq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat
2020-09-18T04:24:24Z,belimumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab
2020-09-18T04:24:24Z,belinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat
2020-09-18T04:24:24Z,belotecan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belotecan-hydrochloride
2020-09-18T04:24:24Z,bemarituzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr2-monoclonal-antibody-fpa144
2020-09-18T04:24:24Z,bemiparin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium
2020-09-18T04:24:24Z,bempegaldesleukin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785056
2020-09-18T04:24:24Z,Benadryl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride
2020-09-18T04:24:24Z,benazepril hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benazepril-hydrochloride
2020-09-18T04:24:24Z,bendamustine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride
2020-09-18T04:24:24Z,bendamustine-containing nanoparticle-based formulation RXDX-107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-containing-nanoparticle-based-formulation-rxdx-107
2020-09-18T04:24:24Z,Bendeka,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride
2020-09-18T04:24:24Z,Bendopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa
2020-09-18T04:24:24Z,Benefin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage
2020-09-18T04:24:24Z,benegrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benegrastim
2020-09-18T04:24:24Z,Benemid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid
2020-09-18T04:24:24Z,Beneo Synergy 1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligofructose-enriched-inulin
2020-09-18T04:24:24Z,Benlysta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab
2020-09-18T04:24:24Z,Benoquin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monobenzone
2020-09-18T04:24:24Z,benralizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794137
2020-09-18T04:24:24Z,benzaldehyde dimethane sulfonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzaldehyde-dimethane-sulfonate
2020-09-18T04:24:24Z,benzoylphenylurea,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzoylphenylurea
2020-09-18T04:24:24Z,benzydamine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride
2020-09-18T04:24:24Z,BEP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bep-regimen
2020-09-18T04:24:24Z,berberine chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berberine-chloride
2020-09-18T04:24:24Z,berubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berubicin-hydrochloride
2020-09-18T04:24:24Z,Berubigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin
2020-09-18T04:24:24Z,Besponsa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin
2020-09-18T04:24:24Z,BET bromodomain inhibitor ZEN-3694,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-zen-3694
2020-09-18T04:24:24Z,BET bromodomains 2/3/4 inhibitor MK-8628,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomains-2-3-4-inhibitor-mk-8628
2020-09-18T04:24:24Z,BET inhibitor ABBV-744,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794664
2020-09-18T04:24:24Z,BET inhibitor BAY1238097,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bay1238097
2020-09-18T04:24:24Z,BET inhibitor BMS-986158,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bms-986158
2020-09-18T04:24:24Z,BET inhibitor CC-90010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793170
2020-09-18T04:24:24Z,BET inhibitor CPI-0610,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-cpi-0610
2020-09-18T04:24:24Z,BET inhibitor FT-1101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ft-1101
2020-09-18T04:24:24Z,BET inhibitor GS-5829,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gs-5829
2020-09-18T04:24:24Z,BET inhibitor GSK2820151,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gsk2820151
2020-09-18T04:24:24Z,BET inhibitor INCB054329,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-incb054329
2020-09-18T04:24:24Z,BET inhibitor RO6870810,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810
2020-09-18T04:24:24Z,BET-bromodomain inhibitor ODM-207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792467
2020-09-18T04:24:24Z,beta carotene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-carotene
2020-09-18T04:24:24Z,beta-elemene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-elemene
2020-09-18T04:24:24Z,beta-glucan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan
2020-09-18T04:24:24Z,beta-glucan MM-10-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan-mm-10-001
2020-09-18T04:24:24Z,beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/717605
2020-09-18T04:24:24Z,beta-glucan/Lactobacillus casei/Bifidobacterium lactis-based supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan-lactobacillus-casei-bifidobacterium-lactis-based-supplement
2020-09-18T04:24:24Z,beta-hydroxy-beta-methylbutyrate supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-hydroxy-beta-methylbutyrate-supplement
2020-09-18T04:24:24Z,beta-lapachone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone
2020-09-18T04:24:24Z,beta-lapachone prodrug ARQ 761,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone-prodrug-arq-761
2020-09-18T04:24:24Z,beta-thioguanine deoxyriboside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-thioguanine-deoxyriboside
2020-09-18T04:24:24Z,Betadine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution
2020-09-18T04:24:24Z,Betadine Solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution
2020-09-18T04:24:24Z,betaglucin gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801525
2020-09-18T04:24:24Z,betahistine hydrochloride nasal spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801531
2020-09-18T04:24:24Z,Betalin 12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin
2020-09-18T04:24:24Z,BetaMarc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formoterol-fumarate-roxithromycin
2020-09-18T04:24:24Z,betamethasone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betamethasone
2020-09-18T04:24:24Z,bethanechol chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bethanechol-chloride
2020-09-18T04:24:24Z,betulinic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid
2020-09-18T04:24:24Z,bevacizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab
2020-09-18T04:24:24Z,bevacizumab-IRDye 800CW,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab-irdye-800cw
2020-09-18T04:24:24Z,bexarotene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene
2020-09-18T04:24:24Z,Bextra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valdecoxib
2020-09-18T04:24:24Z,Bexxar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab-and-iodine-i-131-tositumomab
2020-09-18T04:24:24Z,bezlotoxumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939
2020-09-18T04:24:24Z,BF-200 gel formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bf-200-gel-formulation
2020-09-18T04:24:24Z,BH3 mimetic ABT-737,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bh3-mimetic-abt-737
2020-09-18T04:24:24Z,BI 2536,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-2536
2020-09-18T04:24:24Z,bi-functional alkylating agent VAL-083,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-functional-alkylating-agent-val-083
2020-09-18T04:24:24Z,bi-shRNA-furin/GMCSF-expressing autologous tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gmcsf-expressing-autologous-tumor-cell-vaccine
2020-09-18T04:24:24Z,Biaxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin
2020-09-18T04:24:24Z,BIBX 1382,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bibx-1382
2020-09-18T04:24:24Z,bicalutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide
2020-09-18T04:24:24Z,Bicitra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate
2020-09-18T04:24:24Z,BiCNU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine
2020-09-20T05:26:50Z,Bifidobacterium animalis ssp. lactis probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802338
2020-09-18T04:24:24Z,Bifidobacterium animalis/Lactobacillus rhamnosus probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-lactobacillus-rhamnosus-probiotic-supplement
2020-09-18T04:24:24Z,Bifidobacterium lactis/Lactobacillus acidophilus/inulin probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792560
2020-09-18T04:24:24Z,Bifidobacterium lactis/Lactobacillus acidophilus/L. plantarum/L. salivarius probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/758035
2020-09-18T04:24:24Z,Bifidobacterium longum/Lactobacillus acidophilus/Enterococcus faecalis probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798827
2020-09-18T04:24:24Z,bifunctional expression vector plasmid DNA-bi-shRNA EWS/FLI1 type 1 lipoplex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780967
2020-09-18T04:24:24Z,bimagrumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimagrumab
2020-09-18T04:24:24Z,bimatoprost ophthalmic solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimatoprost-ophthalmic-solution
2020-09-18T04:24:24Z,binimetinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib
2020-09-18T04:24:24Z,Binosto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium
2020-09-18T04:24:24Z,bintrafusp alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795582
2020-09-18T04:24:24Z,bio-enhanced curcumin extract formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439
2020-09-18T04:24:24Z,Biocurcumax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798439
2020-09-18T04:24:24Z,Biomed 101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biomed-101
2020-09-18T04:24:24Z,Bioperine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperine-extract-standardized
2020-09-18T04:24:24Z,Biopress,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil
2020-09-18T04:24:24Z,BioResponse DIM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-microencapsulated-diindolylmethane
2020-09-18T04:24:24Z,Biotest-HCIG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous
2020-09-18T04:24:24Z,biricodar dicitrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biricodar-dicitrate
2020-09-18T04:24:24Z,birinapant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birinapant
2020-09-18T04:24:24Z,bisacodyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisacodyl
2020-09-18T04:24:24Z,bisantrene hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride
2020-09-18T04:24:24Z,bismuth Bi213 monoclonal antibody M195,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bismuth-bi213-monoclonal-antibody-m195
2020-09-18T04:24:24Z,bismuth subsalicylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bismuth-subsalicylate
2020-09-18T04:24:24Z,bisoprolol fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisoprolol-fumarate
2020-09-18T04:24:24Z,bispecific antibody 2B1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-2b1
2020-09-18T04:24:24Z,bispecific antibody 4G7xH22,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-4g7xh22
2020-09-18T04:24:24Z,bispecific antibody AMG 509,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800690
2020-09-18T04:24:24Z,bispecific antibody GS-1423,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800422
2020-09-18T04:24:24Z,bispecific antibody MDX-H210,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx-h210
2020-09-18T04:24:24Z,bispecific antibody MDX447,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx447
2020-09-18T04:24:24Z,bisthianostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799197
2020-09-18T04:24:24Z,BiTE Antibody AMG 910,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801178
2020-09-18T04:24:24Z,bivalent BRD4 inhibitor AZD5153,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793144
2020-09-18T04:24:24Z,bivalent HPV16/18 therapeutic cervical cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-hpv16-18-therapeutic-cervical-cancer-vaccine
2020-09-18T04:24:24Z,bizelesin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizelesin
2020-09-18T04:24:24Z,BL22 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin
2020-09-18T04:24:24Z,black cohosh,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-cohosh
2020-09-18T04:24:24Z,black currant juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797026
2020-09-18T04:24:24Z,black raspberry nectar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-raspberry-nectar
2020-09-18T04:24:24Z,black tea,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-tea
2020-09-18T04:24:24Z,Blenrep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-drug-conjugate-gsk2857916
2020-09-18T04:24:24Z,bleomycin sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bleomycin-sulfate
2020-09-18T04:24:24Z,BLI850,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bli850
2020-09-18T04:24:24Z,blinatumomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab
2020-09-18T04:24:24Z,Blincyto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab
2020-09-18T04:24:24Z,blue citrus-based herbal capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blue-citrus-based-herbal-capsule
2020-09-18T04:24:24Z,blueberry powder supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blueberry-powder-supplement
2020-09-18T04:24:24Z,BMI1 inhibitor PTC596,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bmi1-inhibitor-ptc596
2020-09-18T04:24:24Z,BMS-214662,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bms-214662
2020-09-18T04:24:24Z,boanmycin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boanmycin-hydrochloride
2020-09-18T04:24:24Z,boceprevir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir
2020-09-18T04:24:24Z,bone metastasis targeting peptide-11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bone-metastasis-targeting-peptide-11
2020-09-18T04:24:24Z,Boniva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibandronate-sodium
2020-09-18T04:24:24Z,Boost,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink
2020-09-18T04:24:24Z,Boost Breeze,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797097
2020-09-18T04:24:24Z,boron-dipyrromethene-modified olaparib fluorescent imaging agent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boron-dipyrromethene-modified-olaparib-fluorescent-imaging-agent
2020-09-18T04:24:24Z,boronophenylalanine-fructose complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boronophenylalanine-fructose-complex
2020-09-18T04:24:24Z,bortezomib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib
2020-09-18T04:24:24Z,Bosulif,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib
2020-09-18T04:24:24Z,bosutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib
2020-09-18T04:24:24Z,Boswellia serrata extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boswellia-serrata-extract
2020-09-18T04:24:24Z,botanical agent BEL-X-HG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793949
2020-09-18T04:24:24Z,botanical agent LEAC-102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-leac-102
2020-09-18T04:24:24Z,botanical extract DCB-BO1301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extract-dcb-bo1301
2020-09-18T04:24:24Z,botanical extracts rinse IZN-6N4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-extracts-rinse-izn-6n4
2020-09-18T04:24:24Z,botanical lotion CG428,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-lotion-cg428
2020-09-18T04:24:24Z,BOTOX,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a
2020-09-18T04:24:24Z,Botox cosmetic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a
2020-09-18T04:24:24Z,botulinum toxin E EB-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797646
2020-09-18T04:24:24Z,botulinum toxin type A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a
2020-09-18T04:24:24Z,bovine lactoferrin supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bovine-lactoferrin-supplement
2020-09-18T04:24:24Z,Bowman-Birk inhibitor concentrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bowman-birk-inhibitor-concentrate
2020-09-18T04:24:24Z,BP-Cx1-platinum complex BP-C1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bp-cx1-platinum-complex-bp-c1
2020-09-18T04:24:24Z,brachyury-expressing modified vaccinia Ankara-TRICOM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brachyury-expressing-modified-vaccinia-ankara-tricom-vaccine
2020-09-18T04:24:24Z,brachyury-expressing yeast vaccine GI-6301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brachyury-expressing-yeast-vaccine-gi-6301
2020-09-18T04:24:24Z,BRAF inhibitor ARQ 736,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-arq-736
2020-09-18T04:24:24Z,BRAF inhibitor PLX8394,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-plx8394
2020-09-18T04:24:24Z,BRAF V600E kinase inhibitor RO5212054,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-v600e-kinase-inhibitor-ro5212054
2020-09-18T04:24:24Z,BRAF(V600E) inhibitor CEP-32496,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-inhibitor-cep-32496
2020-09-18T04:24:24Z,BRAF(V600E) kinase inhibitor ABM-1310,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801208
2020-09-18T04:24:24Z,BRAF/EGFR inhibitor BGB-283,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-egfr-inhibitor-bgb-283
2020-09-18T04:24:24Z,Braftovi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib
2020-09-18T04:24:24Z,BRAFV600/PI3K inhibitor ASN003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600-pi3k-inhibitor-asn003
2020-09-18T04:24:24Z,brain tumor initiating cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brain-tumor-initiating-cell-vaccine
2020-09-18T04:24:24Z,Brakiva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-hydrochloride
2020-09-18T04:24:24Z,branched chain amino acid supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/branched-chain-amino-acid-supplement
2020-09-18T04:24:24Z,Brassica vegetable,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brassica-vegetable
2020-09-18T04:24:24Z,BRD4 inhibitor PLX2853,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792077
2020-09-18T04:24:24Z,BRD4 inhibitor PLX51107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx51107
2020-09-18T04:24:24Z,brentuximab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin
2020-09-18T04:24:24Z,brepocitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798452
2020-09-18T04:24:24Z,brequinar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brequinar
2020-09-18T04:24:24Z,Brevicon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,brexucabtagene autoleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259
2020-09-18T04:24:24Z,Bria-IMT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792158
2020-09-18T04:24:24Z,briciclib sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/briciclib-sodium
2020-09-18T04:24:24Z,Bridion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugammadex-sodium
2020-09-18T04:24:24Z,brigatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib
2020-09-18T04:24:24Z,brilacidin oral rinse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilacidin-oral-rinse
2020-09-18T04:24:24Z,brimonidine tartrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate
2020-09-18T04:24:24Z,brimonidine tartrate nanoemulsion OCU-300,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797485
2020-09-18T04:24:24Z,brincidofovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brincidofovir
2020-09-18T04:24:24Z,Brintellix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vortioxetine-hydrobromide
2020-09-18T04:24:24Z,brivanib alaninate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivanib-alaninate
2020-09-18T04:24:24Z,brivaracetam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577
2020-09-18T04:24:24Z,Briviact,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792577
2020-09-18T04:24:24Z,brivudine phosphoramidate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivudine-phosphoramidate
2020-09-18T04:24:24Z,broad-spectrum human papillomavirus vaccine V505,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broad-spectrum-human-papillomavirus-vaccine-v505
2020-09-18T04:24:24Z,broccoli sprout extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-extract
2020-09-18T04:24:24Z,broccoli sprout/broccoli seed extract supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-broccoli-seed-extract-supplement
2020-09-18T04:24:24Z,bromelain,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelain
2020-09-18T04:24:24Z,bromocriptine mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromocriptine-mesylate
2020-09-18T04:24:24Z,bromodeoxyuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodeoxyuridine
2020-09-18T04:24:24Z,bromodomain inhibitor ABBV-075,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromodomain-inhibitor-abbv-075
2020-09-18T04:24:24Z,bromovinyl-deoxyuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromovinyl-deoxyuridine
2020-09-18T04:24:24Z,brontictuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brontictuzumab
2020-09-18T04:24:24Z,brostallicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brostallicin
2020-09-18T04:24:24Z,bruceantin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bruceantin
2020-09-18T04:24:24Z,Brukinsa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111
2020-09-18T04:24:24Z,Brussels sprout,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brussels-sprout
2020-09-18T04:24:24Z,bryostatin 1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bryostatin-1
2020-09-18T04:24:24Z,BTK inhibitor ARQ 531,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-arq-531
2020-09-18T04:24:24Z,BTK inhibitor CC-292,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-cc-292
2020-09-18T04:24:24Z,BTK inhibitor CT-1530,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-ct-1530
2020-09-18T04:24:24Z,BTK inhibitor DTRMWXHS-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-dtrmwxhs-12
2020-09-18T04:24:24Z,BTK inhibitor GDC-0853,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-gdc-0853
2020-09-18T04:24:24Z,BTK inhibitor HZ-A-018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802311
2020-09-18T04:24:24Z,BTK inhibitor ICP-022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795368
2020-09-18T04:24:24Z,BTK inhibitor LOXO-305,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797383
2020-09-18T04:24:24Z,BTK inhibitor M7583,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-m7583
2020-09-18T04:24:24Z,BTK inhibitor SAR442168,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801899
2020-09-18T04:24:24Z,BTK inhibitor TG-1701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798666
2020-09-18T04:24:24Z,budesonide/formoterol fumarate dihydrate inhalation aerosol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol
2020-09-18T04:24:24Z,budigalimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-monoclonal-antibody-abbv-181
2020-09-18T04:24:24Z,buformin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buformin-hydrochloride
2020-09-18T04:24:24Z,Bulkamid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyacrylamide-hydrogel
2020-09-18T04:24:24Z,buparlisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buparlisib
2020-09-18T04:24:24Z,Buphenyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phenylbutyrate
2020-09-18T04:24:24Z,bupivacaine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride
2020-09-18T04:24:24Z,bupivacaine hydrochloride liposome injectable suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride-liposome-injectable-suspension
2020-09-18T04:24:24Z,buprenorphine transdermal matrix patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buprenorphine-transdermal-matrix-patch
2020-09-18T04:24:24Z,bupropion hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride
2020-09-18T04:24:24Z,bupropion hydrochloride controlled-release,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878
2020-09-18T04:24:24Z,burixafor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burixafor
2020-09-18T04:24:24Z,burosumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgf23-igg1-monoclonal-antibody-krn23
2020-09-18T04:24:24Z,buserelin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin
2020-09-18T04:24:24Z,Bushen Culuan decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797882
2020-09-18T04:24:24Z,Bushen-Jianpi decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793123
2020-09-18T04:24:24Z,Buspar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buspirone-hydrochloride
2020-09-18T04:24:24Z,buspirone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buspirone-hydrochloride
2020-09-18T04:24:24Z,busulfan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan
2020-09-18T04:24:24Z,busulfan-melphalan regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan-melphalan-regimen
2020-09-18T04:24:24Z,Busulfex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan
2020-09-18T04:24:24Z,buthionine sulfoximine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buthionine-sulfoximine
2020-09-18T04:24:24Z,butylscopolamine bromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/butylscopolamine-bromide
2020-09-18T04:24:24Z,BXQ-350 nanovesicle formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation
2020-09-18T04:24:24Z,Byetta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exenatide
2020-09-18T04:24:24Z,c-Kit inhibitor PLX9486,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-kit-inhibitor-plx9486
2020-09-18T04:24:24Z,c-Met inhibitor ABN401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800797
2020-09-18T04:24:24Z,c-Met inhibitor AL2846,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-al2846
2020-09-18T04:24:24Z,c-Met inhibitor AMG 208,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-208
2020-09-18T04:24:24Z,c-Met inhibitor AMG 337,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-337
2020-09-18T04:24:24Z,c-Met inhibitor CBT-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793087
2020-09-18T04:24:24Z,c-Met inhibitor HS-10241,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-hs-10241
2020-09-18T04:24:24Z,c-Met inhibitor JNJ-38877605,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-jnj-38877605
2020-09-18T04:24:24Z,c-Met inhibitor MSC2156119J,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-msc2156119j
2020-09-18T04:24:24Z,c-Met inhibitor PLB1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-plb1001
2020-09-18T04:24:24Z,c-myb antisense oligonucleotide G4460,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-myb-antisense-oligonucleotide-g4460
2020-09-18T04:24:24Z,C-VISA BikDD: liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-visa-bikdd-liposome
2020-09-18T04:24:24Z,C3-targeted complement inhibitor APL-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c3-targeted-complement-inhibitor-apl-2
2020-09-18T04:24:24Z,CAB-ROR2-ADC BA3021,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794991
2020-09-18T04:24:24Z,cabazitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel
2020-09-18T04:24:24Z,cabergoline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline
2020-09-18T04:24:24Z,cabiralizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab
2020-09-18T04:24:24Z,Cablivi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab
2020-09-18T04:24:24Z,Cabometyx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate
2020-09-18T04:24:24Z,cabozantinib-s-malate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate
2020-09-18T04:24:24Z,cadazolid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cadazolid
2020-09-18T04:24:24Z,CAF regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen
2020-09-18T04:24:24Z,caffeine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caffeine
2020-09-18T04:24:24Z,CAIX inhibitor DTP348,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caix-inhibitor-dtp348
2020-09-18T04:24:24Z,calaspargase pegol-mknl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol
2020-09-18T04:24:24Z,calcipotriene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcipotriene
2020-09-18T04:24:24Z,calcitriol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol
2020-09-18T04:24:24Z,calcium aluminosilicate anti-diarrheal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-aluminosilicate-anti-diarrheal
2020-09-18T04:24:24Z,calcium carbonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-carbonate
2020-09-18T04:24:24Z,calcium chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-chloride
2020-09-18T04:24:24Z,calcium citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate
2020-09-18T04:24:24Z,calcium glucarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-glucarate
2020-09-18T04:24:24Z,calcium gluconate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-gluconate
2020-09-18T04:24:24Z,calcium release-activated channel inhibitor CM4620,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800239
2020-09-18T04:24:24Z,calcium release-activated channels inhibitor RP4010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010
2020-09-18T04:24:24Z,calcium-41 chloride aqueous solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-41-chloride-aqueous-solution
2020-09-18T04:24:24Z,calcium-46 chloride aqueous solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-46-chloride-aqueous-solution
2020-09-18T04:24:24Z,calcium-sensing receptor agonists SK 1403,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793192
2020-09-18T04:24:24Z,Calculus bovis/Moschus/Olibanum/Myrrha capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calculus-bovis-moschus-olibanum-myrrha-capsule
2020-09-18T04:24:24Z,Caldolor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen-intravenous
2020-09-18T04:24:24Z,Calendula officinalis/Plantago major/Cochlearia armoracia/ Hamamelis virginiana herbal toothpaste,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/666847
2020-09-18T04:24:24Z,calfactant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calfactant
2020-09-18T04:24:24Z,Calomist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin
2020-09-18T04:24:24Z,Calquence,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib
2020-09-18T04:24:24Z,CALR exon 9 mutant peptide vaccine/Montanide ISA-51,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797846
2020-09-18T04:24:24Z,calusterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calusterone
2020-09-18T04:24:24Z,camidanlumab tesirine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-pbd-antibody-drug-conjugate-adct-301
2020-09-18T04:24:24Z,Campath,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab
2020-09-18T04:24:24Z,Camptogen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan
2020-09-18T04:24:24Z,Camptosar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride
2020-09-18T04:24:24Z,camptothecin analogue TLC388,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-analogue-tlc388
2020-09-18T04:24:24Z,camptothecin-20(S)-O-propionate hydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-20s-o-propionate-hydrate
2020-09-18T04:24:24Z,camrelizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-shr-1210
2020-09-18T04:24:24Z,canagliflozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800676
2020-09-18T04:24:24Z,canakinumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795723
2020-09-18T04:24:24Z,canarypox-hIL-12 melanoma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canarypox-hil-12-melanoma-vaccine
2020-09-18T04:24:24Z,cancer peptide vaccine S-588410,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cancer-peptide-vaccine-s-588410
2020-09-18T04:24:24Z,cancer stemness kinase inhibitor BBI503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cancer-stemness-kinase-inhibitor-bbi503
2020-09-18T04:24:24Z,Cancidas,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate
2020-09-18T04:24:24Z,candesartan cilexetil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candesartan-cilexetil
2020-09-18T04:24:24Z,Candida albicans antigen injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750
2020-09-18T04:24:24Z,Candin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792750
2020-09-18T04:24:24Z,canerpaturev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-1-hf10
2020-09-18T04:24:24Z,canertinib dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride
2020-09-18T04:24:24Z,canfosfamide hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canfosfamide-hydrochloride
2020-09-18T04:24:24Z,Cannabics SR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule
2020-09-18T04:24:24Z,Cannabics SR capsules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule
2020-09-18T04:24:24Z,cannabidiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol
2020-09-18T04:24:24Z,cannabinoid-derived inhalation capsule PPP011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801683
2020-09-18T04:24:24Z,cannabinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinol
2020-09-18T04:24:24Z,Cannabis extract oil SR capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabis-extract-oil-sr-capsule
2020-09-18T04:24:24Z,cantrixil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797919
2020-09-18T04:24:24Z,cantuzumab ravtansine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantuzumab-ravtansine
2020-09-18T04:24:24Z,Cap binding complex 80/20 binder ABX-464,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797148
2020-09-18T04:24:24Z,capecitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine
2020-09-18T04:24:24Z,capecitabine rapidly disintegrating tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-rapidly-disintegrating-tablet
2020-09-18T04:24:24Z,capecitabine/methotrexate/vinorelbine regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine-methotrexate-vinorelbine-regimen
2020-09-18T04:24:24Z,Capesaris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogen-receptor-agonist-gtx-758
2020-09-18T04:24:24Z,Caphosol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/supersaturated-calcium-phosphate-rinse
2020-09-18T04:24:24Z,capivasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-azd5363
2020-09-18T04:24:24Z,caplacizumab-yhdp,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caplacizumab
2020-09-18T04:24:24Z,capmatinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib
2020-09-18T04:24:24Z,Capoten,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril
2020-09-18T04:24:24Z,CAPOX regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capox-regimen
2020-09-18T04:24:24Z,Captisol-enabled Melphalan IV,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride-sulfobutyl-ether-beta-cyclodextrin-complex
2020-09-18T04:24:24Z,captopril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/captopril
2020-09-18T04:24:24Z,CAR-T cells AMG 119,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793448
2020-09-18T04:24:24Z,Carac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil
2020-09-18T04:24:24Z,caracemide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caracemide
2020-09-18T04:24:24Z,carbamazepine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine
2020-09-18T04:24:24Z,carbidopa/levodopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793473
2020-09-18T04:24:24Z,Carbocaine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride
2020-09-18T04:24:24Z,carbogen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbogen
2020-09-18T04:24:24Z,carbohydrate supplement drink,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbohydrate-supplement-drink
2020-09-18T04:24:24Z,carbon C 11 alpha-methyltryptophan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-alpha-methyltryptophan
2020-09-18T04:24:24Z,carbon C 11 choline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline
2020-09-18T04:24:24Z,carbon C 11 erlotinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-erlotinib-hydrochloride
2020-09-18T04:24:24Z,carbon C 11 glutamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-glutamine
2020-09-18T04:24:24Z,carbon C 11 martinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797648
2020-09-18T04:24:24Z,carbon C 11 metformin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-metformin
2020-09-18T04:24:24Z,carbon C 11 N-desmethyl-loperamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-n-desmethyl-loperamide
2020-09-18T04:24:24Z,carbon C 11 PBR-28,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-pbr-28
2020-09-18T04:24:24Z,carbon C 11 sarcosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-sarcosine
2020-09-18T04:24:24Z,carbon C 11 sepantronium bromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-sepantronium-bromide
2020-09-18T04:24:24Z,carbon C 11 temozolomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-temozolomide
2020-09-18T04:24:24Z,carbon C 11-JNJ-63779586,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792629
2020-09-18T04:24:24Z,carbon C 11-osimertinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795702
2020-09-18T04:24:24Z,carbon C 13 acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-acetate
2020-09-18T04:24:24Z,carbon C 13 dextromethorphan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-dextromethorphan
2020-09-18T04:24:24Z,carbon C 13 idasanutlin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-idasanutlin
2020-09-18T04:24:24Z,carbon C 13 lycopene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-lycopene
2020-09-18T04:24:24Z,carbon C 13 octanoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-octanoate
2020-09-18T04:24:24Z,carbon C 13 phytoene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytoene
2020-09-18T04:24:24Z,carbon C 13 phytofluene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-phytofluene
2020-09-18T04:24:24Z,carbon C 13/nitrogen N 15-labeled valine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-nitrogen-n-15-labeled-valine
2020-09-18T04:24:24Z,carbon C 14 anlotinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-anlotinib-hydrochloride
2020-09-18T04:24:24Z,carbon C 14 dacomitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-dacomitinib
2020-09-18T04:24:24Z,carbon C 14 eribulin acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-eribulin-acetate
2020-09-18T04:24:24Z,carbon C 14 gilteritinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-gilteritinib
2020-09-18T04:24:24Z,carbon C 14 idasanutlin;Index term;Drug/agent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-idasanutlin-index-term-drug-agent
2020-09-18T04:24:24Z,carbon C 14 ombrabulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ombrabulin
2020-09-18T04:24:24Z,carbon C 14 oxaliplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-oxaliplatin
2020-09-18T04:24:24Z,carbon C 14 pevonedistat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792532
2020-09-18T04:24:24Z,carbon C 14 roniciclib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-roniciclib
2020-09-18T04:24:24Z,carbon C 14 selumetinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-selumetinib
2020-09-18T04:24:24Z,carbon C 14 telotristat etiprate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-telotristat-etiprate
2020-09-18T04:24:24Z,carbon C 14 vemurafenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-vemurafenib
2020-09-18T04:24:24Z,carbon C 14-AC0010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-ac0010
2020-09-18T04:24:24Z,carbon C 14-labeled ixazomib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-labeled-ixazomib
2020-09-18T04:24:24Z,carbon C 14-pamiparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801792
2020-09-18T04:24:24Z,carbon C 14-TAK-659,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794993
2020-09-18T04:24:24Z,carbon C14 EGFR inhibitor ASP8273,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-egfr-inhibitor-asp8273
2020-09-18T04:24:24Z,carbon C14 lenvatinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c14-lenvatinib-mesylate
2020-09-18T04:24:24Z,carbon nanoparticle-based formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-nanoparticle-based-formulation
2020-09-18T04:24:24Z,carbon-11 acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-11-acetate
2020-09-18T04:24:24Z,carboplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin
2020-09-18T04:24:24Z,carboplatin-Taxol regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-regimen
2020-09-18T04:24:24Z,carboplatin-Taxol-bevacizumab regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-taxol-bevacizumab-regimen
2020-09-18T04:24:24Z,carboxyamidotriazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole
2020-09-18T04:24:24Z,carboxyamidotriazole orotate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole-orotate
2020-09-18T04:24:24Z,carboxylesterase-expressing allogeneic neural stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxylesterase-expressing-allogeneic-neural-stem-cells
2020-09-18T04:24:24Z,carboxyphenyl retinamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyphenyl-retinamide
2020-09-18T04:24:24Z,carbutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbutamide
2020-09-18T04:24:24Z,carcinoembryonic antigen peptide 1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1
2020-09-18T04:24:24Z,carcinoembryonic antigen peptide 1-6D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d
2020-09-18T04:24:24Z,carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-peptide-1-6d-virus-like-replicon-particles-vaccine
2020-09-18T04:24:24Z,carcinoembryonic antigen RNA-pulsed DC cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-rna-pulsed-dc-cancer-vaccine
2020-09-18T04:24:24Z,carcinoembryonic antigen-expressing measles virus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carcinoembryonic-antigen-expressing-measles-virus
2020-09-18T04:24:24Z,Cardiolite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi
2020-09-18T04:24:24Z,Cardizem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diltiazem-hydrochloride
2020-09-18T04:24:24Z,Cardura,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxazosin-mesylate
2020-09-18T04:24:24Z,carfilzomib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib
2020-09-18T04:24:24Z,caricotamide/tretazicar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caricotamide-tretazicar
2020-09-18T04:24:24Z,carlumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carlumab
2020-09-18T04:24:24Z,carmustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine
2020-09-18T04:24:24Z,carmustine implant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-implant
2020-09-18T04:24:24Z,carmustine sustained-release implant wafer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-sustained-release-implant-wafer
2020-09-18T04:24:24Z,Carnitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocarnitine
2020-09-18T04:24:24Z,carnosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine
2020-09-18T04:24:24Z,carnosine/hibiscus-based oral mucoadhesive tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799646
2020-09-18T04:24:24Z,carotuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-endoglin-monoclonal-antibody-trc105
2020-09-18T04:24:24Z,carrageenan-containing gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrageenan-containing-gel
2020-09-18T04:24:24Z,carrimycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801877
2020-09-18T04:24:24Z,carrot/Ji-Lin ginseng/licorice root/tangerine peel soy beverage,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrot-ji-lin-ginseng-licorice-root-tangerine-peel-soy-beverage
2020-09-18T04:24:24Z,Cartilade,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage
2020-09-18T04:24:24Z,carubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carubicin
2020-09-18T04:24:24Z,carvedilol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol
2020-09-18T04:24:24Z,carvedilol phosphate extended-release capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol-phosphate-extended-release-capsule
2020-09-18T04:24:24Z,casein/whey protein/soy protein/pea protein/fat mix/EPA/DHA-based nutritional supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770796
2020-09-18T04:24:24Z,caseinate protein isolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caseinate-protein-isolate
2020-09-18T04:24:24Z,Casodex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide
2020-09-18T04:24:24Z,casopitant mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/casopitant-mesylate
2020-09-18T04:24:24Z,caspofungin acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caspofungin-acetate
2020-09-18T04:24:24Z,Catapres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-hydrochloride
2020-09-18T04:24:24Z,cathepsin-activatable Cy5 fluorescent imaging probe LUM015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-activatable-cy5-fluorescent-imaging-probe-lum015
2020-09-18T04:24:24Z,cathepsin-cleavable NIR substrate probe 6QC-ICG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800448
2020-09-18T04:24:24Z,cationic liposome-encapsulated paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cationic-liposome-encapsulated-paclitaxel
2020-09-18T04:24:24Z,catumaxomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catumaxomab
2020-09-18T04:24:24Z,Cavatak,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21
2020-09-18T04:24:24Z,Caverject,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil
2020-09-18T04:24:24Z,CB10-277,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cb10-277
2020-09-18T04:24:24Z,CBP/beta-catenin antagonist PRI-724,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cbp-beta-catenin-antagonist-pri-724
2020-09-18T04:24:24Z,CBP/beta-catenin modulator E7386,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793902
2020-09-18T04:24:24Z,CBT-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdr-modulator-cbt-1
2020-09-18T04:24:24Z,CC-1088,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-1088
2020-09-18T04:24:24Z,CC-401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-401
2020-09-18T04:24:24Z,CC-8490,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cc-8490
2020-09-18T04:24:24Z,CCL21-expressing H1944 cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccl21-expressing-h1944-cell-vaccine
2020-09-18T04:24:24Z,CCR2 antagonist CCX872-B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-antagonist-ccx872-b
2020-09-18T04:24:24Z,CCR2 antagonist PF-04136309,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-antagonist-pf-04136309
2020-09-18T04:24:24Z,CCR2/CCR5 antagonist BMS-813160,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-ccr5-antagonist-bms-813160
2020-09-18T04:24:24Z,CCR4 inhibitor FLX475,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796771
2020-09-18T04:24:24Z,CD-expressing Bifidobacterium APS001F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd-expressing-bifidobacterium-aps001f
2020-09-18T04:24:24Z,CD105/Yb-1/SOX2/CDH3/MDM2 polypeptide plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polypeptide-plasmid-dna-vaccine
2020-09-18T04:24:24Z,CD11b agonist GB1275,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799988
2020-09-18T04:24:24Z,CD123-CD33 compound CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802178
2020-09-18T04:24:24Z,CD133 antigen peptide-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd133-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,CD137L/Epstein-Barr virus-targeting autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793585
2020-09-18T04:24:24Z,CD138CAR-CD137/TCRzeta-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd138car-cd137-tcrzeta-expressing-t-lymphocytes
2020-09-18T04:24:24Z,CD16/IL15/CD33 trispecific killer cell engager,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793158
2020-09-18T04:24:24Z,CD19-targeted 4-1BB ligand RO7227166,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800608
2020-09-18T04:24:24Z,CD19/CD3 dual-affinity retargeting protein JNJ-64052781,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-cd3-dual-affinity-retargeting-protein-jnj-64052781
2020-09-18T04:24:24Z,CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-lymphocytes
2020-09-18T04:24:24Z,CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-enriched-t-lymphocytes
2020-09-18T04:24:24Z,CD19CAR-CD28zeta-4-1BB-expressing allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd28zeta-4-1bb-expressing-allogeneic-t-lymphocytes
2020-09-18T04:24:24Z,CD19CAR-CD3zeta-4-1BB-CD28-expressing autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-4-1bb-cd28-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,CD19CAR-CD3zeta-4-1BB-expressing allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocytes
2020-09-18T04:24:24Z,CD19CAR-CD3zeta-expressing autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,CD20-CD19 compound CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802177
2020-09-18T04:24:24Z,CD20-targeted polypeptide TRU-015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd20-targeted-polypeptide-tru-015
2020-09-18T04:24:24Z,CD22 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801521
2020-09-18T04:24:24Z,CD24 extracellular domain-IgG1 Fc domain recombinant fusion protein CD24Fc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd24-extracellular-domain-igg1-fc-domain-recombinant-fusion-protein-cd24fc
2020-09-18T04:24:24Z,CD28/ICOS antagonist ALPN-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800691
2020-09-18T04:24:24Z,CD28CAR/CD137CAR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd28car-cd137car-expressing-t-lymphocytes
2020-09-18T04:24:24Z,CD3/CD28 costimulated vaccine-primed autologous T-cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd3-cd28-costimulated-vaccine-primed-autologous-t-cells
2020-09-18T04:24:24Z,CD3+/CD19+ cell-depleted unrelated or partially matched donor-derived allogeneic peripheral blood stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798991
2020-09-18T04:24:24Z,CD30 CAR-expressing autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd30-car-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,CD33-specific CAR lentiviral vector-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792699
2020-09-18T04:24:24Z,CD33-targeting antibody-drug conjugate IMGN779,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-targeting-antibody-drug-conjugate-imgn779
2020-09-18T04:24:24Z,CD33CAR-CD3zeta-4-1BB-expressing autologous T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,CD34/TK75-transduced donor lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd34-tk75-transduced-donor-lymphocytes
2020-09-18T04:24:24Z,CD4+CD25+ regulatory T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd4cd25-regulatory-t-cells
2020-09-18T04:24:24Z,"CD40 agonist monoclonal antibody CP-870,893",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonist-monoclonal-antibody-cp-870893
2020-09-18T04:24:24Z,CD40 agonistic monoclonal antibody APX005M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m
2020-09-18T04:24:24Z,CD40L-Fc fusion protein MEDI 5083,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792628
2020-09-18T04:24:24Z,CD44 targeted agent SPL-108,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44-targeted-agent-spl-108
2020-09-18T04:24:24Z,CD44v6-specific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801822
2020-09-18T04:24:24Z,CD45RA-depleted donor T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796920
2020-09-18T04:24:24Z,CD47 antagonist ALX-148,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd47-antagonist-alx-148
2020-09-18T04:24:24Z,CD56-enriched CD3-positive donor lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796843
2020-09-18T04:24:24Z,CD73 inhibitor AB680,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800218
2020-09-18T04:24:24Z,CD73 inhibitor LY3475070,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801213
2020-09-18T04:24:24Z,CD8+ and CD4+ donor memory T cells-expressing HA1-specific TCR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8-and-cd4-donor-memory-t-cells-expressing-ha1-specific-tcr
2020-09-18T04:24:24Z,CD8+NKG2D+ AKT cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8nkg2d-akt-cells
2020-09-18T04:24:24Z,CD80 fusion protein FPT155,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800619
2020-09-20T05:26:50Z,CD80-Fc fusion protein ALPN-202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802337
2020-09-18T04:24:24Z,CDC7 inhibitor TAK-931,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-inhibitor-tak-931
2020-09-18T04:24:24Z,CDC7 kinase inhibitor BMS-863233,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-bms-863233
2020-09-18T04:24:24Z,CDC7 kinase inhibitor LY3143921 hydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792646
2020-09-18T04:24:24Z,CDC7 kinase inhibitor NMS-1116354,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-nms-1116354
2020-09-18T04:24:24Z,CDK inhibitor P276-00,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-p276-00
2020-09-18T04:24:24Z,CDK inhibitor SNS-032,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-sns-032
2020-09-18T04:24:24Z,CDK1 inhibitor BEY1107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799135
2020-09-18T04:24:24Z,CDK2/4/6/FLT3 inhibitor FN-1501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795267
2020-09-18T04:24:24Z,CDK2/5/9 inhibitor CYC065,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-5-9-inhibitor-cyc065
2020-09-18T04:24:24Z,CDK4 inhibitor P1446A-05,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-inhibitor-p1446a-05
2020-09-18T04:24:24Z,CDK4/6 inhibitor BPI-16350,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796716
2020-09-18T04:24:24Z,CDK4/6 inhibitor CS3002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802263
2020-09-18T04:24:24Z,CDK4/6 inhibitor FCN-437,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799711
2020-09-18T04:24:24Z,CDK4/6 inhibitor G1T38,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-g1t38
2020-09-18T04:24:24Z,CDK4/6 inhibitor SHR6390,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-shr6390
2020-09-18T04:24:24Z,CDK7 inhibitor CT7001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794642
2020-09-18T04:24:24Z,CDK7 inhibitor SY-1365,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk7-inhibitor-sy-1365
2020-09-18T04:24:24Z,CDK8/19 inhibitor SEL 120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800129
2020-09-18T04:24:24Z,CDK9 inhibitor AZD4573,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793903
2020-09-18T04:24:24Z,CDKI AT7519,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-at7519
2020-09-18T04:24:24Z,CDKI R547,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdki-r547
2020-09-18T04:24:24Z,CDKs/JAK2/FLT3 inhibitor TG02 citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdks-jak2-flt3-inhibitor-tg02-citrate
2020-09-18T04:24:24Z,Ce-Vi-Sol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid
2020-09-18T04:24:24Z,CEA-Scan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arcitumomab
2020-09-18T04:24:24Z,CEA-targeting agent RG6123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797964
2020-09-18T04:24:24Z,CEA/tetanus toxoid T helper epitope fusion protein-expressing DNA plasmid vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/666096
2020-09-18T04:24:24Z,CeaVac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine
2020-09-18T04:24:24Z,CEBPA-targeting saRNA MTL-CEBPA liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebpa-targeting-sarna-mtl-cebpa-liposome
2020-09-18T04:24:24Z,cebranopadol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebranopadol
2020-09-18T04:24:24Z,Cecon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid
2020-09-18T04:24:24Z,cedazuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799445
2020-09-18T04:24:24Z,cediranib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate
2020-09-18T04:24:24Z,cefazolin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium
2020-09-18T04:24:24Z,cefepime hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefepime-hydrochloride
2020-09-18T04:24:24Z,cefixime,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefixime
2020-09-18T04:24:24Z,cefmetazole sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefmetazole-sodium
2020-09-18T04:24:24Z,cefotaxime,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefotaxime
2020-09-18T04:24:24Z,cefoxitin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefoxitin-sodium
2020-09-18T04:24:24Z,cefpodoxime proxetil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefpodoxime-proxetil
2020-09-18T04:24:24Z,ceftazidime sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium
2020-09-18T04:24:24Z,ceftazidime/avibactam sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-avibactam-sodium
2020-09-18T04:24:24Z,ceftobiprole medocaril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftobiprole-medocaril
2020-09-18T04:24:24Z,ceftolozane-tazobactam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424
2020-09-18T04:24:24Z,ceftriaxone sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftriaxone-sodium
2020-09-18T04:24:24Z,Celebrex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib
2020-09-18T04:24:24Z,celecoxib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib
2020-09-18T04:24:24Z,Celestone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betamethasone
2020-09-18T04:24:24Z,Celexa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citalopram-hydrobromide
2020-09-18T04:24:24Z,Celiptium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate
2020-09-18T04:24:24Z,cell cycle checkpoint/DNA repair antagonist IC83,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cell-cycle-checkpoint-dna-repair-antagonist-ic83
2020-09-18T04:24:24Z,Cellcept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolate-mofetil
2020-09-18T04:24:24Z,CEM regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cem-regimen
2020-09-18T04:24:24Z,cemiplimab-rwlc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810
2020-09-18T04:24:24Z,cenersen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenersen
2020-09-18T04:24:24Z,cenisertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cenisertib
2020-09-18T04:24:24Z,Cenolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid
2020-09-18T04:24:24Z,CEOP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceop-regimen
2020-09-18T04:24:24Z,Cepacol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778
2020-09-18T04:24:24Z,cephalexin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cephalexin
2020-09-18T04:24:24Z,ceralasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-azd6738
2020-09-18T04:24:24Z,ceramide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide
2020-09-18T04:24:24Z,ceramide nanoliposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome
2020-09-18T04:24:24Z,Cerazette,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desogestral
2020-09-18T04:24:24Z,cerdulatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-jak-inhibitor-prt062070
2020-09-18T04:24:24Z,cereblon E3 ubiquitin ligase modulating agent CC-92480,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792155
2020-09-18T04:24:24Z,cereblon E3 ubiquitin ligase modulating agent CC-99282,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801633
2020-09-18T04:24:24Z,cereblon modulator CC-90009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-modulator-cc-90009
2020-09-18T04:24:24Z,Cerebyx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055
2020-09-18T04:24:24Z,Cereport,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobradimil
2020-09-18T04:24:24Z,Cerespan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride
2020-09-18T04:24:24Z,cergutuzumab amunaleukin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cergutuzumab-amunaleukin
2020-09-18T04:24:24Z,ceritinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib
2020-09-18T04:24:24Z,certolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/certolizumab
2020-09-18T04:24:24Z,Cerubidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride
2020-09-18T04:24:24Z,Cervarix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine
2020-09-18T04:24:24Z,Cervene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfa-pe38-immunotoxin
2020-09-18T04:24:24Z,cesium Cs 131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cesium-cs-131
2020-09-18T04:24:24Z,cesium Cs 137,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cesium-cs-137
2020-09-18T04:24:24Z,cEt KRAS antisense oligonucleotide AZD4785,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792660
2020-09-18T04:24:24Z,Cetacort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,Cetane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid
2020-09-18T04:24:24Z,cetrelimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-jnj-63723283
2020-09-18T04:24:24Z,cetuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab
2020-09-18T04:24:24Z,cetuximab-IR700 conjugate RM-1929,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-ir700-conjugate-rm-1929
2020-09-18T04:24:24Z,cetuximab-IRDye 800,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-irdye-800
2020-09-18T04:24:24Z,cetuximab-loaded ethylcellulose polymeric nanoparticles decorated with octreotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797050
2020-09-18T04:24:24Z,CEV regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cev-regimen
2020-09-18T04:24:24Z,Cevalin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascorbic-acid
2020-09-18T04:24:24Z,cevidoplenib dimesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801206
2020-09-18T04:24:24Z,cevimeline hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevimeline-hydrochloride
2020-09-18T04:24:24Z,cFMS tyrosine kinase inhibitor ARRY-382,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cfms-tyrosine-kinase-inhibitor-arry-382
2020-09-18T04:24:24Z,chamomile,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chamomile
2020-09-18T04:24:24Z,Chantix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline
2020-09-18T04:24:24Z,checkpoint kinase inhibitor AZD7762,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/checkpoint-kinase-inhibitor-azd7762
2020-09-18T04:24:24Z,Chemet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947
2020-09-18T04:24:24Z,Chemophase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-hyaluronidase
2020-09-18T04:24:24Z,Chemoplaque,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808
2020-09-18T04:24:24Z,chewing gum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chewing-gum
2020-09-18T04:24:24Z,chiauranib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chiauranib
2020-09-18T04:24:24Z,chimeric costimulatory converting receptor-modified NK-92 cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798735
2020-09-18T04:24:24Z,chimeric fibril-reactive monoclonal antibody 111F4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-111f4
2020-09-18T04:24:24Z,chimeric humanized anti-CD47 antibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-humanized-anti-cd47-antibody
2020-09-18T04:24:24Z,Chinese herbal formulation LC09,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-lc09
2020-09-18T04:24:24Z,Chinese herbal formulation PHY906,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906
2020-09-18T04:24:24Z,Chinese herbal medicine YQ1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-medicine-yq1
2020-09-18T04:24:24Z,Chinese herbs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbs
2020-09-18T04:24:24Z,ChiNing decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chining-decoction
2020-09-18T04:24:24Z,ChiRhoStim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin
2020-09-18T04:24:24Z,Chirocaine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levobupivacaine-hydrochloride
2020-09-18T04:24:24Z,chitin oligosaccharides supplement T-ChOS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chitin-oligosaccharides-supplement-t-chos
2020-09-18T04:24:24Z,Chk1 inhibitor CCT245737,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-cct245737
2020-09-18T04:24:24Z,Chk1 inhibitor GDC-0425,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0425
2020-09-18T04:24:24Z,Chk1 inhibitor GDC-0575,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0575
2020-09-18T04:24:24Z,chk1 inhibitor PF-477736,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-pf-477736
2020-09-18T04:24:24Z,Chk1 inhibitor SCH 900776,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-sch-900776
2020-09-18T04:24:24Z,chlorambucil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil
2020-09-18T04:24:24Z,chlorambucil-prednisone regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil-prednisone-regimen
2020-09-18T04:24:24Z,Chloraprep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-ethyl-alcohol-mouthwash
2020-09-18T04:24:24Z,chlorhexidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine
2020-09-18T04:24:24Z,chlorhexidine gluconate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-gluconate
2020-09-18T04:24:24Z,chlorhexidine gluconate skin cleanser,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800700
2020-09-18T04:24:24Z,chlorhexidine/ethyl alcohol mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-ethyl-alcohol-mouthwash
2020-09-18T04:24:24Z,chlorine dioxide sterilization,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799647
2020-09-18T04:24:24Z,chlorogenic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorogenic-acid
2020-09-18T04:24:24Z,chloroquine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquine
2020-09-18T04:24:24Z,chloroquinoxaline sulfonamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquinoxaline-sulfonamide
2020-09-30T06:13:12Z,chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802824
2020-09-18T04:24:24Z,chlorotoxin-indocyanine green imaging Agent BLZ-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorotoxin-indocyanine-green-imaging-agent-blz-100
2020-09-18T04:24:24Z,chlorozotocin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin
2020-09-18T04:24:24Z,chlorpromazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpromazine
2020-09-18T04:24:24Z,chlorpropamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide
2020-09-18T04:24:24Z,chlorzoxazone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorzoxazone
2020-09-18T04:24:24Z,cholecalciferol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol
2020-09-18T04:24:24Z,cholecalciferol/d-alpha tocopherol/L-selenomethionine/green tea extract/saw palmetto berry extract/daidzein/genistein/lycopene prostate health supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/596155
2020-09-18T04:24:24Z,cholecalciferol/whey protein isolate/EPA/DHA-based nutritional supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecalciferol-whey-protein-isolate-epa-dha-based-nutritional-supplement
2020-09-18T04:24:24Z,CholestaGel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride
2020-09-18T04:24:24Z,Choletec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin
2020-09-18T04:24:24Z,cholic acid-24-13C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798636
2020-09-18T04:24:24Z,"cholic-2,2,4,4-D4 acid",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798635
2020-09-18T04:24:24Z,choline kinase alpha inhibitor TCD-717,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-kinase-alpha-inhibitor-tcd-717
2020-09-18T04:24:24Z,choline magnesium trisalicylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-magnesium-trisalicylate
2020-09-18T04:24:24Z,CHOP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen
2020-09-18T04:24:24Z,CHP-NY-ESO-1 peptide vaccine IMF-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chp-ny-eso-1-peptide-vaccine-imf-001
2020-09-18T04:24:24Z,chromomycin A3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chromomycin-a3
2020-09-18T04:24:24Z,Cialis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tadalafil
2020-09-18T04:24:24Z,cibisatamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-cd3-bispecific-antibody-ro6958688
2020-09-18T04:24:24Z,ciclopirox olamine lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-olamine-lotion
2020-09-18T04:24:24Z,ciclopirox olamine oral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-olamine-oral
2020-09-18T04:24:24Z,ciclopirox prodrug CPX-POM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794795
2020-09-18T04:24:24Z,Cidan herbal capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidan-herbal-capsule
2020-09-18T04:24:24Z,cidofovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir
2020-09-18T04:24:24Z,cilengitide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cilengitide
2020-09-18T04:24:24Z,cimetidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cimetidine
2020-09-18T04:24:24Z,cinacalcet hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinacalcet-hydrochloride
2020-09-18T04:24:24Z,Cinnamomum cassia capsules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797004
2020-09-18T04:24:24Z,cinobufagin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinobufagin
2020-09-18T04:24:24Z,cinobufotalin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793122
2020-09-18T04:24:24Z,cintredekin besudotox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintredekin-besudotox
2020-09-18T04:24:24Z,Cipro,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin
2020-09-18T04:24:24Z,ciprofloxacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin
2020-09-18T04:24:24Z,Circadin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-melatonin
2020-09-18T04:24:24Z,cirmtuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cirmtuzumab
2020-09-18T04:24:24Z,cis-urocanic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cis-urocanic-acid
2020-09-18T04:24:24Z,cisatracurium besylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisatracurium-besylate
2020-09-18T04:24:24Z,cisplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin
2020-09-18T04:24:24Z,cisplatin transmucosal patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795340
2020-09-18T04:24:24Z,cisplatin-e therapeutic implant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant
2020-09-18T04:24:24Z,cisplatin/vinblastine/cell penetration enhancer formulation INT230-6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-vinblastine-cell-penetration-enhancer-formulation-int230-6
2020-09-18T04:24:24Z,Cistane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin
2020-09-18T04:24:24Z,citalopram hydrobromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citalopram-hydrobromide
2020-09-18T04:24:24Z,Citanest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride
2020-09-18T04:24:24Z,citatuzumab bogatox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citatuzumab-bogatox
2020-09-18T04:24:24Z,citicoline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citicoline
2020-09-18T04:24:24Z,Citracal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-citrate
2020-09-18T04:24:24Z,Citroma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-citrate
2020-09-18T04:24:24Z,Civacir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous
2020-09-18T04:24:24Z,cixutumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cixutumumab
2020-09-18T04:24:24Z,CK2-targeting synthetic peptide CIGB-300,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ck2-targeting-synthetic-peptide-cigb-300
2020-09-18T04:24:24Z,cladribine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine
2020-09-18T04:24:24Z,Claforan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefotaxime
2020-09-18T04:24:24Z,Claravis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin
2020-09-18T04:24:24Z,Clarinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid
2020-09-18T04:24:24Z,clarithromycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clarithromycin
2020-09-18T04:24:24Z,Claritin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loratadine
2020-09-18T04:24:24Z,Class 1 PI3K family inhibitor XL147,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-pi3k-family-inhibitor-xl147
2020-09-18T04:24:24Z,class 1/4 histone deacetylase inhibitor OKI-179,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801634
2020-09-18T04:24:24Z,clevidipine butyrate injectable emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevidipine-butyrate-injectable-emulsion
2020-09-18T04:24:24Z,Cleviprex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevidipine-butyrate-injectable-emulsion
2020-09-18T04:24:24Z,clevudine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevudine
2020-09-18T04:24:24Z,clindamycin phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-phosphate
2020-09-18T04:24:24Z,clindamycin/hydrocortisone lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-hydrocortisone-lotion
2020-09-18T04:24:24Z,Clino-San vaginal lubricant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clino-san-vaginal-lubricant
2020-09-18T04:24:24Z,ClinOleic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olive-oil-soya-oil-egg-lecithin-based-emulsion
2020-09-18T04:24:24Z,Clinoril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac
2020-09-18T04:24:24Z,clioquinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clioquinol
2020-09-18T04:24:24Z,clobetasol propionate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clobetasol-propionate
2020-09-18T04:24:24Z,clodronate disodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clodronate-disodium
2020-09-18T04:24:24Z,clofarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine
2020-09-18T04:24:24Z,clofibrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofibrate
2020-09-18T04:24:24Z,Clolar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine
2020-09-18T04:24:24Z,Clomid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate
2020-09-18T04:24:24Z,clomiphene citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate
2020-09-18T04:24:24Z,clonidine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-hydrochloride
2020-09-18T04:24:24Z,Clonidine Lauriad,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-containing-mucoadhesive-buccal-tablet
2020-09-18T04:24:24Z,clonidine-containing mucoadhesive buccal tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clonidine-containing-mucoadhesive-buccal-tablet
2020-09-18T04:24:24Z,clopidogrel bisulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clopidogrel-bisulfate
2020-09-18T04:24:24Z,Cloretazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine
2020-09-18T04:24:24Z,Clostridium butyricum CBM 588 probiotic strain,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794751
2020-09-18T04:24:24Z,Clostridium butyricum-containing probiotic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-containing-probiotic
2020-09-18T04:24:24Z,Clostridium novyi-NT spores,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-novyi-nt-spores
2020-09-18T04:24:24Z,clotrimazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole
2020-09-18T04:24:24Z,clozapine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800675
2020-09-18T04:24:24Z,cMet CAR-mRNA electroporated autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmet-car-mrna-electroporated-autologous-t-lymphocytes
2020-09-18T04:24:24Z,CMF regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen
2020-09-18T04:24:24Z,CMV pp65 peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmv-pp65-peptide
2020-09-18T04:24:24Z,CMV/EBV/ADV/BKV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792787
2020-09-18T04:24:24Z,CMVpp65-A*0201 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmvpp65-a0201-peptide-vaccine
2020-09-18T04:24:24Z,CMVpp65/gB plasmid vaccine ASP0113,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmvpp65-gb-plasmid-vaccine-asp0113
2020-09-18T04:24:24Z,CNDO-109-activated allogeneic natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cndo-109-activated-allogeneic-natural-killer-cells
2020-09-18T04:24:24Z,CNGRC peptide-TNF alpha conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate
2020-09-18T04:24:24Z,cobalamin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobalamin
2020-09-18T04:24:24Z,Cobavite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin
2020-09-18T04:24:24Z,cobimetinib fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib
2020-09-18T04:24:24Z,cobomarsen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lna-based-antimir-155-mrg-106
2020-09-18T04:24:24Z,Cocculus/nux vomica/tabacum/petroleum extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cocculus-nux-vomica-tabacum-petroleum-extract
2020-09-18T04:24:24Z,cocoa extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cocoa-extract
2020-09-18T04:24:24Z,codeine phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/codeine-phosphate
2020-09-18T04:24:24Z,coenzyme Q10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coenzyme-q10
2020-09-18T04:24:24Z,CoFactor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin
2020-09-18T04:24:24Z,cofetuzumab pelidotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-pf-06647020
2020-09-18T04:24:24Z,Coffea arabica extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794158
2020-09-18T04:24:24Z,coffee dietary supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coffee-dietary-supplement
2020-09-18T04:24:24Z,colchicine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colchicine
2020-09-18T04:24:24Z,cold contaminant-free iobenguane I 131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cold-contaminant-free-iobenguane-i-131
2020-09-18T04:24:24Z,COLD-fX,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2
2020-09-18T04:24:24Z,colesevelam hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride
2020-09-18T04:24:24Z,colistimethate sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium
2020-09-18T04:24:24Z,collagen/aloe vera/vitamin E/lidocaine topical hydrogel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/collagen-aloe-vera-vitamin-e-lidocaine-topical-hydrogel
2020-09-18T04:24:24Z,colloidal gold-bound tumor necrosis factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor
2020-09-18T04:24:24Z,colloidal modified fluid gelatin plasma substitute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794070
2020-09-18T04:24:24Z,colloidal oatmeal cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-oatmeal-cream
2020-09-18T04:24:24Z,colorectal cancer peptide vaccine PolyPEPI1018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794166
2020-09-18T04:24:24Z,Colprosterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone
2020-09-18T04:24:24Z,Coly-Mycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colistimethate-sodium
2020-09-18T04:24:24Z,Combidex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10
2020-09-18T04:24:24Z,Combotox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deglycosylated-ricin-a-chain-conjugated-anti-cd19-anti-cd22-immunotoxins
2020-09-18T04:24:24Z,combretastatin A1 diphosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/combretastatin-a1-diphosphate
2020-09-18T04:24:24Z,Cometriq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate
2020-09-23T07:08:11Z,commensal bacterial strain formulation VE800,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802787
2020-09-18T04:24:24Z,Commit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-lozenge
2020-09-18T04:24:24Z,complement factor D inhibitor ACH-4471,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792524
2020-09-18T04:24:24Z,compound Kushen injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-kushen-injection
2020-09-18T04:24:24Z,compound sodium lactate solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-sodium-lactate-solution
2020-09-18T04:24:24Z,Comtan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801668
2020-09-18T04:24:24Z,conatumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conatumumab
2020-09-18T04:24:24Z,conbercept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798956
2020-09-18T04:24:24Z,Concentraid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate
2020-09-18T04:24:24Z,concentrated beet crystals,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-beet-crystals
2020-09-18T04:24:24Z,concentrated lingzhi mushroom extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799459
2020-09-18T04:24:24Z,"concentrated, fortified, collagen protein hydrolysate liquid supplement",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-fortified-collagen-protein-hydrolysate-liquid-supplement
2020-09-18T04:24:24Z,Concerta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride
2020-09-18T04:24:24Z,conditionally active biologic anti-AXL antibody-drug conjugate BA3011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795303
2020-09-18T04:24:24Z,conditionally replicative adenovirus 5/3-delta24,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-replicative-adenovirus-5-3-delta24
2020-09-18T04:24:24Z,conjugated estrogens,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens
2020-09-18T04:24:24Z,conjugated estrogens/bazedoxifene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene
2020-09-18T04:24:24Z,conjugated linoleic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid
2020-09-18T04:24:24Z,Constant-T,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,Contego,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-144
2020-09-18T04:24:24Z,contrast agent CS-1000,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contrast-agent-cs-1000
2020-09-18T04:24:24Z,copanlisib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride
2020-09-18T04:24:24Z,COPDAC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen
2020-09-18T04:24:24Z,Copiktra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib
2020-09-18T04:24:24Z,COPP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-regimen
2020-09-18T04:24:24Z,COPP-ABV regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-abv-regimen
2020-09-18T04:24:24Z,copper chloride formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-chloride-formulation
2020-09-18T04:24:24Z,copper Cu 62 ethylglyoxal bis(thiosemicarbazone),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ethylglyoxal-bisthiosemicarbazone
2020-09-18T04:24:24Z,copper Cu 62-ATSM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-atsm
2020-09-18T04:24:24Z,copper Cu 62-PTSM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-62-ptsm
2020-09-18T04:24:24Z,copper Cu 64 anti-CEA monoclonal antibody M5A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-anti-cea-monoclonal-antibody-m5a
2020-09-18T04:24:24Z,copper Cu 64 DOTA-daratumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-daratumumab
2020-09-18T04:24:24Z,copper Cu 64 NOTA-PSMAi-PEG-Cy5.5-C' dots,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800203
2020-09-18T04:24:24Z,copper Cu 64 plerixafor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-plerixafor
2020-09-18T04:24:24Z,copper Cu 64 TP3805,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-tp3805
2020-09-18T04:24:24Z,copper Cu 64 trastuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-trastuzumab
2020-09-18T04:24:24Z,copper Cu 64-ATSM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-atsm
2020-09-18T04:24:24Z,copper Cu 64-CB-TE1A1P-PEG4-LLP2A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796462
2020-09-18T04:24:24Z,copper Cu 64-DOTA B-Fab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-b-fab
2020-09-18T04:24:24Z,copper Cu 64-DOTA-AE105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-ae105
2020-09-18T04:24:24Z,copper Cu 64-DOTA-anti-HER3 monoclonal antibody U3-1287,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-anti-her3-monoclonal-antibody-u3-1287
2020-09-18T04:24:24Z,copper Cu 64-DOTA-ECL1i,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797547
2020-09-18T04:24:24Z,copper Cu 64-DOTA-rituximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-rituximab
2020-09-18T04:24:24Z,copper Cu 64-DOTA-trastuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-trastuzumab
2020-09-18T04:24:24Z,copper Cu 67 Tyr3-octreotate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801332
2020-09-18T04:24:24Z,copper Cu-64-DOTA-alendronate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793386
2020-09-18T04:24:24Z,copper gluconate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-gluconate
2020-09-18T04:24:24Z,copper supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-supplement
2020-09-18T04:24:24Z,cord blood-derived CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801490
2020-09-18T04:24:24Z,cord blood-derived CMV/AdV/EBV/BKV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798318
2020-09-18T04:24:24Z,cord blood-derived expanded allogeneic natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793416
2020-09-18T04:24:24Z,Cordarone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride
2020-09-18T04:24:24Z,cordycepin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin
2020-09-18T04:24:24Z,Coreg,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol
2020-09-18T04:24:24Z,Coreg CR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carvedilol-phosphate-extended-release-capsule
2020-09-18T04:24:24Z,Corgard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadolol
2020-09-18T04:24:24Z,Coriolus versicolor extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coriolus-versicolor-extract
2020-09-18T04:24:24Z,Corlanor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792710
2020-09-18T04:24:24Z,corn starch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801632
2020-09-18T04:24:24Z,Cort-Dome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,Cortalone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone
2020-09-18T04:24:24Z,Cortef,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,Cortenema,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,corticorelin acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate
2020-09-18T04:24:24Z,corticotropin-releasing hormone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin-releasing-hormone
2020-09-18T04:24:24Z,Cortispray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,Cortril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,Corynebacterium granulosum P40,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corynebacterium-granulosum-p40
2020-09-18T04:24:24Z,Cosmegen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin
2020-09-18T04:24:24Z,Cotara,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-tnt-1-b
2020-09-18T04:24:24Z,Cotellic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib
2020-09-18T04:24:24Z,Cotrim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole
2020-09-18T04:24:24Z,Coumadin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium
2020-09-18T04:24:24Z,coumarin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coumarin
2020-09-18T04:24:24Z,Coversin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332
2020-09-18T04:24:24Z,coxsackievirus A21,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-a21
2020-09-18T04:24:24Z,Cozaar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losartan-potassium
2020-09-18T04:24:24Z,"CP-724,714",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cp-724714
2020-09-18T04:24:24Z,CpG oligodeoxynucleotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide
2020-09-18T04:24:24Z,CpG oligodeoxynucleotide GNKG168,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-gnkg168
2020-09-18T04:24:24Z,CpG oligodeoxynucleotide TLR9 agonist DV281,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-tlr9-agonist-dv281
2020-09-18T04:24:24Z,CR2-fH fusion protein TT30,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cr2-fh-fusion-protein-tt30
2020-09-18T04:24:24Z,creatine monohydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/creatine-monohydrate
2020-09-18T04:24:24Z,crenolanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib
2020-09-18T04:24:24Z,crenolanib besylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib-besylate
2020-09-18T04:24:24Z,Creon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase
2020-09-18T04:24:24Z,Crestor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosuvastatin-calcium
2020-09-18T04:24:24Z,cridanimod sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cridanimod-sodium
2020-09-18T04:24:24Z,CRISPR/Cas9-edited HPV16/18 E6/E7 plasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792534
2020-09-18T04:24:24Z,CRISPR/Cas9-mediated PD-1 and TCR gene-deleted anti-mesothelin CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797099
2020-09-18T04:24:24Z,Crixivan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indinavir-sulfate
2020-09-18T04:24:24Z,crizanlizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizanlizumab
2020-09-18T04:24:24Z,crizotinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib
2020-09-18T04:24:24Z,crofelemer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer
2020-09-18T04:24:24Z,crolibulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crolibulin
2020-09-18T04:24:24Z,cromolyn sodium inhalant PA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cromolyn-sodium-inhalant-pa101
2020-09-18T04:24:24Z,crotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crotoxin
2020-09-18T04:24:24Z,CRTH2 antagonist ACT-774312,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798382
2020-09-18T04:24:24Z,crystalline genistein formulation AXP107-11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crystalline-genistein-formulation-axp107-11
2020-09-18T04:24:24Z,CSF-1R inhibitor BLZ945,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf-1r-inhibitor-blz945
2020-09-18T04:24:24Z,CSF1R inhibitor DCC-3014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/csf1r-inhibitor-dcc-3014
2020-09-18T04:24:24Z,CTLA-4-directed probody BMS-986249,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792162
2020-09-18T04:24:24Z,CTP-37-DT vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctp-37-dt-vaccine
2020-09-18T04:24:24Z,Cubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin
2020-09-18T04:24:24Z,Culturelle,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg
2020-09-18T04:24:24Z,Cuprenil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine
2020-09-18T04:24:24Z,Cuprimine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine
2020-09-18T04:24:24Z,curcumin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin
2020-09-18T04:24:24Z,curcumin-based gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-based-gel
2020-09-18T04:24:24Z,curcumin/chondroitin sulfate/hyaluronic acid/quercetin soft gels,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795369
2020-09-18T04:24:24Z,curcumin/doxorubicin-encapsulating nanoparticle IMX-110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794327
2020-09-18T04:24:24Z,curcumin/green tea extract/Polygonum cuspidatum extract/soybean extract capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/612154
2020-09-18T04:24:24Z,cusatuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-monoclonal-antibody-argx-110
2020-09-18T04:24:24Z,custirsen sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium
2020-09-18T04:24:24Z,CVP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cvp-regimen
2020-09-18T04:24:24Z,CXC chemokine receptor 2 antagonist AZD5069,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxc-chemokine-receptor-2-antagonist-azd5069
2020-09-18T04:24:24Z,Cxcr1/2 inhibitor SX-682,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792795
2020-09-18T04:24:24Z,CXCR2 antagonist QBM076,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793940
2020-09-18T04:24:24Z,CXCR4 antagonist BL-8040,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-bl-8040
2020-09-18T04:24:24Z,CXCR4 antagonist USL311,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-usl311
2020-09-18T04:24:24Z,CXCR4 inhibitor MSX-122,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-msx-122
2020-09-18T04:24:24Z,CXCR4 peptide antagonist LY2510924,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-peptide-antagonist-ly2510924
2020-09-23T07:08:11Z,CXCR4/E-selectin antagonist GMI-1359,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802777
2020-09-18T04:24:24Z,cyanocobalamin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin
2020-09-18T04:24:24Z,cyanocobalamin/dexamethasone/gentamicin/procaine formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyanocobalamin-dexamethasone-gentamicin-procaine-formulation
2020-09-18T04:24:24Z,cyclin B1 peptide-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-b1-peptide-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,cyclin-dependent kinase 8/19 inhibitor BCD 115,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792544
2020-09-18T04:24:24Z,cyclin-dependent kinase inhibitor PF-06873600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793673
2020-09-18T04:24:24Z,cyclobenzaprine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride
2020-09-18T04:24:24Z,dexamethasone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone
2020-09-18T04:24:24Z,cyclodextrin-based polymer-camptothecin CRLX101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclodextrin-based-polymer-camptothecin-crlx101
2020-09-18T04:24:24Z,Cycloflex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride
2020-09-18T04:24:24Z,cycloleucine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloleucine
2020-09-18T04:24:24Z,cyclopentenyl cytosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclopentenyl-cytosine
2020-09-18T04:24:24Z,cyclophosphamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide
2020-09-18T04:24:24Z,CycloSam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673
2020-09-18T04:24:24Z,cyclosporine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine
2020-09-18T04:24:24Z,cyclosporine ophthalmic emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine-ophthalmic-emulsion
2020-09-18T04:24:24Z,Cyklokapron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tranexamic-acid
2020-09-18T04:24:24Z,CYL-02 plasmid DNA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyl-02-plasmid-dna
2020-09-18T04:24:24Z,Cynviloq™,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle
2020-09-18T04:24:24Z,CYP11A1 inhibitor ODM-208,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795704
2020-09-18T04:24:24Z,CYP11A1 inhibitor ODM-209,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801473
2020-09-18T04:24:24Z,CYP17 inhibitor CFG920,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-inhibitor-cfg920
2020-09-18T04:24:24Z,CYP17 lyase inhibitor ASN001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-lyase-inhibitor-asn001
2020-09-18T04:24:24Z,CYP17/androgen receptor inhibitor ODM 204,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-androgen-receptor-inhibitor-odm-204
2020-09-18T04:24:24Z,cyproheptadine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproheptadine-hydrochloride
2020-09-18T04:24:24Z,cyproterone acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproterone-acetate
2020-09-18T04:24:24Z,Cyramza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab
2020-09-18T04:24:24Z,Cyren A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,cysteine-rich non-denatured whey protein isolate IMN1207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207
2020-09-18T04:24:24Z,Cysview,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate-hydrochloride
2020-09-18T04:24:24Z,cytadine analogue RX-3117,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytadine-analogue-rx-3117
2020-09-18T04:24:24Z,cytarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine
2020-09-18T04:24:24Z,cytarabine liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-liposome
2020-09-18T04:24:24Z,cytarabine monophosphate prodrug MB07133,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine-monophosphate-prodrug-mb07133
2020-09-18T04:24:24Z,cytarabine-asparagine prodrug BST-236,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795601
2020-09-18T04:24:24Z,cytochlor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytochlor
2020-09-18T04:24:24Z,cytokine-based biologic agent IRX-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irx-2
2020-09-18T04:24:24Z,cytokine-induced killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-induced-killer-cells
2020-09-18T04:24:24Z,cytokine-treated veto cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794144
2020-09-18T04:24:24Z,cytomegalovirus IE-1-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytomegalovirus-ie-1-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,cytomegalovirus pp65-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytomegalovirus-pp65-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,Cytomel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine-sodium
2020-09-18T04:24:24Z,D-cycloserine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine
2020-09-18T04:24:24Z,D-methionine formulation MRX-1024,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-methionine-formulation-mrx-1024
2020-09-18T04:24:24Z,D1/3-MAGE-3-His fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d1-3-mage-3-his-fusion-protein
2020-09-18T04:24:24Z,DAB389 epidermal growth factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dab389-epidermal-growth-factor
2020-09-18T04:24:24Z,dabigatran etexilate mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate
2020-09-18T04:24:24Z,dabrafenib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib
2020-09-18T04:24:24Z,dacarbazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine
2020-09-18T04:24:24Z,dacetuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab
2020-09-18T04:24:24Z,DACH polymer platinate AP5346,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-polymer-platinate-ap5346
2020-09-18T04:24:24Z,DACH-platin micelle NC-4016,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-platin-micelle-nc-4016
2020-09-18T04:24:24Z,daclatasvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclatasvir
2020-09-18T04:24:24Z,daclizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab
2020-09-18T04:24:24Z,Dacogen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine
2020-09-18T04:24:24Z,dacomitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib
2020-09-18T04:24:24Z,dactinomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin
2020-09-18T04:24:24Z,Dakin's solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dakins-solution
2020-09-18T04:24:24Z,dalantercept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalantercept
2020-09-18T04:24:24Z,dalbavancin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691
2020-09-18T04:24:24Z,Daliresp,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast
2020-09-18T04:24:24Z,dalotuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalotuzumab
2020-09-18T04:24:24Z,dalteparin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium
2020-09-18T04:24:24Z,danazol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol
2020-09-18T04:24:24Z,daniquidone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daniquidone
2020-09-18T04:24:24Z,Danocrine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol
2020-09-18T04:24:24Z,danusertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danusertib
2020-09-18T04:24:24Z,danvatirsen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464
2020-09-30T06:13:12Z,dapagliflozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802820
2020-09-18T04:24:24Z,daporinad,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daporinad
2020-09-18T04:24:24Z,dapsone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone
2020-09-18T04:24:24Z,"dapsone gel, 5%",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone-gel-5pct
2020-09-18T04:24:24Z,Daptacel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed
2020-09-18T04:24:24Z,daptomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daptomycin
2020-09-18T04:24:24Z,Daraprim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrimethamine
2020-09-18T04:24:24Z,daratumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab
2020-09-18T04:24:24Z,daratumumab and hyaluronidase-fihj,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698
2020-09-18T04:24:24Z,darbepoetin alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darbepoetin-alfa
2020-09-18T04:24:24Z,darinaparsin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darinaparsin
2020-09-18T04:24:24Z,darolutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201
2020-09-18T04:24:24Z,daromun,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794649
2020-09-18T04:24:24Z,Darzalex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab
2020-09-18T04:24:24Z,Darzalex Faspro,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795698
2020-09-18T04:24:24Z,dasabuvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasabuvir
2020-09-18T04:24:24Z,dasatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasatinib
2020-09-18T04:24:24Z,daunorubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride
2020-09-18T04:24:24Z,daunorubicin hydrochloride and cytarabine liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome
2020-09-18T04:24:24Z,DaunoXome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-daunorubicin-citrate
2020-09-18T04:24:24Z,Daurismo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hedgehog-inhibitor-pf-04449913
2020-09-18T04:24:24Z,DAVANAT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative
2020-09-18T04:24:24Z,DC-cholesterol liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-cholesterol-liposome
2020-09-18T04:24:24Z,DC-OVA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dc-ova-vaccine
2020-09-18T04:24:24Z,DCR ligand-bearing liposome-encapsulated melanoma antigens vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dcr-ligand-bearing-liposome-encapsulated-melanoma-antigens-vaccine
2020-09-18T04:24:24Z,DDAVP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate
2020-09-18T04:24:24Z,DEC-205/NY-ESO-1 fusion protein CDX-1401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dec-205-ny-eso-1-fusion-protein-cdx-1401
2020-09-18T04:24:24Z,Decavac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed
2020-09-18T04:24:24Z,decitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine
2020-09-18T04:24:24Z,decitabine and cedazuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cda-inhibitor-e7727-decitabine-combination-agent-astx727
2020-09-18T04:24:24Z,Declomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demeclocycline-hydrochloride
2020-09-18T04:24:24Z,defactinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defactinib
2020-09-18T04:24:24Z,deferasirox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferasirox
2020-09-18T04:24:24Z,deferoxamine mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate
2020-09-18T04:24:24Z,defibrotide sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defibrotide-sodium
2020-09-18T04:24:24Z,Definity,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren
2020-09-18T04:24:24Z,Definity,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren-lipid-microspheres
2020-09-18T04:24:24Z,Defitelio,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defibrotide-sodium
2020-09-18T04:24:24Z,degarelix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix
2020-09-18T04:24:24Z,deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deglycosylated-ricin-a-chain-conjugated-anti-cd19-anti-cd22-immunotoxins
2020-09-18T04:24:24Z,dehydrated human amnion/chorion membrane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dehydrated-human-amnion-chorion-membrane
2020-09-18T04:24:24Z,Del-Vi-A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839
2020-09-18T04:24:24Z,Deladumone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,delanzomib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delanzomib
2020-09-18T04:24:24Z,Delatestryl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022
2020-09-18T04:24:24Z,delta-8-tetrahydrocannabinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delta-8-tetrahydrocannabinol
2020-09-18T04:24:24Z,Delta-Cortef,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone
2020-09-18T04:24:24Z,delta-tocopherol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delta-tocopherol
2020-09-18T04:24:24Z,DeltaRex-G,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1
2020-09-18T04:24:24Z,demcizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demcizumab
2020-09-18T04:24:24Z,demeclocycline hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demeclocycline-hydrochloride
2020-09-18T04:24:24Z,Demerol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meperidine-hydrochloride
2020-09-18T04:24:24Z,demineralized bone matrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demineralized-bone-matrix
2020-09-18T04:24:24Z,DEMSER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine
2020-09-18T04:24:24Z,Dendrid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine
2020-09-18T04:24:24Z,dendritic cell-autologous lung tumor vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-autologous-lung-tumor-vaccine
2020-09-18T04:24:24Z,dendritic cell-CEA peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-cea-peptide-vaccine
2020-09-18T04:24:24Z,dendritic cell-gp100-MART-1 antigen vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-gp100-mart-1-antigen-vaccine
2020-09-18T04:24:24Z,dendritic cell-idiotype-keyhole limpet hemocyanin vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-idiotype-keyhole-limpet-hemocyanin-vaccine
2020-09-18T04:24:24Z,dendritic cell-MART-1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-mart-1-peptide-vaccine
2020-09-18T04:24:24Z,dendritic cell-precision multiple antigen T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-precision-multiple-antigen-t-lymphocytes
2020-09-18T04:24:24Z,dendritic cell-targeting lentiviral vector ID-LV305,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-targeting-lentiviral-vector-id-lv305
2020-09-18T04:24:24Z,Dendrobium huoshanense granules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802041
2020-09-18T04:24:24Z,denenicokin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denenicokin
2020-09-18T04:24:24Z,dengue virus adjuvant PV-001-DV,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801795
2020-09-18T04:24:24Z,denibulin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denibulin-hydrochloride
2020-09-18T04:24:24Z,denileukin diftitox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox
2020-09-18T04:24:24Z,denintuzumab mafodotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin
2020-09-18T04:24:24Z,denosumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab
2020-09-18T04:24:24Z,deoxycytidine analogue TAS-109,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deoxycytidine-analogue-tas-109
2020-09-18T04:24:24Z,Depacon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium
2020-09-18T04:24:24Z,Depacon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid
2020-09-18T04:24:24Z,Depade,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride
2020-09-18T04:24:24Z,Depakene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid
2020-09-18T04:24:24Z,Depakote,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium
2020-09-18T04:24:24Z,Depakote ER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium
2020-09-18T04:24:24Z,depAndro,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate
2020-09-18T04:24:24Z,DEPDC1/MPHOSH1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depdc1-mphosh1-peptide-vaccine
2020-09-18T04:24:24Z,Depen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine
2020-09-18T04:24:24Z,Deplin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate
2020-09-18T04:24:24Z,Depo-Heparin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium
2020-09-18T04:24:24Z,Depo-Medrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate
2020-09-18T04:24:24Z,Depo-Provera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate
2020-09-18T04:24:24Z,Depo-Testosterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate
2020-09-18T04:24:24Z,Depotest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate
2020-09-18T04:24:24Z,derazantinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-arq-087
2020-09-18T04:24:24Z,derma-membrane-structure topical cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derma-membrane-structure-topical-cream
2020-09-18T04:24:24Z,DermACELL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709
2020-09-18T04:24:24Z,Dermacort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,DermaMatrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acelullar-cadaveric-dermal-matrix
2020-09-18T04:24:24Z,Desferal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferoxamine-mesylate
2020-09-18T04:24:24Z,desflurane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desflurane
2020-09-18T04:24:24Z,desipramine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desipramine-hydrochloride
2020-09-18T04:24:24Z,deslorelin acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deslorelin-acetate
2020-09-18T04:24:24Z,desmopressin acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate
2020-09-18T04:24:24Z,desogestral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desogestral
2020-09-18T04:24:24Z,desvenlafaxine succinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desvenlafaxine-succinate
2020-09-18T04:24:24Z,detorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detorubicin
2020-09-18T04:24:24Z,Detox-B adjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant
2020-09-18T04:24:24Z,DetoxPC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detoxpc
2020-09-18T04:24:24Z,deuterated 3-methylhistidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-3-methylhistidine
2020-09-18T04:24:24Z,deuterated enzalutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797006
2020-09-18T04:24:24Z,deuterated phenanthrene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-phenanthrene
2020-09-18T04:24:24Z,deuterium oxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterium-oxide
2020-09-20T05:26:50Z,devimistat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/68-bisbenzylthiooctanoic-acid
2020-09-18T04:24:24Z,dexamethasone intravitreal implant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone-intravitreal-implant
2020-09-18T04:24:24Z,Dexampex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate
2020-09-18T04:24:24Z,dexanabinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexanabinol
2020-09-18T04:24:24Z,Dexedrine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate
2020-09-18T04:24:24Z,dexmedetomidine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexmedetomidine-hydrochloride
2020-09-18T04:24:24Z,dexpanthenol cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream
2020-09-18T04:24:24Z,dexpanthenol mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-mouthwash
2020-09-18T04:24:24Z,dexrazoxane hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride
2020-09-18T04:24:24Z,Dextri-Maltose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin
2020-09-18T04:24:24Z,dextroamphetamine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate
2020-09-18T04:24:24Z,dextroamphetamine-amphetamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-amphetamine
2020-09-18T04:24:24Z,dextromethorphan hydrobromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextromethorphan-hydrobromide
2020-09-18T04:24:24Z,dextropropoxyphene hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextropropoxyphene-hydrochloride
2020-09-18T04:24:24Z,Dextrostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate
2020-09-18T04:24:24Z,dexverapamil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexverapamil
2020-09-18T04:24:24Z,dezamizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794047
2020-09-18T04:24:24Z,DHA-paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel
2020-09-18T04:24:24Z,DHAP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dhap-regimen
2020-09-18T04:24:24Z,DHEA mustard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dhea-mustard
2020-09-18T04:24:24Z,dHER2+AS15 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dher2as15-vaccine
2020-09-18T04:24:24Z,DI-Leu16-IL2 immunocytokine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/di-leu16-il2-immunocytokine
2020-09-18T04:24:24Z,Diabeta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide
2020-09-18T04:24:24Z,Diabinese,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide
2020-09-18T04:24:24Z,diacetylmorphine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diacetylmorphine-hydrochloride
2020-09-18T04:24:24Z,diammonium glycyrrhizinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diammonium-glycyrrhizinate
2020-09-18T04:24:24Z,dianhydrogalactitol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol
2020-09-18T04:24:24Z,Diastyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,diazepinomicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazepinomicin
2020-09-18T04:24:24Z,diaziquone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diaziquone
2020-09-18T04:24:24Z,diazooxonorleucine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazooxonorleucine
2020-09-18T04:24:24Z,diazoxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazoxide
2020-09-18T04:24:24Z,Dibenzyline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenoxybenzamine-hydrochloride
2020-09-18T04:24:24Z,dichloromethotrexate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dichloromethotrexate
2020-09-18T04:24:24Z,diclofenac epolamine patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-epolamine-patch
2020-09-18T04:24:24Z,diclofenac sodium gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-sodium-gel
2020-09-18T04:24:24Z,didanosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine
2020-09-18T04:24:24Z,didemnin B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didemnin-b
2020-09-18T04:24:24Z,dideoxyadenosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dideoxyadenosine
2020-09-18T04:24:24Z,dienogest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dienogest
2020-09-18T04:24:24Z,diethyldithiocarbamate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethyldithiocarbamate
2020-09-18T04:24:24Z,diethylstilbestrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Difflam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride
2020-09-18T04:24:24Z,Difinsa53,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethicone-containing-botanicals-based-lotion
2020-09-18T04:24:24Z,Diflucan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole
2020-09-18T04:24:24Z,diflunisal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal
2020-09-18T04:24:24Z,digestible starch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799712
2020-09-18T04:24:24Z,digoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/digoxin
2020-09-18T04:24:24Z,dihydro-5-azacytidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydro-5-azacytidine
2020-09-18T04:24:24Z,dihydrolenperone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrolenperone
2020-09-18T04:24:24Z,dihydroorotate dehydrogenase inhibitor AG-636,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797356
2020-09-18T04:24:24Z,dihydroorotate dehydrogenase inhibitor ASLAN003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795787
2020-09-18T04:24:24Z,dihydroorotate dehydrogenase inhibitor BAY2402234,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793941
2020-09-18T04:24:24Z,dihydrotestosterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydrotestosterone
2020-09-18T04:24:24Z,diindolylmethane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diindolylmethane
2020-09-18T04:24:24Z,Dilaudid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride
2020-09-18T04:24:24Z,Dilaudid HP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride
2020-09-18T04:24:24Z,diltiazem hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diltiazem-hydrochloride
2020-09-18T04:24:24Z,Dimericine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion
2020-09-18T04:24:24Z,dimesna,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna
2020-09-18T04:24:24Z,dimethicone-containing botanicals-based lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethicone-containing-botanicals-based-lotion
2020-09-18T04:24:24Z,dimethyl fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate
2020-09-18T04:24:24Z,dimethyl sulfoxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-sulfoxide
2020-09-18T04:24:24Z,dimethylbusulfan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylbusulfan
2020-09-18T04:24:24Z,Dimorphone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride
2020-09-18T04:24:24Z,dinaciclib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib
2020-09-18T04:24:24Z,dinitrophenyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinitrophenyl
2020-09-18T04:24:24Z,dinoprost tromethamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinoprost-tromethamine
2020-09-18T04:24:24Z,dinutuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab
2020-09-18T04:24:24Z,Dioscorea nipponica Makino extract DNE3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dioscorea-nipponica-makino-extract-dne3
2020-09-18T04:24:24Z,Diovan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valsartan
2020-09-18T04:24:24Z,diphencyprone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone
2020-09-18T04:24:24Z,diphenhydramine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride
2020-09-18T04:24:24Z,diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride-dexamethasone-nystatin-magic-mouthwash
2020-09-18T04:24:24Z,diphtheria toxin fragment-interleukin-2 fusion protein E7777,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxin-fragment-interleukin-2-fusion-protein-e7777
2020-09-18T04:24:24Z,diphtheria toxoid/tetanus toxoid vaccine adsorbed,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed
2020-09-18T04:24:24Z,"diphtheria toxoid/tetanus toxoid/acellular pertussis adsorbed, recombinant hepatitis B/inactivated poliovirus vaccine combined",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/561774
2020-09-18T04:24:24Z,diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed
2020-09-18T04:24:24Z,diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-Haemophilus influenzae type b vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/772556
2020-09-18T04:24:24Z,Diprivan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propofol
2020-09-18T04:24:24Z,dipyridamole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dipyridamole
2020-09-18T04:24:24Z,disaccharide tripeptide glycerol dipalmitoyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disaccharide-tripeptide-glycerol-dipalmitoyl
2020-09-18T04:24:24Z,Disalcid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902
2020-09-18T04:24:24Z,distilled water,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/distilled-water
2020-09-18T04:24:24Z,disulfiram,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disulfiram
2020-09-18T04:24:24Z,Disulone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone
2020-09-18T04:24:24Z,divalproex sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium
2020-09-18T04:24:24Z,Divine 9 with Carragel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrageenan-containing-gel
2020-09-18T04:24:24Z,DJ-927,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dj-927
2020-09-18T04:24:24Z,DKK1-neutralizing monoclonal antibody DKN-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dkk1-neutralizing-monoclonal-antibody-dkn-01
2020-09-18T04:24:24Z,DLK1/ EPHA2/HBB/NRP1/RGS5/TEM1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/757880
2020-09-18T04:24:24Z,DM-CHOC-PEN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dm-choc-pen
2020-09-18T04:24:24Z,DM4-conjugated anti-Cripto monoclonal antibody BIIB015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dm4-conjugated-anti-cripto-monoclonal-antibody-biib015
2020-09-18T04:24:24Z,DNA interference oligonucleotide PNT2258,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258
2020-09-18T04:24:24Z,DNA minor groove binding agent PM060184,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-pm060184
2020-09-18T04:24:24Z,DNA minor groove binding agent SG2000,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-minor-groove-binding-agent-sg2000
2020-09-18T04:24:24Z,DNA plasmid encoding interleukin-12 INO-9012,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-plasmid-encoding-interleukin-12-ino-9012
2020-09-18T04:24:24Z,DNA plasmid vector pPRA-PSM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-plasmid-vector-ppra-psm-vaccine
2020-09-18T04:24:24Z,DNA plasmid-encoding interleukin-12/HPV DNA plasmids therapeutic vaccine MEDI0457,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775854
2020-09-18T04:24:24Z,DNA vaccine VB10.16,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-vaccine-vb1016
2020-09-18T04:24:24Z,DNA-dependent protein kinase inhibitor VX-984,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-inhibitor-vx-984
2020-09-18T04:24:24Z,DNA-dependent protein kinase-targeting siDNA DT01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-targeting-sidna-dt01
2020-09-18T04:24:24Z,DNA-PK inhibitor AZD7648,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800695
2020-09-18T04:24:24Z,DNA-PK/PI3K delta inhibitor BR101801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801432
2020-09-18T04:24:24Z,DNA-PK/TOR kinase inhibitor CC-115,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-tor-kinase-inhibitor-cc-115
2020-09-18T04:24:24Z,DNAi® drug PNT2258,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-interference-oligonucleotide-pnt2258
2020-09-18T04:24:24Z,DNMT1 inhibitor NTX-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802300
2020-09-18T04:24:24Z,DNP-modified autologous renal cell carcinoma tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnp-modified-autologous-renal-cell-carcinoma-tumor-cell-vaccine
2020-09-18T04:24:24Z,DNR-expressing nasopharyngeal carcinoma-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnr-expressing-nasopharyngeal-carcinoma-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,dobutamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dobutamine
2020-09-18T04:24:24Z,docetaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel
2020-09-18T04:24:24Z,docetaxel emulsion ANX-514,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-emulsion-anx-514
2020-09-18T04:24:24Z,docetaxel formulation CKD-810,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-formulation-ckd-810
2020-09-18T04:24:24Z,docetaxel lipid microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-lipid-microspheres
2020-09-18T04:24:24Z,docetaxel nanoparticle CPC634,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-docetaxel
2020-09-18T04:24:24Z,docetaxel polymeric micelles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799405
2020-09-18T04:24:24Z,docetaxel-loaded nanopharmaceutical CRLX301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-loaded-nanopharmaceutical-crlx301
2020-09-18T04:24:24Z,docetaxel-PNP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-pnp
2020-09-18T04:24:24Z,docetaxel/ritonavir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798993
2020-09-18T04:24:24Z,docosahexaenoic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docosahexaenoic-acid
2020-09-18T04:24:24Z,dolasetron mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolasetron-mesylate
2020-09-18T04:24:24Z,dolastatin 10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolastatin-10
2020-09-18T04:24:24Z,dolcanatide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794176
2020-09-18T04:24:24Z,Dolobid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diflunisal
2020-09-18T04:24:24Z,Dolophine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride
2020-09-18T04:24:24Z,dolutegravir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir
2020-09-18T04:24:24Z,domatinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-4sc-202
2020-09-18T04:24:24Z,Domestrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Domolene-HC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,donepezil hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donepezil-hydrochloride
2020-09-18T04:24:24Z,donor lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-lymphocytes
2020-09-18T04:24:24Z,donor regulatory T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-regulatory-t-lymphocytes
2020-09-18T04:24:24Z,donor-derived CD34+ hematopoietic stem and progenitor cells plus CD3+ T cells MDR-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793675
2020-09-18T04:24:24Z,donor-derived cytokine-induced memory-like natural killer cell,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792552
2020-09-18T04:24:24Z,donor-derived WT1/PRAME/NY-ESO-1/survivin-specific T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-derived-wt1-prame-ny-eso-1-survivin-specific-t-lymphocytes
2020-09-18T04:24:24Z,dopamine–somatostatin chimeric molecule BIM-23A760,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dopamine-somatostatin-chimeric-molecule-bim-23a760
2020-09-18T04:24:24Z,Dopar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa
2020-09-18T04:24:24Z,Doptelet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793425
2020-09-18T04:24:24Z,dornase alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa
2020-09-18T04:24:24Z,dornase alfa inhalation solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution
2020-09-18T04:24:24Z,dostarlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-tsr-042
2020-09-18T04:24:24Z,Dostinex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabergoline
2020-09-18T04:24:24Z,DOTAP:chol-Fus1 liposome complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapchol-fus1-liposome-complex
2020-09-18T04:24:24Z,DOTAREM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine
2020-09-18T04:24:24Z,dovitinib lactate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate
2020-09-18T04:24:24Z,Dovonex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcipotriene
2020-09-18T04:24:24Z,doxazosin mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxazosin-mesylate
2020-09-18T04:24:24Z,doxepin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride
2020-09-18T04:24:24Z,doxercalciferol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxercalciferol
2020-09-18T04:24:24Z,doxifluridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxifluridine
2020-09-18T04:24:24Z,Doxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome
2020-09-18T04:24:24Z,doxorubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride
2020-09-18T04:24:24Z,doxorubicin hydrochloride liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride-liposome
2020-09-18T04:24:24Z,doxorubicin prodrug/prodrug-activating biomaterial SQ3370,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800071
2020-09-18T04:24:24Z,doxorubicin-eluting beads,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-eluting-beads
2020-09-18T04:24:24Z,doxorubicin-HPMA conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hpma-conjugate
2020-09-18T04:24:24Z,doxorubicin-loaded EGFR-targeting nanocells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells
2020-09-18T04:24:24Z,doxorubicin-magnetic targeted carrier complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-magnetic-targeted-carrier-complex
2020-09-18T04:24:24Z,doxycycline calcium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-calcium
2020-09-18T04:24:24Z,doxycycline hyclate injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-hyclate-injection
2020-09-18T04:24:24Z,DPT/BCG/measles/Serratia/pneumococcus vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpt-bcg-measles-serratia-pneumococcus-vaccine
2020-09-18T04:24:24Z,DPT/typhoid/Staphylococcus aureus/paratyphoid A/paratyphoid B vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpt-typhoid-staphylococcus-aureus-paratyphoid-a-paratyphoid-b-vaccine
2020-09-18T04:24:24Z,DR5 HexaBody agonist GEN1029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794053
2020-09-18T04:24:24Z,dronabinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol
2020-09-18T04:24:24Z,droperidol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/droperidol
2020-09-18T04:24:24Z,Droxia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea
2020-09-18T04:24:24Z,DTA-H19 plasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dta-h19-plasmid
2020-09-18T04:24:24Z,dual PI3 kinase/mTOR inhibitor GDC-0980,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-pi3-kinase-mtor-inhibitor-gdc-0980
2020-09-18T04:24:24Z,dual variable domain immunoglobulin ABT-165,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-variable-domain-immunoglobulin-abt-165
2020-09-18T04:24:24Z,dual-affinity B7-H3/CD3-targeted protein MGD009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-affinity-b7-h3-cd3-targeted-protein-mgd009
2020-09-18T04:24:24Z,Duavee,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens-bazedoxifene
2020-09-18T04:24:24Z,duborimycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duborimycin
2020-09-18T04:24:24Z,dulanermin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin
2020-09-18T04:24:24Z,duloxetine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duloxetine-hydrochloride
2020-09-18T04:24:24Z,DuoBody-CD3xCD20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798973
2020-09-18T04:24:24Z,Duphaston,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783
2020-09-18T04:24:24Z,dupilumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743
2020-09-18T04:24:24Z,Dupixent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798743
2020-09-18T04:24:24Z,durvalumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab
2020-09-18T04:24:24Z,dutasteride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutasteride
2020-09-18T04:24:24Z,dUTPase inhibitor TAS-114,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutpase-inhibitor-tas-114
2020-09-18T04:24:24Z,duvelisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib
2020-09-18T04:24:24Z,DWJ1319,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dwj1319
2020-09-18T04:24:24Z,Dyclone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778
2020-09-18T04:24:24Z,dyclonine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794778
2020-09-18T04:24:24Z,dydrogesterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795783
2020-09-18T04:24:24Z,Dymelor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetohexamide
2020-09-18T04:24:24Z,Dynacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride
2020-09-18T04:24:24Z,Dysport,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-type-a
2020-09-18T04:24:24Z,E-101 solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-101-solution
2020-09-18T04:24:24Z,E-Mycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin
2020-09-18T04:24:24Z,E-Z Prep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution
2020-09-18T04:24:24Z,E-Z Scrub,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution
2020-09-18T04:24:24Z,E. coli CD-expressing genetically modified neural stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-coli-cd-expressing-genetically-modified-neural-stem-cells
2020-09-18T04:24:24Z,E2F1 pathway activator ARQ 171,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e2f1-pathway-activator-arq-171
2020-09-18T04:24:24Z,E7820,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e7820
2020-09-18T04:24:24Z,East Indian sandalwood oil cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792786
2020-09-18T04:24:24Z,East Indian sandalwood oil mouth rinse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-mouth-rinse
2020-09-18T04:24:24Z,EBNA-1 inhibitor VK-2019,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797645
2020-09-18T04:24:24Z,ebselen-containing oral capsule SPI-1005,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebselen-containing-oral-capsule-spi-1005
2020-09-18T04:24:24Z,EBV LMP-2A-specific autologous CD8+ T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796750
2020-09-18T04:24:24Z,echinomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin
2020-09-18T04:24:24Z,Ecotrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid
2020-09-18T04:24:24Z,ecromeximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ecromeximab
2020-09-18T04:24:24Z,ectoine mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801658
2020-09-18T04:24:24Z,eculizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab
2020-09-18T04:24:24Z,edatrexate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate
2020-09-18T04:24:24Z,Edecrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid
2020-09-18T04:24:24Z,edotecarin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edotecarin
2020-09-18T04:24:24Z,edoxaban tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edoxaban-tosylate
2020-09-18T04:24:24Z,edrecolomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edrecolomab
2020-09-18T04:24:24Z,EED inhibitor MAK683,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683
2020-09-18T04:24:24Z,EF5,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ef5
2020-09-18T04:24:24Z,efalizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efalizumab
2020-09-18T04:24:24Z,efaproxiral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral
2020-09-18T04:24:24Z,flaxseed lignan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799713
2020-09-18T04:24:24Z,efatutazone dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride
2020-09-18T04:24:24Z,efavirenz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz
2020-09-18T04:24:24Z,Effexor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine
2020-09-18T04:24:24Z,Effexor XR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793527
2020-09-18T04:24:24Z,efineptakin alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793669
2020-09-18T04:24:24Z,eflapegrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012
2020-09-18T04:24:24Z,eflornithine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride
2020-09-18T04:24:24Z,eflornithine hydrochloride ointment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride-ointment
2020-09-18T04:24:24Z,EFS-ADA lentiviral vector-transduced CD34-positive autologous lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efs-ada-lentiviral-vector-transduced-cd34-positive-autologous-lymphocytes
2020-09-18T04:24:24Z,eftilagimod alpha,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imp321
2020-09-18T04:24:24Z,Efudex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection
2020-09-18T04:24:24Z,Efudex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil
2020-09-18T04:24:24Z,Eg5 kinesin-related motor protein inhibitor 4SC-205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-4sc-205
2020-09-18T04:24:24Z,Eg5 kinesin-related motor protein inhibitor ARQ 621,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eg5-kinesin-related-motor-protein-inhibitor-arq-621
2020-09-18T04:24:24Z,EGb761,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egb761
2020-09-18T04:24:24Z,EGF vaccine EGF-PTI,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798974
2020-09-18T04:24:24Z,EGFR antagonist Hemay022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antagonist-hemay022
2020-09-18T04:24:24Z,EGFR antisense DNA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antisense-dna
2020-09-18T04:24:24Z,EGFR CAR-CD3zeta-4-1BB-expressing autologous T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-car-cd3zeta-4-1bb-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,EGFR inhibitor ABT-414,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-abt-414
2020-09-18T04:24:24Z,EGFR inhibitor ASP8273,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-asp8273
2020-09-18T04:24:24Z,EGFR inhibitor AZD3759,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-azd3759
2020-09-18T04:24:24Z,EGFR inhibitor DBPR112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794067
2020-09-18T04:24:24Z,EGFR inhibitor EGF816,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-egf816
2020-09-18T04:24:24Z,EGFR mutant-selective inhibitor TQB3804,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801857
2020-09-18T04:24:24Z,EGFR mutant-specific inhibitor BPI-7711,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794290
2020-09-18T04:24:24Z,EGFR mutant-specific inhibitor CK-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101
2020-09-18T04:24:24Z,EGFR mutant-specific inhibitor D-0316,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795785
2020-09-18T04:24:24Z,EGFR mutant-specific inhibitor ZN-e4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793946
2020-09-18T04:24:24Z,EGFR T790M antagonist BPI-15086,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086
2020-09-18T04:24:24Z,EGFR T790M inhibitor PF-06747775,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-inhibitor-pf-06747775
2020-09-18T04:24:24Z,EGFR tyrosine kinase inhibitor HS-10296,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-tyrosine-kinase-inhibitor-hs-10296
2020-09-18T04:24:24Z,EGFR/EGFRvIII inhibitor WSD0922-FU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800200
2020-09-18T04:24:24Z,EGFR/FLT3/Abl inhibitor SKLB1028,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-flt3-abl-inhibitor-sklb1028
2020-09-18T04:24:24Z,EGFR/HER2 inhibitor AV-412,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-av-412
2020-09-18T04:24:24Z,EGFR/HER2 inhibitor DZD9008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800418
2020-09-18T04:24:24Z,EGFR/HER2 inhibitor TAK-788,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-ap32788
2020-09-18T04:24:24Z,EGFR/VEGFR/RET inhibitor HA121-28,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801763
2020-09-18T04:24:24Z,EGFRBi-armed autologous activated T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfrbi-armed-autologous-activated-t-cells
2020-09-18T04:24:24Z,eicosapentaenoic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid
2020-09-18T04:24:24Z,eicosapentaenoic acid monoacylglyceride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797223
2020-09-18T04:24:24Z,eicosapentaenoic acid-enriched nutritional supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid-enriched-nutritional-supplement
2020-09-18T04:24:24Z,eIF4E antisense oligonucleotide ISIS 183750,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eif4e-antisense-oligonucleotide-isis-183750
2020-09-18T04:24:24Z,elacestrant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-modulator-rad1901
2020-09-18T04:24:24Z,elacytarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacytarabine
2020-09-18T04:24:24Z,elagolix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786
2020-09-18T04:24:24Z,elbasvir/grazoprevir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922
2020-09-18T04:24:24Z,Eldecort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,Eldisine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate
2020-09-18T04:24:24Z,Eldopar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa
2020-09-18T04:24:24Z,electrokinetically modified water,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/electrokinetically-modified-water
2020-09-18T04:24:24Z,fotemustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fotemustine
2020-09-18T04:24:24Z,electrolyte-free parenteral nutrition emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/electrolyte-free-parenteral-nutrition-emulsion
2020-09-18T04:24:24Z,elesclomol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol
2020-09-18T04:24:24Z,elesclomol sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elesclomol-sodium
2020-09-18T04:24:24Z,Elidel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimecrolimus-cream
2020-09-18T04:24:24Z,Eligard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate
2020-09-18T04:24:24Z,Eliquis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apixaban
2020-09-18T04:24:24Z,elisidepsin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elisidepsin
2020-09-18T04:24:24Z,Elitek,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase
2020-09-18T04:24:24Z,Elixophyllin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,ellagic acid/Annona muricata supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ellagic-acid-annona-muricata-supplement
2020-09-18T04:24:24Z,Ellence,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride
2020-09-18T04:24:24Z,elliptinium acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate
2020-09-18T04:24:24Z,Elmiron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium
2020-09-18T04:24:24Z,Elocon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mometasone-furoate
2020-09-18T04:24:24Z,elotuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab
2020-09-18T04:24:24Z,Eloxatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin
2020-09-18T04:24:24Z,elsamitrucin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsamitrucin
2020-09-18T04:24:24Z,elsiglutide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elsiglutide
2020-09-18T04:24:24Z,Elspar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase
2020-09-18T04:24:24Z,eltrombopag olamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine
2020-09-18T04:24:24Z,Elunate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib
2020-09-18T04:24:24Z,Elzonris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401
2020-09-18T04:24:24Z,emactuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab
2020-09-18T04:24:24Z,emapalumab-lzsg,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501
2020-09-18T04:24:24Z,Embospheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres
2020-09-18T04:24:24Z,Emcyt,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium
2020-09-18T04:24:24Z,Emend,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprepitant
2020-09-18T04:24:24Z,emepepimut-S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s
2020-09-18T04:24:24Z,Emergent-EZ,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate
2020-09-18T04:24:24Z,Empirin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid
2020-09-18T04:24:24Z,Empliciti,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab
2020-09-18T04:24:24Z,emtricitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine
2020-09-18T04:24:24Z,Emtriva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emtricitabine
2020-09-18T04:24:24Z,Enacard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate
2020-09-18T04:24:24Z,enadenotucirev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev
2020-09-18T04:24:24Z,enadenotucirev-expressing anti-CD40 agonistic monoclonal antibody NG-350,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797804
2020-09-18T04:24:24Z,enadenotucirev-expressing FAP/CD3 bispecific FAP-TAc NG-641,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800703
2020-09-18T04:24:24Z,enalapril maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate
2020-09-18T04:24:24Z,enasidenib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate
2020-09-18T04:24:24Z,enavatuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enavatuzumab
2020-09-18T04:24:24Z,Enbrel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept
2020-09-18T04:24:24Z,enclomiphene citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enclomiphene-citrate
2020-09-18T04:24:24Z,encochleated amphotericin B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793120
2020-09-18T04:24:24Z,encorafenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib
2020-09-18T04:24:24Z,EndoClot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-modified-polymer-hemostatic-powder
2020-09-18T04:24:24Z,Endometrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progesterone-vaginal-insert
2020-09-18T04:24:24Z,endothelin B receptor agonist SPI-1620,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/endothelin-b-receptor-agonist-spi-1620
2020-09-18T04:24:24Z,enfortumab vedotin-ejfv,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce
2020-09-18T04:24:24Z,Engerix-B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant
2020-09-18T04:24:24Z,engineered human umbilical vein endothelial cells AB-205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798637
2020-09-18T04:24:24Z,engineered toxin body-targeting HER2 MT-5111,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798930
2020-09-18T04:24:24Z,Enhanzyn,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/detox-b-adjuvant
2020-09-18T04:24:24Z,Enhertu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a
2020-09-18T04:24:24Z,eniluracil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eniluracil
2020-09-18T04:24:24Z,enoblituzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoblituzumab
2020-09-18T04:24:24Z,enobosarm,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm
2020-09-18T04:24:24Z,enoxaparin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoxaparin-sodium
2020-09-18T04:24:24Z,Enpresse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,ensartinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensartinib
2020-09-18T04:24:24Z,ensituximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensituximab
2020-09-18T04:24:24Z,Ensure,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink
2020-09-18T04:24:24Z,entacapone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801668
2020-09-18T04:24:24Z,entecavir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entecavir
2020-09-18T04:24:24Z,Enterade,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-electrolyte-mixture-based-dietary-supplement
2020-09-18T04:24:24Z,EnteraGam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate
2020-09-18T04:24:24Z,Entereg,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvimopan
2020-09-18T04:24:24Z,Enterex Glutapak-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine
2020-09-18T04:24:24Z,enteric-coated TRPM8 agonist D-3263 hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-trpm8-agonist-d-3263-hydrochloride
2020-09-18T04:24:24Z,enteric-coated zoledronic acid tablet MER-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-zoledronic-acid-tablet-mer-101
2020-09-18T04:24:24Z,Entericin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid
2020-09-18T04:24:24Z,Enterococcus gallinarum strain MRx0518,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798317
2020-09-18T04:24:24Z,entinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat
2020-09-18T04:24:24Z,entolimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entolimod
2020-09-18T04:24:24Z,entospletinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib
2020-09-18T04:24:24Z,entrectinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib
2020-09-18T04:24:24Z,Entresto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813
2020-09-18T04:24:24Z,Entyvio,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab
2020-09-18T04:24:24Z,enzalutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide
2020-09-18T04:24:24Z,enzastaurin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzastaurin-hydrochloride
2020-09-18T04:24:24Z,enzymatically hydrolyzed whey protein-based nutritional supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzymatically-hydrolyzed-whey-protein-based-nutritional-supplement
2020-09-18T04:24:24Z,Eoquin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone
2020-09-18T04:24:24Z,Eovist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium
2020-09-18T04:24:24Z,EP4 antagonist ONO-4578,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792745
2020-09-18T04:24:24Z,epacadostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat
2020-09-18T04:24:24Z,EpCAM-specific CAR-expressing autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcam-specific-car-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,EphA2-targeting bicycle toxin conjugate BT5528,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801972
2020-09-18T04:24:24Z,EphA2-targeting DOPC-encapsulated siRNA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-dopc-encapsulated-sirna
2020-09-18T04:24:24Z,EpiCept NP-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketamine-amitriptyline-np-h-cream
2020-09-18T04:24:24Z,epidermal growth factor ointment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epidermal-growth-factor-ointment
2020-09-18T04:24:24Z,epidiferphane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799672
2020-09-18T04:24:24Z,Epidiolex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol
2020-09-18T04:24:24Z,epigallocatechin gallate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epigallocatechin-gallate
2020-09-18T04:24:24Z,Epilex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium
2020-09-18T04:24:24Z,epirubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride
2020-09-18T04:24:24Z,epitinib succinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793471
2020-09-18T04:24:24Z,Epitol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine
2020-09-18T04:24:24Z,Epival,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium
2020-09-18T04:24:24Z,Epivir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamivudine
2020-09-18T04:24:24Z,eplerenone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eplerenone
2020-09-18T04:24:24Z,EPOCH regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen
2020-09-18T04:24:24Z,EPOCH-O regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-o-regimen
2020-09-18T04:24:24Z,epoetin alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa
2020-09-18T04:24:24Z,epoetin beta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-beta
2020-09-18T04:24:24Z,epoetin zeta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-zeta
2020-09-18T04:24:24Z,Epogen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa
2020-09-18T04:24:24Z,epothilone analog UTD1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-analog-utd1
2020-09-18T04:24:24Z,epothilone D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-d
2020-09-18T04:24:24Z,epothilone KOS-1584,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epothilone-kos-1584
2020-09-18T04:24:24Z,epratuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab
2020-09-18T04:24:24Z,epratuzumab-cys-tesirine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794990
2020-09-18T04:24:24Z,eprodisate disodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprodisate-disodium
2020-09-18T04:24:24Z,EPS8 peptide-specific dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792670
2020-09-18T04:24:24Z,ER alpha proteolysis-targeting chimera protein degrader ARV-471,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799764
2020-09-18T04:24:24Z,ERa36 modulator icaritin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/era36-modulator-icaritin
2020-09-18T04:24:24Z,erastin analogue PRLX 93936,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erastin-analogue-prlx-93936
2020-09-18T04:24:24Z,Eraxis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anidulafungin
2020-09-18T04:24:24Z,erb-38 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erb-38-immunotoxin
2020-09-18T04:24:24Z,Erbitux,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab
2020-09-18T04:24:24Z,erdafitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib
2020-09-18T04:24:24Z,Ergamisol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride
2020-09-18T04:24:24Z,ergocalciferol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ergocalciferol
2020-09-18T04:24:24Z,eribulin mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate
2020-09-18T04:24:24Z,eritoran tetrasodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eritoran-tetrasodium
2020-09-18T04:24:24Z,Erivedge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib
2020-09-18T04:24:24Z,ERK 1/2 inhibitor ASTX029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794989
2020-09-18T04:24:24Z,ERK inhibitor CC-90003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-cc-90003
2020-09-18T04:24:24Z,ERK inhibitor GDC-0994,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-gdc-0994
2020-09-18T04:24:24Z,ERK inhibitor LTT462,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-ltt462
2020-09-18T04:24:24Z,ERK1/2 inhibitor JSI-1187,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801859
2020-09-18T04:24:24Z,ERK1/2 inhibitor KO-947,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ko-947
2020-09-18T04:24:24Z,ERK1/2 inhibitor LY3214996,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-ly3214996
2020-09-18T04:24:24Z,Erleada,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide
2020-09-18T04:24:24Z,erlotinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride
2020-09-18T04:24:24Z,ertapenem sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertapenem-sodium
2020-09-18T04:24:24Z,ertumaxomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertumaxomab
2020-09-18T04:24:24Z,Erwinaze,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase-erwinia-chrysanthemi
2020-09-18T04:24:24Z,Ery-Tab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin
2020-09-18T04:24:24Z,ERYC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin
2020-09-18T04:24:24Z,erythrocyte-encapsulated L-asparaginase suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythrocyte-encapsulated-l-asparaginase-suspension
2020-09-18T04:24:24Z,erythromycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin
2020-09-18T04:24:24Z,erythromycin topical cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin-topical-cream
2020-09-18T04:24:24Z,escitalopram oxalate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/escitalopram-oxalate
2020-09-18T04:24:24Z,Eskalith,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate
2020-09-18T04:24:24Z,esmolol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esmolol
2020-09-18T04:24:24Z,esomeprazole magnesium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esomeprazole-magnesium
2020-09-18T04:24:24Z,esorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esorubicin
2020-09-18T04:24:24Z,Essiac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/essiac
2020-09-18T04:24:24Z,Estinyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol
2020-09-18T04:24:24Z,Estrace,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol
2020-09-18T04:24:24Z,estradiol vaginal ring,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-vaginal-ring
2020-09-18T04:24:24Z,estradiol valerate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-valerate
2020-09-18T04:24:24Z,estradiol/norethindrone acetate tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-norethindrone-acetate-tablet
2020-09-18T04:24:24Z,estramustine phosphate sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estramustine-phosphate-sodium
2020-09-18T04:24:24Z,ESTRING,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estradiol-vaginal-ring
2020-09-18T04:24:24Z,estriol vaginal gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estriol-vaginal-gel
2020-09-18T04:24:24Z,Estrobene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,EstroGel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-estrogen
2020-09-18T04:24:24Z,estrogen receptor agonist GTx-758,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogen-receptor-agonist-gtx-758
2020-09-18T04:24:24Z,Estrosyn,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Estybon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium
2020-09-18T04:24:24Z,eszopiclone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eszopiclone
2020-09-18T04:24:24Z,etanercept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanercept
2020-09-18T04:24:24Z,etanidazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etanidazole
2020-09-18T04:24:24Z,etaracizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab
2020-09-18T04:24:24Z,etelcalcetide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide
2020-09-18T04:24:24Z,ethacrynic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethacrynic-acid
2020-09-18T04:24:24Z,ethambutol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethambutol
2020-09-18T04:24:24Z,ethanol-containing nasal solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800780
2020-09-18T04:24:24Z,ethaselen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethaselen
2020-09-18T04:24:24Z,Ethinoral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol
2020-09-18T04:24:24Z,ethinyl estradiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol
2020-09-18T04:24:24Z,ethinyl estradiol/levonorgestrel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,ethinyl estradiol/norethindrone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,ethiodized oil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil
2020-09-18T04:24:24Z,ethosuximide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethosuximide
2020-09-18T04:24:24Z,ethyl alcohol mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-alcohol-mouthwash
2020-09-18T04:24:24Z,ethyl icosapentate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate
2020-09-18T04:24:24Z,ethylene-vinyl alcohol copolymer-based embolic agent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethylene-vinyl-alcohol-copolymer-based-embolic-agent
2020-09-18T04:24:24Z,Ethyol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine
2020-09-18T04:24:24Z,etidronate-cytarabine conjugate MBC-11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etidronate-cytarabine-conjugate-mbc-11
2020-09-18T04:24:24Z,Etilamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buserelin
2020-09-18T04:24:24Z,etirinotecan pegol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etirinotecan-pegol
2020-09-18T04:24:24Z,etodolac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac
2020-09-18T04:24:24Z,Etopophos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-phosphate
2020-09-18T04:24:24Z,etoposide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide
2020-09-18T04:24:24Z,etoposide phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-phosphate
2020-09-18T04:24:24Z,etoposide prodrug CAP7.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-prodrug-cap71
2020-09-18T04:24:24Z,etoricoxib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoricoxib
2020-09-18T04:24:24Z,Etrenol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone
2020-09-18T04:24:24Z,Etretin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin
2020-09-18T04:24:24Z,Ets-family transcription factor inhibitor TK216,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ets-family-transcription-factor-inhibitor-tk216
2020-09-18T04:24:24Z,Eucerin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-lotion
2020-09-18T04:24:24Z,Evaux spring water-based cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-cream
2020-09-18T04:24:24Z,Evaux spring water-based topical spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-topical-spray
2020-09-18T04:24:24Z,Evaux thermal spring water-based solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-thermal-spring-water-based-solution
2020-09-18T04:24:24Z,everolimus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus
2020-09-18T04:24:24Z,everolimus tablets for oral suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-tablets-for-oral-suspension
2020-09-18T04:24:24Z,everolimus/exemestane regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus-exemestane-regimen
2020-09-18T04:24:24Z,Everone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022
2020-09-18T04:24:24Z,Evista,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride
2020-09-18T04:24:24Z,eVLP CMV gB-pp65 plus GM-CSF VBI-1901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792152
2020-09-18T04:24:24Z,evocalcet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793594
2020-09-18T04:24:24Z,evofosfamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evofosfamide
2020-09-18T04:24:24Z,Evomela,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride
2020-09-18T04:24:24Z,EvoNail,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-thermal-spring-water-based-solution
2020-09-18T04:24:24Z,Evoskin cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evaux-spring-water-based-cream
2020-09-18T04:24:24Z,Evoxac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevimeline-hydrochloride
2020-09-18T04:24:24Z,ex vivo-activated autologous lymph node lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-activated-autologous-lymph-node-lymphocytes
2020-09-18T04:24:24Z,ex vivo-expanded autologous T cells IMA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101
2020-09-18T04:24:24Z,ex vivo-expanded HER2-specific T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-her2-specific-t-cells
2020-09-18T04:24:24Z,exatecan mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exatecan-mesylate
2020-09-18T04:24:24Z,Exelon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivastigmine-tartrate
2020-09-18T04:24:24Z,exemestane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane
2020-09-18T04:24:24Z,exenatide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exenatide
2020-09-18T04:24:24Z,exendin 9-39,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exendin-9-39
2020-09-18T04:24:24Z,Exherin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adh-1
2020-09-18T04:24:24Z,exisulind,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exisulind
2020-09-18T04:24:24Z,Exjade,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deferasirox
2020-09-18T04:24:24Z,expanded cord blood ECT-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795709
2020-09-18T04:24:24Z,expanded cord blood stem cells mixed with engineered human endothelial cells AB-110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795426
2020-09-18T04:24:24Z,expanded/activated gamma/delta T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796975
2020-09-18T04:24:24Z,Exparel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride-liposome-injectable-suspension
2020-09-18T04:24:24Z,extended release bupivacaine hydrochloride resorbable matrix formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation
2020-09-18T04:24:24Z,extended-release flucytosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine
2020-09-18T04:24:24Z,extended-release galantamine hydrobromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963
2020-09-18T04:24:24Z,extended-release granisetron polymer formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation
2020-09-18T04:24:24Z,extended-release microsphere capsule-based oxycodone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794051
2020-09-18T04:24:24Z,extended-release onapristone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-onapristone
2020-09-18T04:24:24Z,Extren,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid
2020-09-18T04:24:24Z,ezatiostat hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezatiostat-hydrochloride
2020-09-18T04:24:24Z,ezetimibe,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe
2020-09-18T04:24:24Z,ezetimibe/simvastatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe-simvastatin
2020-09-18T04:24:24Z,EZH1/2 inhibitor HH2853,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802064
2020-09-18T04:24:24Z,EZH2 inhibitor CPI-0209,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800217
2020-09-18T04:24:24Z,EZH2 inhibitor CPI-1205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-cpi-1205
2020-09-18T04:24:24Z,EZH2 inhibitor PF-06821497,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795703
2020-09-18T04:24:24Z,EZH2 inhibitor SHR2554,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797374
2020-09-18T04:24:24Z,F 18 fluorodeoxygalactose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluorodeoxygalactose
2020-09-18T04:24:24Z,F-18 16 alpha-fluoroestradiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-16-alpha-fluoroestradiol
2020-09-18T04:24:24Z,F-18 fluoroethyltyrosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluoroethyltyrosine
2020-09-18T04:24:24Z,F16-IL2 fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f16-il2-fusion-protein
2020-09-18T04:24:24Z,FACT complex-targeting curaxin CBL0137,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fact-complex-targeting-curaxin-cbl0137
2020-09-18T04:24:24Z,factor B inhibitor LNP023,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795707
2020-09-18T04:24:24Z,factor D inhibitor ALXN2050,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802304
2020-09-18T04:24:24Z,factor VII-targeting immunoconjugate protein ICON-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1
2020-09-18T04:24:24Z,factor VIIa inhibitor PCI-27483,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-viia-inhibitor-pci-27483
2020-09-18T04:24:24Z,fadrozole hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadrozole-hydrochloride
2020-09-18T04:24:24Z,FAK inhibitor GSK2256098,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-gsk2256098
2020-09-18T04:24:24Z,FAK inhibitor PF-00562271,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-pf-00562271
2020-09-18T04:24:24Z,FAK inhibitor VS-4718,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-vs-4718
2020-09-18T04:24:24Z,FAK/ALK/ROS1 inhibitor APG-2449,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801583
2020-09-18T04:24:24Z,falimarev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev
2020-09-18T04:24:24Z,fam-trastuzumab deruxtecan-nxki,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-adc-ds-8201a
2020-09-18T04:24:24Z,famitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famitinib
2020-09-18T04:24:24Z,famotidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famotidine
2020-09-18T04:24:24Z,FAP-specific CD8-positive T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fap-specific-cd8-positive-t-cells
2020-09-18T04:24:24Z,Fareston,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate
2020-09-18T04:24:24Z,farletuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/farletuzumab
2020-09-18T04:24:24Z,Farydak,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat
2020-09-18T04:24:24Z,Fas receptor agonist APO010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fas-receptor-agonist-apo010
2020-09-18T04:24:24Z,Fasigyn,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole
2020-09-18T04:24:24Z,Faslodex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant
2020-09-18T04:24:24Z,FASN inhibitor TVB-2640,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fasn-inhibitor-tvb-2640
2020-09-18T04:24:24Z,fat emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fat-emulsion
2020-09-18T04:24:24Z,fazarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fazarabine
2020-09-18T04:24:24Z,Fc-engineered anti-CD40 agonist antibody 2141-V11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800787
2020-09-18T04:24:24Z,febuxostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/febuxostat
2020-09-18T04:24:24Z,FEC Regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fec-regimen
2020-09-18T04:24:24Z,fecal microbiota transplantation capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800681
2020-09-18T04:24:24Z,fedratinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348
2020-09-18T04:24:24Z,Feldene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxicam
2020-09-18T04:24:24Z,Femara,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole
2020-09-18T04:24:24Z,Femest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens
2020-09-18T04:24:24Z,Feminone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol
2020-09-18T04:24:24Z,fenofibrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenofibrate
2020-09-18T04:24:24Z,fenretinide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide
2020-09-18T04:24:24Z,fenretinide lipid matrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide-lipid-matrix
2020-09-18T04:24:24Z,Fenretinide Lym-X-Sorb,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide-lipid-matrix
2020-09-18T04:24:24Z,fentanyl buccal soluble film,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-buccal-soluble-film
2020-09-18T04:24:24Z,fentanyl citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate
2020-09-18T04:24:24Z,fentanyl citrate buccal tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-buccal-tablet
2020-09-18T04:24:24Z,fentanyl citrate pectin-based nasal spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray
2020-09-18T04:24:24Z,fentanyl citrate-containing nasal spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-containing-nasal-spray
2020-09-18T04:24:24Z,fentanyl matrix transdermal patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-matrix-transdermal-patch
2020-09-18T04:24:24Z,fentanyl sublingual spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-sublingual-spray
2020-09-18T04:24:24Z,Fentora,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-buccal-tablet
2020-09-18T04:24:24Z,Feraheme,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite
2020-09-18T04:24:24Z,Feridex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxides-injectable-solution
2020-09-18T04:24:24Z,fermented soybean extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800204
2020-09-18T04:24:24Z,fermented soybean protein beverage,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-protein-beverage
2020-09-18T04:24:24Z,fermented wheat germ extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract
2020-09-18T04:24:24Z,Ferndex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dextroamphetamine-sulfate
2020-09-18T04:24:24Z,ferric carboxymaltose solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution
2020-09-18T04:24:24Z,Ferrlecit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-ferric-gluconate-complex-in-sucrose
2020-09-18T04:24:24Z,ferrous fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrous-fumarate
2020-09-18T04:24:24Z,ferrous sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrous-sulfate
2020-09-18T04:24:24Z,ferumoxides injectable solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxides-injectable-solution
2020-09-18T04:24:24Z,ferumoxsil oral suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxsil-oral-suspension
2020-09-18T04:24:24Z,ferumoxtran-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10
2020-09-18T04:24:24Z,ferumoxytol non-stoichiometric magnetite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxytol-non-stoichiometric-magnetite
2020-09-18T04:24:24Z,fesoterodine fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fesoterodine-fumarate
2020-09-18T04:24:24Z,fexofenadine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexofenadine-hydrochloride
2020-09-18T04:24:24Z,FGF/FGFR pathway inhibitor E7090,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-fgfr-pathway-inhibitor-e7090
2020-09-18T04:24:24Z,FGF401 inhibitor FGF401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf401-inhibitor-fgf401
2020-09-18T04:24:24Z,FGFR inhibitor ASP5878,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-asp5878
2020-09-18T04:24:24Z,FGFR inhibitor AZD4547,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-azd4547
2020-09-18T04:24:24Z,FGFR inhibitor CPL304110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802158
2020-09-18T04:24:24Z,FGFR inhibitor debio 1347,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-debio-1347
2020-09-18T04:24:24Z,FGFR inhibitor1/2/3 HMPL-453,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792789
2020-09-18T04:24:24Z,FGFR1 receptor antagonist HGS1036,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-receptor-antagonist-hgs1036
2020-09-18T04:24:24Z,FGFR4 antagonist INCB062079,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-antagonist-incb062079
2020-09-18T04:24:24Z,FGFR4 inhibitor H3B-6527,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527
2020-09-18T04:24:24Z,FGFR4 inhibitor ICP-105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798826
2020-09-18T04:24:24Z,fibrin sealant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant
2020-09-18T04:24:24Z,Fibrocaps,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant
2020-09-18T04:24:24Z,fibromun,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-fusion-protein-l19tnfalpha
2020-09-18T04:24:24Z,ficlatuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ficlatuzumab
2020-09-18T04:24:24Z,fidaxomicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fidaxomicin
2020-09-18T04:24:24Z,Fidelin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone
2020-09-18T04:24:24Z,figitumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/figitumumab
2020-09-18T04:24:24Z,filgrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim
2020-09-18T04:24:24Z,filgrastim-primed peripheral blood progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim-primed-peripheral-blood-progenitor-cells
2020-09-18T04:24:24Z,fimaporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799987
2020-09-18T04:24:24Z,finasteride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride
2020-09-18T04:24:24Z,Firdapse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifampridine
2020-09-18T04:24:24Z,Firmagon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix
2020-09-18T04:24:24Z,fish oil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil
2020-09-18T04:24:24Z,fish oil/glycerol/egg lecithin-based emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fish-oil-glycerol-egg-lecithin-based-emulsion
2020-09-18T04:24:24Z,fisogatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-blu-554
2020-09-18T04:24:24Z,Flagyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride
2020-09-18T04:24:24Z,flanvotumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flanvotumab
2020-09-18T04:24:24Z,flavone acetic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavone-acetic-acid
2020-09-18T04:24:24Z,flavonoid tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flavonoid-tablet
2020-09-18T04:24:24Z,flaxseed,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed
2020-09-18T04:24:24Z,Flector Patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-epolamine-patch
2020-09-18T04:24:24Z,Fleet Phospho-soda,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-biphosphate-sodium-phosphate-oral-laxative
2020-09-18T04:24:24Z,Flexeril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride
2020-09-18T04:24:24Z,Flexiban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride
2020-09-18T04:24:24Z,flibanserin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797893
2020-09-18T04:24:24Z,Flomax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamsulosin-hydrochloride
2020-09-18T04:24:24Z,Flonase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate
2020-09-18T04:24:24Z,Florafur,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur
2020-09-18T04:24:24Z,Florinef,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate
2020-09-18T04:24:24Z,flotetuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-monoclonal-antibody-mgd006
2020-09-18T04:24:24Z,Flovent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate
2020-09-18T04:24:24Z,floxuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine
2020-09-18T04:24:24Z,FLT3 inhibitor FF-10101 succinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ff-10101-succinate
2020-09-18T04:24:24Z,FLT3 inhibitor HM43239,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799742
2020-09-18T04:24:24Z,FLT3 inhibitor SKI-G-801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794986
2020-09-18T04:24:24Z,FLT3/CDK4/6 inhibitor FLX925,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-cdk4-6-inhibitor-flx925
2020-09-20T05:26:50Z,FLT3/FGFR dual kinase inhibitor MAX-40279,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802333
2020-09-18T04:24:24Z,FLT3/KIT kinase inhibitor AKN-028,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-kinase-inhibitor-akn-028
2020-09-18T04:24:24Z,FLT3/KIT/CSF1R inhibitor NMS-03592088,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801585
2020-09-18T04:24:24Z,Flt3/MerTK inhibitor MRX-2843,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793562
2020-09-18T04:24:24Z,flu matrix peptide p58-66,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flu-matrix-peptide-p58-66
2020-09-18T04:24:24Z,Fluarix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
2020-09-18T04:24:24Z,Flublok,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
2020-09-18T04:24:24Z,fluciclatide F 18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclatide-f-18
2020-09-18T04:24:24Z,fluconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluconazole
2020-09-18T04:24:24Z,flucytosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flucytosine
2020-09-18T04:24:24Z,fludarabine phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate
2020-09-18T04:24:24Z,Fludase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181
2020-09-18T04:24:24Z,fludeoxyglucose F 18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludeoxyglucose-f-18
2020-09-18T04:24:24Z,fludrocortisone acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludrocortisone-acetate
2020-09-18T04:24:24Z,FluLaval,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
2020-09-18T04:24:24Z,flumatinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flumatinib-mesylate
2020-09-18T04:24:24Z,FluMist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-live-attenuated-influenza-vaccine
2020-09-18T04:24:24Z,fluocinonide cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream
2020-09-18T04:24:24Z,fluorescein sodium injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection
2020-09-18T04:24:24Z,fluorescein-conjugated Wisteria floribunda lectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792555
2020-09-18T04:24:24Z,fluorescence imaging agent EMI-137,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescence-imaging-agent-emi-137
2020-09-18T04:24:24Z,fluorescent antibody SGM-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-antibody-sgm-101
2020-09-18T04:24:24Z,fluorescent cRGDY PEG-Cy5.5 C dots,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-crgdy-peg-cy55-c-dots
2020-09-18T04:24:24Z,fluorescent dye LS301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-dye-ls301
2020-09-20T05:26:50Z,fluorescent imaging agent cRGD-ZW800-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802375
2020-09-18T04:24:24Z,fluorescent imaging ligand OTL38,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-imaging-ligand-otl38
2020-09-18T04:24:24Z,fluorescent protease-activated peptide AVB-620,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-protease-activated-peptide-avb-620
2020-09-18T04:24:24Z,Fluorescite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-sodium-injection
2020-09-18T04:24:24Z,fluorine 18 F-fludarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-18-f-fludarabine
2020-09-18T04:24:24Z,fluorine F 18 alphaVbeta6-binding peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alphavbeta6-binding-peptide
2020-09-18T04:24:24Z,fluorine F 18 C-SNAT4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799978
2020-09-18T04:24:24Z,fluorine F 18 choline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-choline
2020-09-18T04:24:24Z,fluorine F 18 clofarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-clofarabine
2020-09-18T04:24:24Z,fluorine F 18 CP18 peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-cp18-peptide
2020-09-18T04:24:24Z,fluorine F 18 d-FMAU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-d-fmau
2020-09-18T04:24:24Z,fluorine F 18 dabrafenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dabrafenib
2020-09-18T04:24:24Z,fluorine F 18 DASA-23,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796994
2020-09-18T04:24:24Z,fluorine F 18 DCFBC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfbc
2020-09-18T04:24:24Z,fluorine F 18 DCFPyL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dcfpyl
2020-09-18T04:24:24Z,fluorine F 18 EF5,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ef5
2020-09-18T04:24:24Z,fluorine F 18 FDHT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht
2020-09-18T04:24:24Z,fluorine F 18 FEQA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-feqa
2020-09-18T04:24:24Z,fluorine F 18 fluoro furanyl norprogesterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-furanyl-norprogesterone
2020-09-18T04:24:24Z,fluorine F 18 fluoro-PEG6-IPQA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoro-peg6-ipqa
2020-09-18T04:24:24Z,fluorine F 18 fluorobenzyl triphenyl phosphonium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorobenzyl-triphenyl-phosphonium
2020-09-18T04:24:24Z,fluorine F 18 fluorodopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorodopa
2020-09-18T04:24:24Z,fluorine F 18 fluoroethylcholine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoroethylcholine
2020-09-18T04:24:24Z,fluorine F 18 fluoromethylcholine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoromethylcholine
2020-09-18T04:24:24Z,fluorine F 18 fluoropaclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoropaclitaxel
2020-09-18T04:24:24Z,fluorine F 18 fluorthanatrace,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorthanatrace
2020-09-18T04:24:24Z,fluorine F 18 FMDHT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fmdht
2020-09-18T04:24:24Z,fluorine F 18 FP-R01-MG-F2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fp-r01-mg-f2
2020-09-18T04:24:24Z,fluorine F 18 galacto-RGD peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-galacto-rgd-peptide
2020-09-18T04:24:24Z,fluorine F 18 integrin alpha v beta 6-targeted binding peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792848
2020-09-18T04:24:24Z,Fluorine F 18 ISO-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-iso-1
2020-09-18T04:24:24Z,fluorine F 18 L-glutamate derivative BAY94-9392,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-l-glutamate-derivative-bay94-9392
2020-09-18T04:24:24Z,fluorine F 18 NOS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800445
2020-09-18T04:24:24Z,fluorine F 18 ODS2004436,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ods2004436
2020-09-18T04:24:24Z,fluorine F 18 PARP inhibitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794783
2020-09-18T04:24:24Z,fluorine F 18 RGD-based integrin peptide-polymer AH111585,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-rgd-based-integrin-peptide-polymer-ah111585
2020-09-18T04:24:24Z,fluorine F 18 RGD-K5,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-rgd-k5
2020-09-18T04:24:24Z,fluorine F 18 SKI-249380,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ski-249380
2020-09-18T04:24:24Z,fluorine F 18 sodium fluoride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-sodium-fluoride
2020-09-18T04:24:24Z,fluorine F 18 tetrafluoroborate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792157
2020-09-18T04:24:24Z,"fluorine F 18-4-L-fluoroglutamine (2S,4R)",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-4-l-fluoroglutamine-2s4r
2020-09-18T04:24:24Z,fluorine F 18-5-fluoro-2-deoxycytidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-5-fluoro-2-deoxycytidine
2020-09-18T04:24:24Z,fluorine F 18-6-fluorodopamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-6-fluorodopamine
2020-09-18T04:24:24Z,fluorine F 18-active site inhibited factor VIIa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796741
2020-09-18T04:24:24Z,fluorine F 18-AIF-NOTA-neurotensin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795028
2020-09-18T04:24:24Z,fluorine F 18-Al-NOTA-MATBBN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792640
2020-09-18T04:24:24Z,fluorine F 18-Al-NOTA-octreotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801491
2020-09-18T04:24:24Z,fluorine F 18-AlF-cys-variant 3 pH low insertion peptides,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799307
2020-09-18T04:24:24Z,fluorine F 18-alfatide II,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alfatide-ii
2020-09-18T04:24:24Z,fluorine F 18-ara-G,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ara-g
2020-09-18T04:24:24Z,fluorine F 18-AV-133,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-av-133
2020-09-18T04:24:24Z,fluorine F 18-azafol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794120
2020-09-18T04:24:24Z,fluorine F 18-BMS-986229,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800220
2020-09-18T04:24:24Z,fluorine F 18-fluciclovine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluciclovine
2020-09-18T04:24:24Z,fluorine F 18-fluoroazomycin arabinoside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18f-fluoroazomycin-arabinoside
2020-09-18T04:24:24Z,fluorine F 18-fluorothymidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorothymidine
2020-09-18T04:24:24Z,fluorine F 18-labeled S-(3-Fluoropropyl)homocysteine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-labeled-s-3-fluoropropylhomocysteine-hydrochloride
2020-09-18T04:24:24Z,fluorine F 18-PSMA-1007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800312
2020-09-18T04:24:24Z,Fluorofur,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur
2020-09-18T04:24:24Z,Fluoroplex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil
2020-09-18T04:24:24Z,fluoropyrimidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801791
2020-09-18T04:24:24Z,fluorouracil implant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-implant
2020-09-18T04:24:24Z,fluorouracil injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-injection
2020-09-18T04:24:24Z,fluorouracil-e therapeutic implant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil-e-therapeutic-implant
2020-09-18T04:24:24Z,fluoxymesterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone
2020-09-18T04:24:24Z,fluphenazine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluphenazine-hydrochloride
2020-09-18T04:24:24Z,flurbiprofen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flurbiprofen
2020-09-18T04:24:24Z,Flurizan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil
2020-09-18T04:24:24Z,Flushield,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
2020-09-18T04:24:24Z,flutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutamide
2020-09-18T04:24:24Z,flutemetamol F-18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18
2020-09-18T04:24:24Z,fluticasone propionate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluticasone-propionate
2020-09-18T04:24:24Z,fluvastatin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvastatin-sodium
2020-09-18T04:24:24Z,Fluvirin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
2020-09-18T04:24:24Z,fluvoxamine maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvoxamine-maleate
2020-09-18T04:24:24Z,Fluzone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
2020-09-18T04:24:24Z,fluzoparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluzoparib
2020-09-18T04:24:24Z,FMS inhibitor JNJ-40346527,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-inhibitor-jnj-40346527
2020-09-18T04:24:24Z,Fms/Trk tyrosine kinase inhibitor PLX7486,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-trk-tyrosine-kinase-inhibitor-plx7486
2020-09-18T04:24:24Z,folate binding protein E39 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-e39-peptide-vaccine
2020-09-18T04:24:24Z,folate binding protein J65 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-binding-protein-j65-peptide-vaccine
2020-09-18T04:24:24Z,folate receptor alpha-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-alpha-loaded-dendritic-cell-vaccine
2020-09-18T04:24:24Z,folate receptor-targeted epothilone BMS753493,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-epothilone-bms753493
2020-09-18T04:24:24Z,folate receptor-targeted technetium Tc 99m EC20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-technetium-tc-99m-ec20
2020-09-18T04:24:24Z,folate receptor-targeted tubulysin conjugate EC1456,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-tubulysin-conjugate-ec1456
2020-09-18T04:24:24Z,folate receptor-targeted vinca alkaloid EC0489,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-vinca-alkaloid-ec0489
2020-09-18T04:24:24Z,folate receptor-targeted vinca alkaloid/mitomycin C EC0225,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-vinca-alkaloid-mitomycin-c-ec0225
2020-09-18T04:24:24Z,folate-FITC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-fitc
2020-09-18T04:24:24Z,FOLFIRI regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-regimen
2020-09-18T04:24:24Z,FOLFIRI-bevacizumab regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-bevacizumab-regimen
2020-09-18T04:24:24Z,FOLFIRI-cetuximab regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-cetuximab-regimen
2020-09-18T04:24:24Z,FOLFIRINOX regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfirinox-regimen
2020-09-18T04:24:24Z,FOLFOX regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfox-regimen
2020-09-18T04:24:24Z,folic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folic-acid
2020-09-18T04:24:24Z,folitixorin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folitixorin
2020-09-18T04:24:24Z,Follutein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin
2020-09-18T04:24:24Z,Folotyn,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralatrexate
2020-09-18T04:24:24Z,Fonatol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,fondaparinux sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fondaparinux-sodium
2020-09-18T04:24:24Z,Forane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane
2020-09-18T04:24:24Z,foretinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foretinib
2020-09-18T04:24:24Z,Forfivo XL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride
2020-09-18T04:24:24Z,formestane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formestane
2020-09-18T04:24:24Z,formoterol fumarate oral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formoterol-fumarate-oral
2020-09-18T04:24:24Z,formoterol fumarate/roxithromycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/formoterol-fumarate-roxithromycin
2020-09-18T04:24:24Z,forodesine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/forodesine-hydrochloride
2020-09-18T04:24:24Z,Fortamet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride
2020-09-18T04:24:24Z,Fortaz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium
2020-09-18T04:24:24Z,Fosamax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alendronate-sodium
2020-09-18T04:24:24Z,fosbretabulin disodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium
2020-09-18T04:24:24Z,fosbretabulin tromethamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine
2020-09-18T04:24:24Z,fosfomycin tromethamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine
2020-09-18T04:24:24Z,fosgemcitabine palabenamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-phosphoramidate-nuc-1031
2020-09-18T04:24:24Z,foslinanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-trx-818
2020-09-18T04:24:24Z,fosnetupitant/palonosetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792159
2020-09-18T04:24:24Z,fosphenytoin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797055
2020-09-18T04:24:24Z,fosquidone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosquidone
2020-09-18T04:24:24Z,fostamatinib disodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium
2020-09-18T04:24:24Z,fostriecin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostriecin
2020-09-18T04:24:24Z,fowlpox virus vaccine vector,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-virus-vaccine-vector
2020-09-18T04:24:24Z,fowlpox-NY-ESO-1 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-ny-eso-1-vaccine
2020-09-18T04:24:24Z,Fragmin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium
2020-09-18T04:24:24Z,Fragmin V,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalteparin-sodium
2020-09-18T04:24:24Z,freeze-dried black raspberry bioadhesive gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/freeze-dried-black-raspberry-bioadhesive-gel
2020-09-18T04:24:24Z,French maritime pine bark extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/french-maritime-pine-bark-extract
2020-09-18T04:24:24Z,fresolimumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fresolimumab
2020-09-18T04:24:24Z,fructooligosaccharide supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fructooligosaccharide-supplement
2020-09-18T04:24:24Z,fructooligosaccharide/Lactobacillus paracasei/Lactobacillus rhamnosus/Lactobacillus acidophilus/Bifidobacterium lactis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778524
2020-09-18T04:24:24Z,fruit and vegetable extracts,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruit-and-vegetable-extracts
2020-09-18T04:24:24Z,fruquintinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib
2020-09-18T04:24:24Z,FU-LV regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fu-lv-regimen
2020-09-18T04:24:24Z,FUDF,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine
2020-09-18T04:24:24Z,Fulphila,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim
2020-09-18T04:24:24Z,fulranumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulranumab
2020-09-18T04:24:24Z,fulvestrant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant
2020-09-18T04:24:24Z,Fulyzaq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer
2020-09-18T04:24:24Z,fumagillin-derived polymer conjugate XMT-1107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fumagillin-derived-polymer-conjugate-xmt-1107
2020-09-18T04:24:24Z,Fungizone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amphotericin-b-deoxycholate
2020-09-18T04:24:24Z,fuorescence imaging agent IC2000,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793140
2020-09-18T04:24:24Z,furosemide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide
2020-09-18T04:24:24Z,furosemide topical gel CLS006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793933
2020-09-18T04:24:24Z,furosemide/digoxin topical gel CLS003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798476
2020-09-18T04:24:24Z,fursultiamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fursultiamine
2020-09-18T04:24:24Z,fusidic acid/betamethasone valerate topical cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fusidic-acid-betamethasone-valerate-topical-cream
2020-09-18T04:24:24Z,Fusilev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoleucovorin-calcium
2020-09-18T04:24:24Z,futibatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-tas-120
2020-09-18T04:24:24Z,futuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793850
2020-09-18T04:24:24Z,Fycompa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perampanel
2020-09-18T04:24:24Z,G protein-coupled estrogen receptor agonist LNS8801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799991
2020-09-18T04:24:24Z,G-quadruplex stabilizer BMVC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g-quadruplex-stabilizer-bmvc
2020-09-18T04:24:24Z,G2 checkpoint inhibitor CBP501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g2-checkpoint-inhibitor-cbp501
2020-09-18T04:24:24Z,G207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g207
2020-09-18T04:24:24Z,G250 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g250-peptide-vaccine
2020-09-18T04:24:24Z,Ga-68-labeled F(ab') 2- trastuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ga-68-labeled-fab-2--trastuzumab
2020-09-18T04:24:24Z,gabapentin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin
2020-09-18T04:24:24Z,Gadavist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol
2020-09-18T04:24:24Z,gadobenate dimeglumine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine
2020-09-18T04:24:24Z,gadobutrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol
2020-09-18T04:24:24Z,gadodiamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide
2020-09-18T04:24:24Z,gadofosveset trisodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium
2020-09-18T04:24:24Z,gadolinium-chelate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-chelate
2020-09-18T04:24:24Z,gadopentetate dimeglumine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine
2020-09-18T04:24:24Z,gadopiclenol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadolinium-based-contrast-agent-p03277
2020-09-18T04:24:24Z,gadoterate meglumine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoterate-meglumine
2020-09-18T04:24:24Z,Gadovist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobutrol
2020-09-18T04:24:24Z,gadoxetate disodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium
2020-09-18T04:24:24Z,Gag:267-274 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gag267-274-peptide-vaccine
2020-09-18T04:24:24Z,galactomannan derivative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactomannan-derivative
2020-09-18T04:24:24Z,galactose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galactose
2020-09-18T04:24:24Z,galantamine hydrobromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide
2020-09-18T04:24:24Z,galectin inhibitor GR-MD-02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-inhibitor-gr-md-02
2020-09-18T04:24:24Z,galectin-1 inhibitor OTX008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-1-inhibitor-otx008
2020-09-18T04:24:24Z,galeterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galeterone
2020-09-18T04:24:24Z,galinpepimut-S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798450
2020-09-18T04:24:24Z,galiximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galiximab
2020-09-18T04:24:24Z,gallium citrate Ga 67,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-citrate-ga-67
2020-09-18T04:24:24Z,gallium Ga 68 FAPi-46,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799979
2020-09-18T04:24:24Z,gallium Ga 68 NODAGA-CBP8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796976
2020-09-18T04:24:24Z,gallium Ga 68-citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-citrate
2020-09-18T04:24:24Z,gallium Ga 68-DOTA-exendin-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-exendin-4
2020-09-18T04:24:24Z,gallium Ga 68-DOTA-FAPI-04,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801864
2020-09-18T04:24:24Z,gallium Ga 68-DOTANOC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotanoc
2020-09-18T04:24:24Z,gallium Ga 68-DOTATATE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotatate
2020-09-18T04:24:24Z,gallium Ga 68-edotreotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide
2020-09-18T04:24:24Z,gallium Ga 68-labeled affibody molecule ABY-025,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-affibody-molecule-aby-025
2020-09-18T04:24:24Z,gallium Ga 68-labeled BNOTA-PRGD2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-bnota-prgd2
2020-09-18T04:24:24Z,gallium Ga 68-labeled DOTA Di-HSG peptide IMP-288,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-dota-di-hsg-peptide-imp-288
2020-09-18T04:24:24Z,gallium Ga 68-labeled DX600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801839
2020-09-18T04:24:24Z,gallium Ga 68-labeled MLN6907,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-mln6907
2020-09-18T04:24:24Z,gallium Ga 68-labeled NODAGA-MJ9,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-nodaga-mj9
2020-09-18T04:24:24Z,gallium Ga 68-labeled PSMA-11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11
2020-09-18T04:24:24Z,gallium Ga 68-labeled RM2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-grpr-antagonist-bay86-7548
2020-09-18T04:24:24Z,gallium Ga 68-NEB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neb
2020-09-18T04:24:24Z,gallium Ga 68-NeoB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794408
2020-09-18T04:24:24Z,gallium Ga 68-NODAGA-Ac-Cys-ZEGFR:1907,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ac-cys-zegfr1907
2020-09-18T04:24:24Z,gallium Ga 68-NODAGA-E(c[RGDyK])2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-ecrgdyk2
2020-09-18T04:24:24Z,gallium Ga 68-NODAGA-ZIGF-1R:4：40,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-zigf-1r440
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-3PTATE-RGD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-3ptate-rgd
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-Aca-BBN(7-14),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-aca-bbn7-14
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-AE105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-ae105
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-anti-HER2 nanobody VHH1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794875
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-anti-MMR-VHH2 nanobody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802301
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-BBN-RGD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-bbn-rgd
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-hGZP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802303
2020-09-20T05:26:50Z,gallium Ga 68-NOTA-MAL-Cys39-exendin-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802335
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-NFB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-nfb
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-RM26,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792850
2020-09-18T04:24:24Z,gallium Ga 68-NOTA-Sgc8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794320
2020-09-18T04:24:24Z,gallium Ga 68-P15-041,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p15-041
2020-09-18T04:24:24Z,gallium Ga 68-P16-093,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792561
2020-09-18T04:24:24Z,gallium Ga 68-pentixafor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-pentixafor
2020-09-18T04:24:24Z,gallium Ga 68-PSMA-617,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799659
2020-09-18T04:24:24Z,gallium Ga 68-PSMA-R2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794409
2020-09-18T04:24:24Z,gallium Ga 68-RGD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-rgd
2020-09-18T04:24:24Z,gallium Ga 68-satoreotide trizoxetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-ops202
2020-09-18T04:24:24Z,gallium Ga 68-THP-PSMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799422
2020-09-18T04:24:24Z,gallium Ga-labeled PSMA-11-gadoxetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800242
2020-09-18T04:24:24Z,gallium maltolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-maltolate
2020-09-18T04:24:24Z,gallium nitrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-nitrate
2020-09-18T04:24:24Z,gallium-based bone resorption inhibitor AP-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800117
2020-09-18T04:24:24Z,GalNAc-Anti-C5 siRNA ALN-CC5,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galnac-anti-c5-sirna-aln-cc5
2020-09-18T04:24:24Z,galunisertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galunisertib
2020-09-18T04:24:24Z,gamboge resin extract TSB-9-W1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamboge-resin-extract-tsb-9-w1
2020-09-18T04:24:24Z,Gamifant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501
2020-09-18T04:24:24Z,Gamimune N,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,gamma-delta tocotrienol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-delta-tocotrienol
2020-09-18T04:24:24Z,gamma-secretase/Notch signalling pathway inhibitor RO4929097,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-notch-signalling-pathway-inhibitor-ro4929097
2020-09-18T04:24:24Z,gamma-tocopherol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-tocopherol
2020-09-18T04:24:24Z,Gammagard S/D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,Gammar-P,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,ganciclovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir
2020-09-18T04:24:24Z,gandotinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gandotinib
2020-09-18T04:24:24Z,ganetespib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganetespib
2020-09-18T04:24:24Z,Ganite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-nitrate
2020-09-18T04:24:24Z,ganitumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganitumab
2020-09-18T04:24:24Z,Gardasil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-quadrivalent-vaccine
2020-09-18T04:24:24Z,Gardasil 9,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine
2020-09-18T04:24:24Z,garlic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/garlic
2020-09-18T04:24:24Z,garlic extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/garlic-extract
2020-09-18T04:24:24Z,Gastrimmune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin
2020-09-18T04:24:24Z,gastrin immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin
2020-09-18T04:24:24Z,GastroMARK,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxsil-oral-suspension
2020-09-18T04:24:24Z,gataparsen sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gataparsen-sodium
2020-09-18T04:24:24Z,gatipotuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ta-muc1-monoclonal-antibody-pankomab
2020-09-18T04:24:24Z,gavilimomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gavilimomab
2020-09-18T04:24:24Z,gavinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gavinostat
2020-09-18T04:24:24Z,Gavreto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-mutation-fusion-inhibitor-blu-667
2020-09-18T04:24:24Z,Gazyva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab
2020-09-18T04:24:24Z,GBM antigens and alloantigens immunotherapeutic vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801582
2020-09-18T04:24:24Z,GD2 lactone/GD3 lactone-KLH conjugate bivalent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gd2-lactone-gd3-lactone-klh-conjugate-bivalent-vaccine
2020-09-18T04:24:24Z,GD2-CAR-expressing autologous T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gd2-car-expressing-autologous-t-lymphocytes
2020-09-18T04:24:24Z,gedatolisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gedatolisib
2020-09-18T04:24:24Z,Gedeptin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-encoding-ecoli-pnp
2020-09-18T04:24:24Z,gefitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gefitinib
2020-09-18T04:24:24Z,Gelclair,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyvinylpyrrolidone-sodium-hyaluronate-gel
2020-09-18T04:24:24Z,Gelfoam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-gelatin-sponge
2020-09-18T04:24:24Z,gelonin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gelonin
2020-09-18T04:24:24Z,GEM640,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aeg35156
2020-09-18T04:24:24Z,gemcitabine 5'-elaidic acid ester,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-5-elaidic-acid-ester
2020-09-18T04:24:24Z,gemcitabine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride
2020-09-18T04:24:24Z,gemcitabine hydrochloride emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride-emulsion
2020-09-18T04:24:24Z,gemcitabine prodrug LY2334737,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-prodrug-ly2334737
2020-09-18T04:24:24Z,gemcitabine-cisplatin regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-cisplatin-regimen
2020-09-18T04:24:24Z,gemcitabine-erlotinib regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-erlotinib-regimen
2020-09-18T04:24:24Z,gemcitabine-oxaliplatin regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-oxaliplatin-regimen
2020-09-18T04:24:24Z,gemcitabine-releasing intravesical system,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793540
2020-09-18T04:24:24Z,gemfibrozil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemfibrozil
2020-09-18T04:24:24Z,gemigliptin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemigliptin
2020-09-18T04:24:24Z,GemRIS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793540
2020-09-18T04:24:24Z,gemtuzumab ozogamicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin
2020-09-18T04:24:24Z,Gemzar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride
2020-09-18T04:24:24Z,Genasense,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium
2020-09-18T04:24:24Z,Gencept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,gene-edited autologous neoantigen-targeted NeoTCR-P1 T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798453
2020-09-18T04:24:24Z,genetically engineered HSV-1 expressing IL-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genetically-engineered-hsv-1-expressing-il-12
2020-09-18T04:24:24Z,genetically modified interleukin-12 transgene-encoding Bifidobacterium longum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801308
2020-09-18T04:24:24Z,genetically-modified anti-HER2-CAR-CD28zeta-expressing allogeneic NK-92/5.28.z cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794325
2020-09-18T04:24:24Z,genetically-modified MAGE-A3-expressing MG1 Maraba virus vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genetically-modified-mage-a3-expressing-mg1-maraba-virus-vaccine
2020-09-18T04:24:24Z,Genexol-PM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle
2020-09-18T04:24:24Z,Gengraf,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine
2020-09-18T04:24:24Z,genistein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein
2020-09-18T04:24:24Z,genolimzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792527
2020-09-18T04:24:24Z,Genotropin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatotropin
2020-09-18T04:24:24Z,gentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794351
2020-09-18T04:24:24Z,geranylgeranyltransferase I inhibitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745403
2020-09-18T04:24:24Z,Gesterol 100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone
2020-09-18T04:24:24Z,ghrelin peptide analogue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ghrelin-peptide-analogue
2020-09-18T04:24:24Z,GI-4000 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gi-4000-vaccine
2020-09-18T04:24:24Z,Gilotrif,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate
2020-09-18T04:24:24Z,gilteritinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib
2020-09-18T04:24:24Z,gilteritinib fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792549
2020-09-18T04:24:24Z,gimatecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gimatecan
2020-09-18T04:24:24Z,gimeracil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gimeracil
2020-09-18T04:24:24Z,ginger extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginger-extract
2020-09-18T04:24:24Z,ginseng compound,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginseng-compound
2020-09-18T04:24:24Z,ginseng/lingzhi mushroom/Cordyceps sinensis/rose oral liquid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795503
2020-09-18T04:24:24Z,girentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab
2020-09-18T04:24:24Z,GITR agonist MEDI1873,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitr-agonist-medi1873
2020-09-18T04:24:24Z,GITRL RNA-transfected autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gitrl-rna-transfected-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,givosiran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792164
2020-09-18T04:24:24Z,glasdegib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hedgehog-inhibitor-pf-04449913
2020-09-18T04:24:24Z,glecaprevir/pibrentasvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798328
2020-09-18T04:24:24Z,Gleevec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate
2020-09-18T04:24:24Z,glembatumumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glembatumumab-vedotin
2020-09-18T04:24:24Z,Gleostine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine
2020-09-18T04:24:24Z,glesatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glesatinib
2020-09-18T04:24:24Z,Gliadel Wafer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-implant
2020-09-18T04:24:24Z,gliclazide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gliclazide
2020-09-18T04:24:24Z,glimepiride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glimepiride
2020-09-18T04:24:24Z,glioblastoma cancer vaccine ERC1671,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-cancer-vaccine-erc1671
2020-09-18T04:24:24Z,glioblastoma multiforme multipeptide vaccine IMA950,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-multiforme-multipeptide-vaccine-ima950
2020-09-18T04:24:24Z,glioma lysate vaccine GBM6-AD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioma-lysate-vaccine-gbm6-ad
2020-09-18T04:24:24Z,glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioma-associated-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,glioma-associated peptide-loaded dendritic cell vaccine SL-701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioma-associated-peptide-loaded-dendritic-cell-vaccine-sl-701
2020-09-18T04:24:24Z,glipizide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glipizide
2020-09-18T04:24:24Z,glisoxepide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glisoxepide
2020-09-18T04:24:24Z,Globo H-DT vaccine OBI-833,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globo-h-dt-vaccine-obi-833
2020-09-18T04:24:24Z,Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globo-h-gm2-lewis-y-muc1-32aa-stnc-tfc-tnc-klh-conjugate-vaccine
2020-09-18T04:24:24Z,globulin component macrophage-activating factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globulin-component-macrophage-activating-factor
2020-09-18T04:24:24Z,glofitamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792571
2020-09-18T04:24:24Z,glucarpidase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucarpidase
2020-09-18T04:24:24Z,Glucidex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin
2020-09-18T04:24:24Z,glucocorticoid receptor antagonist ORIC-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798818
2020-09-18T04:24:24Z,Glucodry,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin
2020-09-18T04:24:24Z,Glucophage,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride
2020-09-18T04:24:24Z,Glucophage XR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride
2020-09-18T04:24:24Z,glucosamine sulfate/chondroitin sulfate tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucosamine-sulfate-chondroitin-sulfate-tablet
2020-09-18T04:24:24Z,Glucotrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glipizide
2020-09-18T04:24:24Z,glucuronic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucuronic-acid
2020-09-18T04:24:24Z,glumetinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795718
2020-09-18T04:24:24Z,Glumetza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride
2020-09-18T04:24:24Z,glutaminase inhibitor IPN60090,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799989
2020-09-18T04:24:24Z,glutamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine
2020-09-18T04:24:24Z,Glutapak-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine
2020-09-18T04:24:24Z,GlutaSolve,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine
2020-09-18T04:24:24Z,Glutasolve Resource,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine
2020-09-18T04:24:24Z,glutathione,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione
2020-09-18T04:24:24Z,glutathione disulfide NOV-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione-disulfide-nov-002
2020-09-18T04:24:24Z,glutathione pegylated liposomal doxorubicin hydrochloride formulation 2B3-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/748730
2020-09-18T04:24:24Z,gluten-free compact nutritional supplement drink,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gluten-free-compact-nutritional-supplement-drink
2020-09-18T04:24:24Z,gluten-free DHA/EPA/GLA/antioxidant-rich nutritional liquid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gluten-free-dha-epa-gla-antioxidant-rich-nutritional-liquid
2020-09-18T04:24:24Z,gluten-free/fiber enriched compact nutritional supplement drink,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gluten-free-fiber-enriched-compact-nutritional-supplement-drink
2020-09-18T04:24:24Z,glyburide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide
2020-09-18T04:24:24Z,glycerin enema,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycerin-enema
2020-09-18T04:24:24Z,glycine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycine
2020-09-18T04:24:24Z,glyco-engineered anti-CD20 monoclonal antibody CHO H01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793171
2020-09-18T04:24:24Z,glycooptimized trastuzumab-GEX,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycooptimized-trastuzumab-gex
2020-09-18T04:24:24Z,glycopeptide antibiotic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycopeptide-antibiotic
2020-09-18T04:24:24Z,glycopyrrolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycopyrrolate
2020-09-18T04:24:24Z,glycosaminoglycan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795583
2020-09-18T04:24:24Z,glycosylated recombinant human G-CSF AVI-014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosylated-recombinant-human-g-csf-avi-014
2020-09-18T04:24:24Z,glycosylated recombinant human interleukin-7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosylated-recombinant-human-interleukin-7
2020-09-18T04:24:24Z,glymidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glymidine
2020-09-18T04:24:24Z,Glyset,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miglitol
2020-09-18T04:24:24Z,GlyT2/5HT2a antagonist VVZ-149,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyt2-5ht2a-antagonist-vvz-149
2020-09-18T04:24:24Z,GM-CSF-encoding oncolytic adenovirus CGTG-102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm-csf-encoding-oncolytic-adenovirus-cgtg-102
2020-09-18T04:24:24Z,GM-K562 cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm-k562-cell-vaccine
2020-09-18T04:24:24Z,GM.CD40L cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gmcd40l-cell-vaccine
2020-09-18T04:24:24Z,GM2-KLH vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm2-klh-vaccine
2020-09-18T04:24:24Z,GM2/GD2/GD3 lactone-KLH conjugate trivalent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm2-gd2-gd3-lactone-klh-conjugate-trivalent-vaccine
2020-09-18T04:24:24Z,gold sodium thiomalate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate
2020-09-18T04:24:24Z,goldenrod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goldenrod
2020-09-18T04:24:24Z,golimumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golimumab
2020-09-18T04:24:24Z,golnerminogene pradenovec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec
2020-09-18T04:24:24Z,golotimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golotimod
2020-09-18T04:24:24Z,golvatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golvatinib
2020-09-18T04:24:24Z,gonadotrophin releasing hormone analogue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotrophin-releasing-hormone-analogue
2020-09-18T04:24:24Z,gonadotropin-releasing hormone receptor antagonist OBE2109,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792557
2020-09-18T04:24:24Z,Goodbelly Probiotic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/736258
2020-09-18T04:24:24Z,goserelin acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate
2020-09-18T04:24:24Z,goserelin acetate extended-release microspheres LY01005,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795737
2020-09-18T04:24:24Z,gossypol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gossypol
2020-09-18T04:24:24Z,gp100 antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100-antigen
2020-09-18T04:24:24Z,gp100-fowlpox vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100-fowlpox-vaccine
2020-09-18T04:24:24Z,gp100:154-162 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100154-162-peptide-vaccine
2020-09-18T04:24:24Z,gp100:209-217(210M) peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/476335
2020-09-18T04:24:24Z,gp100:209-217(210M) peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100209-217210m-peptide-vaccine
2020-09-18T04:24:24Z,gp100:280-288(288V) peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100280-288288v-peptide-vaccine
2020-09-18T04:24:24Z,GP2 peptide/GM-CSF vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp2-peptide-gm-csf-vaccine
2020-09-18T04:24:24Z,gp96-secreting allogeneic bladder cancer cell vaccine HS-410,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp96-secreting-allogeneic-bladder-cancer-cell-vaccine-hs-410
2020-09-18T04:24:24Z,GPI-0100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gpi-0100
2020-09-18T04:24:24Z,GPX-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gpx-100
2020-09-18T04:24:24Z,Gralise,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin
2020-09-18T04:24:24Z,granisetron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794007
2020-09-18T04:24:24Z,granisetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-hydrochloride
2020-09-18T04:24:24Z,granisetron hydrochloride nasal spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-hydrochloride-nasal-spray
2020-09-18T04:24:24Z,granisetron transdermal system,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-transdermal-system
2020-09-18T04:24:24Z,Granix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim
2020-09-18T04:24:24Z,Granocyte,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenograstim
2020-09-18T04:24:24Z,grape seed extract supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grape-seed-extract-supplement
2020-09-18T04:24:24Z,grapiprant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-receptor-antagonist-aat-007
2020-09-18T04:24:24Z,green propolis supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802229
2020-09-18T04:24:24Z,green tea,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea
2020-09-18T04:24:24Z,green tea extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-extract
2020-09-18T04:24:24Z,green tea extract-based antioxidant supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-extract-based-antioxidant-supplement
2020-09-18T04:24:24Z,green tea lozenge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-lozenge
2020-09-18T04:24:24Z,green tea/licorice extract-based antioxidant solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797089
2020-09-18T04:24:24Z,growth hormone receptor antisense oligonucleotide IONIS-GHR-LRx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799097
2020-09-18T04:24:24Z,GS-pan Notch inhibitor BMS-986115,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-bms-986115
2020-09-18T04:24:24Z,GS/pan-Notch inhibitor AL101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-bms-906024
2020-09-18T04:24:24Z,GSK-3 inhibitor 9-ING-41,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796464
2020-09-18T04:24:24Z,GTI-2040,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gti-2040
2020-09-18T04:24:24Z,GTN transdermal patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-transdermal-patch
2020-09-18T04:24:24Z,guadecitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guadecitabine
2020-09-18T04:24:24Z,guanabenz acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guanabenz-acetate
2020-09-18T04:24:24Z,guanazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guanazole
2020-09-18T04:24:24Z,guarana supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guarana-supplement
2020-09-18T04:24:24Z,gum Arabic solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794796
2020-09-18T04:24:24Z,guselkumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792847
2020-09-18T04:24:24Z,gusperimus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus
2020-09-18T04:24:24Z,GVAX pancreatic cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gvax-pancreatic-cancer-vaccine
2020-09-18T04:24:24Z,Gwt1 inhibitor APX001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794878
2020-09-18T04:24:24Z,Gyne-Lotrimin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole
2020-09-18T04:24:24Z,H1299 tumor cell lysate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/h1299-tumor-cell-lysate-vaccine
2020-09-18T04:24:24Z,H3.3K27M-specific peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/h33k27m-specific-peptide-vaccine
2020-09-18T04:24:24Z,HAAH lambda phage vaccine SNS-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792681
2020-09-18T04:24:24Z,Haelan 951,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-protein-beverage
2020-09-18T04:24:24Z,Haemophilus influenzae b vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine
2020-09-18T04:24:24Z,hafnium oxide-containing nanoparticles NBTXR3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hafnium-oxide-containing-nanoparticles-nbtxr3
2020-09-18T04:24:24Z,Halaven,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate
2020-09-18T04:24:24Z,Haldol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haloperidol
2020-09-18T04:24:24Z,halichondrin analogue E7130,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795713
2020-09-18T04:24:24Z,Halodrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone
2020-09-18T04:24:24Z,halofuginone hydrobromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halofuginone-hydrobromide
2020-09-18T04:24:24Z,haloperidol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haloperidol
2020-09-18T04:24:24Z,Halotestin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone
2020-09-18T04:24:24Z,haNK,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92
2020-09-18T04:24:24Z,Harvoni,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793914
2020-09-18T04:24:24Z,Havrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-a-vaccine
2020-09-18T04:24:24Z,HCV DNA vaccine INO-8000,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hcv-dna-vaccine-ino-8000
2020-09-18T04:24:24Z,HDAC class I/IIb inhibitor HG146,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797880
2020-09-18T04:24:24Z,HDAC inhibitor ACY-241,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-acy-241
2020-09-18T04:24:24Z,HDAC inhibitor AR-42,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ar-42
2020-09-18T04:24:24Z,HDAC inhibitor CG200745,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cg200745
2020-09-18T04:24:24Z,HDAC inhibitor CHR-2845,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-chr-2845
2020-09-18T04:24:24Z,HDAC inhibitor CKD-581,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792522
2020-09-18T04:24:24Z,HDAC inhibitor CXD101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-cxd101
2020-09-18T04:24:24Z,HDAC inhibitor MPT0E028,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-mpt0e028
2020-09-18T04:24:24Z,HDAC inhibitor OBP-801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-obp-801
2020-09-18T04:24:24Z,HDAC inhibitor SHP-141,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-shp-141
2020-09-18T04:24:24Z,HDAC inhibitor VRx-3996,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-chr-3996
2020-09-18T04:24:24Z,HDAC/EGFR/Her2 inhibitor CUDC-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-egfr-her2-inhibitor-cudc-101
2020-09-18T04:24:24Z,HDAC6 inhibitor KA2507,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac6-inhibitor-ka2507
2020-09-18T04:24:24Z,HDM2 inhibitor MK-8242,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdm2-inhibitor-mk-8242
2020-09-18T04:24:24Z,heat-killed bacterium Mycobacterium obuense IMM-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/696524
2020-09-18T04:24:24Z,heat-treated varicella-zoster virus vaccine V212,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heat-treated-varicella-zoster-virus-vaccine-v212
2020-09-18T04:24:24Z,Hecoria,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus
2020-09-18T04:24:24Z,Hectorol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxercalciferol
2020-09-18T04:24:24Z,Helicobacter pylori therapeutic vaccine IMX101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793842
2020-09-18T04:24:24Z,Hemangeol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propranolol-hydrochloride
2020-09-18T04:24:24Z,Hematide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-peptide-based-erythropoiesis-stimulating-agent
2020-09-18T04:24:24Z,hematoporphyrin derivative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hematoporphyrin-derivative
2020-09-18T04:24:24Z,hemiasterlin analogue E7974,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hemiasterlin-analogue-e7974
2020-09-18T04:24:24Z,hemoporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800073
2020-09-18T04:24:24Z,henatinib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/henatinib-maleate
2020-09-18T04:24:24Z,Hep-Lock,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparin-sodium
2020-09-18T04:24:24Z,heparan sulfate glycosaminoglycan mimetic M402,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparan-sulfate-glycosaminoglycan-mimetic-m402
2020-09-18T04:24:24Z,heparan sulfate glycosaminoglycan mimetic nanopolymer mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparan-sulfate-glycosaminoglycan-mimetic-nanopolymer-mouthwash
2020-09-18T04:24:24Z,heparin calcium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparin-calcium
2020-09-18T04:24:24Z,heparin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparin-sodium
2020-09-18T04:24:24Z,hepatitis A vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-a-vaccine
2020-09-18T04:24:24Z,hepatitis B vaccine (recombinant),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant
2020-09-18T04:24:24Z,hepatitis B virus antigen peptides/hepatitis G2 cell protein lysate-activated dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792626
2020-09-18T04:24:24Z,hepatitis C immune globulin intravenous,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-c-immune-globulin-intravenous
2020-09-18T04:24:24Z,hepcidin mimetic PTG-300,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799095
2020-09-18T04:24:24Z,Hepsera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adefovir-dipivoxil
2020-09-18T04:24:24Z,hepsulfam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepsulfam
2020-09-18T04:24:24Z,"HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-neu-cea-peptides-gm-csf-montanide-isa-51-vaccine
2020-09-18T04:24:24Z,HER-2-positive B-cell peptide antigen IMU-131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-positive-b-cell-peptide-antigen-imu-131
2020-09-18T04:24:24Z,HER-2/neu intracellular domain protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-neu-intracellular-domain-protein
2020-09-18T04:24:24Z,HER-2/neu peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-neu-peptide-vaccine
2020-09-18T04:24:24Z,HER2 ECD+TM virus-like replicon particles vaccine AVX901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-ecdtm-virus-like-replicon-particles-vaccine-avx901
2020-09-18T04:24:24Z,HER2 inhibitor TAS0728,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792168
2020-09-18T04:24:24Z,HER2 tri-specific natural killer cell engager DF1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801897
2020-09-18T04:24:24Z,HER2-pulsed type-1 polarized autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-pulsed-type-1-polarized-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,HER2-targeted DARPin MP0274,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792625
2020-09-18T04:24:24Z,HER2-targeted liposomal doxorubicin hydrochloride MM-302,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeted-liposomal-doxorubicin-hydrochloride-mm-302
2020-09-18T04:24:24Z,HER2-targeting antibody Fc fragment FS102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeting-antibody-fc-fragment-fs102
2020-09-18T04:24:24Z,HER2Bi-armed activated T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2bi-armed-activated-t-cells
2020-09-18T04:24:24Z,herba scutellaria barbata,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herba-scutellaria-barbata
2020-09-18T04:24:24Z,herbal polysaccharide saliva substitute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herbal-polysaccharide-saliva-substitute
2020-09-18T04:24:24Z,Herceptin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab
2020-09-18T04:24:24Z,Herceptin Hylecta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797111
2020-09-18T04:24:24Z,herpes zoster vaccine GSK1437173A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a
2020-09-18T04:24:24Z,Herplex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine
2020-09-18T04:24:24Z,Herzuma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab
2020-09-18T04:24:24Z,hetastarch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch
2020-09-18T04:24:24Z,heterodimeric interleukin-15,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heterodimeric-interleukin-15
2020-09-18T04:24:24Z,hetrombopag olamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801787
2020-09-18T04:24:24Z,Hexa-Betalin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride
2020-09-18T04:24:24Z,Hexalen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine
2020-09-18T04:24:24Z,hexamethylene bisacetamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexamethylene-bisacetamide
2020-09-18T04:24:24Z,hexamethylmelamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/altretamine
2020-09-18T04:24:24Z,hexaminolevulinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate
2020-09-18T04:24:24Z,hexaminolevulinate hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hexaminolevulinate-hydrochloride
2020-09-18T04:24:24Z,Hextend,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch
2020-09-18T04:24:24Z,HibTITER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine
2020-09-18T04:24:24Z,HIF-1alpha inhibitor PX-478,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-1alpha-inhibitor-px-478
2020-09-18T04:24:24Z,HIF-2alpha inhibitor PT2385,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-2alpha-inhibitor-pt2385
2020-09-18T04:24:24Z,HIF-2alpha inhibitor PT2977,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-2alpha-inhibitor-pt2977
2020-09-18T04:24:24Z,HIF2a RNAi ARO-HIF2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801198
2020-09-18T04:24:24Z,high-selenium baker's yeast,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/high-selenium-bakers-yeast
2020-09-18T04:24:24Z,high-selenium Brassica juncea,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/high-selenium-brassica-juncea
2020-09-18T04:24:24Z,high-titer RSV immune globulin RI-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/high-titer-rsv-immune-globulin-ri-001
2020-09-18T04:24:24Z,highly purified Staphylococcal protein A PRTX-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/highly-purified-staphylococcal-protein-a-prtx-100
2020-09-18T04:24:24Z,Hiltonol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-iclc
2020-09-18T04:24:24Z,histone-lysine N-methyltransferase EZH2 inhibitor GSK2816126,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histone-lysine-n-methyltransferase-ezh2-inhibitor-gsk2816126
2020-09-18T04:24:24Z,histrelin acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histrelin-acetate
2020-09-18T04:24:24Z,Hivid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalcitabine
2020-09-18T04:24:24Z,HLA-A*0201-restricted TERT(572Y)/TERT(572) peptides vaccine Vx-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-tert572y-tert572-peptides-vaccine-vx-001
2020-09-18T04:24:24Z,HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-trp2-gp100-epha2-her2-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*0201-restricted URLC10-VEGFR1-VEGFR2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-urlc10-vegfr1-vegfr2-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*0201-restricted VEGFR1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-vegfr1-peptide-vaccine
2020-09-18T04:24:24Z,HLA-A*0201-restricted VEGFR1-VEGFR2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a0201-restricted-vegfr1-vegfr2-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted CDCA1-A24-56 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-cdca1-a24-56-peptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted CDCA1-KIF20A multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-cdca1-kif20a-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted KOC1-TTK-CO16-DEPDC1-MPHOSPH1 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-koc1-ttk-co16-depdc1-mphosph1-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted multipeptide vaccine S-488410,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-multipeptide-vaccine-s-488410
2020-09-18T04:24:24Z,HLA-A*2402-restricted URLC10 peptides vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-peptides-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted URLC10-CDCA1-KIF20A multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-cdca1-kif20a-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted URLC10-CDCA1-VEGFR1-VEGFR2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-cdca1-vegfr1-vegfr2-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted URLC10-KOC1-VEGFR1-VEGFR2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-koc1-vegfr1-vegfr2-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted URLC10-TTK-KOC1 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-ttk-koc1-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted URLC10-TTK-VEGFR1-VEGFR2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-urlc10-ttk-vegfr1-vegfr2-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted VEGFR1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-vegfr1-peptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2402-restricted VEGFR1/2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2402-restricted-vegfr1-2-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A*2404-restricted RNF43-TOMM34-VEGFR1-VEGFR2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2404-restricted-rnf43-tomm34-vegfr1-vegfr2-multipeptide-vaccine
2020-09-18T04:24:24Z,HLA-A1-binding MAGE-1/MAGE-3 multipeptide-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/667445
2020-09-18T04:24:24Z,"HLA-A1, A2, B35-restricted survivin peptides/Montanide ISA-51 vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a1-a2-b35-restricted-survivin-peptides-montanide-isa-51-vaccine
2020-09-18T04:24:24Z,HLA-A2-binding TYR/MART-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/667444
2020-09-18T04:24:24Z,HLA-A2-restricted melanoma-specific peptides vaccine GRN-1201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-restricted-melanoma-specific-peptides-vaccine-grn-1201
2020-09-18T04:24:24Z,HLA-A2-restricted synthetic glioma antigen peptides vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-restricted-synthetic-glioma-antigen-peptides-vaccine
2020-09-18T04:24:24Z,"HLA-A2, A3-restricted FGF-5 peptides/Montanide ISA-51 vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-a3-restricted-fgf-5-peptides-montanide-isa-51-vaccine
2020-09-18T04:24:24Z,"HLA-DP0401/0402-restricted, MAGE-A3-reactive T cell receptor-transduced autologous T cells",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/760677
2020-09-18T04:24:24Z,HM2/MMAE antibody-drug conjugate ALT-P7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793586
2020-09-18T04:24:24Z,HO/02/02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ho-02-02
2020-09-18T04:24:24Z,Hodgkin's antigens-GM-CSF-expressing cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hodgkins-antigens-gm-csf-expressing-cell-vaccine
2020-09-18T04:24:24Z,honey,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/honey
2020-09-18T04:24:24Z,honey-containing mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/honey-containing-mouthwash
2020-09-18T04:24:24Z,horse anti-thymocyte globulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794074
2020-09-18T04:24:24Z,host dendritic cell vaccine-001 MSSM/BIIR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/host-dendritic-cell-vaccine-001-mssm-biir
2020-09-18T04:24:24Z,Hou Gu Mi Xi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hou-gu-mi-xi
2020-09-18T04:24:24Z,HPPH,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpph
2020-09-18T04:24:24Z,HPV 16 E6 peptides vaccine/candida albicans extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e6-peptides-vaccine-candida-albicans-extract
2020-09-18T04:24:24Z,HPV 16 E7 antigen-expressing Lactobacillis casei vaccine BLS-ILB-E710c,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-antigen-expressing-lactobacillis-casei-vaccine-bls-ilb-e710c
2020-09-18T04:24:24Z,HPV 16 E7:86-93 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e786-93-peptide-vaccine
2020-09-18T04:24:24Z,HPV DNA plasmids therapeutic vaccine VGX-3100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-dna-plasmids-therapeutic-vaccine-vgx-3100
2020-09-18T04:24:24Z,HPV E1/E2 interaction inhibitor gel AP611074,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e1-e2-interaction-inhibitor-gel-ap611074
2020-09-18T04:24:24Z,HPV E6/E7 DNA vaccine GX-188E,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-dna-vaccine-gx-188e
2020-09-18T04:24:24Z,HPV E6/E7-encoding arenavirus vaccine HB-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800472
2020-09-18T04:24:24Z,HPV L1 VLP vaccine V504,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-l1-vlp-vaccine-v504
2020-09-18T04:24:24Z,HPV types 16/18 E6/E7-adenoviral transduced autologous lymphocytes/alpha-galactosylceramide vaccine BVAC-C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785876
2020-09-18T04:24:24Z,HPV-16 E7 TCR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-tcr-expressing-t-lymphocytes
2020-09-18T04:24:24Z,HPV-6-targeting immunotherapeutic vaccine INO-3106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-6-targeting-immunotherapeutic-vaccine-ino-3106
2020-09-18T04:24:24Z,HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc fusion protein CUE-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798742
2020-09-18T04:24:24Z,HPV16 L2/E6/E7 fusion protein vaccine TA-CIN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-l2-e6-e7-fusion-protein-vaccine-ta-cin
2020-09-18T04:24:24Z,HPV16-E6-T27,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793193
2020-09-18T04:24:24Z,HPV16-E7-T512,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793194
2020-09-18T04:24:24Z,HPV16-E711-19 peptide vaccine DPX-E7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e711-19-peptide-vaccine-dpx-e7
2020-09-18T04:24:24Z,HPV6/11-targeted DNA plasmid vaccine INO-3107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802021
2020-09-18T04:24:24Z,Hsp70-peptide TKD/IL-2-activated autologous natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp70-peptide-tkd-il-2-activated-autologous-natural-killer-cells
2020-09-18T04:24:24Z,Hsp90 antagonist KW-2478,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-antagonist-kw-2478
2020-09-18T04:24:24Z,Hsp90 inhibitor AB-010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-ab-010
2020-09-18T04:24:24Z,Hsp90 inhibitor AT13387,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-at13387
2020-09-18T04:24:24Z,Hsp90 inhibitor AUY922,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-auy922
2020-09-18T04:24:24Z,Hsp90 inhibitor BIIB028,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-biib028
2020-09-18T04:24:24Z,Hsp90 inhibitor CNF2024,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-cnf2024
2020-09-18T04:24:24Z,Hsp90 inhibitor debio 0932,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-debio-0932
2020-09-18T04:24:24Z,Hsp90 inhibitor DS-2248,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-ds-2248
2020-09-18T04:24:24Z,HSP90 inhibitor HSP990,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-hsp990
2020-09-18T04:24:24Z,Hsp90 inhibitor MPC-3100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-mpc-3100
2020-09-18T04:24:24Z,HSP90 inhibitor PU-H71,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-pu-h71
2020-09-18T04:24:24Z,Hsp90 inhibitor SNX-2112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-snx-2112
2020-09-18T04:24:24Z,Hsp90 inhibitor SNX-5422 mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-snx-5422-mesylate
2020-09-18T04:24:24Z,Hsp90 inhibitor TQB3474,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801900
2020-09-18T04:24:24Z,Hsp90 inhibitor XL888,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-xl888
2020-09-18T04:24:24Z,HSP90-targeted photosensitizer HS-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801530
2020-09-18T04:24:24Z,HSP90-targeted SN-38 conjugate PEN-866,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793183
2020-09-18T04:24:24Z,HSP90alpha/beta inhibitor TAS-116,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90alpha-beta-inhibitor-tas-116
2020-09-18T04:24:24Z,HspE7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hspe7
2020-09-18T04:24:24Z,HSV-TK-transduced donor lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsv-tk-transduced-donor-lymphocytes
2020-09-18T04:24:24Z,hTERT I540/R572Y/D988Y multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-i540-r572y-d988y-multipeptide-vaccine
2020-09-18T04:24:24Z,hTERT mRNA /survivin peptide-double-loaded autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/715580
2020-09-18T04:24:24Z,hTERT multipeptide/Montanide ISA-51 VG/imiquimod GX 301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-multipeptide-montanide-isa-51-vg-imiquimod-gx-301
2020-09-18T04:24:24Z,hTERT vaccine V934/V935,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-vaccine-v934-v935
2020-09-18T04:24:24Z,hTERT-encoding DNA vaccine INVAC-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-encoding-dna-vaccine-invac-1
2020-09-18T04:24:24Z,hTERT/survivin/CMV multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-survivin-cmv-multipeptide-vaccine
2020-09-18T04:24:24Z,hTERT/survivin/melanoma tumor cell-derived mRNA-transfected dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/653980
2020-09-18T04:24:24Z,hu14.18-IL2 fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hu1418-il2-fusion-protein
2020-09-18T04:24:24Z,huachansu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huachansu
2020-09-18T04:24:24Z,Huaier extract granule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huaier-extract-granule
2020-09-18T04:24:24Z,Huang Qi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huang-qi
2020-09-18T04:24:24Z,huBC1-huIL12 fusion protein AS1409,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hubc1-huil12-fusion-protein-as1409
2020-09-18T04:24:24Z,Humalog,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-lispro
2020-09-18T04:24:24Z,human acellular dermal matrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799709
2020-09-18T04:24:24Z,human anti-CD30 CAR-expressing autologous T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796481
2020-09-18T04:24:24Z,human combinatorial antibody library-based antibody VAY736,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-combinatorial-antibody-library-based-antibody-vay736
2020-09-18T04:24:24Z,human gp100 plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-gp100-plasmid-dna-vaccine
2020-09-18T04:24:24Z,human lactoferrin peptide hLF1-11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-lactoferrin-peptide-hlf1-11
2020-09-18T04:24:24Z,human lysozyme-containing goat milk,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802324
2020-09-18T04:24:24Z,human MHC non-restricted cytotoxic T-cell line TALL-104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-mhc-non-restricted-cytotoxic-t-cell-line-tall-104
2020-09-18T04:24:24Z,human monoclonal antibody 216,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-monoclonal-antibody-216
2020-09-18T04:24:24Z,human monoclonal antibody B11-hCG beta fusion protein CDX-1307,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-monoclonal-antibody-b11-hcg-beta-fusion-protein-cdx-1307
2020-09-18T04:24:24Z,human myeloid progenitor cells CLT-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-myeloid-progenitor-cells-clt-008
2020-09-18T04:24:24Z,human papillomavirus 16 E7 peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-papillomavirus-16-e7-peptide
2020-09-18T04:24:24Z,human papillomavirus vaccine V503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-papillomavirus-vaccine-v503
2020-09-18T04:24:24Z,human prostate-specific membrane antigen plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-prostate-specific-membrane-antigen-plasmid-dna-vaccine
2020-09-18T04:24:24Z,human trefoil factor 1-secreting Lactococcus lactis AG013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-trefoil-factor-1-secreting-lactococcus-lactis-ag013
2020-09-18T04:24:24Z,human varicella zoster immune globulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-varicella-zoster-immune-globulin
2020-09-18T04:24:24Z,Humatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paromomycin-sulfate
2020-09-18T04:24:24Z,Humira,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adalimumab
2020-09-18T04:24:24Z,Humulin N,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-nph
2020-09-18T04:24:24Z,Humulin R Insulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-regular
2020-09-18T04:24:24Z,HVP E6/E7-encoding Semliki Forest virus vaccine Vvax001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792714
2020-09-18T04:24:24Z,Hyalo GYN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid-based-hydrating-vaginal-gel
2020-09-18T04:24:24Z,hyaluronic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid
2020-09-18T04:24:24Z,hyaluronic acid-based hydrating vaginal gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid-based-hydrating-vaginal-gel
2020-09-18T04:24:24Z,hyaluronic acid-containing topical cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid-containing-topical-cream
2020-09-18T04:24:24Z,Hycamtin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride
2020-09-18T04:24:24Z,Hycamtin Capsules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-topotecan-hydrochloride
2020-09-18T04:24:24Z,hycanthone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hycanthone
2020-09-18T04:24:24Z,Hydeltra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone
2020-09-18T04:24:24Z,Hydeltrasol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone
2020-09-18T04:24:24Z,hydrated sodium calcium aluminosilicate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrated-sodium-calcium-aluminosilicate
2020-09-18T04:24:24Z,hydrazine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrazine-sulfate
2020-09-18T04:24:24Z,Hydrea,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea
2020-09-18T04:24:24Z,hydrocodone/acetaminophen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocodone-acetaminophen
2020-09-18T04:24:24Z,hydrocortisone sodium succinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate
2020-09-18T04:24:24Z,hydrocortisone sodium succinate/aluminum phosphate gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792851
2020-09-18T04:24:24Z,Hydrocortone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,hydrogen peroxide-hyaluronic acid tumor injectable formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrogen-peroxide-hyaluronic-acid-tumor-injectable-formulation
2020-09-18T04:24:24Z,hydromorphone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride
2020-09-18T04:24:24Z,Hydrostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride
2020-09-18T04:24:24Z,hydroxychloroquine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxychloroquine
2020-09-18T04:24:24Z,hydroxytyrosol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxytyrosol
2020-09-18T04:24:24Z,hydroxyurea,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea
2020-09-18T04:24:24Z,HylaCare™ cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronic-acid-containing-topical-cream
2020-09-18T04:24:24Z,Hymorphan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride
2020-09-18T04:24:24Z,Hyper-CVAD regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyper-cvad-regimen
2020-09-18T04:24:24Z,Hyperacute Melanoma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b16alphagal-melanoma-vaccine
2020-09-18T04:24:24Z,HyperAcute-Lung Cancer Vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/539100
2020-09-18T04:24:24Z,Hyperacute-Pancreatic Cancer Vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l
2020-09-18T04:24:24Z,HyperAcute™ Renal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/756792
2020-09-18T04:24:24Z,hyperbaric oxygen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperbaric-oxygen
2020-09-18T04:24:24Z,hyperimmune bovine colostrum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperimmune-bovine-colostrum
2020-09-18T04:24:24Z,hyperpolarized carbon C 13 pyruvate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/688700
2020-09-18T04:24:24Z,hyperpolarized helium 3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-helium-3
2020-09-18T04:24:24Z,hyperpolarized xenon 129,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-xenon-129
2020-09-18T04:24:24Z,hypertonic saline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypertonic-saline
2020-09-18T04:24:24Z,hypoxia-activated prodrug TH-4000,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypoxia-activated-prodrug-th-4000
2020-09-18T04:24:24Z,Hypoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypoxia-activated-prodrug-th-4000
2020-09-18T04:24:24Z,Hytone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,I 131 monoclonal antibody CC49,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/i-131-monoclonal-antibody-cc49
2020-09-18T04:24:24Z,IAP inhibitor AT-406,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iap-inhibitor-at-406
2020-09-18T04:24:24Z,IAP inhibitor HGS1029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iap-inhibitor-hgs1029
2020-09-18T04:24:24Z,iAPA-based dendritic cells/cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iapa-based-dendritic-cells-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,ibandronate sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibandronate-sodium
2020-09-18T04:24:24Z,iberdomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crl4crbn-e3-ubiquitin-ligase-modulator-cc-220
2020-09-18T04:24:24Z,Ibrance,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palbociclib
2020-09-18T04:24:24Z,ibrexafungerp,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798632
2020-09-18T04:24:24Z,ibritumomab tiuxetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibritumomab-tiuxetan
2020-09-18T04:24:24Z,ibrutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib
2020-09-18T04:24:24Z,ibudilast,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796798
2020-09-18T04:24:24Z,ibuprofen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen
2020-09-18T04:24:24Z,ibuprofen intravenous,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen-intravenous
2020-09-18T04:24:24Z,IC-GREEN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-solution
2020-09-18T04:24:24Z,iC9-GD2-CAR-CD28-OX40-expressing autologous NKT cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792461
2020-09-18T04:24:24Z,iC9-GD2-CD28-OX40-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ic9-gd2-cd28-ox40-expressing-t-lymphocytes
2020-09-18T04:24:24Z,ICE regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ice-regimen
2020-09-18T04:24:24Z,Iclusig,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ponatinib-hydrochloride
2020-09-18T04:24:24Z,icodextrin solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icodextrin-solution
2020-09-18T04:24:24Z,icosapent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799811
2020-09-18T04:24:24Z,icotinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icotinib-hydrochloride
2020-09-18T04:24:24Z,icrucumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icrucumab
2020-09-18T04:24:24Z,Idamycin PFS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride
2020-09-18T04:24:24Z,idarubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride
2020-09-18T04:24:24Z,idarubicin-eluting beads,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-eluting-beads
2020-09-18T04:24:24Z,idasanutlin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idasanutlin
2020-09-18T04:24:24Z,idelalisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib
2020-09-18T04:24:24Z,IDH1(R132) inhibitor IDH305,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1r132-inhibitor-idh305
2020-09-18T04:24:24Z,IDH1R132H mutation-targeting IDH1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1r132h-mutation-targeting-idh1-peptide-vaccine
2020-09-18T04:24:24Z,IDH1R132H-specific peptide vaccine PEPIDH1M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1r132h-specific-peptide-vaccine-pepidh1m
2020-09-18T04:24:24Z,Idhifa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate
2020-09-18T04:24:24Z,idiotype-pulsed autologous dendritic cell vaccine APC8020,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idiotype-pulsed-autologous-dendritic-cell-vaccine-apc8020
2020-09-18T04:24:24Z,IDO inhibitor NLG919,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-inhibitor-nlg919
2020-09-18T04:24:24Z,IDO-1 inhibitor LY3381916,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794987
2020-09-18T04:24:24Z,IDO-1 inhibitor PF-06840003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-1-inhibitor-pf-06840003
2020-09-18T04:24:24Z,IDO/TDO inhibitor HTI-1090,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793153
2020-09-18T04:24:24Z,IDO1 inhibitor BMS-986205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-bms-986205
2020-09-18T04:24:24Z,IDO1 inhibitor KHK2455,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-khk2455
2020-09-18T04:24:24Z,IDO1/TDO2 inhibitor M4112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800701
2020-09-18T04:24:24Z,idoxuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine
2020-09-18T04:24:24Z,idronoxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idronoxil
2020-09-18T04:24:24Z,idronoxil suppository NOX66,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idronoxil-suppository-nox66
2020-09-18T04:24:24Z,ifetroban sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798288
2020-09-18T04:24:24Z,Ifex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide
2020-09-18T04:24:24Z,ifosfamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide
2020-09-18T04:24:24Z,IGF-1R antagonist BMS-754807,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-1r-antagonist-bms-754807
2020-09-18T04:24:24Z,IGF-1R antisense oligodeoxynucleotide-treated autologous glioma cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-1r-antisense-oligodeoxynucleotide-treated-autologous-glioma-cells
2020-09-18T04:24:24Z,IGF-1R inhibitor PL225B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-1r-inhibitor-pl225b
2020-09-18T04:24:24Z,IGF-1R/IR inhibitor KW-2450,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-1r-ir-inhibitor-kw-2450
2020-09-18T04:24:24Z,IGF-methotrexate conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igf-methotrexate-conjugate
2020-09-18T04:24:24Z,IgM-enriched immunoglobulins,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795366
2020-09-18T04:24:24Z,IH636 grape seed proanthocyanidin extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ih636-grape-seed-proanthocyanidin-extract
2020-09-18T04:24:24Z,IL-10 immunomodulator MK-1966,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-10-immunomodulator-mk-1966
2020-09-18T04:24:24Z,IL-12-expressing mesenchymal stem cell vaccine GX-051,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-12-expressing-mesenchymal-stem-cell-vaccine-gx-051
2020-09-18T04:24:24Z,"IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based immunotherapeutic agent SAR441000",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800230
2020-09-18T04:24:24Z,IL-2 plasmid DNA/lipid complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-plasmid-dna-lipid-complex
2020-09-18T04:24:24Z,IL-2 recombinant fusion protein ALT-801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-recombinant-fusion-protein-alt-801
2020-09-18T04:24:24Z,IL-2/9/15 gamma chain receptor inhibitor BNZ-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792153
2020-09-18T04:24:24Z,IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-lptn-gene-modified-allogeneic-neuroblastoma-tumor-cell-vaccine
2020-09-18T04:24:24Z,IL13Ralpha2-specific hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing autologous TN/MEM Cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795828
2020-09-18T04:24:24Z,IL13Ralpha2-specific hinge-optimized 41BB-co-stimulatory CAR truncated CD19-expressing autologous T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/763113
2020-09-18T04:24:24Z,IL4-Pseudomonas exotoxin fusion protein MDNA55,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il4-pseudomonas-exotoxin-fusion-protein-mdna55
2020-09-18T04:24:24Z,ilaprazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilaprazole
2020-09-18T04:24:24Z,Ilaris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795723
2020-09-18T04:24:24Z,Ilopan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol-cream
2020-09-18T04:24:24Z,iloprost,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iloprost
2020-09-18T04:24:24Z,ilorasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilorasertib
2020-09-18T04:24:24Z,Ilotycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin
2020-09-18T04:24:24Z,Iluyma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799836
2020-09-18T04:24:24Z,Imagent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflubron
2020-09-18T04:24:24Z,imaging agent QRH-882260 heptapeptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792736
2020-09-18T04:24:24Z,imalumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imalumab
2020-09-18T04:24:24Z,imatinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate
2020-09-18T04:24:24Z,Imbruvica,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib
2020-09-18T04:24:24Z,imetelstat sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imetelstat-sodium
2020-09-18T04:24:24Z,imexon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imexon
2020-09-18T04:24:24Z,Imfinzi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab
2020-09-18T04:24:24Z,imidazole mustard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazole-mustard
2020-09-18T04:24:24Z,imidazolyl ethanamide pentandioic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid
2020-09-18T04:24:24Z,imipenem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imipenem
2020-09-18T04:24:24Z,imiquimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod
2020-09-18T04:24:24Z,imisopasem manganese,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imisopasem-manganese
2020-09-18T04:24:24Z,Imitrex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumatriptan-succinate
2020-09-18T04:24:24Z,Imlygic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talimogene-laherparepvec
2020-09-18T04:24:24Z,immediate-release afuresertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-afuresertib
2020-09-18T04:24:24Z,immediate-release bupropion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800123
2020-09-18T04:24:24Z,immediate-release onapristone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-onapristone
2020-09-18T04:24:24Z,ImmTher,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disaccharide-tripeptide-glycerol-dipalmitoyl
2020-09-18T04:24:24Z,Immucell WGP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan
2020-09-18T04:24:24Z,Immun-Aid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement
2020-09-18T04:24:24Z,immune checkpoint inhibitor ASP8374,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immune-checkpoint-inhibitor-asp8374
2020-09-18T04:24:24Z,immunoadjuvant QS-DG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunoadjuvant-qs-dg
2020-09-18T04:24:24Z,Immunocal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/whey-protein-isolate
2020-09-18T04:24:24Z,immunoconjugate RO5479599,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunoconjugate-ro5479599
2020-09-18T04:24:24Z,immunocytokine NHS-IL12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunocytokine-nhs-il12
2020-09-18T04:24:24Z,immunocytokine NHS-IL2-LT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunocytokine-nhs-il2-lt
2020-09-18T04:24:24Z,immunological adjuvant OPT-821,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunological-adjuvant-opt-821
2020-09-18T04:24:24Z,immunomodulator LAM-003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793859
2020-09-18T04:24:24Z,immunomodulator OHR/AVR118,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-ohr-avr118
2020-09-18T04:24:24Z,immunomodulatory agent CC-11006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulatory-agent-cc-11006
2020-09-18T04:24:24Z,immunotherapeutic combination product CMB305,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-combination-product-cmb305
2020-09-18T04:24:24Z,immunotherapeutic GSK1572932A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-gsk1572932a
2020-09-18T04:24:24Z,immunotherapy regimen MKC-1106-MT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapy-regimen-mkc-1106-mt
2020-09-18T04:24:24Z,immunotoxin CMD-193,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotoxin-cmd-193
2020-09-18T04:24:24Z,immunotoxin D2C7-(scdsFv)-PE38KDEL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotoxin-d2c7-scdsfv-pe38kdel
2020-09-18T04:24:24Z,Immunox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymopentin
2020-09-18T04:24:24Z,Imodium A-D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loperamide-hydrochloride
2020-09-18T04:24:24Z,Impact,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-omega-3-fatty-acids-nucleotides-oral-supplement
2020-09-18T04:24:24Z,Imprime PGG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pgg-beta-glucan
2020-09-18T04:24:24Z,IMT-1012 immunotherapeutic vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imt-1012-immunotherapeutic-vaccine
2020-09-18T04:24:24Z,Imuran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azathioprine-sodium
2020-09-18T04:24:24Z,Imvamune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908
2020-09-18T04:24:24Z,inactivated poliovirus vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inactivated-poliovirus-vaccine
2020-09-18T04:24:24Z,inalimarev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inalimarev
2020-09-18T04:24:24Z,Inapsine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/droperidol
2020-09-18T04:24:24Z,Incel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biricodar-dicitrate
2020-09-18T04:24:24Z,Incivek,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaprevir
2020-09-18T04:24:24Z,incomplete Freund's adjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incomplete-freunds-adjuvant
2020-09-18T04:24:24Z,incyclinide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incyclinide
2020-09-18T04:24:24Z,Inderal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propranolol-hydrochloride
2020-09-18T04:24:24Z,indibulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indibulin
2020-09-18T04:24:24Z,indicine-N-oxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indicine-n-oxide
2020-09-18T04:24:24Z,indinavir sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indinavir-sulfate
2020-09-18T04:24:24Z,Indium 111 ProstaScint,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-capromab-pendetide
2020-09-18T04:24:24Z,indium In 111 anti-CD45 monoclonal antibody BC8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-cd45-monoclonal-antibody-bc8
2020-09-18T04:24:24Z,indium In 111 anti-EGFR monoclonal antibody ABT-806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-anti-egfr-monoclonal-antibody-abt-806
2020-09-18T04:24:24Z,indium In 111 bevacizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-bevacizumab
2020-09-18T04:24:24Z,indium In 111 capromab pendetide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-capromab-pendetide
2020-09-18T04:24:24Z,indium In 111 chimeric monoclonal antibody 806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-chimeric-monoclonal-antibody-806
2020-09-18T04:24:24Z,indium In 111 CHX-A DTPA trastuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-chx-a-dtpa-trastuzumab
2020-09-18T04:24:24Z,indium In 111 ibritumomab tiuxetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-ibritumomab-tiuxetan
2020-09-18T04:24:24Z,indium In 111 minigastrin analog CP04,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794068
2020-09-18T04:24:24Z,indium In 111 monoclonal antibody BrE-3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-bre-3
2020-09-18T04:24:24Z,indium In 111 monoclonal antibody HuJ591,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793674
2020-09-18T04:24:24Z,indium In 111 monoclonal antibody huPAM4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-hupam4
2020-09-18T04:24:24Z,indium In 111 pentetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetate
2020-09-18T04:24:24Z,indium In 111 pentetreotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide
2020-09-18T04:24:24Z,indium In 111 pertuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pertuzumab
2020-09-18T04:24:24Z,indium In 111-autologous CMV-pp65-LAMP mRNA-loaded dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798929
2020-09-18T04:24:24Z,indium In 111-CMD-193,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-cmd-193
2020-09-18T04:24:24Z,Kanjinti,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab
2020-09-18T04:24:24Z,indium In 111-DOTA-biotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-biotin
2020-09-18T04:24:24Z,indium In 111-DOTA-exendin-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-exendin-4
2020-09-18T04:24:24Z,indium In 111-DOTA-girentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-girentuximab
2020-09-18T04:24:24Z,indium In 111-DOTA-h11B6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799793
2020-09-18T04:24:24Z,indium In 111-FPI-1547,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797341
2020-09-18T04:24:24Z,indium In 111-labeled autologous peripheral blood mononuclear cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-labeled-autologous-peripheral-blood-mononuclear-cells
2020-09-18T04:24:24Z,indium In 111-labeled autologous polymorphonuclear leukocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-labeled-autologous-polymorphonuclear-leukocytes
2020-09-18T04:24:24Z,indium In-111-DOTA-di-HSG peptide IMP-288,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-di-hsg-peptide-imp-288
2020-09-18T04:24:24Z,Indocin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indomethacin
2020-09-18T04:24:24Z,indocyanine green solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-solution
2020-09-18T04:24:24Z,indocyanine green-labeled polymeric micelles ONM-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797414
2020-09-18T04:24:24Z,indocyanine green/albumin solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-albumin-solution
2020-09-18T04:24:24Z,indole-3-carbinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indole-3-carbinol
2020-09-18T04:24:24Z,indole-3-carbinol/calcium/Schizandra/vitamin D3/milk thistle/stinging nettle/lignan-based nutritional capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/669230
2020-09-18T04:24:24Z,"indoleamine 2,3-dioxygenase peptide vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoleamine-23-dioxygenase-peptide-vaccine
2020-09-18T04:24:24Z,indomethacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indomethacin
2020-09-18T04:24:24Z,indoximod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod
2020-09-18T04:24:24Z,indoximod prodrug NLG802,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792849
2020-09-18T04:24:24Z,inducible CD4+CD25+ regulatory T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inducible-cd4cd25-regulatory-t-cells
2020-09-29T06:06:26Z,inebilizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-medi-551
2020-09-18T04:24:24Z,inecalcitol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inecalcitol
2020-09-18T04:24:24Z,Infanrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed
2020-09-18T04:24:24Z,Infasurf Intratracheal Suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calfactant
2020-09-18T04:24:24Z,Infergen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1
2020-09-18T04:24:24Z,infigratinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-kinase-inhibitor-bgj398
2020-09-18T04:24:24Z,infliximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab
2020-09-24T06:46:08Z,Infugem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride
2020-09-18T04:24:24Z,Infumorph,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,ingenol derivative LEO 43204 gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-derivative-leo-43204-gel
2020-09-18T04:24:24Z,ingenol mebutate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate
2020-09-18T04:24:24Z,ingenol mebutate gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate-gel
2020-09-18T04:24:24Z,iniparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iniparib
2020-09-18T04:24:24Z,injectable Astragalus membranaceus polysaccharide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-astragalus-membranaceus-polysaccharide
2020-09-18T04:24:24Z,injectable liposomal vinorelbine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/injectable-liposomal-vinorelbine
2020-09-18T04:24:24Z,Injectafer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferric-carboxymaltose-solution
2020-09-18T04:24:24Z,iNKT cell agonist ABX196,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801520
2020-09-18T04:24:24Z,Inlyta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axitinib
2020-09-18T04:24:24Z,innate defense regulator SGX942,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/innate-defense-regulator-sgx942
2020-09-18T04:24:24Z,innate immunostimulator rBBX-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/innate-immunostimulator-rbbx-01
2020-09-18T04:24:24Z,Innohep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinzaparin-sodium
2020-09-18T04:24:24Z,INO-1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ino-1001
2020-09-18T04:24:24Z,inodiftagene vixteplasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796809
2020-09-18T04:24:24Z,inosine 5'- monophosphate dehydrogenase inhibitor FF-10501-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-5--monophosphate-dehydrogenase-inhibitor-ff-10501-01
2020-09-18T04:24:24Z,inosine dialdehyde,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-dialdehyde
2020-09-18T04:24:24Z,inositol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inositol
2020-09-18T04:24:24Z,inotuzumab ozogamicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin
2020-09-18T04:24:24Z,Inqovi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cda-inhibitor-e7727-decitabine-combination-agent-astx727
2020-09-18T04:24:24Z,Inrebic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348
2020-09-18T04:24:24Z,Insegia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-immunotoxin
2020-09-18T04:24:24Z,Inspra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eplerenone
2020-09-18T04:24:24Z,insulin lispro,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-lispro
2020-09-18T04:24:24Z,"insulin, NPH",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-nph
2020-09-18T04:24:24Z,"insulin, regular",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-regular
2020-09-18T04:24:24Z,integrin receptor antagonist GLPG0187,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/integrin-receptor-antagonist-glpg0187
2020-09-18T04:24:24Z,Intercoat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-adhesion-barrier-gel
2020-09-18T04:24:24Z,interferon alfacon-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-alfacon-1
2020-09-18T04:24:24Z,interferon beta-secreting mesenchymal stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-beta-secreting-mesenchymal-stem-cells
2020-09-18T04:24:24Z,interferon gamma-1b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b
2020-09-18T04:24:24Z,interferon-gamma-expressing adenovirus vaccine ASN-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-expressing-adenovirus-vaccine-asn-002
2020-09-18T04:24:24Z,interleukin-12 gene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-gene
2020-09-18T04:24:24Z,interleukin-12-Fc fusion protein DF6002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801838
2020-09-18T04:24:24Z,interleukin-15/interleukin-15 receptor alpha complex-Fc fusion protein XmAb24306,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801195
2020-09-18T04:24:24Z,interleukin-15/interleukin-15 receptor alpha sushi+ domain fusion protein SO-C101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801174
2020-09-18T04:24:24Z,interleukin-2 gene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-2-gene
2020-09-18T04:24:24Z,intetumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/intetumumab
2020-09-18T04:24:24Z,IntraDose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-e-therapeutic-implant
2020-09-18T04:24:24Z,Intralipid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fat-emulsion
2020-09-18T04:24:24Z,intranasal ketamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/intranasal-ketamine
2020-09-18T04:24:24Z,Intron A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b
2020-09-18T04:24:24Z,inulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inulin
2020-09-18T04:24:24Z,Invanz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertapenem-sodium
2020-09-18T04:24:24Z,Invirase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saquinavir-mesylate
2020-09-18T04:24:24Z,INxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il4-pseudomonas-exotoxin-fusion-protein-mdna55
2020-09-18T04:24:24Z,iobenguane I 131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131
2020-09-18T04:24:24Z,iobitridol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobitridol
2020-09-18T04:24:24Z,iodinated contrast dye,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-contrast-dye
2020-09-18T04:24:24Z,iodinated polyethylene glycol-based hydrogel tissue marker,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683
2020-09-18T04:24:24Z,iodine 131-6-beta-iodomethyl-19-norcholesterol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-131-6-beta-iodomethyl-19-norcholesterol
2020-09-18T04:24:24Z,iodine I 123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123
2020-09-18T04:24:24Z,iodine I 123 ADAM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-adam
2020-09-18T04:24:24Z,iodine I 123 anti-CEA recombinant diabody T84.66,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-anti-cea-recombinant-diabody-t8466
2020-09-18T04:24:24Z,iodine I 123 iodobenzamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-iodobenzamide
2020-09-18T04:24:24Z,iodine I 123 iodometomidate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-iodometomidate
2020-09-18T04:24:24Z,iodine I 124,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124
2020-09-18T04:24:24Z,iodine I 124 CPD-1028,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-cpd-1028
2020-09-18T04:24:24Z,iodine I 124 FIAU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-fiau
2020-09-18T04:24:24Z,iodine I 124 iobenguane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iobenguane
2020-09-18T04:24:24Z,iodine I 124 iodo-azomycin galactopyranoside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iodo-azomycin-galactopyranoside
2020-09-18T04:24:24Z,iodine I 124 iododeoxyuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-iododeoxyuridine
2020-09-18T04:24:24Z,iodine I 124 monoclonal antibody 3F8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-3f8
2020-09-18T04:24:24Z,iodine I 124 monoclonal antibody 8H9,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-8h9
2020-09-18T04:24:24Z,iodine I 124 monoclonal antibody A33,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-a33
2020-09-18T04:24:24Z,iodine I 124 monoclonal antibody M5A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797482
2020-09-18T04:24:24Z,iodine I 124 NM404,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-nm404
2020-09-18T04:24:24Z,iodine I 124 phospholipid ether analogue CLR1404,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-phospholipid-ether-analogue-clr1404
2020-09-18T04:24:24Z,iodine I 124 PU-AD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-pu-ad
2020-09-18T04:24:24Z,iodine I 124-labeled anti-phosphatidylserine monoclonal antibody PGN650,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-anti-phosphatidylserine-monoclonal-antibody-pgn650
2020-09-18T04:24:24Z,iodine I 124-labeled anti-PSCA A11 minibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-anti-psca-a11-minibody
2020-09-18T04:24:24Z,iodine I 124-labeled HSP90 inhibitor PUH71,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-labeled-hsp90-inhibitor-puh71
2020-09-18T04:24:24Z,iodine I 125,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-125
2020-09-18T04:24:24Z,iodine I 125 anti-EGFR-425 monoclonal antibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-125-anti-egfr-425-monoclonal-antibody
2020-09-18T04:24:24Z,iodine I 131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131
2020-09-18T04:24:24Z,karenitecin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/karenitecin
2020-09-18T04:24:24Z,iodine I 131 anti-fibronectin antibody fragment L19-SIP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-anti-fibronectin-antibody-fragment-l19-sip
2020-09-18T04:24:24Z,iodine I 131 chimeric monoclonal antibody G-250,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-chimeric-monoclonal-antibody-g-250
2020-09-18T04:24:24Z,iodine I 131 ethiodized oil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-ethiodized-oil
2020-09-18T04:24:24Z,iodine I 131 iodocholesterol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-iodocholesterol
2020-09-18T04:24:24Z,Iodine I 131 Lipiodol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-ethiodized-oil
2020-09-18T04:24:24Z,iodine I 131 MIP-1095,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-mip-1095
2020-09-18T04:24:24Z,iodine I 131 monoclonal antibody 3F8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-3f8
2020-09-18T04:24:24Z,iodine I 131 monoclonal antibody 81C6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-81c6
2020-09-18T04:24:24Z,iodine I 131 monoclonal antibody BC8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-bc8
2020-09-18T04:24:24Z,iodine I 131 monoclonal antibody CC49-deltaCH2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-cc49-deltach2
2020-09-18T04:24:24Z,iodine I 131 monoclonal antibody F16SIP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-f16sip
2020-09-18T04:24:24Z,iodine I 131 monoclonal antibody TNT-1/B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-tnt-1-b
2020-09-18T04:24:24Z,iodine I 131 NM404,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-nm404
2020-09-18T04:24:24Z,iodine I 131 rituximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-rituximab
2020-09-18T04:24:24Z,iodine I 131 SGMIB-anti-HER2 VHH1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-sgmib-anti-her2-vhh1
2020-09-18T04:24:24Z,iodine I 131 tenatumomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tenatumomab
2020-09-18T04:24:24Z,iodine I 131 TM-601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tm-601
2020-09-18T04:24:24Z,iodine I 131 tositumomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tositumomab
2020-09-18T04:24:24Z,iodine I 131-labeled anti-CEA/anti-HSG bispecific monoclonal antibody TF2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-labeled-anti-cea-anti-hsg-bispecific-monoclonal-antibody-tf2
2020-09-18T04:24:24Z,iodine I 131-omburtamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-8h9
2020-09-18T04:24:24Z,iodine I-124 girentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-girentuximab
2020-09-18T04:24:24Z,iodine-123 metaiodobenzylguanidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-123-metaiodobenzylguanidine
2020-09-18T04:24:24Z,iodixanol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodixanol
2020-09-18T04:24:24Z,Iodotope,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131
2020-09-18T04:24:24Z,ioflubenzamide I-131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ioflubenzamide-i-131
2020-09-18T04:24:24Z,iofolastat I123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iofolastat-i123
2020-09-18T04:24:24Z,iohexol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iohexol
2020-09-18T04:24:24Z,ionic silver-impregnated sodium carboxymethyl cellulose antimicrobial dressing,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/632702
2020-09-18T04:24:24Z,iopromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iopromide
2020-09-18T04:24:24Z,Ioversol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794044
2020-09-18T04:24:24Z,ipafricept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipafricept
2020-09-18T04:24:24Z,ipamorelin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipamorelin
2020-09-18T04:24:24Z,ipatasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipatasertib
2020-09-18T04:24:24Z,ipilimumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab
2020-09-18T04:24:24Z,IPOL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inactivated-poliovirus-vaccine
2020-09-18T04:24:24Z,ipomeanol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipomeanol
2020-09-18T04:24:24Z,iproplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iproplatin
2020-09-18T04:24:24Z,iPSC-derived CD16-expressing natural killer cells FT516,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799446
2020-09-18T04:24:24Z,iPSC-derived CD16/IL-15RF-expressing anti-CD19 CAR-NK cells FT596,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801177
2020-09-18T04:24:24Z,IRAK4 inhibitor CA-4948,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794871
2020-09-18T04:24:24Z,iratumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iratumumab
2020-09-18T04:24:24Z,IRDye800-labeled heterodimeric peptide KSP-QRH 919288G,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801307
2020-09-18T04:24:24Z,IRDye800CW-labeled heptapeptide KSP-910638G,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792794
2020-09-18T04:24:24Z,Iressa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gefitinib
2020-09-18T04:24:24Z,iriduim Ir 192,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iriduim-ir-192
2020-09-18T04:24:24Z,irinotecan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride
2020-09-18T04:24:24Z,irinotecan hydrochloride liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome
2020-09-18T04:24:24Z,irinotecan-eluting beads,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-eluting-beads
2020-09-18T04:24:24Z,irinotecan/P-glycoprotein inhibitor HM30181AK combination tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-p-glycoprotein-inhibitor-hm30181ak-combination-tablet
2020-09-18T04:24:24Z,irofulven,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irofulven
2020-09-18T04:24:24Z,iron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron
2020-09-18T04:24:24Z,iron dextran complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-dextran-complex
2020-09-18T04:24:24Z,iron isomaltoside 1000,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-isomaltoside-1000
2020-09-18T04:24:24Z,iron sucrose injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-sucrose-injection
2020-09-18T04:24:24Z,irradiated allogeneic human lung cancer cells expressing OX40L-Ig vaccine HS-130,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799760
2020-09-18T04:24:24Z,isatuximab-irfc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isatuximab
2020-09-18T04:24:24Z,isavuconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isavuconazole
2020-09-18T04:24:24Z,Iscar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract
2020-09-18T04:24:24Z,Iscomatrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saponin-cholesterol-phospholipid-adjuvant
2020-09-18T04:24:24Z,Isentress,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltegravir-potassium
2020-09-18T04:24:24Z,ISIS 2503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-2503
2020-09-18T04:24:24Z,ISIS 3521,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-3521
2020-09-18T04:24:24Z,ISIS 5132,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isis-5132
2020-09-18T04:24:24Z,ISIS-STAT3rx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-antisense-oligonucleotide-isis-481464
2020-09-18T04:24:24Z,iso-fludelone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iso-fludelone
2020-09-18T04:24:24Z,Isoflo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane
2020-09-18T04:24:24Z,isoflurane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoflurane
2020-09-18T04:24:24Z,isoniazid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoniazid
2020-09-18T04:24:24Z,isopropyl alcohol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802330
2020-09-18T04:24:24Z,isoquercetin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoquercetin
2020-09-18T04:24:24Z,isosulfan blue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isosulfan-blue
2020-09-18T04:24:24Z,isotretinoin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin
2020-09-18T04:24:24Z,ispinesib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ispinesib
2020-09-18T04:24:24Z,ISS 1018 CpG oligodeoxynucleotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iss-1018-cpg-oligodeoxynucleotide
2020-09-18T04:24:24Z,Istodax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romidepsin
2020-09-18T04:24:24Z,itacitinib adipate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itacitinib
2020-09-18T04:24:24Z,ITK inhibitor CPI-818,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798593
2020-09-18T04:24:24Z,itraconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole
2020-09-18T04:24:24Z,itraconazole dispersion in polymer matrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole-dispersion-in-polymer-matrix
2020-09-18T04:24:24Z,ivabradine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792710
2020-09-18T04:24:24Z,IVAC mutanome vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivac-mutanome-vaccine
2020-09-18T04:24:24Z,Iveegam EN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,ivosidenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1-inhibitor-ag-120
2020-09-18T04:24:24Z,ixabepilone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone
2020-09-18T04:24:24Z,ixabepilone (oral),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone-oral
2020-09-18T04:24:24Z,ixazomib citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixazomib-citrate
2020-09-18T04:24:24Z,Ixempra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixabepilone
2020-09-18T04:24:24Z,Ixoten,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide
2020-09-18T04:24:24Z,JAK inhibitor INCB047986,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak-inhibitor-incb047986
2020-09-18T04:24:24Z,JAK1 inhibitor AZD4205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795786
2020-09-18T04:24:24Z,JAK1 inhibitor INCB052793,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak1-inhibitor-incb052793
2020-09-18T04:24:24Z,JAK2 inhibitor AZD1480,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-azd1480
2020-09-18T04:24:24Z,JAK2 inhibitor BMS-911543,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-bms-911543
2020-09-18T04:24:24Z,JAK2 inhibitor WP1066,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-wp1066
2020-09-18T04:24:24Z,JAK2 inhibitor XL019,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-xl019
2020-09-18T04:24:24Z,JAK2/Src inhibitor NS-018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-src-inhibitor-ns-018
2020-09-18T04:24:24Z,JAK3 inhibitor PF-06651600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798451
2020-09-18T04:24:24Z,Jakafi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate
2020-09-20T05:26:50Z,Jarlsberg cheese,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802336
2020-09-18T04:24:24Z,JEB regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jeb-regimen
2020-09-18T04:24:24Z,Jelmyto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c
2020-09-18T04:24:24Z,Jevtana,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel
2020-09-18T04:24:24Z,Jin Fu Kang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jin-fu-kang
2020-09-18T04:24:24Z,Juice Plus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruit-and-vegetable-extracts
2020-09-18T04:24:24Z,JUNOVAN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifamurtide
2020-09-18T04:24:24Z,Juven,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/juven
2020-09-18T04:24:24Z,Jynneos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908
2020-09-18T04:24:24Z,Kadcyla,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ado-trastuzumab-emtansine
2020-09-18T04:24:24Z,Kadian,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,kanglaite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanglaite
2020-09-18T04:24:24Z,kanitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800350
2020-09-18T04:24:24Z,karonudib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792474
2020-09-18T04:24:24Z,Kava-based supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kava-based-supplement
2020-09-18T04:24:24Z,Keflex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cephalexin
2020-09-18T04:24:24Z,Kefzol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefazolin-sodium
2020-09-18T04:24:24Z,Kenalog,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide
2020-09-18T04:24:24Z,Kepivance,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifermin
2020-09-18T04:24:24Z,Keppra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levetiracetam
2020-09-18T04:24:24Z,KeraStat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-keratin
2020-09-18T04:24:24Z,Ketalar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketamine-hydrochloride
2020-09-18T04:24:24Z,ketamine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketamine-hydrochloride
2020-09-18T04:24:24Z,ketamine/amitriptyline NP-H cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketamine-amitriptyline-np-h-cream
2020-09-18T04:24:24Z,ketoconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole
2020-09-18T04:24:24Z,ketoprofen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoprofen
2020-09-18T04:24:24Z,ketorolac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketorolac
2020-09-18T04:24:24Z,ketorolac tromethamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketorolac-tromethamine
2020-09-18T04:24:24Z,Kevetrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioureidobutyronitrile
2020-09-18T04:24:24Z,keyhole limpet hemocyanin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/keyhole-limpet-hemocyanin
2020-09-18T04:24:24Z,Keytruda,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab
2020-09-18T04:24:24Z,Kiacta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprodisate-disodium
2020-09-18T04:24:24Z,Kineret,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anakinra
2020-09-18T04:24:24Z,Kisqali,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribociclib
2020-09-18T04:24:24Z,KLH-FITC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/klh-fitc
2020-09-18T04:24:24Z,Komed HC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,KOS-953,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanespimycin
2020-09-18T04:24:24Z,Koselugo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib
2020-09-18T04:24:24Z,KRAS G12C inhibitor LY3499446,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800237
2020-09-18T04:24:24Z,KRAS G12C inhibitor MRTX849,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796791
2020-09-18T04:24:24Z,KRAS-MAPK signaling pathway inhibitor JAB-3312,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799443
2020-09-18T04:24:24Z,KRASG12C inhibitor JNJ-74699157,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800416
2020-09-18T04:24:24Z,KRN5500,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krn5500
2020-09-18T04:24:24Z,KSP inhibitor ARRY-520,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ksp-inhibitor-arry-520
2020-09-18T04:24:24Z,KSP inhibitor AZD4877,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ksp-inhibitor-azd4877
2020-09-18T04:24:24Z,KSP/VEGF siRNAs ALN-VSP02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ksp-vegf-sirnas-aln-vsp02
2020-09-18T04:24:24Z,kunecatechins ointment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kunecatechins-ointment
2020-09-18T04:24:24Z,KW-2149,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kw-2149
2020-09-18T04:24:24Z,Kymriah,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisagenlecleucel
2020-09-18T04:24:24Z,Kynacyte,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/safingol
2020-09-18T04:24:24Z,Kyprolis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib
2020-09-18T04:24:24Z,"L-377,202",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-377202
2020-09-18T04:24:24Z,L-alanosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-alanosine
2020-09-18T04:24:24Z,L-arginine/Korean ginseng/ Gingko biloba/damiana-based supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng--gingko-biloba-damiana-based-supplement
2020-09-18T04:24:24Z,L-Asnase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase
2020-09-18T04:24:24Z,L-Carnipure L-Carnitine L-Tartrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-carnitine-l-tartrate
2020-09-18T04:24:24Z,L-carnitine L-tartrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-carnitine-l-tartrate
2020-09-18T04:24:24Z,L-citrulline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-citrulline
2020-09-18T04:24:24Z,L-gossypol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-gossypol
2020-09-18T04:24:24Z,L-leucyl-L-leucine methyl ester,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-leucyl-l-leucine-methyl-ester
2020-09-18T04:24:24Z,L-lysine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine
2020-09-18T04:24:24Z,L-lysine/L-arginine-containing amino acid solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796487
2020-09-18T04:24:24Z,L-menthol preparation NPO-11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-menthol-preparation-npo-11
2020-09-18T04:24:24Z,L-methylfolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate
2020-09-18T04:24:24Z,L19-IL2 monoclonal antibody-cytokine fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l19-il2-monoclonal-antibody-cytokine-fusion-protein
2020-09-18T04:24:24Z,labetuzumab-SN-38 immunoconjugate IMMU-130,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labetuzumab-sn-38-immunoconjugate-immu-130
2020-09-18T04:24:24Z,LaBID,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,lacosamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lacosamide
2020-09-18T04:24:24Z,Lactobacillus acidophilus/estriol vaginal tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-acidophilus-estriol-vaginal-tablet
2020-09-18T04:24:24Z,lenvatinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenvatinib-mesylate
2020-09-18T04:24:24Z,Lactobacillus acidophilus/Streptococcus thermophilus/Bifidobacterium lactis/L. rhamnosus/B. longum/B. bifidum-based probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/741869
2020-09-18T04:24:24Z,Lactobacillus brevis CD2 lozenge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-brevis-cd2-lozenge
2020-09-18T04:24:24Z,lactobacillus fermented extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-fermented-extract
2020-09-18T04:24:24Z,Lactobacillus plantarum 299v/Lactobacillus acidophilus/Bifidobacterium lactis probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/736258
2020-09-18T04:24:24Z,Lactobacillus plantarum strain 299,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-plantarum-strain-299
2020-09-18T04:24:24Z,Lactobacillus plantarum strain 299v,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-plantarum-strain-299v
2020-09-18T04:24:24Z,Lactobacillus probiotic BSL_PS6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800946
2020-09-18T04:24:24Z,Lactobacillus reuteri probiotic tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792504
2020-09-18T04:24:24Z,Lactobacillus rhamnosus GG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg
2020-09-18T04:24:24Z,Lactobacillus rhamnosus/L. acidophilus/L. plantarum/Enterococcus faecium aqueous probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796788
2020-09-18T04:24:24Z,Lactobacillus rhamnosus/L. jensenii/L. crispatus/L. gasseri oral supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-l-jensenii-l-crispatus-l-gasseri-oral-supplement
2020-09-18T04:24:24Z,Lactobacillus rhamnosus/Lactobacillus reuteri probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792864
2020-09-18T04:24:24Z,Lactobacillus-based probiotic capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-based-probiotic-capsule
2020-09-18T04:24:24Z,lactoferrin-derived lytic peptide LTX-315,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactoferrin-derived-lytic-peptide-ltx-315
2020-09-18T04:24:24Z,ladiratuzumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-liv-1-monoclonal-antibody-mmae-conjugate-sgn-liv1a
2020-09-18T04:24:24Z,laetrile,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laetrile
2020-09-18T04:24:24Z,LAIR-2 fusion protein NC410,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801912
2020-09-18T04:24:24Z,lamellar body mimetic mouth spray LMS-611,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamellar-body-mimetic-mouth-spray-lms-611
2020-09-18T04:24:24Z,Lamictal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamotrigine
2020-09-18T04:24:24Z,lamivudine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamivudine
2020-09-18T04:24:24Z,lamotrigine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamotrigine
2020-09-18T04:24:24Z,Lanoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/digoxin
2020-09-18T04:24:24Z,lanreotide acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-acetate
2020-09-18T04:24:24Z,lanreotide acetate copolymer microparticles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-acetate-copolymer-microparticles
2020-09-18T04:24:24Z,Lanreotide Autogel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-long-acting-aqueous-gel
2020-09-18T04:24:24Z,lanreotide long-acting aqueous gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-long-acting-aqueous-gel
2020-09-18T04:24:24Z,lapatinib ditosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapatinib-ditosylate
2020-09-18T04:24:24Z,lapuleucel-T,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapuleucel-t
2020-09-18T04:24:24Z,Laradopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa
2020-09-18T04:24:24Z,largetrifoliolious bugbane rhizome supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/largetrifoliolious-bugbane-rhizome-supplement
2020-09-18T04:24:24Z,Larodopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa
2020-09-18T04:24:24Z,laromustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine
2020-09-18T04:24:24Z,larotaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotaxel
2020-09-18T04:24:24Z,larotinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801495
2020-09-18T04:24:24Z,larotrectinib sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotrectinib
2020-09-18T04:24:24Z,Lasix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide
2020-09-18T04:24:24Z,Laudicon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride
2020-09-18T04:24:24Z,Lazanda,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray
2020-09-18T04:24:24Z,lazertinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792503
2020-09-18T04:24:24Z,lead Pb 212 TCMC-trastuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lead-pb-212-tcmc-trastuzumab
2020-09-18T04:24:24Z,ledipasvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir
2020-09-18T04:24:24Z,ledipasvir mixture with sofosbuvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793914
2020-09-18T04:24:24Z,leflunomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leflunomide
2020-09-18T04:24:24Z,lenalidomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenalidomide
2020-09-18T04:24:24Z,lenapenem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenapenem
2020-09-18T04:24:24Z,lenograstim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenograstim
2020-09-18T04:24:24Z,Lenti-D/ABCD1-transduced autologous hematopoietic stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenti-d-abcd1-transduced-autologous-hematopoietic-stem-cells
2020-09-18T04:24:24Z,LentiGlobin BB305 Drug Product,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-beta-at87q-globin-gene-transduced-cd34-positive-cells
2020-09-18T04:24:24Z,lentivirus vector CCR5 shRNA/TRIM5alpha/TAR decoy-transduced autologous CD34-positive hematopoietic progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782403
2020-09-18T04:24:24Z,lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/730576
2020-09-18T04:24:24Z,Lenvima,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenvatinib-mesylate
2020-09-18T04:24:24Z,lenzilumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenzilumab
2020-09-18T04:24:24Z,LEP-ETU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-paclitaxel
2020-09-18T04:24:24Z,lepirudin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lepirudin
2020-09-18T04:24:24Z,leridistim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leridistim
2020-09-18T04:24:24Z,lerisetron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lerisetron
2020-09-18T04:24:24Z,leronlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ccr5-monoclonal-antibody-pro-140
2020-09-18T04:24:24Z,Lescol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvastatin-sodium
2020-09-18T04:24:24Z,Lessina,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,lestaurtinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lestaurtinib
2020-09-18T04:24:24Z,letermovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letermovir
2020-09-18T04:24:24Z,letrozole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole
2020-09-18T04:24:24Z,letrozole/palbociclib regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole-palbociclib-regimen
2020-09-18T04:24:24Z,leucine-enhanced essential amino acid dietary supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucine-enhanced-essential-amino-acid-dietary-supplement
2020-09-18T04:24:24Z,leucovorin calcium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium
2020-09-18T04:24:24Z,leukemic apoptotic corpse-pulsed autologous dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leukemic-apoptotic-corpse-pulsed-autologous-dendritic-cells
2020-09-18T04:24:24Z,Leukeran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorambucil
2020-09-18T04:24:24Z,Leukine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim
2020-09-18T04:24:24Z,leuprolide acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate
2020-09-18T04:24:24Z,Leuvectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-plasmid-dna-lipid-complex
2020-09-18T04:24:24Z,levamisole hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride
2020-09-18T04:24:24Z,Levaquin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levofloxacin
2020-09-18T04:24:24Z,levetiracetam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levetiracetam
2020-09-18T04:24:24Z,Levitra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vardenafil-hydrochloride
2020-09-18T04:24:24Z,Levlite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,levobupivacaine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levobupivacaine-hydrochloride
2020-09-18T04:24:24Z,levocarnitine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocarnitine
2020-09-18T04:24:24Z,levocetirizine dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocetirizine-dihydrochloride
2020-09-18T04:24:24Z,levodopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa
2020-09-18T04:24:24Z,levofloxacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levofloxacin
2020-09-18T04:24:24Z,levoketoconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole
2020-09-18T04:24:24Z,levoleucovorin calcium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoleucovorin-calcium
2020-09-18T04:24:24Z,levonantradol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonantradol
2020-09-18T04:24:24Z,levonorgestrel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel
2020-09-18T04:24:24Z,levonorgestrel-releasing intrauterine system,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel-releasing-intrauterine-system
2020-09-18T04:24:24Z,Levopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa
2020-09-18T04:24:24Z,Levora,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,levothyroxine sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/39298
2020-09-18T04:24:24Z,levothyroxine sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levothyroxine-sodium
2020-09-18T04:24:24Z,Levoxyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levothyroxine-sodium
2020-09-18T04:24:24Z,Levulan Kerastick,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminolevulinic-acid-hydrochloride
2020-09-18T04:24:24Z,Lexapro,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/escitalopram-oxalate
2020-09-18T04:24:24Z,lexatumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexatumumab
2020-09-18T04:24:24Z,lexibulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexibulin
2020-09-18T04:24:24Z,Lexiscan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regadenoson
2020-09-18T04:24:24Z,Lialda,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine
2020-09-18T04:24:24Z,liarozole fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liarozole-fumarate
2020-09-18T04:24:24Z,Libtayo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-regn2810
2020-09-18T04:24:24Z,licartin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licartin
2020-09-18T04:24:24Z,licochalcone A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792490
2020-09-18T04:24:24Z,licogliflozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792743
2020-09-18T04:24:24Z,licorice root extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licorice-root-extract
2020-09-18T04:24:24Z,Lidex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream
2020-09-18T04:24:24Z,lidocaine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride
2020-09-18T04:24:24Z,lidocaine hydrochloride ophthalmic gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride-ophthalmic-gel
2020-09-18T04:24:24Z,lidocaine mixture with tribenoside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801443
2020-09-18T04:24:24Z,lidocaine patch 5%,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-patch-5pct
2020-09-18T04:24:24Z,lidocaine topical,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793948
2020-09-18T04:24:24Z,Lidoderm,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-patch-5pct
2020-09-18T04:24:24Z,light-activated AU-011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-activated-au-011
2020-09-18T04:24:24Z,light-emitting oncolytic vaccinia virus GL-ONC1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/light-emitting-oncolytic-vaccinia-virus-gl-onc1
2020-09-18T04:24:24Z,lilotomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800126
2020-09-18T04:24:24Z,limonene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/limonene
2020-09-18T04:24:24Z,linaclotide acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linaclotide-acetate
2020-09-18T04:24:24Z,linagliptin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793591
2020-09-18T04:24:24Z,linezolid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linezolid
2020-09-18T04:24:24Z,linifanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linifanib
2020-09-18T04:24:24Z,linoleyl carbonate-paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linoleyl-carbonate-paclitaxel
2020-09-18T04:24:24Z,Linomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roquinimex
2020-09-18T04:24:24Z,linsitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linsitinib
2020-09-18T04:24:24Z,lintuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lintuzumab
2020-09-18T04:24:24Z,Linzess,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linaclotide-acetate
2020-09-18T04:24:24Z,Lioresal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen
2020-09-18T04:24:24Z,liothyronine sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine-sodium
2020-09-18T04:24:24Z,lipegfilgrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lipegfilgrastim
2020-09-18T04:24:24Z,lipid nanoparticle encapsulated mRNAs encoding human IL-12A/IL-12B MEDI-1191,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798427
2020-09-18T04:24:24Z,lipid nanoparticle encapsulating mRNAs encoding human OX40L/IL-23/IL-36gamma mRNA-2752,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796816
2020-09-18T04:24:24Z,lipid nanoparticle-encapsulated OX40L mRNA-2416,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lipid-nanoparticle-encapsulated-ox40l-mrna-2416
2020-09-18T04:24:24Z,Lipiodol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil
2020-09-18T04:24:24Z,Lipitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atorvastatin-calcium
2020-09-18T04:24:24Z,Lipo-Hepin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heparin-sodium
2020-09-18T04:24:24Z,Lipo-Lutin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone
2020-09-18T04:24:24Z,lipopolysaccharide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lipopolysaccharide
2020-09-18T04:24:24Z,liposomal alpha galactosylceramide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799312
2020-09-18T04:24:24Z,liposomal amphotericin B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-amphotericin-b
2020-09-18T04:24:24Z,liposomal annamycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-annamycin
2020-09-18T04:24:24Z,liposomal belotecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-belotecan
2020-09-18T04:24:24Z,liposomal c-raf antisense oligonucleotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-c-raf-antisense-oligonucleotide
2020-09-18T04:24:24Z,liposomal cisplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cisplatin
2020-09-18T04:24:24Z,liposomal curcumin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-curcumin
2020-09-18T04:24:24Z,liposomal daunorubicin citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-daunorubicin-citrate
2020-09-18T04:24:24Z,liposomal docetaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-docetaxel
2020-09-18T04:24:24Z,liposomal eribulin mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-eribulin-mesylate
2020-09-18T04:24:24Z,liposomal HPV-16 E6/E7 multipeptide vaccine PDS0101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-hpv-16-e6-e7-multipeptide-vaccine-pds0101
2020-09-18T04:24:24Z,liposomal interleukin-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-interleukin-2
2020-09-18T04:24:24Z,liposomal lurtotecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-lurtotecan
2020-09-18T04:24:24Z,liposomal mitoxantrone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-mitoxantrone-hydrochloride
2020-09-18T04:24:24Z,liposomal MUC1/PET-lipid A vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-muc1-pet-lipid-a-vaccine
2020-09-18T04:24:24Z,liposomal NDDP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-nddp
2020-09-18T04:24:24Z,liposomal oxaliplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-oxaliplatin
2020-09-18T04:24:24Z,liposomal paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-paclitaxel
2020-09-18T04:24:24Z,liposomal rhenium Re 186,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-rhenium-re-186
2020-09-18T04:24:24Z,liposomal SN-38,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-sn-38
2020-09-18T04:24:24Z,liposomal T4N5 lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-t4n5-lotion
2020-09-18T04:24:24Z,liposomal topotecan FF-10850,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799933
2020-09-18T04:24:24Z,liposomal topotecan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-hydrochloride
2020-09-18T04:24:24Z,liposomal tretinoin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-tretinoin
2020-09-18T04:24:24Z,liposomal vinorelbine tartrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-vinorelbine-tartrate
2020-09-18T04:24:24Z,liposome-encapsulated doxorubicin citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-doxorubicin-citrate
2020-09-18T04:24:24Z,liposome-encapsulated miR-34 mimic MRX34,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-mir-34-mimic-mrx34
2020-09-18T04:24:24Z,liposome-encapsulated RB94 plasmid DNA gene therapy agent SGT-94,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-rb94-plasmid-dna-gene-therapy-agent-sgt-94
2020-09-18T04:24:24Z,liposome-encapsulated recombinant human enzyme Cu/Zn superoxide-dismutase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-recombinant-human-enzyme-cu-zn-superoxide-dismutase
2020-09-18T04:24:24Z,liposome-encapsulated TAAs mRNA vaccine W_ova1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802273
2020-09-18T04:24:24Z,liposome-incorporated Grb2 antisense oligodeoxynucleotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-incorporated-grb2-antisense-oligodeoxynucleotide
2020-09-18T04:24:24Z,Lipotecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-analogue-tlc388
2020-09-18T04:24:24Z,Liquamar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenprocoumon
2020-09-18T04:24:24Z,liraglutide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792738
2020-09-18T04:24:24Z,liraglutide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liraglutide
2020-09-18T04:24:24Z,lirilumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lirilumab
2020-09-18T04:24:24Z,lisdexamfetamine dimesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisdexamfetamine-dimesylate
2020-09-18T04:24:24Z,lisinopril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisinopril
2020-09-18T04:24:24Z,lisocabtagene maraleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/778386
2020-09-18T04:24:24Z,listeria monocytogenes-LLO-PSA ADXS31-142,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/listeria-monocytogenes-llo-psa-adxs31-142
2020-09-18T04:24:24Z,Lithane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate
2020-09-18T04:24:24Z,lithium carbonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate
2020-09-18T04:24:24Z,Lithobid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate
2020-09-18T04:24:24Z,Lithonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate
2020-09-18T04:24:24Z,Lithotabs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lithium-carbonate
2020-09-18T04:24:24Z,litronesib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/litronesib
2020-09-18T04:24:24Z,live attenuated measles virus vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-measles-virus-vaccine
2020-09-18T04:24:24Z,live freeze-dried lactic acid bacteria probiotic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-freeze-dried-lactic-acid-bacteria-probiotic
2020-09-18T04:24:24Z,live-attenuated double-deleted Listeria monocytogenes bacteria JNJ-64041809,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-double-deleted-listeria-monocytogenes-bacteria-jnj-64041809
2020-09-18T04:24:24Z,live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-monocytogenes-cancer-vaccine-adxs11-001
2020-09-18T04:24:24Z,live-attenuated Listeria monocytogenes encoding EGFRvIII-mesothelin vaccine JNJ-64041757,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777270
2020-09-18T04:24:24Z,live-attenuated Listeria monocytogenes encoding EGFRvIII-NY-ESO-1 vaccine ADU-623,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/754227
2020-09-18T04:24:24Z,live-attenuated listeria-encoding human mesothelin vaccine CRS-207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-encoding-human-mesothelin-vaccine-crs-207
2020-09-18T04:24:24Z,liver X receptor beta agonist RGX-104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liver-x-receptor-beta-agonist-rgx-104
2020-09-18T04:24:24Z,Lm-tLLO-neoantigens vaccine ADXS-NEO,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793901
2020-09-18T04:24:24Z,LMB-1 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-1-immunotoxin
2020-09-18T04:24:24Z,LMB-2 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-2-immunotoxin
2020-09-18T04:24:24Z,LMB-7 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-7-immunotoxin
2020-09-18T04:24:24Z,LMB-9 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-9-immunotoxin
2020-09-18T04:24:24Z,LmddA-LLO-chHER2 fusion protein-secreting live-attenuated Listeria cancer vaccine ADXS31-164,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770190
2020-09-18T04:24:24Z,LMP-2:340-349 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp-2340-349-peptide-vaccine
2020-09-18T04:24:24Z,LMP-2:419-427 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp-2419-427-peptide-vaccine
2020-09-18T04:24:24Z,LMP/BARF1/ EBNA1-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp-barf1--ebna1-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,LMP1-specific chimeric antigen receptor-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp1-specific-chimeric-antigen-receptor-expressing-t-lymphocytes
2020-09-18T04:24:24Z,LMP2-specific T-cell receptor-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801627
2020-09-18T04:24:24Z,LMP2a-specific cytotoxic T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp2a-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,LMP7 inhibitor M3258,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800618
2020-09-18T04:24:24Z,lobaplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobaplatin
2020-09-18T04:24:24Z,lobradimil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobradimil
2020-09-18T04:24:24Z,Lodine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etodolac
2020-09-18T04:24:24Z,lometrexol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lometrexol
2020-09-18T04:24:24Z,lomustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine
2020-09-18T04:24:24Z,lonafarnib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonafarnib
2020-09-18T04:24:24Z,lonaprisan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonaprisan
2020-09-18T04:24:24Z,loncastuximab tesirine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adct-402
2020-09-18T04:24:24Z,long peptide vaccine 7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-peptide-vaccine-7
2020-09-18T04:24:24Z,long-acting release pasireotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-release-pasireotide
2020-09-18T04:24:24Z,Lonsurf,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine-and-tipiracil-hydrochloride
2020-09-18T04:24:24Z,loperamide hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loperamide-hydrochloride
2020-09-18T04:24:24Z,Lopid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemfibrozil
2020-09-18T04:24:24Z,lopinavir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lopinavir
2020-09-18T04:24:24Z,Loprox Lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-olamine-lotion
2020-09-18T04:24:24Z,Lopurin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium
2020-09-18T04:24:24Z,loratadine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loratadine
2020-09-18T04:24:24Z,lorazepam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorazepam
2020-09-18T04:24:24Z,Lorbrena,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorlatinib
2020-09-18T04:24:24Z,Lorcet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocodone-acetaminophen
2020-09-18T04:24:24Z,lorlatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorlatinib
2020-09-18T04:24:24Z,lorvotuzumab mertansine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorvotuzumab-mertansine
2020-09-18T04:24:24Z,losartan potassium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losartan-potassium
2020-09-18T04:24:24Z,Lotensin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benazepril-hydrochloride
2020-09-18T04:24:24Z,Lotrimin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole
2020-09-18T04:24:24Z,lovastatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lovastatin
2020-09-18T04:24:24Z,Lovaxin C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-monocytogenes-cancer-vaccine-adxs11-001
2020-09-18T04:24:24Z,Lovaza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794285
2020-09-18T04:24:24Z,Lovenox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoxaparin-sodium
2020-09-18T04:24:24Z,LOXL2 inhibitor PAT-1251,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800789
2020-09-18T04:24:24Z,Lozanoc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole
2020-09-18T04:24:24Z,LRP-1-targeted peptide-drug conjugate GRN1005,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lrp-1-targeted-peptide-drug-conjugate-grn1005
2020-09-18T04:24:24Z,LRP5/6 antagonist BI 905677,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799658
2020-09-18T04:24:24Z,LSD1 inhibitor CC-90011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-cc-90011
2020-09-18T04:24:24Z,LSD1 inhibitor GSK2879552,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-gsk2879552
2020-09-18T04:24:24Z,LSD1 inhibitor IMG-7289,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-img-7289
2020-09-18T04:24:24Z,LSD1 inhibitor RO7051790,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-ro7051790
2020-09-18T04:24:24Z,LSD1 inhibitor SYHA1807,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801980
2020-09-18T04:24:24Z,lubiprostone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lubiprostone
2020-09-18T04:24:24Z,Lucanix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belagenpumatucel-l
2020-09-18T04:24:24Z,lucanthone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucanthone
2020-09-18T04:24:24Z,lucatumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucatumumab
2020-09-18T04:24:24Z,Lucentis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranibizumab
2020-09-18T04:24:24Z,lucitanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucitanib
2020-09-18T04:24:24Z,Lucorteum Sol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone
2020-09-23T07:08:11Z,Ludiomil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802781
2020-09-18T04:24:24Z,Lugol's solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lugols-solution
2020-09-18T04:24:24Z,Lumason,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802160
2020-09-18T04:24:24Z,Lumirem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxsil-oral-suspension
2020-09-18T04:24:24Z,Lumitene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-carotene
2020-09-18T04:24:24Z,Lumoxiti,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox
2020-09-18T04:24:24Z,Lunesta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eszopiclone
2020-09-18T04:24:24Z,lung tumor-associated antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-tumor-associated-antigen
2020-09-18T04:24:24Z,lung-targeted immunomodulator QBKPN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-targeted-immunomodulator-qbkpn
2020-09-18T04:24:24Z,Lupron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate
2020-09-18T04:24:24Z,Lupron Depot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate
2020-09-18T04:24:24Z,lurbinectedin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurbinectedin
2020-09-18T04:24:24Z,lurtotecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan
2020-09-18T04:24:24Z,luspatercept-aamt,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luspatercept
2020-09-18T04:24:24Z,Lutathera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tate
2020-09-18T04:24:24Z,Luteohormone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone
2020-09-18T04:24:24Z,luteolin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793029
2020-09-18T04:24:24Z,lutetium Lu 177 anti-CA19-9 monoclonal antibody 5B1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-anti-ca19-9-monoclonal-antibody-5b1
2020-09-18T04:24:24Z,lutetium Lu 177 DOTA-biotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-biotin
2020-09-18T04:24:24Z,lutetium Lu 177 DOTA-N3-CTT1403,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797172
2020-09-18T04:24:24Z,lutetium Lu 177 DOTA-tetulomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tetulomab
2020-09-18T04:24:24Z,lutetium Lu 177 monoclonal antibody J591,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-monoclonal-antibody-j591
2020-09-18T04:24:24Z,lutetium Lu 177 PP-F11N,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-pp-f11n
2020-09-18T04:24:24Z,matuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matuzumab
2020-09-18T04:24:24Z,lutetium Lu 177 satoreotide tetraxetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-jr11
2020-09-18T04:24:24Z,lutetium Lu 177-capromab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-capromab
2020-09-18T04:24:24Z,lutetium Lu 177-DOTA-di-HSG peptide IMP-288,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-di-hsg-peptide-imp-288
2020-09-18T04:24:24Z,lutetium Lu 177-DOTA-EB-TATE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794348
2020-09-18T04:24:24Z,lutetium Lu 177-DOTA-IPN01087,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796889
2020-09-18T04:24:24Z,lutetium Lu 177-DOTA-octreotate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-octreotate
2020-09-18T04:24:24Z,lutetium Lu 177-dotatate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-tate
2020-09-18T04:24:24Z,lutetium Lu 177-DTPA-omburtamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802279
2020-09-18T04:24:24Z,lutetium LU 177-edotreotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-edotreotide
2020-09-18T04:24:24Z,lutetium Lu 177-NeoB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797487
2020-09-18T04:24:24Z,lutetium Lu 177-PSMA-617,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792497
2020-09-18T04:24:24Z,lutetium Lu-177 girentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-girentuximab
2020-09-18T04:24:24Z,lutetium Lu-177 PSMA-R2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793409
2020-09-18T04:24:24Z,Lutex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium
2020-09-18T04:24:24Z,Lutrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium
2020-09-18T04:24:24Z,Luvox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluvoxamine-maleate
2020-09-18T04:24:24Z,LV.IL-2/B7.1-transduced AML blast vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lvil-2-b71-transduced-aml-blast-vaccine
2020-09-18T04:24:24Z,LY6K/VEGFR1/VEGFR2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ly6k-vegfr1-vegfr2-multipeptide-vaccine
2020-09-18T04:24:24Z,Lyc-O-Mato,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lycopene
2020-09-18T04:24:24Z,lycopene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lycopene
2020-09-18T04:24:24Z,Lymphazurin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isosulfan-blue
2020-09-18T04:24:24Z,LymphoCide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab
2020-09-18T04:24:24Z,lymphokine-activated killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lymphokine-activated-killer-cells
2020-09-18T04:24:24Z,lymphoma TAA-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lymphoma-taa-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,Lymphoseek,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-tilmanocept
2020-09-18T04:24:24Z,LymphoStat-B antibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belimumab
2020-09-18T04:24:24Z,Lynparza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaparib
2020-09-18T04:24:24Z,lyophilized black raspberry lozenge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyophilized-black-raspberry-lozenge
2020-09-18T04:24:24Z,lyophilized black raspberry saliva substitute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyophilized-black-raspberry-saliva-substitute
2020-09-18T04:24:24Z,Lyrica,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pregabalin
2020-09-18T04:24:24Z,lysine-specific demethylase 1 inhibitor INCB059872,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lysine-specific-demethylase-1-inhibitor-incb059872
2020-09-18T04:24:24Z,lyso-thermosensitive liposomal doxorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposomal-doxorubicin
2020-09-18T04:24:24Z,Lysodren,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane
2020-09-18T04:24:24Z,m-azidopyrimethamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/m-azidopyrimethamine
2020-09-18T04:24:24Z,M87o-transduced CD34+ peripheral blood stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/m87o-transduced-cd34-peripheral-blood-stem-cells
2020-09-18T04:24:24Z,Ma Zi Ren Wan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ma-zi-ren-wan
2020-09-20T05:26:50Z,Maackia amurensis seed lectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802340
2020-09-18T04:24:24Z,Maalox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide-aluminum-hydroxide
2020-09-18T04:24:24Z,macimorelin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macimorelin
2020-09-18T04:24:24Z,macitentan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macitentan
2020-09-18T04:24:24Z,macrocycle-bridged STING agonist E7766,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799924
2020-09-18T04:24:24Z,macrogol 3350-based oral osmotic laxative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrogol-3350-based-oral-osmotic-laxative
2020-09-18T04:24:24Z,Maekmoondong-tang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794323
2020-09-18T04:24:24Z,mafosfamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mafosfamide
2020-09-18T04:24:24Z,MAG-Tn3/AS15 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mag-tn3-as15-vaccine
2020-09-18T04:24:24Z,MAGE-10.A2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-10a2
2020-09-18T04:24:24Z,MAGE-3.A1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-3a1-peptide-vaccine
2020-09-18T04:24:24Z,"MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a1-her-2-neu-fbp-peptides-ovarian-cancer-vaccine
2020-09-18T04:24:24Z,"MAGE-A1, MAGE-A3, NY-ESO-1 peptides vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a1-mage-a3-ny-eso-1-peptides-vaccine
2020-09-18T04:24:24Z,MAGE-A3 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-peptide-vaccine
2020-09-18T04:24:24Z,MAGE-A3 reactive T cell receptor-transduced autologous T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-reactive-t-cell-receptor-transduced-autologous-t-cells
2020-09-18T04:24:24Z,MAGE-A3-expressing adenovirus type5 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type5-vaccine
2020-09-18T04:24:24Z,MAGE-A3/HPV 16 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-hpv-16-peptide-vaccine
2020-09-18T04:24:24Z,MAGE-A4-specific TCR gene-transduced T lymphocytes TBI-1201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a4-specific-tcr-gene-transduced-t-lymphocytes-tbi-1201
2020-09-18T04:24:24Z,magnesium citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-citrate
2020-09-18T04:24:24Z,magnesium glycinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793899
2020-09-18T04:24:24Z,magnesium hydroxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide
2020-09-18T04:24:24Z,magnesium hydroxide/aluminum hydroxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide-aluminum-hydroxide
2020-09-18T04:24:24Z,magnesium isoglycyrrhizinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-isoglycyrrhizinate
2020-09-18T04:24:24Z,magnesium L-threonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-l-threonate
2020-09-18T04:24:24Z,magnesium oxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-oxide
2020-09-18T04:24:24Z,magnesium valproate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-valproate
2020-09-18T04:24:24Z,magnesium-based bone void filler,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794178
2020-09-18T04:24:24Z,magnesium-rich mineral water,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792733
2020-09-18T04:24:24Z,Magnevist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine
2020-09-18T04:24:24Z,magrolimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-hu5f9-g4
2020-09-18T04:24:24Z,Mai Dong,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mai-dong
2020-09-18T04:24:24Z,Maitake mushroom extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maitake-mushroom-extract
2020-09-18T04:24:24Z,Makarol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Maldex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin
2020-09-18T04:24:24Z,Maldrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin
2020-09-18T04:24:24Z,malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malignant-glioma-tumor-lysate-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,MALT1 inhibitor JNJ-67856633,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798315
2020-09-18T04:24:24Z,maltodextrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin
2020-09-18T04:24:24Z,maltose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltose
2020-09-18T04:24:24Z,Malva sylvestris/Alcea digitata herbal compound,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malva-sylvestris-alcea-digitata-herbal-compound
2020-09-18T04:24:24Z,mammaglobin-A DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mammaglobin-a-dna-vaccine
2020-09-18T04:24:24Z,mangafodipir trisodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mangafodipir-trisodium
2020-09-18T04:24:24Z,manganese chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801788
2020-09-18T04:24:24Z,manganese/L-alanine/vitamin D3-containing contrast agent formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800686
2020-09-18T04:24:24Z,Mangoral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800686
2020-09-18T04:24:24Z,mannitol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannitol
2020-09-18T04:24:24Z,Manuka honey,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manuka-honey
2020-09-18T04:24:24Z,mapatumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mapatumumab
2020-09-23T07:08:11Z,maprotiline hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802781
2020-09-18T04:24:24Z,Maraba oncolytic virus expressing mutant HPV E6/E7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797163
2020-09-18T04:24:24Z,maraviroc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraviroc
2020-09-18T04:24:24Z,Marcaine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride
2020-09-18T04:24:24Z,marcellomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marcellomycin
2020-09-18T04:24:24Z,margetuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/margetuximab
2020-09-18T04:24:24Z,marijuana,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marijuana
2020-09-18T04:24:24Z,marimastat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marimastat
2020-09-18T04:24:24Z,Marinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol
2020-09-18T04:24:24Z,marizomib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marizomib
2020-09-18T04:24:24Z,Marqibo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate-liposome
2020-09-18T04:24:24Z,MART-1 antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen
2020-09-18T04:24:24Z,MART-1 reactive CD8+ lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-reactive-cd8-lymphocytes
2020-09-18T04:24:24Z,MART-1:26-35(27L) peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-126-3527l-peptide-vaccine
2020-09-18T04:24:24Z,MART-1:27-35 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-127-35-peptide-vaccine
2020-09-18T04:24:24Z,MART-1/gp100/Tyrosinase/MAGE-A3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/750374
2020-09-18T04:24:24Z,masitinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masitinib-mesylate
2020-09-18T04:24:24Z,masoprocol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol
2020-09-18T04:24:24Z,mast cell stabilizer TF002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mast-cell-stabilizer-tf002
2020-09-18T04:24:24Z,MAT2A inhibitor AG-270,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793947
2020-09-18T04:24:24Z,Matricaria recutita gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matricaria-recutita-gel
2020-09-18T04:24:24Z,Matricaria recutita topical infusion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matricaria-recutita-topical-infusion
2020-09-18T04:24:24Z,Matulane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride
2020-09-18T04:24:24Z,mavorixafor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-x4p-001
2020-09-18T04:24:24Z,Mavyret,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798328
2020-09-18T04:24:24Z,Maxalt,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rizatriptan-benzoate
2020-09-18T04:24:24Z,Maxipime,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefepime-hydrochloride
2020-09-18T04:24:24Z,maytansine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maytansine
2020-09-18T04:24:24Z,MC-Glucan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran
2020-09-18T04:24:24Z,MCL-1 inhibitor ABBV-467,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802326
2020-09-18T04:24:24Z,MCL-1 Inhibitor AMG 176,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-amg-176
2020-09-18T04:24:24Z,MCL-1 inhibitor AMG 397,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795697
2020-09-18T04:24:24Z,Mcl-1 inhibitor AZD5991,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-azd5991
2020-09-18T04:24:24Z,Mcl-1 inhibitor MIK665,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-mik665
2020-09-18T04:24:24Z,MCPyV TAg-specific polyclonal autologous CD8-positive T cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcpyv-tag-specific-polyclonal-autologous-cd8-positive-t-cell-vaccine
2020-09-18T04:24:24Z,MCT/LCT lipid emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-lipid-emulsion
2020-09-18T04:24:24Z,MCT/LCT/fish oil omega-3 fatty triglyceride lipid emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-fish-oil-omega-3-fatty-triglyceride-lipid-emulsion
2020-09-18T04:24:24Z,MDM2 antagonist ASTX295,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798989
2020-09-18T04:24:24Z,MDM2 antagonist RO5045337,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-ro5045337
2020-09-18T04:24:24Z,MDM2 antagonist RO6839921,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-ro6839921
2020-09-18T04:24:24Z,MDM2 inhibitor BI 907828,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795735
2020-09-18T04:24:24Z,MDM2 inhibitor KRT-232,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795802
2020-09-18T04:24:24Z,MDM2 inhibitor KRT-232,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-amg-232
2020-09-18T04:24:24Z,MDM2/MDMX inhibitor ALRN-6924,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-mdmx-inhibitor-alrn-6924
2020-09-18T04:24:24Z,MDR modulator CBT-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdr-modulator-cbt-1
2020-09-18T04:24:24Z,measles/mumps/rubella vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/measles-mumps-rubella-vaccine
2020-09-18T04:24:24Z,Measurin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylsalicylic-acid
2020-09-18T04:24:24Z,mebendazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mebendazole
2020-09-18T04:24:24Z,mecapegfilgrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802310
2020-09-18T04:24:24Z,mechlorethamine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride
2020-09-18T04:24:24Z,mechlorethamine hydrochloride gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride-gel
2020-09-18T04:24:24Z,Meclan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclocycline-sulfosalicylate
2020-09-18T04:24:24Z,meclocycline sulfosalicylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclocycline-sulfosalicylate
2020-09-18T04:24:24Z,meclofenamate sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclofenamate-sodium
2020-09-18T04:24:24Z,Meclomen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meclofenamate-sodium
2020-09-18T04:24:24Z,Medihoney™,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manuka-honey
2020-09-18T04:24:24Z,medroxyprogesterone acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate
2020-09-18T04:24:24Z,mefloquine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mefloquine
2020-09-18T04:24:24Z,Mefoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefoxitin-sodium
2020-09-18T04:24:24Z,megestrol acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate
2020-09-18T04:24:24Z,MEK 1/2 inhibitor AS703988/MSC2015103B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-as703988-msc2015103b
2020-09-18T04:24:24Z,MEK 1/2 inhibitor FCN-159,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801657
2020-09-18T04:24:24Z,MEK inhibitor AZD8330,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-azd8330
2020-09-18T04:24:24Z,MEK inhibitor CS3006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795024
2020-09-18T04:24:24Z,MEK inhibitor GDC-0623,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-gdc-0623
2020-09-18T04:24:24Z,MEK inhibitor HL-085,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801764
2020-09-18T04:24:24Z,MEK inhibitor RO4987655,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-ro4987655
2020-09-18T04:24:24Z,MEK inhibitor SHR 7390,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793097
2020-09-18T04:24:24Z,MEK inhibitor TAK-733,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-tak-733
2020-09-18T04:24:24Z,MEK inhibitor WX-554,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-wx-554
2020-09-18T04:24:24Z,MEK-1/MEKK-1 inhibitor E6201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-mekk-1-inhibitor-e6201
2020-09-18T04:24:24Z,MEK/Aurora kinase dual inhibitor BI 847325,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-aurora-kinase-dual-inhibitor-bi-847325
2020-09-18T04:24:24Z,Mekinist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trametinib
2020-09-18T04:24:24Z,Mektovi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib
2020-09-18T04:24:24Z,Melan-A VLP vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melan-a-vlp-vaccine
2020-09-18T04:24:24Z,Melan-A/MAGE-3.DP4 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melan-a-mage-3dp4-peptide-vaccine
2020-09-18T04:24:24Z,melanoma helper peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melanoma-helper-peptide-vaccine
2020-09-18T04:24:24Z,NAMPT Inhibitor OT-82,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798968
2020-09-18T04:24:24Z,melanoma TRP2 CTL epitope vaccine SCIB1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melanoma-trp2-ctl-epitope-vaccine-scib1
2020-09-18T04:24:24Z,MELITAC 12.1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melitac-121-peptide-vaccine
2020-09-18T04:24:24Z,MELK inhibitor OTS167,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melk-inhibitor-ots167
2020-09-18T04:24:24Z,Mellaril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioridazine-hydrochloride
2020-09-18T04:24:24Z,meloxicam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam
2020-09-18T04:24:24Z,melphalan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan
2020-09-18T04:24:24Z,melphalan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride
2020-09-18T04:24:24Z,melphalan hydrochloride/sulfobutyl ether beta-cyclodextrin complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride-sulfobutyl-ether-beta-cyclodextrin-complex
2020-09-18T04:24:24Z,melphalan-flufenamide prodrug,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide-prodrug
2020-09-18T04:24:24Z,memantine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/memantine-hydrochloride
2020-09-18T04:24:24Z,membrane-bound interleukin-21-expanded haploidentical natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/membrane-bound-interleukin-21-expanded-haploidentical-natural-killer-cells
2020-09-18T04:24:24Z,membrane-disrupting peptide EP-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/membrane-disrupting-peptide-ep-100
2020-09-18T04:24:24Z,menadione topical lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menadione-topical-lotion
2020-09-18T04:24:24Z,menatetrenone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menatetrenone
2020-09-18T04:24:24Z,menin-MLL interaction inhibitor KO 539,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799439
2020-09-18T04:24:24Z,menin-MLL interaction inhibitor SNDX-5613,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800199
2020-09-18T04:24:24Z,menogaril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menogaril
2020-09-18T04:24:24Z,Menogarol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menogaril
2020-09-18T04:24:24Z,meperidine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meperidine-hydrochloride
2020-09-18T04:24:24Z,mepivacaine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride
2020-09-18T04:24:24Z,mepolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796922
2020-09-18T04:24:24Z,mercaptopurine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine
2020-09-18T04:24:24Z,mercaptopurine oral suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-oral-suspension
2020-09-18T04:24:24Z,mercaptopurine tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-tablet
2020-09-18T04:24:24Z,merestinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/merestinib
2020-09-18T04:24:24Z,meropenem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meropenem
2020-09-18T04:24:24Z,Merrem I.V.,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meropenem
2020-09-18T04:24:24Z,mesalamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine
2020-09-18T04:24:24Z,mesenchymal stromal cells-derived exosomes with KRAS G12D siRNA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794048
2020-09-18T04:24:24Z,mesna,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna
2020-09-18T04:24:24Z,Mesnex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesna
2020-09-18T04:24:24Z,mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/732671
2020-09-18T04:24:24Z,mesothelin/CD3e tri-specific T-cell activating construct HPN536,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799094
2020-09-18T04:24:24Z,mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelioma-tumor-lysate-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,MET kinase inhibitor OMO-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792712
2020-09-18T04:24:24Z,MET receptor tyrosine kinase inhibitor SGX523,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-receptor-tyrosine-kinase-inhibitor-sgx523
2020-09-18T04:24:24Z,Met tyrosine kinase inhibitor BMS-777607,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-bms-777607
2020-09-18T04:24:24Z,MET tyrosine kinase inhibitor EMD 1204831,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-emd-1204831
2020-09-18T04:24:24Z,MET tyrosine kinase inhibitor PF-04217903,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-pf-04217903
2020-09-18T04:24:24Z,MET tyrosine kinase inhibitor SAR125844,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-sar125844
2020-09-18T04:24:24Z,MET x MET bispecific antibody REGN5093,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800420
2020-09-18T04:24:24Z,meta-fluorine F 18 fluorobenzylguanidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meta-fluorine-f-18-fluorobenzylguanidine
2020-09-18T04:24:24Z,metahexamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metahexamide
2020-09-18T04:24:24Z,MetAP2 inhibitor APL-1202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798664
2020-09-18T04:24:24Z,MetAP2 inhibitor SDX-7320,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metap2-inhibitor-sdx-7320
2020-09-18T04:24:24Z,metarrestin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800687
2020-09-18T04:24:24Z,Metastat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/incyclinide
2020-09-18T04:24:24Z,Metastron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/strontium-chloride-sr-89
2020-09-18T04:24:24Z,metatinib tromethamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metatinib-tromethamine
2020-09-18T04:24:24Z,metformide hydrochloride/pioglitazone hydrochloride extended-release tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformide-hydrochloride-pioglitazone-hydrochloride-extended-release-tablet
2020-09-18T04:24:24Z,metformin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride
2020-09-18T04:24:24Z,methadone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride
2020-09-18T04:24:24Z,Methadose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methadone-hydrochloride
2020-09-18T04:24:24Z,methanol extraction residue of BCG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methanol-extraction-residue-of-bcg
2020-09-18T04:24:24Z,methazolamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methazolamide
2020-09-18T04:24:24Z,methionine aminopeptidase 2 inhibitor M8891,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methionine-aminopeptidase-2-inhibitor-m8891
2020-09-18T04:24:24Z,methionine C 11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methionine-c-11
2020-09-18T04:24:24Z,Methosarb,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calusterone
2020-09-18T04:24:24Z,methotrexate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate
2020-09-18T04:24:24Z,methotrexate-e therapeutic implant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate-e-therapeutic-implant
2020-09-18T04:24:24Z,methotrexate-encapsulating autologous tumor-derived microparticles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate-encapsulating-autologous-tumor-derived-microparticles
2020-09-18T04:24:24Z,methoxsalen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen
2020-09-18T04:24:24Z,methoxy polyethylene glycol epoetin beta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxy-polyethylene-glycol-epoetin-beta
2020-09-18T04:24:24Z,methoxyamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxyamine
2020-09-18T04:24:24Z,methoxyflurane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxyflurane
2020-09-18T04:24:24Z,methyl-5-aminolevulinate hydrochloride cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methyl-5-aminolevulinate-hydrochloride-cream
2020-09-18T04:24:24Z,methylcantharidimide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801753
2020-09-18T04:24:24Z,methylene blue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue
2020-09-18T04:24:24Z,methylene dimethane sulfonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-dimethane-sulfonate
2020-09-18T04:24:24Z,methylmercaptopurine riboside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylmercaptopurine-riboside
2020-09-18T04:24:24Z,methylnaltrexone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylnaltrexone
2020-09-18T04:24:24Z,methylnaltrexone bromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylnaltrexone-bromide
2020-09-18T04:24:24Z,methylphenidate hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride
2020-09-18T04:24:24Z,methylprednisolone acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate
2020-09-18T04:24:24Z,methylselenocysteine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylselenocysteine
2020-09-18T04:24:24Z,Meti-derm,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone
2020-09-18T04:24:24Z,metoclopramide hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoclopramide-hydrochloride
2020-09-18T04:24:24Z,metoprine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoprine
2020-09-18T04:24:24Z,metoprolol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoprolol
2020-09-18T04:24:24Z,metronidazole hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride
2020-09-18T04:24:24Z,Metvixia cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methyl-5-aminolevulinate-hydrochloride-cream
2020-09-18T04:24:24Z,metyrosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metyrosine
2020-09-18T04:24:24Z,Mevacor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lovastatin
2020-09-18T04:24:24Z,MG 98,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mg-98
2020-09-18T04:24:24Z,Micafungin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micafungin
2020-09-18T04:24:24Z,micellar nanoparticle-encapsulated cisplatin NC-6004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-cisplatin-nc-6004
2020-09-18T04:24:24Z,micellar nanoparticle-encapsulated epirubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micellar-nanoparticle-encapsulated-epirubicin
2020-09-18T04:24:24Z,Michelia alba leaf oil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797813
2020-09-18T04:24:24Z,micro needle array-doxorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795832
2020-09-18T04:24:24Z,microbial ecosystem therapeutics-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798423
2020-09-18T04:24:24Z,microbiome GEN-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801465
2020-09-18T04:24:24Z,microbiome SER-401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799975
2020-09-18T04:24:24Z,microbiome-derived peptide vaccine EO2401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799761
2020-09-18T04:24:24Z,Microgynon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,Micronase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyburide
2020-09-18T04:24:24Z,micronutrient-fortified probiotic yogurt,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micronutrient-fortified-probiotic-yogurt
2020-09-18T04:24:24Z,microtubule inhibitor SCB01A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-inhibitor-scb01a
2020-09-18T04:24:24Z,microtubule-targeted agent BAL101553,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microtubule-targeted-agent-bal101553
2020-09-18T04:24:24Z,midazolam hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-hydrochloride
2020-09-18T04:24:24Z,midazolam-containing buccal liquid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-containing-buccal-liquid
2020-09-18T04:24:24Z,midostaurin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin
2020-09-18T04:24:24Z,mifamurtide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifamurtide
2020-09-18T04:24:24Z,Mifeprex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifepristone
2020-09-18T04:24:24Z,mifepristone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mifepristone
2020-09-18T04:24:24Z,miglitol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miglitol
2020-09-18T04:24:24Z,MiHA-loaded PD-L1/L2-silenced dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miha-loaded-pd-l1-l2-silenced-dendritic-cell-vaccine
2020-09-18T04:24:24Z,milademetan tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-ds-3032b
2020-09-18T04:24:24Z,milatuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab
2020-09-18T04:24:24Z,milatuzumab-doxorubicin antibody-drug conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab-doxorubicin-antibody-drug-conjugate
2020-09-18T04:24:24Z,milciclib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-trka-inhibitor-pha-848125-ac
2020-09-18T04:24:24Z,Milestrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Milk of Magnesia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide
2020-09-18T04:24:24Z,milk protein-based energy drink,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milk-protein-based-energy-drink
2020-09-18T04:24:24Z,milk thistle,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milk-thistle
2020-09-18T04:24:24Z,milled seed mix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793931
2020-09-18T04:24:24Z,milodistim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milodistim
2020-09-18T04:24:24Z,miltefosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miltefosine
2020-09-18T04:24:24Z,mimotope-P10s-PADRE peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mimotope-p10s-padre-peptide-vaccine
2020-09-18T04:24:24Z,Minnelide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptolide-analogue
2020-09-18T04:24:24Z,Minocin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride
2020-09-18T04:24:24Z,minocycline hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride
2020-09-18T04:24:24Z,minocycline-EDTA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-edta
2020-09-18T04:24:24Z,Mintezol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiabendazole
2020-09-18T04:24:24Z,mipsagargin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mipsagargin
2020-09-18T04:24:24Z,mirabegron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirabegron
2020-09-18T04:24:24Z,Miraluma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi
2020-09-18T04:24:24Z,Mirapex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pramipexole-dihydrochloride
2020-09-18T04:24:24Z,Mirasol-treated allogeneic platelets,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirasol-treated-allogeneic-platelets
2020-09-18T04:24:24Z,Mircera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxy-polyethylene-glycol-epoetin-beta
2020-09-18T04:24:24Z,Mirena,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel-releasing-intrauterine-system
2020-09-18T04:24:24Z,miridesap,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794046
2020-09-18T04:24:24Z,mirtazapine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirtazapine
2020-09-18T04:24:24Z,mirvetuximab soravtansine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirvetuximab-soravtansine
2020-09-18T04:24:24Z,misonidazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/misonidazole
2020-09-18T04:24:24Z,mistletoe extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mistletoe-extract
2020-09-18T04:24:24Z,Mithracin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin
2020-09-18T04:24:24Z,MitoGel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation
2020-09-18T04:24:24Z,mitoguazone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoguazone
2020-09-18T04:24:24Z,mitolactol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitolactol
2020-09-18T04:24:24Z,mitomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c
2020-09-18T04:24:24Z,mitosis inhibitor T 1101 tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793127
2020-09-18T04:24:24Z,mitosis-angiogenesis inhibitor R1530,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitosis-angiogenesis-inhibitor-r1530
2020-09-18T04:24:24Z,mitotane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitotane
2020-09-18T04:24:24Z,mitoxantrone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride
2020-09-18T04:24:24Z,mivobulin isethionate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivobulin-isethionate
2020-09-18T04:24:24Z,mixed bacteria vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mixed-bacteria-vaccine
2020-09-18T04:24:24Z,MK0731,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mk0731
2020-09-18T04:24:24Z,MKC-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mkc-1
2020-09-18T04:24:24Z,MKNK1 inhibitor BAY 1143269,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mknk1-inhibitor-bay-1143269
2020-09-18T04:24:24Z,MLN2704,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mln2704
2020-09-18T04:24:24Z,MNK1/2 inhibitor ETC-1907206,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794054
2020-09-18T04:24:24Z,MnSOD mimetic BMX-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnsod-mimetic-bmx-001
2020-09-18T04:24:24Z,MnSOD-plasmid liposomes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnsod-plasmid-liposomes
2020-09-18T04:24:24Z,Mobec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam
2020-09-18T04:24:24Z,Mobic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam
2020-09-18T04:24:24Z,Mobicox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam
2020-09-18T04:24:24Z,Mobilan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-tlr5-tlr5-agonist-nanoformulation-m-vm3
2020-09-18T04:24:24Z,Mobista,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-flt3-ligand
2020-09-18T04:24:24Z,mocetinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mocetinostat
2020-09-18T04:24:24Z,modafinil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modafinil
2020-09-18T04:24:24Z,Modicon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,Nimotop,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimodipine
2020-09-18T04:24:24Z,modified citrus pectin supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-citrus-pectin-supplement
2020-09-18T04:24:24Z,modified vaccinia Ankara (Bavarian Nordic)-HER2 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-ankara-bavarian-nordic-her2-vaccine
2020-09-18T04:24:24Z,modified vaccinia virus ankara vaccine expressing p53,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-virus-ankara-vaccine-expressing-p53
2020-09-18T04:24:24Z,modified vitamin D binding protein macrophage activator EF-022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vitamin-d-binding-protein-macrophage-activator-ef-022
2020-09-18T04:24:24Z,modified-release calcifediol capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-release-calcifediol-capsule
2020-09-18T04:24:24Z,modotuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793840
2020-09-18T04:24:24Z,Modrastane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilostane
2020-09-18T04:24:24Z,Modufolin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796585
2020-09-18T04:24:24Z,MOF compound RiMO-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795715
2020-09-18T04:24:24Z,mogamulizumab-kpkc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mogamulizumab
2020-09-18T04:24:24Z,moisturizing cream WO2085,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799500
2020-09-18T04:24:24Z,molibresib besylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801626
2020-09-18T04:24:24Z,molybdenum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/molybdenum
2020-09-18T04:24:24Z,momelotinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/momelotinib
2020-09-18T04:24:24Z,mometasone furoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mometasone-furoate
2020-09-18T04:24:24Z,monalizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monalizumab
2020-09-18T04:24:24Z,Monjuvi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574
2020-09-18T04:24:24Z,Mono-Gesic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902
2020-09-18T04:24:24Z,monobenzone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monobenzone
2020-09-18T04:24:24Z,monocarboxylate transporter 1 inhibitor AZD3965,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monocarboxylate-transporter-1-inhibitor-azd3965
2020-09-18T04:24:24Z,monoclonal antibody 105AD7 anti-idiotype vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-105ad7-anti-idiotype-vaccine
2020-09-18T04:24:24Z,monoclonal antibody 11D10 anti-idiotype vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-11d10-anti-idiotype-vaccine
2020-09-18T04:24:24Z,monoclonal antibody 14G2A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-14g2a
2020-09-18T04:24:24Z,monoclonal antibody 3F8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3f8
2020-09-18T04:24:24Z,monoclonal antibody 3H1 anti-idiotype vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-3h1-anti-idiotype-vaccine
2020-09-18T04:24:24Z,monoclonal antibody 4B5 anti-idiotype vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-4b5-anti-idiotype-vaccine
2020-09-18T04:24:24Z,monoclonal antibody A27.15,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-a2715
2020-09-18T04:24:24Z,monoclonal antibody A33,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-a33
2020-09-18T04:24:24Z,monoclonal antibody AbGn-7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-abgn-7
2020-09-18T04:24:24Z,monoclonal antibody AK002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-ak002
2020-09-18T04:24:24Z,monoclonal antibody ASP1948,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795699
2020-09-18T04:24:24Z,monoclonal antibody CAL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cal
2020-09-18T04:24:24Z,monoclonal antibody CC49,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49
2020-09-18T04:24:24Z,monoclonal antibody CC49-delta CH2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cc49-delta-ch2
2020-09-18T04:24:24Z,monoclonal antibody CEP-37250/KHK2804,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-cep-37250-khk2804
2020-09-18T04:24:24Z,monoclonal antibody E2.3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-e23
2020-09-18T04:24:24Z,monoclonal antibody GD2 anti-idiotype vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-gd2-anti-idiotype-vaccine
2020-09-18T04:24:24Z,monoclonal antibody HeFi-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-hefi-1
2020-09-18T04:24:24Z,monoclonal antibody Hu3S193,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-hu3s193
2020-09-18T04:24:24Z,monoclonal antibody HuAFP31,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huafp31
2020-09-18T04:24:24Z,monoclonal antibody HuHMFG1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-huhmfg1
2020-09-18T04:24:24Z,monoclonal antibody HuPAM4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-hupam4
2020-09-18T04:24:24Z,monoclonal antibody L6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-l6
2020-09-18T04:24:24Z,monoclonal antibody Lym-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-lym-1
2020-09-18T04:24:24Z,monoclonal antibody m170,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-m170
2020-09-18T04:24:24Z,monoclonal antibody Me1-14 F(ab')2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-me1-14-fab2
2020-09-18T04:24:24Z,monoclonal antibody Mik-beta-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-mik-beta-1
2020-09-18T04:24:24Z,monoclonal antibody NEO-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795513
2020-09-18T04:24:24Z,monoclonal antibody R24,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-r24
2020-09-18T04:24:24Z,monoclonal antibody RAV12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-rav12
2020-09-18T04:24:24Z,monoclonal antibody SGN-30,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-sgn-30
2020-09-18T04:24:24Z,monoclonal antibody TRK-950,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-trk-950
2020-09-18T04:24:24Z,monoclonal microbial EDP1503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795263
2020-09-18T04:24:24Z,monoclonal T-cell receptor anti-CD3 scFv fusion protein IMCgp100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-t-cell-receptor-anti-cd3-scfv-fusion-protein-imcgp100
2020-09-18T04:24:24Z,Monofer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-isomaltoside-1000
2020-09-18T04:24:24Z,monophosphoryl lipid A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monophosphoryl-lipid-a
2020-09-18T04:24:24Z,monosialotetrahexosylganglioside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monosialotetrahexosylganglioside
2020-09-18T04:24:24Z,Montanide ISA 51 VG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montanide-isa-51-vg
2020-09-18T04:24:24Z,Montanide ISA 720,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montanide-isa-720
2020-09-18T04:24:24Z,montelukast sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montelukast-sodium
2020-09-18T04:24:24Z,Monurol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosfomycin-tromethamine
2020-09-18T04:24:24Z,MOPP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mopp-regimen
2020-09-18T04:24:24Z,Morinda citrifolia fruit extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morinda-citrifolia-fruit-extract
2020-09-18T04:24:24Z,morphine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,morphine sulfate sustained-release tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate-sustained-release-tablet
2020-09-18T04:24:24Z,mosedipimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoacetyldiglyceride-ec-18
2020-09-18T04:24:24Z,mosunetuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774847
2020-09-18T04:24:24Z,motesanib diphosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motesanib-diphosphate
2020-09-18T04:24:24Z,motexafin gadolinium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-gadolinium
2020-09-18T04:24:24Z,motexafin lutetium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-lutetium
2020-09-18T04:24:24Z,Motrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen
2020-09-18T04:24:24Z,mouse gp100 plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mouse-gp100-plasmid-dna-vaccine
2020-09-18T04:24:24Z,mouse prostate-specific membrane antigen plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mouse-prostate-specific-membrane-antigen-plasmid-dna-vaccine
2020-09-18T04:24:24Z,mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mouse-renal-adenocarcinoma-cell-encapsulated-agarose-agarose-macrobeads
2020-09-18T04:24:24Z,MOv-gamma chimeric receptor gene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mov-gamma-chimeric-receptor-gene
2020-09-18T04:24:24Z,MOv19 CAR-CD3zeta-4-1BB-expressing allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798634
2020-09-18T04:24:24Z,Movalis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam
2020-09-18T04:24:24Z,Movantik,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxegol
2020-09-18T04:24:24Z,Movatec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam
2020-09-18T04:24:24Z,Moviprep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/742409
2020-09-18T04:24:24Z,moxetumomab pasudotox-tdfk,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox
2020-09-18T04:24:24Z,moxidectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801909
2020-09-18T04:24:24Z,moxifloxacin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride
2020-09-18T04:24:24Z,Mozobil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plerixafor
2020-09-18T04:24:24Z,MP-3549.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mp-35491
2020-09-18T04:24:24Z,Mps1 inhibitor BAY 1217389,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-inhibitor-bay-1217389
2020-09-18T04:24:24Z,Mps1 inhibitor BOS172722,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794872
2020-09-18T04:24:24Z,Mps1 kinase inhibitor BAY1161909,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-kinase-inhibitor-bay1161909
2020-09-18T04:24:24Z,mRNA-based personalized cancer vaccine mRNA-4157,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792256
2020-09-18T04:24:24Z,mRNA-based TriMixMelanoma vaccine ECI-006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794159
2020-09-18T04:24:24Z,mRNA-based tumor-specific neoantigen boosting vaccine GRT-R902,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796480
2020-09-18T04:24:24Z,mRNA-derived KRAS-targeted vaccine V941,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798633
2020-09-18T04:24:24Z,mRNA-derived lung cancer vaccine BI 1361849,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-lung-cancer-vaccine-cv9202
2020-09-18T04:24:24Z,mRNA-derived prostate cancer vaccine CV9103,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-prostate-cancer-vaccine-cv9103
2020-09-18T04:24:24Z,mRNA-derived prostate cancer vaccine CV9104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-prostate-cancer-vaccine-cv9104
2020-09-18T04:24:24Z,MS Contin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,MSir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,MTF-1 inhibitor APTO-253 HCl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtf-1-inhibitor-apto-253-hcl
2020-09-18T04:24:24Z,mTOR inhibitor GDC-0349,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-inhibitor-gdc-0349
2020-09-18T04:24:24Z,mTOR kinase inhibitor AZD8055,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-azd8055
2020-09-18T04:24:24Z,mTOR kinase inhibitor OSI-027,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-osi-027
2020-09-18T04:24:24Z,mTOR1/2 kinase inhibitor ME-344,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor1-2-kinase-inhibitor-me-344
2020-09-18T04:24:24Z,mTORC 1/2 inhibitor LXI-15029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792688
2020-09-18T04:24:24Z,mTORC1/2 kinase inhibitor BI 860585,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtorc1-2-kinase-inhibitor-bi-860585
2020-09-18T04:24:24Z,mTORC1/mTORC2/DHFR inhibitor ABTL0812,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtorc1-mtorc2-dhfr-inhibitor-abtl0812
2020-09-20T05:26:50Z,MUC-1/WT1 peptide-primed autologous dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802334
2020-09-18T04:24:24Z,MUC1 antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-antigen
2020-09-18T04:24:24Z,MUC1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-peptide-vaccine
2020-09-18T04:24:24Z,MUC1 peptide-poly-ICLC adjuvant vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-peptide-poly-iclc-adjuvant-vaccine
2020-09-18T04:24:24Z,MUC1-KLH conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-klh-conjugate-vaccine
2020-09-18T04:24:24Z,MUC1-KLH vaccine/QS21,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-klh-vaccine-qs21
2020-09-18T04:24:24Z,MUC1-targeted peptide GO-2-03-2C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-targeted-peptide-go-2-03-2c
2020-09-18T04:24:24Z,MUC16-targeted antibody-drug conjugate DMUC5754A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc16-targeted-antibody-drug-conjugate-dmuc5754a
2020-09-18T04:24:24Z,mucoadhesive hydrogel gargle,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-hydrogel-gargle
2020-09-18T04:24:24Z,mucoadhesive oral wound rinse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-oral-wound-rinse
2020-09-18T04:24:24Z,mucoadhesive paclitaxel formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-paclitaxel-formulation
2020-09-18T04:24:24Z,Mucomyst,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine
2020-09-18T04:24:24Z,MuGard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mucoadhesive-oral-wound-rinse
2020-09-18T04:24:24Z,multi-AGC kinase inhibitor AT13148,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-agc-kinase-inhibitor-at13148
2020-09-18T04:24:24Z,multi-antigen-directed autologous T cells NEXI-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802476
2020-09-18T04:24:24Z,multi-epitope anti-folate receptor peptide vaccine TPIV 200,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-anti-folate-receptor-peptide-vaccine-tpiv-200
2020-09-18T04:24:24Z,multi-epitope folate receptor alpha peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-folate-receptor-alpha-peptide-vaccine
2020-09-18T04:24:24Z,multi-epitope HER2 peptide vaccine H2NVAC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799763
2020-09-20T05:26:50Z,multi-epitope HER2 peptide vaccine TPIV100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802235
2020-09-18T04:24:24Z,multi-epitope melanoma peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-melanoma-peptide-vaccine
2020-09-18T04:24:24Z,multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ICT-107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776267
2020-09-18T04:24:24Z,multi-kinase inhibitor XL092,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798432
2020-09-18T04:24:24Z,multi-kinase inhibitorTPX-0022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798966
2020-09-18T04:24:24Z,multi-mode kinase inhibitor EOC317,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799401
2020-09-18T04:24:24Z,multi-peptide CMV-Modified Vaccinia Ankara vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-peptide-cmv-modified-vaccinia-ankara-vaccine
2020-09-18T04:24:24Z,multicarotenoid supplement MCS-8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multicarotenoid-supplement-mcs-8
2020-09-18T04:24:24Z,multiepitope TARP-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiepitope-tarp-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,Multiferon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multisubtype-natural-human-leukocyte-interferon-alpha
2020-09-18T04:24:24Z,multifunctional/multitargeted anticancer agent OMN54,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multifunctional-multitargeted-anticancer-agent-omn54
2020-09-18T04:24:24Z,MultiHance,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadobenate-dimeglumine
2020-09-18T04:24:24Z,MultiHance,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopentetate-dimeglumine
2020-09-18T04:24:24Z,multikinase inhibitor 4SC-203,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-4sc-203
2020-09-18T04:24:24Z,multikinase inhibitor AT9283,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-at9283
2020-09-18T04:24:24Z,multikinase inhibitor SAR103168,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-sar103168
2020-09-18T04:24:24Z,Multikine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-leukocyte-interleukin
2020-09-18T04:24:24Z,multipeptide vaccine S-588210,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multipeptide-vaccine-s-588210
2020-09-18T04:24:24Z,multiple TAA-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multiple-taa-loaded-dendritic-cell-vaccine
2020-09-18T04:24:24Z,MultiStem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-multipotent-adult-progenitor-cells
2020-09-18T04:24:24Z,multisubtype natural human leukocyte interferon alpha,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multisubtype-natural-human-leukocyte-interferon-alpha
2020-09-18T04:24:24Z,multitargeted tyrosine kinase inhibitor JNJ-26483327,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multitargeted-tyrosine-kinase-inhibitor-jnj-26483327
2020-09-18T04:24:24Z,multivitamin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multivitamin
2020-09-18T04:24:24Z,mureletecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mureletecan
2020-09-18T04:24:24Z,murine TYRP2 plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murine-tyrp2-plasmid-dna-vaccine
2020-09-18T04:24:24Z,muromonab-CD3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muromonab-cd3
2020-09-18T04:24:24Z,muscadine grape skin extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muscadine-grape-skin-extract
2020-09-18T04:24:24Z,Muscadine Plus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muscadine-grape-skin-extract
2020-09-18T04:24:24Z,muscarinic agonist APD515,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muscarinic-agonist-apd515
2020-09-18T04:24:24Z,MUSE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprostadil
2020-09-18T04:24:24Z,Mustargen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride
2020-09-18T04:24:24Z,mutant IDH1 inhibitor DS-1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792460
2020-09-18T04:24:24Z,mutant p53 activator COTI-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-p53-activator-coti-2
2020-09-18T04:24:24Z,mutant p53 peptide pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-p53-peptide-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,mutant-selective EGFR inhibitor PF-06459988,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-selective-egfr-inhibitor-pf-06459988
2020-09-18T04:24:24Z,MVA tumor-specific neoantigen boosting vaccine MVA-209-FSP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800851
2020-09-18T04:24:24Z,MVA-BN smallpox vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801908
2020-09-18T04:24:24Z,MVA-EBNA1/LMP2 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-ebna1-lmp2-vaccine
2020-09-18T04:24:24Z,MVA-FCU1 TG4023,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-fcu1-tg4023
2020-09-18T04:24:24Z,MVA-HPV16E6/E7-IL2 vaccine TG4001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-viral-vector-ro5217790
2020-09-18T04:24:24Z,MVA-MUC1-IL2 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-muc1-il2-vaccine
2020-09-18T04:24:24Z,MVA-PSA-PAP prostate cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-psa-pap-prostate-cancer-vaccine
2020-09-18T04:24:24Z,MVAC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvac-regimen
2020-09-18T04:24:24Z,Mvasi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab
2020-09-18T04:24:24Z,MVF-HER-2(597-626)-MVF-HER-2 (266-296) peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvf-her-2597-626-mvf-her-2-266-296-peptide-vaccine
2020-09-18T04:24:24Z,MVX-1-loaded macrocapsule/autologous tumor cell vaccine MVX-ONCO-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvx-1-loaded-macrocapsule-autologous-tumor-cell-vaccine-mvx-onco-1
2020-09-18T04:24:24Z,MYC-targeting siRNA DCR-MYC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/myc-targeting-sirna-dcr-myc
2020-09-18T04:24:24Z,Mycelex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole
2020-09-18T04:24:24Z,Mycelex Troche,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clotrimazole
2020-09-18T04:24:24Z,mycobacterial cell wall-DNA complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycobacterial-cell-wall-dna-complex
2020-09-18T04:24:24Z,Mycobacterium tuberculosis arabinomannan Z-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycobacterium-tuberculosis-arabinomannan-z-100
2020-09-18T04:24:24Z,Mycobacterium w,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycobacterium-w
2020-09-18T04:24:24Z,Mycobutin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rifabutin
2020-09-18T04:24:24Z,mycophenolate mofetil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolate-mofetil
2020-09-18T04:24:24Z,mycophenolic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid
2020-09-18T04:24:24Z,Myfortic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolic-acid
2020-09-18T04:24:24Z,Mylanta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-hydroxide-aluminum-hydroxide
2020-09-18T04:24:24Z,Myleran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/busulfan
2020-09-18T04:24:24Z,Mylotarg,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin
2020-09-18T04:24:24Z,Mylovenge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idiotype-pulsed-autologous-dendritic-cell-vaccine-apc8020
2020-09-18T04:24:24Z,Myochrysine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gold-sodium-thiomalate
2020-09-18T04:24:24Z,Myrbetriq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirabegron
2020-09-18T04:24:24Z,N-acetylcysteine/simethicone solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-acetylcysteine-simethicone-solution
2020-09-18T04:24:24Z,N-dihydrogalactochitosan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801765
2020-09-18T04:24:24Z,N-methylformamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-methylformamide
2020-09-18T04:24:24Z,N-oleyl-phosphatidylethanolamine/epigallocatechin gallate supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692
2020-09-18T04:24:24Z,NA-17/MAGE-3.A2/NY-ESO-1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/na-17-mage-3a2-ny-eso-1-peptide-vaccine
2020-09-18T04:24:24Z,NA17-A antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/na17-a-antigen
2020-09-18T04:24:24Z,NA17.A2 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/na17a2-peptide-vaccine
2020-09-18T04:24:24Z,nab-paclitaxel/rituximab-coated nanoparticle AR160,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel-rituximab-coated-nanoparticle-ar160
2020-09-18T04:24:24Z,nabilone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabilone
2020-09-18T04:24:24Z,nabiximols,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols
2020-09-18T04:24:24Z,nadofaragene firadenovec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-interferon-sch-721015
2020-09-18T04:24:24Z,nadolol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadolol
2020-09-18T04:24:24Z,nadroparin calcium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadroparin-calcium
2020-09-18T04:24:24Z,nafoxidine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nafoxidine-hydrochloride
2020-09-18T04:24:24Z,nalbuphine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793677
2020-09-18T04:24:24Z,naloxegol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxegol
2020-09-18T04:24:24Z,naloxone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxone-hydrochloride
2020-09-18T04:24:24Z,naltrexone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride
2020-09-18T04:24:24Z,Namenda,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/memantine-hydrochloride
2020-09-18T04:24:24Z,nandrolone decanoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nandrolone-decanoate
2020-09-18T04:24:24Z,nanocell-encapsulated miR-16-based microRNA mimic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanocell-encapsulated-mir-16-based-microrna-mimic
2020-09-18T04:24:24Z,Nanopac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799071
2020-09-18T04:24:24Z,nanoparticle albumin-bound docetaxel ABI-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-docetaxel-abi-008
2020-09-18T04:24:24Z,nanoparticle albumin-bound rapamycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-rapamycin
2020-09-18T04:24:24Z,nanoparticle paclitaxel ointment SOR007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792258
2020-09-18T04:24:24Z,nanoparticle SN-38-encapsulated micelle formulation IT-141,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792648
2020-09-18T04:24:24Z,nanoparticle-based manganese-containing contrast agent SN132D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800590
2020-09-18T04:24:24Z,nanoparticle-encapsulated doxorubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-encapsulated-doxorubicin-hydrochloride
2020-09-18T04:24:24Z,nanoscale coordination polymer nanoparticles CPI-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796802
2020-09-18T04:24:24Z,nanosomal docetaxel lipid suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanosomal-docetaxel-lipid-suspension
2020-09-18T04:24:24Z,napabucasin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/napabucasin
2020-09-18T04:24:24Z,naphthalimide analogue UNBS5162,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naphthalimide-analogue-unbs5162
2020-09-18T04:24:24Z,Naprosyn,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naproxen
2020-09-18T04:24:24Z,naproxen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naproxen
2020-09-18T04:24:24Z,naptumomab estafenatox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naptumomab-estafenatox
2020-09-18T04:24:24Z,Narcan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naloxone-hydrochloride
2020-09-18T04:24:24Z,Nardil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenelzine-sulfate
2020-09-18T04:24:24Z,narnatumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/narnatumab
2020-09-18T04:24:24Z,Naropin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropivacaine-hydrochloride
2020-09-18T04:24:24Z,Nasacort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide
2020-09-18T04:24:24Z,nasal saline irrigation solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nasal-saline-irrigation-solution
2020-09-18T04:24:24Z,Nasalfent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate-pectin-based-nasal-spray
2020-09-18T04:24:24Z,natalizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natalizumab
2020-09-18T04:24:24Z,nateglinide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nateglinide
2020-09-18T04:24:24Z,Natrecor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesiritide
2020-09-18T04:24:24Z,natural human interferon alpha OPC-18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-human-interferon-alpha-opc-18
2020-09-18T04:24:24Z,natural killer cells ZRx101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-killer-cells-zrx101
2020-09-18T04:24:24Z,navitoclax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navitoclax
2020-09-18T04:24:24Z,navy bean powder,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navy-bean-powder
2020-09-18T04:24:24Z,naxitamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/humanized-monoclonal-antibody-3f8
2020-09-18T04:24:24Z,ncmtRNA oligonucleotide Andes-1537,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ncmtrna-oligonucleotide-andes-1537
2020-09-18T04:24:24Z,near-infrared imaging agent HS-196,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794407
2020-09-18T04:24:24Z,NebuPent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamidine-isethionate
2020-09-18T04:24:24Z,necitumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/necitumumab
2020-09-18T04:24:24Z,nedaplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nedaplatin
2020-09-18T04:24:24Z,NEDD8 activating enzyme E1 inhibitor TAS4464,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nedd8-activating-enzyme-e1-inhibitor-tas4464
2020-09-18T04:24:24Z,nedisertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-msc2490484a
2020-09-18T04:24:24Z,nefopam hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nefopam-hydrochloride
2020-09-18T04:24:24Z,neihulizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neihulizumab
2020-09-18T04:24:24Z,nelarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelarabine
2020-09-18T04:24:24Z,nelfinavir mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelfinavir-mesylate
2020-09-18T04:24:24Z,nelipepimut-S plus GM-CSF vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelipepimut-s-plus-gm-csf-vaccine
2020-09-18T04:24:24Z,neo-multiple TAA-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792548
2020-09-18T04:24:24Z,Neo-Oestronol I,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,neoantigen DNA-based pancreatic cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-dna-based-pancreatic-cancer-vaccine
2020-09-18T04:24:24Z,neoantigen peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784730
2020-09-18T04:24:24Z,neoantigen-based glioblastoma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-glioblastoma-vaccine
2020-09-18T04:24:24Z,neoantigen-based melanoma-poly-ICLC vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-melanoma-poly-iclc-vaccine
2020-09-18T04:24:24Z,neoantigen-based renal cell carcinoma-poly-ICLC vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797484
2020-09-18T04:24:24Z,neoantigen-based therapeutic cancer vaccine GRT-C903,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799972
2020-09-18T04:24:24Z,neoantigen-based therapeutic cancer vaccine GRT-R904,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799974
2020-09-18T04:24:24Z,nimotuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimotuzumab
2020-09-18T04:24:24Z,neoantigen-encoding personalized virus-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796893
2020-09-18T04:24:24Z,neoantigen-HSP70 peptide cancer vaccine AGEN2017,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine
2020-09-18T04:24:24Z,neoantigen-loaded autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-loaded-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,Neogest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norgestrel
2020-09-18T04:24:24Z,neomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neomycin
2020-09-18T04:24:24Z,Neoquin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone
2020-09-18T04:24:24Z,Neoral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine
2020-09-18T04:24:24Z,Neoscan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-citrate-ga-67
2020-09-18T04:24:24Z,Neovastat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage-extract-ae-941
2020-09-18T04:24:24Z,Neptazane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methazolamide
2020-09-18T04:24:24Z,neratinib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib-maleate
2020-09-18T04:24:24Z,Nerlynx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib-maleate
2020-09-18T04:24:24Z,nesiritide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesiritide
2020-09-18T04:24:24Z,nesvacumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesvacumab
2020-09-18T04:24:24Z,netazepide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netazepide
2020-09-18T04:24:24Z,netupitant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant
2020-09-18T04:24:24Z,netupitant and palonosetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-and-palonosetron-hydrochloride
2020-09-18T04:24:24Z,Neugranin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-albumin-human-granulocyte-colony-stimulating-factor
2020-09-18T04:24:24Z,Neulasta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim
2020-09-18T04:24:24Z,Neumega,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin
2020-09-18T04:24:24Z,Neupogen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim
2020-09-18T04:24:24Z,Neuradiab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-81c6
2020-09-18T04:24:24Z,neural stem cells-expressing CRAd-S-pk7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neural-stem-cells-expressing-crad-s-pk7
2020-09-18T04:24:24Z,Neurontin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gabapentin
2020-09-18T04:24:24Z,Neutrexin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimetrexate-glucuronate
2020-09-18T04:24:24Z,neutrophil activation probe imaging agent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neutrophil-activation-probe-imaging-agent
2020-09-18T04:24:24Z,Neuvenge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapuleucel-t
2020-09-18T04:24:24Z,nevirapine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nevirapine
2020-09-18T04:24:24Z,Nexavar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorafenib-tosylate
2020-09-18T04:24:24Z,Nexium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/esomeprazole-magnesium
2020-09-18T04:24:24Z,Nexrutine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phellodendron-amurense-bark-extract
2020-09-18T04:24:24Z,Nexterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amiodarone-hydrochloride
2020-09-18T04:24:24Z,NG-nitro-L-arginine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-nitro-l-arginine
2020-09-18T04:24:24Z,niacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacin
2020-09-18T04:24:24Z,niacinamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide
2020-09-18T04:24:24Z,Niagen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797351
2020-09-18T04:24:24Z,nicardipine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicardipine
2020-09-18T04:24:24Z,niclosamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niclosamide
2020-09-18T04:24:24Z,NicoDerm CQ,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-patch
2020-09-18T04:24:24Z,nicorandil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicorandil
2020-09-18T04:24:24Z,Nicorette,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-gum
2020-09-18T04:24:24Z,nicotinamide riboside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797351
2020-09-18T04:24:24Z,nicotine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine
2020-09-18T04:24:24Z,nicotine gum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-gum
2020-09-18T04:24:24Z,nicotine lozenge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-lozenge
2020-09-18T04:24:24Z,nicotine nasal spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-nasal-spray
2020-09-18T04:24:24Z,nicotine patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-patch
2020-09-18T04:24:24Z,Nicotrol NS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotine-nasal-spray
2020-09-18T04:24:24Z,NicVax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3-aminomethyl-nicotine-p-aeruginosa-r-exoprotein-a-conjugate-vaccine
2020-09-18T04:24:24Z,nidanilimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793891
2020-09-18T04:24:24Z,Niferex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron
2020-09-18T04:24:24Z,nifurtimox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nifurtimox
2020-09-18T04:24:24Z,Nilandron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilutamide
2020-09-18T04:24:24Z,nilotinib hydrochloride monohydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib
2020-09-18T04:24:24Z,nilutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilutamide
2020-09-18T04:24:24Z,Nimbex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisatracurium-besylate
2020-09-18T04:24:24Z,nimesulide-hyaluronic acid conjugate CA102N,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799428
2020-09-18T04:24:24Z,nimodipine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimodipine
2020-09-18T04:24:24Z,nimustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine
2020-09-18T04:24:24Z,ningetinib tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792698
2020-09-18T04:24:24Z,Ninlaro,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixazomib-citrate
2020-09-18T04:24:24Z,nintedanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib
2020-09-18T04:24:24Z,Nipent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin
2020-09-18T04:24:24Z,nipocalimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801196
2020-09-18T04:24:24Z,NIR fluorochrome VM110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nir-fluorochrome-vm110
2020-09-18T04:24:24Z,niraparib tosylate monohydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niraparib-tosylate-monohydrate
2020-09-18T04:24:24Z,nirogacestat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-inhibitor-pf-03084014
2020-09-18T04:24:24Z,nitazoxanide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitazoxanide
2020-09-18T04:24:24Z,nitric oxide-releasing acetylsalicylic acid derivative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitric-oxide-releasing-acetylsalicylic-acid-derivative
2020-09-18T04:24:24Z,nitroglycerin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin
2020-09-18T04:24:24Z,nitroglycerin transdermal patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-transdermal-patch
2020-09-18T04:24:24Z,nitroglycerin/sodium citrate/ethanol solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitroglycerin-sodium-citrate-ethanol-solution
2020-09-18T04:24:24Z,Niu Xi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niu-xi
2020-09-18T04:24:24Z,nivolumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab
2020-09-18T04:24:24Z,Nizoral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole
2020-09-18T04:24:24Z,NLRP3 agonist BMS-986299,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795266
2020-09-18T04:24:24Z,NM-3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nm-3
2020-09-18T04:24:24Z,nolatrexed dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nolatrexed-dihydrochloride
2020-09-18T04:24:24Z,non-adjuvanted A(H1N1) influenza vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/non-adjuvanted-ah1n1-influenza-vaccine
2020-09-18T04:24:24Z,non-small cell lung cancer mRNA-derived vaccine CV9201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/non-small-cell-lung-cancer-mrna-derived-vaccine-cv9201
2020-09-18T04:24:24Z,Norcept-E,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,Norcuron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecuronium-bromide
2020-09-18T04:24:24Z,Nordette,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,norepinephrine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norepinephrine
2020-09-18T04:24:24Z,Norethin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,norethindrone acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate
2020-09-18T04:24:24Z,Norflex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orphenadrine-citrate
2020-09-18T04:24:24Z,norgestrel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norgestrel
2020-09-18T04:24:24Z,Norglycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolazamide
2020-09-18T04:24:24Z,Norinyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,Norlutate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norethindrone-acetate
2020-09-18T04:24:24Z,NormoCort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole
2020-09-18T04:24:24Z,Norplant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel
2020-09-18T04:24:24Z,Norpramin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desipramine-hydrochloride
2020-09-18T04:24:24Z,North American ginseng extract AFX-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/north-american-ginseng-extract-afx-2
2020-09-18T04:24:24Z,Nortrel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,Norvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ritonavir
2020-09-18T04:24:24Z,noscapine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/noscapine-hydrochloride
2020-09-18T04:24:24Z,Notch signaling pathway inhibitor MK0752,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/notch-signaling-pathway-inhibitor-mk0752
2020-09-18T04:24:24Z,Novaban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropisetron-hydrochloride
2020-09-18T04:24:24Z,Novarel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin
2020-09-18T04:24:24Z,NovaSoy,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-isoflavones
2020-09-18T04:24:24Z,Novolauden,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydromorphone-hydrochloride
2020-09-18T04:24:24Z,Novolin N,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-nph
2020-09-18T04:24:24Z,Noxafil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/posaconazole
2020-09-18T04:24:24Z,Nozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800780
2020-09-18T04:24:24Z,Nplate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romiplostim
2020-09-18T04:24:24Z,NS5B polymerase inhibitor BMS-791325,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ns5b-polymerase-inhibitor-bms-791325
2020-09-18T04:24:24Z,NSCLC antigen-loaded dendritic cell-derived exosomes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/681902
2020-09-18T04:24:24Z,NSCLC-specific marrow-infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799448
2020-09-18T04:24:24Z,NTRK/ROS1 inhibitor DS-6051b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ntrk-ros1-inhibitor-ds-6051b
2020-09-18T04:24:24Z,Nubeqa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ar-antagonist-odm-201
2020-09-18T04:24:24Z,Nucala,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796922
2020-09-18T04:24:24Z,nucleoside analog DFP-10917,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nucleoside-analog-dfp-10917
2020-09-18T04:24:24Z,nucleotide analog prodrug NUC-3373,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795584
2020-09-18T04:24:24Z,nucleotide analogue GS 9219,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nucleotide-analogue-gs-9219
2020-09-18T04:24:24Z,Numorphan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxymorphone-hydrochloride
2020-09-18T04:24:24Z,nutraceutical TBL-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutraceutical-tbl-12
2020-09-18T04:24:24Z,Nutracort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,NutreStore,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine
2020-09-18T04:24:24Z,Nutri-jelly,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792465
2020-09-18T04:24:24Z,Nutri-jelly with PEITC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792466
2020-09-18T04:24:24Z,nutrient-rich whole wheat flour supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutrient-rich-whole-wheat-flour-supplement
2020-09-18T04:24:24Z,Nutrison,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/770796
2020-09-18T04:24:24Z,nutritional supplement drink,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink
2020-09-18T04:24:24Z,nutritional supplement drink (pediatric),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink-pediatric
2020-09-18T04:24:24Z,nutritious semisolid food gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792465
2020-09-18T04:24:24Z,nutritious semisolid food gel with phenethyl isothiocyanate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792466
2020-09-18T04:24:24Z,Nuvigil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/armodafinil
2020-09-18T04:24:24Z,Nuvion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/visilizumab
2020-09-18T04:24:24Z,NY-ESO-1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-peptide-vaccine
2020-09-18T04:24:24Z,NY-ESO-1 plasmid DNA cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-plasmid-dna-cancer-vaccine
2020-09-18T04:24:24Z,NY-ESO-1 protein vaccine plus Montanide ISA-51 VG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-protein-vaccine-plus-montanide-isa-51-vg
2020-09-18T04:24:24Z,NY-ESO-1 protein/microparticle MDP/bacterial DNA-containing MIS416 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-protein-microparticle-mdp-bacterial-dna-containing-mis416-vaccine
2020-09-18T04:24:24Z,NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-reactive-tcr-retroviral-vector-transduced-autologous-pbl
2020-09-18T04:24:24Z,NY-ESO-1-specific CD4-positive T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-specific-cd4-positive-t-lymphocytes
2020-09-18T04:24:24Z,NY-ESO-1-specific TCR gene-transduced T lymphocytes TBI-1301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-specific-tcr-gene-transduced-t-lymphocytes-tbi-1301
2020-09-18T04:24:24Z,NY-ESO-1(157-165) peptide-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1157-165-peptide-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,NY-ESO-1/GLA-SE vaccine ID-G305,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-gla-se-vaccine-id-g305
2020-09-18T04:24:24Z,NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-lage-1-hla-class-i-ii-peptide-vaccine
2020-09-18T04:24:24Z,NY-ESO-1/MART-1 peptide-pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-mart-1-peptide-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,NY-ESO-1/PRAME/MAGE-A3/WT-1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-prame-mage-a3-wt-1-peptide-vaccine
2020-09-18T04:24:24Z,NY-ESO-1b peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1b-peptide-vaccine
2020-09-18T04:24:24Z,NY-ESO-B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-b
2020-09-18T04:24:24Z,O6-benzylguanine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/o6-benzylguanine
2020-09-18T04:24:24Z,oat biscuit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oat-biscuit
2020-09-18T04:24:24Z,obatoclax mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obatoclax-mesylate
2020-09-18T04:24:24Z,obinutuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab
2020-09-18T04:24:24Z,oblimersen sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium
2020-09-18T04:24:24Z,ocaratuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ocaratuzumab
2020-09-18T04:24:24Z,ocrelizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ocrelizumab
2020-09-18T04:24:24Z,Octreoscan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide
2020-09-18T04:24:24Z,octreotide acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate
2020-09-18T04:24:24Z,octreotide pamoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate
2020-09-18T04:24:24Z,odanacatib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/odanacatib
2020-09-18T04:24:24Z,Odomzo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonidegib
2020-09-18T04:24:24Z,OEPA regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oepa-regimen
2020-09-18T04:24:24Z,Oestrogenine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Oestromenin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Oestromon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,ofatumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab
2020-09-18T04:24:24Z,OFF regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/off-regimen
2020-09-18T04:24:24Z,ofloxacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofloxacin
2020-09-18T04:24:24Z,ofranergene obadenovec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angiogenesis-inhibitor-gt-111
2020-09-18T04:24:24Z,Ogivri,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab
2020-09-18T04:24:24Z,oglufanide disodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oglufanide-disodium
2020-09-18T04:24:24Z,olanzapine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olanzapine
2020-09-18T04:24:24Z,olaparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaparib
2020-09-18T04:24:24Z,olaptesed pegol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sdf-1-targeted-agent-nox-a12
2020-09-18T04:24:24Z,olaratumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaratumab
2020-09-18T04:24:24Z,oleandrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oleandrin
2020-09-18T04:24:24Z,oleclumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-medi9447
2020-09-18T04:24:24Z,oligofructose-enriched inulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligofructose-enriched-inulin
2020-09-18T04:24:24Z,oligomeric procyanidin complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligomeric-procyanidin-complex
2020-09-18T04:24:24Z,oligonucleotide SPC2996,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oligonucleotide-spc2996
2020-09-18T04:24:24Z,olive oil extract/curcumin-based capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olive-oil-extract-curcumin-based-capsule
2020-09-18T04:24:24Z,olive oil/soya oil/egg lecithin-based emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olive-oil-soya-oil-egg-lecithin-based-emulsion
2020-09-18T04:24:24Z,olmutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-hm61713
2020-09-18T04:24:24Z,olutasidenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780143
2020-09-18T04:24:24Z,Olysio,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simeprevir
2020-09-18T04:24:24Z,omacetaxine mepesuccinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omacetaxine-mepesuccinate
2020-09-18T04:24:24Z,omalizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omalizumab
2020-09-18T04:24:24Z,omaveloxolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nrf2-activator-rta-408
2020-09-18T04:24:24Z,ombitasvir/paritaprevir/ritonavir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ombitasvir-paritaprevir-ritonavir
2020-09-18T04:24:24Z,ombrabulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ombrabulin
2020-09-18T04:24:24Z,omega-3 fatty acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omega-3-fatty-acid
2020-09-18T04:24:24Z,omega-3-acid ethyl esters,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794285
2020-09-18T04:24:24Z,omeprazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omeprazole
2020-09-18T04:24:24Z,omiganan pentahydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omiganan-pentahydrochloride
2020-09-18T04:24:24Z,Omnipaque,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iohexol
2020-09-18T04:24:24Z,OmniScan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadodiamide
2020-09-18T04:24:24Z,onartuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onartuzumab
2020-09-18T04:24:24Z,Oncaspar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase
2020-09-18T04:24:24Z,OncoGel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pgla-peg-copolymer-based-paclitaxel
2020-09-18T04:24:24Z,OncoLAR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate
2020-09-18T04:24:24Z,oncolytic adenovirus Ad5-DNX-2401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-ad5-dnx-2401
2020-09-18T04:24:24Z,oncolytic adenovirus CAdVEC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797393
2020-09-18T04:24:24Z,oncolytic adenovirus encoding GM-CSF,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-encoding-gm-csf
2020-09-18T04:24:24Z,oncolytic adenovirus ICOVIR5-infected autologous mesenchymal stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-icovir5-infected-autologous-mesenchymal-stem-cells
2020-09-18T04:24:24Z,oncolytic adenovirus ORCA-010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800320
2020-09-18T04:24:24Z,oncolytic herpes simplex virus encoding GM-CSF,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-herpes-simplex-virus-encoding-gm-csf
2020-09-18T04:24:24Z,oncolytic HSV-1 C134,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798723
2020-09-18T04:24:24Z,oncolytic HSV-1 rQNestin34.5v.2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-rqnestin345v2
2020-09-18T04:24:24Z,oncolytic HSV-1 rRp450,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-rrp450
2020-09-18T04:24:24Z,oncolytic HSV-1716,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1716
2020-09-18T04:24:24Z,oncolytic measles virus encoding thyroidal sodium iodide symporter,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-measles-virus-encoding-thyroidal-sodium-iodide-symporter
2020-09-18T04:24:24Z,oncolytic Newcastle disease virus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus
2020-09-18T04:24:24Z,oncolytic Newcastle disease virus MEDI5395,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799776
2020-09-18T04:24:24Z,oncolytic type 2 herpes simplex virus expressing granulocyte macrophage colony-stimulating factor OH2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801354
2020-09-23T07:08:11Z,oncolytic vaccinia virus T601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792489
2020-09-18T04:24:24Z,oncolytic vaccinia virus TG6002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792489
2020-09-18T04:24:24Z,oncolytic virus ASP9801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798437
2020-09-18T04:24:24Z,oncolytic virus RP1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797350
2020-09-18T04:24:24Z,Onconase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranpirnase
2020-09-18T04:24:24Z,Oncophage,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitespen
2020-09-18T04:24:24Z,Oncoquest-L vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-proteoliposome-chronic-lymphocytic-leukemia-vaccine
2020-09-18T04:24:24Z,OncoVax-PR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-prostate-cancer-vaccine
2020-09-18T04:24:24Z,Oncoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-extract-based-antioxidant-supplement
2020-09-18T04:24:24Z,ondansetron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron
2020-09-18T04:24:24Z,ondansetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron-hydrochloride
2020-09-18T04:24:24Z,Onivyde,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride-liposome
2020-09-18T04:24:24Z,Onrigin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laromustine
2020-09-18T04:24:24Z,Onsolis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-buccal-soluble-film
2020-09-18T04:24:24Z,Ontak,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox
2020-09-18T04:24:24Z,Ontruzant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab
2020-09-18T04:24:24Z,Onureg,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine
2020-09-18T04:24:24Z,onvansertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792149
2020-09-18T04:24:24Z,Onyx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethylene-vinyl-alcohol-copolymer-based-embolic-agent
2020-09-18T04:24:24Z,ONYX-015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onyx-015
2020-09-18T04:24:24Z,opaganib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sphingosine-kinase-2-inhibitor-abc294640
2020-09-18T04:24:24Z,Opana,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxymorphone-hydrochloride
2020-09-18T04:24:24Z,"OPCs/green tea,/spirullina/curcumin/antrodia camphorate/fermented soymilk extract capsule",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/665369
2020-09-18T04:24:24Z,Opdivo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab
2020-09-18T04:24:24Z,Opdivo Injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab
2020-09-18T04:24:24Z,opebacan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opebacan
2020-09-18T04:24:24Z,opioid agonist GIC-1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-agonist-gic-1001
2020-09-18T04:24:24Z,opioid agonist GIC-1002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-agonist-gic-1002
2020-09-18T04:24:24Z,opioid growth factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opioid-growth-factor
2020-09-18T04:24:24Z,opium tincture,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opium-tincture
2020-09-18T04:24:24Z,oportuzumab monatox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oportuzumab-monatox
2020-09-18T04:24:24Z,OPPA regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oppa-regimen
2020-09-18T04:24:24Z,oprelvekin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprelvekin
2020-09-18T04:24:24Z,oprozomib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprozomib
2020-09-18T04:24:24Z,OptiPrep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodixanol
2020-09-18T04:24:24Z,Optiray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794044
2020-09-18T04:24:24Z,Optison,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren-protein-type-a-microspheres
2020-09-18T04:24:24Z,Ora-Testryl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone
2020-09-18T04:24:24Z,Oracit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate
2020-09-18T04:24:24Z,Oradoxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-docetaxel
2020-09-18T04:24:24Z,oral aminolevulinic acid hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-aminolevulinic-acid-hydrochloride
2020-09-18T04:24:24Z,oral azacitidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-azacitidine
2020-09-18T04:24:24Z,oral cancer vaccine V3-P,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792852
2020-09-18T04:24:24Z,oral docetaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-docetaxel
2020-09-18T04:24:24Z,oral fludarabine phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-fludarabine-phosphate
2020-09-18T04:24:24Z,oral Hsp90 inhibitor IPI-493,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-hsp90-inhibitor-ipi-493
2020-09-18T04:24:24Z,oral microencapsulated diindolylmethane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-microencapsulated-diindolylmethane
2020-09-18T04:24:24Z,oral milataxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-milataxel
2020-09-18T04:24:24Z,oral moisturizing jelly,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792473
2020-09-18T04:24:24Z,oral myoma vaccine V3-myoma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797410
2020-09-18T04:24:24Z,oral picoplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-picoplatin
2020-09-18T04:24:24Z,oral rehydration solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-rehydration-solution
2020-09-18T04:24:24Z,oral sodium phenylbutyrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-sodium-phenylbutyrate
2020-09-18T04:24:24Z,oral therapeutic vaccine V3-X,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792496
2020-09-18T04:24:24Z,oral topotecan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-topotecan-hydrochloride
2020-09-18T04:24:24Z,Oralet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate
2020-09-18T04:24:24Z,Oramorph,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,Oramorph SR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,orantinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orantinib
2020-09-18T04:24:24Z,Orathecin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan
2020-09-18T04:24:24Z,oraxol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oraxol
2020-09-18T04:24:24Z,Orazol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enteric-coated-zoledronic-acid-tablet-mer-101
2020-09-18T04:24:24Z,oregovomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oregovomab
2020-09-18T04:24:24Z,Orencia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abatacept
2020-09-18T04:24:24Z,Orestralyn,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol
2020-09-18T04:24:24Z,Orilissa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793786
2020-09-18T04:24:24Z,ormaplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ormaplatin
2020-09-18T04:24:24Z,orphenadrine citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orphenadrine-citrate
2020-09-18T04:24:24Z,Orplatna,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/satraplatin
2020-09-18T04:24:24Z,ortataxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ortataxel
2020-09-18T04:24:24Z,orteronel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orteronel
2020-09-18T04:24:24Z,Ortho-Novum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,Orthoclone OKT3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muromonab-cd3
2020-09-18T04:24:24Z,Orudis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoprofen
2020-09-18T04:24:24Z,Oruvail,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoprofen
2020-09-18T04:24:24Z,OSE 2101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ose-2101
2020-09-18T04:24:24Z,oseltamivir phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oseltamivir-phosphate
2020-09-18T04:24:24Z,OSI-7904L,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osi-7904l
2020-09-18T04:24:24Z,osilodrostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osilodrostat
2020-09-18T04:24:24Z,osimertinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osimertinib
2020-09-18T04:24:24Z,Osmitrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannitol
2020-09-18T04:24:24Z,Ossirene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ammonium-trichlorotellurate
2020-09-18T04:24:24Z,Ostarine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm
2020-09-18T04:24:24Z,Osteocrete,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794178
2020-09-18T04:24:24Z,otlertuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/otlertuzumab
2020-09-18T04:24:24Z,ovapuldencel-T,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ovapuldencel-t
2020-09-18T04:24:24Z,OvaRex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oregovomab
2020-09-18T04:24:24Z,ovarian cancer peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ovarian-cancer-peptide-vaccine
2020-09-18T04:24:24Z,ovarian cancer stem cell/hTERT/survivin mRNAs-loaded autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/699229
2020-09-18T04:24:24Z,ovarian tumor antigen-activated autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ovarian-tumor-antigen-activated-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,OVax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine
2020-09-18T04:24:24Z,Ovcon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-norethindrone
2020-09-18T04:24:24Z,Ovrette,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norgestrel
2020-09-18T04:24:24Z,OX40L-expressing oncolytic adenovirus DNX-2440,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797863
2020-09-18T04:24:24Z,oxaliplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin
2020-09-18T04:24:24Z,oxaliplatin eluting beads,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801475
2020-09-18T04:24:24Z,oxaliplatin-encapsulated transferrin-conjugated N-glutaryl phosphatidylethanolamine liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/669661
2020-09-18T04:24:24Z,Oxandrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxandrolone
2020-09-18T04:24:24Z,oxandrolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxandrolone
2020-09-18T04:24:24Z,oxcarbazepine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxcarbazepine
2020-09-18T04:24:24Z,Oxecta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride
2020-09-18T04:24:24Z,Oxepa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gluten-free-dha-epa-gla-antioxidant-rich-nutritional-liquid
2020-09-18T04:24:24Z,oxidative phosphorylation inhibitor IACS-010759,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-iacs-010759
2020-09-18T04:24:24Z,oxidative phosphorylation inhibitor IM156,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793779
2020-09-18T04:24:24Z,oxidized avidin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidized-avidin
2020-09-18T04:24:24Z,oxitriptan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxitriptan
2020-09-18T04:24:24Z,OxPhos Inhibitor VLX600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxphos-inhibitor-vlx600
2020-09-18T04:24:24Z,Oxsoralen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen
2020-09-18T04:24:24Z,Oxsoralen-Ultra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen
2020-09-18T04:24:24Z,oxycodone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride
2020-09-18T04:24:24Z,oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride-naloxone-hydrochloride-prolonged-release-tablet
2020-09-18T04:24:24Z,oxycodone/acetaminophen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-acetaminophen
2020-09-18T04:24:24Z,OxyContin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride
2020-09-18T04:24:24Z,oxymorphone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxymorphone-hydrochloride
2020-09-18T04:24:24Z,ozarelix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ozarelix
2020-09-18T04:24:24Z,Ozurdex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone-intravitreal-implant
2020-09-18T04:24:24Z,p-cadherin antagonist PF-03732010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-antagonist-pf-03732010
2020-09-18T04:24:24Z,P-cadherin inhibitor PCA062,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-inhibitor-pca062
2020-09-18T04:24:24Z,P-cadherin-targeting agent PF-06671008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-targeting-agent-pf-06671008
2020-09-18T04:24:24Z,P-glycoprotein inhibitor HM30181AK,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-glycoprotein-inhibitor-hm30181ak
2020-09-18T04:24:24Z,P-p68 inhibitor RX-5902,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-p68-inhibitor-rx-5902
2020-09-18T04:24:24Z,p.DOM-WT1-126 DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdom-wt1-126-dna-vaccine
2020-09-18T04:24:24Z,p.DOM-WT1-37 DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdom-wt1-37-dna-vaccine
2020-09-18T04:24:24Z,pegvisomant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegvisomant
2020-09-18T04:24:24Z,p300/CBP bromodomain inhibitor CCS1477,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797847
2020-09-18T04:24:24Z,p38 MAPK inhibitor LY2228820 dimesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p38-mapk-inhibitor-ly2228820-dimesylate
2020-09-18T04:24:24Z,p38 MAPK inhibitor LY3007113,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p38-mapk-inhibitor-ly3007113
2020-09-18T04:24:24Z,p38/Tie2 kinase inhibitor Arry-614,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p38-tie2-kinase-inhibitor-arry-614
2020-09-18T04:24:24Z,p53 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine
2020-09-18T04:24:24Z,p53 synthetic long peptide (70-251) vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-synthetic-long-peptide-70-251-vaccine
2020-09-18T04:24:24Z,p53-HDM2 protein-protein interaction inhibitor APG-115,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-protein-protein-interaction-inhibitor-apg-115
2020-09-18T04:24:24Z,p53-HDM2 protein-protein interaction inhibitor MI-773,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-protein-protein-interaction-inhibitor-mi-773
2020-09-18T04:24:24Z,p53/HDM2 interaction inhibitor CGM097,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-cgm097
2020-09-18T04:24:24Z,p70S6K inhibitor LY2584702,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p70s6k-inhibitor-ly2584702
2020-09-18T04:24:24Z,p70S6K/Akt inhibitor MSC2363318A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p70s6k-akt-inhibitor-msc2363318a
2020-09-18T04:24:24Z,p97 inhibitor CB-5083,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5083
2020-09-18T04:24:24Z,p97 Inhibitor CB-5339,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800449
2020-09-18T04:24:24Z,p97 inhibitor CB-5339 tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800450
2020-09-18T04:24:24Z,paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel
2020-09-18T04:24:24Z,paclitaxel albumin-stabilized nanoparticle formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-albumin-stabilized-nanoparticle-formulation
2020-09-18T04:24:24Z,paclitaxel injection concentrate for nanodispersion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-injection-concentrate-for-nanodispersion
2020-09-18T04:24:24Z,paclitaxel poliglumex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex
2020-09-18T04:24:24Z,paclitaxel polymeric micelle formulation NANT-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-loaded-polymeric-micelle
2020-09-18T04:24:24Z,paclitaxel vitamin E-based emulsion formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-vitamin-e-based-emulsion-formulation
2020-09-18T04:24:24Z,pacritinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacritinib
2020-09-18T04:24:24Z,PAD regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pad-regimen
2020-09-18T04:24:24Z,Padcev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nectin-4-antibody-drug-conjugate-asg-22ce
2020-09-18T04:24:24Z,padeliporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padeliporfin
2020-09-18T04:24:24Z,PADRE 965.10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padre-96510
2020-09-18T04:24:24Z,PADRE-CMV fusion peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padre-cmv-fusion-peptide-vaccine
2020-09-18T04:24:24Z,PAK4 inhibitor PF-03758309,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pak4-inhibitor-pf-03758309
2020-09-18T04:24:24Z,PAK4/NAMPT inhibitor KPT-9274,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pak4-nampt-inhibitor-kpt-9274
2020-09-18T04:24:24Z,palbociclib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palbociclib
2020-09-18T04:24:24Z,Palestrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,palifermin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifermin
2020-09-18T04:24:24Z,palifosfamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifosfamide
2020-09-18T04:24:24Z,palifosfamide tromethamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palifosfamide-tromethamine
2020-09-18T04:24:24Z,palladium Pd 103,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palladium-pd-103
2020-09-18T04:24:24Z,palladium-bacteriopheophorbide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palladium-bacteriopheophorbide
2020-09-18T04:24:24Z,palonosetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palonosetron-hydrochloride
2020-09-18T04:24:24Z,pamidronate disodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamidronate-disodium
2020-09-18T04:24:24Z,pamiparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-bgb-290
2020-09-18T04:24:24Z,Pamolyn 300,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-linoleic-acid
2020-09-18T04:24:24Z,pamrevlumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctgf-monoclonal-antibody-fg-3019
2020-09-18T04:24:24Z,pan-AKT inhibitor ARQ 751,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq-751
2020-09-18T04:24:24Z,pan-AKT kinase inhibitor GSK690693,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-kinase-inhibitor-gsk690693
2020-09-18T04:24:24Z,pan-FGFR inhibitor LY2874455,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-inhibitor-ly2874455
2020-09-18T04:24:24Z,pan-FGFR tyrosine kinase inhibitor BAY1163877,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-fgfr-tyrosine-kinase-inhibitor-bay1163877
2020-09-18T04:24:24Z,pan-FLT3/Pan-BTK multi-kinase inhibitor CG-806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798821
2020-09-18T04:24:24Z,pan-HER kinase inhibitor AC480,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-her-kinase-inhibitor-ac480
2020-09-18T04:24:24Z,pan-HER/VEGFR2 receptor tyrosine kinase inhibitor BMS-690514,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-her-vegfr2-receptor-tyrosine-kinase-inhibitor-bms-690514
2020-09-18T04:24:24Z,pan-KRAS inhibitor BI 1701963,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799903
2020-09-18T04:24:24Z,pan-mutant-IDH1 inhibitor BAY1436032,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay1436032
2020-09-18T04:24:24Z,pan-mutation-selective EGFR inhibitor CLN-081,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799981
2020-09-18T04:24:24Z,pan-PI3K inhibitor CLR457,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-inhibitor-clr457
2020-09-18T04:24:24Z,pan-PI3K/mTOR inhibitor PQR309,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-mtor-inhibitor-pqr309
2020-09-18T04:24:24Z,pan-PI3K/mTOR inhibitor SF1126,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-mtor-inhibitor-sf1126
2020-09-18T04:24:24Z,pan-PIM inhibitor INCB053914,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pim-inhibitor-incb053914
2020-09-18T04:24:24Z,pan-PIM kinase inhibitor AZD1208,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pim-kinase-inhibitor-azd1208
2020-09-18T04:24:24Z,pan-Raf inhibitor LXH254,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-lxh254
2020-09-18T04:24:24Z,pan-RAF inhibitor LY3009120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-ly3009120
2020-09-18T04:24:24Z,pan-RAF kinase inhibitor CCT3833,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-cct3833
2020-09-18T04:24:24Z,pan-RAF kinase inhibitor TAK-580,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-tak-580
2020-09-18T04:24:24Z,pan-selectin antagonist GMI-1070,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-selectin-antagonist-gmi-1070
2020-09-18T04:24:24Z,pan-TRK inhibitor NOV1601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801625
2020-09-18T04:24:24Z,pan-TRK inhibitor ONO-7579,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-ono-7579
2020-09-18T04:24:24Z,pan-VEGFR/Tie2 tyrosine kinase inhibitor CEP-11981,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-vegfr-tie2-tyrosine-kinase-inhibitor-cep-11981
2020-09-18T04:24:24Z,Pancrease,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase
2020-09-18T04:24:24Z,pancrelipase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase
2020-09-18T04:24:24Z,Panglobulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,Panhematin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hemin
2020-09-18T04:24:24Z,panitumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab
2020-09-18T04:24:24Z,panitumumab-IRDye800,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab-irdye800
2020-09-18T04:24:24Z,PankoMab-GEX,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ta-muc1-monoclonal-antibody-pankomab
2020-09-18T04:24:24Z,panobinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat
2020-09-18T04:24:24Z,panobinostat nanoparticle formulation MTX110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793526
2020-09-18T04:24:24Z,Panretin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin
2020-09-18T04:24:24Z,pantoprazole sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pantoprazole-sodium
2020-09-18T04:24:24Z,PANVAC-F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/falimarev
2020-09-18T04:24:24Z,PANVAC-V,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inalimarev
2020-09-18T04:24:24Z,Panwarfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium
2020-09-18T04:24:24Z,Panzem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol
2020-09-18T04:24:24Z,papaverine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride
2020-09-18T04:24:24Z,para-toluenesulfonamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795724
2020-09-18T04:24:24Z,Paraflex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorzoxazone
2020-09-18T04:24:24Z,parathyroid hormone-related protein (1-36),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parathyroid-hormone-related-protein-1-36
2020-09-18T04:24:24Z,parecoxib sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parecoxib-sodium
2020-09-18T04:24:24Z,paricalcitol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paricalcitol
2020-09-18T04:24:24Z,Parlodel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromocriptine-mesylate
2020-09-18T04:24:24Z,Parnate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tranylcypromine-sulfate
2020-09-18T04:24:24Z,paromomycin sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paromomycin-sulfate
2020-09-18T04:24:24Z,paroxetine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paroxetine-hydrochloride
2020-09-18T04:24:24Z,PARP 1/2 inhibitor IMP4297,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800374
2020-09-18T04:24:24Z,PARP 1/2 inhibitor NOV1401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794354
2020-09-18T04:24:24Z,PARP inhibitor CEP-9722,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-cep-9722
2020-09-18T04:24:24Z,PARP inhibitor E7016,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-e7016
2020-09-18T04:24:24Z,PARP inhibitor NMS-03305293,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802331
2020-09-18T04:24:24Z,PARP-1/2 inhibitor ABT-767,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-abt-767
2020-09-18T04:24:24Z,PARP/Tankyrase inhibitor 2X-121,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-e7449
2020-09-18T04:24:24Z,PARP7 inhibitor RBN-2397,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800790
2020-09-18T04:24:24Z,Parsabiv,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etelcalcetide
2020-09-18T04:24:24Z,partially engineered T-regulatory cell donor graft TRGFT-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800419
2020-09-18T04:24:24Z,partially HLA-matched AdV/CMV/EBV-specific allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795554
2020-09-18T04:24:24Z,ParvOryx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parvovirus-h-1
2020-09-18T04:24:24Z,parvovirus H-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parvovirus-h-1
2020-09-18T04:24:24Z,pasireotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pasireotide
2020-09-18T04:24:24Z,patent blue V dye,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patent-blue-v-dye
2020-09-18T04:24:24Z,patidegib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patidegib
2020-09-18T04:24:24Z,photodynamic compound TLD-1433,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801697
2020-09-18T04:24:24Z,patient-specific follicular lymphoma-derived anti-idiotype vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patient-specific-follicular-lymphoma-derived-anti-idiotype-vaccine
2020-09-18T04:24:24Z,Patisiran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-transthyretin-sirna-aln-ttr02
2020-09-18T04:24:24Z,patritumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab
2020-09-18T04:24:24Z,patupilone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patupilone
2020-09-18T04:24:24Z,Pavabid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride
2020-09-18T04:24:24Z,Paxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paroxetine-hydrochloride
2020-09-18T04:24:24Z,pazopanib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pazopanib-hydrochloride
2020-09-18T04:24:24Z,pBCAR3 phosphopeptide-tetanus peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbcar3-phosphopeptide-tetanus-peptide-vaccine
2020-09-18T04:24:24Z,pBCAR3/pIRS2-phosphopeptide-tetanus peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbcar3-pirs2-phosphopeptide-tetanus-peptide-vaccine
2020-09-18T04:24:24Z,pbi-shRNA STMN1 lipoplex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbi-shrna-stmn1-lipoplex
2020-09-18T04:24:24Z,PBN derivative OKN-007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbn-derivative-okn-007
2020-09-18T04:24:24Z,PBTL CD19CAR-28 zeta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pbtl-cd19car-28-zeta
2020-09-18T04:24:24Z,PCV regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pcv-regimen
2020-09-18T04:24:24Z,PD-1 knockout autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-knockout-autologous-t-lymphocytes
2020-09-18T04:24:24Z,PD-1 knockout EBV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792501
2020-09-18T04:24:24Z,PD-1-directed probody CX-188,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797958
2020-09-18T04:24:24Z,PD-L1 inhibitor INCB086550,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797120
2020-09-18T04:24:24Z,PD-L1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792500
2020-09-18T04:24:24Z,PD-L1/IDO peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792518
2020-09-18T04:24:24Z,PD-L1/PD-L2 peptide-Montanide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794357
2020-09-18T04:24:24Z,PD-L1/PD-L2/VISTA antagonist CA-170,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-pd-l2-vista-antagonist-ca-170
2020-09-18T04:24:24Z,PD-L2 peptide-Montanide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794356
2020-09-18T04:24:24Z,PD0325901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd0325901
2020-09-18T04:24:24Z,PDK1 inhibitor AR-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdk1-inhibitor-ar-12
2020-09-18T04:24:24Z,pDNA-encoding Emm55 autologous cancer cell vaccine IFx-Hu2.0,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796807
2020-09-18T04:24:24Z,PE/HPV16 E7/KDEL fusion protein/GPI-0100 TVGV-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-tvgv-1
2020-09-18T04:24:24Z,PEB regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peb-regimen
2020-09-18T04:24:24Z,PectaSol-C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-citrus-pectin-supplement
2020-09-18T04:24:24Z,Pedi-Vit-A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839
2020-09-18T04:24:24Z,PediaBerry,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801392
2020-09-18T04:24:24Z,PEDIARIX,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/561774
2020-09-18T04:24:24Z,PediaSure,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritional-supplement-drink-pediatric
2020-09-18T04:24:24Z,PedvaxHIB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haemophilus-influenzae-b-vaccine
2020-09-18T04:24:24Z,PEG-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/742409
2020-09-18T04:24:24Z,PEG-based laxative NER1006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-based-laxative-ner1006
2020-09-18T04:24:24Z,PEG-conjugated TLR7/8 agonist NKTR-262,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795599
2020-09-18T04:24:24Z,PEG-interferon alfa-2a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interferon-alfa-2a
2020-09-18T04:24:24Z,PEG-interleukin-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interleukin-2
2020-09-18T04:24:24Z,PEG-Intron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b
2020-09-18T04:24:24Z,PEG-linked L-RNA oligonucleotide hepcidin-targeting agent NOX-H94,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-linked-l-rna-oligonucleotide-hepcidin-targeting-agent-nox-h94
2020-09-18T04:24:24Z,PEG-PEI-cholesterol lipopolymer-encased IL-12 DNA plasmid vector GEN-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-pei-cholesterol-lipopolymer-encased-il-12-dna-plasmid-vector-gen-1
2020-09-18T04:24:24Z,PEG-proline-interferon alpha-2b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-proline-interferon-alpha-2b
2020-09-18T04:24:24Z,PEG4000/simethicone/sodium sulphate/sodium bicarbonate/electrolytes oral solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797373
2020-09-18T04:24:24Z,pegaspargase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase
2020-09-18T04:24:24Z,PEGASYS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-interferon-alfa-2a
2020-09-18T04:24:24Z,pegdinetanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegdinetanib
2020-09-18T04:24:24Z,pegfilgrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim
2020-09-18T04:24:24Z,pegfilgrastim anti-neutropenic factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-anti-neutropenic-factor
2020-09-18T04:24:24Z,pegfilgrastim biosimilar LA-EP2006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim-biosimilar-la-ep2006
2020-09-18T04:24:24Z,peginterferon alfa-2b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b
2020-09-18T04:24:24Z,pegol sihematide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegol-sihematide
2020-09-18T04:24:24Z,pegteograstim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegteograstim
2020-09-18T04:24:24Z,pegylated anti-GFR antibody fragment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-anti-gfr-antibody-fragment
2020-09-18T04:24:24Z,pegylated arginine deiminase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-arginine-deiminase
2020-09-18T04:24:24Z,pegylated deoxycytidine analogue DFP-14927,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798748
2020-09-18T04:24:24Z,pegylated granulocyte colony stimulating factor MAXY-G34,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-granulocyte-colony-stimulating-factor-maxy-g34
2020-09-18T04:24:24Z,pegylated interferon alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-interferon-alfa
2020-09-18T04:24:24Z,pegylated liposomal irinotecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-irinotecan
2020-09-18T04:24:24Z,pegylated liposomal mitomycin C lipid-based prodrug,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-mitomycin-c-lipid-based-prodrug
2020-09-18T04:24:24Z,pegylated liposomal mitoxantrone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-mitoxantrone-hydrochloride
2020-09-18T04:24:24Z,pegylated recombinant human arginase I BCT-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-arginase-i-bct-100
2020-09-18T04:24:24Z,pegylated recombinant human hyaluronidase PH20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-hyaluronidase-ph20
2020-09-18T04:24:24Z,pegylated recombinant human interleukin-10 AM0010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-interleukin-10-am0010
2020-09-18T04:24:24Z,pegylated recombinant interleukin-2 THOR-707,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798926
2020-09-18T04:24:24Z,pegylated recombinant L-asparaginase Erwinia chrysanthemi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-l-asparaginase-erwinia-chrysanthemi
2020-09-18T04:24:24Z,pegylated SN-38 conjugate PLX038,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800470
2020-09-18T04:24:24Z,pegzilarginase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-human-recombinant-arginase-aeb1102
2020-09-18T04:24:24Z,pelareorep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wild-type-reovirus
2020-09-18T04:24:24Z,pelitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelitinib
2020-09-18T04:24:24Z,pelitrexol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelitrexol
2020-09-18T04:24:24Z,Pemazyre,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-incb054828
2020-09-18T04:24:24Z,pembrolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab
2020-09-18T04:24:24Z,pemetrexed disodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium
2020-09-18T04:24:24Z,pemigatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-incb054828
2020-09-18T04:24:24Z,Pen-Vee,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillin-v-potassium
2020-09-18T04:24:24Z,penclomedine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penclomedine
2020-09-18T04:24:24Z,penicillamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine
2020-09-18T04:24:24Z,penicillin V potassium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillin-v-potassium
2020-09-18T04:24:24Z,Pentam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamidine-isethionate
2020-09-18T04:24:24Z,pentamethylmelamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamethylmelamine
2020-09-18T04:24:24Z,pentamidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamidine
2020-09-18T04:24:24Z,pentamidine isethionate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentamidine-isethionate
2020-09-18T04:24:24Z,Pentasa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine
2020-09-18T04:24:24Z,pentavalent KLH conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentavalent-klh-conjugate-vaccine
2020-09-18T04:24:24Z,pentetic acid calcium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentetic-acid-calcium
2020-09-18T04:24:24Z,pentosan polysulfate sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentosan-polysulfate-sodium
2020-09-18T04:24:24Z,pentostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin
2020-09-18T04:24:24Z,pentoxifylline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentoxifylline
2020-09-18T04:24:24Z,PEP-3-KLH conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pep-3-klh-conjugate-vaccine
2020-09-18T04:24:24Z,PEP-CMV vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pep-cmv-vaccine
2020-09-18T04:24:24Z,Pepcid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famotidine
2020-09-18T04:24:24Z,Pepcid AC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famotidine
2020-09-18T04:24:24Z,peplomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peplomycin
2020-09-18T04:24:24Z,Peptamen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzymatically-hydrolyzed-whey-protein-based-nutritional-supplement
2020-09-18T04:24:24Z,peptide-dye conjugate ALM-488,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801845
2020-09-20T05:26:50Z,peptidoglycan complex of spirulina K-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802332
2020-09-18T04:24:24Z,Pepto-Bismol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bismuth-subsalicylate
2020-09-18T04:24:24Z,perampanel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perampanel
2020-09-18T04:24:24Z,Percocet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-acetaminophen
2020-09-18T04:24:24Z,Perdolat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine
2020-09-18T04:24:24Z,peretinoin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peretinoin
2020-09-18T04:24:24Z,perflenapent emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflenapent-emulsion
2020-09-18T04:24:24Z,perflubron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflubron
2020-09-18T04:24:24Z,perflutren,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren
2020-09-18T04:24:24Z,perflutren lipid microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren-lipid-microspheres
2020-09-18T04:24:24Z,Premarin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens
2020-09-18T04:24:24Z,perflutren protein-type A microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perflutren-protein-type-a-microspheres
2020-09-18T04:24:24Z,perfosfamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perfosfamide
2020-09-18T04:24:24Z,Pergamid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perfosfamide
2020-09-18T04:24:24Z,Periactin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyproheptadine-hydrochloride
2020-09-18T04:24:24Z,Peridex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-gluconate
2020-09-18T04:24:24Z,perifosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perifosine
2020-09-18T04:24:24Z,perillyl alcohol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perillyl-alcohol
2020-09-18T04:24:24Z,perindopril erbumine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perindopril-erbumine
2020-09-18T04:24:24Z,Perjeta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab
2020-09-18T04:24:24Z,Permitil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluphenazine-hydrochloride
2020-09-18T04:24:24Z,Persantine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dipyridamole
2020-09-18T04:24:24Z,personalized cancer vaccine RO7198457,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-cancer-vaccine-ro7198457
2020-09-18T04:24:24Z,personalized genomic vaccine 001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-genomic-vaccine-001
2020-09-18T04:24:24Z,personalized live-attenuated double-deleted Listeria monocytogenes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-live-attenuated-double-deleted-listeria-monocytogenes
2020-09-18T04:24:24Z,personalized neoantigen DNA vaccine GNOS-PVO2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801211
2020-09-18T04:24:24Z,personalized neoantigen peptide vaccine iNeo-Vac-P01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798703
2020-09-18T04:24:24Z,personalized neoepitope yeast vaccine YE-NEO-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797413
2020-09-18T04:24:24Z,personalized polyepitope plasmid DNA breast cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-polyepitope-plasmid-dna-breast-cancer-vaccine
2020-09-18T04:24:24Z,personalized synthetic long peptide breast cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-synthetic-long-peptide-breast-cancer-vaccine
2020-09-18T04:24:24Z,personalized synthetic long peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793411
2020-09-18T04:24:24Z,Pertofrane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desipramine-hydrochloride
2020-09-18T04:24:24Z,pertuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab
2020-09-18T04:24:24Z,"pertuzumab, trastuzumab, and hyaluronidase-zzxf",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801876
2020-09-18T04:24:24Z,petrolatum-mineral oil-lanolin-ceresin ointment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/petrolatum-mineral-oil-lanolin-ceresin-ointment
2020-09-18T04:24:24Z,pevonedistat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pevonedistat
2020-09-18T04:24:24Z,pexastimogene-devacirepvec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexastimogene-devacirepvec
2020-09-18T04:24:24Z,pexidartinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexidartinib
2020-09-18T04:24:24Z,PGG beta-glucan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pgg-beta-glucan
2020-09-18T04:24:24Z,PGLA/PEG copolymer-based paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pgla-peg-copolymer-based-paclitaxel
2020-09-18T04:24:24Z,PH20 hyaluronidase-expressing adenovirus VCN-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ph20-hyaluronidase-expressing-adenovirus-vcn-01
2020-09-18T04:24:24Z,Phaleria macrocarpa Extract DLBS-1425,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phaleria-macrocarpa-extract-dlbs-1425
2020-09-18T04:24:24Z,pharmacological ascorbate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795829
2020-09-18T04:24:24Z,PHC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/596155
2020-09-18T04:24:24Z,Phellodendron amurense bark extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phellodendron-amurense-bark-extract
2020-09-18T04:24:24Z,phenelzine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenelzine-sulfate
2020-09-18T04:24:24Z,Phenergan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride
2020-09-18T04:24:24Z,phenethyl isothiocyanate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenethyl-isothiocyanate
2020-09-18T04:24:24Z,phenethyl isothiocyanate-containing watercress juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenethyl-isothiocyanate-containing-watercress-juice
2020-09-18T04:24:24Z,phenformin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenformin-hydrochloride
2020-09-18T04:24:24Z,phenobarbital,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenobarbital
2020-09-18T04:24:24Z,phenoxybenzamine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenoxybenzamine-hydrochloride
2020-09-18T04:24:24Z,phenprocoumon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phenprocoumon
2020-09-18T04:24:24Z,phentolamine mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phentolamine-mesylate
2020-09-18T04:24:24Z,Phesgo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801876
2020-09-18T04:24:24Z,phosphatidylcholine-bound silybin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphatidylcholine-bound-silybin
2020-09-18T04:24:24Z,PhosphoLean,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800692
2020-09-18T04:24:24Z,phospholipid ether-drug conjugate CLR 131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phospholipid-ether-drug-conjugate-clr-131
2020-09-18T04:24:24Z,Phosphoral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phosphate
2020-09-18T04:24:24Z,phosphorodiamidate morpholino oligomer AVI-4126,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorodiamidate-morpholino-oligomer-avi-4126
2020-09-18T04:24:24Z,phosphorus P32,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorus-p32
2020-09-18T04:24:24Z,Photochlor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpph
2020-09-18T04:24:24Z,photocyanine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photocyanine
2020-09-18T04:24:24Z,Photolon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochlorin-sodium-polyvinylpyrrolidone-complex
2020-09-18T04:24:24Z,photosensitizer LUZ 11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photosensitizer-luz-11
2020-09-18T04:24:24Z,Phyllocontin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline
2020-09-18T04:24:24Z,phytochemical,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochemical
2020-09-18T04:24:24Z,phytochlorin sodium-polyvinylpyrrolidone complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochlorin-sodium-polyvinylpyrrolidone-complex
2020-09-18T04:24:24Z,phytonadione,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytonadione
2020-09-18T04:24:24Z,PI-88,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi-88
2020-09-18T04:24:24Z,PI3K alpha inhibitor MLN1117,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-mln1117
2020-09-18T04:24:24Z,PI3K alpha/beta inhibitor BAY1082439,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-beta-inhibitor-bay1082439
2020-09-18T04:24:24Z,PI3K alpha/mTOR inhibitor PWT33597 mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-mtor-inhibitor-pwt33597-mesylate
2020-09-18T04:24:24Z,PI3K delta inhibitor HMPL 689,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792706
2020-09-18T04:24:24Z,PI3K delta inhibitor ME-401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-me-401
2020-09-18T04:24:24Z,PI3K delta inhibitor SHC014748M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799414
2020-09-18T04:24:24Z,PI3K inhibitor ACP-319,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-acp-319
2020-09-18T04:24:24Z,PI3K inhibitor BGT226,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-bgt226
2020-09-18T04:24:24Z,PI3K inhibitor GDC-0077,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0077
2020-09-18T04:24:24Z,PI3K inhibitor GDC-0084,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0084
2020-09-18T04:24:24Z,PI3K inhibitor GDC-0941 bismesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc-0941-bismesylate
2020-09-18T04:24:24Z,PI3K inhibitor GSK1059615,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gsk1059615
2020-09-18T04:24:24Z,PI3K inhibitor GSK2126458,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gsk2126458
2020-09-18T04:24:24Z,PI3K inhibitor PX-866,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-px-866
2020-09-18T04:24:24Z,PI3K inhibitor WX-037,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-wx-037
2020-09-18T04:24:24Z,PI3K inhibitor ZSTK474,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-zstk474
2020-09-18T04:24:24Z,PI3K p110beta/delta inhibitor KA2237,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-p110beta-delta-inhibitor-ka2237
2020-09-18T04:24:24Z,PI3K-alpha inhibitor MEN1611,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797093
2020-09-18T04:24:24Z,PI3K-beta inhibitor GSK2636771,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-gsk2636771
2020-09-18T04:24:24Z,PI3K-beta Inhibitor SAR260301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-sar260301
2020-09-18T04:24:24Z,PI3K-delta inhibitor AMG 319,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-amg-319
2020-09-18T04:24:24Z,PI3K-delta inhibitor INCB050465,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-incb050465
2020-09-18T04:24:24Z,PI3K-delta inhibitor YY-20394,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797151
2020-09-18T04:24:24Z,PI3K-gamma inhibitor IPI-549,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-gamma-inhibitor-ipi-549
2020-09-18T04:24:24Z,PI3K/HDAC inhibitor CUDC-907,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-hdac-inhibitor-cudc-907
2020-09-18T04:24:24Z,PI3K/mTOR dual kinase inhibitor XL765,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-dual-kinase-inhibitor-xl765
2020-09-18T04:24:24Z,PI3K/mTOR inhibitor LY3023414,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-inhibitor-ly3023414
2020-09-18T04:24:24Z,PI3K/mTOR kinase inhibitor BEZ235,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-bez235
2020-09-18T04:24:24Z,PI3K/mTOR kinase inhibitor DS-7423,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-ds-7423
2020-09-18T04:24:24Z,PI3K/mTOR kinase inhibitor PF-04691502,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-pf-04691502
2020-09-18T04:24:24Z,PI3K/mTOR kinase inhibitor VS-5584,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-kinase-inhibitor-vs-5584
2020-09-18T04:24:24Z,PI3K/mTOR/ALK-1/DNA-PK inhibitor P7170,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtor-alk-1-dna-pk-inhibitor-p7170
2020-09-18T04:24:24Z,PI3K/mTORC1/mTORC2 inhibitor DCBCI0901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-mtorc1-mtorc2-inhibitor-dcbci0901
2020-09-18T04:24:24Z,PI3Ka/mTOR inhibitor PKI-179,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3ka-mtor-inhibitor-pki-179
2020-09-18T04:24:24Z,PI3Kalpha inhibitor AZD8835,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3kalpha-inhibitor-azd8835
2020-09-18T04:24:24Z,PI3Kbeta inhibitor AZD8186,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3kbeta-inhibitor-azd8186
2020-09-18T04:24:24Z,PI3Kdelta inhibitor INCB040093,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3kdelta-inhibitor-incb040093
2020-09-18T04:24:24Z,pibenzimol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibenzimol
2020-09-18T04:24:24Z,pibrozelesin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pibrozelesin
2020-09-18T04:24:24Z,Picato,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate
2020-09-18T04:24:24Z,Picato,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-mebutate-gel
2020-09-18T04:24:24Z,picibanil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picibanil
2020-09-18T04:24:24Z,picoplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picoplatin
2020-09-18T04:24:24Z,picropodophyllin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picropodophyllin
2020-09-18T04:24:24Z,pidilizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pidilizumab
2020-09-18T04:24:24Z,pilocarpine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilocarpine-hydrochloride
2020-09-18T04:24:24Z,PIM kinase inhibitor LGH447,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-lgh447
2020-09-18T04:24:24Z,Pim kinase inhibitor SGI-1776,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-sgi-1776
2020-09-18T04:24:24Z,PIM kinase inhibitor TP-3654,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797841
2020-09-18T04:24:24Z,PIM/FLT3 kinase inhibitor SEL24,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-flt3-kinase-inhibitor-sel24
2020-09-18T04:24:24Z,pimasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimasertib
2020-09-18T04:24:24Z,pimecrolimus cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimecrolimus-cream
2020-09-18T04:24:24Z,pimodivir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797081
2020-09-18T04:24:24Z,pimonidazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimonidazole
2020-09-18T04:24:24Z,pinaverium bromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinaverium-bromide
2020-09-18T04:24:24Z,pinometostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dot1l-inhibitor-epz-5676
2020-09-18T04:24:24Z,pioglitazone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pioglitazone-hydrochloride
2020-09-18T04:24:24Z,piperacillin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperacillin-sodium
2020-09-18T04:24:24Z,piperazinedione,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperazinedione
2020-09-18T04:24:24Z,piperine extract (standardized),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperine-extract-standardized
2020-09-18T04:24:24Z,Pipracil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piperacillin-sodium
2020-09-18T04:24:24Z,Piqray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib
2020-09-18T04:24:24Z,pirarubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirarubicin
2020-09-18T04:24:24Z,pirfenidone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirfenidone
2020-09-18T04:24:24Z,piritramide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piritramide
2020-09-18T04:24:24Z,piritrexim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piritrexim
2020-09-18T04:24:24Z,pirotinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirotinib
2020-09-18T04:24:24Z,piroxantrone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxantrone
2020-09-18T04:24:24Z,piroxicam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/piroxicam
2020-09-18T04:24:24Z,pIRS2 phosphopeptide-tetanus peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirs2-phosphopeptide-tetanus-peptide-vaccine
2020-09-18T04:24:24Z,Pitocin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oxytocin
2020-09-18T04:24:24Z,pixantrone dimaleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pixantrone-dimaleate
2020-09-18T04:24:24Z,PK-R allosteric activator AG-348,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796492
2020-09-18T04:24:24Z,PKC-beta inhibitor MS-553,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795373
2020-09-18T04:24:24Z,placebo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/placebo
2020-09-18T04:24:24Z,pladienolide derivative E7107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pladienolide-derivative-e7107
2020-09-18T04:24:24Z,Plan B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levonorgestrel
2020-09-18T04:24:24Z,plant-derived hematopoiesis enhancer PG2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plant-derived-hematopoiesis-enhancer-pg2
2020-09-18T04:24:24Z,plasmacytoid dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmacytoid-dendritic-cell-vaccine
2020-09-18T04:24:24Z,plasmid encoding antiangiogenic metargidin peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmid-encoding-antiangiogenic-metargidin-peptide
2020-09-18T04:24:24Z,Plasmodium vivax–infected red blood cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794436
2020-09-18T04:24:24Z,platinum acetylacetonate-titanium dioxide nanoparticles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793980
2020-09-18T04:24:24Z,Plavix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clopidogrel-bisulfate
2020-09-18T04:24:24Z,PLED-based MnSOD mimetic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pled-based-mnsod-mimetic
2020-09-18T04:24:24Z,pleiotropic pathway modifier CC-122 hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pleiotropic-pathway-modifier-cc-122-hydrochloride
2020-09-18T04:24:24Z,Plenvu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/742409
2020-09-18T04:24:24Z,plerixafor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plerixafor
2020-09-18T04:24:24Z,plevitrexed,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plevitrexed
2020-09-18T04:24:24Z,plicamycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin
2020-09-18T04:24:24Z,plinabulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plinabulin
2020-09-18T04:24:24Z,plitidepsin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plitidepsin
2020-09-18T04:24:24Z,PLK1 inhibitor CYC140,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798706
2020-09-18T04:24:24Z,PLK1 inhibitor TAK-960,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-tak-960
2020-09-18T04:24:24Z,plozalizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plozalizumab
2020-09-18T04:24:24Z,PM00104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pm00104
2020-09-18T04:24:24Z,pneumococcal 13-valent conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-13-valent-conjugate-vaccine
2020-09-18T04:24:24Z,pneumococcal 7-valent conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-7-valent-conjugate-vaccine
2020-09-18T04:24:24Z,pneumococcal polyvalent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-polyvalent-vaccine
2020-09-18T04:24:24Z,Pneumovax 23,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-polyvalent-vaccine
2020-09-18T04:24:24Z,pNGVL3-hICD vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pngvl3-hicd-vaccine
2020-09-18T04:24:24Z,pNGVL4a-CRT/E7(detox) DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pngvl4a-crt-e7detox-dna-vaccine
2020-09-18T04:24:24Z,pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 fusion protein TA-CIN vaccine PVX-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801534
2020-09-18T04:24:24Z,pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pngvl4a-sig-e7detox-hsp70-dna-vaccine
2020-09-18T04:24:24Z,PNP-expressing ovine atadenovirus FP253,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pnp-expressing-ovine-atadenovirus-fp253
2020-09-18T04:24:24Z,Pnu-Imune 23,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-polyvalent-vaccine
2020-09-18T04:24:24Z,Pol I inhibitor CX5461,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pol-i-inhibitor-cx5461
2020-09-18T04:24:24Z,polaprezinc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc
2020-09-18T04:24:24Z,polatuzumab vedotin-piiq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin
2020-09-18T04:24:24Z,polidocanol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797212
2020-09-18T04:24:24Z,poliglusam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796923
2020-09-18T04:24:24Z,polihexanide solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polihexanide-solution
2020-09-18T04:24:24Z,Polivy,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin
2020-09-18T04:24:24Z,pollen extract PCC-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798478
2020-09-18T04:24:24Z,Polo-like kinase 1 inhibitor GSK-461364,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-gsk-461364
2020-09-18T04:24:24Z,Polo-like kinase 1 inhibitor MK1496,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-mk1496
2020-09-18T04:24:24Z,Polo-like kinase 1 inhibitor NMS-1286937,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-nms-1286937
2020-09-18T04:24:24Z,Polo-like kinase 4 inhibitor CFI-400945 fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-4-inhibitor-cfi-400945-fumarate
2020-09-18T04:24:24Z,Polocaine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepivacaine-hydrochloride
2020-09-18T04:24:24Z,poly AU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-au
2020-09-18T04:24:24Z,poly IC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-ic
2020-09-18T04:24:24Z,poly ICLC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-iclc
2020-09-18T04:24:24Z,poly-alendronate dextran-guanidine conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-alendronate-dextran-guanidine-conjugate
2020-09-18T04:24:24Z,poly-gamma glutamic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-gamma-glutamic-acid
2020-09-18T04:24:24Z,poly-TLR agonist polyantigenic vaccine CADI-05,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-tlr-agonist-polyantigenic-vaccine-cadi-05
2020-09-18T04:24:24Z,polyacrylamide hydrogel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyacrylamide-hydrogel
2020-09-18T04:24:24Z,polyamine analogue PG11047,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-pg11047
2020-09-18T04:24:24Z,polyamine analogue SBP-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-analogue-sbp-101
2020-09-18T04:24:24Z,polyamine transport inhibitor AMXT-1501 dicaprate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792572
2020-09-18T04:24:24Z,polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/755346
2020-09-18T04:24:24Z,polyethylene glycol 1000 cetyl ether cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-1000-cetyl-ether-cream
2020-09-18T04:24:24Z,polyethylene glycol 3350-containing enema NER1008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-3350-containing-enema-ner1008
2020-09-18T04:24:24Z,polyethylene glycol hydrogel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-hydrogel
2020-09-18T04:24:24Z,polyethylene glycol recombinant endostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-recombinant-endostatin
2020-09-18T04:24:24Z,polyethyleneglycol-7-ethyl-10-hydroxycamptothecin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin
2020-09-18T04:24:24Z,polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethyleneglycol-7-ethyl-10-hydroxycamptothecin-dfp-13318
2020-09-18T04:24:24Z,Polygam S/D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,polyglutamate camptothecin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyglutamate-camptothecin
2020-09-18T04:24:24Z,polyinosinic-polycytidylic acid/inactivated rabies virus vaccine YS-ON-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792708
2020-09-18T04:24:24Z,polymer-conjugated IL-15 receptor agonist NKTR-255,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800122
2020-09-18T04:24:24Z,polymer-cyanoacrylate hypoallergenic barrier solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797360
2020-09-18T04:24:24Z,polymer-encapsulated luteolin nanoparticle,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793030
2020-09-18T04:24:24Z,polymeric camptothecin prodrug XMT-1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymeric-camptothecin-prodrug-xmt-1001
2020-09-18T04:24:24Z,Polymox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin
2020-09-18T04:24:24Z,PolyMVA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-vitamin-mineral-supplement-polymva
2020-09-18T04:24:24Z,polymyxin B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymyxin-b
2020-09-18T04:24:24Z,polymyxin-B immobilized fiber PMX-20R,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymyxin-b-immobilized-fiber-pmx-20r
2020-09-18T04:24:24Z,Polyphenon E Ointment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kunecatechins-ointment
2020-09-18T04:24:24Z,polypodium leucotomos extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polypodium-leucotomos-extract
2020-09-18T04:24:24Z,polysaccharide-K,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysaccharide-k
2020-09-18T04:24:24Z,Refludan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lepirudin
2020-09-18T04:24:24Z,polysiloxane/gadolinium chelates-based nanoparticles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polysiloxane-gadolinium-chelates-based-nanoparticles
2020-09-18T04:24:24Z,polyunsaturated fatty acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyunsaturated-fatty-acid
2020-09-18T04:24:24Z,polyvalent antigen-KLH conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyvalent-antigen-klh-conjugate-vaccine
2020-09-18T04:24:24Z,polyvalent melanoma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyvalent-melanoma-vaccine
2020-09-18T04:24:24Z,polyvinylpyrrolidone-sodium hyaluronate gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyvinylpyrrolidone-sodium-hyaluronate-gel
2020-09-18T04:24:24Z,pomalidomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomalidomide
2020-09-18T04:24:24Z,Pomalyst,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomalidomide
2020-09-18T04:24:24Z,pomegranate juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomegranate-juice
2020-09-18T04:24:24Z,pomegranate liquid extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomegranate-liquid-extract
2020-09-18T04:24:24Z,pomegranate-extract pill,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomegranate-extract-pill
2020-09-18T04:24:24Z,POMx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomegranate-extract-pill
2020-09-18T04:24:24Z,ponatinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ponatinib-hydrochloride
2020-09-18T04:24:24Z,ponesimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ponesimod
2020-09-18T04:24:24Z,pooled mutant KRAS-targeted long peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799759
2020-09-18T04:24:24Z,porcupine inhibitor CGX1321,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792268
2020-09-18T04:24:24Z,porcupine inhibitor ETC-1922159,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-etc-1922159
2020-09-18T04:24:24Z,porcupine inhibitor RXC004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795722
2020-09-18T04:24:24Z,porcupine inhibitor WNT974,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-wnt974
2020-09-18T04:24:24Z,porcupine inhibitor XNW7201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801526
2020-09-18T04:24:24Z,porfimer sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfimer-sodium
2020-09-18T04:24:24Z,porfiromycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin
2020-09-18T04:24:24Z,Portia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,Portrazza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/necitumumab
2020-09-18T04:24:24Z,posaconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/posaconazole
2020-09-18T04:24:24Z,Posidur,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-bupivacaine-hydrochloride-resorbable-matrix-formulation
2020-09-18T04:24:24Z,Poteligeo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mogamulizumab
2020-09-18T04:24:24Z,povidone-iodine solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution
2020-09-18T04:24:24Z,powdered mixed berry extract supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801392
2020-09-18T04:24:24Z,pozelimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801702
2020-09-18T04:24:24Z,poziotinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poziotinib
2020-09-18T04:24:24Z,PP14 derivative-treated HLA-matched donor mononuclear cell-enriched leukocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/571184
2020-09-18T04:24:24Z,PPAR-alpha antagonist TPST-1120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800961
2020-09-18T04:24:24Z,PPE-expressing replication-defective HSV-1 vector NP2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppe-expressing-replication-defective-hsv-1-vector-np2
2020-09-18T04:24:24Z,PPI-2458,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppi-2458
2020-09-18T04:24:24Z,PR-104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pr-104
2020-09-18T04:24:24Z,PR1 leukemia peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pr1-leukemia-peptide-vaccine
2020-09-18T04:24:24Z,pracinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pracinostat
2020-09-18T04:24:24Z,Pradaxa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabigatran-etexilate-mesylate
2020-09-18T04:24:24Z,pralatrexate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralatrexate
2020-09-18T04:24:24Z,pralsetinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-mutation-fusion-inhibitor-blu-667
2020-09-18T04:24:24Z,PRAME-targeting T-cell receptor/I\inducible caspase 9 BPX-701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prame-targeting-t-cell-receptor-iinducible-caspase-9-bpx-701
2020-09-18T04:24:24Z,pramipexole dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pramipexole-dihydrochloride
2020-09-18T04:24:24Z,Prandin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repaglinide
2020-09-18T04:24:24Z,prasterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prasterone
2020-09-18T04:24:24Z,Pravachol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pravastatin-sodium
2020-09-18T04:24:24Z,pravastatin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pravastatin-sodium
2020-09-18T04:24:24Z,Precedex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexmedetomidine-hydrochloride
2020-09-18T04:24:24Z,Precose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acarbose
2020-09-18T04:24:24Z,prednisolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone
2020-09-18T04:24:24Z,prednisone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone
2020-09-18T04:24:24Z,pregabalin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pregabalin
2020-09-18T04:24:24Z,Pregnyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin
2020-09-18T04:24:24Z,preimplantation factor PIF-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/preimplantation-factor-pif-1
2020-09-18T04:24:24Z,Prelay,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone
2020-09-18T04:24:24Z,Prelone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone
2020-09-18T04:24:24Z,Prevnar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-7-valent-conjugate-vaccine
2020-09-18T04:24:24Z,Prevnar 13,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pneumococcal-13-valent-conjugate-vaccine
2020-09-18T04:24:24Z,prexasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexasertib
2020-09-18T04:24:24Z,Prialt,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziconotide
2020-09-18T04:24:24Z,prilocaine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride
2020-09-18T04:24:24Z,Prilosec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omeprazole
2020-09-18T04:24:24Z,PRIMA-1 analog APR-246,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prima-1-analog-apr-246
2020-09-18T04:24:24Z,primary prostate cancer tissue/hTERT/survivin mRNA-loaded autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/685700
2020-09-18T04:24:24Z,prime cancer vaccine MVA-BN-CV301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prime-cancer-vaccine-mva-bn-cv301
2020-09-18T04:24:24Z,priming cancer vaccine GRT-C901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796478
2020-09-18T04:24:24Z,Primosteston,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022
2020-09-18T04:24:24Z,Prinivil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisinopril
2020-09-18T04:24:24Z,prinomastat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prinomastat
2020-09-18T04:24:24Z,Pristiq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desvenlafaxine-succinate
2020-09-18T04:24:24Z,pritelivir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritelivir
2020-09-18T04:24:24Z,pritumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802036
2020-09-18T04:24:24Z,PRMT1 inhibitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797357
2020-09-18T04:24:24Z,PRMT1 inhibitor GSK3368715,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795836
2020-09-18T04:24:24Z,PRMT5 inhibitor JNJ-64619178,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799112
2020-09-18T04:24:24Z,PRMT5 inhibitor PRT811,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800369
2020-09-18T04:24:24Z,Pro-Stat 101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-fortified-collagen-protein-hydrolysate-liquid-supplement
2020-09-18T04:24:24Z,proapoptotic sulindac analog CP-461,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proapoptotic-sulindac-analog-cp-461
2020-09-18T04:24:24Z,probenecid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid
2020-09-18T04:24:24Z,probiotic acidophilus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probiotic-acidophilus
2020-09-18T04:24:24Z,probiotic supplement WeiLeShu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801340
2020-09-18T04:24:24Z,procarbazine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procarbazine-hydrochloride
2020-09-18T04:24:24Z,procaspase activating compound-1 VO-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/procaspase-activating-compound-1-vo-100
2020-09-18T04:24:24Z,prochlorperazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prochlorperazine
2020-09-18T04:24:24Z,Prochymal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remestemcel-l
2020-09-18T04:24:24Z,Procrit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa
2020-09-18T04:24:24Z,Procto-glyvenol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801443
2020-09-18T04:24:24Z,Proctocort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,Prodiaben,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpropamide
2020-09-18T04:24:24Z,Proellex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate
2020-09-18T04:24:24Z,Profasi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin
2020-09-18T04:24:24Z,proflavine hemisulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proflavine-hemisulfate
2020-09-18T04:24:24Z,progenipoietin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progenipoietin
2020-09-18T04:24:24Z,Progenta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate
2020-09-18T04:24:24Z,progesterone vaginal insert,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/progesterone-vaginal-insert
2020-09-18T04:24:24Z,Progestin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone
2020-09-18T04:24:24Z,Proglycem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diazoxide
2020-09-18T04:24:24Z,Prograf,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus
2020-09-18T04:24:24Z,prohibitin-targeting peptide 1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prohibitin-targeting-peptide-1
2020-09-18T04:24:24Z,Prokine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim
2020-09-18T04:24:24Z,Prolarix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caricotamide-tretazicar
2020-09-18T04:24:24Z,Prolastin-C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-1-proteinase-inhibitor-human
2020-09-18T04:24:24Z,Proleukin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin
2020-09-18T04:24:24Z,Prolia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab
2020-09-18T04:24:24Z,Prolixin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluphenazine-hydrochloride
2020-09-18T04:24:24Z,Prolutin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone
2020-09-18T04:24:24Z,Promacta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine
2020-09-18T04:24:24Z,promestriene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800432
2020-09-18T04:24:24Z,promethazine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride
2020-09-18T04:24:24Z,Promycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porfiromycin
2020-09-18T04:24:24Z,pronase oral solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pronase-oral-solution
2020-09-18T04:24:24Z,propacetamol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propacetamol
2020-09-18T04:24:24Z,propofol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propofol
2020-09-18T04:24:24Z,regadenoson,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regadenoson
2020-09-18T04:24:24Z,propranolol hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propranolol-hydrochloride
2020-09-18T04:24:24Z,propylthiouracil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/propylthiouracil
2020-09-18T04:24:24Z,Prorex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride
2020-09-18T04:24:24Z,Proscar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride
2020-09-18T04:24:24Z,prostate cancer vaccine ONY-P1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-cancer-vaccine-ony-p1
2020-09-18T04:24:24Z,Prostate Health Cocktail,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/596155
2020-09-18T04:24:24Z,prostate tumor antigen-activated autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-tumor-antigen-activated-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,prostatic acid phosphatase-sargramostim fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostatic-acid-phosphatase-sargramostim-fusion-protein
2020-09-18T04:24:24Z,PROSTVAC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec
2020-09-18T04:24:24Z,protease inhibitor formulation LB1148,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protease-inhibitor-formulation-lb1148
2020-09-18T04:24:24Z,protease-activated anti-PD-L1 antibody prodrug CX-072,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protease-activated-anti-pd-l1-antibody-prodrug-cx-072
2020-09-18T04:24:24Z,protein arginine methyltransferase 5 inhibitor GSK3326595,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-gsk3326595
2020-09-18T04:24:24Z,protein arginine methyltransferase 5 inhibitor PF-06939999,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797355
2020-09-18T04:24:24Z,protein arginine methyltransferase 5 inhibitor PRT543,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798738
2020-09-18T04:24:24Z,protein kinase C inhibitor IDE196,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-lxs196
2020-09-18T04:24:24Z,protein phosphatase 2A inhibitor LB-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-phosphatase-2a-inhibitor-lb-100
2020-09-18T04:24:24Z,protein stabilized liposomal docetaxel nanoparticles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-stabilized-liposomal-docetaxel-nanoparticles
2020-09-18T04:24:24Z,proteolytic enzymes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proteolytic-enzymes
2020-09-18T04:24:24Z,Protonix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pantoprazole-sodium
2020-09-18T04:24:24Z,protopine/nuciferine supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802156
2020-09-18T04:24:24Z,Provecta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pv-10
2020-09-18T04:24:24Z,Provenge,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipuleucel-t
2020-09-18T04:24:24Z,Proventil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate
2020-09-18T04:24:24Z,Provera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/medroxyprogesterone-acetate
2020-09-18T04:24:24Z,Provigan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride
2020-09-18T04:24:24Z,Provigil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modafinil
2020-09-18T04:24:24Z,proxalutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proxalutamide
2020-09-18T04:24:24Z,PSA prostate cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-prostate-cancer-vaccine
2020-09-18T04:24:24Z,PSA RNA-pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-rna-pulsed-dendritic-cell-vaccine
2020-09-18T04:24:24Z,PSA-PAP/KLH-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-pap-klh-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,PSA:154-163(155L) peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa154-163155l-peptide-vaccine
2020-09-18T04:24:24Z,PSA/IL-2/GM-CSF vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-il-2-gm-csf-vaccine
2020-09-18T04:24:24Z,PSA/PSMA DNA plasmid INO-5150,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psa-psma-dna-plasmid-ino-5150
2020-09-18T04:24:24Z,Pseudomonas aeruginosa preparation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pseudomonas-aeruginosa-preparation
2020-09-18T04:24:24Z,psilocybine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psilocybine
2020-09-18T04:24:24Z,PSMA-targeted docetaxel nanoparticles BIND-014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-docetaxel-nanoparticles-bind-014
2020-09-18T04:24:24Z,PSMA-targeted PET imaging agent fluorine F 18 CTT-1057,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-pet-imaging-agent-fluorine-f-18-ctt-1057
2020-09-18T04:24:24Z,PSMA-targeted tubulysin B-containing conjugate EC1169,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-tubulysin-b-containing-conjugate-ec1169
2020-09-18T04:24:24Z,PSMA-targeting agent-technetium Tc99m EC0652,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeting-agent-technetium-tc99m-ec0652
2020-09-18T04:24:24Z,PSMA/CD3 tri-specific T-cell activating construct HPN424,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795833
2020-09-18T04:24:24Z,PSMA/TARP peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-tarp-peptide-vaccine
2020-09-18T04:24:24Z,Psoria-Gold,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-based-gel
2020-09-18T04:24:24Z,pterostilbene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794141
2020-09-18T04:24:24Z,pTVG-HP plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ptvg-hp-plasmid-dna-vaccine
2020-09-18T04:24:24Z,Pulmozyme,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dornase-alfa-inhalation-solution
2020-09-18T04:24:24Z,pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pumvc3-higfbp-2-multi-epitope-plasmid-dna-vaccine
2020-09-18T04:24:24Z,pUMVC3-IGFBP2-HER2-IGF1R plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pumvc3-igfbp2-her2-igf1r-plasmid-dna-vaccine
2020-09-18T04:24:24Z,Purinethol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine
2020-09-18T04:24:24Z,Purixan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine
2020-09-18T04:24:24Z,Purixan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine-oral-suspension
2020-09-18T04:24:24Z,Purlytin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rostaporfin
2020-09-18T04:24:24Z,purple grape juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/purple-grape-juice
2020-09-18T04:24:24Z,PV-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pv-10
2020-09-18T04:24:24Z,PV701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pv701
2020-09-18T04:24:24Z,PVA microporous hydrospheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pva-microporous-hydrospheres
2020-09-18T04:24:24Z,PVA microporous hydrospheres/doxorubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pva-microporous-hydrospheres-doxorubicin-hydrochloride
2020-09-18T04:24:24Z,pVAXrcPSAv53l vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pvaxrcpsav53l-vaccine
2020-09-18T04:24:24Z,PVDF/sirolimus topical,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pvdf-sirolimus-topical
2020-09-18T04:24:24Z,Pycnogenol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/french-maritime-pine-bark-extract
2020-09-18T04:24:24Z,pyrazinamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazinamide
2020-09-18T04:24:24Z,pyrazine diazohydroxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazine-diazohydroxide
2020-09-18T04:24:24Z,pyrazofurin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazofurin
2020-09-18T04:24:24Z,pyrazoloacridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazoloacridine
2020-09-18T04:24:24Z,pyridoxine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride
2020-09-18T04:24:24Z,pyrimethamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrimethamine
2020-09-18T04:24:24Z,pyrotinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrotinib
2020-09-18T04:24:24Z,pyroxamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyroxamide
2020-09-18T04:24:24Z,pyrrolobenzodiazepine-based anti-CD19 antibody-drug conjugate SGN-CD19B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrrolobenzodiazepine-based-anti-cd19-antibody-drug-conjugate-sgn-cd19b
2020-09-18T04:24:24Z,pyruvate kinase inhibitor TLN-232,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyruvate-kinase-inhibitor-tln-232
2020-09-18T04:24:24Z,pyrvinium pamoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800895
2020-09-18T04:24:24Z,Q-Can Plus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800204
2020-09-18T04:24:24Z,Qapzola,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone
2020-09-18T04:24:24Z,qilisheng immunoregulatory oral solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794790
2020-09-18T04:24:24Z,Qinlock,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kit-pdgfr-inhibitor-dcc-2618
2020-09-18T04:24:24Z,Qnasl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate
2020-09-18T04:24:24Z,QS21,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/qs21
2020-09-18T04:24:24Z,Quadramet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium
2020-09-18T04:24:24Z,quadrivalent inactivated influenza vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-inactivated-influenza-vaccine
2020-09-18T04:24:24Z,quarfloxacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quarfloxacin
2020-09-18T04:24:24Z,quaternary ammonium polyethylenimine nanoparticles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quaternary-ammonium-polyethylenimine-nanoparticles
2020-09-18T04:24:24Z,Quelicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677
2020-09-18T04:24:24Z,quercetin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quercetin
2020-09-18T04:24:24Z,Quillivant XR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride
2020-09-18T04:24:24Z,quinacrine dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-dihydrochloride
2020-09-18T04:24:24Z,Quinamed,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amonafide-dihydrochloride
2020-09-18T04:24:24Z,quinidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinidine
2020-09-18T04:24:24Z,quinine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinine
2020-09-18T04:24:24Z,quisinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quisinostat
2020-09-18T04:24:24Z,Quixin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levofloxacin
2020-09-18T04:24:24Z,Qvar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate
2020-09-18T04:24:24Z,R-(-)-gossypol acetic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r---gossypol-acetic-acid
2020-09-18T04:24:24Z,R-CHOP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-chop-regimen
2020-09-18T04:24:24Z,R-CVP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-cvp-regimen
2020-09-18T04:24:24Z,R-EPOCH regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-epoch-regimen
2020-09-18T04:24:24Z,R-Gene 10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793609
2020-09-18T04:24:24Z,R-ICE regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-ice-regimen
2020-09-18T04:24:24Z,R(+)XK469,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxk469
2020-09-18T04:24:24Z,R1 Cooling Gel Plus R2 Moisturizing/Sun Protecting Lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r1-cooling-gel-plus-r2-moisturizing-sun-protecting-lotion
2020-09-18T04:24:24Z,rabbit anti-thymocyte globulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793943
2020-09-18T04:24:24Z,rabeprazole sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole-sodium
2020-09-18T04:24:24Z,rabusertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabusertib
2020-09-18T04:24:24Z,racemetyrosine/methoxsalen/phenytoin/sirolimus SM-88,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplastic-agent-combination-sm-88
2020-09-18T04:24:24Z,racemic XK469,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemic-xk469
2020-09-18T04:24:24Z,racotumomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racotumomab
2020-09-18T04:24:24Z,rAD-p53,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rad-p53
2020-09-18T04:24:24Z,RAD51 inhibitor CYT-0851,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799774
2020-09-18T04:24:24Z,RadiaPlex Rx Gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-hyaluronate-topical-hydrogel
2020-09-18T04:24:24Z,radiosensitizer RRx-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radiosensitizer-rrx-001
2020-09-18T04:24:24Z,radium bromatum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797213
2020-09-18T04:24:24Z,radium Ra 223 dichloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride
2020-09-18T04:24:24Z,Radix Angelicae sinensis/Radix Astragali herbal supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radix-angelicae-sinensis-radix-astragali-herbal-supplement
2020-09-18T04:24:24Z,radotinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib-hydrochloride
2020-09-18T04:24:24Z,Raf kinase inhibitor HM95573,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-kinase-inhibitor-hm95573
2020-09-18T04:24:24Z,Raf kinase inhibitor XL281,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-kinase-inhibitor-xl281
2020-09-18T04:24:24Z,Raf/MEK dual kinase inhibitor RO5126766,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-mek-dual-kinase-inhibitor-ro5126766
2020-09-18T04:24:24Z,raloxifene hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride
2020-09-18T04:24:24Z,raltegravir potassium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltegravir-potassium
2020-09-18T04:24:24Z,raltitrexed,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltitrexed
2020-09-18T04:24:24Z,ramelteon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramelteon
2020-09-18T04:24:24Z,ramipril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramipril
2020-09-18T04:24:24Z,ramosetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramosetron-hydrochloride
2020-09-18T04:24:24Z,ramucirumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab
2020-09-18T04:24:24Z,Ranexa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranolazine
2020-09-18T04:24:24Z,ranibizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranibizumab
2020-09-18T04:24:24Z,ranimustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranimustine
2020-09-18T04:24:24Z,ranitidine hydrochloride/bismuth potassium citrate/sucralfate hydrate formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776756
2020-09-18T04:24:24Z,ranolazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranolazine
2020-09-18T04:24:24Z,ranpirnase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ranpirnase
2020-09-18T04:24:24Z,Rapaflo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silodosin
2020-09-18T04:24:24Z,Rapamune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus
2020-09-18T04:24:24Z,rapamycin-polarized Th1/Tc1 autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rapamycin-polarized-th1-tc1-autologous-t-lymphocytes
2020-09-18T04:24:24Z,RARalpha agonist IRX5183,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raralpha-agonist-irx5183
2020-09-18T04:24:24Z,ras peptide cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ras-peptide-cancer-vaccine
2020-09-18T04:24:24Z,rasburicase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasburicase
2020-09-18T04:24:24Z,ravuconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravuconazole
2020-09-18T04:24:24Z,ravulizumab-cwvz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/complement-c5-inhibitor-alxn1210
2020-09-18T04:24:24Z,Rayaldee,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-release-calcifediol-capsule
2020-09-18T04:24:24Z,RayGel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/reduced-glutathione-l-cysteine-anthocyanins-gel
2020-09-18T04:24:24Z,Razadyne,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide
2020-09-18T04:24:24Z,Razadyne ER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797963
2020-09-18T04:24:24Z,razoxane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/razoxane
2020-09-18T04:24:24Z,Re-186 hydroxyethylidene diphosphonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/re-186-hydroxyethylidene-diphosphonate
2020-09-18T04:24:24Z,realgar-Indigo naturalis formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/realgar-indigo-naturalis-formulation
2020-09-18T04:24:24Z,rebamipide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebamipide
2020-09-18T04:24:24Z,rebastinib tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebastinib-tosylate
2020-09-18T04:24:24Z,Rebetol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin
2020-09-18T04:24:24Z,rebimastat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebimastat
2020-09-18T04:24:24Z,Reblozyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luspatercept
2020-09-18T04:24:24Z,Recentin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate
2020-09-18T04:24:24Z,recombinant 70-kD heat-shock protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-70-kd-heat-shock-protein
2020-09-18T04:24:24Z,recombinant adenovirus-hIFN-beta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-hifn-beta
2020-09-18T04:24:24Z,recombinant adenovirus-interferon/Syn3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-interferon-syn3
2020-09-18T04:24:24Z,recombinant adenovirus-L523S vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-l523s-vaccine
2020-09-18T04:24:24Z,recombinant adenovirus-p53 SCH-58500,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-p53-sch-58500
2020-09-18T04:24:24Z,recombinant attenuated Salmonella typhimurium expressing IL-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-attenuated-salmonella-typhimurium-expressing-il-2
2020-09-18T04:24:24Z,recombinant B. pertussis adenylate cyclase toxin-tyrosinase A2 epitope vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/698993
2020-09-18T04:24:24Z,recombinant bacterial minicells VAX014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801175
2020-09-18T04:24:24Z,recombinant bispecific single-chain antibody rM28,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bispecific-single-chain-antibody-rm28
2020-09-18T04:24:24Z,recombinant bovine basic fibroblast growth factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797007
2020-09-18T04:24:24Z,recombinant CD40-ligand,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cd40-ligand
2020-09-18T04:24:24Z,recombinant cell-surface anchored sialidase DAS181,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-cell-surface-anchored-sialidase-das181
2020-09-18T04:24:24Z,recombinant dHER2 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-dher2-vaccine
2020-09-18T04:24:24Z,recombinant DNA-L523S vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-dna-l523s-vaccine
2020-09-18T04:24:24Z,recombinant EphB4-HSA fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-ephb4-hsa-fusion-protein
2020-09-18T04:24:24Z,recombinant Erwinia asparaginase JZP-458,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800241
2020-09-18T04:24:24Z,recombinant flt3 ligand,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-flt3-ligand
2020-09-18T04:24:24Z,recombinant fowlpox GM-CSF vaccine adjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-gm-csf-vaccine-adjuvant
2020-09-18T04:24:24Z,recombinant fowlpox-B7.1 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-b71-vaccine
2020-09-18T04:24:24Z,recombinant fowlpox-CEA(6D)/TRICOM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-cea6d-tricom-vaccine
2020-09-18T04:24:24Z,recombinant fowlpox-prostate specific antigen vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-prostate-specific-antigen-vaccine
2020-09-18T04:24:24Z,recombinant fowlpox-TRICOM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-tricom-vaccine
2020-09-18T04:24:24Z,recombinant fowlpox-tyrosinase vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-tyrosinase-vaccine
2020-09-18T04:24:24Z,recombinant HSA/filgrastim fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794078
2020-09-18T04:24:24Z,recombinant hsp110-gp100 chaperone complex vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-hsp110-gp100-chaperone-complex-vaccine
2020-09-18T04:24:24Z,recombinant human 6Ckine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-6ckine
2020-09-18T04:24:24Z,recombinant human adenovirus type 5 H101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-adenovirus-type-5-h101
2020-09-18T04:24:24Z,recombinant human albumin-human granulocyte colony-stimulating factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-albumin-human-granulocyte-colony-stimulating-factor
2020-09-18T04:24:24Z,recombinant human angiotensin converting enzyme 2 APN01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-angiotensin-converting-enzyme-2-apn01
2020-09-18T04:24:24Z,recombinant human bone morphogenetic protein 2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-bone-morphogenetic-protein-2
2020-09-18T04:24:24Z,recombinant human bone morphogenetic protein 4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-bone-morphogenetic-protein-4
2020-09-18T04:24:24Z,recombinant human chorionic gonadotropin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-chorionic-gonadotropin
2020-09-18T04:24:24Z,recombinant human EGF-rP64K/Montanide ISA 51 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine
2020-09-18T04:24:24Z,recombinant human endostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-endostatin
2020-09-18T04:24:24Z,recombinant human epidermal growth factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-epidermal-growth-factor
2020-09-18T04:24:24Z,recombinant human granulocyte colony-stimulating factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-granulocyte-colony-stimulating-factor
2020-09-18T04:24:24Z,recombinant human hyaluronidase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-hyaluronidase
2020-09-18T04:24:24Z,recombinant human interleukin-15,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-15
2020-09-18T04:24:24Z,recombinant human interleukin-22 IgG2-Fc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-interleukin-22-igg2-fc
2020-09-18T04:24:24Z,recombinant human mannose-binding lectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-mannose-binding-lectin
2020-09-18T04:24:24Z,recombinant human papillomavirus 11-valent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800414
2020-09-18T04:24:24Z,recombinant human papillomavirus bivalent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-bivalent-vaccine
2020-09-18T04:24:24Z,recombinant human papillomavirus nonavalent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine
2020-09-18T04:24:24Z,recombinant human papillomavirus quadrivalent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-quadrivalent-vaccine
2020-09-18T04:24:24Z,recombinant human serum amyloid P/pentraxin 2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-serum-amyloid-p-pentraxin-2
2020-09-18T04:24:24Z,recombinant human stem cell factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-stem-cell-factor
2020-09-18T04:24:24Z,recombinant interferon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon
2020-09-18T04:24:24Z,recombinant interferon alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa
2020-09-18T04:24:24Z,recombinant interferon alfa-2b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b
2020-09-18T04:24:24Z,recombinant interferon Alpha 2b-like protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2b-like-protein
2020-09-18T04:24:24Z,recombinant interferon alpha-1b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-1b
2020-09-18T04:24:24Z,recombinant interferon alpha-2a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a
2020-09-18T04:24:24Z,recombinant interferon beta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta
2020-09-18T04:24:24Z,recombinant interferon gamma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-gamma
2020-09-18T04:24:24Z,recombinant interleukin-1-alpha,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-1-alpha
2020-09-18T04:24:24Z,recombinant interleukin-1-beta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-1-beta
2020-09-18T04:24:24Z,recombinant interleukin-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-12
2020-09-18T04:24:24Z,recombinant interleukin-18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-18
2020-09-18T04:24:24Z,recombinant interleukin-3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-3
2020-09-18T04:24:24Z,recombinant interleukin-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-4
2020-09-18T04:24:24Z,recombinant interleukin-6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6
2020-09-18T04:24:24Z,recombinant interleukin-7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-7
2020-09-18T04:24:24Z,recombinant leukocyte interleukin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-leukocyte-interleukin
2020-09-18T04:24:24Z,recombinant macrophage colony-stimulating factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-macrophage-colony-stimulating-factor
2020-09-18T04:24:24Z,recombinant MAGE-3.1 antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-mage-31-antigen
2020-09-18T04:24:24Z,recombinant MIP1-alpha variant ECI301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-mip1-alpha-variant-eci301
2020-09-18T04:24:24Z,recombinant modified vaccinia Ankara-5T4 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-modified-vaccinia-ankara-5t4-vaccine
2020-09-18T04:24:24Z,recombinant nematode anticoagulant protein c2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-nematode-anticoagulant-protein-c2
2020-09-18T04:24:24Z,recombinant oncolytic poliovirus PVS-RIPO,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oncolytic-poliovirus-pvs-ripo
2020-09-18T04:24:24Z,recombinant Ornithodoros moubata saliva-derived small protein complement C5 inhibitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795332
2020-09-18T04:24:24Z,recombinant oxytocin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oxytocin
2020-09-18T04:24:24Z,recombinant parathyroid hormone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-parathyroid-hormone
2020-09-18T04:24:24Z,recombinant platelet factor 4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-platelet-factor-4
2020-09-18T04:24:24Z,recombinant PRAME protein plus AS15 adjuvant GSK2302025A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-prame-protein-plus-as15-adjuvant-gsk2302025a
2020-09-18T04:24:24Z,recombinant Saccharomyces cerevisia-CEA(610D) vaccine GI-6207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-saccharomyces-cerevisia-cea610d-vaccine-gi-6207
2020-09-18T04:24:24Z,recombinant soluble human CD4 protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-soluble-human-cd4-protein
2020-09-18T04:24:24Z,recombinant super-compound interferon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-super-compound-interferon
2020-09-18T04:24:24Z,recombinant thymosin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thymosin
2020-09-18T04:24:24Z,recombinant thyroid-stimulating hormone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyroid-stimulating-hormone
2020-09-18T04:24:24Z,recombinant thyrotropin alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyrotropin-alfa
2020-09-18T04:24:24Z,recombinant transforming growth factor-beta-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-transforming-growth-factor-beta-2
2020-09-18T04:24:24Z,recombinant tumor necrosis factor family protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tumor-necrosis-factor-family-protein
2020-09-18T04:24:24Z,recombinant tyrosinase-related protein-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tyrosinase-related-protein-2
2020-09-18T04:24:24Z,recombinant vaccinia prostate-specific antigen vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-prostate-specific-antigen-vaccine
2020-09-18T04:24:24Z,recombinant vaccinia-B7.1 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-b71-vaccine
2020-09-18T04:24:24Z,recombinant vaccinia-CEA(6D)-TRICOM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-cea6d-tricom-vaccine
2020-09-18T04:24:24Z,recombinant vaccinia-MUC1 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc1-vaccine
2020-09-18T04:24:24Z,recombinant vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-multiepitope-melanoma-peptides-b71-b72-vaccine
2020-09-18T04:24:24Z,recombinant vaccinia-NY-ESO-1 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-ny-eso-1-vaccine
2020-09-18T04:24:24Z,recombinant vaccinia-TRICOM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-tricom-vaccine
2020-09-18T04:24:24Z,recombinant vesicular stomatitis virus-expressing interferon-beta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vesicular-stomatitis-virus-expressing-interferon-beta
2020-09-18T04:24:24Z,recombinant vesicular stomatitis virus-expressing interferon-beta and tyrosinase-related protein 1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797080
2020-09-18T04:24:24Z,Recombivax HB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine-recombinant
2020-09-18T04:24:24Z,Recorlev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levoketoconazole
2020-09-18T04:24:24Z,Recormon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-beta
2020-09-18T04:24:24Z,Rectoid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,red tomato juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/red-tomato-juice
2020-09-18T04:24:24Z,reduced glutathione-L-cysteine-anthocyanins gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/reduced-glutathione-l-cysteine-anthocyanins-gel
2020-09-18T04:24:24Z,refametinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/refametinib
2020-09-18T04:24:24Z,Regenecare,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/collagen-aloe-vera-vitamin-e-lidocaine-topical-hydrogel
2020-09-18T04:24:24Z,Regitine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phentolamine-mesylate
2020-09-18T04:24:24Z,Reglan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoclopramide-hydrochloride
2020-09-18T04:24:24Z,regorafenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regorafenib
2020-09-18T04:24:24Z,Regular Novolin R,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/insulin-regular
2020-09-18T04:24:24Z,relacorilant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucocorticoid-receptor-antagonist-cort125134
2020-09-18T04:24:24Z,related donor adenovirus-specific cytotoxic T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793864
2020-09-18T04:24:24Z,relatlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-bms-986016
2020-09-18T04:24:24Z,Relenza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanamivir
2020-09-18T04:24:24Z,Relistor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylnaltrexone-bromide
2020-09-18T04:24:24Z,relugolix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relugolix
2020-09-18T04:24:24Z,Remeron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirtazapine
2020-09-18T04:24:24Z,remestemcel-L,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remestemcel-l
2020-09-18T04:24:24Z,Remicade,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab
2020-09-18T04:24:24Z,Remifemin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-cohosh
2020-09-18T04:24:24Z,remifentanil hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remifentanil-hydrochloride
2020-09-18T04:24:24Z,Reminyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galantamine-hydrobromide
2020-09-18T04:24:24Z,Remitogen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apolizumab
2020-09-18T04:24:24Z,renal cell carcinoma peptides vaccine IMA901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/renal-cell-carcinoma-peptides-vaccine-ima901
2020-09-18T04:24:24Z,renal cell carcinoma/CD40L RNA-transfected autologous dendritic cell vaccine AGS-003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/599024
2020-09-18T04:24:24Z,Rencarex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab
2020-09-18T04:24:24Z,Renova,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
2020-09-18T04:24:24Z,Reolysin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wild-type-reovirus
2020-09-18T04:24:24Z,repaglinide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repaglinide
2020-09-18T04:24:24Z,reparixin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/reparixin
2020-09-18T04:24:24Z,RepHresh Pro-B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792864
2020-09-18T04:24:24Z,repotrectinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-ros1-ntrk-src-multi-kinase-inhibitor-tpx-0005
2020-09-18T04:24:24Z,Requip,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropinirole-hydrochloride
2020-09-18T04:24:24Z,Resectisol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannitol
2020-09-18T04:24:24Z,Resimmune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1
2020-09-18T04:24:24Z,resiniferatoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiniferatoxin
2020-09-18T04:24:24Z,resiquimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod
2020-09-18T04:24:24Z,resiquimod gel CD11301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792492
2020-09-18T04:24:24Z,resiquimod topical gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod-topical-gel
2020-09-18T04:24:24Z,resistant starch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resistant-starch
2020-09-18T04:24:24Z,resminostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resminostat
2020-09-18T04:24:24Z,Respbid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,Restasis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine-ophthalmic-emulsion
2020-09-18T04:24:24Z,resveratrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resveratrol
2020-09-18T04:24:24Z,resveratrol formulation SRT501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resveratrol-formulation-srt501
2020-09-18T04:24:24Z,RET inhibitor DS-5010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796992
2020-09-18T04:24:24Z,RET/SRC inhibitor TPX-0046,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802260
2020-09-18T04:24:24Z,Retacrit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoetin-alfa
2020-09-18T04:24:24Z,retaspimycin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retaspimycin-hydrochloride
2020-09-18T04:24:24Z,Retevmo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-loxo-292
2020-09-20T05:26:50Z,retifanlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-mga012
2020-09-18T04:24:24Z,Retin-A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
2020-09-18T04:24:24Z,Retin-A MICRO,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
2020-09-18T04:24:24Z,retinoid 9cUAB30,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinoid-9cuab30
2020-09-18T04:24:24Z,retinoid X receptor agonist IRX4204,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinoid-x-receptor-agonist-irx4204
2020-09-18T04:24:24Z,retinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinol
2020-09-18T04:24:24Z,retinyl acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retinyl-acetate
2020-09-18T04:24:24Z,retrovector encoding mutant anti-cyclin G1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1
2020-09-18T04:24:24Z,Retrovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine
2020-09-18T04:24:24Z,Revia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naltrexone-hydrochloride
2020-09-18T04:24:24Z,Revival,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-protein-isolate
2020-09-18T04:24:24Z,Revlimid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenalidomide
2020-09-18T04:24:24Z,RevM10 gene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/revm10-gene
2020-09-18T04:24:24Z,REXIN-G,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retrovector-encoding-mutant-anti-cyclin-g1
2020-09-18T04:24:24Z,rexinoid NRX194204,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rexinoid-nrx194204
2020-09-18T04:24:24Z,Rezulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone
2020-09-18T04:24:24Z,RFT5-dgA immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rft5-dga-immunotoxin
2020-09-18T04:24:24Z,rhEndostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-endostatin
2020-09-18T04:24:24Z,rhenium Re 188 BMEDA-liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-bmeda-liposome
2020-09-18T04:24:24Z,rhenium Re 188 ethiodized oil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-ethiodized-oil
2020-09-18T04:24:24Z,rhenium Re 188 etidronate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795714
2020-09-18T04:24:24Z,Rheumatrex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate
2020-09-18T04:24:24Z,rhizoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhizoxin
2020-09-18T04:24:24Z,RhoC peptide vaccine RV001V,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793139
2020-09-18T04:24:24Z,rhubarb/licorice herbal supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhubarb-licorice-herbal-supplement
2020-09-18T04:24:24Z,ribavirin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin
2020-09-18T04:24:24Z,ribociclib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribociclib
2020-09-18T04:24:24Z,riboflavin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riboflavin
2020-09-18T04:24:24Z,ribonuclease QBI-139,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribonuclease-qbi-139
2020-09-18T04:24:24Z,ribosome-inactivating protein CY503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribosome-inactivating-protein-cy503
2020-09-18T04:24:24Z,Riboxamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiazofurin
2020-09-18T04:24:24Z,rice bran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rice-bran
2020-09-18T04:24:24Z,ricolinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ricolinostat
2020-09-18T04:24:24Z,ridaforolimus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ridaforolimus
2020-09-18T04:24:24Z,Ridaura,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/auranofin
2020-09-18T04:24:24Z,rifabutin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rifabutin
2020-09-18T04:24:24Z,rifaximin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rifaximin
2020-09-18T04:24:24Z,RIG-I selective ligand RGT100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792545
2020-09-18T04:24:24Z,rigosertib sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium
2020-09-18T04:24:24Z,rilimogene galvacirepvec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec
2020-09-18T04:24:24Z,rilimogene galvacirepvec/rilimogene glafolivec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec
2020-09-18T04:24:24Z,rilimogene glafolivec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-fowlpox-psal-155tricom-vaccine
2020-09-18T04:24:24Z,rilotumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilotumumab
2020-09-18T04:24:24Z,Rilutek,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riluzole
2020-09-18T04:24:24Z,riluzole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riluzole
2020-09-18T04:24:24Z,rimiducid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rimiducid
2020-09-18T04:24:24Z,rindopepimut,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rindopepimut
2020-09-18T04:24:24Z,rintatolimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod
2020-09-18T04:24:24Z,Riomet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride
2020-09-18T04:24:24Z,RIPK1 inhibitor GSK3145095,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795835
2020-09-18T04:24:24Z,ripretinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kit-pdgfr-inhibitor-dcc-2618
2020-09-18T04:24:24Z,risedronate sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risedronate-sodium
2020-09-18T04:24:24Z,risperidone formulation in rumenic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/risperidone-formulation-in-rumenic-acid
2020-09-18T04:24:24Z,Ritalin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylphenidate-hydrochloride
2020-09-18T04:24:24Z,ritonavir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ritonavir
2020-09-18T04:24:24Z,Rituxan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab
2020-09-18T04:24:24Z,Rituxan Hycela,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-and-hyaluronidase-human
2020-09-18T04:24:24Z,rituximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab
2020-09-18T04:24:24Z,rituximab and hyaluronidase human,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-and-hyaluronidase-human
2020-09-18T04:24:24Z,rituximab conjugate CON-4619,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792533
2020-09-18T04:24:24Z,RIVAC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794075
2020-09-18T04:24:24Z,rivaroxaban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivaroxaban
2020-09-18T04:24:24Z,rivastigmine tartrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivastigmine-tartrate
2020-09-18T04:24:24Z,rivogenlecleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-t-lymphocytes-bpx-501
2020-09-18T04:24:24Z,rizatriptan benzoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rizatriptan-benzoate
2020-09-18T04:24:24Z,RK-0202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rk-0202
2020-09-18T04:24:24Z,RNA electroporated CD19CAR-CD3zeta-4-1BB-expressing autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/766088
2020-09-18T04:24:24Z,RNAdjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792862
2020-09-18T04:24:24Z,RNR inhibitor COH29,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rnr-inhibitor-coh29
2020-09-18T04:24:24Z,robatumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/robatumumab
2020-09-18T04:24:24Z,Robimycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin
2020-09-18T04:24:24Z,Robinul,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycopyrrolate
2020-09-18T04:24:24Z,ROBO1-targeted BiCAR-NKT cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801656
2020-09-18T04:24:24Z,Rocaltrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcitriol
2020-09-18T04:24:24Z,Rocephin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftriaxone-sodium
2020-09-18T04:24:24Z,rociletinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rociletinib
2020-09-18T04:24:24Z,ROCK2 inhibitor KD025,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rock2-inhibitor-kd025
2020-09-18T04:24:24Z,rocuronium bromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocuronium-bromide
2020-09-18T04:24:24Z,rofecoxib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rofecoxib
2020-09-18T04:24:24Z,Roferon-A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alpha-2a
2020-09-18T04:24:24Z,roflumilast,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roflumilast
2020-09-18T04:24:24Z,rolapitant hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride
2020-09-18T04:24:24Z,Rolontis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/long-acting-granulocyte-colony-stimulating-factor-receptor-spi-2012
2020-09-18T04:24:24Z,romidepsin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romidepsin
2020-09-18T04:24:24Z,romiplostim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romiplostim
2020-09-18T04:24:24Z,Romozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone
2020-09-18T04:24:24Z,roniciclib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roniciclib
2020-09-18T04:24:24Z,ropidoxuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropidoxuridine
2020-09-18T04:24:24Z,ropinirole hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropinirole-hydrochloride
2020-09-18T04:24:24Z,ropivacaine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropivacaine-hydrochloride
2020-09-18T04:24:24Z,roquinimex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roquinimex
2020-09-18T04:24:24Z,ROR1 CAR-specific autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ror1-car-specific-autologous-t-lymphocytes
2020-09-18T04:24:24Z,RORgamma agonist LYC-55716,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rorgamma-agonist-lyc-55716
2020-09-18T04:24:24Z,rosiglitazone maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosiglitazone-maleate
2020-09-18T04:24:24Z,rostaporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rostaporfin
2020-09-18T04:24:24Z,rosuvastatin calcium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosuvastatin-calcium
2020-09-18T04:24:24Z,Rotarix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rotavirus-vaccine
2020-09-18T04:24:24Z,rotavirus vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rotavirus-vaccine
2020-09-18T04:24:24Z,Rou Cong Rong,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rou-cong-rong
2020-09-18T04:24:24Z,rovalpituzumab tesirine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rovalpituzumab-tesirine
2020-09-18T04:24:24Z,Rowasa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesalamine
2020-09-18T04:24:24Z,roxadustat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roxadustat
2020-09-18T04:24:24Z,Roxanol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,Roxicodone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxycodone-hydrochloride
2020-09-18T04:24:24Z,Rozerem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramelteon
2020-09-18T04:24:24Z,Rozlytrek,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib
2020-09-18T04:24:24Z,RP-Mycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erythromycin
2020-09-18T04:24:24Z,RSK1-4 inhibitor PMD-026,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799807
2020-09-18T04:24:24Z,RSV fusion inhibitor GS-5806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rsv-fusion-inhibitor-gs-5806
2020-09-18T04:24:24Z,RSV fusion protein inhibitor JNJ-53718678,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799775
2020-09-18T04:24:24Z,rubitecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rubitecan
2020-09-18T04:24:24Z,Rubraca,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-camsylate
2020-09-18T04:24:24Z,rucaparib camsylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-camsylate
2020-09-18T04:24:24Z,rucaparib phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-phosphate
2020-09-18T04:24:24Z,ruthenium Ru 106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-ru-106
2020-09-18T04:24:24Z,ruthenium-based photosensitizer TLD1411,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792528
2020-09-18T04:24:24Z,ruthenium-based small molecule therapeutic BOLD-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801840
2020-09-18T04:24:24Z,ruthenium-based transferrin targeting agent NKP-1339,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-transferrin-targeting-agent-nkp-1339
2020-09-18T04:24:24Z,Ruxience,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab
2020-09-18T04:24:24Z,ruxolitinib phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate
2020-09-18T04:24:24Z,Rydapt,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin
2020-09-18T04:24:24Z,S-3304,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-3304
2020-09-18T04:24:24Z,S-adenosyl-L-methionine disulfate p-toluene-sulfonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate
2020-09-18T04:24:24Z,S-adenosylmethionine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosylmethionine
2020-09-18T04:24:24Z,S-equol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-equol
2020-09-18T04:24:24Z,S1P receptor agonist KRP203,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s1p-receptor-agonist-krp203
2020-09-18T04:24:24Z,sabarubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sabarubicin
2020-09-18T04:24:24Z,Saccharomyces boulardii probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saccharomyces-boulardii-probiotic-supplement
2020-09-18T04:24:24Z,sacituzumab govitecan-hziy,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan
2020-09-18T04:24:24Z,sacubitril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798813
2020-09-18T04:24:24Z,safingol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/safingol
2020-09-18T04:24:24Z,sagopilone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone
2020-09-18T04:24:24Z,Salagen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilocarpine-hydrochloride
2020-09-18T04:24:24Z,Salflex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902
2020-09-18T04:24:24Z,salirasib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salirasib
2020-09-18T04:24:24Z,salmonella VNP20009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salmonella-vnp20009
2020-09-18T04:24:24Z,salsalate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902
2020-09-18T04:24:24Z,Salsitab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801902
2020-09-18T04:24:24Z,Salvia hispanica seed,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-hispanica-seed
2020-09-18T04:24:24Z,Salvia officinalis extract tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-officinalis-extract-tablet
2020-09-18T04:24:24Z,SAM-e Complete,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate
2020-09-18T04:24:24Z,Sam68 modulator CWP232291,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sam68-modulator-cwp232291
2020-09-18T04:24:24Z,samalizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samalizumab
2020-09-18T04:24:24Z,samarium Sm 153 lexidronam pentasodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium
2020-09-18T04:24:24Z,samarium Sm 153-DOTMP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799673
2020-09-18T04:24:24Z,Samcyprone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone
2020-09-18T04:24:24Z,Sancuso,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794007
2020-09-18T04:24:24Z,Sancuso,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-transdermal-system
2020-09-18T04:24:24Z,Sandimmun,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine
2020-09-18T04:24:24Z,Sandimmune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine
2020-09-18T04:24:24Z,Sandoglobulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,Sandostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate
2020-09-18T04:24:24Z,Sandostatin Lar Depot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate
2020-09-18T04:24:24Z,Sandostatin pamoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate
2020-09-18T04:24:24Z,Sandostatin pamoate LAR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-pamoate
2020-09-18T04:24:24Z,SangCya,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine
2020-09-18T04:24:24Z,sapacitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapacitabine
2020-09-18T04:24:24Z,sapanisertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapanisertib
2020-09-18T04:24:24Z,sapitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapitinib
2020-09-18T04:24:24Z,saponin-based immunoadjuvant OBI-821,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saponin-based-immunoadjuvant-obi-821
2020-09-18T04:24:24Z,saponin-cholesterol-phospholipid adjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saponin-cholesterol-phospholipid-adjuvant
2020-09-18T04:24:24Z,saquinavir mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saquinavir-mesylate
2020-09-18T04:24:24Z,saracatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saracatinib
2020-09-18T04:24:24Z,Sarasar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonafarnib
2020-09-18T04:24:24Z,Sarclisa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isatuximab
2020-09-18T04:24:24Z,SarCNU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sarcnu
2020-09-18T04:24:24Z,sargramostim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim
2020-09-18T04:24:24Z,sargramostim plasmid DNA hepatocellular carcinoma vaccine adjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim-plasmid-dna-hepatocellular-carcinoma-vaccine-adjuvant
2020-09-18T04:24:24Z,sargramostim plasmid DNA melanoma vaccine adjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim-plasmid-dna-melanoma-vaccine-adjuvant
2020-09-18T04:24:24Z,sargramostim plasmid DNA pancreatic tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim-plasmid-dna-pancreatic-tumor-cell-vaccine
2020-09-18T04:24:24Z,sasanlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-checkpoint-inhibitor-pf-06801591
2020-09-18T04:24:24Z,Sativex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols
2020-09-18T04:24:24Z,satraplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/satraplatin
2020-09-18T04:24:24Z,Satric,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metronidazole-hydrochloride
2020-09-18T04:24:24Z,savolitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volitinib
2020-09-18T04:24:24Z,saw palmetto berry extract supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saw-palmetto-berry-extract-supplement
2020-09-18T04:24:24Z,saxagliptin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saxagliptin-hydrochloride
2020-09-18T04:24:24Z,SB-743921,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sb-743921
2020-09-18T04:24:24Z,SB-AS02B adjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sb-as02b-adjuvant
2020-09-18T04:24:24Z,SB-AS15 adjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sb-as15-adjuvant
2020-09-18T04:24:24Z,Sclerosol Intrapleural Aerosol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talc
2020-09-18T04:24:24Z,Seasonale,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,Seasonique,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,seclidemstat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794410
2020-09-18T04:24:24Z,sedoxantrone trihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sedoxantrone-trihydrochloride
2020-09-18T04:24:24Z,Seigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-fermented-extract
2020-09-18T04:24:24Z,selatinib ditosilate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selatinib-ditosilate
2020-09-18T04:24:24Z,selected vegetables/Sun's soup,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selected-vegetables-suns-soup
2020-09-18T04:24:24Z,selective androgen receptor modulator LY2452473,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-ly2452473
2020-09-18T04:24:24Z,selective androgen receptor modulator RAD140,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-rad140
2020-09-18T04:24:24Z,selective estrogen receptor covalent antagonist H3B-6545,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793979
2020-09-18T04:24:24Z,selective estrogen receptor degrader ARN-810,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-arn-810
2020-09-18T04:24:24Z,selective estrogen receptor degrader AZD9496,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9496
2020-09-18T04:24:24Z,selective estrogen receptor degrader AZD9833,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799429
2020-09-18T04:24:24Z,selective estrogen receptor degrader LX-039,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800319
2020-09-18T04:24:24Z,selective estrogen receptor degrader LY3484356,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802339
2020-09-18T04:24:24Z,selective estrogen receptor degrader SRN-927,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-srn-927
2020-09-18T04:24:24Z,selective estrogen receptor degraderLSZ102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degraderlsz102
2020-09-18T04:24:24Z,selective glucocorticoid receptor antagonist CORT125281,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794071
2020-09-18T04:24:24Z,selective human estrogen-receptor alpha partial agonist TTC-352,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793141
2020-09-18T04:24:24Z,selenium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selenium
2020-09-18T04:24:24Z,seliciclib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seliciclib
2020-09-18T04:24:24Z,selicrelumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonist-monoclonal-antibody-ro7009789
2020-09-18T04:24:24Z,selinexor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor
2020-09-18T04:24:24Z,selpercatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-loxo-292
2020-09-18T04:24:24Z,selumetinib sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib
2020-09-18T04:24:24Z,Selzentry,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraviroc
2020-09-18T04:24:24Z,semaxanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semaxanib
2020-09-18T04:24:24Z,semuloparin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semuloparin
2020-09-18T04:24:24Z,semustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semustine
2020-09-18T04:24:24Z,Seneca Valley virus-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seneca-valley-virus-001
2020-09-18T04:24:24Z,senna extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/senna-extract
2020-09-18T04:24:24Z,senna fruit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/senna-fruit
2020-09-18T04:24:24Z,Sensipar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinacalcet-hydrochloride
2020-09-18T04:24:24Z,Sensorcaine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupivacaine-hydrochloride
2020-09-18T04:24:24Z,sepantronium bromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sepantronium-bromide
2020-09-18T04:24:24Z,Septra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole
2020-09-18T04:24:24Z,SERD G1T48,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793441
2020-09-18T04:24:24Z,SERD GDC-9545,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792379
2020-09-18T04:24:24Z,SERD SAR439859,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793484
2020-09-18T04:24:24Z,SERD SHR9549,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799640
2020-09-18T04:24:24Z,serdemetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serdemetan
2020-09-18T04:24:24Z,seribantumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seribantumab
2020-09-18T04:24:24Z,serine hydrolase monoacylglycerol lipase inhibitor ABX-1431,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792713
2020-09-18T04:24:24Z,serine protease inhibitor WX-671,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-protease-inhibitor-wx-671
2020-09-18T04:24:24Z,serine/threonine kinase inhibitor XL418,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-threonine-kinase-inhibitor-xl418
2020-09-18T04:24:24Z,Seromycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-cycloserine
2020-09-18T04:24:24Z,Serophene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clomiphene-citrate
2020-09-18T04:24:24Z,serplulimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795682
2020-09-18T04:24:24Z,sertraline hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sertraline-hydrochloride
2020-09-18T04:24:24Z,serum-derived bovine immunoglobulin protein isolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate
2020-09-18T04:24:24Z,sevacizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sevacizumab
2020-09-18T04:24:24Z,seviteronel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seviteronel
2020-09-18T04:24:24Z,sevoflurane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sevoflurane
2020-09-18T04:24:24Z,shark cartilage,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage
2020-09-18T04:24:24Z,shark cartilage extract AE-941,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage-extract-ae-941
2020-09-18T04:24:24Z,sheddase inhibitor INCB007839,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheddase-inhibitor-incb007839
2020-09-18T04:24:24Z,Sheng Di Huang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-di-huang
2020-09-18T04:24:24Z,Sheng-Mai San,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-mai-san
2020-09-18T04:24:24Z,Sheng-Yu-Tang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheng-yu-tang
2020-09-18T04:24:24Z,Shi Pi Yin herbal decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shi-pi-yin-herbal-decoction
2020-09-18T04:24:24Z,Shingrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797077
2020-09-18T04:24:24Z,short chain fatty acid HQK-1004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/short-chain-fatty-acid-hqk-1004
2020-09-18T04:24:24Z,SHP-1 agonist SC-43,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795711
2020-09-18T04:24:24Z,SHP2 inhibitor JAB-3068,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797845
2020-09-18T04:24:24Z,SHP2 inhibitor RMC-4630,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798916
2020-09-18T04:24:24Z,SHP2 inhibitor TNO155,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-tno155
2020-09-18T04:24:24Z,Shu Di Huang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shu-di-huang
2020-09-18T04:24:24Z,sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sialyl-lewis-keyhole-limpet-hemocyanin-conjugate-vaccine
2020-09-18T04:24:24Z,siG12D LODER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sig12d-loder
2020-09-18T04:24:24Z,Sigosix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interleukin-6
2020-09-18T04:24:24Z,silatecan AR-67,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silatecan-ar-67
2020-09-18T04:24:24Z,sildenafil citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sildenafil-citrate
2020-09-18T04:24:24Z,silicon phthalocyanine 4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silicon-phthalocyanine-4
2020-09-18T04:24:24Z,silmitasertib sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib
2020-09-18T04:24:24Z,silodosin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silodosin
2020-09-18T04:24:24Z,siltuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siltuximab
2020-09-18T04:24:24Z,Silvadene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine
2020-09-18T04:24:24Z,silver nitrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-nitrate
2020-09-18T04:24:24Z,silver sulfadiazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine
2020-09-18T04:24:24Z,Silybin-Phytosome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphatidylcholine-bound-silybin
2020-09-18T04:24:24Z,silymarin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silymarin
2020-09-18T04:24:24Z,simeprevir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simeprevir
2020-09-18T04:24:24Z,simethicone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simethicone
2020-09-18T04:24:24Z,simmiparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simmiparib
2020-09-18T04:24:24Z,simmitecan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simmitecan-hydrochloride
2020-09-18T04:24:24Z,simmitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800788
2020-09-18T04:24:24Z,simo decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simo-decoction
2020-09-18T04:24:24Z,Simulect,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/basiliximab
2020-09-18T04:24:24Z,simvastatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simvastatin
2020-09-18T04:24:24Z,Sinemet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793473
2020-09-18T04:24:24Z,Sinequan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxepin-hydrochloride
2020-09-18T04:24:24Z,Singulair,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montelukast-sodium
2020-09-18T04:24:24Z,sintilimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pdcd1-monoclonal-antibody-ibi308
2020-09-18T04:24:24Z,sipjeondaebo-tang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipjeondaebo-tang
2020-09-18T04:24:24Z,siplizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siplizumab
2020-09-18T04:24:24Z,sipuleucel-T,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipuleucel-t
2020-09-18T04:24:24Z,siremadlin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdm2-inhibitor-hdm201
2020-09-18T04:24:24Z,siRNA-expressing SV40 vector,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirna-expressing-sv40-vector
2020-09-18T04:24:24Z,siRNA-transfected peripheral blood mononuclear cells APN401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirna-transfected-peripheral-blood-mononuclear-cells-apn401
2020-09-18T04:24:24Z,sirolimus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus
2020-09-18T04:24:24Z,SIRPa-Fc fusion protein TTI-621,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-fusion-protein-tti-621
2020-09-18T04:24:24Z,SIRPa-Fc-CD40L fusion protein SL-172154,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801935
2020-09-18T04:24:24Z,SIRPa-IgG4-Fc Fusion Protein TTI-622,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793524
2020-09-18T04:24:24Z,sisunatovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801179
2020-09-18T04:24:24Z,sitravatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sitravatinib
2020-09-18T04:24:24Z,sivifene gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sivifene-gel
2020-09-18T04:24:24Z,Sixofilan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran
2020-09-18T04:24:24Z,sizofiran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sizofiran
2020-09-18T04:24:24Z,SK-Diphenhydramine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride
2020-09-18T04:24:24Z,SK-Furosemide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide
2020-09-18T04:24:24Z,SK-Probenecid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probenecid
2020-09-18T04:24:24Z,SLC6A8 inhibitor RGX-202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794147
2020-09-18T04:24:24Z,SLCT inhibitor GNS561,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794352
2020-09-18T04:24:24Z,Slo-bid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,Slo-Phyllin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,SMAC mimetic BI 891065,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793013
2020-09-18T04:24:24Z,Smac mimetic CUDC-427,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-cudc-427
2020-09-18T04:24:24Z,Smac mimetic GDC-0152,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-gdc-0152
2020-09-18T04:24:24Z,SMAC mimetic LCL161,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-lcl161
2020-09-18T04:24:24Z,SMO antagonist BMS 833923,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smo-antagonist-bms-833923
2020-09-18T04:24:24Z,smoked plum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoked-plum
2020-09-18T04:24:24Z,smokeless tobacco,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smokeless-tobacco
2020-09-18T04:24:24Z,Smoothened antagonist LDE225 topical,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoothened-antagonist-lde225-topical
2020-09-18T04:24:24Z,Smoothened antagonist LEQ506,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoothened-antagonist-leq506
2020-09-18T04:24:24Z,SN-38-loaded polymeric micelles NK012,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sn-38-loaded-polymeric-micelles-nk012
2020-09-18T04:24:24Z,SNS01-T nanoparticles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sns01-t-nanoparticles
2020-09-18T04:24:24Z,soblidotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soblidotin
2020-09-18T04:24:24Z,SOD1 inhibitor ATN-224,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sod1-inhibitor-atn-224
2020-09-18T04:24:24Z,sodium alginate microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-alginate-microspheres
2020-09-18T04:24:24Z,sodium bicarbonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate
2020-09-18T04:24:24Z,sodium bicarbonate solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate-solution
2020-09-18T04:24:24Z,sodium bicarbonate/potassium bicarbonate/anhydrous citric acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-bicarbonate-potassium-bicarbonate-anhydrous-citric-acid
2020-09-18T04:24:24Z,sodium biphosphate/sodium phosphate oral laxative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-biphosphate-sodium-phosphate-oral-laxative
2020-09-18T04:24:24Z,sodium borocaptate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-borocaptate
2020-09-18T04:24:24Z,sodium carboxymethylcellulose dressing,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-carboxymethylcellulose-dressing
2020-09-18T04:24:24Z,sodium citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate
2020-09-18T04:24:24Z,sodium dichloroacetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-dichloroacetate
2020-09-18T04:24:24Z,sodium ferric gluconate complex in sucrose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-ferric-gluconate-complex-in-sucrose
2020-09-18T04:24:24Z,sodium fluoride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-fluoride
2020-09-18T04:24:24Z,sodium glycididazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-glycididazole
2020-09-18T04:24:24Z,sodium hyaluronate topical hydrogel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-hyaluronate-topical-hydrogel
2020-09-18T04:24:24Z,sodium iodide I-131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-iodide-i-131
2020-09-18T04:24:24Z,sodium metaarsenite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-metaarsenite
2020-09-18T04:24:24Z,sodium nitrate supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-nitrate-supplement
2020-09-18T04:24:24Z,sodium phenylbutyrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phenylbutyrate
2020-09-18T04:24:24Z,sodium phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phosphate
2020-09-18T04:24:24Z,sodium picosulfate/magnesium oxide/citric acid oral laxative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-picosulfate-magnesium-oxide-citric-acid-oral-laxative
2020-09-18T04:24:24Z,sodium salicylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-salicylate
2020-09-18T04:24:24Z,sodium selenite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-selenite
2020-09-18T04:24:24Z,sodium stibogluconate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-stibogluconate
2020-09-18T04:24:24Z,sodium sulfate/potassium sulfate/magnesium sulfate-based laxative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-sulfate-potassium-sulfate-magnesium-sulfate-based-laxative
2020-09-18T04:24:24Z,sodium thiosulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-thiosulfate
2020-09-18T04:24:24Z,sodium-potassium adenosine triphosphatase inhibitor RX108,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795834
2020-09-18T04:24:24Z,Sodothiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-thiosulfate
2020-09-18T04:24:24Z,sofosbuvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sofosbuvir
2020-09-18T04:24:24Z,Solaraze,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diclofenac-sodium-gel
2020-09-18T04:24:24Z,Solatene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-carotene
2020-09-18T04:24:24Z,Soliris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eculizumab
2020-09-18T04:24:24Z,solitomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/solitomab
2020-09-18T04:24:24Z,Solu-Cortef,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate
2020-09-18T04:24:24Z,soluble guanylate cyclase stimulator IW-1701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793944
2020-09-18T04:24:24Z,somatotropin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatotropin
2020-09-18T04:24:24Z,Somatuline Depot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lanreotide-acetate
2020-09-18T04:24:24Z,Somavert,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegvisomant
2020-09-18T04:24:24Z,Somophyllin-CRT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,Somophyllin-T,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,sonepcizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab
2020-09-18T04:24:24Z,sonidegib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonidegib
2020-09-18T04:24:24Z,sorafenib tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorafenib-tosylate
2020-09-18T04:24:24Z,Sorghum bicolor supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorghum-bicolor-supplement
2020-09-18T04:24:24Z,Soriatane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acitretin
2020-09-18T04:24:24Z,sotagliflozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotagliflozin
2020-09-18T04:24:24Z,sotatercept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotatercept
2020-09-18T04:24:24Z,sotorasib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794411
2020-09-18T04:24:24Z,sotrastaurin acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotrastaurin-acetate
2020-09-18T04:24:24Z,Sotret,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin
2020-09-18T04:24:24Z,soy isoflavones,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-isoflavones
2020-09-18T04:24:24Z,soy lecithin/glycerol dioleate-based oral spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-lecithin-glycerol-dioleate-based-oral-spray
2020-09-18T04:24:24Z,soy protein isolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-protein-isolate
2020-09-18T04:24:24Z,SpagoPix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800590
2020-09-18T04:24:24Z,spanlecortemlocel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-umbilical-cord-blood-product-hsc835
2020-09-18T04:24:24Z,sparfosic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sparfosic-acid
2020-09-18T04:24:24Z,spartalizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spartalizumab
2020-09-18T04:24:24Z,spherical nucleic acid nanoparticle NU-0129,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spherical-nucleic-acid-nanoparticle-nu-0129
2020-09-18T04:24:24Z,Spiriva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiotropium-bromide-monohydrate
2020-09-18T04:24:24Z,spirogermanium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirogermanium
2020-09-18T04:24:24Z,spiromustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spiromustine
2020-09-18T04:24:24Z,spironolactone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spironolactone
2020-09-18T04:24:24Z,spiroplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spiroplatin
2020-09-18T04:24:24Z,spirulina-based dietary supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796977
2020-09-18T04:24:24Z,spleen tyrosine kinase inhibitor TAK-659,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spleen-tyrosine-kinase-inhibitor-tak-659
2020-09-18T04:24:24Z,splicing inhibitor H3B-8800,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/splicing-inhibitor-h3b-8800
2020-09-18T04:24:24Z,Sporanox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itraconazole
2020-09-18T04:24:24Z,Sprycel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasatinib
2020-09-18T04:24:24Z,spyrine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trientine-hydrochloride
2020-09-18T04:24:24Z,SR-T100 gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sr-t100-gel
2020-09-18T04:24:24Z,SR31747A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sr31747a
2020-09-18T04:24:24Z,Src kinase inhibitor KX2-391,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-kinase-inhibitor-kx2-391
2020-09-18T04:24:24Z,Src kinase inhibitor KX2-391 ointment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-kinase-inhibitor-kx2-391-ointment
2020-09-18T04:24:24Z,Src/Abl kinase inhibitor AZD0424,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-abl-kinase-inhibitor-azd0424
2020-09-18T04:24:24Z,src/tubulin inhibitor KX02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/src-tubulin-inhibitor-kx02
2020-09-18T04:24:24Z,SS1(dsFv)-PE38 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ss1dsfv-pe38-immunotoxin
2020-09-18T04:24:24Z,SSD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine
2020-09-18T04:24:24Z,ssRNA-based immunomodulator CV8102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792862
2020-09-18T04:24:24Z,SSTR2-targeting protein/DM1 conjugate PEN-221,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sstr2-targeting-protein-dm1-conjugate-pen-221
2020-09-18T04:24:24Z,St. John's wort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/st-johns-wort
2020-09-18T04:24:24Z,stabilized sulphur hexafluoride microbubble-based contrast agent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stabilized-sulphur-hexafluoride-microbubble-based-contrast-agent
2020-09-18T04:24:24Z,Stakel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padeliporfin
2020-09-18T04:24:24Z,standardized freeze-dried table grape powder,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/standardized-freeze-dried-table-grape-powder
2020-09-18T04:24:24Z,Stanford V regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stanford-v-regimen
2020-09-18T04:24:24Z,staphylococcus aureus protein A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/staphylococcus-aureus-protein-a
2020-09-18T04:24:24Z,Starlix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nateglinide
2020-09-18T04:24:24Z,STAT inhibitor OPB-111077,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat-inhibitor-opb-111077
2020-09-18T04:24:24Z,STAT3 decoy oligonucleotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-decoy-oligonucleotide
2020-09-18T04:24:24Z,STAT3 inhibitor C188-9,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793126
2020-09-18T04:24:24Z,STAT3 inhibitor DSP-0337,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793774
2020-09-18T04:24:24Z,STAT3 inhibitor OPB-31121,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-opb-31121
2020-09-18T04:24:24Z,STAT3 inhibitor OPB-51602,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-opb-51602
2020-09-18T04:24:24Z,STAT3 inhibitor TTI-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796468
2020-09-18T04:24:24Z,Statex SR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/morphine-sulfate
2020-09-18T04:24:24Z,stavudine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stavudine
2020-09-18T04:24:24Z,Stelara,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ustekinumab
2020-09-18T04:24:24Z,Stelazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluoperazine-hydrochloride
2020-09-18T04:24:24Z,Sterile Talc Powder,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talc
2020-09-18T04:24:24Z,Steritalc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talc
2020-09-18T04:24:24Z,steroid sulfatase inhibitor BN 83495,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/steroid-sulfatase-inhibitor-bn-83495
2020-09-18T04:24:24Z,Stilbestrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Stilbetin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Stilboestroform,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Stilboestrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Stimate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desmopressin-acetate
2020-09-18T04:24:24Z,Stimuvax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emepepimut-s
2020-09-18T04:24:24Z,STING agonist BMS-986301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800468
2020-09-18T04:24:24Z,STING agonist GSK3745417,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800130
2020-09-18T04:24:24Z,STING agonist IMSA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800118
2020-09-18T04:24:24Z,STING agonist MK-1454,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-mk-1454
2020-09-18T04:24:24Z,STING agonist SB 11285,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799980
2020-09-18T04:24:24Z,STING agonist TAK-676,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801843
2020-09-18T04:24:24Z,STING-activating cyclic dinucleotide agonist ADU-S100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-adu-s100
2020-09-18T04:24:24Z,STING-expressing E. coli SYNB1891,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800451
2020-09-18T04:24:24Z,Stivarga,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regorafenib
2020-09-18T04:24:24Z,Stoxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idoxuridine
2020-09-18T04:24:24Z,Strattera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atomoxetine-hydrochloride
2020-09-18T04:24:24Z,strawberry-blackberry-black raspberry-blueberry berry mixture,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/strawberry-blackberry-black-raspberry-blueberry-berry-mixture
2020-09-18T04:24:24Z,streptavidin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptavidin
2020-09-18T04:24:24Z,streptonigrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptonigrin
2020-09-18T04:24:24Z,streptozocin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin
2020-09-18T04:24:24Z,Stromagen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-expanded-mesenchymal-stem-cells-oti-010
2020-09-18T04:24:24Z,strontium chloride Sr 89,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/strontium-chloride-sr-89
2020-09-18T04:24:24Z,SU014813,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/su014813
2020-09-18T04:24:24Z,Sublimaze,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate
2020-09-18T04:24:24Z,submicron particle paclitaxel sterile suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799071
2020-09-18T04:24:24Z,substance P-saporin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/substance-p-saporin
2020-09-18T04:24:24Z,succimer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798947
2020-09-18T04:24:24Z,succinylcholine chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795677
2020-09-18T04:24:24Z,Sufenta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sufentanil-citrate
2020-09-18T04:24:24Z,sufentanil citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sufentanil-citrate
2020-09-18T04:24:24Z,sufentanil transdermal system,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sufentanil-transdermal-system
2020-09-18T04:24:24Z,Sufortan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/penicillamine
2020-09-18T04:24:24Z,sugammadex sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugammadex-sodium
2020-09-18T04:24:24Z,Sulfamethoprim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole
2020-09-18T04:24:24Z,sulfasalazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfasalazine
2020-09-18T04:24:24Z,sulfatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfatinib
2020-09-18T04:24:24Z,Sulfatrim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole
2020-09-18T04:24:24Z,Sulforadex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-alpha-cyclodextrin-complex-sfx-01
2020-09-18T04:24:24Z,sulforaphane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane
2020-09-18T04:24:24Z,sulforaphane/alpha-cyclodextrin complex SFX-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-alpha-cyclodextrin-complex-sfx-01
2020-09-18T04:24:24Z,sulfur hexafluoride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfur-hexafluoride
2020-09-18T04:24:24Z,sulfur hexafluoride lipid microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802160
2020-09-18T04:24:24Z,sulindac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulindac
2020-09-18T04:24:24Z,Sulmeprim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole
2020-09-18T04:24:24Z,sulofenur,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulofenur
2020-09-18T04:24:24Z,sumac/black cumin powder,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumac-black-cumin-powder
2020-09-18T04:24:24Z,sumatriptan succinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumatriptan-succinate
2020-09-18T04:24:24Z,sumoylation inhibitor TAK-981,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795544
2020-09-18T04:24:24Z,sunitinib malate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate
2020-09-18T04:24:24Z,sunscreen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunscreen
2020-09-18T04:24:24Z,Supect,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib-hydrochloride
2020-09-18T04:24:24Z,super enhancer inhibitor GZ17-6.02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797048
2020-09-18T04:24:24Z,superagonist interleukin-15:interleukin-15 receptor alphaSu/Fc fusion complex N-803,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751380
2020-09-18T04:24:24Z,superoxide dismutasemimetic GC4711,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802254
2020-09-18T04:24:24Z,supersaturated calcium phosphate rinse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/supersaturated-calcium-phosphate-rinse
2020-09-18T04:24:24Z,supinoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-p68-inhibitor-rx-5902
2020-09-18T04:24:24Z,Supprelin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histrelin-acetate
2020-09-18T04:24:24Z,Suprane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desflurane
2020-09-18T04:24:24Z,Suprax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefixime
2020-09-18T04:24:24Z,Suprep®,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-sulfate-potassium-sulfate-magnesium-sulfate-based-laxative
2020-09-18T04:24:24Z,suramin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium
2020-09-18T04:24:24Z,survivin antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-antigen
2020-09-18T04:24:24Z,survivin antigen vaccine DPX-Survivac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-antigen-vaccine-dpx-survivac
2020-09-18T04:24:24Z,survivin mRNA antagonist EZN-3042,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-mrna-antagonist-ezn-3042
2020-09-18T04:24:24Z,survivin Sur1M2 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-sur1m2-peptide-vaccine
2020-09-18T04:24:24Z,survivin-expressing CVD908ssb-TXSVN vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797123
2020-09-18T04:24:24Z,survivin/p53/HER2 antigen-loaded autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-p53-her2-antigen-loaded-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,sustained-exposure dexamethasone formulation OTO-104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-exposure-dexamethasone-formulation-oto-104
2020-09-18T04:24:24Z,sustained-release mitomycin C hydrogel formulation UGN-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation
2020-09-18T04:24:24Z,Sustiva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efavirenz
2020-09-18T04:24:24Z,Sustol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794007
2020-09-18T04:24:24Z,Sustol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-granisetron-polymer-formulation
2020-09-18T04:24:24Z,Sutent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate
2020-09-18T04:24:24Z,sutimlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793893
2020-09-18T04:24:24Z,SVN53-67/M57-KLH peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/svn53-67-m57-klh-peptide-vaccine
2020-09-18T04:24:24Z,Syk inhibitor HMPL-523,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/syk-inhibitor-hmpl-523
2020-09-18T04:24:24Z,Sylatron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2b
2020-09-18T04:24:24Z,Sylvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siltuximab
2020-09-18T04:24:24Z,Symadine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride
2020-09-18T04:24:24Z,Symbicort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol
2020-09-18T04:24:24Z,Symmetrel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amantadine-hydrochloride
2020-09-18T04:24:24Z,Sympt-X,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine
2020-09-18T04:24:24Z,Sympt-X G.I.,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutamine
2020-09-18T04:24:24Z,synbiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synbiotic-supplement
2020-09-18T04:24:24Z,Syndros,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol
2020-09-18T04:24:24Z,Synestrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Synribo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omacetaxine-mepesuccinate
2020-09-18T04:24:24Z,synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-brain-tumor-peptides-pulsed-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-breast-cancer-peptides-tetanus-toxoid-montanide-isa-51-vaccine
2020-09-18T04:24:24Z,synthetic breast cancer peptides-tetanus toxoid-poly ICLC vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-breast-cancer-peptides-tetanus-toxoid-poly-iclc-vaccine
2020-09-18T04:24:24Z,synthetic colorectal tumor-associated peptides vaccine IMA910,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-colorectal-tumor-associated-peptides-vaccine-ima910
2020-09-18T04:24:24Z,synthetic glioblastoma mutated tumor-specific peptides vaccine therapy APVAC2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761688
2020-09-18T04:24:24Z,synthetic glioblastoma tumor-associated peptides vaccine therapy APVAC1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-glioblastoma-tumor-associated-peptides-vaccine-therapy-apvac1
2020-09-18T04:24:24Z,synthetic hTERT DNA vaccine INO-1400,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-htert-dna-vaccine-ino-1400
2020-09-18T04:24:24Z,synthetic human papillomavirus 16 E6 peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-papillomavirus-16-e6-peptide
2020-09-18T04:24:24Z,synthetic human secretin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-human-secretin
2020-09-18T04:24:24Z,synthetic hypericin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-hypericin
2020-09-18T04:24:24Z,synthetic long E6 peptide-Toll-like receptor ligand conjugate vaccine ISA201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/784216
2020-09-18T04:24:24Z,synthetic long E6/E7 peptides vaccine HPV-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-e6-e7-peptides-vaccine-hpv-01
2020-09-18T04:24:24Z,synthetic long HPV16 E6/E7 peptides vaccine ISA101b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793552
2020-09-18T04:24:24Z,tapentadol hydrochloride ER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tapentadol-hydrochloride-er
2020-09-18T04:24:24Z,synthetic melanoma-associated antigens vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-melanoma-associated-antigens-vaccine
2020-09-18T04:24:24Z,synthetic peptide-based erythropoiesis stimulating agent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-peptide-based-erythropoiesis-stimulating-agent
2020-09-18T04:24:24Z,synthetic peptides E-PRA and E-PSM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-peptides-e-pra-and-e-psm-vaccine
2020-09-18T04:24:24Z,synthetic plumbagin PCUR-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792711
2020-09-18T04:24:24Z,synthetic TERT DNA vaccine INO-1401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-tert-dna-vaccine-ino-1401
2020-09-18T04:24:24Z,synthetic vaccine particles-rapamycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792481
2020-09-18T04:24:24Z,Synthoestrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Synthroid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/39298
2020-09-18T04:24:24Z,Synthroid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levothyroxine-sodium
2020-09-18T04:24:24Z,Syntocinon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oxytocin
2020-09-18T04:24:24Z,T-Guard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799985
2020-09-18T04:24:24Z,T-Phyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,T1E28z CAR-expressing autologous CD4-positive T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t1e28z-car-expressing-autologous-cd4-positive-t-lymphocytes
2020-09-18T04:24:24Z,T900607,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t900607
2020-09-18T04:24:24Z,Tab-cel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147
2020-09-18T04:24:24Z,tabalumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabalumab
2020-09-18T04:24:24Z,tabelecleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792147
2020-09-18T04:24:24Z,Tabloid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine
2020-09-18T04:24:24Z,Tabrecta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib
2020-09-18T04:24:24Z,TAC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tac-regimen
2020-09-18T04:24:24Z,tacedinaline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacedinaline
2020-09-18T04:24:24Z,TachoSil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-fibrin-sealant-patch
2020-09-18T04:24:24Z,tacrolimus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus
2020-09-18T04:24:24Z,tadalafil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tadalafil
2020-09-18T04:24:24Z,tafamidis meglumine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafamidis-meglumine
2020-09-18T04:24:24Z,tafasitamab-cxix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-xmab5574
2020-09-18T04:24:24Z,Tafinlar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib
2020-09-20T05:26:50Z,Tag7 gene-modified vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802329
2020-09-18T04:24:24Z,Tagamet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cimetidine
2020-09-18T04:24:24Z,tagraxofusp-erzs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dt388il3-fusion-protein-sl-401
2020-09-18T04:24:24Z,Tagrisso,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osimertinib
2020-09-18T04:24:24Z,Takecab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793169
2020-09-18T04:24:24Z,talabostat mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talabostat-mesylate
2020-09-18T04:24:24Z,talacotuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talacotuzumab
2020-09-18T04:24:24Z,talactoferrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talactoferrin
2020-09-18T04:24:24Z,taladegib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taladegib
2020-09-18T04:24:24Z,talampanel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talampanel
2020-09-18T04:24:24Z,talaporfin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talaporfin-sodium
2020-09-18T04:24:24Z,talazoparib tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib
2020-09-18T04:24:24Z,talc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talc
2020-09-18T04:24:24Z,TALEN-edited HPV16/18 E6/E7 plasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792535
2020-09-18T04:24:24Z,talimogene laherparepvec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talimogene-laherparepvec
2020-09-18T04:24:24Z,Tality,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802067
2020-09-18T04:24:24Z,talmapimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talmapimod
2020-09-18T04:24:24Z,talotrexin ammonium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talotrexin-ammonium
2020-09-18T04:24:24Z,taltirelin hydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taltirelin-hydrate
2020-09-18T04:24:24Z,Talzenna,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib
2020-09-18T04:24:24Z,TAM/c-Met inhibitor RXDX-106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793447
2020-09-18T04:24:24Z,tamibarotene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamibarotene
2020-09-18T04:24:24Z,Tamiflu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oseltamivir-phosphate
2020-09-18T04:24:24Z,tamoxifen citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate
2020-09-18T04:24:24Z,tamsulosin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamsulosin-hydrochloride
2020-09-18T04:24:24Z,tandutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tandutinib
2020-09-18T04:24:24Z,tanespimycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanespimycin
2020-09-18T04:24:24Z,tanezumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanezumab
2020-09-18T04:24:24Z,tangerine tomato juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tangerine-tomato-juice
2020-09-18T04:24:24Z,tanibirumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanibirumab
2020-09-18T04:24:24Z,tanomastat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanomastat
2020-09-18T04:24:24Z,Tarceva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride
2020-09-18T04:24:24Z,tarenflurbil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarenflurbil
2020-09-18T04:24:24Z,tarextumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarextumab
2020-09-18T04:24:24Z,Targocid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teicoplanin
2020-09-18T04:24:24Z,Targretin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bexarotene
2020-09-18T04:24:24Z,tariquidar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tariquidar
2020-09-18T04:24:24Z,TARP 27-35 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarp-27-35-peptide-vaccine
2020-09-18T04:24:24Z,TARP 29-37-9V peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarp-29-37-9v-peptide-vaccine
2020-09-18T04:24:24Z,Tarvacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bavituximab
2020-09-18T04:24:24Z,TAS-108,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tas-108
2020-09-18T04:24:24Z,tasadenoturev-infected allogeneic bone marrow-derived mesenchymal stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797921
2020-09-18T04:24:24Z,taselisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taselisib
2020-09-18T04:24:24Z,Tasigna,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib
2020-09-18T04:24:24Z,tasisulam sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasisulam-sodium
2020-09-18T04:24:24Z,Tasmar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolcapone
2020-09-18T04:24:24Z,tasquinimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasquinimod
2020-09-18T04:24:24Z,taurolidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurolidine
2020-09-18T04:24:24Z,taurultam analogue GP-2250,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797809
2020-09-18T04:24:24Z,Tavalisse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fostamatinib-disodium
2020-09-18T04:24:24Z,Tavocept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna
2020-09-18T04:24:24Z,tavokinogene telseplasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795694
2020-09-18T04:24:24Z,taxol analogue SID 530,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taxol-analogue-sid-530
2020-09-18T04:24:24Z,Taxoprexin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dha-paclitaxel
2020-09-18T04:24:24Z,Taxotere,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel
2020-09-18T04:24:24Z,tazarotene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene
2020-09-18T04:24:24Z,tazemetostat hydrobromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazemetostat
2020-09-18T04:24:24Z,Tazicef,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftazidime-sodium
2020-09-18T04:24:24Z,Tazorac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazarotene
2020-09-18T04:24:24Z,Tazverik,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazemetostat
2020-09-18T04:24:24Z,Tc 99m sestamibi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tc-99m-sestamibi
2020-09-18T04:24:24Z,TCR alpha/beta/CD19-depleted allogeneic hematopoietic progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796921
2020-09-18T04:24:24Z,"TCR-specific, alpha fetoprotein-enhanced autologous T lymphocytes",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-specific-alpha-fetoprotein-enhanced-autologous-t-lymphocytes
2020-09-18T04:24:24Z,Tecartus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802259
2020-09-18T04:24:24Z,Tecentriq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab
2020-09-18T04:24:24Z,Tecfidera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethyl-fumarate
2020-09-18T04:24:24Z,TechneScan MDP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-methylene-diphosphonate
2020-09-18T04:24:24Z,technetium Tc 94m sestamibi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-94m-sestamibi
2020-09-18T04:24:24Z,technetium Tc 99 hydrazinonicotinamide-tricine-linked interleukin-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99-hydrazinonicotinamide-tricine-linked-interleukin-2
2020-09-18T04:24:24Z,technetium Tc 99m demobesin-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-demobesin-4
2020-09-18T04:24:24Z,technetium Tc 99m DTPA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-dtpa
2020-09-18T04:24:24Z,technetium Tc 99m ethylenedicysteine-deoxyglucose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-ethylenedicysteine-deoxyglucose
2020-09-18T04:24:24Z,technetium Tc 99m galactosyl human serum albumin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-galactosyl-human-serum-albumin
2020-09-18T04:24:24Z,technetium Tc 99m glycopeptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-glycopeptide
2020-09-18T04:24:24Z,technetium Tc 99m human serum albumin colloid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-human-serum-albumin-colloid
2020-09-18T04:24:24Z,technetium Tc 99m hydroxydiphosphonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-hydroxydiphosphonate
2020-09-18T04:24:24Z,technetium Tc 99m mebrofenin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin
2020-09-18T04:24:24Z,technetium Tc 99m methylene diphosphonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-methylene-diphosphonate
2020-09-18T04:24:24Z,technetium Tc 99m sulfur colloid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sulfur-colloid
2020-09-18T04:24:24Z,technetium Tc 99m-3PRGD2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-3prgd2
2020-09-18T04:24:24Z,technetium Tc 99m-labeled albumin microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-albumin-microspheres
2020-09-18T04:24:24Z,technetium Tc 99m-labeled macroaggregated albumin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-macroaggregated-albumin
2020-09-18T04:24:24Z,technetium Tc 99m-labeled tilmanocept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-tilmanocept
2020-09-18T04:24:24Z,technetium Tc 99m-NC100692,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-nc100692
2020-09-18T04:24:24Z,technetium TC-99m,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m
2020-09-18T04:24:24Z,technetium Tc-99m anti-HER2 affibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797157
2020-09-18T04:24:24Z,technetium Tc-99m tetrofosmin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-tetrofosmin
2020-09-18T04:24:24Z,technetium Tc-99m-labeled rhenium sulfide nanocolloid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-labeled-rhenium-sulfide-nanocolloid
2020-09-18T04:24:24Z,tecogalan sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tecogalan-sodium
2020-09-18T04:24:24Z,Tectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrodotoxin
2020-09-18T04:24:24Z,tegafur,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur
2020-09-18T04:24:24Z,tegafur-gimeracil-oteracil potassium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium
2020-09-18T04:24:24Z,tegafur-gimeracil-oteracil potassium-leucovorin calcium oral formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium-leucovorin-calcium-oral-formulation
2020-09-18T04:24:24Z,tegafur-uracil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil
2020-09-18T04:24:24Z,tegavivint,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795712
2020-09-18T04:24:24Z,teglarinad chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teglarinad-chloride
2020-09-18T04:24:24Z,Tegretol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbamazepine
2020-09-18T04:24:24Z,teicoplanin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teicoplanin
2020-09-18T04:24:24Z,telaglenastat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutaminase-inhibitor-cb-839
2020-09-18T04:24:24Z,telaprevir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaprevir
2020-09-18T04:24:24Z,telapristone acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate
2020-09-18T04:24:24Z,telatinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telatinib-mesylate
2020-09-18T04:24:24Z,telavancin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telavancin-hydrochloride
2020-09-18T04:24:24Z,telbivudine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telbivudine
2020-09-18T04:24:24Z,TELCYTA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canfosfamide-hydrochloride
2020-09-18T04:24:24Z,Telintra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezatiostat-hydrochloride
2020-09-18T04:24:24Z,telisotuzumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759579
2020-09-18T04:24:24Z,Telomelysin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telomerase-specific-type-5-adenovirus-obp-301
2020-09-18T04:24:24Z,telomerase-specific type 5 adenovirus OBP-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telomerase-specific-type-5-adenovirus-obp-301
2020-09-18T04:24:24Z,telomerase: 540-548 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telomerase-540-548-peptide-vaccine
2020-09-18T04:24:24Z,telotristat etiprate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate
2020-09-18T04:24:24Z,teloxantrone hydrochoride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochoride
2020-09-18T04:24:24Z,Temferon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801353
2020-09-18T04:24:24Z,Temodar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide
2020-09-18T04:24:24Z,temoporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temoporfin
2020-09-18T04:24:24Z,temozolomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide
2020-09-18T04:24:24Z,Tempol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-piperidine-nitroxide-mts-01
2020-09-18T04:24:24Z,Tempostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halofuginone-hydrobromide
2020-09-18T04:24:24Z,temsirolimus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temsirolimus
2020-09-18T04:24:24Z,tenalisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-gamma-inhibitor-rp6530
2020-09-18T04:24:24Z,tenifatecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenifatecan
2020-09-18T04:24:24Z,teniposide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide
2020-09-18T04:24:24Z,tenofovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir
2020-09-18T04:24:24Z,tenofovir disoproxil fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir-disoproxil-fumarate
2020-09-18T04:24:24Z,teprotumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teprotumumab
2020-09-18T04:24:24Z,terameprocol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terameprocol
2020-09-18T04:24:24Z,terephthalamidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terephthalamidine
2020-09-18T04:24:24Z,terlipressin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794786
2020-09-18T04:24:24Z,teroxirone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teroxirone
2020-09-18T04:24:24Z,tertomotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tertomotide
2020-09-18T04:24:24Z,tesetaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesetaxel
2020-09-18T04:24:24Z,tesevatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesevatinib
2020-09-18T04:24:24Z,Teslac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testolactone
2020-09-18T04:24:24Z,Testate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022
2020-09-18T04:24:24Z,Testoderm,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone
2020-09-18T04:24:24Z,testolactone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testolactone
2020-09-18T04:24:24Z,Testolin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone
2020-09-18T04:24:24Z,Testolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-rad140
2020-09-18T04:24:24Z,testosterone cypionate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate
2020-09-18T04:24:24Z,testosterone enanthate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795022
2020-09-18T04:24:24Z,testosterone gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-gel
2020-09-18T04:24:24Z,testosterone undecanoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-undecanoate
2020-09-18T04:24:24Z,testosterone vaginal cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-vaginal-cream
2020-09-18T04:24:24Z,Testostroval,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone
2020-09-18T04:24:24Z,Testostroval-PA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone
2020-09-18T04:24:24Z,Testro AQ,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone
2020-09-18T04:24:24Z,tetanus peptide melanoma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-peptide-melanoma-vaccine
2020-09-18T04:24:24Z,tetanus toxoid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-toxoid
2020-09-18T04:24:24Z,tetanus toxoid helper peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-toxoid-helper-peptide
2020-09-18T04:24:24Z,tetanus-CMV fusion peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-cmv-fusion-peptide-vaccine
2020-09-18T04:24:24Z,TetMYB vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793449
2020-09-18T04:24:24Z,tetracycline antibiotic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-antibiotic
2020-09-18T04:24:24Z,tetracycline hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetracycline-hydrochloride
2020-09-18T04:24:24Z,tetradecanoylphorbol acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetradecanoylphorbol-acetate
2020-09-18T04:24:24Z,tetrahydrouridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrahydrouridine
2020-09-18T04:24:24Z,tetraphenyl chlorin disulfonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetraphenyl-chlorin-disulfonate
2020-09-18T04:24:24Z,tetravalent RNA-lipoplex cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetravalent-rna-lipoplex-cancer-vaccine
2020-09-18T04:24:24Z,tetrodotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrodotoxin
2020-09-18T04:24:24Z,tezacitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tezacitabine
2020-09-18T04:24:24Z,TGF-beta receptor 1 inhibitor PF-06952229,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798316
2020-09-18T04:24:24Z,TGF-beta receptor 1 kinase inhibitor SH3051,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801834
2020-09-18T04:24:24Z,TGF-beta receptor 1 kinase inhibitor YL-13027,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801356
2020-09-18T04:24:24Z,TGF-beta-resistant LMP-specific cytotoxic T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-resistant-lmp-specific-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,TGFa-PE38 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfa-pe38-immunotoxin
2020-09-18T04:24:24Z,TGFbDNRII-transduced autologous tumor-infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbdnrii-transduced-autologous-tumor-infiltrating-lymphocytes
2020-09-18T04:24:24Z,TGFbeta inhibitor LY3200882,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-inhibitor-ly3200882
2020-09-18T04:24:24Z,TGFbeta receptor ectodomain-IgG Fc fusion protein AVID200,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797961
2020-09-18T04:24:24Z,thalicarpine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalicarpine
2020-09-18T04:24:24Z,thalidomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide
2020-09-18T04:24:24Z,Thalomid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide
2020-09-18T04:24:24Z,Theo-24,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,Theobid Duracap,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,Theochron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,theophylline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,Therapav,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride
2020-09-18T04:24:24Z,therapeutic allogeneic cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-allogeneic-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,therapeutic allogeneic lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-allogeneic-lymphocytes
2020-09-18T04:24:24Z,therapeutic angiotensin-(1-7),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-angiotensin-1-7
2020-09-18T04:24:24Z,therapeutic autologous dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-autologous-dendritic-cells
2020-09-18T04:24:24Z,therapeutic autologous lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-autologous-lymphocytes
2020-09-18T04:24:24Z,therapeutic breast/ovarian/prostate cancer vaccine DPX-0907,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-breast-ovarian-prostate-cancer-vaccine-dpx-0907
2020-09-18T04:24:24Z,therapeutic cancer vaccine ATP128,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799990
2020-09-18T04:24:24Z,therapeutic dendritic cells/cytokine-induced killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-dendritic-cells-cytokine-induced-killer-cells
2020-09-18T04:24:24Z,therapeutic epinephrine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-epinephrine
2020-09-18T04:24:24Z,therapeutic estetrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estetrol
2020-09-18T04:24:24Z,therapeutic estradiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol
2020-09-18T04:24:24Z,therapeutic ex vivo-expanded allogeneic gamma delta T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796746
2020-09-18T04:24:24Z,therapeutic ex-vivo-treated autologous central memory T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794184
2020-09-18T04:24:24Z,therapeutic gamma delta T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-gamma-delta-t-lymphocytes
2020-09-18T04:24:24Z,therapeutic hemin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hemin
2020-09-18T04:24:24Z,therapeutic human antithrombin-III,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-human-antithrombin-iii
2020-09-18T04:24:24Z,therapeutic hydrocortisone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hydrocortisone
2020-09-18T04:24:24Z,therapeutic immune globulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,therapeutic insulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-insulin
2020-09-18T04:24:24Z,therapeutic invariant natural killer T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792638
2020-09-18T04:24:24Z,therapeutic liver cancer peptide vaccine IMA970A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793143
2020-09-18T04:24:24Z,therapeutic lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-lotion
2020-09-18T04:24:24Z,therapeutic melatonin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-melatonin
2020-09-18T04:24:24Z,therapeutic progesterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-progesterone
2020-09-18T04:24:24Z,therapeutic testosterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-testosterone
2020-09-18T04:24:24Z,therapeutic triiodothyronine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-triiodothyronine
2020-09-18T04:24:24Z,therapeutic tumor infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-tumor-infiltrating-lymphocytes
2020-09-18T04:24:24Z,TheraSphere,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-glass-microspheres
2020-09-18T04:24:24Z,Thermazene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silver-sulfadiazine
2020-09-18T04:24:24Z,ThermoDox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposomal-doxorubicin
2020-09-18T04:24:24Z,thiabendazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiabendazole
2020-09-18T04:24:24Z,thiamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiamine
2020-09-18T04:24:24Z,thiarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiarabine
2020-09-18T04:24:24Z,Thibenzole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiabendazole
2020-09-18T04:24:24Z,thioguanine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine
2020-09-18T04:24:24Z,thioredoxin-1 inhibitor PX-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioredoxin-1-inhibitor-px-12
2020-09-18T04:24:24Z,thioridazine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioridazine-hydrochloride
2020-09-18T04:24:24Z,thiotepa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa
2020-09-18T04:24:24Z,thioureidobutyronitrile,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioureidobutyronitrile
2020-09-18T04:24:24Z,THL-P,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thl-p
2020-09-18T04:24:24Z,Thorazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorpromazine
2020-09-18T04:24:24Z,thorium Th 227 anetumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795118
2020-09-18T04:24:24Z,threonine tyrosine kinase inhibitor CFI-402257,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/threonine-tyrosine-kinase-inhibitor-cfi-402257
2020-09-18T04:24:24Z,thrombomodulin alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thrombomodulin-alfa
2020-09-18T04:24:24Z,Thymectacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivudine-phosphoramidate
2020-09-18T04:24:24Z,thymidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidine
2020-09-18T04:24:24Z,thymidylate synthase inhibitor CX1106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800351
2020-09-18T04:24:24Z,thymidylate synthase inhibitor DFP-11207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-dfp-11207
2020-09-18T04:24:24Z,Thymitaq,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nolatrexed-dihydrochloride
2020-09-18T04:24:24Z,Thymoglobulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin
2020-09-18T04:24:24Z,thymopentin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymopentin
2020-09-18T04:24:24Z,Thyrogen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyrotropin-alfa
2020-09-18T04:24:24Z,thyroxine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thyroxine
2020-09-18T04:24:24Z,Thytropar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-thyroid-stimulating-hormone
2020-09-18T04:24:24Z,tiazofurin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiazofurin
2020-09-18T04:24:24Z,tibolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tibolone
2020-09-18T04:24:24Z,Tibsovo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1-inhibitor-ag-120
2020-09-18T04:24:24Z,TICE BCG solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution
2020-09-18T04:24:24Z,tigapotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigapotide
2020-09-18T04:24:24Z,tigatuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigatuzumab
2020-09-18T04:24:24Z,tigecycline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigecycline
2020-09-18T04:24:24Z,TIGIT-targeting agent MK-7684,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigit-targeting-agent-mk-7684
2020-09-18T04:24:24Z,TIL 1383I T cell receptor-transduced autologous T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/til-1383i-t-cell-receptor-transduced-autologous-t-cells
2020-09-18T04:24:24Z,tilarginine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ng-monomethyl-l-arginine
2020-09-18T04:24:24Z,tildrakizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799836
2020-09-18T04:24:24Z,timolol maleate gel forming solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/timolol-maleate-gel-forming-solution
2020-09-18T04:24:24Z,timonacic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/timonacic
2020-09-18T04:24:24Z,Timoptic-XE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/timolol-maleate-gel-forming-solution
2020-09-18T04:24:24Z,Tindamax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole
2020-09-18T04:24:24Z,tinidazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole
2020-09-18T04:24:24Z,tinostamustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-vorinostat-fusion-molecule-edo-s101
2020-09-18T04:24:24Z,tinzaparin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinzaparin-sodium
2020-09-18T04:24:24Z,tiomolibdate diammonium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiomolibdate-diammonium
2020-09-18T04:24:24Z,tiotropium bromide monohydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiotropium-bromide-monohydrate
2020-09-18T04:24:24Z,tipifarnib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipifarnib
2020-09-18T04:24:24Z,tirabrutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirabrutinib
2020-09-18T04:24:24Z,tirapazamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirapazamine
2020-09-18T04:24:24Z,Tirazone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirapazamine
2020-09-18T04:24:24Z,tisagenlecleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisagenlecleucel
2020-09-18T04:24:24Z,tislelizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-bgb-a317
2020-09-18T04:24:24Z,tisotumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tf-monoclonal-antibody-mmae-conjugate
2020-09-18T04:24:24Z,TISSEEL VH,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibrin-sealant
2020-09-18T04:24:24Z,titanium dioxide/zinc oxide sunscreen cream SPF 60,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/titanium-dioxide-zinc-oxide-sunscreen-cream-spf-60
2020-09-18T04:24:24Z,tivantinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tivantinib
2020-09-18T04:24:24Z,Tivicay,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolutegravir
2020-09-18T04:24:24Z,tivozanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tivozanib
2020-09-18T04:24:24Z,tizanidine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tizanidine-hydrochloride
2020-09-18T04:24:24Z,TLR 2/6/9 agonist PUL-042,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-2-6-9-agonist-pul-042
2020-09-18T04:24:24Z,TLR agonist BDB001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795388
2020-09-18T04:24:24Z,TLR agonist BSG-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797412
2020-09-18T04:24:24Z,TLR-directed cationic lipid-DNA complex JVRS-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-directed-cationic-lipid-dna-complex-jvrs-100
2020-09-18T04:24:24Z,TLR4 agonist G100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100
2020-09-18T04:24:24Z,TLR4 agonist GSK1795091,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-gsk1795091
2020-09-18T04:24:24Z,TLR7 agonist ANA773 tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-ana773-tosylate
2020-09-18T04:24:24Z,TLR7 agonist BNT411,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800313
2020-09-18T04:24:24Z,TLR7 agonist LHC165,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800232
2020-09-18T04:24:24Z,TLR7/8 agonist MEDI9197,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-8-agonist-medi9197
2020-09-18T04:24:24Z,TLR8 agonist DN1508052,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798329
2020-09-18T04:24:24Z,TLR8 agonist VTX-2337,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-vtx-2337
2020-09-18T04:24:24Z,TLR9 Agonist AST-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797159
2020-09-18T04:24:24Z,TLR9 agonist DUK-CPG-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-duk-cpg-001
2020-09-18T04:24:24Z,TLR9 agonist EMD 1201081,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-emd-1201081
2020-09-18T04:24:24Z,TLR9 agonist IMO-2055,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-imo-2055
2020-09-18T04:24:24Z,TLR9 agonist MGN1703,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-mgn1703
2020-09-18T04:24:24Z,TLR9 agonist SD-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-sd-101
2020-09-18T04:24:24Z,TM4SF1-CAR/EpCAM-CAR-expressing autologous T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802161
2020-09-18T04:24:24Z,TMPRSS6 RNAi SLN124,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802321
2020-09-18T04:24:24Z,TNFerade,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golnerminogene-pradenovec
2020-09-18T04:24:24Z,TNP-470,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tnp-470
2020-09-18T04:24:24Z,tobramycin sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tobramycin-sulfate
2020-09-18T04:24:24Z,Tobrex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tobramycin-sulfate
2020-09-18T04:24:24Z,Toca FC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-flucytosine
2020-09-18T04:24:24Z,tocilizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab
2020-09-18T04:24:24Z,tocladesine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocladesine
2020-09-18T04:24:24Z,tocophersolan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocophersolan
2020-09-18T04:24:24Z,Tocosol Paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-vitamin-e-based-emulsion-formulation
2020-09-18T04:24:24Z,tocotrienol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocotrienol
2020-09-18T04:24:24Z,tocotrienol-rich fraction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocotrienol-rich-fraction
2020-09-18T04:24:24Z,tofacitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tofacitinib
2020-09-18T04:24:24Z,Tolak,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil
2020-09-18T04:24:24Z,tolazamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolazamide
2020-09-18T04:24:24Z,tolbutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolbutamide
2020-09-18T04:24:24Z,tolcapone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolcapone
2020-09-18T04:24:24Z,tolfenamic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolfenamic-acid
2020-09-18T04:24:24Z,Tolinase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolazamide
2020-09-18T04:24:24Z,toll-like receptor 7 agonist DSP-0509,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794076
2020-09-18T04:24:24Z,Toll-like receptor 9 agonist IMO-2125,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-9-agonist-imo-2125
2020-09-18T04:24:24Z,tomato-soy juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomato-soy-juice
2020-09-18T04:24:24Z,tomivosertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-eft508
2020-09-18T04:24:24Z,Tomudex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raltitrexed
2020-09-18T04:24:24Z,tomuzotuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794657
2020-09-18T04:24:24Z,Topamax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topiramate
2020-09-18T04:24:24Z,topical ammonia-oxidizing bacteria-based probiotic solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794123
2020-09-18T04:24:24Z,topical betulinic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-betulinic-acid
2020-09-18T04:24:24Z,topical calcitriol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-calcitriol
2020-09-18T04:24:24Z,topical cantharidine solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798969
2020-09-18T04:24:24Z,topical celecoxib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792678
2020-09-18T04:24:24Z,topical cocaine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-cocaine-hydrochloride
2020-09-18T04:24:24Z,topical fibrinogen-depleted human standardized platelet lysate CAM-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794650
2020-09-18T04:24:24Z,topical fluorouracil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fluorouracil
2020-09-18T04:24:24Z,topical gemcitabine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-gemcitabine-hydrochloride
2020-09-18T04:24:24Z,topical keratin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-keratin
2020-09-18T04:24:24Z,topical menthol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-menthol
2020-09-18T04:24:24Z,topical myristyl nicotinate cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-myristyl-nicotinate-cream
2020-09-18T04:24:24Z,topical naloxone hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-naloxone-hydrochloride
2020-09-18T04:24:24Z,topical phenylephrine solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-phenylephrine-solution
2020-09-18T04:24:24Z,topical piperidine nitroxide MTS-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-piperidine-nitroxide-mts-01
2020-09-18T04:24:24Z,topical potassium dobesilate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793156
2020-09-18T04:24:24Z,topical sirolimus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-sirolimus
2020-09-18T04:24:24Z,topical VBP-926 solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792148
2020-09-18T04:24:24Z,topical vitamin E,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-vitamin-e
2020-09-18T04:24:24Z,topical wound spray HP802-247,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-wound-spray-hp802-247
2020-09-18T04:24:24Z,topiramate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topiramate
2020-09-18T04:24:24Z,topoisomerase I inhibitor Genz-644282,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-inhibitor-genz-644282
2020-09-18T04:24:24Z,topoisomerase I inhibitor LMP400,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-inhibitor-lmp400
2020-09-18T04:24:24Z,topoisomerase I inhibitor LMP776,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-inhibitor-lmp776
2020-09-18T04:24:24Z,topoisomerase I/II inhibitor NEV-801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-ii-inhibitor-nev-801
2020-09-18T04:24:24Z,topotecan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride
2020-09-18T04:24:24Z,topotecan sustained-release episcleral plaque,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801808
2020-09-18T04:24:24Z,topsalysin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topsalysin
2020-09-18T04:24:24Z,Toradol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketorolac-tromethamine
2020-09-18T04:24:24Z,Toraymyxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymyxin-b-immobilized-fiber-pmx-20r
2020-09-18T04:24:24Z,TORC1/2 kinase inhibitor DS-3078a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/torc1-2-kinase-inhibitor-ds-3078a
2020-09-18T04:24:24Z,TORC1/TORC2 inhibitor ATG-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-cc-223
2020-09-18T04:24:24Z,toremifene citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toremifene-citrate
2020-09-18T04:24:24Z,toripalimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-js001
2020-09-18T04:24:24Z,Torisel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temsirolimus
2020-09-18T04:24:24Z,TORKi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-cc-223
2020-09-18T04:24:24Z,tosedostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tosedostat
2020-09-18T04:24:24Z,tositumomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab
2020-09-18T04:24:24Z,tositumomab and iodine I 131 tositumomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tositumomab-and-iodine-i-131-tositumomab
2020-09-18T04:24:24Z,total tumor mRNA-pulsed tumor-specific ex vivo-expanded autologous lymphocyte transfer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794995
2020-09-18T04:24:24Z,total tumor RNA-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/total-tumor-rna-loaded-dendritic-cell-vaccine
2020-09-18T04:24:24Z,Totect,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride
2020-09-18T04:24:24Z,Toviaz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fesoterodine-fumarate
2020-09-18T04:24:24Z,tozasertib lactate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozasertib-lactate
2020-09-18T04:24:24Z,TPF regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpf-regimen
2020-09-18T04:24:24Z,TPI 287,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpi-287
2020-09-18T04:24:24Z,TPO receptor agonist ONO-7746,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tpo-receptor-agonist-ono-7746
2020-09-18T04:24:24Z,trabectedin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabectedin
2020-09-18T04:24:24Z,trabedersen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabedersen
2020-09-18T04:24:24Z,TraceIT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683
2020-09-18T04:24:24Z,TraceIT Hydrogel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683
2020-09-18T04:24:24Z,TraceIT Tissue Marker,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792683
2020-09-18T04:24:24Z,Tradjenta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793591
2020-09-18T04:24:24Z,TRAIL receptor agonist ABBV-621,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792269
2020-09-18T04:24:24Z,trametinib dimethyl sulfoxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trametinib
2020-09-18T04:24:24Z,tranexamic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tranexamic-acid
2020-09-18T04:24:24Z,trans sodium crocetinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trans-sodium-crocetinate
2020-09-18T04:24:24Z,transdermal 17beta-estradiol gel BHR-200,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-17beta-estradiol-gel-bhr-200
2020-09-18T04:24:24Z,transdermal 4-hydroxytestosterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-4-hydroxytestosterone
2020-09-18T04:24:24Z,transdermal estrogen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transdermal-estrogen
2020-09-18T04:24:24Z,transferrin receptor-targeted anti-RRM2 siRNA CALAA-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-receptor-targeted-anti-rrm2-sirna-calaa-01
2020-09-18T04:24:24Z,transferrin receptor-targeted liposomal p53 cDNA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-receptor-targeted-liposomal-p53-cdna
2020-09-18T04:24:24Z,transferrin-CRM107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-crm107
2020-09-18T04:24:24Z,transgenic lymphocyte immunization vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transgenic-lymphocyte-immunization-vaccine
2020-09-18T04:24:24Z,TransMID,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-crm107
2020-09-18T04:24:24Z,transthyretin antisense oligonucleotide ISIS-TTR Rx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transthyretin-antisense-oligonucleotide-isis-ttr-rx
2020-09-18T04:24:24Z,transthyretin stabilizer AG10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801176
2020-09-18T04:24:24Z,tranylcypromine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tranylcypromine-sulfate
2020-09-18T04:24:24Z,TrasGEX,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycooptimized-trastuzumab-gex
2020-09-18T04:24:24Z,trastuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab
2020-09-18T04:24:24Z,trastuzumab and hyaluronidase-oysk,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797111
2020-09-18T04:24:24Z,trastuzumab conjugate BI-CON-02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792543
2020-09-18T04:24:24Z,trastuzumab duocarmazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-duocarmazine
2020-09-18T04:24:24Z,trastuzumab monomethyl auristatin F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801696
2020-09-18T04:24:24Z,trastuzumab/tesirine antibody-drug conjugate ADCT-502,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-tesirine-antibody-drug-conjugate-adct-502
2020-09-18T04:24:24Z,Trasylol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprotinin-bovine
2020-09-18T04:24:24Z,Traumasept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution
2020-09-18T04:24:24Z,Traumeel S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/traumeel-s
2020-09-18T04:24:24Z,Travasol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amino-acid-injection
2020-09-18T04:24:24Z,Trazimera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab
2020-09-18T04:24:24Z,Treanda,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride
2020-09-18T04:24:24Z,trebananib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trebananib
2020-09-18T04:24:24Z,Trelstar Depot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin-pamoate
2020-09-18T04:24:24Z,tremelimumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tremelimumab
2020-09-18T04:24:24Z,Tremfya,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792847
2020-09-18T04:24:24Z,Trental,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentoxifylline
2020-09-18T04:24:24Z,treosulfan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/treosulfan
2020-09-18T04:24:24Z,tretinoin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
2020-09-18T04:24:24Z,Trexall,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate
2020-09-18T04:24:24Z,tri-virus/GD2-specific allogeneic cytotoxic T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tri-virus-gd2-specific-allogeneic-cytotoxic-t-lymphocytes
2020-09-18T04:24:24Z,TriAb,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-11d10-anti-idiotype-vaccine
2020-09-18T04:24:24Z,triamcinolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone
2020-09-18T04:24:24Z,triamcinolone acetonide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide
2020-09-18T04:24:24Z,triamcinolone acetonide transdermal system SUN-131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794014
2020-09-18T04:24:24Z,triapine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triapine
2020-09-18T04:24:24Z,triazinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazinate
2020-09-18T04:24:24Z,triazine derivative TriN2755,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazine-derivative-trin2755
2020-09-18T04:24:24Z,tributyrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tributyrin
2020-09-18T04:24:24Z,tricaprin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793955
2020-09-18T04:24:24Z,trichostatin A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801296
2020-09-18T04:24:24Z,triciribine phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triciribine-phosphate
2020-09-18T04:24:24Z,triclosan/copolymer/fluoride toothpaste,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792732
2020-09-18T04:24:24Z,Tricor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenofibrate
2020-09-18T04:24:24Z,trientine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trientine-hydrochloride
2020-09-18T04:24:24Z,trifluoperazine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluoperazine-hydrochloride
2020-09-18T04:24:24Z,trifluridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine
2020-09-18T04:24:24Z,trifluridine and tipiracil hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine-and-tipiracil-hydrochloride
2020-09-18T04:24:24Z,trigriluzole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trigriluzole
2020-09-18T04:24:24Z,Trileptal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxcarbazepine
2020-09-18T04:24:24Z,Trilisate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-magnesium-trisalicylate
2020-09-18T04:24:24Z,trilostane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trilostane
2020-09-18T04:24:24Z,trimeric GITRL-Fc OMP-336B11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimeric-gitrl-fc-omp-336b11
2020-09-18T04:24:24Z,trimetazidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793610
2020-09-18T04:24:24Z,trimethoprim-sulfamethoxazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethoprim-sulfamethoxazole
2020-09-18T04:24:24Z,trimethylcolchicinic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimethylcolchicinic-acid
2020-09-18T04:24:24Z,trimetrexate glucuronate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimetrexate-glucuronate
2020-09-18T04:24:24Z,Trimox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin
2020-09-18T04:24:24Z,Triostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine-sodium
2020-09-18T04:24:24Z,Tripedia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-acellular-pertussis-vaccine-adsorbed
2020-09-18T04:24:24Z,triptolide analogue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptolide-analogue
2020-09-18T04:24:24Z,triptorelin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin
2020-09-18T04:24:24Z,triptorelin pamoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptorelin-pamoate
2020-09-18T04:24:24Z,tris-acryl gelatin microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres
2020-09-18T04:24:24Z,Trisenox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide
2020-09-18T04:24:24Z,trivalent influenza vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
2020-09-18T04:24:24Z,trivalent live-attenuated influenza vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-live-attenuated-influenza-vaccine
2020-09-18T04:24:24Z,Trivora,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol-levonorgestrel
2020-09-18T04:24:24Z,TRK inhibitor LOXO-195,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-loxo-195
2020-09-18T04:24:24Z,TRK inhibitor TQB3558,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801913
2020-09-18T04:24:24Z,TrkA inhibitor VMD-928,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793945
2020-09-18T04:24:24Z,Trodelvy,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan
2020-09-18T04:24:24Z,trodusquemine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trodusquemine
2020-09-18T04:24:24Z,trofosfamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide
2020-09-18T04:24:24Z,troglitazone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troglitazone
2020-09-18T04:24:24Z,tropisetron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropisetron
2020-09-18T04:24:24Z,tropisetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropisetron-hydrochloride
2020-09-18T04:24:24Z,tropomysin receptor kinase inhibitor AZD7451,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tropomysin-receptor-kinase-inhibitor-azd7451
2020-09-18T04:24:24Z,TroVax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-modified-vaccinia-ankara-5t4-vaccine
2020-09-18T04:24:24Z,troxacitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine
2020-09-18T04:24:24Z,troxacitabine nucleotide prodrug MIV-818,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796799
2020-09-18T04:24:24Z,Troxatyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine
2020-09-18T04:24:24Z,TRP2 mRNA-electroporated autologous langerhans-type dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trp2-mrna-electroporated-autologous-langerhans-type-dendritic-cell-vaccine
2020-09-18T04:24:24Z,TRPV6 calcium channel inhibitor SOR-C13,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trpv6-calcium-channel-inhibitor-sor-c13
2020-09-18T04:24:24Z,truncated tissue factor/NGR peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/truncated-tissue-factor-ngr-peptide
2020-09-18T04:24:24Z,Truphylline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminophylline
2020-09-18T04:24:24Z,Truxima,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab
2020-09-18T04:24:24Z,tryptophanase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophanase
2020-09-18T04:24:24Z,TS-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium
2020-09-18T04:24:24Z,TS-ONE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium
2020-09-18T04:24:24Z,TSP-1 mimetic fusion protein CVX-045,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tsp-1-mimetic-fusion-protein-cvx-045
2020-09-18T04:24:24Z,TTI-237,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tti-237
2020-09-18T04:24:24Z,tubercidin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubercidin
2020-09-18T04:24:24Z,tubulin inhibitor ALB 109564(a),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-inhibitor-alb-109564a
2020-09-18T04:24:24Z,tubulin polymerization inhibitor CKD-516,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-polymerization-inhibitor-ckd-516
2020-09-18T04:24:24Z,tubulin polymerization inhibitor VERU-111,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797224
2020-09-18T04:24:24Z,tubulin-binding agent SSR97225,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-binding-agent-ssr97225
2020-09-18T04:24:24Z,tucatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erbb-2-inhibitor-arry-380
2020-09-18T04:24:24Z,tucidinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat
2020-09-18T04:24:24Z,tucotuzumab celmoleukin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucotuzumab-celmoleukin
2020-09-18T04:24:24Z,Tukysa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erbb-2-inhibitor-arry-380
2020-09-18T04:24:24Z,tumor peptide-loaded myeloid dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-peptide-loaded-myeloid-dendritic-cells
2020-09-18T04:24:24Z,tumor-cells apoptosis factor hormone-peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-cells-apoptosis-factor-hormone-peptide
2020-09-18T04:24:24Z,tumor-homing peptide iRGD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tumor-homing-peptide-irgd
2020-09-18T04:24:24Z,Turalio,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexidartinib
2020-09-18T04:24:24Z,Tygacil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigecycline
2020-09-18T04:24:24Z,Tykerb,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapatinib-ditosylate
2020-09-18T04:24:24Z,Tylenol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen
2020-09-18T04:24:24Z,Tymlos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797359
2020-09-18T04:24:24Z,type-1 polarized dendritic cell-induced antigen-specific autologous cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782595
2020-09-18T04:24:24Z,typhoid vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/typhoid-vaccine
2020-09-18T04:24:24Z,tyroserleutide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyroserleutide
2020-09-18T04:24:24Z,tyrosinase peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosinase-peptide
2020-09-18T04:24:24Z,tyrosinase-related protein-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosinase-related-protein-1
2020-09-18T04:24:24Z,tyrosine kinase inhibitor OSI-930,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-osi-930
2020-09-18T04:24:24Z,tyrosine kinase inhibitor TL-895,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801850
2020-09-18T04:24:24Z,tyrosine kinase inhibitor XL228,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-xl228
2020-09-18T04:24:24Z,Tysabri,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natalizumab
2020-09-18T04:24:24Z,Tyzeka,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telbivudine
2020-09-18T04:24:24Z,UAE inhibitor TAK-243,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-mln7243
2020-09-18T04:24:24Z,ubidecarenone nanodispersion BPM31510,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510
2020-09-18T04:24:24Z,ublituximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ublituximab
2020-09-18T04:24:24Z,udenafil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/udenafil
2020-09-18T04:24:24Z,ulimorelin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulimorelin-hydrochloride
2020-09-18T04:24:24Z,ulinastatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulinastatin
2020-09-18T04:24:24Z,ulipristal acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal-acetate
2020-09-18T04:24:24Z,ulixertinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-bvd-523
2020-09-18T04:24:24Z,ulocuplumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulocuplumab
2020-09-18T04:24:24Z,Uloric,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/febuxostat
2020-09-18T04:24:24Z,Ultandren,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoxymesterone
2020-09-18T04:24:24Z,Ultane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sevoflurane
2020-09-18T04:24:24Z,Ultiva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remifentanil-hydrochloride
2020-09-18T04:24:24Z,Ultomiris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/complement-c5-inhibitor-alxn1210
2020-09-18T04:24:24Z,Ultradine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution
2020-09-18T04:24:24Z,Ultravist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iopromide
2020-09-18T04:24:24Z,Ultresa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase
2020-09-18T04:24:24Z,ULvWF multimer-targeting agent ARC1779,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulvwf-multimer-targeting-agent-arc1779
2020-09-18T04:24:24Z,umbilical cord blood-derived CD4+/CD25+ T-regulatory cells CK0801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797053
2020-09-18T04:24:24Z,umbilical cord blood-derived hematopoietic CD34-positive progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-hematopoietic-cd34-positive-progenitor-cells
2020-09-18T04:24:24Z,umbilical cord blood-derived mesenchymal stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-mesenchymal-stem-cells
2020-09-18T04:24:24Z,umbilical cord blood-derived natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-natural-killer-cells
2020-09-18T04:24:24Z,umbralisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-tgr-1202
2020-09-18T04:24:24Z,Unasyn,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ampicillin-sodium-sulbactam-sodium
2020-09-18T04:24:24Z,Uncaria tomentosa extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uncaria-tomentosa-extract
2020-09-18T04:24:24Z,uniformly-labeled [13C]fructose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800235
2020-09-18T04:24:24Z,uniformly-labeled [13C]glucose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-u-13c-glucose
2020-09-18T04:24:24Z,uniformly-labeled [13C]glutamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800233
2020-09-18T04:24:24Z,uniformly-labeled [13C]lactate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800234
2020-09-18T04:24:24Z,Uniphyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/theophylline
2020-09-18T04:24:24Z,Unituxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab
2020-09-18T04:24:24Z,uproleselan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/e-selectin-antagonist-gmi-1271
2020-09-18T04:24:24Z,uracil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil
2020-09-18T04:24:24Z,uracil ointment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil-ointment
2020-09-18T04:24:24Z,urelumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urelumab
2020-09-18T04:24:24Z,uridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine
2020-09-18T04:24:24Z,uridine triacetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate
2020-09-18T04:24:24Z,URLC10 peptide/Montanide ISA51 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urlc10-peptide-montanide-isa51-vaccine
2020-09-18T04:24:24Z,URLC10-TTK-KOC1-VEGFR1-VEGFR2 multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urlc10-ttk-koc1-vegfr1-vegfr2-multipeptide-vaccine
2020-09-18T04:24:24Z,urokinase-derived peptide A6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urokinase-derived-peptide-a6
2020-09-18T04:24:24Z,Urolene Blue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylene-blue
2020-09-18T04:24:24Z,Uroxatrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alfuzosin-hydrochloride
2020-09-18T04:24:24Z,URSO,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol
2020-09-18T04:24:24Z,ursodiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol
2020-09-18T04:24:24Z,ursolic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801981
2020-09-18T04:24:24Z,USP14/UCHL5 inhibitor VLX1570,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/usp14-uchl5-inhibitor-vlx1570
2020-09-18T04:24:24Z,ustekinumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ustekinumab
2020-09-18T04:24:24Z,Utimox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin
2020-09-18T04:24:24Z,UV1 telomerase peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uv1-telomerase-peptide-vaccine
2020-09-18T04:24:24Z,Uvadex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen
2020-09-18T04:24:24Z,Uvidem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-dendritic-cell-allogeneic-melanoma-tumor-cell-lysate-vaccine
2020-09-18T04:24:24Z,V-Boost,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801582
2020-09-18T04:24:24Z,V-Boost Immunitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801582
2020-09-18T04:24:24Z,V930 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/v930-vaccine
2020-09-18T04:24:24Z,VAC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vac-regimen
2020-09-18T04:24:24Z,vaccine-sensitized draining lymph node cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccine-sensitized-draining-lymph-node-cells
2020-09-18T04:24:24Z,vaccinia virus (vvDD-CDSR),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccinia-virus-vvdd-cdsr
2020-09-18T04:24:24Z,vaccinia-tyrosinase vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccinia-tyrosinase-vaccine
2020-09-18T04:24:24Z,Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia extract granules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735790
2020-09-18T04:24:24Z,vactosertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk5-inhibitor-tew-7197
2020-09-18T04:24:24Z,vadastuximab talirine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadastuximab-talirine
2020-09-18T04:24:24Z,vadimezan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadimezan
2020-09-18T04:24:24Z,Vagestrol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diethylstilbestrol
2020-09-18T04:24:24Z,Vagifem,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol
2020-09-18T04:24:24Z,valacyclovir hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valacyclovir-hydrochloride
2020-09-18T04:24:24Z,Valchlor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mechlorethamine-hydrochloride-gel
2020-09-18T04:24:24Z,Valcyte,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valganciclovir
2020-09-18T04:24:24Z,valdecoxib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valdecoxib
2020-09-18T04:24:24Z,valemetostat tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-ds-3201
2020-09-18T04:24:24Z,Valeriana officinalis extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valeriana-officinalis-extract
2020-09-18T04:24:24Z,valganciclovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valganciclovir
2020-09-18T04:24:24Z,Valparin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divalproex-sodium
2020-09-18T04:24:24Z,valproic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid
2020-09-18T04:24:24Z,valproic acid-expanded umbilical cord blood-derived CD34-positive cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796966
2020-09-18T04:24:24Z,valrubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valrubicin
2020-09-18T04:24:24Z,valsartan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valsartan
2020-09-18T04:24:24Z,valspodar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valspodar
2020-09-18T04:24:24Z,Valstar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valrubicin
2020-09-18T04:24:24Z,Valtrex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valacyclovir-hydrochloride
2020-09-18T04:24:24Z,VAMP Regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vamp-regimen
2020-09-18T04:24:24Z,Vancenase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate
2020-09-18T04:24:24Z,Vanceril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclomethasone-dipropionate
2020-09-18T04:24:24Z,vandetanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib
2020-09-18T04:24:24Z,vandetanib-eluting radiopaque bead BTG-002814,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792793
2020-09-18T04:24:24Z,Vanicream Sunscreen SPF 60,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/titanium-dioxide-zinc-oxide-sunscreen-cream-spf-60
2020-09-18T04:24:24Z,Vaniqa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride
2020-09-18T04:24:24Z,Vanos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluocinonide-cream
2020-09-18T04:24:24Z,Vantas,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histrelin-acetate
2020-09-18T04:24:24Z,vantictumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vantictumab
2020-09-18T04:24:24Z,Vantin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cefpodoxime-proxetil
2020-09-18T04:24:24Z,Vaqta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-a-vaccine
2020-09-18T04:24:24Z,vardenafil hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vardenafil-hydrochloride
2020-09-18T04:24:24Z,varenicline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varenicline
2020-09-18T04:24:24Z,Vargatef,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib
2020-09-18T04:24:24Z,varicella vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-vaccine
2020-09-18T04:24:24Z,varicella zoster virus strain Oka/Merck live antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen
2020-09-18T04:24:24Z,Varivax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-vaccine
2020-09-18T04:24:24Z,Varivax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen
2020-09-18T04:24:24Z,VariZIG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-varicella-zoster-immune-globulin
2020-09-18T04:24:24Z,VariZIG vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-varicella-zoster-immune-globulin
2020-09-18T04:24:24Z,varlilumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlilumab
2020-09-18T04:24:24Z,varlitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlitinib
2020-09-18T04:24:24Z,Varubi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride
2020-09-18T04:24:24Z,Vasal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride
2020-09-18T04:24:24Z,Vascepa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethyl-icosapentate
2020-09-18T04:24:24Z,vascular disrupting agent BNC105P,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-disrupting-agent-bnc105p
2020-09-18T04:24:24Z,vascular endothelial growth factor antisense oligonucleotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-endothelial-growth-factor-antisense-oligonucleotide
2020-09-18T04:24:24Z,Vaso-Pav,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride
2020-09-18T04:24:24Z,Vasospan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/papaverine-hydrochloride
2020-09-18T04:24:24Z,Vasotec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enalapril-maleate
2020-09-18T04:24:24Z,Vasovist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadofosveset-trisodium
2020-09-18T04:24:24Z,Vastarel MR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793610
2020-09-18T04:24:24Z,vatalanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vatalanib
2020-09-18T04:24:24Z,VCL-CB01 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vcl-cb01-vaccine
2020-09-18T04:24:24Z,VDAC/HK2 modulator ointment VDA-1102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vdac-hk2-modulator-ointment-vda-1102
2020-09-18T04:24:24Z,vecabrutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-sns-062
2020-09-18T04:24:24Z,Vectibix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panitumumab
2020-09-18T04:24:24Z,Vectrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minocycline-hydrochloride
2020-09-18T04:24:24Z,vecuronium bromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecuronium-bromide
2020-09-18T04:24:24Z,vedolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vedolizumab
2020-09-18T04:24:24Z,VEGF inhibitor PTC299,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegf-inhibitor-ptc299
2020-09-18T04:24:24Z,VEGF/HGF-targeting DARPin MP0250,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegf-hgf-targeting-darpin-mp0250
2020-09-18T04:24:24Z,VEGFR inhibitor KRN951,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-inhibitor-krn951
2020-09-18T04:24:24Z,VEGFR-2 DNA vaccine VXM01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-2-dna-vaccine-vxm01
2020-09-18T04:24:24Z,VEGFR/FGFR inhibitor ODM-203,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-fgfr-inhibitor-odm-203
2020-09-18T04:24:24Z,VEGFR/PDGFR dual kinase inhibitor TAK-593,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-tak-593
2020-09-18T04:24:24Z,VEGFR1-1084 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr1-1084-peptide-vaccine
2020-09-18T04:24:24Z,VEGFR2 tyrosine kinase inhibitor PF-00337210,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr2-tyrosine-kinase-inhibitor-pf-00337210
2020-09-18T04:24:24Z,VEGFR2-169 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr2-169-peptide-vaccine
2020-09-18T04:24:24Z,VEGFR2-targeted contrast agent BR55,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr2-targeted-contrast-agent-br55
2020-09-18T04:24:24Z,Veglin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-endothelial-growth-factor-antisense-oligonucleotide
2020-09-18T04:24:24Z,VeIP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veip-regimen
2020-09-18T04:24:24Z,velafermin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velafermin
2020-09-18T04:24:24Z,Velcade,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib
2020-09-18T04:24:24Z,veledimex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801675
2020-09-18T04:24:24Z,veliparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veliparib
2020-09-18T04:24:24Z,velpatasvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798440
2020-09-18T04:24:24Z,veltuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veltuzumab
2020-09-18T04:24:24Z,vemurafenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vemurafenib
2020-09-18T04:24:24Z,Venclexta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax
2020-09-18T04:24:24Z,venetoclax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax
2020-09-18T04:24:24Z,venlafaxine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine
2020-09-18T04:24:24Z,venlafaxine hydrochloride extended release,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793527
2020-09-18T04:24:24Z,Venofer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-sucrose-injection
2020-09-18T04:24:24Z,Venoglobulin-I,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,Venoglobulin-S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,Ventavis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iloprost
2020-09-18T04:24:24Z,Ventolin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albuterol-sulfate
2020-09-18T04:24:24Z,vepoloxamer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vepoloxamer
2020-09-18T04:24:24Z,verapamil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verapamil
2020-09-18T04:24:24Z,Verapamil SR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verapamil
2020-09-18T04:24:24Z,Veregen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kunecatechins-ointment
2020-09-18T04:24:24Z,Vermox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mebendazole
2020-09-18T04:24:24Z,Versed,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midazolam-hydrochloride
2020-09-18T04:24:24Z,verteporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verteporfin
2020-09-18T04:24:24Z,verubulin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verubulin-hydrochloride
2020-09-18T04:24:24Z,Verzenio,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib
2020-09-18T04:24:24Z,Vesanoid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
2020-09-18T04:24:24Z,Vfend,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voriconazole
2020-09-18T04:24:24Z,viagenpumatucel-L,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/viagenpumatucel-l
2020-09-18T04:24:24Z,Viagmox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxifloxacin-hydrochloride
2020-09-18T04:24:24Z,Viagra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sildenafil-citrate
2020-09-18T04:24:24Z,Vibativ,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telavancin-hydrochloride
2020-09-18T04:24:24Z,Vibramycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-calcium
2020-09-18T04:24:24Z,Vicodin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocodone-acetaminophen
2020-09-18T04:24:24Z,vicriviroc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798939
2020-09-18T04:24:24Z,Victoza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792738
2020-09-18T04:24:24Z,Victoza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liraglutide
2020-09-18T04:24:24Z,Victrelis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/boceprevir
2020-09-18T04:24:24Z,vidarabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine
2020-09-18T04:24:24Z,Vidaza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine
2020-09-18T04:24:24Z,Videne,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine-solution
2020-09-18T04:24:24Z,Videx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine
2020-09-18T04:24:24Z,Videx EC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didanosine
2020-09-18T04:24:24Z,Vigil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gmcsf-expressing-autologous-tumor-cell-vaccine
2020-09-18T04:24:24Z,vilaprisan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792636
2020-09-18T04:24:24Z,vildagliptin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vildagliptin
2020-09-18T04:24:24Z,vinblastine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinblastine-sulfate
2020-09-18T04:24:24Z,vincristine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate
2020-09-18T04:24:24Z,vincristine sulfate liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate-liposome
2020-09-18T04:24:24Z,vindesine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate
2020-09-18T04:24:24Z,Vinetra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muscadine-grape-skin-extract
2020-09-18T04:24:24Z,vinflunine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinflunine
2020-09-18T04:24:24Z,vinorelbine tartrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate
2020-09-18T04:24:24Z,vinorelbine tartrate emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate-emulsion
2020-09-18T04:24:24Z,vinorelbine tartrate oral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate-oral
2020-09-18T04:24:24Z,vintafolide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vintafolide
2020-09-18T04:24:24Z,Viokace,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase
2020-09-18T04:24:24Z,Vioxx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rofecoxib
2020-09-18T04:24:24Z,VIP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vip-regimen
2020-09-18T04:24:24Z,Vira-A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidarabine
2020-09-18T04:24:24Z,Viracept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelfinavir-mesylate
2020-09-18T04:24:24Z,Viramune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nevirapine
2020-09-18T04:24:24Z,Virazid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin
2020-09-18T04:24:24Z,Virazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribavirin
2020-09-18T04:24:24Z,Viread,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenofovir-disoproxil-fumarate
2020-09-18T04:24:24Z,Virend,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crofelemer
2020-09-18T04:24:24Z,Virilon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-cypionate
2020-09-18T04:24:24Z,Virulizin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/virulizin
2020-09-18T04:24:24Z,Visco-ease,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lamellar-body-mimetic-mouth-spray-lms-611
2020-09-18T04:24:24Z,visilizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/visilizumab
2020-09-18T04:24:24Z,Visipaque,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodixanol
2020-09-18T04:24:24Z,vismodegib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib
2020-09-18T04:24:24Z,Vistide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cidofovir
2020-09-18T04:24:24Z,Vistogard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uridine-triacetate
2020-09-18T04:24:24Z,vistusertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vistusertib
2020-09-18T04:24:24Z,Visudyne,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verteporfin
2020-09-18T04:24:24Z,VitaBlue tablet formation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blueberry-powder-supplement
2020-09-18T04:24:24Z,vitamin A compound,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797839
2020-09-18T04:24:24Z,vitamin D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-d
2020-09-18T04:24:24Z,vitamin E,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-e
2020-09-18T04:24:24Z,vitamin K,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-k
2020-09-18T04:24:24Z,vitamin K1-containing urea skin cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-k1-containing-urea-skin-cream
2020-09-18T04:24:24Z,vitamins/minerals/proteins-based synthetic meal replacement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802067
2020-09-18T04:24:24Z,vitespen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitespen
2020-09-18T04:24:24Z,Vitrakvi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotrectinib
2020-09-18T04:24:24Z,Vivelle,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-estradiol
2020-09-18T04:24:24Z,Vizamyl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flutemetamol-f-18
2020-09-18T04:24:24Z,Vizimpro,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib
2020-09-18T04:24:24Z,VLP-encapsulated TLR9 agonist CMP-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vlp-encapsulated-tlr9-agonist-cmp-001
2020-09-18T04:24:24Z,vocimagene amiretrorepvec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vocimagene-amiretrorepvec
2020-09-18T04:24:24Z,vofatamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-monoclonal-antibody-b-701
2020-09-18T04:24:24Z,voglibose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voglibose
2020-09-18T04:24:24Z,volasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volasertib
2020-09-18T04:24:24Z,volociximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volociximab
2020-09-18T04:24:24Z,Voluven,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetastarch
2020-09-18T04:24:24Z,von Hippel-Lindau peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/von-hippel-lindau-peptide-vaccine
2020-09-18T04:24:24Z,vonoprazan fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793169
2020-09-18T04:24:24Z,vopratelimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-jtx-2011
2020-09-18T04:24:24Z,vorasidenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh-mutant-inhibitor-ag-881
2020-09-18T04:24:24Z,Voraxaze,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucarpidase
2020-09-18T04:24:24Z,voriconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voriconazole
2020-09-18T04:24:24Z,vorinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat
2020-09-18T04:24:24Z,vorolanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-dual-kinase-inhibitor-x-82
2020-09-18T04:24:24Z,vorsetuzumab-mafodotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorsetuzumab-mafodotin
2020-09-18T04:24:24Z,vortioxetine hydrobromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vortioxetine-hydrobromide
2020-09-18T04:24:24Z,vosaroxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosaroxin
2020-09-18T04:24:24Z,Votrient,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pazopanib-hydrochloride
2020-09-18T04:24:24Z,voxelotor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793847
2020-09-18T04:24:24Z,voxilaprevir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798441
2020-09-18T04:24:24Z,VSL#3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-freeze-dried-lactic-acid-bacteria-probiotic
2020-09-18T04:24:24Z,VT30 topical gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801911
2020-09-18T04:24:24Z,Vumon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teniposide
2020-09-18T04:24:24Z,Vytorin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe-simvastatin
2020-09-18T04:24:24Z,Vyvanse,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisdexamfetamine-dimesylate
2020-09-18T04:24:24Z,Vyxeos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daunorubicin-hydrochloride-and-cytarabine-liposome
2020-09-18T04:24:24Z,warfarin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/warfarin-sodium
2020-09-18T04:24:24Z,water O-15,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/water-o-15
2020-09-18T04:24:24Z,water-based vaginal lubricant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/water-based-vaginal-lubricant
2020-09-18T04:24:24Z,Wee1 kinase inhibitor Debio 0123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801754
2020-09-18T04:24:24Z,Welchol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colesevelam-hydrochloride
2020-09-18T04:24:24Z,Wellbutrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride
2020-09-18T04:24:24Z,Wellbutrin SR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878
2020-09-18T04:24:24Z,Wellbutrin XL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878
2020-09-18T04:24:24Z,wheatgrass juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wheatgrass-juice
2020-09-18T04:24:24Z,whey protein isolate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/whey-protein-isolate
2020-09-18T04:24:24Z,whey protein isolate nutritional supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797097
2020-09-18T04:24:24Z,white button mushroom extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/white-button-mushroom-extract
2020-09-18T04:24:24Z,white carrot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/white-carrot
2020-09-18T04:24:24Z,white wine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/white-wine
2020-09-18T04:24:24Z,Winobanin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danazol
2020-09-18T04:24:24Z,WinRho SDF,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-immune-globulin
2020-09-18T04:24:24Z,Wnt signaling pathway inhibitor SM08502,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wnt-signaling-pathway-inhibitor-sm08502
2020-09-18T04:24:24Z,Wnt-5a mimic hexapeptide foxy-5,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wnt-5a-mimic-hexapeptide-foxy-5
2020-09-18T04:24:24Z,WT-1 analogue peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt-1-analogue-peptide-vaccine
2020-09-18T04:24:24Z,WT1 124-138 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-124-138-peptide-vaccine
2020-09-18T04:24:24Z,WT1 126-134 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-126-134-peptide-vaccine
2020-09-18T04:24:24Z,WT1 235-243 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-235-243-peptide-vaccine
2020-09-18T04:24:24Z,WT1 247-261 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-247-261-peptide-vaccine
2020-09-18T04:24:24Z,WT1 mRNA-electroporated autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-mrna-electroporated-autologous-dendritic-cell-vaccine
2020-09-18T04:24:24Z,WT1 peptide vaccine OCV-501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-peptide-vaccine-ocv-501
2020-09-18T04:24:24Z,WT1 peptide vaccine WT2725,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-peptide-vaccine-wt2725
2020-09-18T04:24:24Z,WT1 protein-derived peptide vaccine DSP-7888,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-protein-derived-peptide-vaccine-dsp-7888
2020-09-18T04:24:24Z,WT1-A10/AS01B immunotherapeutic GSK2130579A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-a10-as01b-immunotherapeutic-gsk2130579a
2020-09-18T04:24:24Z,WT1-loaded artificial adjuvant vector cell immunotherapeutic ASP7517,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800591
2020-09-18T04:24:24Z,WT1-sensitized T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-sensitized-t-cells
2020-09-18T04:24:24Z,WT1/PRAME/survivin-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798990
2020-09-18T04:24:24Z,WT1/PSMA/hTERT-encoding plasmid DNA INO-5401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795318
2020-09-18T04:24:24Z,wu-ling-san,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san
2020-09-18T04:24:24Z,Wymox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amoxicillin
2020-09-18T04:24:24Z,Wytensin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guanabenz-acetate
2020-09-18T04:24:24Z,xaliproden hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xaliproden-hydrochloride
2020-09-18T04:24:24Z,Xalkori,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib
2020-09-18T04:24:24Z,Xanax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alprazolam
2020-09-18T04:24:24Z,xanthohumol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xanthohumol
2020-09-18T04:24:24Z,Xanthotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxsalen
2020-09-18T04:24:24Z,Xarelto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivaroxaban
2020-09-18T04:24:24Z,XBP1-US/XBP1-SP/CD138/CS1 multipeptide vaccine PVX-410,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xbp1-us-xbp1-sp-cd138-cs1-multipeptide-vaccine-pvx-410
2020-09-18T04:24:24Z,Xcytrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-gadolinium
2020-09-18T04:24:24Z,XELIRI regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xeliri-regimen
2020-09-18T04:24:24Z,Xeloda,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine
2020-09-18T04:24:24Z,XELOX regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xelox-regimen
2020-09-18T04:24:24Z,xenogeneic tyrosinase DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xenogeneic-tyrosinase-dna-vaccine
2020-09-18T04:24:24Z,xenon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xenon
2020-09-18T04:24:24Z,xentuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xentuzumab
2020-09-18T04:24:24Z,Xerecept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticorelin-acetate
2020-09-18T04:24:24Z,Xermelo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate
2020-09-18T04:24:24Z,Xgeva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab
2020-09-18T04:24:24Z,xianling gubao,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xianling-gubao
2020-09-18T04:24:24Z,Xiaoai Jiedu decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799435
2020-09-18T04:24:24Z,XIAP/cIAP1 antagonist ASTX660,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xiap-ciap1-antagonist-astx660
2020-09-18T04:24:24Z,Xifaxan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rifaximin
2020-09-18T04:24:24Z,Xilonix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interleukin-1-alpha-monoclonal-antibody-mabp1
2020-09-18T04:24:24Z,Xinlay,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atrasentan-hydrochloride
2020-09-18T04:24:24Z,xinmailong,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796790
2020-09-18T04:24:24Z,XL820,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xl820
2020-09-18T04:24:24Z,XL844,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xl844
2020-09-18T04:24:24Z,Xofigo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride
2020-09-18T04:24:24Z,Xofluza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800205
2020-09-18T04:24:24Z,Xolair,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omalizumab
2020-09-18T04:24:24Z,Xolegel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketoconazole
2020-09-18T04:24:24Z,Xospata,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792549
2020-09-18T04:24:24Z,XPO1 inhibitor KPT-8602,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xpo1-inhibitor-kpt-8602
2020-09-18T04:24:24Z,Xpovio,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor
2020-09-18T04:24:24Z,Xtampza ER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794051
2020-09-18T04:24:24Z,Xtandi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide
2020-09-18T04:24:24Z,Xylocaine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride
2020-09-18T04:24:24Z,Xylocitin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-hydrochloride
2020-09-18T04:24:24Z,Xylonest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prilocaine-hydrochloride
2020-09-18T04:24:24Z,Xyotax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex
2020-09-18T04:24:24Z,Xyzal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocetirizine-dihydrochloride
2020-09-18T04:24:24Z,Y-90 OctreoTher,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-edotreotide
2020-09-18T04:24:24Z,Y-shape branched pegylated filgrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/y-shape-branched-pegylated-filgrastim
2020-09-18T04:24:24Z,Yang Yin Fang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fang
2020-09-18T04:24:24Z,Yang Yin Fu Zheng,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yang-yin-fu-zheng
2020-09-18T04:24:24Z,Yervoy,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab
2020-09-18T04:24:24Z,Yescarta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel
2020-09-18T04:24:24Z,Yi Qi Fang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-fang
2020-09-18T04:24:24Z,Yi Qi Yang Yin Fang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yi-qi-yang-yin-fang
2020-09-18T04:24:24Z,yiqi-yangyin-jiedu herbal decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yiqi-yangyin-jiedu-herbal-decoction
2020-09-18T04:24:24Z,YM598,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ym598
2020-09-18T04:24:24Z,Yondelis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabectedin
2020-09-29T06:06:26Z,Yonsa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate
2020-09-18T04:24:24Z,yoshi-864,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yoshi-864
2020-09-18T04:24:24Z,young autologous tumor-infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795823
2020-09-18T04:24:24Z,yttrium Y 90 anti-CD19 monoclonal antibody BU12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd19-monoclonal-antibody-bu12
2020-09-18T04:24:24Z,yttrium Y 90 anti-CD45 monoclonal antibody AHN-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd45-monoclonal-antibody-ahn-12
2020-09-18T04:24:24Z,yttrium Y 90 anti-CD45 monoclonal antibody BC8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd45-monoclonal-antibody-bc8
2020-09-18T04:24:24Z,yttrium Y 90 anti-CD66 monoclonal antibody BW 250/183,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cd66-monoclonal-antibody-bw-250-183
2020-09-18T04:24:24Z,yttrium Y 90 anti-CDH3 monoclonal antibody FF-21101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cdh3-monoclonal-antibody-ff-21101
2020-09-18T04:24:24Z,yttrium Y 90 anti-CEA monoclonal antibody cT84.66,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cea-monoclonal-antibody-ct8466
2020-09-18T04:24:24Z,yttrium Y 90 clivatuzumab tetraxetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-clivatuzumab-tetraxetan
2020-09-18T04:24:24Z,yttrium Y 90 colloid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-colloid
2020-09-18T04:24:24Z,yttrium Y 90 daclizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-daclizumab
2020-09-18T04:24:24Z,yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-anti-cea-monoclonal-antibody-m5a
2020-09-18T04:24:24Z,yttrium Y 90 DOTA-biotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-biotin
2020-09-18T04:24:24Z,yttrium Y 90 epratuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-epratuzumab
2020-09-18T04:24:24Z,yttrium Y 90 glass microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-glass-microspheres
2020-09-18T04:24:24Z,yttrium Y 90 ibritumomab tiuxetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-ibritumomab-tiuxetan
2020-09-18T04:24:24Z,yttrium Y 90 monoclonal antibody B3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-b3
2020-09-18T04:24:24Z,yttrium Y 90 monoclonal antibody BrE-3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-bre-3
2020-09-18T04:24:24Z,yttrium Y 90 monoclonal antibody Hu3S193,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-hu3s193
2020-09-18T04:24:24Z,yttrium Y 90 monoclonal antibody MN-14,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-monoclonal-antibody-mn-14
2020-09-18T04:24:24Z,yttrium Y 90 resin microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-resin-microspheres
2020-09-18T04:24:24Z,yttrium Y 90 tacatuzumab tetraxetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-tacatuzumab-tetraxetan
2020-09-18T04:24:24Z,yttrium Y 90-DOTA-di-HSG peptide IMP-288,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-di-hsg-peptide-imp-288
2020-09-18T04:24:24Z,yttrium Y 90-DOTA-girentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-dota-girentuximab
2020-09-18T04:24:24Z,yttrium Y 90-edotreotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-edotreotide
2020-09-18T04:24:24Z,yttrium Y 90-labeled anti-FZD10 monoclonal antibody OTSA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-labeled-anti-fzd10-monoclonal-antibody-otsa101
2020-09-18T04:24:24Z,yttrium Y 90-labeled basiliximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-labeled-basiliximab
2020-09-18T04:24:24Z,yttrium-90 polycarbonate brachytherapy plaque,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-90-polycarbonate-brachytherapy-plaque
2020-09-18T04:24:24Z,Z-360,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/z-360
2020-09-18T04:24:24Z,Z-endoxifen hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/z-endoxifen-hydrochloride
2020-09-18T04:24:24Z,zafirlukast,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zafirlukast
2020-09-18T04:24:24Z,zalcitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalcitabine
2020-09-18T04:24:24Z,Zaltrap,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziv-aflibercept
2020-09-18T04:24:24Z,zalutumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalutumumab
2020-09-18T04:24:24Z,Zalypsis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pm00104
2020-09-18T04:24:24Z,Zanaflex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tizanidine-hydrochloride
2020-09-18T04:24:24Z,zanamivir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanamivir
2020-09-18T04:24:24Z,zanolimumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanolimumab
2020-09-18T04:24:24Z,Zanosar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin
2020-09-18T04:24:24Z,zanubrutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-bgb-3111
2020-09-18T04:24:24Z,Zarnestra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipifarnib
2020-09-18T04:24:24Z,Zarontin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethosuximide
2020-09-18T04:24:24Z,Zarxio,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim
2020-09-18T04:24:24Z,ZD6126,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zd6126
2020-09-18T04:24:24Z,Zejula,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niraparib-tosylate-monohydrate
2020-09-18T04:24:24Z,Zelboraf,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vemurafenib
2020-09-18T04:24:24Z,Zemplar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paricalcitol
2020-09-18T04:24:24Z,Zemuron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocuronium-bromide
2020-09-18T04:24:24Z,Zenapax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daclizumab
2020-09-18T04:24:24Z,Zenpep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase
2020-09-18T04:24:24Z,Zentel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798650
2020-09-18T04:24:24Z,Zepatier,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797922
2020-09-18T04:24:24Z,Zepzelca,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurbinectedin
2020-09-18T04:24:24Z,Zerbaxa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795424
2020-09-18T04:24:24Z,Zerit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stavudine
2020-09-18T04:24:24Z,Zestril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisinopril
2020-09-18T04:24:24Z,Zetia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezetimibe
2020-09-18T04:24:24Z,Zevalin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibritumomab-tiuxetan
2020-09-18T04:24:24Z,Zeven,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/682691
2020-09-18T04:24:24Z,Zeven,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-debio-0932
2020-09-18T04:24:24Z,zhongyao fufang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zhongyao-fufang
2020-09-18T04:24:24Z,Ziagen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abacavir-sulfate
2020-09-18T04:24:24Z,zibotentan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zibotentan
2020-09-18T04:24:24Z,ziconotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziconotide
2020-09-18T04:24:24Z,zidovudine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zidovudine
2020-09-18T04:24:24Z,zileuton,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zileuton
2020-09-18T04:24:24Z,zilucoplan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792463
2020-09-18T04:24:24Z,zimberelimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797805
2020-09-18T04:24:24Z,zinc finger nuclease ZFN-603,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-finger-nuclease-zfn-603
2020-09-18T04:24:24Z,zinc finger nuclease ZFN-758,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-finger-nuclease-zfn-758
2020-09-18T04:24:24Z,zinc gluconate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-gluconate
2020-09-18T04:24:24Z,zinc oxide/aluminum starch octenylsuccinate/glycyrrhetinic phytosome/vitamin E/botanical extracts-based skin protectant paste,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/708408
2020-09-18T04:24:24Z,zinc sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-sulfate
2020-09-18T04:24:24Z,Zinecard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexrazoxane-hydrochloride
2020-09-18T04:24:24Z,zinostatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinostatin
2020-09-18T04:24:24Z,Zinplava,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793939
2020-09-18T04:24:24Z,Zipan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride
2020-09-18T04:24:24Z,Zirabev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab
2020-09-18T04:24:24Z,zirconium Zr 89 anti-CD8 antibody ZED88082A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800947
2020-09-18T04:24:24Z,zirconium Zr 89-anti-EGFR monoclonal antibody ABT-806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792536
2020-09-18T04:24:24Z,zirconium Zr 89-bevacizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-bevacizumab
2020-09-18T04:24:24Z,zirconium Zr 89-cetuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-cetuximab
2020-09-18T04:24:24Z,zirconium Zr 89-desferrioxamine B monoclonal antibody huJ591,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-desferrioxamine-b-monoclonal-antibody-huj591
2020-09-18T04:24:24Z,zirconium Zr 89-Df-IAB22M2C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-df-iab22m2c
2020-09-18T04:24:24Z,zirconium Zr 89-Df-IAB2M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-df-iab2m
2020-09-18T04:24:24Z,zirconium Zr 89-DFO-cRGDY PEG-Cy5-C' dots,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795696
2020-09-18T04:24:24Z,zirconium Zr 89-DFO-daratumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795437
2020-09-18T04:24:24Z,zirconium Zr 89-DFO-SC16.56,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800447
2020-09-18T04:24:24Z,zirconium Zr 89-DFO-vandortuzumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745657
2020-09-18T04:24:24Z,zirconium Zr 89-labeled anti-CA19-9 monoclonal antibody 5B1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-anti-ca19-9-monoclonal-antibody-5b1
2020-09-18T04:24:24Z,zirconium Zr 89-labeled anti-PIGF monoclonal antibody RO5323441,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-anti-pigf-monoclonal-antibody-ro5323441
2020-09-18T04:24:24Z,zirconium Zr 89-labeled atezolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-atezolizumab
2020-09-18T04:24:24Z,zirconium Zr 89-labeled monoclonal antibody MMOT0530A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-monoclonal-antibody-mmot0530a
2020-09-18T04:24:24Z,zirconium Zr 89-labeled RO5479599,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-labeled-ro5479599
2020-09-18T04:24:24Z,zirconium Zr 89-nanocolloidal albumin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-nanocolloidal-albumin
2020-09-18T04:24:24Z,zirconium Zr 89-panitumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795428
2020-09-18T04:24:24Z,zirconium Zr 89-pembrolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792546
2020-09-18T04:24:24Z,zirconium Zr 89-pertuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-pertuzumab
2020-09-18T04:24:24Z,zirconium Zr 89-TAK-164,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/799309
2020-09-18T04:24:24Z,zirconium Zr 89-trastuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-trastuzumab
2020-09-18T04:24:24Z,zirconium Zr 89˗DFO˗REGN3504,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797339
2020-09-18T04:24:24Z,Zithromax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azithromycin
2020-09-18T04:24:24Z,ziv-aflibercept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziv-aflibercept
2020-09-18T04:24:24Z,Zocor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simvastatin
2020-09-18T04:24:24Z,Zofran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron
2020-09-18T04:24:24Z,Zofran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ondansetron-hydrochloride
2020-09-18T04:24:24Z,Zoladex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate
2020-09-18T04:24:24Z,zolbetuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/claudiximab
2020-09-18T04:24:24Z,zoledronic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid
2020-09-18T04:24:24Z,Zolinza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat
2020-09-18T04:24:24Z,zolmitriptan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolmitriptan
2020-09-18T04:24:24Z,Zoloft,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sertraline-hydrochloride
2020-09-18T04:24:24Z,zolpidem tartrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolpidem-tartrate
2020-09-18T04:24:24Z,Zometa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid
2020-09-18T04:24:24Z,Zomig,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolmitriptan
2020-09-18T04:24:24Z,zopiclone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zopiclone
2020-09-18T04:24:24Z,zoptarelin doxorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoptarelin-doxorubicin
2020-09-18T04:24:24Z,Zortress,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus
2020-09-18T04:24:24Z,zorubicin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorubicin-hydrochloride
2020-09-18T04:24:24Z,Zostavax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen
2020-09-18T04:24:24Z,"zoster vaccine recombinant, adjuvanted",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797077
2020-09-18T04:24:24Z,zosuquidar trihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zosuquidar-trihydrochloride
2020-09-18T04:24:24Z,zotatifin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800362
2020-09-18T04:24:24Z,Zovirax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/531923
2020-09-18T04:24:24Z,Zovirax for injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium
2020-09-18T04:24:24Z,Zurinol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium
2020-09-18T04:24:24Z,Zyban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792878
2020-09-18T04:24:24Z,Zyban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride
2020-09-18T04:24:24Z,Zybrestat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine
2020-09-18T04:24:24Z,ZYBRESTAT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium
2020-09-18T04:24:24Z,ZYC300,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zyc300
2020-09-18T04:24:24Z,Zydelig,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib
2020-09-18T04:24:24Z,Zyflo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zileuton
2020-09-18T04:24:24Z,Zykadia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib
2020-09-18T04:24:24Z,Zyloprim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium
2020-09-18T04:24:24Z,Zymase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancrelipase
2020-09-18T04:24:24Z,Zyprexa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olanzapine
2020-09-18T04:24:24Z,Zytiga,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate
2020-09-18T04:24:24Z,Zyvox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linezolid
2020-10-04T00:40:08Z,Zyclara,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod
2020-10-06T23:28:05Z,DNAJB1/PRKACA fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803026
2020-10-06T23:28:05Z,pramlintide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803038
2020-10-10T22:28:55Z,Shingrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a
2020-10-10T22:28:55Z,"zoster vaccine recombinant, adjuvanted",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herpes-zoster-vaccine-gsk1437173a
2020-10-14T07:19:56Z,(61)Cu-ATSM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-61-atsm
2020-10-14T07:19:56Z,[18F]-ML-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-ml-10
2020-10-14T07:19:56Z,[F-18]HX4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-hx4
2020-10-14T07:19:56Z,[F18]VM4-037,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-vm4-037
2020-10-14T07:19:56Z,[Leu15] gastrin-17,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leu15-gastrin-17
2020-10-14T07:19:56Z,11beta-hydroxysteroid dehydrogenase type 1 inhibitor AZD4017,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/11beta-hydroxysteroid-dehydrogenase-type-1-inhibitor-azd4017
2020-10-14T07:19:56Z,123-I-MIP-1095,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-mip-1095
2020-10-14T07:19:56Z,"16, 16-dimethyl prostaglandin E2",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/1616-dimethyl-prostaglandin-e2
2020-10-14T07:19:56Z,"2-0, 3-0 desulfated heparin",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium
2020-10-14T07:19:56Z,3M Cavilon Advanced Skin Protectant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol-free-hypoallergenic-barrier-film-solution
2020-10-14T07:19:56Z,4-[18F]fluoroglutamic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/4-18ffluoroglutamic-acid
2020-10-14T07:19:56Z,5-aza-4’-thio-2’-deoxycytidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-aza-4-thio-2-deoxycytidine
2020-10-14T07:19:56Z,5-HT4 agonist TAK-954,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-ht4-agonist-tak-954
2020-10-14T07:19:56Z,6 melanoma helper peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-melanoma-helper-peptide-vaccine
2020-10-14T07:19:56Z,7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/17beta-hydroxysteroid-dehydrogenase-type-5-inhibitor-asp9521
2020-10-14T07:19:56Z,852A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-852a
2020-10-14T07:19:56Z,A-101 topical solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/a-101-topical-solution
2020-10-14T07:19:56Z,A2A receptor antagonist EOS100850,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/a2a-receptor-antagonist-eos100850
2020-10-14T07:19:56Z,abaloparatide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abaloparatide
2020-10-14T07:19:56Z,ABBV-221,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losatuxizumab-vedotin
2020-10-14T07:19:56Z,abexinostat tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abexinostat-tosylate
2020-10-14T07:19:56Z,Abraxane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel
2020-10-14T07:19:56Z,absorbable modified polymer hemostatic powder,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxnorm
2020-10-14T07:19:56Z,ABT-510,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tsp-1-mimetic-abt-510
2020-10-14T07:19:56Z,ABT-751,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colchicine-site-binding-agent-abt-751
2020-10-14T07:19:56Z,ABVE-PC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dbve-pc-regimen
2020-10-14T07:19:56Z,acalisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalisib
2020-10-14T07:19:56Z,Acelarin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosgemcitabine-palabenamide
2020-10-14T07:19:56Z,acelullar cadaveric dermal matrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acellular-cadaveric-dermal-matrix
2020-10-14T07:19:56Z,acetylsalicylic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin
2020-10-14T07:19:56Z,acetylsalicylic acid/simvastatin/atenolol/ramipril/thiazide capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin-simvastatin-atenolol-ramipril-thiazide-capsule
2020-10-14T07:19:56Z,Aciphex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole
2020-10-14T07:19:56Z,actinium Ac 225-FPI-1434,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-fpi-1434
2020-10-14T07:19:56Z,actinium Ac-225 anti-PSMA monoclonal antibody J591,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-anti-psma-monoclonal-antibody-j591
2020-10-14T07:19:56Z,activin type IIA receptor Fc fusion protein KER-050,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-iia-receptor-fc-fusion-protein-ker-050
2020-10-14T07:19:56Z,acyclic nucleoside phosphonate prodrug ABI-1968,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclic-nucleoside-phosphonate-prodrug-abi-1968
2020-10-14T07:19:56Z,Aczone Gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone-gel
2020-10-14T07:19:56Z,"Ad5 [E1-, E2b-]-HER2/Neu vaccine ETBX-021",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-e1--e2b--her2-neu-vaccine-etbx-021
2020-10-14T07:19:56Z,Ad5CMV-p53 gene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec
2020-10-14T07:19:56Z,Ad5-SGE-REIC/Dkk-3 MTG-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-sge-reic-dkk-3-mtg-201
2020-10-14T07:19:56Z,adavosertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adavosertib
2020-10-14T07:19:56Z,adenosine A2A receptor antagonist NIR178,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-nir178
2020-10-14T07:19:56Z,adenosine A2A receptor antagonist PBF-509,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taminadenant
2020-10-14T07:19:56Z,adenosine A2A receptor antagonist/phosphodiesterase 10A PBF-999,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-receptor-antagonist-phosphodiesterase-10a-pbf-999
2020-10-14T07:19:56Z,adenosine A2A/A2B receptor antagonist AB928,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2a-a2b-receptor-antagonist-ab928
2020-10-14T07:19:56Z,adenosine A2B receptor antagonist PBF-1129,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenosine-a2b-receptor-antagonist-pbf-1129
2020-10-14T07:19:56Z,adenosine A3 receptor agonist CF102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/namodenoson
2020-10-14T07:19:56Z,adenosine-A2A receptor antagonist CPI-444,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciforadenant
2020-10-14T07:19:56Z,adenoviral cancer vaccine PF-06936308,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-cancer-vaccine-pf-06936308
2020-10-14T07:19:56Z,adenoviral PSA vaccine ETBX-071,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-psa-vaccine-etbx-071
2020-10-14T07:19:56Z,Affinitak,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprinocarsen
2020-10-14T07:19:56Z,adenoviral tumor-specific neoantigen priming vaccine GAd-209-FSP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-gad-209-fsp
2020-10-14T07:19:56Z,adenoviral tumor-specific neoantigen priming vaccine GRT-C901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-grt-c901
2020-10-14T07:19:56Z,adenoviral vector encoding VEGF-C LX-1101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-encoding-vegf-c-lx-1101
2020-10-14T07:19:56Z,adenovirus-expressing mutant HPV E6/E7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-expressing-mutant-hpv-e6-e7
2020-10-14T07:19:56Z,adipose-derived expanded mesenchymal stem cells SCM-010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-expanded-mesenchymal-stem-cells-scm-010
2020-10-14T07:19:56Z,ado trastuzumab emtansine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine
2020-10-14T07:19:56Z,Ad-REIC/DKK3 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-sge-reic-dkk-3-mtg-201
2020-10-14T07:19:56Z,adrenocorticotropic hormone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticotropin
2020-10-14T07:19:56Z,Ad-RTS-hIL-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-rts-hil-12
2020-10-14T07:19:56Z,ADVEXIN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec
2020-10-14T07:19:56Z,AEE788,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-aee788
2020-10-14T07:19:56Z,AEG35156,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xiap-antisense-oligonucleotide-aeg35156
2020-10-14T07:19:56Z,aerosol gemcitabine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aerosol-gemcitabine
2020-10-14T07:19:56Z,Affinitac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprinocarsen
2020-10-14T07:19:56Z,AFP464,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminoflavone-prodrug-afp464
2020-10-14T07:19:56Z,AG-024322,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-2-4-inhibitor-ag-024322
2020-10-14T07:19:56Z,agerafenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-braf-multikinase-inhibitor-rxdx-105
2020-10-14T07:19:56Z,agonistic anti-CD40 monoclonal antibody ADC-1013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitazalimab
2020-10-14T07:19:56Z,agonistic anti-OX40 monoclonal antibody INCAGN01949,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-incagn01949
2020-10-14T07:19:56Z,agonistic anti-OX40 monoclonal antibody MEDI6383,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efizonerimod
2020-10-14T07:19:56Z,AKR1C3-activated prodrug OBI-3424,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akr1c3-activated-prodrug-obi-3424
2020-10-14T07:19:56Z,Akt antisense oligonucleotide RX-0201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/archexin
2020-10-14T07:19:56Z,AKT inhibitor ARQ 092,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miransertib
2020-10-14T07:19:56Z,Akt inhibitor GSK2141795,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uprosertib
2020-10-14T07:19:56Z,Akti-1/2 inhibitor treated tumor infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-treated-tumor-infiltrating-lymphocytes
2020-10-14T07:19:56Z,Akynzeo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-palonosetron-hydrochloride
2020-10-14T07:19:56Z,Alantel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aloe-vera-chamomile-thyme-topical-cream
2020-10-14T07:19:56Z,albendazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole
2020-10-14T07:19:56Z,Albenza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole
2020-10-14T07:19:56Z,ALK inhibitor PLB 1003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-plb-1003
2020-10-14T07:19:56Z,ALK inhibitor WX-0593,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-wx-0593
2020-10-14T07:19:56Z,ALK/c-Met inhibitor TQ-B3139,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-c-met-inhibitor-tq-b3139
2020-10-14T07:19:56Z,alkotinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alkotinib
2020-10-14T07:19:56Z,alkylglycerol/rosemary capsules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alkylglycerol-rosemary-capsules
2020-10-14T07:19:56Z,AlloDerm,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acellular-cadaveric-dermal-matrix
2020-10-14T07:19:56Z,allogeneic acute myeloid leukemia antigen-expressing dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-aml-antigen-expressing-dendritic-cell-vaccine
2020-10-14T07:19:56Z,allogeneic adipose-derived mesenchymal stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-adipose-derived-mesenchymal-stem-cells
2020-10-14T07:19:56Z,allogeneic anti-BCMA CAR-transduced T cells ALLO-715,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-transduced-t-cells-allo-715
2020-10-14T07:19:56Z,allogeneic anti-BCMA/CS1 bispecific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-cs1-bispecific-car-t-cells
2020-10-14T07:19:56Z,allogeneic anti-BCMA-CAR T cells PBCAR269A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-bcma-car-t-cells-pbcar269a
2020-10-14T07:19:56Z,allogeneic anti-CD19 universal CAR-T cells CTA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-universal-car-t-cells-cta101
2020-10-14T07:19:56Z,allogeneic anti-CD19-CAR T cells PBCAR0191,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd19-car-t-cells-pbcar0191
2020-10-14T07:19:56Z,allogeneic anti-CD20 CAR T cells LUCAR-20S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-lucar-20s
2020-10-14T07:19:56Z,allogeneic anti-CD20-CAR T cells PBCAR20A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-anti-cd20-car-t-cells-pbcar20a
2020-10-14T07:19:56Z,allogeneic autophagosome-enriched vaccine DPV-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-autophagosome-enriched-vaccine-dpv-001
2020-10-14T07:19:56Z,allogeneic CD123-specific universal CAR123-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd123-specific-universal-car123-expressing-t-lymphocytes
2020-10-14T07:19:56Z,allogeneic CD19CAR-transfected cytokine-induced killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd19car-transfected-cytokine-induced-killer-cells
2020-10-14T07:19:56Z,allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cd8-leukemia-associated-antigens-specific-t-cells-nexi-001
2020-10-14T07:19:56Z,allogeneic CMV antigen-specific CD4+/CD8+ T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cmv-antigen-specific-cd4-cd8-t-lymphocytes
2020-10-14T07:19:56Z,allogeneic CRISPR-Cas9 engineered anti-CD19 CAR T cells CTX110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-crispr-cas9-engineered-anti-cd19-car-t-cells-ctx110
2020-10-14T07:19:56Z,allogeneic CS1-specific universal CAR-expressing T lymphocytes UCARTCS1A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-cs1-specific-universal-car-expressing-t-lymphocytes-ucartcs1a
2020-10-14T07:19:56Z,allogeneic double negative T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-double-negative-t-cells
2020-10-14T07:19:56Z,allogeneic glial progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-glial-progenitor-cells
2020-10-14T07:19:56Z,allogeneic GM-CSF-secreting breast cancer vaccine SV-BR-1-GM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm
2020-10-14T07:19:56Z,allogeneic GM-CSF-secreting myeloma vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-myeloma-vaccine
2020-10-14T07:19:56Z,allogeneic GM-CSF-transfected myeloma cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-based-myeloma-cell-vaccine
2020-10-14T07:19:56Z,allogeneic HAdV antigen-specific T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hadv-antigen-specific-t-lymphocytes
2020-10-14T07:19:56Z,allogeneic HPV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-hpv-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,allogeneic interleukin-17-producing CD8-positive T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-interleukin-17-producing-cd8-positive-t-cells
2020-10-14T07:19:56Z,allogeneic LMP1-/LMP2- specific cytotoxic T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-lmp1-lmp2-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,allogeneic NKG2DL-targeting CAR-grafted gamma delta T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-nkg2dl-targeting-car-grafted-gamma-delta-t-cells
2020-10-14T07:19:56Z,allogeneic T lymphocytes expressing NY-ESO-1-C259-specific TCR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-t-lymphocytes-expressing-ny-eso-1-c259-specific-tcr
2020-10-14T07:19:56Z,allogeneic tri-functional anti-CD19 CAR-NK cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tri-functional-anti-cd19-car-nk-cells
2020-10-14T07:19:56Z,allogeneic umbilical cord blood-derived HSPCs NLA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-umbilical-cord-blood-derived-hspcs-nla101
2020-10-14T07:19:56Z,allosteric ErbB inhibitor BDTX-189,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allosteric-erbb-inhibitor-bdtx-189
2020-10-14T07:19:56Z,Alocrest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-vinorelbine
2020-10-14T07:19:56Z,aloe vera/chamomile/thyme topical cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aloe-vera-chamomile-thyme-topical-cream
2020-10-14T07:19:56Z,alpha Gal AGI-134,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-gal-agi-134
2020-10-14T07:19:56Z,"alpha-1,3-galactosyltransferase-expressing allogeneic lung tumor cell vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tergenpumatucel-l
2020-10-14T07:19:56Z,alpha-folate receptor-targeting thymidylate synthase inhibitor ONX-0801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idetrexed
2020-10-14T07:19:56Z,alpha-lipoic acid/vitamin/mineral supplement PolyMVA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-palladium-vitamin-mineral-supplement
2020-10-14T07:19:56Z,ALVAC(2) melanoma multi-antigen therapeutic vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvac2-melanoma-multi-antigen-vaccine
2020-10-14T07:19:56Z,alvocidib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-hydrochloride
2020-10-14T07:19:56Z,alvocidib prodrug TP-1287,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-prodrug-tp-1287
2020-10-14T07:19:56Z,amblyomin-X,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amblyomin-x
2020-10-14T07:19:56Z,AML mRNA plus lysate loaded autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aml-mrna-positive-lysate-loaded-autologous-dendritic-cell-vaccine
2020-10-14T07:19:56Z,amnion-derived cellular cytokine solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lissencephaly
2020-10-14T07:19:56Z,amorphous calcium carbonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amorphous-calcium-carbonate
2020-10-14T07:19:56Z,Andro LA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate
2020-10-14T07:19:56Z,androgen receptor antagonist BAY 1161116,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-bay-1161116
2020-10-14T07:19:56Z,androgen receptor antagonist ONC1-0013B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-onc1-0013b
2020-10-14T07:19:56Z,androgen receptor degrader ARV-110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-arv-110
2020-10-14T07:19:56Z,androgen receptor degrader CC-94676,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-degrader-cc-94676
2020-10-14T07:19:56Z,androgen receptor inhibitor EPI-506,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ralaniten-acetate
2020-10-14T07:19:56Z,androgen receptor inhibitor EPI-7386,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-inhibitor-epi-7386
2020-10-14T07:19:56Z,androgen receptor/glucocorticoid receptor antagonist CB-03-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-glucocorticoid-receptor-antagonist-cb-03-10
2020-10-14T07:19:56Z,Anectine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succinylcholine-chloride
2020-10-14T07:19:56Z,angiogenesis/heparanase inhibitor PG545,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pixatimod
2020-10-14T07:19:56Z,Angiozyme,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribozyme-rpi4610
2020-10-14T07:19:56Z,anhydrous enol-oxaloacetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anhydrous-enol-oxaloacetate
2020-10-14T07:19:56Z,anthracycline analogue GPX-150,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camsirubicin
2020-10-14T07:19:56Z,anti-5T4 antibody-drug conjugate ASN004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-asn004
2020-10-14T07:19:56Z,anti-ALK-1 monoclonal antibody PF-03446962,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascrinvacumab
2020-10-14T07:19:56Z,anti-alpha BCMA/anti-alpha CD3 T-cell engaging bispecific antibody TNB-383B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-alpha-bcma-anti-alpha-cd3-t-cell-engaging-bispecific-antibody-tnb-383b
2020-10-14T07:19:56Z,anti-AMHR2 monoclonal antibody GM102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murlentamab
2020-10-14T07:19:56Z,anti-AXL fusion protein AVB-S6-500,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-fusion-protein-avb-s6-500
2020-10-14T07:19:56Z,anti-AXL monoclonal antibody-MMAE conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enapotamab-vedotin
2020-10-14T07:19:56Z,anti-AXL/PBD antibody-drug conjugate ADCT-601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-axl-pbd-antibody-drug-conjugate-adct-601
2020-10-14T07:19:56Z,anti-B7-H3/DXd antibody-drug conjugate DS-7300a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-b7-h3-dxd-antibody-drug-conjugate-ds-7300a
2020-10-14T07:19:56Z,Betadine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
2020-10-14T07:19:56Z,anti-B7-H4 monoclonal antibody FPA150,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alsevalimab
2020-10-14T07:19:56Z,anti-BCMA antibody SEA-BCMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-antibody-sea-bcma
2020-10-14T07:19:56Z,anti-BCMA/anti-CD3 bispecific antibody REGN5459,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-anti-cd3-bispecific-antibody-regn5459
2020-10-14T07:19:56Z,anti-BCMA/CD3 BiTE antibody AMG 420,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-420
2020-10-14T07:19:56Z,anti-BCMA/CD3 BiTE antibody AMG 701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-amg-701
2020-10-14T07:19:56Z,anti-BCMA/CD3 BiTE antibody REGN5458,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-cd3-bite-antibody-regn5458
2020-10-14T07:19:56Z,anti-BCMA/PBD ADC MEDI2228,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-bcma-pbd-adc-medi2228
2020-10-14T07:19:56Z,antibody-drug conjugate ABBV-011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-abbv-011
2020-10-14T07:19:56Z,antibody-drug conjugate ABBV-155,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirzotamab-clezutoclax
2020-10-14T07:19:56Z,antibody-drug conjugate ABBV-176,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolinsatamab-talirine
2020-10-14T07:19:56Z,antibody-drug conjugate ADC XMT-1536,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-adc-xmt-1536
2020-10-14T07:19:56Z,antibody-drug conjugate SC-003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamrintamab-pamozirine
2020-10-14T07:19:56Z,antibody-drug conjugate SC-005,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-005
2020-10-14T07:19:56Z,antibody-drug conjugate SC-007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-007
2020-10-14T07:19:56Z,antibody-like CD95 receptor/Fc-fusion protein CAN-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asunercept
2020-10-14T07:19:56Z,anti-BTLA monoclonal antibody TAB004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-btla-monoclonal-antibody-tab004
2020-10-14T07:19:56Z,anti-C4.4a antibody-drug conjugate BAY1129980,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lupartumab-amadotin
2020-10-14T07:19:56Z,anti-C5aR monoclonal antibody IPH5401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avdoralimab
2020-10-14T07:19:56Z,anti-CD123 ADC IMGN632,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-adc-imgn632
2020-10-14T07:19:56Z,anti-CD123 x anti-CD3 bispecific antibody XmAb14045,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vibecotamab
2020-10-14T07:19:56Z,anti-CD123/CD3 bispecific antibody APVO436,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-apvo436
2020-10-14T07:19:56Z,anti-CD123/CD3 BiTE antibody SAR440234,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bite-antibody-sar440234
2020-10-14T07:19:56Z,anti-CD137 agonistic monoclonal antibody ADG106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-adg106
2020-10-14T07:19:56Z,anti-CD137 agonistic monoclonal antibody AGEN2373,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-agen2373
2020-10-14T07:19:56Z,anti-CD137 agonistic monoclonal antibody ATOR-1017,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ator-1017
2020-10-14T07:19:56Z,anti-CD137 agonistic monoclonal antibody CTX-471,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-ctx-471
2020-10-14T07:19:56Z,anti-CD137 agonistic monoclonal antibody LVGN6051,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd137-agonistic-monoclonal-antibody-lvgn6051
2020-10-14T07:19:56Z,anti-CD166 probody-drug conjugate CX-2009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/praluzatamab-ravtansine
2020-10-14T07:19:56Z,anti-CD19 antibody-T-cell receptor-expressing T cells ET019003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-t-cell-receptor-expressing-t-cells-et019003
2020-10-14T07:19:56Z,anti-CD19 CAR-T cells XLCART001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-t-cells-xlcart001
2020-10-14T07:19:56Z,anti-CD19 fully human monoclonal antibody MDX-1342,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-mdx-1342
2020-10-14T07:19:56Z,anti-CD19/CD20/CD22/CD30 CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd20-cd22-cd30-car-t-cells
2020-10-14T07:19:56Z,anti-CD19/CD22 bispecific ligand-directed toxin DT2219ARL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-anti-cd22-bispecific-immunotoxin-dt2219arl
2020-10-14T07:19:56Z,anti-CD19/CD3 BiTE antibody AMG 562,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-bite-antibody-amg-562
2020-10-14T07:19:56Z,anti-CD19-CAR-CD3zeta-4-1BB-expressing natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-car-cd3zeta-4-1bb-expressing-allogenic-natural-killer-cells
2020-10-14T07:19:56Z,anti-CD19-CD28-zeta modified CAR CD3+ T lymphocytes JCAR015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadacabtagene-leraleucel
2020-10-14T07:19:56Z,anti-CD19-DM4 immunoconjugate SAR3419,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coltuximab-ravtansine
2020-10-14T07:19:56Z,anti-CD20 monoclonal antibody B001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-b001
2020-10-14T07:19:56Z,anti-CD20 monoclonal antibody BAT4306F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-bat4306f
2020-10-14T07:19:56Z,anti-CD20 monoclonal antibody MIL62,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-monoclonal-antibody-mil62
2020-10-14T07:19:56Z,anti-CD20 monoclonal antibody SCT400,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripertamab
2020-10-14T07:19:56Z,anti-CD20/anti-CD3 bispecific IgM antibody IGM2323,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-anti-cd3-bispecific-igm-antibody-igm2323
2020-10-14T07:19:56Z,anti-CD20/CD3 monoclonal antibody REGN1979,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/odronextamab
2020-10-14T07:19:56Z,anti-CD20/CD3 monoclonal antibody XmAb13676,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plamotamab
2020-10-14T07:19:56Z,anti-CD205 antibody-drug conjugate OBT076,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd205-antibody-drug-conjugate-obt076
2020-10-14T07:19:56Z,anti-CD22 ADC TRPH-222,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-adc-trph-222
2020-10-14T07:19:56Z,anti-CD22 monoclonal antibody-MMAE conjugate DCDT2980S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinatuzumab-vedotin
2020-10-14T07:19:56Z,anti-CD228/MMAE antibody-drug conjugate SGN-CD228A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd228-mmae-antibody-drug-conjugate-sgn-cd228a
2020-10-14T07:19:56Z,anti-CD25 monoclonal antibody RO7296682,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd25-monoclonal-antibody-ro7296682
2020-10-14T07:19:56Z,anti-CD26 monoclonal antibody YS110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd26-monoclonal-antibody-ys110
2020-10-14T07:19:56Z,anti-CD3/5T4 IgG1 bispecific antibody GEN1044,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-5t4-bispecific-antibody-gen1044
2020-10-14T07:19:56Z,anti-CD3/anti-BCMA bispecific monoclonal antibody JNJ-64007957,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teclistamab
2020-10-14T07:19:56Z,anti-CD3/anti-BCMA bispecific monoclonal antibody PF-06863135,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-bcma-bispecific-monoclonal-antibody-pf-06863135
2020-10-14T07:19:56Z,anti-CD3/anti-GPRC5D bispecific monoclonal antibody JNJ-64407564,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gprc5d-bispecific-monoclonal-antibody-jnj-64407564
2020-10-14T07:19:56Z,anti-CD3/anti-GUCY2C bispecific antibody PF-07062119,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-anti-gucy2c-bispecific-antibody-pf-07062119
2020-10-14T07:19:56Z,anti-CD3/CD20 bispecific antibody GEN3013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcoritamab
2020-10-14T07:19:56Z,anti-CD3/CD38 bispecific monoclonal antibody AMG 424,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-cd38-bispecific-monoclonal-antibody-amg-424
2020-10-14T07:19:56Z,anti-CD3/CD7-ricin toxin A immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-cd7-ricin-toxin-a-immunotoxin
2020-10-14T07:19:56Z,anti-CD3/humanized 3F8 bispecific antibody-activated T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761606
2020-10-14T07:19:56Z,anti-CD30/DM1 antibody-drug conjugate F0002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd30-dm1-antibody-drug-conjugate-f0002
2020-10-14T07:19:56Z,anti-CD32B monoclonal antibody BI-1206,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd32b-monoclonal-antibody-bi-1206
2020-10-14T07:19:56Z,anti-CD33/CD3 bispecific antibody GEM 333,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-gem-333
2020-10-14T07:19:56Z,anti-CD33/CD3 bispecific antibody JNJ-67571244,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bispecific-antibody-jnj-67571244
2020-10-14T07:19:56Z,anti-CD33/CD3 BiTE antibody AMG 673,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-cd3-bite-antibody-amg-673
2020-10-14T07:19:56Z,anti-CD37-CAR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-car-expressing-t-lymphocytes
2020-10-14T07:19:56Z,anti-CD38 monoclonal antibody SAR442085,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-monoclonal-antibody-sar442085
2020-10-14T07:19:56Z,anti-CD38 monoclonal antibody TAK-079,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mezagitamab
2020-10-14T07:19:56Z,anti-CD38 monoclonal antibody TJ202/MOR202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/felzartamab
2020-10-14T07:19:56Z,anti-CD38/BCMA CAR T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-bcma-car-t-lymphocytes
2020-10-14T07:19:56Z,anti-CD38/CD28xCD3 trispecific T cell engager SAR442257,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd28xcd3-tri-specific-monoclonal-antibody-sar442257
2020-10-14T07:19:56Z,anti-CD38/CD3 bispecific monoclonal antibody GBR 1342,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd38-cd3-bispecific-monoclonal-antibody-gbr-1342
2020-10-14T07:19:56Z,anti-CD38-targeted IgG4-attenuated IFNa TAK-573,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modakafusp-alfa
2020-10-14T07:19:56Z,anti-CD39 monoclonal antibody TTX-030,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd39-monoclonal-antibody-ttx-030
2020-10-14T07:19:56Z,anti-CD4 CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd4-car-t-cells
2020-10-14T07:19:56Z,anti-CD40 agonist monoclonal antibody ABBV-927,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giloralimab
2020-10-14T07:19:56Z,anti-CD40 agonist monoclonal antibody CDX-1140,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-cdx-1140
2020-10-14T07:19:56Z,anti-CD40/anti-4-1BB bispecific agonist monoclonal antibody GEN1042,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-anti-4-1bb-bispecific-agonist-monoclonal-antibody-gen1042
2020-10-14T07:19:56Z,anti-CD40L Fc-fusion protein BMS-986004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letolizumab
2020-10-14T07:19:56Z,anti-CD45 monoclonal antibody BC8-streptavidin conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd45-bc8-monoclonal-antibody-streptavidin-conjugate
2020-10-14T07:19:56Z,anti-CD46 antibody-drug conjugate FOR46,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd46-antibody-drug-conjugate-for46
2020-10-14T07:19:56Z,anti-CD47 ADC SGN-CD47M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-adc-sgn-cd47m
2020-10-14T07:19:56Z,anti-CD47 monoclonal antibody AO-176,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-ao-176
2020-10-14T07:19:56Z,anti-CD47 monoclonal antibody SHR-1603,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-shr-1603
2020-10-14T07:19:56Z,anti-CD47 monoclonal antibody SRF231,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urabrelimab
2020-10-14T07:19:56Z,anti-CD47 monoclonal antibody TJC4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-tjc4
2020-10-14T07:19:56Z,anti-CD47/CD19 bispecific monoclonal antibody TG-1801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-cd19-bispecific-monoclonal-antibody-tg-1801
2020-10-14T07:19:56Z,anti-CD48/MMAE antibody-drug conjugate SGN-CD48A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd48-mmae-antibody-drug-conjugate-sgn-cd48a
2020-10-14T07:19:56Z,anti-CD52 monoclonal antibody ALLO-647,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd52-monoclonal-antibody-allo-647
2020-10-14T07:19:56Z,anti-CD7 CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd7-car-t-cells
2020-10-14T07:19:56Z,anti-CD71/vcMMAE probody-drug conjugate CX-2029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd71-vcmmae-probody-drug-conjugate-cx-2029
2020-10-14T07:19:56Z,anti-CD73 monoclonal antibody CPI-006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-cpi-006
2020-10-14T07:19:56Z,anti-CD73 monoclonal antibody NZV930,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-nzv930
2020-10-14T07:19:56Z,anti-CD73 monoclonal antibody TJ4309,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-tj4309
2020-10-14T07:19:56Z,anti-CEA TCR retroviral vector-transduced autologous lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/630382
2020-10-14T07:19:56Z,anti-CEACAM6 antibody BAY1834942,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam6-antibody-bay1834942
2020-10-14T07:19:56Z,anti-c-KIT monoclonal antibody KTN0158,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-monoclonal-antibody-cdx-0158
2020-10-14T07:19:56Z,anti-claudin18.2 monoclonal antibody AB011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-ab011
2020-10-14T07:19:56Z,anti-claudin18.2 monoclonal antibody TST001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-claudin182-monoclonal-antibody-tst001
2020-10-14T07:19:56Z,anti-CLDN6 monoclonal antibody IMAB027,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-asp1650
2020-10-14T07:19:56Z,anti-CLEC12A/CD3 bispecific antibody MCLA117,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tepoditamab
2020-10-14T07:19:56Z,anti-c-Met antibody-drug conjugate SHR-A1403,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-hti-1066
2020-10-14T07:19:56Z,anti-c-Met antibody-drug conjugate TR1801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-antibody-drug-conjugate-tr1801
2020-10-14T07:19:56Z,anti-c-Met monoclonal antibody ABT-700,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telisotuzumab
2020-10-14T07:19:56Z,anti-c-MET monoclonal antibody HLX55,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-met-monoclonal-antibody-hlx55
2020-10-14T07:19:56Z,anti-c-MET monoclonal antibody LY2875358,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emibetuzumab
2020-10-14T07:19:56Z,anti-CSF-1R monoclonal antibody SNDX-6352,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axatilimab
2020-10-14T07:19:56Z,anti-CTLA4 antibody Fc fusion protein KN044,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-antibody-fc-fusion-protein-kn044
2020-10-14T07:19:56Z,anti-CTLA4 mAb RNA/GITRL RNA-transfected autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-moab-rna-gitrl-rna-transfected-autologous-dendritic-cell-vaccine
2020-10-14T07:19:56Z,anti-CTLA-4 mAb RNA-transfected autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-moab-rna-transfected-autologous-dendritic-cell-vaccine
2020-10-14T07:19:56Z,anti-CTLA-4 monoclonal antibody ADG116,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-adg116
2020-10-14T07:19:56Z,anti-CTLA-4 monoclonal antibody ADU-1604,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-adu-1604
2020-10-14T07:19:56Z,anti-CTLA-4 monoclonal antibody AGEN1181,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-agen1181
2020-10-14T07:19:56Z,anti-CTLA-4 monoclonal antibody AGEN1884,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalifrelimab
2020-10-14T07:19:56Z,anti-CTLA4 monoclonal antibody HBM4003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-hbm4003
2020-10-14T07:19:56Z,anti-CTLA-4 monoclonal antibody MK-1308,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-mk-1308
2020-10-14T07:19:56Z,anti-CTLA-4 monoclonal antibody ONC-392,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-onc-392
2020-10-14T07:19:56Z,anti-CTLA-4 monoclonal antibody REGN4659,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-monoclonal-antibody-regn4659
2020-10-14T07:19:56Z,anti-CTLA-4 probody BMS-986288,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-probody-bms-986288
2020-10-14T07:19:56Z,anti-CTLA-4/anti-PD-1 monoclonal antibody combination BCD-217,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-anti-pd-1-monoclonal-antibody-combination-bcd-217
2020-10-14T07:19:56Z,anti-CTLA-4/LAG-3 bispecific antibody XmAb22841,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-lag-3-bispecific-antibody-xmab22841
2020-10-14T07:19:56Z,anti-CTLA-4/OX40 bispecific antibody ATOR-1015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla-4-ox40-bispecific-antibody-ator-1015
2020-10-14T07:19:56Z,anti-denatured collagen recombinant monoclonal antibody TRC093,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-denatured-collagen-monoclonal-antibody-trc093
2020-10-14T07:19:56Z,anti-DLL3/CD3 BiTE antibody AMG 757,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dll3-cd3-bite-antibody-amg-757
2020-10-14T07:19:56Z,anti-DLL4 monoclonal antibody REGN421,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoticumab
2020-10-14T07:19:56Z,anti-DLL4/VEGF bispecific monoclonal antibody OMP-305B83,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navicixizumab
2020-10-14T07:19:56Z,anti-DR5 agonistic monoclonal antibody INBRX-109,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dr5-agonistic-monoclonal-antibody-inbrx-109
2020-10-14T07:19:56Z,anti-EGFL7 monoclonal antibody MEGF0444A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-trastuzumab
2020-10-14T07:19:56Z,anti-EGFR CAR-transduced IL-12-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-car-transduced-il-12-expressing-t-lymphocytes
2020-10-14T07:19:56Z,anti-EGFR monoclonal antibody ABT-806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab
2020-10-14T07:19:56Z,anti-EGFR monoclonal antibody CPGJ 602,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-cpgj-602
2020-10-14T07:19:56Z,anti-EGFR monoclonal antibody HLX07,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimurutamab
2020-10-14T07:19:56Z,anti-EGFR monoclonal antibody mixture sym004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futuximab-modotuximab-mixture
2020-10-14T07:19:56Z,anti-EGFR monoclonal antibody RO5083945,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imgatuzumab
2020-10-14T07:19:56Z,anti-EGFR TAP antibody-drug conjugate IMGN289,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laprituximab-emtansine
2020-10-14T07:19:56Z,anti-EGFR/c-Met bispecific antibody EMB-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-emb-01
2020-10-14T07:19:56Z,anti-EGFR/DM1 antibody-drug conjugate AVID100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-dm1-antibody-drug-conjugate-avid100
2020-10-14T07:19:56Z,anti-EGFR/HER3 monoclonal antibody MEHD7945A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duligotuzumab
2020-10-14T07:19:56Z,anti-EGFR/PBD antibody-drug conjugate ABBV-321,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serclutamab-talirine
2020-10-14T07:19:56Z,anti-EGFRvIII/CD3 BiTE antibody AMG 596,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-cd3-bite-antibody-amg-596
2020-10-14T07:19:56Z,anti-endosialin/TEM1 monoclonal antibody MORAb-004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ontuxizumab
2020-10-14T07:19:56Z,anti-EphA3 monoclonal antibody KB004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifabotuzumab
2020-10-14T07:19:56Z,anti-ErbB3 antibody ISU104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-antibody-isu104
2020-10-14T07:19:56Z,anti-ErbB3 monoclonal antibody CDX-3379,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379
2020-10-14T07:19:56Z,anti-ErbB3/anti-IGF-1R bispecific monoclonal antibody MM-141,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/istiratumab
2020-10-14T07:19:56Z,anti-FcRn monoclonal antibody SYNT001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orilanolimab
2020-10-14T07:19:56Z,anti-FGFR2 antibody BAY1179470,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab
2020-10-14T07:19:56Z,anti-FL(FITC-E2) CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flfitc-e2-car-t-cells
2020-10-14T07:19:56Z,anti-FLT-1 ribozyme,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribozyme-rpi4610
2020-10-14T07:19:56Z,anti-FLT3/CD3 BiTE antibody AMG 427,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-flt3-cd3-bite-antibody-amg-427
2020-10-14T07:19:56Z,anti-folate receptor-alpha antibody drug conjugate STRO-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-folate-receptor-alpha-antibody-drug-conjugate-stro-002
2020-10-14T07:19:56Z,antifungal agent VL-2397,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-agent-vl-2397
2020-10-14T07:19:56Z,antifungal PC945,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antifungal-pc945
2020-10-14T07:19:56Z,anti-GARP monoclonal antibody ABBV-151,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-garp-monoclonal-antibody-abbv-151
2020-10-14T07:19:56Z,anti-GCC antibody-drug conjugate MLN0264,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indusatumab-vedotin
2020-10-14T07:19:56Z,anti-GCC antibody-drug conjugate TAK-164,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gcc-antibody-drug-conjugate-tak-164
2020-10-14T07:19:56Z,antigen-presenting cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antigen-presenting-cells-expressing-hpv16-e6-e7-sqz-pbmc-hpv
2020-10-14T07:19:56Z,anti-GFRAL monoclonal antibody NGM120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gfral-monoclonal-antibody-ngm120
2020-10-14T07:19:56Z,anti-GITR agonistic monoclonal antibody ASP1951,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-asp1951
2020-10-14T07:19:56Z,anti-GITR agonistic monoclonal antibody INCAGN01876,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ragifilimab
2020-10-14T07:19:56Z,anti-GITR agonistic monoclonal MS-986156,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-bms-986156
2020-10-14T07:19:56Z,anti-globo H monoclonal antibody OBI-888,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-monoclonal-antibody-obi-888
2020-10-14T07:19:56Z,anti-globo H/MMAE antibody-drug conjugate OBI 999,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-globo-h-mmae-antibody-drug-conjugate-obi-999
2020-10-14T07:19:56Z,anti-GPC3 monoclonal antibody GC33,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/codrituzumab
2020-10-14T07:19:56Z,anti-GPC3-CAR-T lymphocytes TAK-102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpc3-car-t-lymphocytes-tak-102
2020-10-14T07:19:56Z,anti-gremlin-1 monoclonal antibody UCB6114,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gremlin-1-monoclonal-antibody-ucb6114
2020-10-14T07:19:56Z,anti-HER2 antibody-drug conjugate A166,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-a166
2020-10-14T07:19:56Z,anti-HER2 antibody-drug conjugate BAT8001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-bat8001
2020-10-14T07:19:56Z,anti-HER2 antibody-drug conjugate DP303c,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-dp303c
2020-10-14T07:19:56Z,anti-HER-2 bispecific antibody KN026,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her-2-bispecific-antibody-kn026
2020-10-14T07:19:56Z,anti-HER2 bispecific antibody-drug conjugate ZW49,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-bispecific-antibody-drug-conjugate-zw49
2020-10-14T07:19:56Z,anti-HER2 immune stimulator-antibody conjugate NJH395,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-immune-stimulator-antibody-conjugate-njh395
2020-10-14T07:19:56Z,anti-HER2 monoclonal antibody B002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-b002
2020-10-14T07:19:56Z,anti-HER2 monoclonal antibody HLX22,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-monoclonal-antibody-hlx22
2020-10-14T07:19:56Z,anti-HER2/Anti-CD3 bispecific monoclonal antibody BTRC 4017A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-cd3-bispecific-monoclonal-antibody-btrc-4017a
2020-10-14T07:19:56Z,anti-HER2/Anti-HER3 bispecific monoclonal antibody MCLA-128,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-anti-her3-bispecific-monoclonal-antibody-mcla-128
2020-10-14T07:19:56Z,anti-HER2/HER2 bispecific antibody ZW25,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-her2-bispecific-antibody-zw25
2020-10-14T07:19:56Z,anti-HER2/HER3 dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-her3-dendritic-cell-vaccine
2020-10-14T07:19:56Z,anti-VISTA monoclonal antibody JNJ 61610588,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvatilimab
2020-10-14T07:19:56Z,anti-HER2/PBD-MA antibody-drug conjugate DHES0815A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-pbd-ma-antibody-drug-conjugate-dhes0815a
2020-10-14T07:19:56Z,anti-HER2-DM1 ADC B003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-dm1-adc-b003
2020-10-14T07:19:56Z,anti-HER3 antibody-drug conjugate U3 1402,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab-deruxtecan
2020-10-14T07:19:56Z,anti-HER3 monoclonal antibody LJM716,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elgemtumab
2020-10-14T07:19:56Z,anti-HIV-1 lentiviral vector-expressing sh5/C46 Cal-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hiv-1-lentiviral-vector-expressing-sh5-c46-cal-1
2020-10-14T07:19:56Z,anti-human integrin alpha v subunit monoclonal antibody EMD 525797,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abituzumab
2020-10-14T07:19:56Z,anti-ICAM-1 monoclonal antibody BI-505,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bersanlimab
2020-10-14T07:19:56Z,anti-ICOS agonist monoclonal antibody BMS-986226,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-monoclonal-antibody-bms-986226
2020-10-14T07:19:56Z,anti-ICOS monoclonal antibody KY1044,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-ky1044
2020-10-14T07:19:56Z,anti-IGF1/2 monoclonal antibody MEDI-573,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dusigitumab
2020-10-14T07:19:56Z,anti-IL-1 alpha monoclonal antibody CA-18C3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bermekimab
2020-10-14T07:19:56Z,anti-IL17A monoclonal antibody CJM112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il17a-monoclonal-antibody-cjm112
2020-10-14T07:19:56Z,anti-IL-8 monoclonal antibody HuMax-IL8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-8-monoclonal-antibody-bms-986253
2020-10-14T07:19:56Z,anti-ILDR2 monoclonal antibody BAY 1905254,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ildr2-monoclonal-antibody-bay-1905254
2020-10-14T07:19:56Z,anti-ILT4 monoclonal antibody MK-4830,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ilt4-monoclonal-antibody-mk-4830
2020-10-14T07:19:56Z,anti-inflammatory antibody ALXN1007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olendalizumab
2020-10-14T07:19:56Z,anti-interleukin 6 monoclonal antibody ALD518,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clazakizumab
2020-10-14T07:19:56Z,anti-interleukin-1 alpha monoclonal antibody MABp1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-mabp1
2020-10-14T07:19:56Z,anti-IRF4 antisense oligonucleotide ION251,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-irf4-antisense-oligonucleotide-ion251
2020-10-14T07:19:56Z,anti-KIR monoclonal antibody IHP 2101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-iph-2101
2020-10-14T07:19:56Z,anti-KIR3DL2 monoclonal antibody IPH4102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lacutamab
2020-10-14T07:19:56Z,anti-K-RAS G12D mTCR-transduced autologous peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-k-ras-g12d-mtcr-transduced-autologous-peripheral-blood-lymphocytes
2020-10-14T07:19:56Z,anti-LAG-3 monoclonal antibody BI 754111,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody
2020-10-14T07:19:56Z,anti-LAG-3 monoclonal antibody IBI-110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-ibi-110
2020-10-14T07:19:56Z,anti-LAG-3 monoclonal antibody LAG525,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ieramilimab
2020-10-14T07:19:56Z,anti-LAG-3 monoclonal antibody REGN3767,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fianlimab
2020-10-14T07:19:56Z,anti-LAG-3 monoclonal antibody Sym022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-monoclonal-antibody-sym022
2020-10-14T07:19:56Z,anti-LAG3 monoclonal antibody TSR-033,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encelimab
2020-10-14T07:19:56Z,anti-LAG-3/PD-L1 bispecific antibody FS118,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lag-3-pd-l1-bispecific-antibody-fs118
2020-10-14T07:19:56Z,anti-LIF monoclonal antibody MSC-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lif-monoclonal-antibody-msc-1
2020-10-14T07:19:56Z,anti-LOXL2 monoclonal antibody GS-6634,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simtuzumab
2020-10-14T07:19:56Z,anti-Ly6E antibody-drug conjugate DLYE5953A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-rg-7841
2020-10-14T07:19:56Z,anti-MAGE-A4 T-cell receptor/anti-CD3 scFv fusion protein IMC-C103C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mage-a4-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-c103c
2020-10-14T07:19:56Z,anti-MASP-2 monoclonal antibody OMS721,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/narsoplimab
2020-10-14T07:19:56Z,Anti-M-CSF monoclonal antibody MCS110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lacnotuzumab
2020-10-14T07:19:56Z,anti-mesothelin cytolytic fusion protein LMB-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100
2020-10-14T07:19:56Z,anti-mesothelin/MMAE antibody-drug conjugate RC88,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-mmae-antibody-drug-conjugate-rc88
2020-10-14T07:19:56Z,anti-mesothelin-CAR mRNA-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-cir-mrna-electroporated-autologous-t-cells
2020-10-14T07:19:56Z,anti-minor histocompatibility complex donor T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-minor-histocompatibility-complex-donor-t-lymphocytes
2020-10-14T07:19:56Z,anti-MMP-9 monoclonal antibody GS-5745,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/andecaliximab
2020-10-14T07:19:56Z,anti-MUC16/CD3 bispecific antibody REGN4018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-cd3-bispecific-antibody-regn4018
2020-10-14T07:19:56Z,anti-MUC16/MMAE antibody-drug conjugate DMUC4064A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc16-mmae-antibody-drug-conjugate-dmuc4064a
2020-10-14T07:19:56Z,anti-MUC17/CD3 BiTE antibody AMG 199,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-muc17-cd3-bite-antibody-amg-199
2020-10-14T07:19:56Z,anti-myeloma monoclonal antibody-DM4 immunoconjugate BT-062,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indatuximab-ravtansine
2020-10-14T07:19:56Z,dalbavancin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalbavancin
2020-10-14T07:19:56Z,anti-NaPi2b antibody-drug conjugate XMT-1592,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-napi2b-antibody-drug-conjugate-xmt-1592
2020-10-14T07:19:56Z,anti-NaPi2b monoclonal antibody XMT-1535,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upifitamab
2020-10-14T07:19:56Z,anti-NaPi2b/MMAE antibody-drug conjugate DNIB0600A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifastuzumab-vedotin
2020-10-14T07:19:56Z,anti-neuropilin-1 monoclonal antibody MNRP1685A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vesencumab
2020-10-14T07:19:56Z,anti-NY-ESO-1 TCR LV-transduced autologous T cells TAEST16001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso-1-tcr-lv-transduced-autologous-t-cells-taest16001
2020-10-14T07:19:56Z,anti-NY-ESO1/LAGE-1A TCR/scFv anti-CD3 IMCnyeso,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ny-eso1-lage-1a-tcr-scfv-anti-cd3-imcnyeso
2020-10-14T07:19:56Z,anti-OX40 agonist monoclonal antibody ABBV-368,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/revdofilimab
2020-10-14T07:19:56Z,anti-OX40 antibody PF-04518600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-agonist-monoclonal-antibody-pf-04518600
2020-10-14T07:19:56Z,anti-OX40 monoclonal antibody IBI101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody-ibi101
2020-10-14T07:19:56Z,anti-OX40 monoclonal antibody MEDI0562,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tavolimab
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody 609A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-609a
2020-10-14T07:19:56Z,anti-PD1 monoclonal antibody AGEN2034,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lung-cancer-pt2b-tnm-finding-v8
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody AK105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-ak105
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody AMG 404,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-amg-404
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody BCD-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prolgolimab
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody BI 754091,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezabenlimab
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody F520,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-f520
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody HX008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-hx008
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody JTX-4014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-jtx-4014
2020-10-14T07:19:56Z,anti-PD-1 monoclonal antibody LZM009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-lzm009
2020-10-14T07:19:56Z,anti-PD1/anti-CTLA4 antibody mixture PSB205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205
2020-10-14T07:19:56Z,anti-PD-1/anti-CTLA-4 DART protein MGD019,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-ctla4-dart-protein-mgd019
2020-10-14T07:19:56Z,anti-PD-1/anti-HER2 bispecific antibody IBI315,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-her2-bispecific-antibody-ibi315
2020-10-14T07:19:56Z,anti-PD-1/anti-LAG-3 bispecific antibody RO7247669,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-bispecific-antibody-ro7247669
2020-10-14T07:19:56Z,anti-PD-1/anti-LAG-3 DART protein MGD013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-lag-3-dart-protein-mgd013
2020-10-14T07:19:56Z,anti-PD-1/anti-PD-L1 bispecific antibody IBI318,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ibi318
2020-10-14T07:19:56Z,anti-PD-1/anti-PD-L1 bispecific antibody LY3434172,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-anti-pd-l1-bispecific-antibody-ly3434172
2020-10-14T07:19:56Z,anti-PD-1/CD47 infusion protein HX009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-cd47-infusion-protein-hx009
2020-10-14T07:19:56Z,anti-PD-1/CTLA-4 bispecific antibody AK104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-ctla-4-bispecific-antibody-ak104
2020-10-14T07:19:56Z,anti-PD1/CTLA4 bispecific antibody XmAb20717,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-ctla4-bispecific-antibody-xmab20717
2020-10-14T07:19:56Z,anti-PD1/ICOS bispecific monoclonal antibody XmAb23104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-icos-bispecific-monoclonal-antibody-xmab23104
2020-10-14T07:19:56Z,anti-PD-1/TIM-3 bispecific antibody RO7121661,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-tim-3-bispecific-antibody-ro7121661
2020-10-14T07:19:56Z,anti-PDGFR alpha monoclonal antibody MEDI-575,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovetumab
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody A167,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-a167
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody BCD-135,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manelimab
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody BGB-A333,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-bgb-a333
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody CBT-502,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-cbt-502
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody CK-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cosibelimab
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody CS1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sugemalimab
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody HLX20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opucolimab
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody IMC-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-imc-001
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody KN035,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/envafolimab
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody MSB2311,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-msb2311
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody RC98,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-rc98
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody SHR-1316,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-shr-1316
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody TG-1501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-tg-1501
2020-10-14T07:19:56Z,anti-PD-L1 monoclonal antibody ZKAB001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-zkab001
2020-10-14T07:19:56Z,anti-PD-L1/4-1BB bispecific antibody INBRX-105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-4-1bb-bispecific-antibody-inbrx-105
2020-10-14T07:19:56Z,anti-PD-L1/anti-4-1BB bispecific monoclonal antibody GEN1046,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-anti-4-1bb-bispecific-monoclonal-antibody-gen1046
2020-10-14T07:19:56Z,anti-PD-L1/CTLA-4 bispecific antibody KN046,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-ctla-4-bispecific-antibody-kn046
2020-10-14T07:19:56Z,anti-PD-L1/TIM-3 bispecific antibody LY3415244,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-tim-3-bispecific-antibody-ly3415244
2020-10-14T07:19:56Z,anti-PRAME T-cell receptor/anti-CD3 scFv fusion protein IMC-F106C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prame-t-cell-receptor-anti-cd3-scfv-fusion-protein-imc-f106c
2020-10-14T07:19:56Z,anti-PRL-3 monoclonal antibody PRL3-zumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prl-3-monoclonal-antibody-prl3-zumab
2020-10-14T07:19:56Z,anti-PSCA fully human monoclonal antibody AGS-1C4D4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psca-monoclonal-antibody-ags-1c4d4
2020-10-14T07:19:56Z,anti-PSMA/CD28 bispecific antibody REGN5678,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd28-bispecific-antibody-regn5678
2020-10-14T07:19:56Z,anti-PSMA/CD3 bispecific antibody CCW702,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bispecific-antibody-ccw702
2020-10-14T07:19:56Z,anti-PSMA/CD3 bispecific antibody JNJ-63898081,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bispecific-antibody-jnj-63898081
2020-10-14T07:19:56Z,anti-PSMA/CD3 BiTE antibody AMG 160,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-bite-antibody-amg-160
2020-10-14T07:19:56Z,anti-PSMA/CD3 BiTE monoclonal antibody MT112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pasotuxizumab
2020-10-14T07:19:56Z,anti-PVRIG monoclonal antibody COM701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pvrig-monoclonal-antibody-com701
2020-10-14T07:19:56Z,anti-RANKL monoclonal antibody GB-223,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-rankl-monoclonal-antibody-gb-223
2020-10-14T07:19:56Z,anti-ROR1 ADC VLS-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ror1-adc-vls-101
2020-10-14T07:19:56Z,anti-RSPO3 monoclonal antibody OMP-131R10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosmantuzumab
2020-10-14T07:19:56Z,anti-RSV nanobody ALX-0171,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gontivimab
2020-10-14T07:19:56Z,anti-S15 monoclonal antibody NC318,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-s15-monoclonal-antibody-nc318
2020-10-14T07:19:56Z,antisecretory factor-enriched egg yolk powder supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisecretory-factor-enriched-egg-yolk-powder-supplement
2020-10-14T07:19:56Z,antisense oligonucleotide QR-313,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisense-oligonucleotide-qr-313
2020-10-14T07:19:56Z,anti-SIRPa monoclonal antibody CC-95251,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-sirpa-monoclonal-antibody-cc-95251
2020-10-14T07:19:56Z,anti-SSTR2/CD3 monoclonal antibody XmAb18087,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tidutamab
2020-10-14T07:19:56Z,anti-TGF-beta monoclonal antibody SAR-439459,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-monoclonal-antibody-sar-439459
2020-10-14T07:19:56Z,anti-TIGIT monoclonal antibody OMP-313M32,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etigilimab
2020-10-14T07:19:56Z,anti-TIM-3 antibody BMS-986258,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-antibody-bms-986258
2020-10-14T07:19:56Z,anti-TIM-3 monoclonal antibody BGB-A425,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-bgb-a425
2020-10-14T07:19:56Z,anti-TIM-3 monoclonal antibody INCAGN02390,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-incagn02390
2020-10-14T07:19:56Z,anti-TIM3 monoclonal antibody SHR-1702,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-shr-1702
2020-10-14T07:19:56Z,anti-TIM-3 monoclonal antibody Sym023,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim-3-monoclonal-antibody-sym023
2020-10-14T07:19:56Z,anti-TIM-3 monoclonal antibody TSR-022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobolimab
2020-10-14T07:19:56Z,anti-TLR2 monoclonal antibody OPN-305,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomaralimab
2020-10-14T07:19:56Z,anti-TRAILR2/CDH17 tetravalent bispecific antibody BI 905711,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trailr2-cdh17-tetravalent-bispecific-antibody-bi-905711
2020-10-14T07:19:56Z,anti-transthyretin siRNA ALN-TTR02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patisiran
2020-10-14T07:19:56Z,anti-TROP2 antibody-drug conjugate BAT8003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-bat8003
2020-10-14T07:19:56Z,anti-TROP2 antibody-drug conjugate SKB264,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-antibody-drug-conjugate-skb264
2020-10-14T07:19:56Z,anti-TROP2/DXd antibody-drug conjugate DS-1062a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-trop2-dxd-antibody-drug-conjugate-ds-1062a
2020-10-14T07:19:56Z,antitumor B key active component-alpha,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antitumor-b-key-active-component-alpha
2020-10-14T07:19:56Z,anti-TWEAK monoclonal antibody RO5458640,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tweak-monoclonal-antibody-rg7212
2020-10-14T07:19:56Z,anti-VEGF monoclonal antibody hPV19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-monoclonal-antibody-hpv19
2020-10-14T07:19:56Z,anti-VEGFR2 monoclonal antibody HLX06,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vulinacimab
2020-10-14T07:19:56Z,anti-VEGFR2 monoclonal antibody MSB0254,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfr2-monoclonal-antibody-msb0254
2020-10-14T07:19:56Z,antiviral agent CSJ148,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-cytomegalovirus-monoclonal-antibody-combination-csj-148
2020-10-14T07:19:56Z,AO+ Mist,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-ammonia-oxidizing-bacteria-based-probiotic-solution
2020-10-14T07:19:56Z,apadamtase alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apadamtase-alfa
2020-10-14T07:19:56Z,apatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivoceranib-mesylate
2020-10-14T07:19:56Z,APE1/Ref-1 redox inhibitor APX3330,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ape1-ref-1-redox-inhibitor-apx3330
2020-10-14T07:19:56Z,Aplenzin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release
2020-10-14T07:19:56Z,aprotinin bovine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprotinin
2020-10-14T07:19:56Z,aprutumab ixadotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab-ixadotin
2020-10-14T07:19:56Z,Aquasol A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound
2020-10-14T07:19:56Z,ARC fusion protein SL-279252,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arc-fusion-protein-sl-279252
2020-10-14T07:19:56Z,Archexin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/archexin
2020-10-14T07:19:56Z,arfolitixorin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arfolitixorin
2020-10-14T07:19:56Z,arginase-1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-1-peptide-vaccine
2020-10-14T07:19:56Z,arginine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-hydrochloride
2020-10-14T07:19:56Z,ArginMax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng-ginkgo-biloba-damiana-based-supplement
2020-10-14T07:19:56Z,aryl hydrocarbon receptor antagonist BAY2416964,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aryl-hydrocarbon-receptor-antagonist-bay2416964
2020-10-14T07:19:56Z,asciminib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asciminib
2020-10-14T07:19:56Z,Asclera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polidocanol
2020-10-14T07:19:56Z,ASK1 inhibitor GS-4997,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selonsertib
2020-10-14T07:19:56Z,ASP9853,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inos-dimerization-inhibitor-asp9853
2020-10-14T07:19:56Z,Asparlas,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol-mknl
2020-10-14T07:19:56Z,Aspergum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin
2020-10-14T07:19:56Z,astatine At 211 anti-CD38 monoclonal antibody OKT10-B10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astatine-at-211-anti-cd38-monoclonal-antibody-okt10-b10
2020-10-14T07:19:56Z,astaxanthin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/astaxanthin
2020-10-14T07:19:56Z,Atgam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin
2020-10-14T07:19:56Z,ATN-161,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-v-beta-1-inhibitor-atn-161
2020-10-14T07:19:56Z,ATR kinase inhibitor BAY1895344,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-bay1895344
2020-10-14T07:19:56Z,ATR kinase inhibitor M1774,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atr-kinase-inhibitor-m1774
2020-10-14T07:19:56Z,ATR kinase inhibitor M6620,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berzosertib
2020-10-14T07:19:56Z,ATR-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitochondrial-oxidative-phosphorylation-inhibitor-atr-101
2020-10-14T07:19:56Z,Atragen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome
2020-10-14T07:19:56Z,auranofin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1r-monoclonal-antibody-imc-cs4
2020-10-14T07:19:56Z,Aurixim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-conjugate-con-4619
2020-10-14T07:19:56Z,aurora A kinase inhibitor LY3295668 erbumine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-ly3295668
2020-10-14T07:19:56Z,autologous CISH-inactivated TILs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cish-inactivated-tils
2020-10-14T07:19:56Z,Aurora B kinase inhibitor TAK-901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-serine-threonine-kinase-inhibitor-tak-901
2020-10-14T07:19:56Z,Aurora kinase A/B inhibitor TT-00420,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-kinase-a-b-inhibitor-tt-00420
2020-10-14T07:19:56Z,autologous AFP-specific T cell receptor T cells C-TCR055,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-afp-specific-t-cell-receptor-transduced-t-cells-c-tcr055
2020-10-14T07:19:56Z,autologous AML/dendritic cell fusion vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-aml-dendritic-cell-fusion-vaccine
2020-10-14T07:19:56Z,autologous anti-BCMA CAR-T cells IM21,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-t-cells-im21
2020-10-14T07:19:56Z,autologous anti-BCMA CAR-transduced T cells KITE-585,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-transduced-t-cells-kite-585
2020-10-14T07:19:56Z,autologous anti-BCMA CD8+ CAR T cells Descartes-11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-cd8-car-t-cells-descartes-11
2020-10-14T07:19:56Z,autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T lymphocytes JCARH125,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orvacabtagene-autoleucel
2020-10-14T07:19:56Z,autologous anti-BCMA-CAR-4-1BB-CD3zeta-expressing T cells CT053,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-4-1bb-cd3zeta-expressing-t-cells-ct053
2020-10-14T07:19:56Z,autologous anti-BCMA-CAR-expressing CD4+/CD8+ T lymphocytes FCARH143,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-expressing-cd4-cd8-t-lymphocytes-fcarh143
2020-10-14T07:19:56Z,autologous anti-BCMA-CAR-mRNA-transfected CD8+ T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-mrna-transfected-cd8-t-lymphocytes
2020-10-14T07:19:56Z,autologous anti-BCMA-CAR-TCRz/4-1BB-expressing T lymphocytes CART-BCMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-bcma-car-tcrz-4-1bb-expressing-t-lymphocytes-cart-bcma
2020-10-14T07:19:56Z,autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T lymphocytes BinD19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-bind19
2020-10-14T07:19:56Z,BET inhibitor CC-90010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-cc-90010
2020-10-14T07:19:56Z,autologous anti-CD19 CAR TCR-zeta/4-1BB-transduced T lymphocytes huCART19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-tcr-zeta-4-1bb-transduced-t-lymphocytes-hucart19
2020-10-14T07:19:56Z,autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-cd3zeta-4-1bb-expressing-t-cells
2020-10-14T07:19:56Z,autologous anti-CD19 CAR-CD3zeta-4-1BB-expressing T cells PZ01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-cd3zeta-4-1bb-expressing-t-cells-pz01
2020-10-14T07:19:56Z,autologous anti-CD19 CAR-expressing T lymphocytes CLIC-1901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-expressing-t-lymphocytes-clic-1901
2020-10-14T07:19:56Z,autologous anti-CD19 CAR-T cells IM19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-im19
2020-10-14T07:19:56Z,autologous anti-CD19 CAR-T cells TBI-1501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-car-t-cells-tbi-1501
2020-10-14T07:19:56Z,autologous anti-CD19 chimeric antigen receptor T cells AUTO1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-chimeric-antigen-receptor-t-cells-auto1
2020-10-14T07:19:56Z,autologous anti-CD19 TAC-T cells TAC01-CD19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-tac-t-cells-tac01-cd19
2020-10-14T07:19:56Z,autologous anti-CD19 T-cell receptor T cells ET190L1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-t-cell-receptor-t-cells-et190l1
2020-10-14T07:19:56Z,autologous anti-CD19/CD20 bispecific nanobody-based CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd20-bispecific-nanobody-based-car-t-cells
2020-10-14T07:19:56Z,autologous anti-CD19/CD22 CAR-T cells AUTO3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19-cd22-car-t-cells-auto3
2020-10-14T07:19:56Z,autologous anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd19car-her2t-cd22car-egfrt-expressing-t-cells
2020-10-14T07:19:56Z,autologous anti-CD20 CAR transduced CD4/CD8 enriched T cells MB-CART20.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd20-car-transduced-cd4-cd8-enriched-t-cells-mb-cart201
2020-10-14T07:19:56Z,autologous anti-CD22 CAR-4-1BB-TCRz-transduced T lymphocytes CART22-65s,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd22-car-4-1bb-tcrz-transduced-t-lymphocytes-cart22-65s
2020-10-14T07:19:56Z,autologous anti-CD38 A2 CAR2-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd38-a2-car2-expressing-t-cells
2020-10-14T07:19:56Z,autologous anti-CD7 CAR/28zeta CRISPR-edited T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-cd7-car-28zeta-crispr-edited-t-lymphocytes
2020-10-14T07:19:56Z,autologous anti-Claudin18.2-transduced T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-claudin182-transduced-t-lymphocytes-ct041
2020-10-14T07:19:56Z,autologous anti-EGFR CAR-transduced CXCR 5-modified T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfr-car-transduced-cxcr-5-modified-t-lymphocytes
2020-10-14T07:19:56Z,autologous anti-EGFRvIII 4SCAR-IgT cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfrviii-4scar-igt-cells
2020-10-14T07:19:56Z,autologous anti-FLT3 CAR T cells AMG 553,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-flt3-car-t-cells-amg-553
2020-10-14T07:19:56Z,autologous anti-GD2CAR-CD28-CD3zeta-IL-15-expressing natural killer T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-gd2car-cd28-cd3zeta-il-15-expressing-natural-killer-t-cells
2020-10-14T07:19:56Z,autologous anti-HLA-A*02/AFP TCRm-expressing T cells ET140202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a02-afp-tcrm-expressing-t-cells-et140202
2020-10-14T07:19:56Z,autologous anti-HLA-A*0201/AFP CAR-T cells ET1402L1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-hla-a0201-afp-car-t-cells-et1402l1
2020-10-14T07:19:56Z,autologous anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T cells AIC100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-icam-1-car-cd28-4-1bb-cd3zeta-expressing-t-cells-aic100
2020-10-14T07:19:56Z,autologous anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-mesothelin-car-cd3zeta-4-1-bb-expressing-t-cells
2020-10-14T07:19:56Z,autologous anti-MUC1*-CAR-4-1BB-CD3zeta-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-muc1-car-4-1bb-cd3zeta-expressing-t-lymphocytes
2020-10-14T07:19:56Z,autologous anti-Muc1/CD33/CD38/CD56/CD123 gene-engineered CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-muc1-cd33-cd38-cd56-cd123-gene-engineered-car-t-cells
2020-10-14T07:19:56Z,autologous anti-NY-ESO-1 mTCR retroviral vector-transduced PBLs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-ny-eso-1-mtcr-retroviral-vector-transduced-pbls
2020-10-14T07:19:56Z,autologous anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T lymphocytes GSK3377794,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/786186
2020-10-14T07:19:56Z,autologous anti-PD-1 antibody-activated tumor-infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-pd-1-antibody-activated-tumor-infiltrating-lymphocytes
2020-10-14T07:19:56Z,autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psca-car-4-1bb-tcrzeta-cd19t-expressing-t-lymphocytes
2020-10-14T07:19:56Z,autologous anti-PSMA gene-modified T-cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-psma-gene-modified-t-lymphocytes
2020-10-14T07:19:56Z,autologous anti-SLAMF7 CAR-expressing T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-slamf7-car-expressing-t-cells
2020-10-14T07:19:56Z,autologous AXL-targeted CAR-T cells CCT301-38,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-axl-targeted-car-t-cells-cct301-38
2020-10-14T07:19:56Z,autologous B-cell/monocyte-presenting HER2/neu antigen vaccine BVAC-B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-b-cell-monocyte-presenting-her2-neu-antigen-vaccine-bvac-b
2020-10-14T07:19:56Z,autologous BCMA/TACI-targeted CAR T cells AUTO2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-taci-targeted-car-t-cells-auto2
2020-10-14T07:19:56Z,danvatirsen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danvatirsen
2020-10-14T07:19:56Z,autologous BCMA-4-1BBz-targeted CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-4-1bbz-targeted-car-t-cells
2020-10-14T07:19:56Z,autologous BCMA-targeted CAR T cells LCAR-B4822M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-lcar-b4822m
2020-10-14T07:19:56Z,autologous BCMA-targeted CAR-T cells CC-98633,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bcma-targeted-car-t-cells-cc-98633
2020-10-14T07:19:56Z,autologous beta-A(T87Q)-globin gene-transduced CD34-positive cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betibeglogene-autotemcel
2020-10-14T07:19:56Z,autologous bi-epitope BCMA-targeted CAR T cells JNJ-68284528,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciltacabtagene-autoleucel
2020-10-14T07:19:56Z,autologous bispecific CD19/CD22-targeted CAR-T cells GC022F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-bispecific-cd19-cd22-targeted-car-t-cells-gc022
2020-10-14T07:19:56Z,autologous CAR-mbIL15-safety switch T cells PRGN-3006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3006
2020-10-14T07:19:56Z,autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ccr4-cd30car-cd28-cd3zeta-expressing-t-lymphocytes
2020-10-14T07:19:56Z,autologous CD123-4SCAR-expressing T cells 4SCAR123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123-4scar-expressing-t-cells-4scar123
2020-10-14T07:19:56Z,autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T lymphocytes MB-102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd123car-cd28-cd3zeta-egfrt-expressing-t-lymphocytes-mb-102
2020-10-14T07:19:56Z,autologous CD138-specific CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd138-specific-car-t-cells
2020-10-14T07:19:56Z,autologous CD19 CAR-expressing CD4+/CD8+ T cells MB-CART19.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-car-expressing-cd4-cd8-t-cells-mb-cart191
2020-10-14T07:19:56Z,autologous CD19/PD-1 bispecific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-pd-1-bispecific-car-t-cells
2020-10-14T07:19:56Z,autologous CD19CAR-CD28-CD137/CD27/CD3zeta-iCasp9-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd137-cd27-cd3zeta-icasp9-expressing-t-lymphocytes
2020-10-14T07:19:56Z,autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-cd8-cd28-cd3zeta-car-mbil15-her1t-t-cells
2020-10-14T07:19:56Z,autologous CD19-targeted CAR T cells JWCAR029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-jwcar029
2020-10-14T07:19:56Z,autologous CD19-targeted CAR-T cells GC007F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-targeted-car-t-cells-gc007f
2020-10-14T07:19:56Z,autologous CD20-4SCAR-expressing T cells 4SCAR20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rfc4-gene
2020-10-14T07:19:56Z,autologous CD22-4SCAR-expressing T cells 4SCAR22,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd22-4scar-expressing-t-cells-4scar22
2020-10-14T07:19:56Z,autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd30car-cd28-cd3zeta-expressing-t-lymphocytes
2020-10-14T07:19:56Z,autologous CD34+-enriched HSPCs transduced with VSV-G encoding IFN-a2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-adipose-derived-mesenchymal-stem-cells
2020-10-14T07:19:56Z,autologous CD34-positive peripheral blood stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd34-positive-peripheral-blood-stem-cells
2020-10-14T07:19:56Z,autologous CD38-4SCAR-expressing T cells 4SCAR38,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd38-4scar-expressing-t-cells-4scar38
2020-10-14T07:19:56Z,autologous CD4+/CD8+ EGFR806 specific 4-1BB-CD3zeta-EGFRt-expressing CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd22-adc-trph-222
2020-10-14T07:19:56Z,autologous CD5-specific CAR-28 zeta CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd5-specific-car-28-zeta-car-t-cells
2020-10-14T07:19:56Z,autologous cervical cancer-specific engineered immune effector cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cervical-cancer-specific-engineered-immune-effector-cells
2020-10-14T07:19:56Z,autologous CLL1-CD33 compound CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cll1-cd33-compound-car-t-cells
2020-10-14T07:19:56Z,autologous clonal neoantigen T cells ATL001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-clonal-neoantigen-t-cells-atl001
2020-10-14T07:19:56Z,autologous c-Met/PD-L1-specific CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-c-met-pd-l1-specific-car-t-cells
2020-10-14T07:19:56Z,autologous CMV-pp65-flLAMP mRNA-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-fllamp-mrna-loaded-dendritic-cell-vaccine
2020-10-14T07:19:56Z,autologous CMV-pp65-shLAMP-1 mRNA loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cmv-pp65-shlamp-1-mrna-loaded-dendritic-cell-vaccine
2020-10-14T07:19:56Z,autologous cytoplasmic activated PD-1 CAR-Tcells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cytoplasmic-activated-pd-1-car-t-cells
2020-10-14T07:19:56Z,autologous deep IL-15 primed T cells TRQ15-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-deep-il-15-primed-t-cells-trq15-01
2020-10-14T07:19:56Z,autologous dendritic cell-based immunotherapeutic AV0113,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/audencel
2020-10-14T07:19:56Z,autologous E6 T cell receptor genetically-modified T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-e6-t-cell-receptor-genetically-modified-t-cells
2020-10-14T07:19:56Z,autologous EGFR-specific CAR-T cells expressing anti-PD-1/CTLA-4 antibodies,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-egfr-specific-car-t-cells-expressing-anti-pd-1-ctla-4-antibodies
2020-10-14T07:19:56Z,autologous EGFRt/BCMA-41BBz-targeted CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-egfrt-bcma-41bbz-targeted-car-t-cells
2020-10-14T07:19:56Z,autologous FRa-4SCAR-expressing T cells 4SCAR-FRa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-fra-4scar-expressing-t-cells-4scar-fra
2020-10-14T07:19:56Z,BET inhibitor GS-5829,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alobresib
2020-10-14T07:19:56Z,autologous genetically-modified MAGE-A4 C1032 CD8alpha T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-genetically-modified-mage-a4-c1032-cd8alpha-t-cells
2020-10-14T07:19:56Z,autologous GM-CSF-secreting lethally irradiated lung cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-lung-cancer-vaccine
2020-10-14T07:19:56Z,autologous GPC3/NY-ESO-1/AFP-specific CD8-positive T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gpc3-ny-eso-1-afp-specific-cd8-positive-t-lymphocytes
2020-10-14T07:19:56Z,autologous HER2 chimeric receptor/TGFbeta dominant negative receptor-expressing EBV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tgfbeta-resistant-her2-ebv-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,autologous HER2-CAR-modified adenovirus-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-her2-car-modified-adenovirus-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-her2-specific-egfrt-expressing-cd4-cd8-positive-car-t-cells
2020-10-14T07:19:56Z,autologous HPV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-hpv-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-deltangfr-cd19car-cd3zeta-4-1bb-expressing-t-lymphocytes
2020-10-14T07:19:56Z,autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ic9-gd2car-cd28-cd3zeta-il-15-expressing-t-lymphocytes
2020-10-14T07:19:56Z,autologous ICASP9-CD19-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-deltangfr-cd19car-expressing-t-cells
2020-10-14T07:19:56Z,autologous iCASP9-CD19-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-icasp9-cd19-expressing-t-lymphocytes
2020-10-14T07:19:56Z,autologous mDC3 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mdc3-vaccine
2020-10-14T07:19:56Z,autologous mDC3/8-KRAS vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mdc3-8-kras-vaccine
2020-10-14T07:19:56Z,autologous mesothelin-specific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesothelin-specific-car-t-cells
2020-10-14T07:19:56Z,autologous mesothelin-specific human mRNA CAR-transfected PBMCs MCY-M11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mesothelin-specific-human-mrna-car-transfected-pbmcs-mcy-m11
2020-10-14T07:19:56Z,autologous monocyte-derived lysate-pulsed dendritic cells PV-001-DC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-monocyte-derived-lysate-pulsed-dendritic-cell-vaccine-pv-001-dc
2020-10-14T07:19:56Z,autologous mRNA-modified anti-cMET CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mrna-modified-anti-cmet-car-t-cells
2020-10-14T07:19:56Z,autologous MUC1-mannan fusion protein pulsed dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/735852
2020-10-14T07:19:56Z,autologous natural killer cell-like CTLs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-natural-killer-cell-like-ctls
2020-10-14T07:19:56Z,autologous nectin-4/FAP-targeted CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nectin-4-fap-targeted-car-t-cells
2020-10-14T07:19:56Z,autologous NKG2D CAR-CD3zeta-DAP10-expressing T lymphocytes CYAD-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-nkg2d-car-cd3zeta-dap10-expressing-t-lymphocytes-cyad-01
2020-10-14T07:19:56Z,autologous NY-ESO-1 TCR-targeted T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-tcr-targeted-t-lymphocytes
2020-10-14T07:19:56Z,autologous NY-ESO-1-melanoma-specific CD8+ T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-melanoma-specific-cd8-t-lymphocytes
2020-10-14T07:19:56Z,autologous NY-ESO-1-redirected CRISPR-edited T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-redirected-crispr-edited-t-cells
2020-10-14T07:19:56Z,autologous NY-ESO-1-specific CD8-positive T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ny-eso-1-specific-cd8-positive-t-lymphocytes
2020-10-14T07:19:56Z,autologous ovarian cancer immunogene-modified T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-cancer-immunogene-modified-t-lymphocytes
2020-10-14T07:19:56Z,autologous ovarian cancer-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ovarian-cancer-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,autologous PBLs retrovirally-transduced with TCRs targeting neoantigens,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pbls-retrovirally-transduced-with-tcrs-targeting-neoantigens
2020-10-14T07:19:56Z,autologous PD-1 antibody-expressing mesothelin-specific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-1-antibody-expressing-mesothelin-specific-car-t-cells
2020-10-14T07:19:56Z,autologous PD1-inhibiting anti-CD19 4-1BB CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd1-inhibiting-anti-cd19-4-1bb-car-t-cells
2020-10-14T07:19:56Z,autologous PD-L1/CD80/CD86-targeted CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pd-l1-cd80-cd86-targeted-car-t-cells
2020-10-14T07:19:56Z,autologous PRAME-targeting TCR-modified T cells MDG1011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prame-targeting-tcr-modified-t-cells-mdg1011
2020-10-14T07:19:56Z,autologous PSMA-4SCAR-expressing T cells 4SCAR-PSMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-4scar-expressing-t-cells-4scar-psma
2020-10-14T07:19:56Z,autologous PSMA-specific TGFβ-resistant CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-psma-specific-tgfb-resistant-car-t-cells
2020-10-14T07:19:56Z,autologous rapamycin-resistant Th1/Tc1 cells RAPA-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-rapamycin-resistant-th1-tc1-cells-rapa-201
2020-10-14T07:19:56Z,autologous renal cell carcinoma tumor lysate-dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-renal-cell-carcinoma-tumor-lysate-pulsed-dendritic-cell-vaccine
2020-10-14T07:19:56Z,autologous ROR2-targeted CAR-T cells CCT301-59,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-ror2-targeted-car-t-cells-cct301-59
2020-10-14T07:19:56Z,autologous TAAs-loaded autologous dendritic cells AV-GBM-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-taas-loaded-autologous-dendritic-cells-av-gbm-1
2020-10-14T07:19:56Z,autologous TBX-4000-treated peripheral blood mononuclear cells TBX-3400,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tbx-4000-treated-peripheral-blood-mononuclear-cells-tbx-3400
2020-10-14T07:19:56Z,autologous TCR-engineered T cells IMA201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima201
2020-10-14T07:19:56Z,autologous TCR-engineered T cells IMA202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima202
2020-10-14T07:19:56Z,autologous TCR-engineered T cells IMA203,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tcr-engineered-t-cells-ima203
2020-10-14T07:19:56Z,autologous tetravalent dendritic cell vaccine MIDRIX4-LUNG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tetravalent-dendritic-cell-vaccine-midrix4-lung
2020-10-14T07:19:56Z,autologous Tn-MUC1-specific CAR T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tn-muc1-specific-car-t-lymphocytes
2020-10-14T07:19:56Z,autologous tumor infiltrating lymphocytes LN-144,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifileucel
2020-10-14T07:19:56Z,autologous tumor-associated antigen-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patient-derived-wt1-prame-survivin-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,autologous tumor-infiltrating lymphocytes MDA-TIL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-mda-til
2020-10-14T07:19:56Z,autologous tumor-specific antigen-loaded dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-specific-antigen-loaded-dendritic-cells
2020-10-14T07:19:56Z,avadomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avadomide
2020-10-14T07:19:56Z,avapritinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avapritinib
2020-10-14T07:19:56Z,avatrombopag maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avatrombopag-maleate
2020-10-14T07:19:56Z,AVN944,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-monophosphate-dehydrogenase-inhibitor-avn944
2020-10-14T07:19:56Z,AXL inhibitor BGB324,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemcentinib
2020-10-14T07:19:56Z,AXL inhibitor DS-1205c,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-ds-1205c
2020-10-14T07:19:56Z,AXL inhibitor SLC-391,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-inhibitor-slc-391
2020-10-14T07:19:56Z,AXL kinase inhibitor TP-0903,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dubermatinib
2020-10-14T07:19:56Z,AXL/ FLT3/VEGFR2 inhibitor KC1036,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl--flt3-vegfr2-inhibitor-kc1036
2020-10-14T07:19:56Z,AXL/cMET receptor tyrosine kinase inhibitor BPI-9016M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-receptor-tyrosine-kinase-cmet-inhibitor-bpi-9016m
2020-10-14T07:19:56Z,Axl/Mer inhibitor INCB081776,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-mer-inhibitor-incb081776
2020-10-14T07:19:56Z,Axumin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclovine-f18
2020-10-14T07:19:56Z,Ayvakit,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avapritinib
2020-10-14T07:19:56Z,azurin-derived cell-penetrating peptide p28,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azurin50-77-cell-penetrating-peptide-p28
2020-10-14T07:19:56Z,B7-DC cross-linking antibody rHIgM12B7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/b7-dc-crosslinking-antibody-rhigm12b7
2020-10-14T07:19:56Z,babaodan capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/babaodan-capsule
2020-10-14T07:19:56Z,balixafortide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balixafortide
2020-10-14T07:19:56Z,baloxavir marboxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baloxavir-marboxil
2020-10-14T07:19:56Z,BAY 56-3722,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camptothecin-glycoconjugate-bay-38-3441
2020-10-14T07:19:56Z,BCG Tokyo-172 strain vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-tokyo-172-strain-vaccine
2020-10-14T07:19:56Z,Bcl-2 inhibitor APG 2575,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-apg-2575
2020-10-14T07:19:56Z,Bcl-2 inhibitor LP-108,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-lp-108
2020-10-14T07:19:56Z,Bcl-2 inhibitor S65487,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-s65487
2020-10-14T07:19:56Z,Bcl-2/Bcl-XL inhibitor APG-1252,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelcitoclax
2020-10-14T07:19:56Z,BCMA CART cells secreting mutant PD-1Fc fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-cart-cells-secreting-mutant-pd-1fc-fusion-protein
2020-10-14T07:19:56Z,BCMA x CD3 T-cell-engaging antibody CC-93269,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-x-cd3-t-cell-engaging-antibody-cc-93269
2020-10-14T07:19:56Z,BCMA-CD19 compound CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcma-cd19-compound-car-t-cells
2020-10-14T07:19:56Z,BCMA-specific CAR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idecabtagene-vicleucel
2020-10-14T07:19:56Z,bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-p210-b3a2-breakpoint-derived-pentapeptide-vaccine
2020-10-14T07:19:56Z,BCR-ABL/KIT/AKT/ERK inhibitor HQP1351,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kit-akt-erk-inhibitor-hqp1351
2020-10-14T07:19:56Z,belantamab mafodotin-blmf,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belantamab-mafodotin
2020-10-14T07:19:56Z,bemarituzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemarituzumab
2020-10-14T07:19:56Z,bempegaldesleukin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bempegaldesleukin
2020-10-14T07:19:56Z,benegrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efbemalenograstim-alfa
2020-10-14T07:19:56Z,benralizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benralizumab
2020-10-14T07:19:56Z,BET bromodomains 2/3/4 inhibitor MK-8628,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birabresib
2020-10-14T07:19:56Z,BET inhibitor ABBV-744,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-abbv-744
2020-10-14T07:19:56Z,Betadine Solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
2020-10-14T07:19:56Z,betaglucin gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betaglucin-gel
2020-10-14T07:19:56Z,betahistine hydrochloride nasal spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betahistine-hydrochloride-nasal-spray
2020-10-14T07:19:56Z,beta-lapachone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapachone
2020-10-14T07:19:56Z,BET-bromodomain inhibitor ODM-207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-odm-207
2020-10-14T07:19:56Z,bezlotoxumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bezlotoxumab
2020-10-14T07:19:56Z,BI 2536,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-bi-2536
2020-10-14T07:19:56Z,BIBX 1382,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-bibx-1382
2020-10-14T07:19:56Z,Bifidobacterium animalis ssp. lactis probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bifidobacterium-animalis-ssp-lactis-probiotic-supplement
2020-10-14T07:19:56Z,bintrafusp alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bintrafusp-alfa
2020-10-14T07:19:56Z,Biocurcumax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation
2020-10-14T07:19:56Z,bio-enhanced curcumin extract formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bio-enhanced-curcumin-extract-formulation
2020-10-14T07:19:56Z,Biotest-HCIG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hepatitis-c-immune-globulin
2020-10-14T07:19:56Z,bi-shRNA-furin/GMCSF-expressing autologous tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gm-csf-expressing-autologous-tumor-cell-vaccine
2020-10-14T07:19:56Z,bispecific antibody AMG 509,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-amg-509
2020-10-14T07:19:56Z,bispecific antibody GS-1423,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-gs-1423
2020-10-14T07:19:56Z,bisthianostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisthianostat
2020-10-14T07:19:56Z,BiTE Antibody AMG 910,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bite-antibody-amg-910
2020-10-14T07:19:56Z,bivalent BRD4 inhibitor AZD5153,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bivalent-brd4-inhibitor-azd5153
2020-10-14T07:19:56Z,black currant juice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/black-currant-juice
2020-10-14T07:19:56Z,Blenrep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belantamab-mafodotin
2020-10-14T07:19:56Z,BLI850,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfate-based-laxative-bli850
2020-10-14T07:19:56Z,Boost Breeze,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/whey-protein-isolate-based-nutritional-supplement
2020-10-14T07:19:56Z,botanical agent BEL-X-HG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-agent-bel-x-hg
2020-10-14T07:19:56Z,botulinum toxin E EB-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botulinum-toxin-e-eb-001
2020-10-14T07:19:56Z,BRAF inhibitor LUT014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-lut014
2020-10-14T07:19:56Z,BRAF V600E kinase inhibitor RO5212054,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-kinase-inhibitor-ro5212054
2020-10-14T07:19:56Z,BRAF(V600E) inhibitor CEP-32496,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agerafenib
2020-10-14T07:19:56Z,BRAF(V600E) kinase inhibitor ABM-1310,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600e-kinase-inhibitor-abm-1310
2020-10-14T07:19:56Z,BRAF/EGFR inhibitor BGB-283,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifirafenib
2020-10-14T07:19:56Z,Brakiva,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride-liposomes
2020-10-14T07:19:56Z,BRD4 inhibitor PLX2853,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx2853
2020-10-14T07:19:56Z,brepocitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brepocitinib
2020-10-14T07:19:56Z,brexucabtagene autoleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel
2020-10-14T07:19:56Z,Bria-IMT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-gm-csf-secreting-breast-cancer-vaccine-sv-br-1-gm
2020-10-14T07:19:56Z,brimonidine tartrate nanoemulsion OCU-300,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brimonidine-tartrate-nanoemulsion-ocu-300
2020-10-14T07:19:56Z,brivaracetam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivaracetam
2020-10-14T07:19:56Z,Briviact,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivaracetam
2020-10-14T07:19:56Z,bromelain,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bromelains
2020-10-14T07:19:56Z,bromodeoxyuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broxuridine
2020-10-14T07:19:56Z,bromodomain inhibitor ABBV-075,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivebresib
2020-10-14T07:19:56Z,Brukinsa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanubrutinib
2020-10-14T07:19:56Z,BTK inhibitor CC-292,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spebrutinib
2020-10-14T07:19:56Z,BTK inhibitor GDC-0853,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenebrutinib
2020-10-14T07:19:56Z,BTK inhibitor HZ-A-018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-hz-a-018
2020-10-14T07:19:56Z,BTK inhibitor ICP-022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-icp-022
2020-10-14T07:19:56Z,BTK inhibitor LOXO-305,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-loxo-305
2020-10-14T07:19:56Z,BTK inhibitor SAR442168,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolebrutinib
2020-10-14T07:19:56Z,BTK inhibitor TG-1701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tg-1701
2020-10-14T07:19:56Z,budigalimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budigalimab
2020-10-14T07:19:56Z,bupivacaine hydrochloride liposome injectable suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-bupivacaine
2020-10-14T07:19:56Z,bupropion hydrochloride controlled-release,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release
2020-10-14T07:19:56Z,burosumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burosumab
2020-10-14T07:19:56Z,Bushen Culuan decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-culuan-decoction
2020-10-14T07:19:56Z,Bushen-Jianpi decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bushen-jianpi-decoction
2020-10-14T07:19:56Z,CAB-ROR2-ADC BA3021,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cab-ror2-adc-ba3021
2020-10-14T07:19:56Z,calaspargase pegol-mknl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol-mknl
2020-10-14T07:19:56Z,calcium glucarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-saccharate
2020-10-14T07:19:56Z,calcium release-activated channel inhibitor CM4620,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channel-inhibitor-cm4620
2020-10-14T07:19:56Z,calcium-sensing receptor agonists SK 1403,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-sensing-receptor-agonist-sk-1403
2020-10-14T07:19:56Z,Caldolor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen-injection
2020-10-14T07:19:56Z,CALR exon 9 mutant peptide vaccine/Montanide ISA-51,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calr-exon-9-mutant-peptide-vaccine-montanide-isa-51
2020-10-14T07:19:56Z,camidanlumab tesirine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camidanlumab-tesirine
2020-10-14T07:19:56Z,camrelizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camrelizumab
2020-10-14T07:19:56Z,canagliflozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canagliflozin
2020-10-14T07:19:56Z,canakinumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canakinumab
2020-10-14T07:19:56Z,cancer stemness kinase inhibitor BBI503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amcasertib
2020-10-14T07:19:56Z,Candida albicans antigen injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candida-albicans-antigen-injection
2020-10-14T07:19:56Z,Candin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/candida-albicans-antigen-injection
2020-10-14T07:19:56Z,canerpaturev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canerpaturev
2020-10-14T07:19:56Z,cannabinoid-derived inhalation capsule PPP011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabinoid-derived-inhalation-capsule-ppp011
2020-10-14T07:19:56Z,cantrixil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cantrixil
2020-10-14T07:19:56Z,Cap binding complex 80/20 binder ABX-464,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cap-binding-complex-80-20-binder-abx-464
2020-10-14T07:19:56Z,capivasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capivasertib
2020-10-14T07:19:56Z,capmatinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib-hydrochloride
2020-10-14T07:19:56Z,carbidopa/levodopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbidopa-levodopa
2020-10-14T07:19:56Z,carbon C 11 martinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-martinostat
2020-10-14T07:19:56Z,carbon C 11 temozolomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c11-temozolomide
2020-10-14T07:19:56Z,carbon C 11-JNJ-63779586,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-jnj-63779586
2020-10-14T07:19:56Z,carbon C 11-osimertinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-osimertinib
2020-10-14T07:19:56Z,carbon C 13 octanoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-13-sodium-octanoate
2020-10-14T07:19:56Z,carbon C 14 idasanutlin;Index term;Drug/agent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-idasanutlin
2020-10-14T07:19:56Z,carbon C 14 pevonedistat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-pevonedistat
2020-10-14T07:19:56Z,carbon C 14-pamiparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-pamiparib
2020-10-14T07:19:56Z,carbon C 14-TAK-659,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-tak-659
2020-10-14T07:19:56Z,carbon C14 lenvatinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-14-lenvatinib-mesylate
2020-10-14T07:19:56Z,carboplatin-Taxol regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-paclitaxel-regimen
2020-10-14T07:19:56Z,carboplatin-Taxol-bevacizumab regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab-carboplatin-paclitaxel-regimen
2020-10-14T07:19:56Z,Cardiolite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sestamibi
2020-10-14T07:19:56Z,carnosine/hibiscus-based oral mucoadhesive tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carnosine-hibiscus-based-oral-mucoadhesive-tablet
2020-10-14T07:19:56Z,carotuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carotuximab
2020-10-14T07:19:56Z,carrimycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrimycin
2020-10-14T07:19:56Z,carrot/Ji-Lin ginseng/licorice root/tangerine peel soy beverage,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carrot-jilin-ginseng-licorice-root-tangerine-peel-soy-beverage
2020-10-14T07:19:56Z,CAR-T cells AMG 119,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/car-t-cells-amg-119
2020-10-14T07:19:56Z,cathepsin-cleavable NIR substrate probe 6QC-ICG,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-cleavable-nir-substrate-probe-6qc-icg
2020-10-14T07:19:56Z,Cavatak,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-v937
2020-10-14T07:19:56Z,CB10-277,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazene-derivative-cb10-277
2020-10-14T07:19:56Z,CBP/beta-catenin modulator E7386,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cbp-beta-catenin-modulator-e7386
2020-10-14T07:19:56Z,CC-1088,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-cytokine-inhibitory-drug-cc-1088
2020-10-14T07:19:56Z,CC-401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jnk-inhibitor-cc-401
2020-10-14T07:19:56Z,CC-8490,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-modulator-cc-8490
2020-10-14T07:19:56Z,CCR4 inhibitor FLX475,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr4-inhibitor-flx475
2020-10-14T07:19:56Z,CD105/Yb-1/SOX2/CDH3/MDM2 polypeptide plasmid DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd105-yb-1-sox2-cdh3-mdm2-polyepitope-plasmid-dna-vaccine
2020-10-14T07:19:56Z,CD11b agonist GB1275,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd11b-agonist-gb1275
2020-10-14T07:19:56Z,CD123-CD33 compound CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd123-cd33-compound-car-t-cells
2020-10-14T07:19:56Z,CD137L/Epstein-Barr virus-targeting autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd137l-epstein-barr-virus-targeting-autologous-dendritic-cell-vaccine
2020-10-14T07:19:56Z,CD16/IL15/CD33 trispecific killer cell engager,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd16-il15-cd33-trispecific-killer-cell-engager
2020-10-14T07:19:56Z,CD19/CD3 dual-affinity retargeting protein JNJ-64052781,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvortuxizumab
2020-10-14T07:19:56Z,CD19CAR-CD3zeta-4-1BB-expressing allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocyte-cells
2020-10-14T07:19:56Z,CD19-targeted 4-1BB ligand RO7227166,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd19-targeted-4-1bb-ligand-ro7227166
2020-10-14T07:19:56Z,CD20-CD19 compound CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd20-cd19-compound-car-t-cells
2020-10-14T07:19:56Z,CD22 immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd22-immunotoxin
2020-10-14T07:19:56Z,CD28/ICOS antagonist ALPN-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd28-icos-antagonist-alpn-101
2020-10-14T07:19:56Z,CD3/CD28 costimulated vaccine-primed autologous T-cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd3-cd28-costimulated-autologous-t-cells
2020-10-14T07:19:56Z,CD33-specific CAR lentiviral vector-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd33-specific-car-lentiviral-vector-transduced-autologous-t-lymphocytes
2020-10-14T07:19:56Z,CD33-targeting antibody-drug conjugate IMGN779,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antibody-drug-conjugate-imgn779
2020-10-14T07:19:56Z,CD34/TK75-transduced donor lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd34-tk75-retroviral-vector-transduced-donor-lymphocytes
2020-10-14T07:19:56Z,CD4+CD25+ regulatory T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd4-cd25-regulatory-t-cells
2020-10-14T07:19:56Z,CD40L-Fc fusion protein MEDI 5083,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40l-fc-fusion-protein-medi5083
2020-10-14T07:19:56Z,CD44v6-specific CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd44v6-specific-car-t-cells
2020-10-14T07:19:56Z,CD45RA-depleted donor T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd45ra-depleted-donor-t-lymphocytes
2020-10-14T07:19:56Z,CD56-enriched CD3-positive donor lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd56-enriched-cd3-positive-donor-lymphocytes
2020-10-14T07:19:56Z,CD73 inhibitor AB680,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd73-inhibitor-ab680
2020-10-14T07:19:56Z,CD73 inhibitor LY3475070,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd73-inhibitor-ly3475070
2020-10-14T07:19:56Z,CD8+NKG2D+ AKT cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd8nkg2d-akt-cell
2020-10-14T07:19:56Z,CD80 fusion protein FPT155,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-fpt155
2020-10-14T07:19:56Z,CD80-Fc fusion protein ALPN-202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd80-fc-fusion-protein-alpn-202
2020-10-14T07:19:56Z,CDC7 inhibitor TAK-931,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simurosertib
2020-10-14T07:19:56Z,CDC7 kinase inhibitor LY3143921 hydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdc7-kinase-inhibitor-ly3143921-hydrate
2020-10-14T07:19:56Z,CDK inhibitor P276-00,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riviciclib
2020-10-14T07:19:56Z,CDK1 inhibitor BEY1107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk1-inhibitor-bey1107
2020-10-14T07:19:56Z,CDK2/4/6/FLT3 inhibitor FN-1501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk2-4-6-flt3-inhibitor-fn-1501
2020-10-14T07:19:56Z,CDK2/5/9 inhibitor CYC065,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadraciclib
2020-10-14T07:19:56Z,CDK4/6 inhibitor BPI-16350,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-bpi-16350
2020-10-14T07:19:56Z,CDK4/6 inhibitor CS3002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-cs3002
2020-10-14T07:19:56Z,CDK4/6 inhibitor FCN-437,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-6-inhibitor-fcn-437
2020-10-14T07:19:56Z,CDK4/6 inhibitor G1T38,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lerociclib
2020-10-14T07:19:56Z,CDK7 inhibitor CT7001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samuraciclib
2020-10-14T07:19:56Z,CDK7 inhibitor SY-1365,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mevociclib
2020-10-14T07:19:56Z,CDK8/19 inhibitor SEL 120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk8-19-inhibitor-sel-120
2020-10-14T07:19:56Z,CDK9 inhibitor AZD4573,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk9-inhibitor-azd4573
2020-10-14T07:19:56Z,CDKI AT7519,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-at7519
2020-10-14T07:19:56Z,CDKI R547,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-r547
2020-10-14T07:19:56Z,CDKs/JAK2/FLT3 inhibitor TG02 citrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zotiraciclib-citrate
2020-10-14T07:19:56Z,CEA-targeting agent RG6123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cea-targeting-agent-rg6123
2020-10-14T07:19:56Z,cedazuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cedazuridine
2020-10-14T07:19:56Z,ceftolozane-tazobactam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftolozane-tazobactam
2020-10-14T07:19:56Z,CEM regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-etoposide-melphalan-regimen
2020-10-14T07:19:56Z,cemiplimab-rwlc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cemiplimab
2020-10-14T07:19:56Z,CEOP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide-epirubicin-vincristine-prednisone
2020-10-14T07:19:56Z,Cepacol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dyclonine-hydrochloride
2020-10-14T07:19:56Z,ceralasertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceralasertib
2020-10-14T07:19:56Z,Cerazette,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desogestrel
2020-10-14T07:19:56Z,cerdulatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cerdulatinib
2020-10-14T07:19:56Z,cereblon E3 ubiquitin ligase modulating agent CC-92480,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-92480
2020-10-14T07:19:56Z,cereblon E3 ubiquitin ligase modulating agent CC-99282,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cereblon-e3-ubiquitin-ligase-modulating-agent-cc-99282
2020-10-14T07:19:56Z,Cerebyx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosphenytoin-sodium
2020-10-14T07:19:56Z,Cereport,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labradimil
2020-10-14T07:19:56Z,cEt KRAS antisense oligonucleotide AZD4785,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cet-kras-antisense-oligonucleotide-azd4785
2020-10-14T07:19:56Z,cetrelimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetrelimab
2020-10-14T07:19:56Z,cetuximab-IR700 conjugate RM-1929,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-sarotalocan
2020-10-14T07:19:56Z,cetuximab-IRDye 800,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-irdye-800cw
2020-10-14T07:19:56Z,cevidoplenib dimesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevidoplenib-dimesylate
2020-10-14T07:19:56Z,Chemet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succimer
2020-10-14T07:19:56Z,Chemoplaque,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque
2020-10-14T07:19:56Z,chewing gum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chewing-gum-dosage-form
2020-10-14T07:19:56Z,chimeric costimulatory converting receptor-modified NK-92 cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-costimulatory-converting-receptor-modified-nk-92-cells
2020-10-14T07:19:56Z,chimeric fibril-reactive monoclonal antibody 111F4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chimeric-fibril-reactive-monoclonal-antibody-cael-101
2020-10-14T07:19:56Z,ChiRhoStim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/secretin-human
2020-10-14T07:19:56Z,Chk1 inhibitor SCH 900776,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-mk-8776
2020-10-14T07:19:56Z,chlorhexidine gluconate skin cleanser,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-gluconate-skin-cleanser
2020-10-14T07:19:56Z,chlorine dioxide sterilization,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorine-dioxide-sterilization
2020-10-14T07:19:56Z,chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorotoxin-eq-cd28-cd3zeta-cd19t-expressing-car-t-lymphocytes
2020-10-14T07:19:56Z,chlorotoxin-indocyanine green imaging Agent BLZ-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozuleristide
2020-10-14T07:19:56Z,cholecalciferol/d-alpha tocopherol/L-selenomethionine/green tea extract/saw palmetto berry extract/daidzein/genistein/lycopene prostate health supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-health-cocktail-dietary-supplement
2020-10-14T07:19:56Z,cholic acid-24-13C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholic-acid-24-13c
2020-10-14T07:19:56Z,"cholic-2,2,4,4-D4 acid",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholic-2244-d4-acid
2020-10-14T07:19:56Z,cibisatamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cibisatamab
2020-10-14T07:19:56Z,ciclopirox prodrug CPX-POM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciclopirox-prodrug-cpx-pom
2020-10-14T07:19:56Z,Cinnamomum cassia capsules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinnamomum-cassia-capsules
2020-10-14T07:19:56Z,cinobufotalin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cinobufotalin
2020-10-14T07:19:56Z,cisplatin transmucosal patch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-transmucosal-patch
2020-10-14T07:19:56Z,Civacir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hepatitis-c-immune-globulin
2020-10-14T07:19:56Z,Class 1 PI3K family inhibitor XL147,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilaralisib
2020-10-14T07:19:56Z,class 1/4 histone deacetylase inhibitor OKI-179,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/class-1-4-histone-deacetylase-inhibitor-oki-179
2020-10-14T07:19:56Z,clevidipine butyrate injectable emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevidipine
2020-10-14T07:19:56Z,Cleviprex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clevidipine
2020-10-14T07:19:56Z,Clostridium butyricum CBM 588 probiotic strain,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-butyricum-cbm-588-probiotic-strain
2020-10-14T07:19:56Z,clozapine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clozapine
2020-10-14T07:19:56Z,c-Met inhibitor ABN401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-abn401
2020-10-14T07:19:56Z,c-Met inhibitor CBT-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-cbt-101
2020-10-14T07:19:56Z,c-Met inhibitor PLB1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bozitinib
2020-10-14T07:19:56Z,CMV pp65 peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmv-n495-peptide
2020-10-14T07:19:56Z,CMV/EBV/ADV/BKV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmv-ebv-adv-bkv-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,cobomarsen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobomarsen
2020-10-14T07:19:56Z,cofetuzumab pelidotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin
2020-10-14T07:19:56Z,Coffea arabica extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coffea-arabica-extract
2020-10-14T07:19:56Z,colloidal modified fluid gelatin plasma substitute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-modified-fluid-gelatin-plasma-substitute
2020-10-14T07:19:56Z,colorectal cancer peptide vaccine PolyPEPI1018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colorectal-cancer-peptide-vaccine-polypepi1018
2020-10-14T07:19:56Z,commensal bacterial strain formulation VE800,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/commensal-bacterial-strain-formulation-ve800
2020-10-14T07:19:56Z,complement factor D inhibitor ACH-4471,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danicopan
2020-10-14T07:19:56Z,Comtan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entacapone
2020-10-14T07:19:56Z,conbercept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conbercept
2020-10-14T07:19:56Z,dapagliflozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapagliflozin
2020-10-14T07:19:56Z,concentrated lingzhi mushroom extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/concentrated-lingzhi-mushroom-extract
2020-10-14T07:19:56Z,conditionally active biologic anti-AXL antibody-drug conjugate BA3011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conditionally-active-biologic-anti-axl-antibody-drug-conjugate-ba3011
2020-10-14T07:19:56Z,conjugated estrogens,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated
2020-10-14T07:19:56Z,Contego,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifileucel
2020-10-14T07:19:56Z,COPP-ABV regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copp-alternating-with-abv-regimen
2020-10-14T07:19:56Z,copper Cu 64 DOTA-daratumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-64-cu-dota-daratumumab
2020-10-14T07:19:56Z,copper Cu 64 NOTA-PSMAi-PEG-Cy5.5-C' dots,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-nota-psmai-peg-cy55-c-dots
2020-10-14T07:19:56Z,copper Cu 64-CB-TE1A1P-PEG4-LLP2A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-cb-te1a1p-peg4-llp2a
2020-10-14T07:19:56Z,copper Cu 64-DOTA-ECL1i,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-ecl1i
2020-10-14T07:19:56Z,copper Cu 67 Tyr3-octreotate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-67-tyr3-octreotate
2020-10-14T07:19:56Z,copper Cu-64-DOTA-alendronate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-alendronate
2020-10-14T07:19:56Z,copper supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper
2020-10-14T07:19:56Z,cord blood-derived CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-car-t-cells
2020-10-14T07:19:56Z,cord blood-derived CMV/AdV/EBV/BKV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-cmv-adv-ebv-bkv-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,cord blood-derived expanded allogeneic natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cord-blood-derived-expanded-allogeneic-natural-killer-cells
2020-10-14T07:19:56Z,Corlanor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivabradine-hydrochloride
2020-10-14T07:19:56Z,corn starch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/starch-corn
2020-10-14T07:19:56Z,corticotropin-releasing hormone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/corticoliberin
2020-10-14T07:19:56Z,Cotara,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-derlotuximab-biotin
2020-10-14T07:19:56Z,coxsackievirus A21,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/coxsackievirus-v937
2020-10-14T07:19:56Z,"CP-724,714",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-inhibitor-cp-724714
2020-10-14T07:19:56Z,CpG oligodeoxynucleotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-28-oligodeoxynucleotide
2020-10-14T07:19:56Z,CRISPR/Cas9-edited HPV16/18 E6/E7 plasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-edited-hpv16-18-e6-e7-plasmid
2020-10-14T07:19:56Z,CRISPR/Cas9-mediated PD-1 and TCR gene-deleted anti-mesothelin CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crispr-cas9-mediated-pd-1-and-tcr-gene-deleted-anti-mesothelin-car-t-cells
2020-10-14T07:19:56Z,CRTH2 antagonist ACT-774312,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crth2-antagonist-act-774312
2020-10-14T07:19:56Z,CTLA-4-directed probody BMS-986249,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ctla-4-directed-probody-bms-986249
2020-10-14T07:19:56Z,curcumin/chondroitin sulfate/hyaluronic acid/quercetin soft gels,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-chondroitin-sulfate-hyaluronic-acid-quercetin-soft-gels
2020-10-14T07:19:56Z,curcumin/doxorubicin-encapsulating nanoparticle IMX-110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin-doxorubicin-encapsulating-nanoparticle-imx-110
2020-10-14T07:19:56Z,cusatuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cusatuzumab
2020-10-14T07:19:56Z,C-VISA BikDD: liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-visa-bikddliposome
2020-10-14T07:19:56Z,Cxcr1/2 inhibitor SX-682,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr1-2-inhibitor-sx-682
2020-10-14T07:19:56Z,CXCR2 antagonist QBM076,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr2-antagonist-qbm076
2020-10-14T07:19:56Z,CXCR4 antagonist BL-8040,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motixafortide
2020-10-14T07:19:56Z,CXCR4 inhibitor MSX-122,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-inhibitor-q-122
2020-10-14T07:19:56Z,CXCR4/E-selectin antagonist GMI-1359,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-e-selectin-antagonist-gmi-1359
2020-10-14T07:19:56Z,cyclin-dependent kinase 8/19 inhibitor BCD 115,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-8-19-inhibitor-bcd-115
2020-10-14T07:19:56Z,cyclin-dependent kinase inhibitor PF-06873600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclin-dependent-kinase-inhibitor-pf-06873600
2020-10-14T07:19:56Z,CycloSam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-dotmp
2020-10-14T07:19:56Z,Cynviloq™,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008
2020-10-14T07:19:56Z,CYP11A1 inhibitor ODM-208,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp11a1-inhibitor-odm-208
2020-10-14T07:19:56Z,CYP11A1 inhibitor ODM-209,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp11a1-inhibitor-odm-209
2020-10-14T07:19:56Z,CYP17 inhibitor CFG920,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-cyp11b2-inhibitor-lae001
2020-10-14T07:19:56Z,cytadine analogue RX-3117,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roducitabine
2020-10-14T07:19:56Z,cytarabine liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-cytarabine
2020-10-14T07:19:56Z,cytarabine-asparagine prodrug BST-236,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspacytarabine
2020-10-14T07:19:56Z,cytokine-based biologic agent IRX-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-based-biologic-agent-irx-2
2020-10-14T07:19:56Z,cytokine-treated veto cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-treated-veto-cells
2020-10-14T07:19:56Z,dabrafenib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib-mesylate
2020-10-14T07:19:56Z,"dapsone gel, 5%",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapsone-gel
2020-10-14T07:19:56Z,daratumumab and hyaluronidase-fihj,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj
2020-10-14T07:19:56Z,darolutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide
2020-10-14T07:19:56Z,daromun,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daromun
2020-10-14T07:19:56Z,Darzalex Faspro,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab-and-hyaluronidase-fihj
2020-10-14T07:19:56Z,daunorubicin hydrochloride and cytarabine liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine
2020-10-14T07:19:56Z,Daurismo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glasdegib-maleate
2020-10-14T07:19:56Z,D-cycloserine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloserine
2020-10-14T07:19:56Z,decitabine and cedazuridine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine-and-cedazuridine
2020-10-14T07:19:56Z,Delatestryl,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate
2020-10-14T07:19:56Z,Del-Vi-A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound
2020-10-14T07:19:56Z,Dendrobium huoshanense granules,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendrobium-huoshanense-granules
2020-10-14T07:19:56Z,dengue virus adjuvant PV-001-DV,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dengue-virus-adjuvant-pv-001-dv
2020-10-14T07:19:56Z,derazantinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derazantinib
2020-10-14T07:19:56Z,DermACELL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-acellular-dermal-matrix
2020-10-14T07:19:56Z,DermaMatrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acellular-cadaveric-dermal-matrix
2020-10-14T07:19:56Z,desogestral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/desogestrel
2020-10-14T07:19:56Z,deuterated enzalutamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/deuterated-enzalutamide
2020-10-14T07:19:56Z,devimistat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/devimistat
2020-10-14T07:19:56Z,dexpanthenol cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol
2020-10-14T07:19:56Z,dezamizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dezamizumab
2020-10-14T07:19:56Z,dHER2+AS15 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dher2-vaccineas15-adjuvant
2020-10-14T07:19:56Z,diethyldithiocarbamate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb
2020-10-14T07:19:56Z,digestible starch,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/digestible-starch
2020-10-14T07:19:56Z,dihydroorotate dehydrogenase inhibitor AG-636,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-ag-636
2020-10-14T07:19:56Z,dihydroorotate dehydrogenase inhibitor ASLAN003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-aslan003
2020-10-14T07:19:56Z,dihydroorotate dehydrogenase inhibitor BAY2402234,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dihydroorotate-dehydrogenase-inhibitor-bay2402234
2020-10-14T07:19:56Z,Dimericine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t4n5-liposomal-lotion
2020-10-14T07:19:56Z,dimethylbusulfan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimethylmyleran
2020-10-14T07:19:56Z,Disalcid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate
2020-10-14T07:19:56Z,DJ-927,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesetaxel
2020-10-14T07:19:56Z,DNA minor groove binding agent PM060184,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plocabulin
2020-10-14T07:19:56Z,DNA plasmid encoding interleukin-12 INO-9012,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocakinogene-sifuplasmid
2020-10-14T07:19:56Z,DNA plasmid vector pPRA-PSM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-vector-ppra-psm-vaccine
2020-10-14T07:19:56Z,DNAJB1/PRKACA fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnajb1-prkaca-fusion-protein
2020-10-14T07:19:56Z,DNA-PK inhibitor AZD7648,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-inhibitor-azd7648
2020-10-14T07:19:56Z,DNA-PK/PI3K delta inhibitor BR101801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-pi3k-delta-inhibitor-br101801
2020-10-14T07:19:56Z,DNMT1 inhibitor NTX-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnmt1-inhibitor-ntx-301
2020-10-14T07:19:56Z,DNP-modified autologous renal cell carcinoma tumor cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinitrophenyl-modified-autologous-renal-cell-carcinoma-tumor-cell-vaccine
2020-10-14T07:19:56Z,docetaxel nanoparticle CPC634,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-nanoparticle-cpc634
2020-10-14T07:19:56Z,docetaxel polymeric micelles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-polymeric-micelles
2020-10-14T07:19:56Z,docetaxel/ritonavir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel-ritonavir
2020-10-14T07:19:56Z,dolcanatide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolcanatide
2020-10-14T07:19:56Z,domatinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/domatinostat
2020-10-14T07:19:56Z,EGFR/EGFRvIII inhibitor WSD0922-FU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-egfrviii-inhibitor-wsd0922-fu
2020-10-14T07:19:56Z,donor-derived cytokine-induced memory-like natural killer cell,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donor-derived-cytokine-induced-memory-like-natural-killer-cells
2020-10-14T07:19:56Z,Doptelet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avatrombopag-maleate
2020-10-14T07:19:56Z,dostarlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dostarlimab
2020-10-14T07:19:56Z,DOTAP:chol-Fus1 liposome complex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dotapcholesterol-fus1-liposome-complex
2020-10-14T07:19:56Z,Doxil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride
2020-10-14T07:19:56Z,doxorubicin hydrochloride liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride
2020-10-14T07:19:56Z,enfortumab vedotin-ejfv,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enfortumab-vedotin
2020-10-14T07:19:56Z,doxorubicin prodrug/prodrug-activating biomaterial SQ3370,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-prodrug-activating-biomaterial-sq3370
2020-10-14T07:19:56Z,doxycycline hyclate injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-hyclate
2020-10-14T07:19:56Z,DR5 HexaBody agonist GEN1029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilogotamab
2020-10-14T07:19:56Z,dual PI3 kinase/mTOR inhibitor GDC-0980,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apitolisib
2020-10-14T07:19:56Z,dual variable domain immunoglobulin ABT-165,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dilpacimab
2020-10-14T07:19:56Z,DuoBody-CD3xCD20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epcoritamab
2020-10-14T07:19:56Z,Duphaston,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dydrogesterone
2020-10-14T07:19:56Z,dupilumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab
2020-10-14T07:19:56Z,Dupixent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dupilumab
2020-10-14T07:19:56Z,dUTPase inhibitor TAS-114,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutpase-dpd-inhibitor-tas-114
2020-10-14T07:19:56Z,Dyclone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dyclonine-hydrochloride
2020-10-14T07:19:56Z,dyclonine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dyclonine-hydrochloride
2020-10-14T07:19:56Z,dydrogesterone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dydrogesterone
2020-10-14T07:19:56Z,E7820,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/integrin-alpha-2-inhibitor-e7820
2020-10-14T07:19:56Z,East Indian sandalwood oil cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/east-indian-sandalwood-oil-cream
2020-10-14T07:19:56Z,EBNA-1 inhibitor VK-2019,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebna-1-inhibitor-vk-2019
2020-10-14T07:19:56Z,EBV LMP-2A-specific autologous CD8+ T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebv-lmp-2a-specific-autologous-cd8-t-cells
2020-10-14T07:19:56Z,Ecotrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin
2020-10-14T07:19:56Z,ectoine mouthwash,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ectoine-mouthwash-eml03
2020-10-14T07:19:56Z,Effexor XR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine-hydrochloride-extended-release
2020-10-14T07:19:56Z,efineptakin alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efineptakin-alfa
2020-10-14T07:19:56Z,eflapegrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflapegrastim
2020-10-14T07:19:56Z,eftilagimod alpha,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha
2020-10-14T07:19:56Z,Efudex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil
2020-10-14T07:19:56Z,EGF vaccine EGF-PTI,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egf-vaccine-egf-pti
2020-10-14T07:19:56Z,EGFR inhibitor ABT-414,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab-mafodotin
2020-10-14T07:19:56Z,EGFR inhibitor ASP8273,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naquotinib
2020-10-14T07:19:56Z,EGFR inhibitor AZD3759,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorifertinib
2020-10-14T07:19:56Z,EGFR inhibitor DBPR112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-inhibitor-dbpr112
2020-10-14T07:19:56Z,EGFR inhibitor EGF816,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nazartinib
2020-10-14T07:19:56Z,EGFR mutant-selective inhibitor TQB3804,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-selective-inhibitor-tqb3804
2020-10-14T07:19:56Z,EGFR mutant-specific inhibitor BPI-7711,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rezivertinib
2020-10-14T07:19:56Z,EGFR mutant-specific inhibitor D-0316,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-d-0316
2020-10-14T07:19:56Z,EGFR mutant-specific inhibitor ZN-e4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-zn-e4
2020-10-14T07:19:56Z,EGFR T790M inhibitor PF-06747775,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavelertinib
2020-10-14T07:19:56Z,EGFR tyrosine kinase inhibitor HS-10296,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-inhibitor-hs-10296
2020-10-14T07:19:56Z,EGFR/HER2 inhibitor DZD9008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-dzd9008
2020-10-14T07:19:56Z,EGFR/HER2 inhibitor TAK-788,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mobocertinib
2020-10-14T07:19:56Z,EGFR/VEGFR/RET inhibitor HA121-28,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-vegfr-ret-inhibitor-ha121-28
2020-10-14T07:19:56Z,EGFRBi-armed autologous activated T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfrbi-armed-autologous-t-cells
2020-10-14T07:19:56Z,eicosapentaenoic acid monoacylglyceride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eicosapentaenoic-acid-monoacylglyceride
2020-10-14T07:19:56Z,elacestrant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elacestrant
2020-10-14T07:19:56Z,elagolix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elagolix
2020-10-14T07:19:56Z,elbasvir/grazoprevir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elbasvir-grazoprevir
2020-10-14T07:19:56Z,Elidel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimecrolimus
2020-10-14T07:19:56Z,Elzonris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tagraxofusp-erzs
2020-10-14T07:19:56Z,emapalumab-lzsg,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab
2020-10-14T07:19:56Z,Empirin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin
2020-10-14T07:19:56Z,enadenotucirev-expressing anti-CD40 agonistic monoclonal antibody NG-350,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-anti-cd40-agonistic-monoclonal-antibody-ng-350a
2020-10-14T07:19:56Z,enadenotucirev-expressing FAP/CD3 bispecific FAP-TAc NG-641,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev-expressing-fap-cd3-bispecific-fap-tac-ng-641
2020-10-14T07:19:56Z,encochleated amphotericin B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encochleated-amphotericin-b
2020-10-14T07:19:56Z,EndoClot,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rxnorm
2020-10-14T07:19:56Z,endothelin B receptor agonist SPI-1620,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sovateltide
2020-10-14T07:19:56Z,Engerix-B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine
2020-10-14T07:19:56Z,engineered human umbilical vein endothelial cells AB-205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-human-umbilical-vein-endothelial-cells-ab-205
2020-10-14T07:19:56Z,engineered toxin body-targeting HER2 MT-5111,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/engineered-toxin-body-targeting-her2-mt-5111
2020-10-14T07:19:56Z,Enhertu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-deruxtecan
2020-10-14T07:19:56Z,entacapone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entacapone
2020-10-14T07:19:56Z,Entericin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin
2020-10-14T07:19:56Z,Enterococcus gallinarum strain MRx0518,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enterococcus-gallinarum-strain-mrx0518
2020-10-14T07:19:56Z,Entresto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacubitril
2020-10-14T07:19:56Z,EP4 antagonist ONO-4578,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ep4-antagonist-ono-4578
2020-10-14T07:19:56Z,EphA2-targeting bicycle toxin conjugate BT5528,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-bicycle-toxin-conjugate-bt5528
2020-10-14T07:19:56Z,epidiferphane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epidiferphane
2020-10-14T07:19:56Z,epitinib succinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epitinib-succinate
2020-10-14T07:19:56Z,epratuzumab-cys-tesirine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab-cys-tesirine
2020-10-14T07:19:56Z,EPS8 peptide-specific dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eps8-peptide-specific-dendritic-cells
2020-10-14T07:19:56Z,ER alpha proteolysis-targeting chimera protein degrader ARV-471,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/er-alpha-proteolysis-targeting-chimera-protein-degrader-arv-471
2020-10-14T07:19:56Z,ERK 1/2 inhibitor ASTX029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-1-2-inhibitor-astx029
2020-10-14T07:19:56Z,ERK1/2 inhibitor JSI-1187,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk1-2-inhibitor-jsi-1187
2020-10-14T07:19:56Z,ethanol-containing nasal solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethanol-containing-nasal-solution
2020-10-14T07:19:56Z,ethyl icosapentate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent-ethyl
2020-10-14T07:19:56Z,etoposide prodrug CAP7.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-toniribate
2020-10-14T07:19:56Z,Eucerin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eucerin
2020-10-14T07:19:56Z,Everone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate
2020-10-14T07:19:56Z,eVLP CMV gB-pp65 plus GM-CSF VBI-1901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evlp-cmv-gb-pp65-plus-gm-csf-vbi-1901
2020-10-14T07:19:56Z,evocalcet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evocalcet
2020-10-14T07:19:56Z,exendin 9-39,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avexitide
2020-10-14T07:19:56Z,expanded cord blood ECT-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ect-001-expanded-cord-blood
2020-10-14T07:19:56Z,expanded/activated gamma/delta T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/expanded-activated-gamma-delta-t-cells
2020-10-14T07:19:56Z,Exparel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-bupivacaine
2020-10-14T07:19:56Z,extended-release galantamine hydrobromide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-galantamine-hydrobromide
2020-10-14T07:19:56Z,extended-release microsphere capsule-based oxycodone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-microsphere-capsule-based-oxycodone
2020-10-14T07:19:56Z,Extren,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin
2020-10-14T07:19:56Z,E-Z Prep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
2020-10-14T07:19:56Z,E-Z Scrub,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
2020-10-14T07:19:56Z,EZH1/2 inhibitor HH2853,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh1-2-inhibitor-hh2853
2020-10-14T07:19:56Z,EZH2 inhibitor CPI-0209,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-cpi-0209
2020-10-14T07:19:56Z,EZH2 inhibitor PF-06821497,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-pf-06821497
2020-10-14T07:19:56Z,EZH2 inhibitor SHR2554,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezh2-inhibitor-shr2554
2020-10-14T07:19:56Z,F 18 fluorodeoxygalactose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodeoxygalactose-f-18
2020-10-14T07:19:56Z,factor B inhibitor LNP023,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iptacopan
2020-10-14T07:19:56Z,factor D inhibitor ALXN2050,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-d-inhibitor-alxn2050
2020-10-14T07:19:56Z,FAK/ALK/ROS1 inhibitor APG-2449,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-alk-ros1-inhibitor-apg-2449
2020-10-14T07:19:56Z,fam-trastuzumab deruxtecan-nxki,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-deruxtecan
2020-10-14T07:19:56Z,Fc-engineered anti-CD40 agonist antibody 2141-V11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fc-engineered-anti-cd40-agonist-antibody-2141-v11
2020-10-14T07:19:56Z,fecal microbiota transplantation capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fecal-microbiota-transplantation-capsule
2020-10-14T07:19:56Z,fedratinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fedratinib
2020-10-14T07:19:56Z,Femest,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated
2020-10-14T07:19:56Z,Feraheme,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide
2020-10-14T07:19:56Z,fermented soybean extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-extract
2020-10-14T07:19:56Z,ferumoxytol non-stoichiometric magnetite,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrosoferric-oxide
2020-10-14T07:19:56Z,FGF401 inhibitor FGF401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roblitinib
2020-10-14T07:19:56Z,FGFR inhibitor CPL304110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-cpl304110
2020-10-14T07:19:56Z,FGFR inhibitor1/2/3 HMPL-453,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr1-2-3-inhibitor-hmpl-453
2020-10-14T07:19:56Z,FGFR1 receptor antagonist HGS1036,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-receptor-antagonist-hgs1036
2020-10-14T07:19:56Z,FGFR4 inhibitor ICP-105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-icp-105
2020-10-14T07:19:56Z,fibromun,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fibromun
2020-10-14T07:19:56Z,fimaporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fimaporfin
2020-10-14T07:19:56Z,fisogatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fisogatinib
2020-10-14T07:19:56Z,flavone acetic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoflaxone
2020-10-14T07:19:56Z,flaxseed lignan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flaxseed-lignan
2020-10-14T07:19:56Z,Fleet Phospho-soda,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phosphate-sodium-biphosphate-laxative
2020-10-14T07:19:56Z,flibanserin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flibanserin
2020-10-14T07:19:56Z,flotetuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flotetuzumab
2020-10-14T07:19:56Z,FLT3 inhibitor HM43239,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-hm43239
2020-10-14T07:19:56Z,FLT3 inhibitor SKI-G-801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ski-g-801
2020-10-14T07:19:56Z,FLT3/FGFR dual kinase inhibitor MAX-40279,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-fgfr-dual-kinase-inhibitor-max-40279
2020-10-14T07:19:56Z,FLT3/KIT/CSF1R inhibitor NMS-03592088,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-kit-csf1r-inhibitor-nms-03592088
2020-10-14T07:19:56Z,Flt3/MerTK inhibitor MRX-2843,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-mertk-inhibitor-mrx-2843
2020-10-14T07:19:56Z,fluorescein-conjugated Wisteria floribunda lectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescein-conjugated-wisteria-floribunda-lectin
2020-10-14T07:19:56Z,fluorescent cRGDY PEG-Cy5.5 C dots,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/first-degree-perineal-laceration
2020-10-14T07:19:56Z,fluorescent imaging agent cRGD-ZW800-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-imaging-agent-crgd-zw800-1
2020-10-14T07:19:56Z,fluorine F 18 C-SNAT4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-c-snat4
2020-10-14T07:19:56Z,fluorine F 18 DASA-23,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-dasa-23
2020-10-14T07:19:56Z,fluorine F 18 fluorodopa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorodopa-f-18
2020-10-14T07:19:56Z,fluorine F 18 fluoromethylcholine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluorocholine
2020-10-14T07:19:56Z,fluorine F 18 integrin alpha v beta 6-targeted binding peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-integrin-alpha-v-beta-6-targeted-peptide
2020-10-14T07:19:56Z,fluorine F 18 NOS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-nos
2020-10-14T07:19:56Z,fluorine F 18 PARP inhibitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-parp-inhibitor
2020-10-14T07:19:56Z,fluorine F 18 RGD-based integrin peptide-polymer AH111585,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclatide-f-18
2020-10-14T07:19:56Z,fluorine F 18 tetrafluoroborate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-tetrafluoroborate
2020-10-14T07:19:56Z,fluorine F 18-active site inhibited factor VIIa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-active-site-inhibited-factor-viia
2020-10-14T07:19:56Z,fluorine F 18-AIF-NOTA-neurotensin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-aif-nota-neurotensin
2020-10-14T07:19:56Z,fluorine F 18-AlF-cys-variant 3 pH low insertion peptides,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-alf-cys-variant-3-ph-low-insertion-peptides
2020-10-14T07:19:56Z,fluorine F 18-Al-NOTA-MATBBN,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-matbbn
2020-10-14T07:19:56Z,fluorine F 18-Al-NOTA-octreotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-al-nota-octreotide
2020-10-14T07:19:56Z,fluorine F 18-azafol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-azafol
2020-10-14T07:19:56Z,fluorine F 18-BMS-986229,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-bms-986229
2020-10-14T07:19:56Z,fluorine F 18-fluciclovine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclovine-f18
2020-10-14T07:19:56Z,fluorine F 18-fluoroazomycin arabinoside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fluoroazomycin-arabinoside
2020-10-14T07:19:56Z,fluorine F 18-fluorothymidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorothymidine-f-18
2020-10-14T07:19:56Z,fluorine F 18-PSMA-1007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-psma-1007
2020-10-14T07:19:56Z,fluoropyrimidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluoropyrimidine
2020-10-14T07:19:56Z,fluorouracil injection,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil
2020-10-14T07:19:56Z,FMS inhibitor JNJ-40346527,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edicotinib
2020-10-14T07:19:56Z,Fms/Trk tyrosine kinase inhibitor PLX7486,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-trk-tyrosine-kinase-inhibitor-plx7486-tosylate
2020-10-14T07:19:56Z,folate receptor alpha-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-folate-receptor-alpha-loaded-dendritic-cell-vaccine
2020-10-14T07:19:56Z,fosgemcitabine palabenamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosgemcitabine-palabenamide
2020-10-14T07:19:56Z,foslinanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib
2020-10-14T07:19:56Z,fosnetupitant/palonosetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosnetupitant-palonosetron-hydrochloride
2020-10-14T07:19:56Z,fosphenytoin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosphenytoin-sodium
2020-10-14T07:19:56Z,fruit and vegetable extracts,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruit-and-vegetable-extract
2020-10-14T07:19:56Z,fuorescence imaging agent IC2000,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescence-imaging-agent-ic2000
2020-10-14T07:19:56Z,furosemide topical gel CLS006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-topical-gel-cls006
2020-10-14T07:19:56Z,furosemide/digoxin topical gel CLS003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide-digoxin-topical-gel-cls003
2020-10-14T07:19:56Z,futibatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futibatinib
2020-10-14T07:19:56Z,futuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futuximab
2020-10-14T07:19:56Z,G protein-coupled estrogen receptor agonist LNS8801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/g-protein-coupled-estrogen-receptor-agonist-lns8801
2020-10-14T07:19:56Z,G2 checkpoint inhibitor CBP501,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-threonine-kinase-inhibitor-cbp501
2020-10-14T07:19:56Z,G207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-g207
2020-10-14T07:19:56Z,Ga-68-labeled F(ab') 2- trastuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-fab2-trastuzumab
2020-10-14T07:19:56Z,gadopiclenol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadopiclenol
2020-10-14T07:19:56Z,galectin inhibitor GR-MD-02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belapectin
2020-10-14T07:19:56Z,galinpepimut-S,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galinpepimut-s
2020-10-14T07:19:56Z,gallium Ga 68 FAPi-46,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-fapi-46
2020-10-14T07:19:56Z,gallium Ga 68 NODAGA-CBP8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nodaga-cbp8
2020-10-14T07:19:56Z,gallium Ga 68-DOTA-FAPI-04,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dota-fapi-04
2020-10-14T07:19:56Z,gallium Ga 68-labeled affibody molecule ABY-025,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-affibody-aby-025
2020-10-14T07:19:56Z,gallium Ga 68-labeled DX600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-dx600
2020-10-14T07:19:56Z,gallium Ga 68-labeled RM2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-rm2
2020-10-14T07:19:56Z,gallium Ga 68-NeoB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-neob
2020-10-14T07:19:56Z,gallium Ga 68-NOTA-anti-HER2 nanobody VHH1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-her2-nanobody-vhh1
2020-10-14T07:19:56Z,gallium Ga 68-NOTA-anti-MMR-VHH2 nanobody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-anti-mmr-vhh2-nanobody
2020-10-14T07:19:56Z,gallium Ga 68-NOTA-BBN-RGD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-bbn7-14-rgd
2020-10-14T07:19:56Z,gallium Ga 68-NOTA-hGZP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-hgzp
2020-10-14T07:19:56Z,gallium Ga 68-NOTA-MAL-Cys39-exendin-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-mal-cys39-exendin-4
2020-10-14T07:19:56Z,gallium Ga 68-NOTA-RM26,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-rm26
2020-10-14T07:19:56Z,gallium Ga 68-NOTA-Sgc8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-sgc8
2020-10-14T07:19:56Z,gallium Ga 68-P16-093,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-p16-093
2020-10-14T07:19:56Z,gallium Ga 68-PSMA-617,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-psma-617
2020-10-14T07:19:56Z,gallium Ga 68-PSMA-R2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-psma-r2
2020-10-14T07:19:56Z,gallium Ga 68-THP-PSMA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-thp-psma
2020-10-14T07:19:56Z,gallium Ga-labeled PSMA-11-gadoxetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-labeled-psma-11-gadoxetate
2020-10-14T07:19:56Z,gallium-based bone resorption inhibitor AP-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-based-bone-resorption-inhibitor-ap-002
2020-10-14T07:19:56Z,Gamifant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab
2020-10-14T07:19:56Z,gamma-secretase/Notch signalling pathway inhibitor RO4929097,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-inhibitor-ro4929097
2020-10-14T07:19:56Z,Gardasil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-human-papillomavirus-types-6-11-16-18-recombinant-vaccine
2020-10-14T07:19:56Z,garlic extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2p132
2020-10-14T07:19:56Z,gatipotuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gatipotuzumab
2020-10-14T07:19:56Z,gavinostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givinostat
2020-10-14T07:19:56Z,Gavreto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralsetinib
2020-10-14T07:19:56Z,GBM antigens and alloantigens immunotherapeutic vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gbm-antigens-and-alloantigens-immunotherapeutic-vaccine
2020-10-14T07:19:56Z,GEM640,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xiap-antisense-oligonucleotide-aeg35156
2020-10-14T07:19:56Z,gemcitabine 5'-elaidic acid ester,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-elaidate
2020-10-14T07:19:56Z,gemcitabine-cisplatin regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-gemcitabine-regimen
2020-10-14T07:19:56Z,gemcitabine-erlotinib regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-gemcitabine-regimen
2020-10-14T07:19:56Z,gemcitabine-oxaliplatin regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemox-regimen
2020-10-14T07:19:56Z,gemcitabine-releasing intravesical system,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-releasing-intravesical-system
2020-10-14T07:19:56Z,GemRIS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-releasing-intravesical-system
2020-10-14T07:19:56Z,gene-edited autologous neoantigen-targeted NeoTCR-P1 T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gene-edited-autologous-neoantigen-targeted-neotcr-p1-t-cells
2020-10-14T07:19:56Z,genetically engineered HSV-1 expressing IL-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-12-expressing-hsv-1-nsc-733972
2020-10-14T07:19:56Z,Genexol-PM,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008
2020-10-14T07:19:56Z,genolimzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genolimzumab
2020-10-14T07:19:56Z,Genotropin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatropin
2020-10-14T07:19:56Z,gentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gentuximab
2020-10-14T07:19:56Z,geranylgeranyltransferase I inhibitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/geranylgeranyltransferase-i-inhibitor
2020-10-14T07:19:56Z,gilteritinib fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib-fumarate
2020-10-14T07:19:56Z,ginseng/lingzhi mushroom/Cordyceps sinensis/rose oral liquid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ginseng-lingzhi-mushroom-cordyceps-sinensis-rose-oral-liquid
2020-10-14T07:19:56Z,givosiran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/givosiran
2020-10-14T07:19:56Z,glasdegib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glasdegib-maleate
2020-10-14T07:19:56Z,glecaprevir/pibrentasvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glecaprevir-pibrentasvir
2020-10-14T07:19:56Z,globulin component macrophage-activating factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-globulin-component-macrophage-activating-factor
2020-10-14T07:19:56Z,glofitamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glofitamab
2020-10-14T07:19:56Z,glucocorticoid receptor antagonist ORIC-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucocorticoid-receptor-antagonist-oric-101
2020-10-14T07:19:56Z,glumetinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glumetinib
2020-10-14T07:19:56Z,glutaminase inhibitor IPN60090,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutaminase-inhibitor-ipn60090
2020-10-14T07:19:56Z,glyco-engineered anti-CD20 monoclonal antibody CHO H01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyco-engineered-anti-cd20-monoclonal-antibody-cho-h01
2020-10-14T07:19:56Z,glycosaminoglycan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycosaminoglycan
2020-10-14T07:19:56Z,golotimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-d-glutamyl-l-tryptophan
2020-10-14T07:19:56Z,gonadotrophin releasing hormone analogue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog
2020-10-14T07:19:56Z,gonadotropin-releasing hormone receptor antagonist OBE2109,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linzagolix
2020-10-14T07:19:56Z,goserelin acetate extended-release microspheres LY01005,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate-extended-release-microspheres-ly01005
2020-10-14T07:19:56Z,gp96-secreting allogeneic bladder cancer cell vaccine HS-410,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vesigenurtucel-l
2020-10-14T07:19:56Z,GPX-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/13-deoxydoxorubicin
2020-10-14T07:19:56Z,granisetron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron
2020-10-14T07:19:56Z,granisetron transdermal system,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-transdermal-patch
2020-10-14T07:19:56Z,grapiprant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grapiprant
2020-10-14T07:19:56Z,green propolis supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-propolis-supplement
2020-10-14T07:19:56Z,green tea/licorice extract-based antioxidant solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-licorice-extract-based-antioxidant-solution
2020-10-14T07:19:56Z,growth hormone receptor antisense oligonucleotide IONIS-GHR-LRx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/growth-hormone-receptor-antisense-oligonucleotide-ionis-ghr-lrx
2020-10-14T07:19:56Z,GS/pan-Notch inhibitor AL101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-al101
2020-10-14T07:19:56Z,GSK-3 inhibitor 9-ING-41,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gsk-3-inhibitor-9-ing-41
2020-10-14T07:19:56Z,GTI-2040,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antisense-oligonucleotide-gti-2040
2020-10-14T07:19:56Z,gum Arabic solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gum-arabic-solution
2020-10-14T07:19:56Z,guselkumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guselkumab
2020-10-14T07:19:56Z,gusperimus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gusperimus-trihydrochloride
2020-10-14T07:19:56Z,GVAX pancreatic cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-pancreatic-cancer-vaccine
2020-10-14T07:19:56Z,Gwt1 inhibitor APX001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosmanogepix
2020-10-14T07:19:56Z,HAAH lambda phage vaccine SNS-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/haah-lambda-phage-vaccine-sns-301
2020-10-14T07:19:56Z,halichondrin analogue E7130,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halichondrin-analogue-e7130
2020-10-14T07:19:56Z,Harvoni,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir-sofosbuvir
2020-10-14T07:19:56Z,HDAC class I/IIb inhibitor HG146,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-class-i-iib-inhibitor-hg146
2020-10-14T07:19:56Z,HDAC inhibitor ACY-241,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citarinostat
2020-10-14T07:19:56Z,HDAC inhibitor CG200745,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivaltinostat
2020-10-14T07:19:56Z,HDAC inhibitor CKD-581,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-ckd-581
2020-10-14T07:19:56Z,HDAC inhibitor SHP-141,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remetinostat
2020-10-14T07:19:56Z,HDAC inhibitor VRx-3996,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanatinostat
2020-10-14T07:19:56Z,heat-killed bacterium Mycobacterium obuense IMM-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heat-treated-bacterium-mycobacterium-obuense-imm-101
2020-10-14T07:19:56Z,Helicobacter pylori therapeutic vaccine IMX101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/helicobacter-pylori-therapeutic-vaccine-imx101
2020-10-14T07:19:56Z,Hematide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginesatide
2020-10-14T07:19:56Z,hemiasterlin analogue E7974,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hemiasterlin-analog-e7974
2020-10-14T07:19:56Z,hemoporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hemoporfin
2020-10-14T07:19:56Z,hepatitis B vaccine (recombinant),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine
2020-10-14T07:19:56Z,hepatitis C immune globulin intravenous,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-hepatitis-c-immune-globulin
2020-10-14T07:19:56Z,hepcidin mimetic PTG-300,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepcidin-mimetic-ptg-300
2020-10-14T07:19:56Z,HER2 inhibitor TAS0728,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-inhibitor-tas0728
2020-10-14T07:19:56Z,HER2 tri-specific natural killer cell engager DF1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-tri-specific-natural-killer-cell-engager-df1001
2020-10-14T07:19:56Z,HER-2-positive B-cell peptide antigen IMU-131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782063
2020-10-14T07:19:56Z,HER2-pulsed type-1 polarized autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-pulsed-autologous-type-1-polarized-dendritic-cell-vaccine
2020-10-14T07:19:56Z,HER2-targeted DARPin MP0274,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeted-darpin-mp0274
2020-10-14T07:19:56Z,Herceptin Hylecta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-hyaluronidase-oysk
2020-10-14T07:19:56Z,hetrombopag olamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hetrombopag-olamine
2020-10-14T07:19:56Z,HIF2a RNAi ARO-HIF2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif2a-rnai-aro-hif2
2020-10-14T07:19:56Z,HIF-2alpha inhibitor PT2977,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belzutifan
2020-10-14T07:19:56Z,highly purified Staphylococcal protein A PRTX-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevifimod
2020-10-14T07:19:56Z,HM2/MMAE antibody-drug conjugate ALT-P7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hm2-mmae-antibody-drug-conjugate-alt-p7
2020-10-14T07:19:56Z,horse anti-thymocyte globulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/horse-anti-thymocyte-globulin
2020-10-14T07:19:56Z,HPV DNA plasmids therapeutic vaccine VGX-3100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizalimogene-ralaplasmid
2020-10-14T07:19:56Z,HPV E6/E7-encoding arenavirus vaccine HB-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-arenavirus-vaccine-hb-201
2020-10-14T07:19:56Z,HPV L1 VLP vaccine V504,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-papilloma-virus-l1-virus-like-particle-v504-vaccine
2020-10-14T07:19:56Z,HPV-16 E7 TCR-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-16-e7-tcr-expressing-t-cells
2020-10-14T07:19:56Z,HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc fusion protein CUE-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e7-specific-hla-a0201-restricted-igg1-fc-fusion-protein-cue-101
2020-10-14T07:19:56Z,HPV16-E6-T27,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e6-t27
2020-10-14T07:19:56Z,HPV16-E711-19 peptide vaccine DPX-E7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpx-e7-hpv-vaccine
2020-10-14T07:19:56Z,HPV16-E7-T512,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv16-e7-t512
2020-10-14T07:19:56Z,HPV6/11-targeted DNA plasmid vaccine INO-3107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv6-11-targeted-dna-plasmid-vaccine-ino-3107
2020-10-14T07:19:56Z,Hsp90 inhibitor AT13387,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onalespib
2020-10-14T07:19:56Z,Hsp90 inhibitor AUY922,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luminespib
2020-10-14T07:19:56Z,Hsp90 inhibitor CNF2024,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-biib021
2020-10-14T07:19:56Z,Hsp90 inhibitor SNX-2112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-snx-5422-mesylate
2020-10-14T07:19:56Z,Hsp90 inhibitor TQB3474,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-tqb3474
2020-10-14T07:19:56Z,HSP90alpha/beta inhibitor TAS-116,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimitespib
2020-10-14T07:19:56Z,HSP90-targeted photosensitizer HS-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-photosensitizer-hs-201
2020-10-14T07:19:56Z,HSP90-targeted SN-38 conjugate PEN-866,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-targeted-sn-38-conjugate-pen-866
2020-10-14T07:19:56Z,HspE7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/verpasep-caltespen
2020-10-14T07:19:56Z,hTERT mRNA /survivin peptide-double-loaded autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-mrna-survivin-peptide-double-loaded-autologous-dendritic-cell-vaccine
2020-10-14T07:19:56Z,hTERT multipeptide/Montanide ISA-51 VG/imiquimod GX 301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-multipeptide-montanide-isa-51-vg-imiquimod-vaccine-gx-301
2020-10-14T07:19:56Z,hu14.18-IL2 fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hu1418-il2-fusion-protein-emd-273063
2020-10-14T07:19:56Z,human acellular dermal matrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-acellular-dermal-matrix
2020-10-14T07:19:56Z,human anti-CD30 CAR-expressing autologous T-lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-anti-cd30-car-expressing-autologous-t-lymphocytes
2020-10-14T07:19:56Z,human combinatorial antibody library-based antibody VAY736,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ianalumab
2020-10-14T07:19:56Z,human lysozyme-containing goat milk,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-lysozyme-containing-goat-milk
2020-10-14T07:19:56Z,human myeloid progenitor cells CLT-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romyelocel-l
2020-10-14T07:19:56Z,human papillomavirus 16 E7 peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-e7-human-papillomavirus-type-16
2020-10-14T07:19:56Z,human trefoil factor 1-secreting Lactococcus lactis AG013,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dapatifagene-navolactibac
2020-10-14T07:19:56Z,HVP E6/E7-encoding Semliki Forest virus vaccine Vvax001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-encoding-semliki-forest-virus-vaccine-vvax001
2020-10-14T07:19:56Z,hydrocortisone sodium succinate/aluminum phosphate gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrocortisone-sodium-succinate-aluminum-phosphate-gel
2020-10-14T07:19:56Z,HyperAcute-Lung Cancer Vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tergenpumatucel-l
2020-10-14T07:19:56Z,Hyper-CVAD regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypercvad-regimen
2020-10-14T07:19:56Z,hyperpolarized carbon C 13 pyruvate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperpolarized-carbon-c-13-pyruvate
2020-10-14T07:19:56Z,IAP inhibitor AT-406,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-debio-1143
2020-10-14T07:19:56Z,iberdomide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iberdomide
2020-10-14T07:19:56Z,ibrexafungerp,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrexafungerp
2020-10-14T07:19:56Z,ibudilast,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibudilast
2020-10-14T07:19:56Z,ibuprofen intravenous,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibuprofen-injection
2020-10-14T07:19:56Z,iC9-GD2-CAR-CD28-OX40-expressing autologous NKT cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ic9-gd2-car-cd28-ox40-expressing-autologous-nkt-cells
2020-10-14T07:19:56Z,icosapent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent
2020-10-14T07:19:56Z,IDO inhibitor NLG919,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navoximod
2020-10-14T07:19:56Z,IDO/TDO inhibitor HTI-1090,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-tdo-inhibitor-hti-1090
2020-10-14T07:19:56Z,IDO1 inhibitor BMS-986205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat
2020-10-14T07:19:56Z,IDO-1 inhibitor LY3381916,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido-1-inhibitor-ly3381916
2020-10-14T07:19:56Z,IDO-1 inhibitor PF-06840003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-pf-06840003
2020-10-14T07:19:56Z,IDO1/TDO2 inhibitor M4112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-tdo2-inhibitor-m4112
2020-10-14T07:19:56Z,ifetroban sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifetroban-sodium
2020-10-14T07:19:56Z,IGF-1R antagonist BMS-754807,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-igf-1r-insr-inhibitor-bms-754807
2020-10-14T07:19:56Z,IgM-enriched immunoglobulins,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/igm-enriched-immunoglobulins
2020-10-14T07:19:56Z,IL-2/9/15 gamma chain receptor inhibitor BNZ-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-9-15-gamma-chain-receptor-inhibitor-bnz-1
2020-10-14T07:19:56Z,Ilaris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canakinumab
2020-10-14T07:19:56Z,Ilopan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol
2020-10-14T07:19:56Z,Iluyma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tildrakizumab
2020-10-14T07:19:56Z,imaging agent QRH-882260 heptapeptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imaging-agent-qrh-882260-heptapeptide
2020-10-14T07:19:56Z,immediate-release afuresertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-tablet-afuresertib
2020-10-14T07:19:56Z,immediate-release bupropion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immediate-release-bupropion
2020-10-14T07:19:56Z,immunological adjuvant OPT-821,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saponin-based-immunoadjuvant-obi-821
2020-10-14T07:19:56Z,immunomodulator LAM-003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-lam-003
2020-10-14T07:19:56Z,Imvamune,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine
2020-10-14T07:19:56Z,indium In 111 minigastrin analog CP04,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-minigastrin-analog-cp04
2020-10-14T07:19:56Z,indium In 111 monoclonal antibody HuJ591,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-monoclonal-antibody-huj591
2020-10-14T07:19:56Z,indium In 111-autologous CMV-pp65-LAMP mRNA-loaded dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-autologous-cmv-pp65-lamp-mrna-loaded-dendritic-cells
2020-10-14T07:19:56Z,indium In 111-DOTA-girentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-girentuximab
2020-10-14T07:19:56Z,indium In 111-DOTA-h11B6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-dota-h11b6
2020-10-14T07:19:56Z,indium In 111-FPI-1547,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-fpi-1547
2020-10-14T07:19:56Z,indocyanine green-labeled polymeric micelles ONM-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-labeled-polymeric-micelles-onm-100
2020-10-14T07:19:56Z,indoximod prodrug NLG802,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod-prodrug-nlg802
2020-10-14T07:19:56Z,inebilizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inebilizumab
2020-10-14T07:19:56Z,infigratinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infigratinib
2020-10-14T07:19:56Z,ingenol derivative LEO 43204 gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ingenol-disoxate
2020-10-14T07:19:56Z,injectable liposomal vinorelbine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-vinorelbine
2020-10-14T07:19:56Z,iNKT cell agonist ABX196,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inkt-cell-agonist-abx196
2020-10-14T07:19:56Z,innate defense regulator SGX942,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dusquetide
2020-10-14T07:19:56Z,inodiftagene vixteplasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inodiftagene-vixteplasmid
2020-10-14T07:19:56Z,inosine 5'- monophosphate dehydrogenase inhibitor FF-10501-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inosine-5-monophosphate-dehydrogenase-inhibitor-ff-10501-01
2020-10-14T07:19:56Z,Inqovi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine-and-cedazuridine
2020-10-14T07:19:56Z,Inrebic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fedratinib
2020-10-14T07:19:56Z,interleukin-12-Fc fusion protein DF6002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-12-fc-fusion-protein-df6002
2020-10-14T07:19:56Z,iodinated contrast dye,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-contrast-agent
2020-10-14T07:19:56Z,iodinated polyethylene glycol-based hydrogel tissue marker,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker
2020-10-14T07:19:56Z,iodine 131-6-beta-iodomethyl-19-norcholesterol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-6-beta-iodomethyl-19-norcholesterol
2020-10-14T07:19:56Z,iodine I 124 iobenguane,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-124
2020-10-14T07:19:56Z,iodine I 124 monoclonal antibody M5A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-monoclonal-antibody-m5a
2020-10-14T07:19:56Z,iodine I 124-labeled anti-phosphatidylserine monoclonal antibody PGN650,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-124-anti-phosphatidylserine-monoclonal-antibody-pgn650
2020-10-14T07:19:56Z,iodine I 131 chimeric monoclonal antibody G-250,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-monoclonal-antibody-g-250
2020-10-14T07:19:56Z,iodine I 131 monoclonal antibody BC8,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-apamistamab
2020-10-14T07:19:56Z,iodine I 131 monoclonal antibody TNT-1/B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-derlotuximab-biotin
2020-10-14T07:19:56Z,iodine I 131-omburtamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-omburtamab
2020-10-14T07:19:56Z,iodine-123 metaiodobenzylguanidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-sulfate-i-123
2020-10-14T07:19:56Z,Ioversol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chemokine-modulation-therapy
2020-10-14T07:19:56Z,iPSC-derived CD16/IL-15RF-expressing anti-CD19 CAR-NK cells FT596,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipsc-derived-cd16-il-15rf-expressing-anti-cd19-car-nk-cells-ft596
2020-10-14T07:19:56Z,iPSC-derived CD16-expressing natural killer cells FT516,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipsc-derived-cd16-expressing-natural-killer-cells-ft516
2020-10-14T07:19:56Z,IRAK4 inhibitor CA-4948,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irak4-inhibitor-ca-4948
2020-10-14T07:19:56Z,IRDye800CW-labeled heptapeptide KSP-910638G,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800cw-labeled-heptapeptide-ksp-910638g
2020-10-14T07:19:56Z,IRDye800-labeled heterodimeric peptide KSP-QRH 919288G,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irdye800-labeled-heterodimeric-peptide-ksp-qrh-919288g
2020-10-14T07:19:56Z,iriduim Ir 192,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iridium-ir-192
2020-10-14T07:19:56Z,irinotecan hydrochloride liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate
2020-10-14T07:19:56Z,ISIS 2503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/h-ras-antisense-oligodeoxynucleotide-isis-2503
2020-10-14T07:19:56Z,ISIS 3521,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprinocarsen
2020-10-14T07:19:56Z,ISIS 5132,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-raf-antisense-oligonucleotide-isis-5132
2020-10-14T07:19:56Z,ISIS-STAT3rx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danvatirsen
2020-10-14T07:19:56Z,isopropyl alcohol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isopropyl-alcohol
2020-10-14T07:19:56Z,itacitinib adipate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itacitinib-adipate
2020-10-14T07:19:56Z,ITK inhibitor CPI-818,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itk-inhibitor-cpi-818
2020-10-14T07:19:56Z,ivabradine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivabradine-hydrochloride
2020-10-14T07:19:56Z,ivosidenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivosidenib
2020-10-14T07:19:56Z,ixabepilone (oral),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-ixabepilone
2020-10-14T07:19:56Z,JAK1 inhibitor AZD4205,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak1-inhibitor-azd4205
2020-10-14T07:19:56Z,JAK2/Src inhibitor NS-018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilginatinib
2020-10-14T07:19:56Z,JAK3 inhibitor PF-06651600,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ritlecitinib
2020-10-14T07:19:56Z,Jarlsberg cheese,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jarlsberg-cheese
2020-10-14T07:19:56Z,Jelmyto,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin
2020-10-14T07:19:56Z,Juice Plus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruit-and-vegetable-extract
2020-10-14T07:19:56Z,Jynneos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine
2020-10-14T07:19:56Z,Kadcyla,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine
2020-10-14T07:19:56Z,kanitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanitinib
2020-10-14T07:19:56Z,karenitecin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cositecan
2020-10-14T07:19:56Z,karonudib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/karonudib
2020-10-14T07:19:56Z,Koselugo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib-sulfate
2020-10-14T07:19:56Z,KRAS G12C inhibitor LY3499446,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-ly3499446
2020-10-14T07:19:56Z,KRAS G12C inhibitor MRTX849,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-g12c-inhibitor-mrtx849
2020-10-14T07:19:56Z,KRASG12C inhibitor JNJ-74699157,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/krasg12c-inhibitor-jnj-74699157
2020-10-14T07:19:56Z,KRAS-MAPK signaling pathway inhibitor JAB-3312,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kras-mapk-signaling-pathway-inhibitor-jab-3312
2020-10-14T07:19:56Z,KSP inhibitor ARRY-520,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filanesib
2020-10-14T07:19:56Z,KSP/VEGF siRNAs ALN-VSP02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ksp-anti-vegf-sirnas-aln-vsp02
2020-10-14T07:19:56Z,KW-2149,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin-c-analog-kw-2149
2020-10-14T07:19:56Z,L19-IL2 monoclonal antibody-cytokine fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darleukin
2020-10-14T07:19:56Z,"L-377,202",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-prodrug-l-377202
2020-10-14T07:19:56Z,labetuzumab-SN-38 immunoconjugate IMMU-130,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labetuzumab-govitecan
2020-10-14T07:19:56Z,Lactobacillus probiotic BSL_PS6,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-probiotic-bsl-ps6
2020-10-14T07:19:56Z,Lactobacillus reuteri probiotic tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-reuteri-probiotic-tablet
2020-10-14T07:19:56Z,Lactobacillus rhamnosus/Lactobacillus reuteri probiotic supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-lactobacillus-reuteri-probiotic-supplement
2020-10-14T07:19:56Z,lactoferrin-derived lytic peptide LTX-315,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxotemitide
2020-10-14T07:19:56Z,ladiratuzumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ladiratuzumab-vedotin
2020-10-14T07:19:56Z,LAIR-2 fusion protein NC410,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lair-2-fusion-protein-nc410
2020-10-14T07:19:56Z,L-alanosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alanosine
2020-10-14T07:19:56Z,LSD1 inhibitor IMG-7289,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bomedemstat
2020-10-14T07:19:56Z,L-arginine/Korean ginseng/ Gingko biloba/damiana-based supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng-ginkgo-biloba-damiana-based-supplement
2020-10-14T07:19:56Z,larotinib mesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotinib-mesylate
2020-10-14T07:19:56Z,lazertinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib
2020-10-14T07:19:56Z,L-citrulline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citrulline
2020-10-14T07:19:56Z,ledipasvir mixture with sofosbuvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ledipasvir-sofosbuvir
2020-10-14T07:19:56Z,LentiGlobin BB305 Drug Product,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betibeglogene-autotemcel
2020-10-14T07:19:56Z,LEP-ETU,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-liposome
2020-10-14T07:19:56Z,leronlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leronlimab
2020-10-14T07:19:56Z,Levitra,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vardenafil-hydrochloride-trihydrate
2020-10-14T07:19:56Z,levocetirizine dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocetirizine
2020-10-14T07:19:56Z,Libtayo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cemiplimab
2020-10-14T07:19:56Z,licochalcone A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licochalcone-a
2020-10-14T07:19:56Z,licogliflozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licogliflozin
2020-10-14T07:19:56Z,licorice root extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licorice
2020-10-14T07:19:56Z,lidocaine mixture with tribenoside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-mixture-with-tribenoside
2020-10-14T07:19:56Z,lidocaine patch 5%,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-patch
2020-10-14T07:19:56Z,lidocaine topical,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-topical
2020-10-14T07:19:56Z,Lidoderm,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-patch
2020-10-14T07:19:56Z,light-emitting oncolytic vaccinia virus GL-ONC1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olvimulogene-nanivacirepvec
2020-10-14T07:19:56Z,lilotomab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lilotomab
2020-10-14T07:19:56Z,linagliptin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linagliptin
2020-10-14T07:19:56Z,liposomal alpha galactosylceramide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-alpha-galactosylceramide
2020-10-14T07:19:56Z,liposomal annamycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/annamycin-liposomal
2020-10-14T07:19:56Z,liposomal belotecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-belotecan
2020-10-14T07:19:56Z,liposomal cisplatin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-liposomal
2020-10-14T07:19:56Z,liposomal interleukin-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interleukin-2-liposome
2020-10-14T07:19:56Z,liposomal lurtotecan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurtotecan-liposome
2020-10-14T07:19:56Z,liposomal MUC1/PET-lipid A vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-muc1-pet-lipid-a-vaccine-ont-10
2020-10-14T07:19:56Z,liposomal paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-liposome
2020-10-14T07:19:56Z,liposomal T4N5 lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t4n5-liposomal-lotion
2020-10-14T07:19:56Z,liposomal topotecan FF-10850,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-topotecan-ff-10850
2020-10-14T07:19:56Z,liposomal topotecan hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-hydrochloride-liposomes
2020-10-14T07:19:56Z,liposomal tretinoin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin-liposome
2020-10-14T07:19:56Z,liposome-encapsulated TAAs mRNA vaccine W_ova1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-taas-mrna-vaccine-w-ova1
2020-10-14T07:19:56Z,liposome-incorporated Grb2 antisense oligodeoxynucleotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen
2020-10-14T07:19:56Z,lisocabtagene maraleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisocabtagene-maraleucel
2020-10-14T07:19:56Z,live-attenuated double-deleted Listeria monocytogenes bacteria JNJ-64041809,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemlimogene-merolisbac
2020-10-14T07:19:56Z,live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axalimogene-filolisbac
2020-10-14T07:19:56Z,live-attenuated Listeria monocytogenes encoding EGFRvIII-mesothelin vaccine JNJ-64041757,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemlimogene-merolisbac
2020-10-14T07:19:56Z,L-lysine/L-arginine-containing amino acid solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine-l-arginine-containing-amino-acid
2020-10-14T07:19:56Z,LMP/BARF1/ EBNA1-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp1-barf1-ebna1-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,LMP2-specific T-cell receptor-transduced autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp2-specific-t-cell-receptor-transduced-autologous-t-lymphocytes
2020-10-14T07:19:56Z,LMP7 inhibitor M3258,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmp7-inhibitor-m3258
2020-10-14T07:19:56Z,Lm-tLLO-neoantigens vaccine ADXS-NEO,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lm-tllo-neoantigens-vaccine-adxs-neo
2020-10-14T07:19:56Z,lobradimil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labradimil
2020-10-14T07:19:56Z,loncastuximab tesirine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loncastuximab-tesirine
2020-10-14T07:19:56Z,Lovaxin C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axalimogene-filolisbac
2020-10-14T07:19:56Z,Lovaza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omega-3-acid-ethyl-esters
2020-10-14T07:19:56Z,LOXL2 inhibitor PAT-1251,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loxl2-inhibitor-pat-1251
2020-10-14T07:19:56Z,LRP-1-targeted peptide-drug conjugate GRN1005,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-trevatide
2020-10-14T07:19:56Z,LRP5/6 antagonist BI 905677,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lrp5-6-antagonist-bi-905677
2020-10-14T07:19:56Z,LSD1 inhibitor RO7051790,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iadademstat
2020-10-14T07:19:56Z,LSD1 inhibitor SYHA1807,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-syha1807
2020-10-14T07:19:56Z,Ludiomil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maprotiline-hydrochloride
2020-10-14T07:19:56Z,Lumason,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfur-hexafluoride-lipid-microspheres
2020-10-14T07:19:56Z,Lutathera,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dotatate
2020-10-14T07:19:56Z,luteolin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luteolin
2020-10-14T07:19:56Z,lutetium Lu 177 DOTA-N3-CTT1403,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-n3-ctt1403
2020-10-14T07:19:56Z,lutetium Lu 177 satoreotide tetraxetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan
2020-10-14T07:19:56Z,lutetium Lu 177-DOTA-EB-TATE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-eb-tate
2020-10-14T07:19:56Z,lutetium Lu 177-DOTA-IPN01087,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dota-ipn01087
2020-10-14T07:19:56Z,lutetium Lu 177-DOTA-octreotate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dotatate
2020-10-14T07:19:56Z,lutetium Lu 177-dotatate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dotatate
2020-10-14T07:19:56Z,lutetium Lu 177-DTPA-omburtamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dtpa-omburtamab
2020-10-14T07:19:56Z,lutetium Lu 177-NeoB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-neob
2020-10-14T07:19:56Z,lutetium Lu 177-PSMA-617,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-psma-617
2020-10-14T07:19:56Z,lutetium Lu-177 PSMA-R2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-psma-r2
2020-10-14T07:19:56Z,LV.IL-2/B7.1-transduced AML blast vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lvil-2-b71-transduced-aml-blast-vaccine-rfusin2-aml1
2020-10-14T07:19:56Z,lyso-thermosensitive liposomal doxorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposome-doxorubicin
2020-10-14T07:19:56Z,Maackia amurensis seed lectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maackia-amurensis-seed-lectin
2020-10-14T07:19:56Z,Maalox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide-magnesium-hydroxide
2020-10-14T07:19:56Z,macrocycle-bridged STING agonist E7766,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrocycle-bridged-sting-agonist-e7766
2020-10-14T07:19:56Z,macrogol 3350-based oral osmotic laxative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrogol-3350-based-iso-osmotic-laxative
2020-10-14T07:19:56Z,Maekmoondong-tang,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maekmoondong-tang
2020-10-14T07:19:56Z,"MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a1-her-2-neu-fbp-peptides-cancer-vaccine
2020-10-14T07:19:56Z,MAGE-A3-expressing adenovirus type5 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type-5-vaccine
2020-10-14T07:19:56Z,MAGE-A4-specific TCR gene-transduced T lymphocytes TBI-1201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a4-specific-tcr-gene-transduced-autologous-t-lymphocytes-tbi-1201
2020-10-14T07:19:56Z,magnesium glycinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-glycinate
2020-10-14T07:19:56Z,magnesium hydroxide/aluminum hydroxide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide-magnesium-hydroxide
2020-10-14T07:19:56Z,magnesium-based bone void filler,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-based-bone-void-filler
2020-10-14T07:19:56Z,magnesium-rich mineral water,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-rich-mineral-water
2020-10-14T07:19:56Z,magrolimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magrolimab
2020-10-14T07:19:56Z,MALT1 inhibitor JNJ-67856633,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/malt1-inhibitor-jnj-67856633
2020-10-14T07:19:56Z,manganese chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-chloride
2020-10-14T07:19:56Z,manganese/L-alanine/vitamin D3-containing contrast agent formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-l-alanine-vitamin-d3-containing-contrast-agent-formulation
2020-10-14T07:19:56Z,Mangoral,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manganese-l-alanine-vitamin-d3-containing-contrast-agent-formulation
2020-10-14T07:19:56Z,maprotiline hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maprotiline-hydrochloride
2020-10-14T07:19:56Z,Maraba oncolytic virus expressing mutant HPV E6/E7,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maraba-oncolytic-virus-expressing-mutant-hpv-e6-e7
2020-10-14T07:19:56Z,MART-1 reactive CD8+ lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-reactive-cd8-t-lymphocytes
2020-10-14T07:19:56Z,MAT2A inhibitor AG-270,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mat2a-inhibitor-ag-270
2020-10-14T07:19:56Z,mavorixafor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavorixafor
2020-10-14T07:19:56Z,Mavyret,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glecaprevir-pibrentasvir
2020-10-14T07:19:56Z,MCL-1 inhibitor ABBV-467,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-abbv-467
2020-10-14T07:19:56Z,MCL-1 Inhibitor AMG 176,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tapotoclax
2020-10-14T07:19:56Z,MCL-1 inhibitor AMG 397,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/murizatoclax
2020-10-14T07:19:56Z,MCPyV TAg-specific polyclonal autologous CD8-positive T cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcpyv-tag-specific-polyclonal-autologous-cd8-positive-t-cells
2020-10-14T07:19:56Z,MCT/LCT/fish oil omega-3 fatty triglyceride lipid emulsion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-fish-oil-omega-3-fatty-acid-lipid-emulsion
2020-10-14T07:19:56Z,MDM2 antagonist ASTX295,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-astx295
2020-10-14T07:19:56Z,MDM2 inhibitor BI 907828,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-bi-907828
2020-10-14T07:19:56Z,MDM2 inhibitor KRT-232,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-inhibitor-krt-232
2020-10-14T07:19:56Z,Measurin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aspirin
2020-10-14T07:19:56Z,mecapegfilgrastim,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mecapegfilgrastim
2020-10-14T07:19:56Z,MEK 1/2 inhibitor FCN-159,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-2-inhibitor-fcn-159
2020-10-14T07:19:56Z,MEK inhibitor CS3006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-cs3006
2020-10-14T07:19:56Z,MEK inhibitor HL-085,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-hl-085
2020-10-14T07:19:56Z,MEK inhibitor SHR 7390,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-shr-7390
2020-10-14T07:19:56Z,MEK/Aurora kinase dual inhibitor BI 847325,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-aurora-kinase-inhibitor-bi-847325
2020-10-14T07:19:56Z,melphalan-flufenamide prodrug,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide
2020-10-14T07:19:56Z,menin-MLL interaction inhibitor KO 539,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-ko-539
2020-10-14T07:19:56Z,menin-MLL interaction inhibitor SNDX-5613,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/menin-mll-interaction-inhibitor-sndx-5613
2020-10-14T07:19:56Z,mepolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepolizumab
2020-10-14T07:19:56Z,mercaptopurine tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/specific-gravity
2020-10-14T07:19:56Z,mesenchymal stromal cells-derived exosomes with KRAS G12D siRNA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesenchymal-stromal-cells-derived-exosomes-with-kras-g12d-sirna
2020-10-14T07:19:56Z,mesothelin/CD3e tri-specific T-cell activating construct HPN536,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mesothelin-cd3e-tri-specific-t-cell-activating-construct-hpn536
2020-10-14T07:19:56Z,MET kinase inhibitor OMO-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-kinase-inhibitor-omo-1
2020-10-14T07:19:56Z,MET receptor tyrosine kinase inhibitor SGX523,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-sgx523
2020-10-14T07:19:56Z,MET x MET bispecific antibody REGN5093,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-x-met-bispecific-antibody-regn5093
2020-10-14T07:19:56Z,MetAP2 inhibitor APL-1202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metap2-inhibitor-apl-1202
2020-10-14T07:19:56Z,metarrestin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metarrestin
2020-10-14T07:19:56Z,methylcantharidimide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylcantharidimide
2020-10-14T07:19:56Z,MG 98,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dnmt1-mixed-backbone-antisense-oligonucleotide-mg-98
2020-10-14T07:19:56Z,micellar nanoparticle-encapsulated cisplatin NC-6004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demplatin-pegraglumer
2020-10-14T07:19:56Z,Michelia alba leaf oil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/michelia-alba-leaf-oil
2020-10-14T07:19:56Z,micro needle array-doxorubicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/micro-needle-array-doxorubicin
2020-10-14T07:19:56Z,microbial ecosystem therapeutics-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbial-ecosystem-therapeutics-4
2020-10-14T07:19:56Z,microbiome GEN-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-gen-001
2020-10-14T07:19:56Z,microbiome SER-401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-ser-401
2020-10-14T07:19:56Z,microbiome-derived peptide vaccine EO2401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microbiome-derived-peptide-vaccine-eo2401
2020-10-14T07:19:56Z,microtubule-targeted agent BAL101553,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisavanbulin
2020-10-14T07:19:56Z,milademetan tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milademetan-tosylate
2020-10-14T07:19:56Z,milatuzumab-doxorubicin antibody-drug conjugate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab-doxorubicin-antibody-drug-conjugate-immu-110
2020-10-14T07:19:56Z,milciclib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milciclib-maleate
2020-10-14T07:19:56Z,milled seed mix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milled-seed-mix
2020-10-14T07:19:56Z,Minnelide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptolide-analog
2020-10-14T07:19:56Z,Miraluma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sestamibi
2020-10-14T07:19:56Z,miridesap,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miridesap
2020-10-14T07:19:56Z,MitoGel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101
2020-10-14T07:19:56Z,mitomycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin
2020-10-14T07:19:56Z,mitosis inhibitor T 1101 tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitosis-inhibitor-t-1101-tosylate
2020-10-14T07:19:56Z,mitosis-angiogenesis inhibitor R1530,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/receptor-tyrosine-kinase-inhibitor-r1530
2020-10-14T07:19:56Z,MLN2704,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-monoclonal-antibody-mln591-dm1-immunoconjugate-mln2704
2020-10-14T07:19:56Z,MNK1/2 inhibitor ETC-1907206,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnk1-2-inhibitor-etc-1907206
2020-10-14T07:19:56Z,MnSOD-plasmid liposomes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-mnsod-plasmid
2020-10-14T07:19:56Z,modotuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modotuximab
2020-10-14T07:19:56Z,Modufolin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arfolitixorin
2020-10-14T07:19:56Z,MOF compound RiMO-301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mof-compound-rimo-301
2020-10-14T07:19:56Z,moisturizing cream WO2085,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moisturizing-cream-wo2085
2020-10-14T07:19:56Z,molibresib besylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/molibresib-besylate
2020-10-14T07:19:56Z,Monjuvi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab
2020-10-14T07:19:56Z,monoclonal antibody ASP1948,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nrp1-antibody-asp1948
2020-10-14T07:19:56Z,monoclonal antibody CC49,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/minretumomab
2020-10-14T07:19:56Z,monoclonal antibody NEO-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-antibody-neo-201
2020-10-14T07:19:56Z,monoclonal antibody SGN-30,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab
2020-10-14T07:19:56Z,monoclonal microbial EDP1503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monoclonal-microbial-edp1503
2020-10-14T07:19:56Z,monoclonal T-cell receptor anti-CD3 scFv fusion protein IMCgp100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tebentafusp
2020-10-14T07:19:56Z,Mono-Gesic,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate
2020-10-14T07:19:56Z,mosedipimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosedipimod
2020-10-14T07:19:56Z,mosunetuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mosunetuzumab
2020-10-14T07:19:56Z,MOv19 CAR-CD3zeta-4-1BB-expressing allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mov19-car-cd3zeta-4-1bb-expressing-allogeneic-t-lymphocytes
2020-10-14T07:19:56Z,moxidectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxidectin
2020-10-14T07:19:56Z,MP-3549.1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-nanoparticle-based-docetaxel-prodrug-mnk-010
2020-10-14T07:19:56Z,Mps1 inhibitor BOS172722,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-inhibitor-bos172722
2020-10-14T07:19:56Z,Mps1 kinase inhibitor BAY1161909,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/empesertib
2020-10-14T07:19:56Z,mRNA-based personalized cancer vaccine mRNA-4157,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-personalized-cancer-vaccine-mrna-4157
2020-10-14T07:19:56Z,mRNA-based TriMixMelanoma vaccine ECI-006,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-trimix-melanoma-vaccine-eci-006
2020-10-14T07:19:56Z,mRNA-based tumor-specific neoantigen boosting vaccine GRT-R902,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-based-tumor-specific-neoantigen-boosting-vaccine-grt-r902
2020-10-14T07:19:56Z,mRNA-derived KRAS-targeted vaccine V941,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-kras-targeted-vaccine-v941
2020-10-14T07:19:56Z,mRNA-derived lung cancer vaccine BI 1361849,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-lung-cancer-vaccine-bi-1361849
2020-10-14T07:19:56Z,mTORC 1/2 inhibitor LXI-15029,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtorc-1-2-inhibitor-lxi-15029
2020-10-14T07:19:56Z,MUC1 antigen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-antigen
2020-10-14T07:19:56Z,MUC1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-peptide-vaccine
2020-10-14T07:19:56Z,MUC1 peptide-poly-ICLC adjuvant vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-peptide-poly-iclc-vaccine
2020-10-14T07:19:56Z,MUC-1/WT1 peptide-primed autologous dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc-1-wt1-peptide-primed-autologous-dendritic-cells
2020-10-14T07:19:56Z,MUC16-targeted antibody-drug conjugate DMUC5754A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sofituzumab-vedotin
2020-10-14T07:19:56Z,MUC1-targeted peptide GO-2-03-2C,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-targeted-peptide-go-203-2c
2020-10-14T07:19:56Z,multi-antigen-directed autologous T cells NEXI-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-antigen-directed-autologous-t-cells-nexi-002
2020-10-14T07:19:56Z,multi-epitope HER2 peptide vaccine H2NVAC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-h2nvac
2020-10-14T07:19:56Z,multi-epitope HER2 peptide vaccine TPIV100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-her2-peptide-vaccine-tpiv100
2020-10-14T07:19:56Z,multiepitope TARP-pulsed autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-tarp-pulsed-autologous-dendritic-cell-vaccine
2020-10-14T07:19:56Z,Multiferon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-subtype-natural-human-leukocyte-interferon-alpha
2020-10-14T07:19:56Z,multi-kinase inhibitor XL092,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-xl092
2020-10-14T07:19:56Z,multi-kinase inhibitorTPX-0022,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-kinase-inhibitor-tpx-0022
2020-10-14T07:19:56Z,multi-mode kinase inhibitor EOC317,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-mode-kinase-inhibitor-eoc317
2020-10-14T07:19:56Z,multisubtype natural human leukocyte interferon alpha,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-subtype-natural-human-leukocyte-interferon-alpha
2020-10-14T07:19:56Z,mutant IDH1 inhibitor DS-1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-idh1-inhibitor-ds-1001
2020-10-14T07:19:56Z,MVA tumor-specific neoantigen boosting vaccine MVA-209-FSP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-tumor-specific-neoantigen-boosting-vaccine-mva-209-fsp
2020-10-14T07:19:56Z,MVA-BN smallpox vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-bn-smallpox-vaccine
2020-10-14T07:19:56Z,MVA-HPV16E6/E7-IL2 vaccine TG4001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipapkinogene-sovacivec
2020-10-14T07:19:56Z,Mylanta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aluminum-hydroxide-magnesium-hydroxide
2020-10-14T07:19:56Z,nadofaragene firadenovec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec
2020-10-14T07:19:56Z,nalbuphine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nalbuphine
2020-10-14T07:19:56Z,NAMPT Inhibitor OT-82,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nampt-inhibitor-ot-82
2020-10-14T07:19:56Z,Nanopac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/submicron-particle-paclitaxel-sterile-suspension
2020-10-14T07:19:56Z,nanoparticle albumin-bound docetaxel ABI-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-docetaxel
2020-10-14T07:19:56Z,nanoparticle paclitaxel ointment SOR007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-paclitaxel-ointment-sor007
2020-10-14T07:19:56Z,nanoparticle SN-38-encapsulated micelle formulation IT-141,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-sn-38-encapsulated-micelle-formulation-it-141
2020-10-14T07:19:56Z,nanoparticle-based manganese-containing contrast agent SN132D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-based-manganese-containing-contrast-agent-sn132d
2020-10-14T07:19:56Z,olutasidenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olutasidenib
2020-10-14T07:19:56Z,nanoscale coordination polymer nanoparticles CPI-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoscale-coordination-polymer-nanoparticles-cpi-100
2020-10-14T07:19:56Z,nasal saline irrigation solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saline
2020-10-14T07:19:56Z,natural human interferon alpha OPC-18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/natural-ifn-alpha-opc-18
2020-10-14T07:19:56Z,naxitamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naxitamab
2020-10-14T07:19:56Z,N-dihydrogalactochitosan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-dihydrogalactochitosan
2020-10-14T07:19:56Z,near-infrared imaging agent HS-196,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/near-infrared-imaging-agent-hs-196
2020-10-14T07:19:56Z,nedisertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib
2020-10-14T07:19:56Z,neoantigen peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-peptide-vaccine
2020-10-14T07:19:56Z,neoantigen-based renal cell carcinoma-poly-ICLC vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-renal-cell-carcinoma-poly-iclc-vaccine
2020-10-14T07:19:56Z,neoantigen-based therapeutic cancer vaccine GRT-C903,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-c903
2020-10-14T07:19:56Z,neoantigen-based therapeutic cancer vaccine GRT-R904,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-therapeutic-cancer-vaccine-grt-r904
2020-10-14T07:19:56Z,neoantigen-encoding personalized virus-2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-encoding-personalized-virus-2
2020-10-14T07:19:56Z,neoantigen-HSP70 peptide cancer vaccine AGEN2017,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-hsp70-peptide-cancer-vaccine-agen2017
2020-10-14T07:19:56Z,neo-multiple TAA-loaded dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neo-multiple-taa-loaded-dendritic-cell-vaccine
2020-10-14T07:19:56Z,neratinib maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib
2020-10-14T07:19:56Z,Nerlynx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib
2020-10-14T07:19:56Z,netazepide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476
2020-10-14T07:19:56Z,netupitant and palonosetron hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/netupitant-palonosetron-hydrochloride
2020-10-14T07:19:56Z,NM-3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isocoumarin-nm-3
2020-10-14T07:19:56Z,Niagen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotinamide-riboside
2020-10-14T07:19:56Z,nicotinamide riboside,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nicotinamide-riboside
2020-10-14T07:19:56Z,nidanilimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nidanilimab
2020-10-14T07:19:56Z,nilotinib hydrochloride monohydrate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib-hydrochloride-monohydrate
2020-10-14T07:19:56Z,nimesulide-hyaluronic acid conjugate CA102N,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimesulide-hyaluronic-acid-conjugate-ca102n
2020-10-14T07:19:56Z,ningetinib tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ningetinib-tosylate
2020-10-14T07:19:56Z,nipocalimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nipocalimab
2020-10-14T07:19:56Z,nirogacestat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nirogacestat
2020-10-14T07:19:56Z,NLRP3 agonist BMS-986299,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nlrp3-agonist-bms-986299
2020-10-14T07:19:56Z,N-oleyl-phosphatidylethanolamine/epigallocatechin gallate supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement
2020-10-14T07:19:56Z,norepinephrine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/norepinephrine-dl-
2020-10-14T07:19:56Z,Nozin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethanol-containing-nasal-solution
2020-10-14T07:19:56Z,NS5B polymerase inhibitor BMS-791325,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beclabuvir
2020-10-14T07:19:56Z,NSCLC antigen-loaded dendritic cell-derived exosomes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nsclc-antigen-loaded-dendritic-cell-derived-exosomes
2020-10-14T07:19:56Z,NSCLC-specific marrow-infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nsclc-specific-marrow-infiltrating-lymphocytes
2020-10-14T07:19:56Z,NTRK/ROS1 inhibitor DS-6051b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taletrectinib
2020-10-14T07:19:56Z,Nubeqa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide
2020-10-14T07:19:56Z,Nucala,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mepolizumab
2020-10-14T07:19:56Z,nucleotide analog prodrug NUC-3373,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosifloxuridine-nafalbenamide
2020-10-14T07:19:56Z,Nutri-jelly,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritious-semisolid-food-gel
2020-10-14T07:19:56Z,Nutri-jelly with PEITC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritious-semisolid-food-gel-with-phenethyl-isothiocyanate
2020-10-14T07:19:56Z,nutritional supplement drink (pediatric),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pediatric-nutritional-supplement-drink
2020-10-14T07:19:56Z,nutritious semisolid food gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritious-semisolid-food-gel
2020-10-14T07:19:56Z,nutritious semisolid food gel with phenethyl isothiocyanate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutritious-semisolid-food-gel-with-phenethyl-isothiocyanate
2020-10-14T07:19:56Z,NY-ESO-1 plasmid DNA cancer vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-plasmid-dna-cancer-vaccine-ppjv7611
2020-10-14T07:19:56Z,NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-lage-1-peptide-vaccine
2020-10-14T07:19:56Z,ofranergene obadenovec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofranergene-obadenovec
2020-10-14T07:19:56Z,olaptesed pegol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaptesed-pegol
2020-10-14T07:19:56Z,oleclumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oleclumab
2020-10-14T07:19:56Z,olmutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olmutinib
2020-10-14T07:19:56Z,omaveloxolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omaveloxolone
2020-10-14T07:19:56Z,omega-3-acid ethyl esters,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omega-3-acid-ethyl-esters
2020-10-14T07:19:56Z,omidubicel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omidubicel
2020-10-14T07:19:56Z,oncolytic adenovirus Ad5-DNX-2401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasadenoturev
2020-10-14T07:19:56Z,oncolytic adenovirus CAdVEC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-cadvec
2020-10-14T07:19:56Z,oncolytic adenovirus ORCA-010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-adenovirus-orca-010
2020-10-14T07:19:56Z,oncolytic HSV-1 C134,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-c134
2020-10-14T07:19:56Z,oncolytic HSV-1716,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv1716
2020-10-14T07:19:56Z,oncolytic Newcastle disease virus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-mth-68h
2020-10-14T07:19:56Z,oncolytic Newcastle disease virus MEDI5395,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-medi5395
2020-10-14T07:19:56Z,oncolytic vaccinia virus T601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-vaccinia-virus-tg6002
2020-10-14T07:19:56Z,oncolytic virus ASP9801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-asp9801
2020-10-14T07:19:56Z,oncolytic virus RP1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-virus-rp1
2020-10-14T07:19:56Z,Onivyde,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate
2020-10-14T07:19:56Z,onvansertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvansertib
2020-10-14T07:19:56Z,ONYX-015,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lontucirev
2020-10-14T07:19:56Z,opaganib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opaganib
2020-10-14T07:19:56Z,opioid agonist GIC-1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimebutine-3-thiocarbamoylbenzenesulfonate
2020-10-14T07:19:56Z,Optiray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chemokine-modulation-therapy
2020-10-14T07:19:56Z,oral cancer vaccine V3-P,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-pancreatic-cancer-vaccine-v3-p
2020-10-14T07:19:56Z,oral fludarabine phosphate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate
2020-10-14T07:19:56Z,oral milataxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milataxel
2020-10-14T07:19:56Z,oral moisturizing jelly,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-moisturizing-jelly
2020-10-14T07:19:56Z,oral myoma vaccine V3-myoma,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-myoma-vaccine-v3-myoma
2020-10-14T07:19:56Z,oral rehydration solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-rehydration-solution-os-1
2020-10-14T07:19:56Z,oral therapeutic vaccine V3-X,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-therapeutic-vaccine-v3-x
2020-10-14T07:19:56Z,Orilissa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elagolix
2020-10-14T07:19:56Z,OSE 2101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-neo-epitope-vaccine-ose-2101
2020-10-14T07:19:56Z,OSI-7904L,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-osi-7904
2020-10-14T07:19:56Z,Osteocrete,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-based-bone-void-filler
2020-10-14T07:19:56Z,OX40L-expressing oncolytic adenovirus DNX-2440,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ox40l-expressing-oncolytic-adenovirus-dnx-2440
2020-10-14T07:19:56Z,oxaliplatin eluting beads,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin-eluting-beads
2020-10-14T07:19:56Z,oxidative phosphorylation inhibitor IM156,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-im156
2020-10-14T07:19:56Z,p300/CBP bromodomain inhibitor CCS1477,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p300-cbp-bromodomain-inhibitor-ccs1477
2020-10-14T07:19:56Z,p38 MAPK inhibitor LY2228820 dimesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ralimetinib-mesylate
2020-10-14T07:19:56Z,p38/Tie2 kinase inhibitor Arry-614,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexmetinib
2020-10-14T07:19:56Z,p53 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine-mps-128
2020-10-14T07:19:56Z,p53 synthetic long peptide (70-251) vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-synthetic-long-peptides-vaccine
2020-10-14T07:19:56Z,p53-HDM2 protein-protein interaction inhibitor MI-773,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-mi-773
2020-10-14T07:19:56Z,p97 Inhibitor CB-5339,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5339
2020-10-14T07:19:56Z,p97 inhibitor CB-5339 tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5339-tosylate
2020-10-14T07:19:56Z,paclitaxel albumin-stabilized nanoparticle formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel
2020-10-14T07:19:56Z,paclitaxel polymeric micelle formulation NANT-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008
2020-10-14T07:19:56Z,paclitaxel vitamin E-based emulsion formulation,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-vitamin-e-based-emulsion
2020-10-14T07:19:56Z,Padcev,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enfortumab-vedotin
2020-10-14T07:19:56Z,palladium-bacteriopheophorbide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padoporfin
2020-10-14T07:19:56Z,pamiparib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamiparib
2020-10-14T07:19:56Z,pamrevlumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamrevlumab
2020-10-14T07:19:56Z,pan-AKT inhibitor ARQ 751,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq751
2020-10-14T07:19:56Z,pan-FGFR tyrosine kinase inhibitor BAY1163877,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rogaratinib
2020-10-14T07:19:56Z,pan-FLT3/Pan-BTK multi-kinase inhibitor CG-806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-flt3-pan-btk-multi-kinase-inhibitor-cg-806
2020-10-14T07:19:56Z,PankoMab-GEX,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gatipotuzumab
2020-10-14T07:19:56Z,pan-KRAS inhibitor BI 1701963,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-kras-inhibitor-bi-1701963
2020-10-14T07:19:56Z,pan-mutant-IDH1 inhibitor BAY1436032,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay-1436032
2020-10-14T07:19:56Z,pan-mutation-selective EGFR inhibitor CLN-081,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutation-selective-egfr-inhibitor-cln-081
2020-10-14T07:19:56Z,panobinostat nanoparticle formulation MTX110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat-nanoparticle-formulation-mtx110
2020-10-14T07:19:56Z,pan-PI3K/mTOR inhibitor PQR309,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimiralisib
2020-10-14T07:19:56Z,pan-PIM inhibitor INCB053914,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uzansertib
2020-10-14T07:19:56Z,pan-selectin antagonist GMI-1070,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivipansel
2020-10-14T07:19:56Z,pan-TRK inhibitor NOV1601,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-nov1601
2020-10-14T07:19:56Z,para-toluenesulfonamide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/para-toluenesulfonamide
2020-10-14T07:19:56Z,PARP 1/2 inhibitor IMP4297,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-imp4297
2020-10-14T07:19:56Z,PARP 1/2 inhibitor NOV1401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-1-2-inhibitor-nov1401
2020-10-14T07:19:56Z,PARP inhibitor NMS-03305293,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-nms-03305293
2020-10-14T07:19:56Z,PARP/Tankyrase inhibitor 2X-121,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-tankyrase-inhibitor-2x-121
2020-10-14T07:19:56Z,PARP7 inhibitor RBN-2397,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp7-inhibitor-rbn-2397
2020-10-14T07:19:56Z,partially engineered T-regulatory cell donor graft TRGFT-201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-engineered-t-regulatory-cell-donor-graft-trgft-201
2020-10-14T07:19:56Z,partially HLA-matched AdV/CMV/EBV-specific allogeneic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/partially-hla-matched-adv-cmv-ebv-specific-allogeneic-t-lymphocytes
2020-10-14T07:19:56Z,patient-specific follicular lymphoma-derived anti-idiotype vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-follicular-lymphoma-derived-idiotype-vaccine
2020-10-14T07:19:56Z,Patisiran,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patisiran
2020-10-14T07:19:56Z,PBTL CD19CAR-28 zeta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-pbtl-cd19car-28-zeta
2020-10-14T07:19:56Z,PD0325901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-pd0325901
2020-10-14T07:19:56Z,PD-1 knockout autologous T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdcd-1-knockout-autologous-t-lymphocytes
2020-10-14T07:19:56Z,PD-1 knockout EBV-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-knockout-ebv-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,PD-1-directed probody CX-188,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-1-directed-probody-cx-188
2020-10-14T07:19:56Z,PD-L1 inhibitor INCB086550,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-inhibitor-incb086550
2020-10-14T07:19:56Z,PD-L1 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-peptide-vaccine
2020-10-14T07:19:56Z,PD-L1/IDO peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-ido-peptide-vaccine
2020-10-14T07:19:56Z,PD-L1/PD-L2 peptide-Montanide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-pd-l2-peptide-montanide-vaccine
2020-10-14T07:19:56Z,PD-L2 peptide-Montanide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l2-peptide-montanide-vaccine
2020-10-14T07:19:56Z,pDNA-encoding Emm55 autologous cancer cell vaccine IFx-Hu2.0,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdna-encoding-emm55-autologous-cancer-cell-vaccine-ifx-hu20
2020-10-14T07:19:56Z,PE/HPV16 E7/KDEL fusion protein/GPI-0100 TVGV-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-gpi-0100-tvgv-1
2020-10-14T07:19:56Z,PediaBerry,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/powdered-mixed-berry-extract-supplement
2020-10-14T07:19:56Z,PediaSure,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pediatric-nutritional-supplement-drink
2020-10-14T07:19:56Z,Pedi-Vit-A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound
2020-10-14T07:19:56Z,PEGASYS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2a
2020-10-14T07:19:56Z,PEG-conjugated TLR7/8 agonist NKTR-262,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-conjugated-tlr7-8-agonist-nktr-262
2020-10-14T07:19:56Z,PEG-interferon alfa-2a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginterferon-alfa-2a
2020-10-14T07:19:56Z,PEG-linked L-RNA oligonucleotide hepcidin-targeting agent NOX-H94,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexaptepid-pegol
2020-10-14T07:19:56Z,pegol sihematide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegol-sihematide-injection
2020-10-14T07:19:56Z,PEG-proline-interferon alpha-2b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b
2020-10-14T07:19:56Z,pegylated anti-GFR antibody fragment,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alacizumab-pegol
2020-10-14T07:19:56Z,pegylated arginine deiminase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegargiminase
2020-10-14T07:19:56Z,pegylated deoxycytidine analogue DFP-14927,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-deoxycytidine-analogue-dfp-14927
2020-10-14T07:19:56Z,pegylated recombinant human hyaluronidase PH20,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegvorhyaluronidase-alfa
2020-10-14T07:19:56Z,pegylated recombinant human interleukin-10 AM0010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegilodecakin
2020-10-14T07:19:56Z,pegylated recombinant interleukin-2 THOR-707,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-interleukin-2-thor-707
2020-10-14T07:19:56Z,pegylated SN-38 conjugate PLX038,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-sn-38-conjugate-plx038
2020-10-14T07:19:56Z,pegzilarginase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegzilarginase
2020-10-14T07:19:56Z,pelareorep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelareorep
2020-10-14T07:19:56Z,Pemazyre,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemigatinib
2020-10-14T07:19:56Z,pemigatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemigatinib
2020-10-14T07:19:56Z,peptide-dye conjugate ALM-488,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peptide-dye-conjugate-alm-488
2020-10-14T07:19:56Z,peptidoglycan complex of spirulina K-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peptidoglycan-complex-of-spirulina-k-001
2020-10-14T07:19:56Z,personalized neoantigen DNA vaccine GNOS-PVO2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-neoantigen-dna-vaccine-gnos-pvo2
2020-10-14T07:19:56Z,personalized neoantigen peptide vaccine iNeo-Vac-P01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-neoantigen-peptide-vaccine-ineo-vac-p01
2020-10-14T07:19:56Z,personalized neoepitope yeast vaccine YE-NEO-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-neoepitope-yeast-vaccine-ye-neo-001
2020-10-14T07:19:56Z,personalized synthetic long peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-synthetic-long-peptide-vaccine
2020-10-14T07:19:56Z,"pertuzumab, trastuzumab, and hyaluronidase-zzxf",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronidase-zzxf-pertuzumab-trastuzumab
2020-10-14T07:19:56Z,P-glycoprotein inhibitor HM30181AK,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encequidar
2020-10-14T07:19:56Z,pharmacological ascorbate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pharmacological-ascorbate
2020-10-14T07:19:56Z,PHC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-health-cocktail-dietary-supplement
2020-10-14T07:19:56Z,Phesgo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyaluronidase-zzxf-pertuzumab-trastuzumab
2020-10-14T07:19:56Z,PhosphoLean,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/n-oleyl-phosphatidylethanolamine-epigallocatechin-gallate-supplement
2020-10-14T07:19:56Z,phosphorus P32,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phosphorus-p-32
2020-10-14T07:19:56Z,photodynamic compound TLD-1433,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/photodynamic-compound-tld-1433
2020-10-14T07:19:56Z,photosensitizer LUZ 11,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/redaporfin
2020-10-14T07:19:56Z,PI3K alpha inhibitor MLN1117,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serabelisib
2020-10-14T07:19:56Z,PI3K delta inhibitor HMPL 689,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-hmpl-689
2020-10-14T07:19:56Z,PI3K delta inhibitor ME-401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zandelisib
2020-10-14T07:19:56Z,PI3K delta inhibitor SHC014748M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-shc014748m
2020-10-14T07:19:56Z,PI3K inhibitor GDC-0077,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-gdc0077
2020-10-14T07:19:56Z,PI3K inhibitor GDC-0084,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paxalisib
2020-10-14T07:19:56Z,PI3K inhibitor GDC-0941 bismesylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pictilisib-bismesylate
2020-10-14T07:19:56Z,PI3K inhibitor GSK2126458,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omipalisib
2020-10-14T07:19:56Z,PI3K inhibitor PX-866,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonolisib
2020-10-14T07:19:56Z,PI3K/HDAC inhibitor CUDC-907,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fimepinostat
2020-10-14T07:19:56Z,PI3K/mTOR dual kinase inhibitor XL765,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxtalisib
2020-10-14T07:19:56Z,PI3K/mTOR inhibitor LY3023414,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samotolisib
2020-10-14T07:19:56Z,PI3K/mTOR kinase inhibitor BEZ235,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactolisib
2020-10-14T07:19:56Z,PI3K/mTOR/ALK-1/DNA-PK inhibitor P7170,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panulisib
2020-10-14T07:19:56Z,PI3K-alpha inhibitor MEN1611,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-inhibitor-men1611
2020-10-14T07:19:56Z,PI3Kdelta inhibitor INCB040093,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dezapelisib
2020-10-14T07:19:56Z,PI3K-delta inhibitor INCB050465,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parsaclisib
2020-10-14T07:19:56Z,PI3K-delta inhibitor YY-20394,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linperlisib
2020-10-14T07:19:56Z,PI-88,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muparfostat
2020-10-14T07:19:56Z,pilocarpine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilocarpine
2020-10-14T07:19:56Z,PIM kinase inhibitor TP-3654,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-tp-3654
2020-10-14T07:19:56Z,pimecrolimus cream,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimecrolimus
2020-10-14T07:19:56Z,pimodivir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimodivir
2020-10-14T07:19:56Z,pinometostat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinometostat
2020-10-14T07:19:56Z,PKC-beta inhibitor MS-553,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pkc-beta-inhibitor-ms-553
2020-10-14T07:19:56Z,PK-R allosteric activator AG-348,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitapivat
2020-10-14T07:19:56Z,Plasmodium vivax–infected red blood cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plasmodium-vivax-infected-red-blood-cell
2020-10-14T07:19:56Z,platinum acetylacetonate-titanium dioxide nanoparticles,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/platinum-acetylacetonate-titanium-dioxide-nanoparticles
2020-10-14T07:19:56Z,pleiotropic pathway modifier CC-122 hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avadomide-hydrochloride
2020-10-14T07:19:56Z,PLK1 inhibitor CYC140,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-cyc140
2020-10-14T07:19:56Z,PM00104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-alkaloid-pm00104
2020-10-14T07:19:56Z,polidocanol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polidocanol
2020-10-14T07:19:56Z,poliglusam,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poliglusam
2020-10-14T07:19:56Z,pollen extract PCC-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pollen-extract-pcc-100
2020-10-14T07:19:56Z,Polo-like kinase 1 inhibitor GSK-461364,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polo-like-kinase-1-inhibitor-gsk461364
2020-10-14T07:19:56Z,polyamine transport inhibitor AMXT-1501 dicaprate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyamine-transport-inhibitor-amxt-1501-dicaprate
2020-10-14T07:19:56Z,polyethyleneglycol-7-ethyl-10-hydroxycamptothecin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/firtecan-pegol
2020-10-14T07:19:56Z,polyinosinic-polycytidylic acid/inactivated rabies virus vaccine YS-ON-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyinosinic-polycytidylic-acid-inactivated-rabies-virus-vaccine-ys-on-001
2020-10-14T07:19:56Z,polymer-conjugated IL-15 receptor agonist NKTR-255,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-conjugated-il-15-receptor-agonist-nktr-255
2020-10-14T07:19:56Z,polymer-cyanoacrylate hypoallergenic barrier solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alcohol-free-hypoallergenic-barrier-film-solution
2020-10-14T07:19:56Z,polymer-encapsulated luteolin nanoparticle,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polymer-encapsulated-luteolin-nanoparticle
2020-10-14T07:19:56Z,PolyMVA,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-palladium-vitamin-mineral-supplement
2020-10-14T07:19:56Z,poly-TLR agonist polyantigenic vaccine CADI-05,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-cadi-05
2020-10-14T07:19:56Z,pooled mutant KRAS-targeted long peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pooled-mutant-kras-targeted-long-peptide-vaccine
2020-10-14T07:19:56Z,porcupine inhibitor CGX1321,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-cgx1321
2020-10-14T07:19:56Z,porcupine inhibitor RXC004,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-rxc004
2020-10-14T07:19:56Z,porcupine inhibitor XNW7201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-xnw7201
2020-10-14T07:19:56Z,povidone-iodine solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
2020-10-14T07:19:56Z,powdered mixed berry extract supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/powdered-mixed-berry-extract-supplement
2020-10-14T07:19:56Z,pozelimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pozelimab
2020-10-14T07:19:56Z,PP14 derivative-treated HLA-matched donor mononuclear cell-enriched leukocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-matched-donor-mononuclear-cell-enriched-leukocytes-apocell
2020-10-14T07:19:56Z,PPAR-alpha antagonist TPST-1120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ppar-alpha-antagonist-tpst-1120
2020-10-14T07:19:56Z,PPI-2458,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methionine-aminopeptidase-2-inhibitor-ppi-2458
2020-10-14T07:19:56Z,PR-104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitrogen-mustard-prodrug-pr-104
2020-10-14T07:19:56Z,pralsetinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralsetinib
2020-10-14T07:19:56Z,PRAME-targeting T-cell receptor/I\inducible caspase 9 BPX-701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prame-targeting-t-cell-receptor-inducible-caspase-9-bpx-701
2020-10-14T07:19:56Z,pramlintide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pramlintide
2020-10-14T07:19:56Z,Premarin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/estrogens-conjugated
2020-10-14T07:19:56Z,priming cancer vaccine GRT-C901,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-tumor-specific-neoantigen-priming-vaccine-grt-c901
2020-10-14T07:19:56Z,Primosteston,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate
2020-10-14T07:19:56Z,pritumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pritumumab
2020-10-14T07:19:56Z,PRMT1 inhibitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor
2020-10-14T07:19:56Z,PRMT1 inhibitor GSK3368715,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt1-inhibitor-gsk3368715
2020-10-14T07:19:56Z,PRMT5 inhibitor JNJ-64619178,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-jnj-64619178
2020-10-14T07:19:56Z,PRMT5 inhibitor PRT811,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prmt5-inhibitor-prt811
2020-10-14T07:19:56Z,probiotic acidophilus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-acidophilus
2020-10-14T07:19:56Z,probiotic supplement WeiLeShu,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/probiotic-supplement-weileshu
2020-10-14T07:19:56Z,prochlorperazine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prochlorperazine-maleate
2020-10-14T07:19:56Z,Procto-glyvenol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lidocaine-mixture-with-tribenoside
2020-10-14T07:19:56Z,promestriene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promestriene
2020-10-14T07:19:56Z,Prostate Health Cocktail,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostate-health-cocktail-dietary-supplement
2020-10-14T07:19:56Z,prostate tumor antigen-activated autologous dendritic cell vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stapuldencel-t
2020-10-14T07:19:56Z,prostatic acid phosphatase-sargramostim fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prostatic-acid-phosphatase-sargramostim-fusion-protein-pa2024
2020-10-14T07:19:56Z,protease-activated anti-PD-L1 antibody prodrug CX-072,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacmilimab
2020-10-14T07:19:56Z,protein arginine methyltransferase 5 inhibitor PF-06939999,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-pf-06939999
2020-10-14T07:19:56Z,protein arginine methyltransferase 5 inhibitor PRT543,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-arginine-methyltransferase-5-inhibitor-prt543
2020-10-14T07:19:56Z,protein kinase C inhibitor IDE196,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-kinase-c-inhibitor-ide196
2020-10-14T07:19:56Z,proteolytic enzymes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pancreatic-proteolytic-enzymes
2020-10-14T07:19:56Z,protopine/nuciferine supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protopine-nuciferine-supplement
2020-10-14T07:19:56Z,Provecta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rose-bengal-solution-pv-10
2020-10-14T07:19:56Z,PSMA/CD3 tri-specific T-cell activating construct HPN424,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-cd3-tri-specific-t-cell-activating-construct-hpn424
2020-10-14T07:19:56Z,recombinant interferon alpha-2a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a
2020-10-14T07:19:56Z,pterostilbene,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pterostilbene
2020-10-14T07:19:56Z,Purlytin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tin-ethyl-etiopurpurin
2020-10-14T07:19:56Z,PV-10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rose-bengal-solution-pv-10
2020-10-14T07:19:56Z,PV701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-newcastle-disease-virus-strain-pv701
2020-10-14T07:19:56Z,pVAXrcPSAv53l vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pvaxrcpsav53l-dna-vaccine
2020-10-14T07:19:56Z,PVDF/sirolimus topical,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-pvdf-sirolimus
2020-10-14T07:19:56Z,pyrrolobenzodiazepine-based anti-CD19 antibody-drug conjugate SGN-CD19B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-drug-conjugate-sgn-cd19b
2020-10-14T07:19:56Z,pyrvinium pamoate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrvinium-pamoate
2020-10-14T07:19:56Z,Q-Can Plus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-extract
2020-10-14T07:19:56Z,qilisheng immunoregulatory oral solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/qilisheng-immunoregulatory-oral-solution
2020-10-14T07:19:56Z,Qinlock,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripretinib
2020-10-14T07:19:56Z,quarfloxacin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quarfloxin
2020-10-14T07:19:56Z,Quelicin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succinylcholine-chloride
2020-10-14T07:19:56Z,quinacrine dihydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-hydrochloride
2020-10-14T07:19:56Z,R(+)XK469,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-ii-beta-inhibitor-racemic-xk469
2020-10-14T07:19:56Z,rabbit anti-thymocyte globulin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabbit-anti-thymocyte-globulin
2020-10-14T07:19:56Z,rabeprazole sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabeprazole
2020-10-14T07:19:56Z,racemetyrosine/methoxsalen/phenytoin/sirolimus SM-88,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemetyrosine-methoxsalen-phenytoin-sirolimus-sm-88
2020-10-14T07:19:56Z,racemic XK469,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-ii-inhibitor-racemic-xk469
2020-10-14T07:19:56Z,RAD51 inhibitor CYT-0851,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rad51-inhibitor-cyt-0851
2020-10-14T07:19:56Z,radium bromatum,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-bromatum
2020-10-14T07:19:56Z,radotinib hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib
2020-10-14T07:19:56Z,rAD-p53,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-encoding-p53
2020-10-14T07:19:56Z,Raf kinase inhibitor HM95573,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belvarafenib
2020-10-14T07:19:56Z,Raf/MEK dual kinase inhibitor RO5126766,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-mek-serine-threonine-kinase-inhibitor-ro5126766
2020-10-14T07:19:56Z,ravulizumab-cwvz,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravulizumab
2020-10-14T07:19:56Z,Razadyne ER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-galantamine-hydrobromide
2020-10-14T07:19:56Z,Re-186 hydroxyethylidene diphosphonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-186-hydroxyethylidene-diphosphonate
2020-10-14T07:19:56Z,recombinant adenovirus-interferon/Syn3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec-syn3
2020-10-14T07:19:56Z,recombinant bacterial minicells VAX014,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bacterial-minicells-vax014
2020-10-14T07:19:56Z,recombinant bovine basic fibroblast growth factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-bovine-basic-fibroblast-growth-factor
2020-10-14T07:19:56Z,recombinant Erwinia asparaginase JZP-458,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-erwinia-asparaginase-jzp-458
2020-10-14T07:19:56Z,recombinant HSA/filgrastim fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-hsa-filgrastim-fusion-protein
2020-10-14T07:19:56Z,recombinant hsp110-gp100 chaperone complex vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-hsp110-gp100-chaperone-complex-vaccine
2020-10-14T07:19:56Z,recombinant human bone morphogenetic protein 2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dibotermin-aalfa
2020-10-14T07:19:56Z,recombinant human epidermal growth factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nepidermin
2020-10-14T07:19:56Z,recombinant human granulocyte colony-stimulating factor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-granulocyte-colony-stimulating-factor
2020-10-14T07:19:56Z,recombinant human mannose-binding lectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannose-binding-lectin
2020-10-14T07:19:56Z,recombinant human papillomavirus 11-valent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-11-valent-vaccine
2020-10-14T07:19:56Z,recombinant human papillomavirus quadrivalent vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quadrivalent-human-papillomavirus-types-6-11-16-18-recombinant-vaccine
2020-10-14T07:19:56Z,recombinant interferon alpha-1b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-1b
2020-10-14T07:19:56Z,recombinant interleukin-12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa
2020-10-14T07:19:56Z,recombinant interleukin-18,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iboctadekin
2020-10-14T07:19:56Z,recombinant interleukin-4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin
2020-10-14T07:19:56Z,recombinant MIP1-alpha variant ECI301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nagrestipen
2020-10-14T07:19:56Z,recombinant platelet factor 4,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iroplact
2020-10-14T07:19:56Z,recombinant Saccharomyces cerevisia-CEA(610D) vaccine GI-6207,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-saccharomyces-cerevisia-cea610d-expressing-vaccine-gi-6207
2020-10-14T07:19:56Z,recombinant vaccinia prostate-specific antigen vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-psa-vaccine
2020-10-14T07:19:56Z,recombinant vaccinia-MUC1 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-vaccinia-muc-1-vaccine
2020-10-14T07:19:56Z,Recombivax HB,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hepatitis-b-vaccine
2020-10-14T07:19:56Z,relacorilant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relacorilant
2020-10-14T07:19:56Z,related donor adenovirus-specific cytotoxic T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/related-donor-adenovirus-specific-cytotoxic-t-cells
2020-10-14T07:19:56Z,relatlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relatlimab
2020-10-14T07:19:56Z,renal cell carcinoma/CD40L RNA-transfected autologous dendritic cell vaccine AGS-003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocapuldencel-t
2020-10-14T07:19:56Z,Reolysin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelareorep
2020-10-14T07:19:56Z,RepHresh Pro-B,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-lactobacillus-reuteri-probiotic-supplement
2020-10-14T07:19:56Z,R-EPOCH regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-r-regimen
2020-10-14T07:19:56Z,repotrectinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib
2020-10-14T07:19:56Z,resiquimod gel CD11301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resiquimod-gel-cd11301
2020-10-14T07:19:56Z,RET inhibitor DS-5010,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-inhibitor-ds-5010
2020-10-14T07:19:56Z,RET/SRC inhibitor TPX-0046,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ret-src-inhibitor-tpx-0046
2020-10-14T07:19:56Z,Retevmo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selpercatinib
2020-10-14T07:19:56Z,retifanlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/retifanlimab
2020-10-14T07:19:56Z,rexinoid NRX194204,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rexinoid-nrx-194204
2020-10-14T07:19:56Z,RFT5-dgA immunotoxin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rft5-dga-immunotoxin-imtox25
2020-10-14T07:19:56Z,R-Gene 10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-hydrochloride
2020-10-14T07:19:56Z,rhenium Re 188 BMEDA-liposome,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-bmeda-labeled-liposomes
2020-10-14T07:19:56Z,rhenium Re 188 etidronate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhenium-re-188-etidronate
2020-10-14T07:19:56Z,RhoC peptide vaccine RV001V,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rhoc-peptide-vaccine-rv001v
2020-10-14T07:19:56Z,ribosome-inactivating protein CY503,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aviscumine
2020-10-14T07:19:56Z,Ridaura,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1r-monoclonal-antibody-imc-cs4
2020-10-14T07:19:56Z,RIG-I selective ligand RGT100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rig-i-selective-ligand-rgt100
2020-10-14T07:19:56Z,rilimogene glafolivec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fowlpox-psa-tricom-vaccine
2020-10-14T07:19:56Z,RIPK1 inhibitor GSK3145095,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripk1-inhibitor-gsk3145095
2020-10-14T07:19:56Z,ripretinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripretinib
2020-10-14T07:19:56Z,rituximab conjugate CON-4619,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab-conjugate-con-4619
2020-10-14T07:19:56Z,RIVAC regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivac-regimen
2020-10-14T07:19:56Z,rivogenlecleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivogenlecleucel
2020-10-14T07:19:56Z,RNAdjuvant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ssrna-based-immunomodulator-cv8102
2020-10-14T07:19:56Z,ROBO1-targeted BiCAR-NKT cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/robo1-targeted-bicar-nkt-cells
2020-10-14T07:19:56Z,ROCK2 inhibitor KD025,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil
2020-10-14T07:19:56Z,Roferon-A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2a
2020-10-14T07:19:56Z,Rolontis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflapegrastim
2020-10-14T07:19:56Z,RORgamma agonist LYC-55716,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintirorgon
2020-10-14T07:19:56Z,rostaporfin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tin-ethyl-etiopurpurin
2020-10-14T07:19:56Z,RSK1-4 inhibitor PMD-026,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rsk1-4-inhibitor-pmd-026
2020-10-14T07:19:56Z,RSV fusion inhibitor GS-5806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/presatovir
2020-10-14T07:19:56Z,RSV fusion protein inhibitor JNJ-53718678,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilematovir
2020-10-14T07:19:56Z,ruthenium-based photosensitizer TLD1411,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-photosensitizer-tld1411
2020-10-14T07:19:56Z,ruthenium-based small molecule therapeutic BOLD-100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-based-small-molecule-therapeutic-bold-100
2020-10-14T07:19:56Z,S-3304,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mmp-inhibitor-s-3304
2020-10-14T07:19:56Z,sacubitril,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacubitril
2020-10-14T07:19:56Z,Salagen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilocarpine
2020-10-14T07:19:56Z,Salflex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate
2020-10-14T07:19:56Z,salsalate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate
2020-10-14T07:19:56Z,Salsitab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salsalate
2020-10-14T07:19:56Z,Salvia officinalis extract tablet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-officinalis-extract
2020-10-14T07:19:56Z,samarium Sm 153-DOTMP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-dotmp
2020-10-14T07:19:56Z,Sancuso,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron-transdermal-patch
2020-10-14T07:19:56Z,Sancuso,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron
2020-10-14T07:19:56Z,sasanlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sasanlimab
2020-10-14T07:19:56Z,savolitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/savolitinib
2020-10-14T07:19:56Z,SB-743921,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ksp-inhibitor-sb-743921
2020-10-14T07:19:56Z,seclidemstat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seclidemstat
2020-10-14T07:19:56Z,selected vegetables/Sun's soup,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suns-soup
2020-10-14T07:19:56Z,selective androgen receptor modulator RAD140,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosilasarm
2020-10-14T07:19:56Z,selective estrogen receptor covalent antagonist H3B-6545,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-covalent-antagonist-h3b-6545
2020-10-14T07:19:56Z,selective estrogen receptor degrader ARN-810,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilanestrant
2020-10-14T07:19:56Z,selective estrogen receptor degrader AZD9833,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9833
2020-10-14T07:19:56Z,selective estrogen receptor degrader LX-039,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lx-039
2020-10-14T07:19:56Z,selective estrogen receptor degrader LY3484356,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-ly3484356
2020-10-14T07:19:56Z,selective estrogen receptor degraderLSZ102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lsz102
2020-10-14T07:19:56Z,selective glucocorticoid receptor antagonist CORT125281,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exicorilant
2020-10-14T07:19:56Z,selective human estrogen-receptor alpha partial agonist TTC-352,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-human-estrogen-receptor-alpha-partial-agonist-ttc-352
2020-10-14T07:19:56Z,selicrelumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selicrelumab
2020-10-14T07:19:56Z,selpercatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selpercatinib
2020-10-14T07:19:56Z,selumetinib sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib-sulfate
2020-10-14T07:19:56Z,SERD G1T48,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-g1t48
2020-10-14T07:19:56Z,SERD GDC-9545,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giredestrant
2020-10-14T07:19:56Z,SERD SAR439859,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-sar439859
2020-10-14T07:19:56Z,SERD SHR9549,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serd-shr9549
2020-10-14T07:19:56Z,serine hydrolase monoacylglycerol lipase inhibitor ABX-1431,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-hydrolase-monoacylglycerol-lipase-inhibitor-abx-1431
2020-10-14T07:19:56Z,serine protease inhibitor WX-671,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/upamostat
2020-10-14T07:19:56Z,Seromycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cycloserine
2020-10-14T07:19:56Z,serplulimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serplulimab
2020-10-14T07:19:56Z,Shingrix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted
2020-10-14T07:19:56Z,SHP-1 agonist SC-43,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp-1-agonist-sc-43
2020-10-14T07:19:56Z,SHP2 inhibitor JAB-3068,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-jab-3068
2020-10-14T07:19:56Z,SHP2 inhibitor RMC-4630,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shp2-inhibitor-rmc-4630
2020-10-14T07:19:56Z,silmitasertib sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib-sodium
2020-10-14T07:19:56Z,simmitinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simmitinib
2020-10-14T07:19:56Z,Sinemet,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbidopa-levodopa
2020-10-14T07:19:56Z,sintilimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sintilimab
2020-10-14T07:19:56Z,siremadlin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siremadlin
2020-10-14T07:19:56Z,siRNA-expressing SV40 vector,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirna-expressing-sv40
2020-10-14T07:19:56Z,SIRPa-Fc fusion protein TTI-621,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ontorpacept
2020-10-14T07:19:56Z,SIRPa-Fc-CD40L fusion protein SL-172154,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-fc-cd40l-fusion-protein-sl-172154
2020-10-14T07:19:56Z,SIRPa-IgG4-Fc Fusion Protein TTI-622,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirpa-igg4-fc-fusion-protein-tti-622
2020-10-14T07:19:56Z,sisunatovir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sisunatovir
2020-10-14T07:19:56Z,sivifene gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sivifene
2020-10-14T07:19:56Z,SLC6A8 inhibitor RGX-202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slc6a8-inhibitor-rgx-202
2020-10-14T07:19:56Z,SLCT inhibitor GNS561,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/slct-inhibitor-gns561
2020-10-14T07:19:56Z,SMAC mimetic BI 891065,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-bi-891065
2020-10-14T07:19:56Z,Smac mimetic CUDC-427,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-gdc-0917
2020-10-14T07:19:56Z,SMO antagonist BMS 833923,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoothened-antagonist-bms-833923
2020-10-14T07:19:56Z,SOD1 inhibitor ATN-224,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bischolinetetrathiomolybdate
2020-10-14T07:19:56Z,sodium biphosphate/sodium phosphate oral laxative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phosphate-sodium-biphosphate-laxative
2020-10-14T07:19:56Z,sodium picosulfate/magnesium oxide/citric acid oral laxative,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-picosulfate-magnesium-oxide-citric-acid-laxative
2020-10-14T07:19:56Z,sodium-potassium adenosine triphosphatase inhibitor RX108,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-potassium-adenosine-triphosphatase-inhibitor-rx108
2020-10-14T07:19:56Z,soluble guanylate cyclase stimulator IW-1701,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinciguat
2020-10-14T07:19:56Z,somatotropin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/somatropin
2020-10-14T07:19:56Z,sotorasib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotorasib
2020-10-14T07:19:56Z,SpagoPix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-based-manganese-containing-contrast-agent-sn132d
2020-10-14T07:19:56Z,spanlecortemlocel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spanlecortemlocel
2020-10-14T07:19:56Z,spirulina-based dietary supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spirulina-based-dietary-supplement
2020-10-14T07:19:56Z,spleen tyrosine kinase inhibitor TAK-659,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivavotinib
2020-10-14T07:19:56Z,SR31747A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sr-bp1-hsi-inhibitor-sr31747a
2020-10-14T07:19:56Z,Src kinase inhibitor KX2-391,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirbanibulin
2020-10-14T07:19:56Z,ssRNA-based immunomodulator CV8102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ssrna-based-immunomodulator-cv8102
2020-10-14T07:19:56Z,STAT3 inhibitor C188-9,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-tti-101
2020-10-14T07:19:56Z,STAT3 inhibitor DSP-0337,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-dsp-0337
2020-10-14T07:19:56Z,STAT3 inhibitor TTI-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-tti-101
2020-10-14T07:19:56Z,steroid sulfatase inhibitor BN 83495,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irosustat
2020-10-14T07:19:56Z,STING agonist BMS-986301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-bms-986301
2020-10-14T07:19:56Z,STING agonist GSK3745417,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-gsk3745417
2020-10-14T07:19:56Z,STING agonist IMSA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-imsa101
2020-10-14T07:19:56Z,STING agonist SB 11285,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-sb-11285
2020-10-14T07:19:56Z,STING agonist TAK-676,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-tak-676
2020-10-14T07:19:56Z,STING-activating cyclic dinucleotide agonist ADU-S100,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-miw815
2020-10-14T07:19:56Z,STING-expressing E. coli SYNB1891,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-expressing-e-coli-synb1891
2020-10-14T07:19:56Z,strawberry-blackberry-black raspberry-blueberry berry mixture,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/strawberry-blackberry-black-raspberry-blueberry-mixture
2020-10-14T07:19:56Z,SU014813,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr2-pdgfr-c-kit-flt-3-inhibitor-su014813
2020-10-14T07:19:56Z,submicron particle paclitaxel sterile suspension,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/submicron-particle-paclitaxel-sterile-suspension
2020-10-14T07:19:56Z,succimer,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succimer
2020-10-14T07:19:56Z,succinylcholine chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/succinylcholine-chloride
2020-10-14T07:19:56Z,Sulforadex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-cyclodextrin-complex
2020-10-14T07:19:56Z,sulforaphane/alpha-cyclodextrin complex SFX-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-cyclodextrin-complex
2020-10-14T07:19:56Z,sulfur hexafluoride lipid microspheres,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfur-hexafluoride-lipid-microspheres
2020-10-14T07:19:56Z,sumoylation inhibitor TAK-981,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumoylation-inhibitor-tak-981
2020-10-14T07:19:56Z,Supect,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib
2020-10-14T07:19:56Z,super enhancer inhibitor GZ17-6.02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/super-enhancer-inhibitor-gz17-602
2020-10-14T07:19:56Z,superagonist interleukin-15:interleukin-15 receptor alphaSu/Fc fusion complex N-803,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa
2020-10-14T07:19:56Z,superoxide dismutasemimetic GC4711,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/superoxide-dismutase-mimetic-gc4711
2020-10-14T07:19:56Z,survivin-expressing CVD908ssb-TXSVN vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/survivin-expressing-cvd908ssb-txsvn-vaccine
2020-10-14T07:19:56Z,sustained-release mitomycin C hydrogel formulation UGN-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sustained-release-mitomycin-c-hydrogel-formulation-ugn-101
2020-10-14T07:19:56Z,Sustol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/granisetron
2020-10-14T07:19:56Z,sutimlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd8-slc45a2-specific-t-lymphocytes
2020-10-14T07:19:56Z,synthetic colorectal tumor-associated peptides vaccine IMA910,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colorectal-tumor-associated-peptides-vaccine-ima910
2020-10-14T07:19:56Z,synthetic human secretin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/secretin-human
2020-10-14T07:19:56Z,synthetic long HPV16 E6/E7 peptides vaccine ISA101b,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-long-hpv16-e6-e7-peptides-vaccine-isa101b
2020-10-14T07:19:56Z,synthetic peptide-based erythropoiesis stimulating agent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peginesatide
2020-10-14T07:19:56Z,synthetic plumbagin PCUR-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-plumbagin-pcur-101
2020-10-14T07:19:56Z,synthetic TERT DNA vaccine INO-1401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-htert-dna-vaccine-ino-1401
2020-10-14T07:19:56Z,synthetic vaccine particles-rapamycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-vaccine-particles-rapamycin
2020-10-14T07:19:56Z,Tab-cel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel
2020-10-14T07:19:56Z,tabelecleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tabelecleucel
2020-10-14T07:19:56Z,Tabrecta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib-hydrochloride
2020-10-14T07:19:56Z,tafasitamab-cxix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tafasitamab
2020-10-14T07:19:56Z,Tafinlar,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib-mesylate
2020-10-14T07:19:56Z,Tag7 gene-modified vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tag7-gene-modified-vaccine
2020-10-14T07:19:56Z,tagraxofusp-erzs,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tagraxofusp-erzs
2020-10-14T07:19:56Z,Takecab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vonoprazan-fumarate
2020-10-14T07:19:56Z,talactoferrin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talactoferrin-alfa
2020-10-14T07:19:56Z,talazoparib tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib-tosylate
2020-10-14T07:19:56Z,TALEN-edited HPV16/18 E6/E7 plasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talen-edited-hpv16-18-e6-e7-plasmid
2020-10-14T07:19:56Z,Tality,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamins-minerals-proteins-based-synthetic-meal-replacement
2020-10-14T07:19:56Z,Talzenna,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib-tosylate
2020-10-14T07:19:56Z,TAM/c-Met inhibitor RXDX-106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tam-c-met-inhibitor-rxdx-106
2020-10-14T07:19:56Z,tanibirumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinvacimab
2020-10-14T07:19:56Z,tapentadol hydrochloride ER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tapentadol-hydrochloride
2020-10-14T07:19:56Z,TAS-108,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-modulator-tas-108
2020-10-14T07:19:56Z,Tasigna,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib-hydrochloride-monohydrate
2020-10-14T07:19:56Z,taurultam analogue GP-2250,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurultam-analogue-gp-2250
2020-10-14T07:19:56Z,tavokinogene telseplasmid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tavokinogene-telseplasmid
2020-10-14T07:19:56Z,Tc 99m sestamibi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sestamibi
2020-10-14T07:19:56Z,TCR alpha/beta/CD19-depleted allogeneic hematopoietic progenitor cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tcr-alpha-beta-cd19-depleted-allogeneic-hematopoietic-progenitor-cells
2020-10-14T07:19:56Z,Tecartus,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brexucabtagene-autoleucel
2020-10-14T07:19:56Z,TechneScan MDP,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-medronate
2020-10-14T07:19:56Z,technetium Tc 99m methylene diphosphonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-medronate
2020-10-14T07:19:56Z,technetium Tc 99m-labeled macroaggregated albumin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-albumin-aggregated
2020-10-14T07:19:56Z,technetium Tc-99m anti-HER2 affibody,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-anti-her2-affibody
2020-10-14T07:19:56Z,tegavivint,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegavivint
2020-10-14T07:19:56Z,telaglenastat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaglenastat
2020-10-14T07:19:56Z,telisotuzumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telisotuzumab-vedotin
2020-10-14T07:19:56Z,teloxantrone hydrochoride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teloxantrone-hydrochloride
2020-10-14T07:19:56Z,Temferon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-adipose-derived-mesenchymal-stem-cells
2020-10-14T07:19:56Z,tenalisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenalisib
2020-10-14T07:19:56Z,terlipressin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/terlipressin
2020-10-14T07:19:56Z,Testate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate
2020-10-14T07:19:56Z,Testolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vosilasarm
2020-10-14T07:19:56Z,testosterone enanthate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/testosterone-enanthate
2020-10-14T07:19:56Z,tetanus toxoid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetanus-toxoid-vaccine
2020-10-14T07:19:56Z,TetMYB vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetmyb-dna-vaccine
2020-10-14T07:19:56Z,tetraphenyl chlorin disulfonate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fimaporfin-a
2020-10-14T07:19:56Z,TGF-beta receptor 1 inhibitor PF-06952229,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-car-mbil15-safety-switch-t-cells-prgn-3005
2020-10-14T07:19:56Z,TGF-beta receptor 1 kinase inhibitor SH3051,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-sh3051
2020-10-14T07:19:56Z,TGF-beta receptor 1 kinase inhibitor YL-13027,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgf-beta-receptor-1-kinase-inhibitor-yl-13027
2020-10-14T07:19:56Z,TGFbeta receptor ectodomain-IgG Fc fusion protein AVID200,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-receptor-ectodomain-igg-fc-fusion-protein-avid200
2020-10-14T07:19:56Z,T-Guard,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-cd7-ricin-toxin-a-immunotoxin
2020-10-14T07:19:56Z,therapeutic breast/ovarian/prostate cancer vaccine DPX-0907,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-breast-ovarian-prostate-peptide-cancer-vaccine-dpx-0907
2020-10-14T07:19:56Z,therapeutic cancer vaccine ATP128,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-cancer-vaccine-atp128
2020-10-14T07:19:56Z,therapeutic ex vivo-expanded allogeneic gamma delta T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-ex-vivo-expanded-allogeneic-gamma-delta-t-cells
2020-10-14T07:19:56Z,therapeutic ex-vivo-treated autologous central memory T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-ex-vivo-treated-autologous-central-memory-t-cells
2020-10-14T07:19:56Z,therapeutic human antithrombin-III,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antithrombin-iii
2020-10-14T07:19:56Z,therapeutic invariant natural killer T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-invariant-natural-killer-t-cells
2020-10-14T07:19:56Z,therapeutic liver cancer peptide vaccine IMA970A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-liver-cancer-peptide-vaccine-ima970a
2020-10-14T07:19:56Z,therapeutic lotion,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eucerin
2020-10-14T07:19:56Z,therapeutic triiodothyronine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liothyronine
2020-10-14T07:19:56Z,ThermoDox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposome-doxorubicin
2020-10-14T07:19:56Z,thorium Th 227 anetumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thorium-th-227-anetumab
2020-10-14T07:19:56Z,thymidylate synthase inhibitor CX1106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymidylate-synthase-inhibitor-cx1106
2020-10-14T07:19:56Z,Tibsovo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivosidenib
2020-10-14T07:19:56Z,tilarginine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilarginine
2020-10-14T07:19:56Z,tildrakizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tildrakizumab
2020-10-14T07:19:56Z,tinostamustine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinostamustine
2020-10-14T07:19:56Z,tislelizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tislelizumab
2020-10-14T07:19:56Z,tisotumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisotumab-vedotin
2020-10-14T07:19:56Z,titanium dioxide/zinc oxide sunscreen cream SPF 60,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/titanium-dioxide-zinc-oxide-sunscreen
2020-10-14T07:19:56Z,TLR agonist BDB001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bdb001
2020-10-14T07:19:56Z,TLR agonist BSG-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr-agonist-bsg-001
2020-10-14T07:19:56Z,TLR7 agonist BNT411,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-bnt411
2020-10-14T07:19:56Z,TLR7 agonist LHC165,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-lhc165
2020-10-14T07:19:56Z,TLR7/8 agonist MEDI9197,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telratolimod
2020-10-14T07:19:56Z,TLR8 agonist DN1508052,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr8-agonist-dn1508052
2020-10-14T07:19:56Z,TLR8 agonist VTX-2337,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motolimod
2020-10-14T07:19:56Z,TLR9 Agonist AST-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-ast-008
2020-10-14T07:19:56Z,TLR9 agonist MGN1703,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lefitolimod
2020-10-14T07:19:56Z,TM4SF1-CAR/EpCAM-CAR-expressing autologous T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tm4sf1-car-epcam-car-expressing-autologous-t-cells
2020-10-14T07:19:56Z,TMPRSS6 RNAi SLN124,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tmprss6-rnai-sln124
2020-10-14T07:19:56Z,TNP-470,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/o-chloroacetylcarbamoylfumagillol
2020-10-14T07:19:56Z,Tocosol Paclitaxel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-vitamin-e-based-emulsion
2020-10-14T07:19:56Z,toll-like receptor 7 agonist DSP-0509,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toll-like-receptor-7-agonist-dsp-0509
2020-10-14T07:19:56Z,Toll-like receptor 9 agonist IMO-2125,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilsotolimod-sodium
2020-10-14T07:19:56Z,tomivosertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomivosertib
2020-10-14T07:19:56Z,tomuzotuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomuzotuximab
2020-10-14T07:19:56Z,topical ammonia-oxidizing bacteria-based probiotic solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-ammonia-oxidizing-bacteria-based-probiotic-solution
2020-10-14T07:19:56Z,topical cantharidine solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-cantharidine-solution
2020-10-14T07:19:56Z,topical celecoxib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-celecoxib
2020-10-14T07:19:56Z,topical fibrinogen-depleted human standardized platelet lysate CAM-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-fibrinogen-depleted-human-standardized-platelet-lysate-cam-101
2020-10-14T07:19:56Z,topical menthol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-menthol-cream
2020-10-14T07:19:56Z,topical potassium dobesilate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-potassium-dobesilate
2020-10-14T07:19:56Z,topical VBP-926 solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-vbp-926-solution
2020-10-14T07:19:56Z,topotecan sustained-release episcleral plaque,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topotecan-sustained-release-episcleral-plaque
2020-10-14T07:19:56Z,TORC1/TORC2 inhibitor ATG-008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onatasertib
2020-10-14T07:19:56Z,toripalimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toripalimab
2020-10-14T07:19:56Z,TORKi,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onatasertib
2020-10-14T07:19:56Z,TPI 287,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taxane-analogue-tpi-287
2020-10-14T07:19:56Z,TraceIT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker
2020-10-14T07:19:56Z,TraceIT Hydrogel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker
2020-10-14T07:19:56Z,TraceIT Tissue Marker,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodinated-polyethylene-glycol-based-hydrogel-tissue-marker
2020-10-14T07:19:56Z,Tradjenta,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linagliptin
2020-10-14T07:19:56Z,TRAIL receptor agonist ABBV-621,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftozanermin-alfa
2020-10-14T07:19:56Z,transthyretin stabilizer AG10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acoramidis
2020-10-14T07:19:56Z,trastuzumab and hyaluronidase-oysk,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-hyaluronidase-oysk
2020-10-14T07:19:56Z,trastuzumab conjugate BI-CON-02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-conjugate-bi-con-02
2020-10-14T07:19:56Z,trastuzumab monomethyl auristatin F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-monomethyl-auristatin-f
2020-10-14T07:19:56Z,Trasylol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprotinin
2020-10-14T07:19:56Z,Traumasept,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
2020-10-14T07:19:56Z,Tremfya,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guselkumab
2020-10-14T07:19:56Z,triamcinolone acetonide transdermal system SUN-131,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide-transdermal-system-sun-131
2020-10-14T07:19:56Z,triazine derivative TriN2755,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triazene-derivative-trin2755
2020-10-14T07:19:56Z,tricaprin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tricaprin
2020-10-14T07:19:56Z,trichostatin A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trichostatin-a
2020-10-14T07:19:56Z,triclosan/copolymer/fluoride toothpaste,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triclosan-copolymer-fluoride-toothpaste
2020-10-14T07:19:56Z,trigriluzole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troriluzole
2020-10-14T07:19:56Z,trimetazidine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimetazidine
2020-10-14T07:19:56Z,triptolide analogue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triptolide-analog
2020-10-14T07:19:56Z,TRK inhibitor LOXO-195,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selitrectinib
2020-10-14T07:19:56Z,TRK inhibitor TQB3558,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trk-inhibitor-tqb3558
2020-10-14T07:19:56Z,TrkA inhibitor VMD-928,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trka-inhibitor-vmd-928
2020-10-14T07:19:56Z,troxacitabine nucleotide prodrug MIV-818,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/troxacitabine-nucleotide-prodrug-miv-818
2020-10-14T07:19:56Z,tryptophanase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tryptophan-23-dioxygenase
2020-10-14T07:19:56Z,TTI-237,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-binding-agent-tti-237
2020-10-14T07:19:56Z,tubulin inhibitor ALB 109564(a),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-inhibitor-alb-109564-dihydrochloride
2020-10-14T07:19:56Z,tubulin polymerization inhibitor VERU-111,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tubulin-polymerization-inhibitor-veru-111
2020-10-14T07:19:56Z,tucatinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucatinib
2020-10-14T07:19:56Z,Tukysa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucatinib
2020-10-14T07:19:56Z,tumor-homing peptide iRGD,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/internalized-arginylglycylaspartic-acid-cyclic-peptide
2020-10-14T07:19:56Z,Tymlos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abaloparatide
2020-10-14T07:19:56Z,tyrosinase-related protein-1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-tyrosinase-related-protein-1
2020-10-14T07:19:56Z,tyrosine kinase inhibitor TL-895,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-tl-895
2020-10-14T07:19:56Z,UAE inhibitor TAK-243,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-tak-243
2020-10-14T07:19:56Z,ubidecarenone nanodispersion BPM31510,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ubidecarenone-nanodispersion-bpm31510n
2020-10-14T07:19:56Z,ulipristal acetate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulipristal
2020-10-14T07:19:56Z,ulixertinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulixertinib
2020-10-14T07:19:56Z,Ultomiris,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravulizumab
2020-10-14T07:19:56Z,Ultradine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
2020-10-14T07:19:56Z,ULvWF multimer-targeting agent ARC1779,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egaptivon-pegol
2020-10-14T07:19:56Z,umbilical cord blood-derived CD4+/CD25+ T-regulatory cells CK0801,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbilical-cord-blood-derived-cd4-cd25-t-regulatory-cells-ck0801
2020-10-14T07:19:56Z,umbralisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbralisib
2020-10-14T07:19:56Z,uniformly-labeled [13C]fructose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cfructose
2020-10-14T07:19:56Z,uniformly-labeled [13C]glucose,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cglucose
2020-10-14T07:19:56Z,uniformly-labeled [13C]glutamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cglutamine
2020-10-14T07:19:56Z,uniformly-labeled [13C]lactate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13clactate
2020-10-14T07:19:56Z,uproleselan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uproleselan
2020-10-14T07:19:56Z,URLC10 peptide/Montanide ISA51 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urlc10-peptide-vaccine
2020-10-14T07:19:56Z,ursolic acid,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursolic-acid
2020-10-14T07:19:56Z,vaccinia virus (vvDD-CDSR),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccinia-virus-dd-cdsr
2020-10-14T07:19:56Z,vactosertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vactosertib
2020-10-14T07:19:56Z,valemetostat tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valemetostat-tosylate
2020-10-14T07:19:56Z,Valeriana officinalis extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valerian
2020-10-14T07:19:56Z,valproic acid-expanded umbilical cord blood-derived CD34-positive cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid-expanded-umbilical-cord-blood-derived-cd34-positive-cells
2020-10-14T07:19:56Z,vandetanib-eluting radiopaque bead BTG-002814,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib-eluting-radiopaque-bead-btg-002814
2020-10-14T07:19:56Z,Vanicream Sunscreen SPF 60,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/titanium-dioxide-zinc-oxide-sunscreen
2020-10-14T07:19:56Z,vardenafil hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vardenafil-hydrochloride-trihydrate
2020-10-14T07:19:56Z,Vascepa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icosapent-ethyl
2020-10-14T07:19:56Z,Vastarel MR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trimetazidine
2020-10-14T07:19:56Z,V-Boost,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gbm-antigens-and-alloantigens-immunotherapeutic-vaccine
2020-10-14T07:19:56Z,V-Boost Immunitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gbm-antigens-and-alloantigens-immunotherapeutic-vaccine
2020-10-14T07:19:56Z,VDAC/HK2 modulator ointment VDA-1102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vdac-hk2-modulator-ointment-vda-110
2020-10-14T07:19:56Z,vecabrutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecabrutinib
2020-10-14T07:19:56Z,VEGFR/PDGFR dual kinase inhibitor TAK-593,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-pdgfr-tyrosine-kinase-inhibitor-tak-593
2020-10-14T07:19:56Z,VEGFR2-169 peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elpamotide
2020-10-14T07:19:56Z,veledimex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veledimex
2020-10-14T07:19:56Z,velpatasvir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/velpatasvir
2020-10-14T07:19:56Z,venlafaxine hydrochloride extended release,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine-hydrochloride-extended-release
2020-10-14T07:19:56Z,vicriviroc,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vicriviroc
2020-10-14T07:19:56Z,Videne,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
2020-10-14T07:19:56Z,Vigil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bi-shrna-furin-gm-csf-expressing-autologous-tumor-cell-vaccine
2020-10-14T07:19:56Z,vilaprisan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vilaprisan
2020-10-14T07:19:56Z,vitamin A compound,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-a-compound
2020-10-14T07:19:56Z,vitamin D,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/d-vitamin
2020-10-14T07:19:56Z,vitamin E,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-e-compound
2020-10-14T07:19:56Z,vitamins/minerals/proteins-based synthetic meal replacement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamins-minerals-proteins-based-synthetic-meal-replacement
2020-10-14T07:19:56Z,vofatamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vofatamab
2020-10-14T07:19:56Z,vonoprazan fumarate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vonoprazan-fumarate
2020-10-14T07:19:56Z,vopratelimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vopratelimab
2020-10-14T07:19:56Z,vorasidenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorasidenib
2020-10-14T07:19:56Z,vorolanib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib
2020-10-14T07:19:56Z,vorsetuzumab-mafodotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorsetzumab-mafodotin
2020-10-14T07:19:56Z,voxelotor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxelotor
2020-10-14T07:19:56Z,voxilaprevir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxilaprevir
2020-10-14T07:19:56Z,VT30 topical gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vt30-topical-gel
2020-10-14T07:19:56Z,Vyxeos,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine
2020-10-14T07:19:56Z,Wee1 kinase inhibitor Debio 0123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wee1-kinase-inhibitor-debio-0123
2020-10-14T07:19:56Z,Wellbutrin SR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release
2020-10-14T07:19:56Z,Wellbutrin XL,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release
2020-10-14T07:19:56Z,whey protein isolate nutritional supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/whey-protein-isolate-based-nutritional-supplement
2020-10-14T07:19:56Z,WT-1 analogue peptide vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-analog-peptide-vaccine
2020-10-14T07:19:56Z,WT1/PRAME/survivin-specific cytotoxic T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-prame-survivin-specific-cytotoxic-t-lymphocytes
2020-10-14T07:19:56Z,WT1/PSMA/hTERT-encoding plasmid DNA INO-5401,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-psma-htert-encoding-plasmid-dna-ino-5401
2020-10-14T07:19:56Z,WT1-loaded artificial adjuvant vector cell immunotherapeutic ASP7517,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-loaded-artificial-adjuvant-vector-cell-immunotherapeutic-asp7517
2020-10-14T07:19:56Z,WT1-sensitized T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-sensitized-allogeneic-t-lymphocytes
2020-10-14T07:19:56Z,Xiaoai Jiedu decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xiaoai-jiedu-decoction
2020-10-14T07:19:56Z,Xilonix,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-mabp1
2020-10-14T07:19:56Z,xinmailong,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xinmailong
2020-10-14T07:19:56Z,XL820,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vgefr-c-kit-pdgfr-tyrosine-kinase-inhibitor-xl820
2020-10-14T07:19:56Z,XL844,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/checkpoint-kinase-inhibitor-xl844
2020-10-14T07:19:56Z,Xofluza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baloxavir-marboxil
2020-10-14T07:19:56Z,Xospata,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib-fumarate
2020-10-14T07:19:56Z,XPO1 inhibitor KPT-8602,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltanexor
2020-10-14T07:19:56Z,Xtampza ER,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/extended-release-microsphere-capsule-based-oxycodone
2020-10-14T07:19:56Z,Xyzal,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levocetirizine
2020-10-14T07:19:56Z,YM598,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/endothelin-receptor-type-a-antagonist-ym598
2020-10-14T07:19:56Z,young autologous tumor-infiltrating lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/young-autologous-tumor-infiltrating-lymphocytes
2020-10-14T07:19:56Z,yttrium Y 90 epratuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-epratuzumab-tetraxetan
2020-10-14T07:19:56Z,yttrium Y 90-labeled anti-FZD10 monoclonal antibody OTSA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-tabituximab-barzuxetan
2020-10-14T07:19:56Z,yttrium Y 90-labeled basiliximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-basiliximab
2020-10-14T07:19:56Z,Z-360,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gastrin-cholecystokinin-type-b-receptor-inhibitor-z-360
2020-10-14T07:19:56Z,Zalypsis,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-alkaloid-pm00104
2020-10-14T07:19:56Z,zanubrutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanubrutinib
2020-10-14T07:19:56Z,ZD6126,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vascular-disrupting-agent-zd6126
2020-10-14T07:19:56Z,Zentel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albendazole
2020-10-14T07:19:56Z,Zepatier,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elbasvir-grazoprevir
2020-10-14T07:19:56Z,Zerbaxa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceftolozane-tazobactam
2020-10-14T07:19:56Z,Zeven,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalbavancin
2020-10-14T07:19:56Z,zilucoplan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zilucoplan
2020-10-14T07:19:56Z,zimberelimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-gls-010
2020-10-14T07:19:56Z,Zinplava,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bezlotoxumab
2020-10-14T07:19:56Z,zirconium Zr 89 anti-CD8 antibody ZED88082A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-anti-cd8-antibody-zed88082a
2020-10-14T07:19:56Z,zirconium Zr 89-anti-EGFR monoclonal antibody ABT-806,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-anti-egfr-monoclonal-antibody-abt-806
2020-10-23T17:31:33Z,foritinib succinate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802918
2020-10-14T07:19:56Z,zirconium Zr 89-DFO-cRGDY PEG-Cy5-C' dots,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-crgdy-peg-cy5-c-dots
2020-10-14T07:19:56Z,zirconium Zr 89-DFO-daratumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-daratumumab
2020-10-14T07:19:56Z,zirconium Zr 89˗DFO˗REGN3504,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-regn3504
2020-10-14T07:19:56Z,zirconium Zr 89-DFO-SC16.56,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-sc1656
2020-10-14T07:19:56Z,zirconium Zr 89-DFO-vandortuzumab vedotin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-mstp2109a
2020-10-14T07:19:56Z,zirconium Zr 89-panitumumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-panitumumab
2020-10-14T07:19:56Z,zirconium Zr 89-pembrolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-pembrolizumab
2020-10-14T07:19:56Z,zirconium Zr 89-pertuzumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-pertuzumab
2020-10-14T07:19:56Z,zirconium Zr 89-TAK-164,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-tak-164
2020-10-14T07:19:56Z,zolbetuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolbetuximab
2020-10-14T07:19:56Z,"zoster vaccine recombinant, adjuvanted",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted
2020-10-14T07:19:56Z,zotatifin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zotatifin
2020-10-14T07:19:56Z,Zovirax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium
2020-10-14T07:19:56Z,Zyban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bupropion-hydrochloride-controlled-release
2020-10-14T07:19:56Z,ZYC300,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/microparticle-encapsulated-cyp1b1-encoding-dna-vaccine-zyc300
2020-10-20T17:44:47Z,allogeneic CD8+ memory T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803125
2020-10-20T17:44:47Z,berzosertib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berzosertib
2020-10-20T17:44:47Z,sabatolimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/777759
2020-10-20T17:44:47Z,Xatmep,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate
2020-10-21T22:58:28Z,anti-RANKL monoclonal antibody JMT103,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802778
2020-10-21T22:58:28Z,attenuated measles virus encoding SCD transgene TMV-018,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802771
2020-10-21T22:58:28Z,Coriolus versicolor-based vaginal gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802779
2020-10-21T22:58:28Z,methotrexate sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate
2020-10-21T22:58:28Z,WT1-H/K-HELP-survivin-H/K-HELP-MAGE-A4-H ⁄ K-HELP-MUC1-22 peptide-loaded autologous dendritic cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802780
2020-10-23T17:31:33Z,adenosine A2A receptor antagonist CS3005,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802908
2020-10-23T17:31:33Z,anti-5T4 antibody-drug conjugate SYD1875,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802782
2020-10-23T17:31:33Z,anti-BTN3A agonistic monoclonal antibody ICT01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802942
2020-10-23T17:31:33Z,anti-CCR7 antibody-drug conjugate JBH492,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802920
2020-10-23T17:31:33Z,anti-IL-27p28 monoclonal antibody SRF388,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802792
2020-10-23T17:31:33Z,anti-Lewis B/Lewis Y monoclonal antibody GNX102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803029
2020-10-23T17:31:33Z,anti-LILRB4 monoclonal antibody IO-202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802926
2020-10-23T17:31:33Z,anti-OX40 agonist monoclonal antibody BGB-A445,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802825
2020-10-23T17:31:33Z,autologous anti-CD19 CAR-4-1BB-CD3zeta-expressing T cells CNCT19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802902
2020-10-23T17:31:33Z,autologous anti-kappa light chain CAR-CD28-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802840
2020-10-23T17:31:33Z,autologous anti-PSMA CAR T cells P-PSMA-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803027
2020-10-23T17:31:33Z,autologous bispecific BCMA/CD19-targeted CAR T cells GC012F,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802916
2020-10-23T17:31:33Z,autologous CAR-CD28-expressing T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802837
2020-10-23T17:31:33Z,autologous CD19-targeted CAR T cells CC 97540,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802907
2020-10-23T17:31:33Z,autologous PD1-knockout CD19-specific CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802819
2020-10-23T17:31:33Z,autologous universal CAR-expressing T lymphocytes UniCAR02-T,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802895
2020-10-23T17:31:33Z,avasopasem manganese,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802841
2020-10-23T17:31:33Z,boron-based gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802919
2020-10-23T17:31:33Z,CD123-specific targeting molecule TM123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802894
2020-10-23T17:31:33Z,c-Met inhibitor GST-HG161,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802843
2020-10-23T17:31:33Z,deflazacort,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802842
2020-10-23T17:31:33Z,deupirfenidone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802943
2020-10-23T17:31:33Z,ditiocarb sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802912
2020-10-23T17:31:33Z,EGFR inhibitor TY-9591,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802783
2020-10-23T17:31:33Z,Emflaza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802842
2020-10-23T17:31:33Z,endothelin B receptor blocker ENB 003,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802784
2020-10-23T17:31:33Z,fenretinide phospholipid suspension ST-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802915
2020-10-23T17:31:33Z,FGFR/CSF-1R inhibitor 3D185,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802839
2020-10-23T17:31:33Z,fluorine F 18-AMBF3-TATE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802786
2020-10-23T17:31:33Z,Imuthiol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802912
2020-10-23T17:31:33Z,inhaled voriconazole,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802845
2020-10-23T17:31:33Z,lymphodepleted autologous CD4-directed CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802838
2020-10-23T17:31:33Z,oncolytic HSV-1-expressing IL-12 and anti-PD-1 antibody T3011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802928
2020-10-23T17:31:33Z,P2RX3 antagonist BAY 1817080,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803037
2020-10-23T17:31:33Z,Prosta-Q,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803041
2020-10-23T17:31:33Z,quercetin/saw palmetto/cranberry/bromelain/papain/zinc supplement,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803041
2020-10-23T17:31:33Z,SRPK1/ABCG2 inhibitor SCO-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803025
2020-10-23T17:31:33Z,TAEK-VAC-HerBy vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803024
2020-10-23T17:31:33Z,thermogenic regulator RZL-012,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802844
2020-10-23T17:31:33Z,Thrombi-Gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802785
2020-10-23T17:31:33Z,TNFalpha/IL-2-encoding oncolytic adenovirus TILT-123,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802826
2020-10-23T17:31:33Z,topical thrombin gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802785
2020-11-03T16:27:35Z,ALDH inhibitor NYH817G and mitochondria complex 1 inhibitor NYH100P,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803109
2020-11-03T16:27:35Z,anti-CD39 monoclonal antibody IPH5201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803103
2020-11-03T16:27:35Z,anti-CD47 monoclonal antibody ZL-1201,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803163
2020-11-03T16:27:35Z,anti-PD1/anti-CTLA4 antibody mixture QL1706,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd1-anti-ctla4-antibody-mixture-psb205
2020-11-03T16:27:35Z,anti-survivin T-cell receptor/anti-CD3 bispecific therapeutic ABBV-184,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803161
2020-11-03T16:27:35Z,BET inhibitor INCB057643,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780220
2020-11-03T16:27:35Z,CDK2 inhibitor PF-07104091,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803259
2020-11-03T16:27:35Z,Cosentyx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803239
2020-11-03T16:27:35Z,ESR1 peptides/GM-CSF/Montanide ISA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803159
2020-11-03T16:27:35Z,Huangqi Guizhi Wuwu decoction,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803106
2020-11-03T16:27:35Z,IAP inhibitor APG-1387,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794301
2020-11-03T16:27:35Z,IDH1/IDH2 dual inhibitor HMPL-306,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803162
2020-11-03T16:27:35Z,IL-15/IL-15 receptor alpha heterodimer NIZ985,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803105
2020-11-03T16:27:35Z,linperlisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linperlisib
2020-11-03T16:27:35Z,motolimod,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motolimod
2020-11-03T16:27:35Z,orelabrutinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-icp-022
2020-11-03T16:27:35Z,PAK4/NAMPT inhibitor ATG-019,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pak4-nampt-inhibitor-kpt-9274
2020-11-03T16:27:35Z,parsaclisib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parsaclisib
2020-11-03T16:27:35Z,secukinumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803239
2020-11-03T16:27:35Z,sodium thiosulfate formulation DB-020,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803108
2020-11-03T16:27:35Z,technetium Tc 99m anti-HER2 affibody HPArk2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803157
2020-11-03T16:27:35Z,tilsotolimod sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilsotolimod-sodium
2020-11-03T16:27:35Z,timolol maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803210
2020-11-26T04:10:25Z,abiraterone amorphous solid dispersion formulation DST-2970,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803232
2020-11-26T04:10:25Z,acetazolamide sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788850
2020-11-26T04:10:25Z,adenosine A2A receptor antagonist AZD4635,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794358
2020-11-26T04:10:25Z,adenovirus 5/F35-human guanylyl cyclase C-PADRE,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802251
2020-11-26T04:10:25Z,ALK/ROS1/Met inhibitor TQ-B3101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791846
2020-11-26T04:10:25Z,allogeneic anti-CD19 CAR-T cells ALLO-501A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802025
2020-11-26T04:10:25Z,allogeneic anti-CD30 CAR-Epstein-Barr virus-specific T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803211
2020-11-26T04:10:25Z,allogeneic CD22-specific universal CAR-expressing T lymphocytes UCART22,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800127
2020-11-26T04:10:25Z,allogeneic CD25/Treg-depleted donor lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801535
2020-11-26T04:10:25Z,allogeneic CD3- CD19- selected natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/789484
2020-11-26T04:10:25Z,allogeneic CD56-positive CD3-negative natural killer cells CYNK-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802398
2020-11-26T04:10:25Z,allogeneic CRISPR-Cas9 engineered anti-BCMA T cells CTX120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802026
2020-11-26T04:10:25Z,allogeneic CRISPR-Cas9-engineered anti-CD70 CAR-T cells CTX130,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802058
2020-11-26T04:10:25Z,allogeneic multi-virus-specific cytotoxic T lymphocytes ALVR105,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802027
2020-11-26T04:10:25Z,allogeneic PD-L1 tumor-targeted high-affinity natural killer cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802453
2020-11-26T04:10:25Z,alpha V beta 8 antagonist PF-06940434,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802007
2020-11-26T04:10:25Z,amivantamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-c-met-bispecific-antibody-jnj-61186372
2020-11-26T04:10:25Z,anti-AG7 antibody drug conjugate AbGn-107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/789018
2020-11-26T04:10:25Z,anti-CD117 monoclonal antibody JSP191,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802461
2020-11-26T04:10:25Z,anti-CD20/anti-CD22 CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803207
2020-11-26T04:10:25Z,anti-CD27 agonistic monoclonal antibody MK-5890,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802005
2020-11-26T04:10:25Z,anti-CD37 bispecific monoclonal antibody GEN3009,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802024
2020-11-26T04:10:25Z,anti-CD38 antibody-drug conjugate STI-6129,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802462
2020-11-26T04:10:25Z,anti-CD39 monoclonal antibody SRF617,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801999
2020-11-26T04:10:25Z,anti-CD47 monoclonal antibody IBI188,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797112
2020-11-26T04:10:25Z,anti-CD47 monoclonal antibody IMC-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802480
2020-11-26T04:10:25Z,anti-CTLA-4 monoclonal antibody IBI310,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803187
2020-11-26T04:10:25Z,anti-EGFR/CD16A bispecific antibody AFM24,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801966
2020-11-26T04:10:25Z,anti-EGFR/CD16A bispecific antibody AFM24,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801967
2020-11-26T04:10:25Z,anti-FRA/eribulin antibody-drug conjugate MORAb-202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802404
2020-11-26T04:10:25Z,anti-GPR20/DXd antibody-drug conjugate DS-6157a,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802044
2020-11-26T04:10:25Z,anti-HER2 antibody conjugated natural killer cells ACE1702,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802031
2020-11-26T04:10:25Z,anti-HER2-DM1 antibody-drug conjugate GQ1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802397
2020-11-26T04:10:25Z,anti-HLA-G antibody TTX-080,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803279
2020-11-26T04:10:25Z,anti-IL-27p28 monoclonal antibody SRF388,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803115
2020-11-26T04:10:25Z,anti-integrin beta-6/MMAE antibody-drug conjugate SGN-B6A,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802023
2020-11-26T04:10:25Z,anti-interleukin-2 receptor subunit gamma monoclonal antibody REGN7257,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802463
2020-11-26T04:10:25Z,anti-latent TGF-beta 1 monoclonal antibody SRK-181,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802238
2020-11-26T04:10:25Z,"anti-LILRB4 ,monoclonal antibody IO-202",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803121
2020-11-26T04:10:25Z,anti-OX40 hexavalent agonist antibody INBRX-106,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802449
2020-11-26T04:10:25Z,anti-OX40 monoclonal antibody MOXR0916,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792458
2020-11-26T04:10:25Z,anti-PD-1 antibody-interleukin-21 mutein fusion protein AMG 256,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802477
2020-11-26T04:10:25Z,anti-PD-1/CTLA-4 bispecific antibody MEDI5752,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802004
2020-11-26T04:10:25Z,anti-PD-L1/CD137 bispecific antibody MCLA-145,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798414
2020-11-26T04:10:25Z,anti-PD-L1/IL-15 fusion protein KD033,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802237
2020-11-26T04:10:25Z,anti-ribonucleoprotein antibody ATRC-101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802038
2020-11-26T04:10:25Z,anti-ROR1/PNU-159682 derivative antibody-drug conjugate NBE-002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802454
2020-11-26T04:10:25Z,anti-TIGIT monoclonal antibody SGN-TGT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802244
2020-11-26T04:10:25Z,anti-TIGIT monoclonal cntibody COM902,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802457
2020-11-26T04:10:25Z,Antivert,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793974
2020-11-26T04:10:25Z,aryl hydrocarbon receptor inhibitor IK-175,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801964
2020-11-26T04:10:25Z,astatine At 211 anti-CD45 monoclonal antibody BC8-B10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/789457
2020-11-26T04:10:25Z,atovaquone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797848
2020-11-26T04:10:25Z,ATR inhibitor RP-3500,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803074
2020-11-26T04:10:25Z,ATR kinase inhibitor VX-803,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802157
2020-11-26T04:10:25Z,autologous anti-B7-H3/CD19 CAR T cells SCRI-CARB7H3(s)x19,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801971
2020-11-26T04:10:25Z,autologous anti-BCMA CAR T cells PHE885,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802475
2020-11-26T04:10:25Z,autologous anti-CD123 CAR-T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801968
2020-11-26T04:10:25Z,autologous anti-CD19 CAR T cells 19(T2)28z1xx,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802242
2020-11-26T04:10:25Z,autologous anti-CD19 T-cell receptor fusion construct T cells TC-110,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802016
2020-11-26T04:10:25Z,autologous anti-CD19CAR-4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T lymphocytes SCRI-huCAR19v2,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803122
2020-11-26T04:10:25Z,autologous anti-GD2-CAR-BBz-iCasp9 retroviral vector-transduced T lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802400
2020-11-26T04:10:25Z,autologous anti-HPV-16 E6 T-cell receptor gene-engineered peripheral blood lymphocytes,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/789729
2020-11-26T04:10:25Z,autologous anti-mesothelin T-cell receptor fusion construct T cells TC-210,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798416
2020-11-26T04:10:25Z,autologous BCL11A-disrupted human hematopoietic stem and progenitor cells HIX763,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803277
2020-11-26T04:10:25Z,autologous CD19 CAR-expressing T cells YTB323,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803293
2020-11-26T04:10:25Z,autologous CD19-targeted CAR T cells CC-97540,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803124
2020-11-26T04:10:25Z,autologous CD34+-enriched HSPCs transduced with lentiviral vector carrying FANCA gene RP-L102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802240
2020-11-26T04:10:25Z,autologous CRISPR-Cas9-modified/BCL11A enhancer-disrupted CD34-positive human hematopoietic stem and progenitor cells CTX001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801170
2020-11-26T04:10:25Z,autologous CRISPR-Cas9-modified/BCL11A gene-disrupted human hematopoietic stem and progenitor cells OTQ923,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803276
2020-11-26T04:10:25Z,autologous NKG2D CAR-T cells CYAD-02,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802256
2020-11-26T04:10:25Z,autologous TCRm-expressing T cells ET140203,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803275
2020-11-26T04:10:25Z,autologous tumor infiltrating lymphocytes LN-145-S1,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802231
2020-11-26T04:10:25Z,autologous UCD19 CAR T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802034
2020-11-26T04:10:25Z,axatilimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axatilimab
2020-11-26T04:10:25Z,Axl/Mer inhibitor PF-07265807,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803296
2020-11-26T04:10:25Z,BCG Tokyo-172 strain solution,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788251
2020-11-26T04:10:25Z,Bcl-2 inhibitor BGB-11417,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803186
2020-11-26T04:10:25Z,BCMA/CD3e tri-specific T-cell activating construct HPN217,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802002
2020-11-26T04:10:25Z,betrixaban,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/789587
2020-11-26T04:10:25Z,Bevyxxa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/789587
2020-11-26T04:10:25Z,binetrakin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binetrakin
2020-11-26T04:10:25Z,bispecific antibody AGEN1223,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801965
2020-11-26T04:10:25Z,Bonine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793974
2020-11-26T04:10:25Z,borofalan (10B),https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803234
2020-11-26T04:10:25Z,BRAF inhibitor BGB-3245,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802245
2020-11-26T04:10:25Z,bumetanide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788832
2020-11-26T04:10:25Z,Bumex,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788832
2020-11-26T04:10:25Z,C/EBP beta antagonist ST101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802478
2020-11-26T04:10:25Z,CDK4/6 inhibitor BPI-1178,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803204
2020-11-26T04:10:25Z,CDK4/6 inhibitor TQB3303,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803183
2020-11-26T04:10:25Z,CDK7 inhibitor SY-5609,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802022
2020-11-26T04:10:25Z,CEA-MUC-1-TRICOM vaccine CV301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/787798
2020-11-26T04:10:25Z,cedazuridine/azacitidine combination agent ASTX030,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802003
2020-11-26T04:10:25Z,certolizumab pegol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791843
2020-11-26T04:10:25Z,cetuximab sarotalocan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-sarotalocan
2020-11-26T04:10:25Z,cevostamab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fcrh5-cd3-bite-antibody-bfcr4350a
2020-11-26T04:10:25Z,Cimzia,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791843
2020-11-26T04:10:25Z,cinrebafusp alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791831
2020-11-26T04:10:25Z,CK1alpha/CDK7/CDK9 inhibitor BTX-A51,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801169
2020-11-26T04:10:25Z,collagenase,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794876
2020-11-26T04:10:25Z,Contrave,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803274
2020-11-26T04:10:25Z,copper Cu 64 dotatate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802234
2020-11-26T04:10:25Z,copper Cu 64-DOTA-pembrolizumab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803282
2020-11-26T04:10:25Z,copper Cu 64-MeCOSar-Tyr3-octreotate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803120
2020-11-26T04:10:25Z,cotsiranib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803235
2020-11-26T04:10:25Z,Cresemba,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794083
2020-11-26T04:10:25Z,CRL4-CRBN modulator KPG-818,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803208
2020-11-26T04:10:25Z,CSF1R inhibitor ABSK021,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802252
2020-11-26T04:10:25Z,Curcuma xanthorrhiza oil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792747
2020-11-26T04:10:25Z,CUX1 wt allele,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802164
2020-11-26T04:10:25Z,deferiprone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761978
2020-11-26T04:10:25Z,delolimogene mupadenorepvec,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802087
2020-11-26T04:10:25Z,dendrimer-conjugated Bcl-2/Bcl-XL inhibitor AZD0466,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802253
2020-11-26T04:10:25Z,dersimelagon,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802028
2020-11-26T04:10:25Z,Diamox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788850
2020-11-26T04:10:25Z,diclofenac sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792632
2020-11-26T04:10:25Z,Ditropan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785751
2020-11-26T04:10:25Z,DKK1-neutralizing monoclonal antibody DKN-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk-1-monoclonal-antibody-ly2812176
2020-11-26T04:10:25Z,doconexent,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/776105
2020-11-26T04:10:25Z,donafenib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/764413
2020-11-26T04:10:25Z,DTRMWXHS-12/everolimus/pomalidomide combination agent DTRM-555,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802451
2020-11-26T04:10:25Z,EGFR/TGFb fusion monoclonal antibody BCA101,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802059
2020-11-26T04:10:25Z,encapsulated rapamycin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802399
2020-11-26T04:10:25Z,engineered red blood cells coexpressing 4-1BBL and IL-15TP RTX-240,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802047
2020-11-26T04:10:25Z,engineered toxin body targeting CD38 TAK-169,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802255
2020-11-26T04:10:25Z,enzyme-inducing antiepileptic drug,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803126
2020-11-26T04:10:25Z,EP2/EP4 antagonist TPST-1495,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803116
2020-11-26T04:10:25Z,EP4 antagonist INV-1120,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802232
2020-11-26T04:10:25Z,ERK1/2 inhibitor HH2710,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802029
2020-11-26T04:10:25Z,esketamine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803252
2020-11-26T04:10:25Z,extended-release metformin hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802233
2020-11-26T04:10:25Z,FAP/4-1BB-targeting fusion protein RO7122290,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803283
2020-11-26T04:10:25Z,fascin Inhibitor NP-G2-044,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793138
2020-11-26T04:10:25Z,feladilimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-agonist-antibody-gsk3359609
2020-11-26T04:10:25Z,Ferriprox,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761978
2020-11-26T04:10:25Z,FGFR2 inhibitor RLY-4008,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803114
2020-11-26T04:10:25Z,Flt3 ligand/anti-CTLA-4 antibody/IL-12 engineered oncolytic Vaccinia virus RIVAL-01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802460
2020-11-26T04:10:25Z,fluorine F 18-WL12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803255
2020-11-26T04:10:25Z,FPV vaccine CV301,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797362
2020-11-26T04:10:25Z,gadolinium-based contrast agent BAY1747846,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802236
2020-11-26T04:10:25Z,gallium Ga 68 gozetotide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-labeled-psma-11
2020-11-26T04:10:25Z,gallium Ga 68-WL12,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803254
2020-11-26T04:10:25Z,ganaxolone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803209
2020-11-26T04:10:25Z,Ganoderma lucidum spores powder capsule,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/764697
2020-11-26T04:10:25Z,Gelnique,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785751
2020-11-26T04:10:25Z,gliquidone,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775360
2020-11-26T04:10:25Z,Glucophage XR,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802233
2020-11-26T04:10:25Z,Glumetza,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802233
2020-11-26T04:10:25Z,glutaminase inhibitor CB-839 hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801359
2020-11-26T04:10:25Z,glutamine antagonist DRP-104,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802458
2020-11-26T04:10:25Z,gorilla-derived adenovirus-expressing HPV-16/18 E6/E7 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802037
2020-11-26T04:10:25Z,haploidentical natural killer cells K-NK002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803128
2020-11-26T04:10:25Z,HER2 inhibitor DZD1516,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802459
2020-11-26T04:10:25Z,HER2-directed TLR8 agonist SBT6050,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802452
2020-11-26T04:10:25Z,HPV 16 E6/E7-encoding arenavirus vaccine HB-202,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802056
2020-11-26T04:10:25Z,Hsp90 inhibitor MPT0B640,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803236
2020-11-26T04:10:25Z,hydroxychloroquine sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801639
2020-11-26T04:10:25Z,IDH1 mutant inhibitor LY3410738,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803295
2020-11-26T04:10:25Z,ilixadencel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797415
2020-11-26T04:10:25Z,imipramine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792682
2020-11-26T04:10:25Z,Imovax Rabies,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802008
2020-11-26T04:10:25Z,India ink,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802456
2020-11-26T04:10:25Z,interleukin-15 fusion protein BJ-001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802006
2020-11-26T04:10:25Z,intermediate-affinity interleukin-2 receptor agonist ALKS 4230,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782089
2020-11-26T04:10:25Z,internalized-arginylglycylaspartic acid cyclic peptide,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/internalized-arginylglycylaspartic-acid-cyclic-peptide
2020-11-26T04:10:25Z,Intuvax,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797415
2020-11-26T04:10:25Z,iopamidol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/790706
2020-11-26T04:10:25Z,isavuconazonium sulfate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794083
2020-11-26T04:10:25Z,Isovue,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/790706
2020-11-26T04:10:25Z,ivermectin,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798955
2020-11-26T04:10:25Z,ivuxolimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-agonist-monoclonal-antibody-pf-04518600
2020-11-26T04:10:25Z,JAK inhibitor,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802011
2020-11-26T04:10:25Z,kefir,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802420
2020-11-26T04:10:25Z,KRAS G12C inhibitor GDC-6036,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802450
2020-11-26T04:10:25Z,lapatinib/letrozole regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/350434
2020-11-26T04:10:25Z,"limonene, (+)-",https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803237
2020-11-26T04:10:25Z,LRP5 antagonist BI 905681,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802154
2020-11-26T04:10:25Z,LSD1 inhibitor TAS1440,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803206
2020-11-26T04:10:25Z,MAGE-A1-specific T-cell receptor-transduced autologous T cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802464
2020-11-26T04:10:25Z,meclizine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793974
2020-11-26T04:10:25Z,Mepron,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797848
2020-11-26T04:10:25Z,mesenchymal stem cells,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792547
2020-11-26T04:10:25Z,mirdametinib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-pd0325901
2020-11-26T04:10:25Z,MLL/MLLT1 fusion protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/791456
2020-11-26T04:10:25Z,mRNA-based personalized cancer vaccine NCI-4650,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795447
2020-11-26T04:10:25Z,Muscadine grape extract,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803286
2020-11-26T04:10:25Z,MVA-BN-brachyury-TRICOM vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795113
2020-11-26T04:10:25Z,naltrexone hydrochloride/bupropion hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803274
2020-11-26T04:10:25Z,non-enzyme-inducing antiepileptic drug,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803127
2020-11-26T04:10:25Z,numidargistat,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginase-inhibitor-incb001158
2020-11-26T04:10:25Z,Nyvepria,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim
2020-11-26T04:10:25Z,ointment OQL011,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801171
2020-11-26T04:10:25Z,olive oil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792624
2020-11-26T04:10:25Z,oncolytic measles virus encoding Helicobacter pylori neutrophil-activating protein,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802401
2020-11-26T04:10:25Z,oxybutynin chloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/785751
2020-11-26T04:10:25Z,panobinostat lactate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat
2020-11-26T04:10:25Z,Pan-TRK inhibitor ONO-7579,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793096
2020-11-26T04:10:25Z,patidegib topical gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802168
2020-11-26T04:10:25Z,PD-1-targeted IL-2 variant antibody fusion protein RO7284755,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803253
2020-11-26T04:10:25Z,PD-L1/4-1BB/HSA trispecific fusion protein NM21-1480,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802455
2020-11-26T04:10:25Z,pelabresib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-cpi-0610
2020-11-26T04:10:25Z,Pemfexy,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium
2020-11-26T04:10:25Z,PEOX-based polymer encapsulated paclitaxel FID-007,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796978
2020-11-26T04:10:25Z,personalized and adjusted neoantigen peptide vaccine PANDA-VAC,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802057
2020-11-26T04:10:25Z,personalized neoantigen DNA vaccine GNOS-PV01,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801973
2020-11-26T04:10:25Z,phosphaplatin PT-112,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795706
2020-11-26T04:10:25Z,PI3K-delta inhibitor BGB-10188,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803203
2020-11-26T04:10:25Z,pimonidazole hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/775865
2020-11-26T04:10:25Z,Plaquenil,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801639
2020-11-26T04:10:25Z,pNGVL4a-CRT-E6E7L2 DNA vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803294
2020-11-26T04:10:25Z,ponsegromab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803242
2020-11-26T04:10:25Z,preladenant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792649
2020-11-26T04:10:25Z,prostaglandin E2 EP4 receptor inhibitor E7046,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792739
2020-11-26T04:10:25Z,proteasome inhibitor TQB3602,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803184
2020-11-26T04:10:25Z,pyrotinib dimaleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801532
2020-11-26T04:10:25Z,pyruvate kinase M2 isoform activator TP-1454,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803280
2020-11-26T04:10:25Z,quinolonyl-oxazolidinone antibiotic DNV3837,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802214
2020-11-26T04:10:25Z,racemetyrosine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802001
2020-11-26T04:10:25Z,ranitidine hydrochloride,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792715
2020-11-26T04:10:25Z,rose geranium in sesame oil nasal spray,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803288
2020-11-26T04:10:25Z,SHP2 inhibitor RLY-1971,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802046
2020-11-26T04:10:25Z,silicone-based film-forming topical gel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802009
2020-11-26T04:10:25Z,simlukafusp alfa,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fap-interleukin-2-fusion-protein-ro6874281
2020-11-26T04:10:25Z,SIRPa-4-1BBL fusion protein DSP107,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802479
2020-11-26T04:10:25Z,Sklice,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798955
2020-11-26T04:10:25Z,sotigalimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonistic-monoclonal-antibody-apx005m
2020-11-26T04:10:25Z,StrataXRT,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802009
2020-11-26T04:10:25Z,Stromectol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/798955
2020-11-26T04:10:25Z,supra-pharmacologic dexamethasone sodium phosphate AVM0703,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802043
2020-11-26T04:10:25Z,sustained-release mitomycin C hydrogel formulation UGN-102,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797493
2020-11-26T04:10:25Z,tankyrase inhibitor STP1002,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802474
2020-11-26T04:10:25Z,thorium Th 227 anetumab corixetan,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thorium-th-227-anetumab
2020-11-26T04:10:25Z,thorium Th 227 anti-HER2 monoclonal antibody BAY2701439,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/800871
2020-11-26T04:10:25Z,thorium Th 227 anti-PSMA monoclonal antibody BAY 2315497,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803273
2020-11-26T04:10:25Z,TIGIT inhibitor M6223,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802403
2020-11-26T04:10:25Z,tiomolibdate choline,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bischolinetetrathiomolybdate
2020-11-26T04:10:25Z,TLR7 agonist JNJ-64794964,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803182
2020-11-26T04:10:25Z,Topoisomerase-1 Inhibitor LMP744,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/787756
2020-11-26T04:10:25Z,trastuzumab-TLR 7/8 agonist BDC-1001,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802017
2020-11-26T04:10:25Z,tumor necrosis factor ligand superfamily member 10,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792578
2020-11-26T04:10:25Z,Ty21a typhoid vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/795116
2020-11-26T04:10:25Z,Udenyca,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim
2020-11-26T04:10:25Z,varlitinib tosylate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793457
2020-11-26T04:10:25Z,Vesigel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797493
2020-11-26T04:10:25Z,vibostolimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigit-targeting-agent-mk-7684
2020-11-26T04:10:25Z,Viralym-M,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802027
2020-11-26T04:10:25Z,VMP regimen,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802163
2020-11-26T04:10:25Z,Voltaren,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792632
2020-11-26T04:10:25Z,voruciclib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797361
2020-11-26T04:10:25Z,VSV-hIFNbeta-NIS,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788964
2020-11-26T04:10:25Z,Wee1 inhibitor ZN-c3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802182
2020-11-26T04:10:25Z,welgenaleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803238
2020-11-26T04:10:25Z,Wistar rabies virus strain PM-1503-3M vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/802008
2020-11-26T04:10:25Z,xevinapant,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-debio-1143
2020-11-26T04:10:25Z,xisomab 3G3,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/801969
2020-11-26T04:10:25Z,Zantac,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/792715
2020-11-26T04:10:25Z,zelavespib,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-pu-h71
2020-11-26T04:10:25Z,zelenoleucel,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803278
2020-11-26T04:10:25Z,Ziextenzo,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegfilgrastim
2020-11-26T04:10:25Z,zirconium Zr 89-DFO-fianlimab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/803287
2020-11-26T04:10:25Z,zirconium Zr 89-DFO-REGN3504,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-dfo-regn3504
2020-11-26T04:10:25Z,zirconium Zr 89-girentuximab,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/764414
